Clustering O 0 6.1383462757191865e-09
of O 0 1.0263233947600814e-13
missense O 0 1.9838383380488267e-08
mutations O 0 1.0552310136802134e-09
in O 0 2.225289050250545e-11
the O 0 5.38054434340296e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 2.5326546619908186e-06
in O 0 1.6214685150117703e-10
a O 0 8.6840760277207e-12
sporadic B-Disease 0 1.2266150406503584e-05
T I-Disease 1 0.9999831914901733
- I-Disease 1 0.885840117931366
cell I-Disease 1 0.9763170480728149
leukaemia I-Disease 1 0.9999911785125732
. O 0 2.0088489205427607e-10

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0002889552852138877
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.6246401930242755e-13
is O 0 1.8813550435418935e-15
a O 0 4.1518336349206236e-14
recessive B-Disease 0 4.092528797627892e-06
multi I-Disease 0 0.23339882493019104
- I-Disease 1 1.0
system I-Disease 0 0.018674159422516823
disorder I-Disease 1 0.9360116124153137
caused O 0 1.0273815218703186e-12
by O 0 3.8246133724514995e-15
mutations O 0 2.8713300834204425e-11
in O 0 6.776447892403725e-13
the O 0 2.3867444513012235e-15
ATM O 0 1.3254654318561876e-10
gene O 0 1.4344052855219669e-11
at O 0 8.013412524689179e-13
11q22 O 0 5.07794750692625e-10
- O 0 9.447327364853209e-10
q23 O 0 2.4564310585617477e-09
( O 0 6.149633753615991e-12
ref O 0 6.422476417355938e-08
. O 0 2.697048584899414e-13
3 O 0 5.725584394621064e-13
) O 0 5.283315018117518e-13
. O 0 3.046740594189745e-12

The O 0 2.7681904078008523e-12
risk O 0 3.444020901799405e-10
of O 0 1.1663794455556327e-14
cancer B-Disease 0 2.97495139633952e-10
, O 0 2.7186578183992227e-13
especially O 0 2.215978268937935e-12
lymphoid B-Disease 0 7.789818567971452e-09
neoplasias I-Disease 0 1.5726075730526645e-07
, O 0 1.5700628460107308e-13
is O 0 2.831486935311856e-15
substantially O 0 6.6678945351283936e-12
elevated O 0 2.2527817285233898e-12
in O 0 4.703478717615894e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.016162734478712082
and O 0 1.3893076142648675e-12
has O 0 1.5738278735799582e-14
long O 0 5.850734393492152e-15
been O 0 1.2375898442444806e-14
associated O 0 3.6603012287805825e-13
with O 0 2.6653193541115172e-11
chromosomal O 1 1.0
instability O 1 1.0
. O 0 2.8652205608104e-10

By O 0 9.558365383910417e-13
analysing O 0 1.4476110976602286e-08
tumour B-Disease 1 1.0
DNA O 0 3.4237841450845963e-09
from O 0 1.7145967534226009e-13
patients O 0 2.19724818851727e-13
with O 0 1.8982881850695727e-16
sporadic B-Disease 0 2.6100051897515186e-08
T I-Disease 1 0.7795621752738953
- I-Disease 0 0.00014597443805541843
cell I-Disease 1 0.827011227607727
prolymphocytic I-Disease 0 0.3656168580055237
leukaemia I-Disease 1 0.9166818857192993
( O 0 4.480433038467346e-11
T B-Disease 0 5.27976737885183e-07
- I-Disease 0 9.291202474059901e-09
PLL I-Disease 0 2.0929583399720286e-08
) O 0 2.0418665673191394e-13
, O 0 1.0114601688214313e-14
a O 0 8.32871318705861e-15
rare O 0 1.2343260094582753e-12
clonal B-Disease 0 1.9926418848292826e-10
malignancy I-Disease 0 1.195452958846488e-09
with O 0 1.3333479141952923e-15
similarities O 0 4.571804631918475e-13
to O 0 2.4729472061015305e-15
a O 0 1.5548411082949576e-12
mature B-Disease 0 5.995936902536414e-08
T I-Disease 0 3.248375651310198e-05
- I-Disease 0 9.834152479015756e-07
cell I-Disease 0 3.322800694149919e-05
leukaemia I-Disease 1 0.9157004356384277
seen O 0 2.6556942755995294e-10
in O 0 1.6816275802411518e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 2.0373267417723995e-13
we O 0 1.1540220395364923e-15
demonstrate O 0 1.7864164144400793e-15
a O 0 5.221986495426495e-15
high O 0 1.3626041484374185e-13
frequency O 0 1.0397854452448563e-12
of O 0 1.8180967595684584e-14
ATM O 0 3.827166139558358e-08
mutations O 0 1.455150444584774e-10
in O 0 5.919580381430478e-10
T B-Disease 0 0.0002284774964209646
- I-Disease 0 4.4655610054178396e-07
PLL I-Disease 0 3.7631994018738624e-06
. O 0 2.0663956656896687e-10

In O 0 6.962867782345228e-12
marked O 0 3.533436835224252e-13
contrast O 0 5.099428908653114e-13
to O 0 6.4764693953644255e-15
the O 0 1.6631369946593783e-14
ATM O 0 8.488996172673069e-08
mutation O 0 1.097244690939636e-11
pattern O 0 2.727262582435941e-10
in O 0 6.421212006557653e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 1.0353051966074944e-12
the O 0 3.6964766634105923e-16
most O 0 2.0159206797129017e-16
frequent O 0 3.055138997012539e-15
nucleotide O 0 2.2582787419581085e-13
changes O 0 2.9084834584150454e-13
in O 0 7.860442982274285e-13
this O 0 5.141404337861977e-13
leukaemia B-Disease 0 1.5111248785615317e-06
were O 0 1.3417592557851687e-11
missense O 0 2.6102148353857046e-07
mutations O 0 2.4414896770963423e-08
. O 0 1.2091933010438538e-10

These O 0 1.8907604973882053e-13
clustered O 0 1.0054757373922918e-11
in O 0 1.512531317912364e-14
the O 0 9.88541447796156e-17
region O 0 8.9358486159586e-15
corresponding O 0 1.6319400935856446e-14
to O 0 3.043135269600525e-15
the O 0 6.311930704261436e-15
kinase O 0 1.7370280561146423e-11
domain O 0 1.6221382960826536e-12
, O 0 5.4428043425340175e-14
which O 0 4.566997516654899e-15
is O 0 3.288617593813438e-16
highly O 0 2.7210831786590728e-15
conserved O 0 2.266765876564325e-14
in O 0 2.0572883945458448e-13
ATM O 0 1.565649054846574e-09
- O 0 7.066179238957027e-12
related O 0 4.11200560363964e-13
proteins O 0 1.159871081558156e-13
in O 0 1.895528005391167e-12
mouse O 0 2.726504799710483e-09
, O 0 6.176387960105112e-12
yeast O 0 3.059154263240771e-09
and O 0 1.3146326475338421e-12
Drosophila O 0 1.7514475980640043e-10
. O 0 2.151005719028265e-12

The O 0 1.1746674596566087e-13
resulting O 0 2.394142284596612e-13
amino O 0 5.0095753933998566e-11
- O 0 3.046302099463105e-10
acid O 0 7.588075675614425e-13
substitutions O 0 1.2394141160436412e-13
are O 0 1.2889869988025717e-15
predicted O 0 2.2706616860206086e-13
to O 0 3.244927369696265e-16
interfere O 0 4.84525614075082e-13
with O 0 1.4615006321589026e-14
ATP O 0 2.2066876104176458e-11
binding O 0 2.480594722686913e-12
or O 0 3.8917155088802335e-12
substrate O 0 3.1104166464679395e-10
recognition O 0 7.05062050410099e-11
. O 0 5.0040648708060687e-11

Two O 0 7.1573597743013195e-12
of O 0 2.788301384012569e-15
seventeen O 0 1.966021789812089e-11
mutated O 0 6.0187472783468365e-09
T B-Disease 0 8.085706326710351e-07
- I-Disease 0 3.5423715072369077e-09
PLL I-Disease 0 2.47149447574202e-08
samples O 0 2.819727437652908e-11
had O 0 1.6285367152035768e-12
a O 0 6.741479323022458e-15
previously O 0 7.598706277915646e-13
reported O 0 5.21677111464669e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 2.3935012904985342e-06
. O 0 2.0743577966442217e-09

In O 0 7.195741398569044e-12
contrast O 0 5.856928657343996e-12
, O 0 1.8553572306984067e-13
no O 0 1.0402709780827496e-13
mutations O 0 3.57969730246932e-11
were O 0 7.234259198629633e-12
detected O 0 4.588486535173075e-11
in O 0 2.6207784857221195e-13
the O 0 9.52261120841123e-16
p53 O 0 1.9803212888969135e-13
gene O 0 1.933732471023908e-12
, O 0 3.974268847638284e-15
suggesting O 0 7.088418258393778e-14
that O 0 3.0603645550223877e-15
this O 0 2.7218955171368076e-13
tumour B-Disease 1 1.0
suppressor O 0 1.0922662774248693e-08
is O 0 3.0525210722824603e-13
not O 0 8.401115869324013e-15
frequently O 0 2.685324564707242e-13
altered O 0 8.336518281248928e-11
in O 0 2.6607643865972364e-10
this O 0 3.1369757486077177e-11
leukaemia B-Disease 0 6.379439582815394e-05
. O 0 3.120760941333067e-11

Occasional O 0 1.080981064660591e-06
missense O 0 1.1064216778322589e-05
mutations O 0 1.740665567240285e-08
in O 0 1.1798241203453408e-11
ATM O 0 9.103672815591324e-10
were O 0 7.683249110719548e-13
also O 0 7.799368417001507e-15
found O 0 1.7509538469736435e-13
in O 0 9.145571452928714e-12
tumour B-Disease 1 1.0
DNA O 0 2.2995847448470386e-09
from O 0 8.397179029591764e-14
patients O 0 4.97575240829707e-14
with O 0 2.528212823657203e-16
B B-Disease 0 1.5058862601335932e-08
- I-Disease 0 3.2559994700420702e-09
cell I-Disease 0 0.035110171884298325
non I-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 0.004348748829215765
( O 0 4.1834778696792085e-11
B B-Disease 0 2.1561938012837345e-08
- I-Disease 0 2.3607500398981074e-09
NHL I-Disease 0 8.039292842543233e-11
) O 0 6.322437300939178e-15
and O 0 5.586218286042369e-15
a O 0 3.3011286304333864e-13
B B-Disease 0 1.2255385151149767e-08
- I-Disease 0 3.1174740566797254e-09
NHL I-Disease 0 8.31045454674495e-10
cell O 0 4.718468726849778e-09
line O 0 9.53629619715457e-09
. O 0 3.125210853993643e-11

The O 0 1.2804651273751883e-14
evidence O 0 3.3228960219251064e-14
of O 0 1.3949704544631042e-17
a O 0 1.820177665409978e-15
significant O 0 7.908120671165381e-15
proportion O 0 4.4586727430788453e-13
of O 0 3.9717984760476166e-15
loss O 0 8.224285835689571e-12
- O 0 1.1844914805936302e-11
of O 0 4.5008972677368364e-14
- O 0 6.224512572039487e-11
function O 0 5.454027867898316e-14
mutations O 0 8.25056765529214e-13
and O 0 5.29966221189844e-14
a O 0 8.556007193970955e-14
complete O 0 3.841410425430708e-13
absence O 0 4.1302261632493453e-13
of O 0 1.4067920234693445e-16
the O 0 1.3165124990939026e-15
normal O 0 2.1888323402038945e-13
copy O 0 1.3977934087971988e-10
of O 0 1.2580713550189738e-15
ATM O 0 1.4947472426474206e-10
in O 0 9.427958495280761e-14
the O 0 1.6971553413045923e-15
majority O 0 3.1260645385212255e-14
of O 0 4.718807674252909e-14
mutated O 0 0.029028775170445442
tumours B-Disease 1 1.0
establishes O 0 4.474596249082197e-09
somatic O 0 1.4807923776061216e-09
inactivation O 0 1.08608111393238e-09
of O 0 1.103016997705509e-15
this O 0 3.2963041531119746e-16
gene O 0 4.684305460883609e-12
in O 0 1.4949787284848637e-13
the O 0 3.885612450148018e-15
pathogenesis O 0 5.890842067618474e-12
of O 0 1.5973066739657818e-15
sporadic B-Disease 0 1.2162981732899425e-08
T I-Disease 0 0.00042731419671326876
- I-Disease 0 2.1938360532658407e-06
PLL I-Disease 0 2.263224416765297e-07
and O 0 3.534710772776922e-13
suggests O 0 1.0342388160082192e-13
that O 0 5.047630268948354e-16
ATM O 0 1.2421186301736498e-10
acts O 0 4.747862259596447e-13
as O 0 1.688849364175904e-12
a O 0 1.1074403893918117e-10
tumour B-Disease 1 1.0
suppressor O 0 1.8102253989127348e-06
. O 0 3.0075630874648596e-10

As O 0 1.1645823194683658e-12
constitutional O 0 3.029400122141028e-14
DNA O 0 1.2242142195806327e-11
was O 0 4.010626737400297e-13
not O 0 3.653495299991153e-16
available O 0 9.580551650135213e-15
, O 0 5.076440506462433e-16
a O 0 8.119939724944569e-14
putative O 0 1.7909388416725847e-09
hereditary O 0 2.97868297138848e-07
predisposition O 0 1.9006254348141738e-08
to O 0 2.106246600741546e-11
T B-Disease 0 3.789770562434569e-05
- I-Disease 0 8.967636944134938e-08
PLL I-Disease 0 1.0806063954760248e-07
will O 0 4.088193000274798e-13
require O 0 1.0538209980212945e-13
further O 0 1.0280083126987596e-13
investigation O 0 1.4770666243932307e-12
. O 0 4.71947378096263e-14
. O 0 9.708129482602357e-13

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 4.147448635194451e-06
kinase O 0 4.1924945293203564e-08
is O 0 1.225572649008605e-13
involved O 0 1.6409345882217722e-15
in O 0 4.517974214283136e-16
the O 0 4.933898096329335e-17
modulation O 0 1.7428272095897784e-13
of O 0 2.1061408059029174e-16
the O 0 1.2441985647055481e-13
Ca2 O 0 6.207742320185616e-09
+ O 0 2.6952435838722977e-09
homeostasis O 0 1.306562968927949e-09
in O 0 3.7593244489597666e-12
skeletal O 0 3.6568703620787346e-08
muscle O 0 7.043794991723473e-10
cells O 0 5.312191242445863e-10
. O 0 3.517604263425511e-11

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999994039535522
DM B-Disease 1 1.0
) O 0 1.6678100567268928e-10
, O 0 8.006865231057446e-15
the O 0 9.466071626833107e-17
most O 0 1.3819530999284674e-15
prevalent O 0 5.194539243191798e-11
muscular B-Disease 0 1.933482423055466e-07
disorder I-Disease 0 6.348321676341584e-06
in O 0 4.80172412248292e-12
adults O 0 1.9741630552516654e-09
, O 0 1.5148177986501823e-14
is O 0 1.009929029714327e-15
caused O 0 1.3991714798011344e-15
by O 0 1.4071469302742441e-15
( O 0 8.32903949803121e-13
CTG O 0 2.127879872304561e-09
) O 0 1.5570127110363374e-13
n O 0 3.754640001685239e-11
- O 0 3.9764475046055736e-10
repeat O 0 1.0411334988580379e-11
expansion O 0 5.761571233130203e-13
in O 0 1.0204631126112078e-14
a O 0 2.988422446922054e-15
gene O 0 2.158967449261695e-12
encoding O 0 4.752519450028359e-13
a O 0 5.538500769662093e-14
protein O 0 2.74585465476207e-10
kinase O 0 1.442465844547769e-07
( O 0 5.68102853648611e-09
DM B-Disease 1 1.0
protein O 0 1.0168329289683697e-08
kinase O 0 1.6925774559695128e-08
; O 0 7.054396129746454e-12
DMPK O 0 2.9138420565288925e-09
) O 0 5.005651316082431e-14
and O 0 1.2387084994820957e-15
involves O 0 2.701112682861658e-15
changes O 0 8.012460730707008e-14
in O 0 3.300708664721874e-12
cytoarchitecture O 0 2.652736270647438e-07
and O 0 1.771226915137092e-11
ion O 0 3.384533486805452e-10
homeostasis O 0 1.5003816855596597e-08
. O 0 2.4367499337762943e-11

To O 0 9.35425036583705e-14
obtain O 0 8.952490983780981e-13
clues O 0 2.698342764506645e-11
to O 0 1.4747447122672288e-15
the O 0 2.933896871464486e-16
normal O 0 1.4788410906550926e-14
biological O 0 8.320048209414788e-14
role O 0 1.1138786833002345e-13
of O 0 2.7024319366770067e-15
DMPK O 0 8.210376822859189e-10
in O 0 5.950554719108547e-13
cellular O 0 1.5645974793532247e-10
ion O 0 3.432429687699745e-12
homeostasis O 0 1.630924909012954e-11
, O 0 1.6276625772020104e-14
we O 0 8.556031207355009e-16
have O 0 1.2241223539023602e-16
compared O 0 1.610178398390495e-15
the O 0 1.2683006807553883e-16
resting O 0 5.500265363609855e-14
[ O 0 2.758785496055627e-13
Ca2 O 0 1.0194257764328807e-11
+ O 0 5.504652844656732e-10
] O 0 7.714141547765507e-10
i O 0 8.211190616336239e-10
, O 0 1.8332363723577976e-15
the O 0 1.6358526287662628e-16
amplitude O 0 3.084155592928393e-15
and O 0 2.003043396634472e-15
shape O 0 5.333259875395235e-13
of O 0 1.4837960004624698e-15
depolarization O 0 1.7570467650274146e-12
- O 0 3.05250824617076e-10
induced O 0 2.340971638759015e-09
Ca2 O 0 4.657078722658525e-09
+ O 0 1.069638821959984e-09
transients O 0 2.4530937281497245e-08
, O 0 1.57263965576155e-14
and O 0 1.0733217034057779e-16
the O 0 1.923002356539187e-17
content O 0 4.43476720325903e-15
of O 0 2.8168231538685487e-16
ATP O 0 9.536699555057204e-12
- O 0 2.3650506466438292e-12
driven O 0 1.6905131808298002e-11
ion O 0 7.174020058564601e-12
pumps O 0 9.352427166042787e-11
in O 0 4.090121470678998e-12
cultured O 0 6.904518841110985e-07
skeletal O 0 1.375774445477873e-06
muscle O 0 2.860186254505237e-10
cells O 0 7.216908494422913e-12
of O 0 1.6485388265057477e-15
wild O 0 2.056359856700274e-12
- O 0 1.5058683189295152e-09
type O 0 1.169672914080877e-09
and O 0 1.2656739805522177e-12
DMPK O 0 3.714639928986685e-09
[ O 0 3.22325326151951e-11
- O 0 1.918570902148531e-08
/ O 0 1.429992380508338e-06
- O 0 1.719855390547309e-06
] O 0 2.599089610200167e-09
knockout O 0 4.6752995785936946e-07
mice O 0 2.5375479708600324e-06
. O 0 1.1550952555561267e-10

In O 0 1.3132499428192279e-11
vitro O 0 9.302444148318045e-09
- O 0 9.470732642569146e-09
differentiated O 0 5.034955563587573e-09
DMPK O 0 6.09391435091311e-08
[ O 0 1.9902832160134665e-10
- O 0 1.1263604271505301e-08
/ O 0 5.1515087307052454e-08
- O 0 5.805863789731802e-09
] O 0 1.3123735605191644e-11
myotubes O 0 2.6763738794621794e-11
exhibit O 0 2.1641485803934601e-13
a O 0 1.6224066361203437e-13
higher O 0 2.638474942001645e-12
resting O 0 1.5484397618281687e-12
[ O 0 3.7248511566834175e-12
Ca2 O 0 3.3871941362839664e-10
+ O 0 8.261008765941824e-09
] O 0 3.0230240533057895e-09
i O 0 1.764161039474743e-10
than O 0 1.4736489480950132e-14
do O 0 3.3178039986593924e-14
wild O 0 5.259937450874386e-13
- O 0 1.222905665620999e-10
type O 0 8.641567322831278e-11
myotubes O 0 3.632043832357823e-10
because O 0 2.0242489935239256e-14
of O 0 4.1644219341802516e-17
an O 0 1.3054696776209891e-16
altered O 0 8.916725864616115e-12
open O 0 7.755205332082848e-12
probability O 0 1.0158688397866183e-13
of O 0 7.026065876157431e-15
voltage O 0 2.5680081325307746e-11
- O 0 1.2538727001132344e-10
dependent O 0 9.09759656497755e-10
l O 0 2.789458664054223e-09
- O 0 4.40008862678809e-11
type O 0 2.900067685995822e-10
Ca2 O 0 4.335924397302904e-10
+ O 0 1.79071590888924e-10
and O 0 3.0135663929564682e-12
Na O 0 5.57690671421085e-10
+ O 0 1.1990008985662826e-10
channels O 0 3.694946126842069e-09
. O 0 1.498035306912726e-10

The O 0 4.992048441287977e-13
mutant O 0 1.966097840089276e-10
myotubes O 0 3.6463215780102587e-10
exhibit O 0 8.360841316154555e-13
smaller O 0 3.2669927960832235e-12
and O 0 4.142330575773734e-12
slower O 0 2.7952213876858423e-09
Ca2 O 0 8.021315278661234e-10
+ O 0 1.7482268410695667e-10
responses O 0 2.9919972749370416e-12
upon O 0 2.664373687565687e-15
triggering O 0 7.203685212361574e-14
by O 0 2.1371062658117257e-15
acetylcholine O 0 8.536248097268384e-11
or O 0 3.5041577278738245e-11
high O 0 2.269963661483132e-10
external O 0 5.1889195162857504e-09
K O 0 5.339438668983121e-09
+ O 0 7.278292413204213e-10
. O 0 1.3972835041786702e-11

In O 0 8.62272753199278e-12
addition O 0 6.797208331127749e-14
, O 0 1.2074369959815326e-14
we O 0 3.1732916757646007e-16
observed O 0 1.1214211972345524e-16
that O 0 1.6181818340380885e-17
these O 0 3.1603413360944705e-16
Ca2 O 0 1.2956201216052232e-11
+ O 0 2.7332551152947637e-11
transients O 0 1.742769956125656e-10
partially O 0 1.6318047173918826e-12
result O 0 1.39011735404552e-14
from O 0 2.252701063881757e-15
an O 0 5.877751541666232e-17
influx O 0 5.993803679294266e-14
of O 0 6.04989365049003e-16
extracellular O 0 1.0748214384487254e-12
Ca2 O 0 1.2555425449312096e-11
+ O 0 1.092478646609607e-12
through O 0 2.555216763411262e-15
the O 0 6.477161421282332e-15
l O 0 1.2962758644263772e-10
- O 0 6.695792358069053e-12
type O 0 9.979332638021532e-11
Ca2 O 0 3.6973202277579276e-10
+ O 0 3.037518014892271e-10
channel O 0 1.0482105849973777e-08
. O 0 1.888456752086043e-10

Neither O 0 4.129560582377678e-11
the O 0 1.2055408280258091e-14
content O 0 6.511550874237562e-14
nor O 0 3.998268729987764e-13
the O 0 5.63838916284613e-16
activity O 0 1.4238141373378033e-13
of O 0 4.529329220336672e-16
Na O 0 3.630249989505785e-10
+ O 0 6.526746365587144e-10
/ O 0 1.2897607426509694e-09
K O 0 4.1379680237874084e-10
+ O 0 4.1620071278281046e-10
ATPase O 0 1.2472287203024734e-08
and O 0 1.557970939758402e-11
sarcoplasmic O 0 6.360498616686527e-08
reticulum O 0 6.966414645148689e-08
Ca2 O 0 3.564849038184548e-08
+ O 0 1.3502848617008567e-08
- O 0 3.014661853484313e-10
ATPase O 0 4.1764719460601896e-10
are O 0 4.253373234132038e-14
affected O 0 4.680996123487477e-14
by O 0 9.529921949778981e-15
DMPK O 0 3.138641773148265e-07
absence O 0 9.245266358037796e-11
. O 0 3.120063018710595e-12

In O 0 1.047344225235669e-10
conclusion O 0 2.1689019937681797e-12
, O 0 1.1525664557682832e-14
our O 0 4.556675679038777e-16
data O 0 1.4114888423376933e-14
suggest O 0 2.950070489136274e-15
that O 0 5.793232608955728e-16
DMPK O 0 1.4951044846611694e-09
is O 0 1.6771461996289592e-15
involved O 0 8.431970738493645e-15
in O 0 3.182386469689595e-14
modulating O 0 1.2044641542821588e-12
the O 0 2.0240741659236124e-15
initial O 0 7.831328664167306e-15
events O 0 6.145868836161046e-16
of O 0 6.14701762459576e-16
excitation O 0 2.347565752902625e-10
- O 0 4.7321932470367756e-06
contraction O 0 1.8890602859755745e-08
coupling O 0 7.938118912198533e-11
in O 0 2.654101764754113e-12
skeletal O 0 7.254928657829396e-09
muscle O 0 5.499437016887043e-10
. O 0 1.1636252942107128e-12
. O 0 7.765769364370678e-13

Constitutional O 0 6.766719962136847e-10
RB1 O 0 8.01250553195132e-06
- O 0 4.151458554702003e-08
gene O 0 7.424693748703248e-09
mutations O 0 4.09212530527725e-09
in O 0 2.0244257659118858e-11
patients O 0 5.036523281765071e-12
with O 0 1.8949539457518245e-15
isolated O 0 4.5416700955591693e-10
unilateral B-Disease 0 1.9708200227341877e-07
retinoblastoma I-Disease 0 0.0004051054420415312
. O 0 2.779272811892497e-09

In O 0 6.064269225669605e-11
most O 0 2.7044458252717396e-13
patients O 0 3.9708560333091836e-13
with O 0 6.74283555511991e-17
isolated O 0 2.3425860209980165e-11
unilateral B-Disease 0 5.480769615928693e-09
retinoblastoma I-Disease 0 5.039396000938723e-06
, O 0 7.778492260024361e-12
tumor B-Disease 0 2.6346305692648286e-10
development O 0 2.34211033813686e-13
is O 0 4.358491462842307e-15
initiated O 0 1.453664120500131e-13
by O 0 2.631786000744209e-15
somatic O 0 4.7862186436375964e-11
inactivation O 0 6.894863846529375e-11
of O 0 9.428087493104672e-17
both O 0 2.7884168451911917e-16
alleles O 0 1.8786748957715094e-13
of O 0 5.144263599219387e-15
the O 0 5.260770660243941e-13
RB1 O 0 2.2510040054157798e-08
gene O 0 4.376857098975506e-09
. O 0 1.034660621068717e-10

However O 0 4.738313907903802e-11
, O 0 5.442067423869906e-14
some O 0 6.769617545772009e-16
of O 0 1.5642607423198393e-17
these O 0 1.266464180976843e-15
patients O 0 3.297827700686289e-15
can O 0 2.826391979194562e-16
transmit O 0 1.389546897684335e-11
retinoblastoma B-Disease 0 1.4636083456309734e-08
predisposition O 0 1.6999678109641536e-07
to O 0 1.750311180714892e-11
their O 0 1.5528140839132787e-12
offspring O 0 5.946896447506234e-11
. O 0 8.029083474470067e-12

To O 0 2.5123723631018113e-13
determine O 0 9.639926796265255e-14
the O 0 3.307856782540017e-15
frequency O 0 8.50501960525385e-13
and O 0 5.624171714826466e-15
nature O 0 1.2152642156888728e-15
of O 0 4.685440039493599e-16
constitutional O 0 2.365420359584647e-12
RB1 O 0 7.870288953881754e-08
- O 0 1.6879783681922333e-10
gene O 0 3.5939012876795573e-10
mutations O 0 2.7137919689224077e-10
in O 0 8.392448194727287e-12
patients O 0 5.936950692349285e-13
with O 0 8.711243509843358e-17
isolated O 0 5.960542823202353e-12
unilateral B-Disease 0 9.646420329190164e-10
retinoblastoma I-Disease 0 3.809193458437221e-07
, O 0 1.2533956077892539e-12
we O 0 7.481805600680503e-15
analyzed O 0 7.374810262255824e-14
DNA O 0 5.767423431196628e-12
from O 0 5.585091986332405e-14
peripheral O 0 8.549075336539147e-10
blood O 0 2.681055377706798e-10
and O 0 1.5114491255796558e-11
from O 0 1.9057982188902534e-12
tumor B-Disease 0 4.0502730058733505e-08
tissue O 0 1.5999719948922575e-07
. O 0 4.245655563228645e-11

The O 0 8.61269131642757e-14
analysis O 0 1.2190734532957492e-12
of O 0 8.31084502703628e-15
tumors B-Disease 1 1.0
from O 0 5.456028424194459e-13
54 O 0 6.239566155419318e-13
( O 0 2.0538852194516843e-13
71 O 0 1.3505352218501354e-11
% O 0 1.014348991628701e-13
) O 0 2.6818526783004004e-14
of O 0 2.4548543705899418e-15
76 O 0 5.768160688673918e-12
informative O 0 2.807848176189509e-09
patients O 0 9.584212312674367e-10
showed O 0 1.2161067985960727e-10
loss O 0 7.382981379033815e-12
of O 0 7.946673587517898e-16
constitutional O 0 3.3013383693436538e-12
heterozygosity O 0 1.4166209894028725e-07
( O 0 1.6454976048407843e-08
LOH O 1 1.0
) O 0 2.4200015255604335e-11
at O 0 4.1456046928622925e-11
intragenic O 0 1.8856225025842832e-08
loci O 0 1.3878637128428295e-09
. O 0 6.663677248885946e-11

Three O 0 2.8342266034098174e-11
of O 0 3.1038146770627495e-14
13 O 0 8.386699537968334e-13
uninformative O 0 9.083578333957121e-08
patients O 0 1.5802426034383643e-08
had O 0 2.96203513105997e-11
constitutional O 0 1.2882177963247088e-11
deletions O 0 2.5810945203375013e-07
. O 0 2.83658624367078e-10

For O 0 8.665060314237694e-13
39 O 0 3.0710818003237828e-12
randomly O 0 1.049644962961005e-12
selected O 0 1.7937847388016515e-11
tumors B-Disease 1 1.0
, O 0 7.2267708310647105e-12
SSCP O 0 2.4148596011741574e-08
, O 0 1.9149722226777938e-13
hetero O 0 1.7208753533282106e-08
- O 0 9.231416325805597e-11
duplex O 0 2.826250788956486e-09
analysis O 0 1.2138622355536977e-12
, O 0 8.033846512680166e-16
sequencing O 0 2.6521455387742976e-14
, O 0 1.927837247071894e-15
and O 0 1.143155983251759e-15
Southern O 0 4.200712314886973e-13
blot O 0 1.5266916619793847e-08
analysis O 0 2.0819899623769622e-11
were O 0 3.508019612644131e-13
used O 0 4.6444439413080227e-14
to O 0 9.150652783250501e-15
identify O 0 1.641138266950115e-11
mutations O 0 4.676508069678675e-10
. O 0 3.6595091540414515e-11

Mutations O 0 2.832031498201104e-08
were O 0 2.066586918952895e-12
detected O 0 1.1999704181697712e-11
in O 0 9.871223033853377e-14
21 O 0 4.611853501629466e-14
( O 0 2.5512246124275578e-14
91 O 0 9.148219291474358e-13
% O 0 4.7314606524189937e-14
) O 0 1.117008232871114e-13
of O 0 4.989411661604493e-13
23 O 0 6.058749058013291e-09
tumors B-Disease 1 1.0
with O 0 5.1544346568732635e-09
LOH O 1 1.0
. O 0 1.669385601976714e-10

In O 0 7.346402999819368e-12
6 O 0 4.4026278933281815e-13
( O 0 6.383429483787506e-13
38 O 0 1.6149176180341174e-12
% O 0 2.8335520439889093e-14
) O 0 5.344519721532312e-14
of O 0 5.062937170744776e-14
16 O 0 4.6030834699450907e-10
tumors B-Disease 1 1.0
without O 0 3.802467229974127e-10
LOH O 1 0.9999997615814209
, O 0 9.958725603062893e-14
one O 0 5.009326168524094e-15
mutation O 0 4.942347529499069e-13
was O 0 1.2000040718052052e-12
detected O 0 6.500314609497737e-12
, O 0 7.113037101599134e-15
and O 0 8.566351245026119e-16
in O 0 8.140435550575871e-15
9 O 0 2.4526465792129234e-14
( O 0 1.7296998252105955e-13
56 O 0 3.672170206803216e-12
% O 0 9.618254950089986e-14
) O 0 6.438315727991598e-14
of O 0 9.365296014282425e-15
the O 0 1.2457480359773232e-11
tumors B-Disease 1 1.0
without O 0 1.3916435781524683e-09
LOH O 1 1.0
, O 0 5.938771609897975e-14
both O 0 7.53806976420187e-15
mutations O 0 1.9464258330104123e-11
were O 0 1.0608765602104775e-11
found O 0 1.813334205014172e-11
. O 0 3.7889539596103194e-12

Thus O 0 8.587647737021142e-13
, O 0 1.531195519498523e-14
a O 0 6.5667999534749395e-15
total O 0 6.059178190383121e-16
of O 0 8.226308809559696e-16
45 O 0 4.6480953309370465e-14
mutations O 0 4.659168884035836e-12
were O 0 7.881330137127218e-12
identified O 0 1.7687634690233267e-10
in O 0 1.9927216821091776e-10
tumors B-Disease 1 1.0
of O 0 4.971230133272997e-13
36 O 0 5.97958488279815e-11
patients O 0 1.5340019532406046e-10
. O 0 4.192670082642236e-12

Thirty O 0 1.1119434262241157e-08
- O 0 8.05354360977617e-09
nine O 0 6.124326740186703e-12
of O 0 2.6437577460450196e-17
the O 0 1.9262851386053894e-16
mutations O 0 1.1101907154004165e-12
- O 0 3.5943296949891845e-12
including O 0 1.1847787799391853e-14
34 O 0 1.965112642922373e-13
small O 0 2.93771490423797e-13
mutations O 0 1.1816939093911571e-10
, O 0 6.043824295198785e-13
2 O 0 1.1501332689240005e-14
large O 0 1.1303088185473514e-13
structural O 0 3.487520316980408e-08
alterations O 0 8.271858291664103e-07
, O 0 1.7975272962808542e-12
and O 0 4.2318747247790944e-13
hypermethylation O 0 1.3342964955143088e-08
in O 0 1.2296394458211068e-10
3 O 0 9.014183149913535e-11
tumors O 1 1.0
- O 0 4.705655555881094e-06
were O 0 1.83324709579491e-11
not O 0 1.732670776332431e-14
detected O 0 2.0164670714445387e-12
in O 0 1.4831687513892043e-14
the O 0 1.0255553052835112e-15
corresponding O 0 2.55425455092384e-13
peripheral O 0 5.575215289432833e-10
blood O 0 7.386379702323254e-11
DNA O 0 6.858930756692416e-09
. O 0 2.2543862610024945e-11

In O 0 8.484592368962485e-12
6 O 0 7.240923897804119e-13
( O 0 9.167992970696148e-13
17 O 0 9.814526036495963e-14
% O 0 1.8895689337896553e-15
) O 0 4.1200698993985874e-16
of O 0 1.3962056005537684e-17
the O 0 2.6074831431798255e-15
36 O 0 4.3980704494961387e-13
patients O 0 2.333264061561008e-13
, O 0 4.153429762630606e-16
a O 0 2.0243726603342248e-14
mutation O 0 3.3978867896439224e-12
was O 0 5.333160996157105e-12
detected O 0 1.7949997391242256e-11
in O 0 1.0002738112628584e-13
constitutional O 0 2.6684997121067047e-14
DNA O 0 7.635980042719481e-11
, O 0 8.309359331246796e-14
and O 0 7.228941701969624e-14
1 O 0 4.8537447661350236e-14
of O 0 8.449900626042006e-16
these O 0 5.906888442730376e-15
mutations O 0 1.6773462772814302e-13
is O 0 1.470138864737415e-15
known O 0 7.901365583411028e-15
to O 0 4.391318224713147e-15
be O 0 1.2885575107466664e-14
associated O 0 2.345865743411807e-13
with O 0 4.062399830591368e-14
reduced O 0 1.9380535370983054e-11
expressivity O 0 3.5205765414048074e-08
. O 0 5.665764732376566e-11

The O 0 5.60175371732796e-15
presence O 0 1.9394779361627153e-14
of O 0 7.400924568599338e-17
a O 0 7.487447348328985e-14
constitutional O 0 9.736867345386258e-14
mutation O 0 2.604002083406165e-13
was O 0 6.334520408213251e-11
not O 0 9.55689274936898e-16
associated O 0 1.1226972788393706e-15
with O 0 3.4155536865911713e-16
an O 0 3.3218421435321326e-15
early O 0 4.405383613459435e-09
age O 0 5.266244471752168e-12
at O 0 2.254062604969964e-12
treatment O 0 3.728347925530118e-12
. O 0 1.2052800164169541e-12

In O 0 1.5295034128115503e-09
1 O 0 1.371924102100408e-10
patient O 0 1.0782214010518487e-09
, O 0 3.761416904942555e-13
somatic O 0 4.975193035328118e-10
mosaicism O 0 3.038320528503391e-08
was O 0 4.3181343917231274e-12
demonstrated O 0 2.0873068695020404e-14
by O 0 1.9968924154250788e-17
molecular O 0 1.6737787777955024e-14
analysis O 0 5.784601449102325e-15
of O 0 1.432520649242194e-16
DNA O 0 2.9049936067782056e-11
and O 0 4.404784439211891e-14
RNA O 0 1.9241282178672492e-10
from O 0 2.1041094214191425e-12
peripheral O 0 8.070323076481145e-08
blood O 0 7.843790506001369e-09
. O 0 1.0339879646936723e-10

In O 0 2.1988781628845544e-10
2 O 0 3.435763609380138e-12
patients O 0 1.5701595839495708e-12
without O 0 3.4110503829875346e-15
a O 0 1.6796641660009326e-13
detectable O 0 1.9643387361156783e-07
mutation O 0 2.125936759966862e-09
in O 0 1.454922848864726e-10
peripheral O 0 2.0465238037559175e-07
blood O 0 1.4744793164211956e-09
, O 0 3.218132683079078e-13
mosaicism O 0 9.194449090976775e-10
was O 0 8.227220120449186e-12
suggested O 0 1.1217015814454778e-12
because O 0 2.6978185717297862e-14
1 O 0 3.4614374084043775e-15
of O 0 1.5847729686265823e-16
the O 0 5.341289137871484e-14
patients O 0 4.704684992279384e-12
showed O 0 1.0570475050819539e-10
multifocal O 0 0.00015083470498211682
tumors B-Disease 1 1.0
and O 0 2.6996787028110703e-09
the O 0 3.5720937926336793e-14
other O 0 1.1594722306839528e-14
later O 0 4.575477366777769e-13
developed O 0 6.794545395066853e-12
bilateral B-Disease 0 7.397098489292375e-10
retinoblastoma I-Disease 0 9.831342140387278e-08
. O 0 2.928393361134596e-10

In O 0 3.973261650247473e-11
conclusion O 0 4.2834824771388613e-13
, O 0 8.571847218304379e-15
our O 0 3.921751693177774e-16
results O 0 5.322845037796669e-16
emphasize O 0 2.2022136650606643e-15
that O 0 8.411978828644533e-17
the O 0 2.433742974352135e-16
manifestation O 0 1.150831545945058e-13
and O 0 3.500612004588531e-14
transmissibility O 0 2.6784114856570618e-11
of O 0 5.943388786493458e-16
retinoblastoma B-Disease 0 7.375859471803192e-12
depend O 0 1.0644021335983953e-13
on O 0 3.710212001452502e-14
the O 0 6.421259496694815e-17
nature O 0 2.7030592175140077e-16
of O 0 5.278499223413211e-17
the O 0 7.847861900264763e-16
first O 0 1.3962635945173867e-14
mutation O 0 6.3539897017408746e-15
, O 0 2.620786007374691e-15
its O 0 2.018313680137793e-16
time O 0 8.648210626631143e-15
in O 0 8.900675742230454e-14
development O 0 3.644617770017129e-14
, O 0 9.54513432269849e-14
and O 0 2.115309948144857e-14
the O 0 5.6394648946891425e-16
number O 0 5.612020180165156e-15
and O 0 1.6981729878632473e-14
types O 0 1.9230492239309498e-14
of O 0 3.3205719779230553e-17
cells O 0 8.203625055473989e-15
that O 0 1.1772641577410294e-14
are O 0 2.284592531972239e-14
affected O 0 1.7377718459100217e-13
. O 0 4.7299448022565874e-14
. O 0 1.837432983542442e-12

Hereditary B-Disease 1 0.9999946355819702
deficiency I-Disease 1 0.9999997615814209
of I-Disease 0 4.191154598398063e-14
the I-Disease 0 5.241124781353232e-15
fifth I-Disease 0 2.243112108817752e-13
component I-Disease 0 5.124799781590361e-13
of I-Disease 0 6.770753628712513e-16
complement I-Disease 0 2.4186759366162658e-12
in O 0 1.214897182855168e-09
man O 0 1.0030393582383113e-07
. O 0 1.4927123773156303e-11

I O 0 0.1263664960861206
. O 0 1.6667099644873673e-10

Clinical O 0 1.4284833582678402e-07
, O 0 1.797716836504648e-11
immunochemical O 0 6.350679626621059e-08
, O 0 8.810120168123436e-12
and O 0 2.968185322093503e-13
family O 0 3.0347566907368284e-13
studies O 0 5.136418200490933e-12
. O 0 2.3951116697590313e-12

The O 0 7.269929558524624e-13
first O 0 5.447935329315305e-14
recognized O 0 4.1035808784209774e-14
human O 0 8.039219517950308e-14
kindred O 0 4.4442464286476024e-07
with O 0 1.0723305576831876e-10
hereditary B-Disease 1 0.9999960660934448
deficiency I-Disease 1 0.9999904632568359
of I-Disease 0 1.1964968878413855e-14
the I-Disease 0 1.6488887146404348e-14
fifth I-Disease 0 1.9308419609270072e-13
component I-Disease 0 1.8898663016464479e-13
of I-Disease 0 2.7254862676771375e-16
complement I-Disease 0 3.6321995758314962e-12
( O 0 6.15900455636087e-11
C5 O 0 9.558708269352678e-10
) O 0 8.714053242007969e-13
is O 0 1.5447750500649504e-13
described O 0 2.0433491704219264e-11
. O 0 4.313706076369828e-12

The O 0 1.1373161527133968e-12
proband O 0 1.7056303036611098e-09
, O 0 1.4379859811035865e-14
a O 0 1.5764175921128935e-14
20 O 0 3.9367895878980597e-14
- O 0 7.720390299281732e-12
year O 0 2.0842428477552133e-11
- O 0 9.75478309239719e-11
old O 0 3.804761838921422e-09
black O 0 5.3728163411370655e-12
female O 0 4.554460975025876e-12
with O 0 2.3416245071433694e-12
systemic B-Disease 1 1.0
lupus I-Disease 1 0.9999974966049194
erythematosus I-Disease 1 1.0
since O 0 2.4179369617627344e-09
age O 0 1.856915399223169e-09
11 O 0 1.009137218233036e-12
, O 0 1.041805293563406e-14
lacked O 0 5.2218047594254635e-12
serum O 0 1.8043802129524833e-12
hemolytic O 0 1.3747164517852184e-10
complement O 0 1.955739389880584e-12
activity O 0 7.312952327032107e-11
, O 0 1.1721942589758977e-13
even O 0 2.720878264448473e-13
during O 0 3.595934314204463e-12
remission O 0 1.0342048745171084e-10
. O 0 8.913115471381738e-13

C5 O 0 1.222134869749425e-06
was O 0 4.1383149684826037e-10
undetectable O 0 7.439531768405061e-10
in O 0 7.746124163106327e-13
her O 0 2.9361729654607885e-14
serum O 0 2.026207503104567e-14
by O 0 9.36443309946741e-16
both O 0 1.5196918972792267e-13
immunodiffusion O 0 9.579337323373238e-09
and O 0 1.3111368544690971e-12
hemolytic O 0 9.311960091906712e-09
assays O 0 1.071146105147136e-08
. O 0 1.8251875705255216e-11

Other O 0 1.0789432498478635e-13
complement O 0 3.971249598697796e-13
components O 0 1.270492066586526e-12
were O 0 1.1187396359779375e-13
normal O 0 6.977062157187408e-13
during O 0 2.9212705388373394e-13
remission O 0 6.512650228135408e-12
of O 0 3.241636381998386e-16
lupus O 0 2.9842393001189293e-09
, O 0 1.0168724552445021e-14
but O 0 1.8643890413710257e-13
C1 O 0 5.435926708763361e-10
, O 0 4.197210206344573e-14
C4 O 0 6.567844046401206e-10
, O 0 6.269724865150261e-13
C2 O 0 7.097876175699014e-10
, O 0 7.142869602001431e-14
and O 0 3.8380485855443736e-13
C3 O 0 1.4222895750037878e-08
levels O 0 2.0063206304654635e-11
fell O 0 1.536941596214092e-07
during O 0 4.764993087602587e-12
exacerbations O 0 1.6888559883909693e-08
. O 0 2.9805999248594395e-12

A O 0 1.3856841230008854e-09
younger O 0 1.598603055485981e-10
half O 0 2.662376178894088e-12
- O 0 9.681658252880254e-11
sister O 0 1.2539612403994482e-10
, O 0 1.0142657791119628e-13
who O 0 7.554452397841305e-14
had O 0 7.06790149410802e-13
no O 0 2.030894170283043e-13
underlying O 0 1.4109310941812225e-11
disease O 0 5.7548667220519434e-11
, O 0 6.918014880570589e-13
was O 0 7.99067964574185e-11
also O 0 2.5474332929556476e-13
found O 0 2.119427246552452e-12
to O 0 1.8949196324471312e-13
lack O 0 8.11032421776936e-11
immunochemically O 0 8.774163120506273e-07
detectable O 0 1.2575126675073989e-05
C5 O 0 5.363858122109377e-07
. O 0 1.822256096017938e-10

By O 0 7.30666048498474e-12
hemolytic O 0 4.445687693532818e-07
assay O 0 2.380849961625131e-09
, O 0 7.023218812074461e-13
she O 0 1.7382757288696843e-13
exhibited O 0 7.715594317419215e-15
1 O 0 1.6634724408823146e-15
- O 0 1.8280609231230427e-12
2 O 0 5.0448219312117324e-15
% O 0 1.971665696378147e-15
of O 0 4.1798918659962183e-17
the O 0 1.0623890623904565e-15
normal O 0 7.719605662169504e-13
serum O 0 4.060738724442903e-12
C5 O 0 1.3437397028415177e-10
level O 0 8.676820113101558e-13
and O 0 2.9214236231018967e-15
normal O 0 6.526044539701325e-15
concentrations O 0 1.251690994640486e-14
of O 0 2.4052961338247627e-17
other O 0 3.4035620823382145e-16
complement O 0 1.7163047784200802e-13
components O 0 1.0564422600611856e-11
. O 0 2.06614933495608e-12

C5 O 0 3.158137076297862e-07
levels O 0 1.1734458890688693e-11
of O 0 1.4373484723437474e-16
other O 0 5.189235185662409e-17
family O 0 8.862787894972299e-16
members O 0 2.8152102840229683e-17
were O 0 1.3802460109023948e-15
either O 0 5.266434231696309e-16
normal O 0 1.080169956843395e-14
or O 0 4.575419988765922e-15
approximately O 0 5.3106382342355506e-15
half O 0 2.381696923015042e-11
- O 0 8.489299929692606e-09
normal O 0 1.1287292628336942e-10
, O 0 6.889331634471127e-14
consistent O 0 8.874778082562651e-13
with O 0 5.912389074689845e-15
autosomal O 0 8.466640721849217e-10
codominant O 0 1.5003922548828541e-09
inheritance O 0 9.434125008978e-11
of O 0 7.257453678007151e-15
the O 0 2.2403957080372253e-14
gene O 0 1.5295828603711925e-08
determining O 0 6.567724852857282e-08
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 3.903688761131008e-10

Normal O 0 3.987388765835931e-07
hemolytic O 0 1.931808947119862e-05
titers O 0 5.335671630746219e-06
were O 0 2.8674878443935015e-11
restored O 0 5.1732585229502526e-12
to O 0 2.7501245502886337e-15
both O 0 1.3740588799149994e-13
homozygous O 1 0.9975985884666443
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 4.1922866955701465e-08
C5D B-Disease 1 1.0
) O 0 8.380047415539049e-13
sera O 0 4.49034004423865e-11
by O 0 1.6088944817309146e-16
addition O 0 1.9701996941046867e-15
of O 0 1.1766075113305382e-16
highly O 0 4.5096450852029e-14
purified O 0 3.5163213486788525e-12
human O 0 1.7597030603500041e-12
C5 O 0 8.937068862735487e-09
. O 0 2.749081517983143e-11

In O 0 2.502360645084689e-11
specific O 0 4.832835520662826e-12
C5 O 0 1.9366956927058254e-09
titrations O 0 1.893131429397954e-09
, O 0 3.743866653325989e-13
however O 0 5.2573468175458674e-14
, O 0 1.3788231861334207e-14
it O 0 4.812425736638306e-15
was O 0 6.1156882509572075e-12
noted O 0 1.0299728870353034e-13
that O 0 6.99663772810833e-17
when O 0 1.5590430193647528e-16
limited O 0 2.866808156272801e-16
amounts O 0 2.571095666556965e-15
of O 0 4.1560150130647445e-15
C5 O 0 1.094391591238697e-11
were O 0 7.737732709341832e-14
assayed O 0 2.3064909357439767e-12
in O 0 7.306286821482256e-15
the O 0 1.2778775793641803e-16
presence O 0 1.5891725530458277e-14
of O 0 8.165592429109324e-16
low O 0 6.42154515326232e-12
dilutions O 0 8.227040160235788e-10
of O 0 4.512103428925716e-15
either O 0 8.523536910998164e-12
C5D B-Disease 1 1.0
serum O 0 6.717580658399669e-11
, O 0 1.656921805705605e-14
curving O 0 2.431822538478956e-12
rather O 0 2.460818753088033e-14
than O 0 2.1477801514965507e-15
linear O 0 2.640366495321872e-13
dose O 0 3.8944000801954815e-10
- O 0 2.1300472496932343e-10
response O 0 1.1389394744161507e-13
plots O 0 1.3362523977947238e-12
were O 0 1.1510913749956941e-12
consistently O 0 8.68417903370335e-15
obtained O 0 5.0032914822913804e-15
, O 0 2.6028009568056405e-16
suggesting O 0 7.208835680900649e-15
some O 0 3.3777336125567076e-15
inhibitory O 0 5.8371030231541e-11
effect O 0 3.038756399287301e-11
. O 0 7.178770165122694e-12

Further O 0 1.2721076796118336e-11
studies O 0 6.014652317865021e-12
suggested O 0 1.2637562437495253e-12
that O 0 6.2209987527583714e-15
low O 0 5.308320102925812e-11
dilutions O 0 1.6931512902829127e-07
of O 0 5.522859188207552e-13
C5D B-Disease 1 1.0
serum O 0 6.0393222540977565e-12
contain O 0 3.482484821890931e-14
a O 0 1.595508020678111e-14
factor O 0 2.524081102819615e-14
( O 0 2.3909192225883558e-14
or O 0 3.281786463676245e-13
factors O 0 9.666458578678691e-14
) O 0 1.5947992235078486e-14
interfering O 0 1.401032284978343e-12
at O 0 2.769648009201542e-12
some O 0 7.062072399712264e-15
step O 0 1.0339449294568398e-13
in O 0 5.5606624549907595e-15
the O 0 1.9127907655551056e-15
hemolytic O 0 4.242994566805436e-10
assay O 0 6.68664568159727e-11
of O 0 1.063492471035021e-14
C5 O 0 1.0188627025398134e-10
, O 0 2.5652174696612568e-15
rather O 0 6.659987659595661e-16
than O 0 1.2017109473789751e-15
a O 0 1.097125777678237e-14
true O 0 1.4288013047009107e-12
C5 O 0 1.2253625891744946e-09
inhibitor O 0 1.068664046144363e-09
or O 0 3.024572259313629e-11
inactivator O 0 3.7749821046872967e-08
. O 0 4.833059299991227e-11

Of O 0 1.4126206985837914e-13
clinical O 0 3.379287127902586e-11
interest O 0 6.343920614521048e-13
are O 0 2.1305102931965143e-14
( O 0 1.2486299700350395e-13
a O 0 7.907796596359762e-13
) O 0 5.736283301659151e-14
the O 0 2.867232276257403e-14
documentation O 0 1.6061889318574885e-10
of O 0 2.7688422843570593e-14
membranous O 0 4.1249790228903294e-05
glomerulonephritis B-Disease 1 1.0
, O 0 3.727969932754149e-09
vasculitis B-Disease 1 1.0
, O 0 2.481742589210967e-10
and O 0 4.327934677306189e-10
arthritis B-Disease 1 1.0
in O 0 1.554774375651241e-14
an O 0 7.780198261460129e-16
individual O 0 1.1366513843157327e-14
lacking O 0 5.733209462732702e-10
C5 O 0 2.0842330084036575e-09
( O 0 1.4956071320640363e-12
and O 0 1.0503889560442917e-14
its O 0 3.402679050490702e-16
biologic O 0 7.382249325726953e-12
functions O 0 2.0141382576940826e-15
) O 0 1.4904731611856755e-15
, O 0 5.072900649896739e-15
and O 0 2.5088131645387667e-14
( O 0 2.9551136386009313e-13
b O 0 3.725840816426462e-11
) O 0 2.205298982571038e-15
a O 0 2.1173928021621553e-14
remarkable O 0 1.7891675554299047e-12
propensity O 0 4.220362670448452e-10
to O 0 1.0658273742747415e-11
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 2.2009500125208525e-11
the O 0 1.709514928433572e-14
proband O 0 2.6461395297161516e-09
, O 0 1.4752295115745898e-14
even O 0 1.2408942044750144e-14
during O 0 1.5853851299254748e-14
periods O 0 2.4296374374205287e-13
of O 0 1.4729054596316049e-16
low O 0 9.753290189373764e-12
- O 0 1.0017252869212734e-12
dose O 0 2.057961613621817e-11
or O 0 5.57247499012592e-13
alternate O 0 3.0483233992573133e-11
- O 0 8.411430996169145e-10
day O 0 3.1843755063376555e-12
corticosteroid O 0 1.996572907003724e-09
therapy O 0 3.4399783022109887e-09
. O 0 1.3613605685455776e-12

Other O 0 9.445832245720542e-14
observations O 0 3.935965865297514e-13
indicate O 0 1.0936664442996735e-13
that O 0 8.467648613264944e-16
the O 0 4.2374781526570426e-14
C5D B-Disease 1 1.0
state O 0 2.580785723473554e-14
is O 0 1.048899448606545e-14
compatible O 0 6.8767357259968964e-12
with O 0 3.622493947061205e-15
normal O 0 3.478794943084784e-13
coagulation O 0 1.4038831132757307e-13
function O 0 1.4903204199694618e-14
and O 0 5.633232426263245e-15
the O 0 4.543692252144144e-16
capacity O 0 2.480477329002621e-15
to O 0 1.092739523439999e-15
mount O 0 1.2997040076123678e-11
a O 0 2.8083607661599785e-10
neutrophilic O 0 7.670662307646126e-05
leukocytosis O 0 2.701300400076434e-05
during O 0 8.98346452782306e-10
pyogenic B-Disease 0 4.117048956686631e-05
infection I-Disease 0 4.649257243727334e-05
. O 0 1.5627386537597765e-11
. O 0 5.99512453569595e-12

Susceptibility O 0 2.0039071557675925e-07
to O 0 3.752216759522753e-09
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 6.84499923409021e-09
twins O 0 1.1857087534039579e-09
: O 0 2.7280570126720543e-15
the O 0 2.737164800611855e-17
role O 0 1.1870227396230514e-14
of O 0 7.749152386360891e-17
genes O 0 7.685608876747962e-13
, O 0 1.046019607736648e-12
HLA O 0 1.278835481954843e-09
, O 0 1.3674234270941166e-13
and O 0 3.436456577198682e-13
the O 0 4.331586359127698e-13
environment O 0 1.0935137517709137e-10
. O 0 2.1793352712740077e-12

OBJECTIVE O 0 4.013156126858597e-11
To O 0 1.82799281489782e-14
determine O 0 1.2058627852490605e-14
the O 0 4.655632420684128e-16
relative O 0 7.551485072020483e-14
effects O 0 1.973414487377312e-12
of O 0 1.6423749677485782e-15
genetic O 0 2.4939364809406506e-11
and O 0 3.7355711514537593e-13
environmental O 0 9.386398146097371e-15
factors O 0 1.0768251931412773e-14
in O 0 1.8698092390818238e-13
susceptibility O 0 3.36793176680672e-10
to O 0 2.648046504294399e-10
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 9.238329766958486e-06
AS B-Disease 1 1.0
) O 0 3.872228059031979e-12
. O 0 9.805530953171937e-13

METHODS O 0 8.234784409921758e-09
Twins O 0 1.0493969249125712e-08
with O 0 1.787843148266105e-13
AS B-Disease 1 1.0
were O 0 3.205884857712324e-14
identified O 0 4.656294271053289e-14
from O 0 1.1271344609335623e-15
the O 0 1.1972680478123895e-15
Royal O 0 1.2392025773577675e-11
National O 0 4.8421309279886304e-14
Hospital O 0 5.079904830118664e-10
for O 0 7.714232898303752e-13
Rheumatic B-Disease 0 0.3754846453666687
Diseases I-Disease 0 1.4318907233246136e-05
database O 0 1.0371017822308204e-08
. O 0 7.329108153708574e-11

Clinical O 0 4.523718359905615e-07
and O 0 1.1618516912448307e-11
radiographic O 0 1.6582294648515017e-08
examinations O 0 4.452352797557069e-08
were O 0 2.3812356708848015e-13
performed O 0 1.4069650934762923e-14
to O 0 1.978785299467395e-16
establish O 0 3.268625821395421e-12
diagnoses O 0 1.245669864147203e-05
, O 0 2.676296033746195e-12
and O 0 9.982754206605549e-12
disease O 0 5.690178328521256e-10
severity O 0 2.051456053642209e-11
was O 0 4.1260845109504507e-13
assessed O 0 4.183000720434614e-14
using O 0 2.789876018261515e-15
a O 0 8.66406488111808e-14
combination O 0 2.210731944729538e-11
of O 0 1.5976251625891141e-13
validated O 0 1.5201463698932827e-10
scoring O 0 2.377880947701527e-10
systems O 0 1.7313538380747673e-09
. O 0 1.8978514940148905e-11

HLA O 0 0.00029971147887408733
typing O 0 1.7033593167070649e-06
for O 0 4.404461170781637e-12
HLA O 0 4.6234756467811167e-08
- O 0 3.7125272300819745e-10
B27 O 0 3.0894637959022475e-09
, O 0 4.3303636501276777e-13
HLA O 0 1.4290543193240524e-09
- O 0 9.406880656370742e-12
B60 O 0 1.1529667498511031e-10
, O 0 2.6607488524195595e-14
and O 0 1.365708354782516e-13
HLA O 0 7.594317175119158e-09
- O 0 1.5015086951564172e-09
DR1 O 0 0.00011771718709496781
was O 0 5.2840763015149506e-11
performed O 0 3.3942429623250517e-14
by O 0 6.975185295230135e-17
polymerase O 0 1.2150962744664207e-13
chain O 0 1.442293956792004e-13
reaction O 0 3.493846159515748e-15
with O 0 5.3661866549164876e-17
sequence O 0 1.4416715908636794e-14
- O 0 4.52436265535594e-13
specific O 0 7.089009741500845e-15
primers O 0 1.6291886728581062e-09
, O 0 1.480642594208631e-13
and O 0 1.3485339147439879e-13
zygosity O 0 4.704582279302372e-10
was O 0 1.1306717281195366e-12
assessed O 0 1.5901717876493082e-12
using O 0 7.218088973748316e-13
microsatellite O 0 4.92368945614885e-09
markers O 0 1.7449604428065868e-08
. O 0 2.514246033591405e-10

Genetic O 0 1.7324744305824424e-08
and O 0 4.2434897826529316e-13
environmental O 0 3.68776037674599e-15
variance O 0 7.913824591032192e-15
components O 0 1.807528627641164e-12
were O 0 1.0884373914318846e-12
assessed O 0 2.4598593561381277e-12
with O 0 6.085863963386368e-16
the O 0 2.5551157123806546e-14
program O 0 1.478504059633512e-12
Mx O 0 1.6311334227747665e-11
, O 0 1.5293266683553486e-15
using O 0 1.835255953013936e-14
data O 0 9.33933269262055e-13
from O 0 6.527015662975352e-15
this O 0 2.15234841193933e-15
and O 0 2.6280454185458393e-14
previous O 0 2.051891236131212e-14
studies O 0 1.5153011495312035e-13
of O 0 3.280838125588499e-15
twins O 0 1.4954895100061094e-09
with O 0 6.440275396313311e-12
AS B-Disease 1 1.0
. O 0 1.903670103498012e-11

RESULTS O 0 1.0290152729908186e-08
Six O 0 1.0097648628706879e-12
of O 0 3.0115623282498576e-15
8 O 0 5.055251790092585e-12
monozygotic O 0 7.20362322681467e-07
( O 0 1.6018583792742902e-08
MZ O 1 0.9999725818634033
) O 0 4.2272806782817085e-11
twin O 0 8.990496347394128e-09
pairs O 0 6.56224311001985e-11
were O 0 5.040956194135582e-11
disease O 0 1.68265526512279e-10
concordant O 0 9.70093796959226e-11
, O 0 3.4751657796002963e-14
compared O 0 3.420337472449797e-13
with O 0 2.3097495799122812e-15
4 O 0 1.687756786541636e-13
of O 0 8.70952480058404e-15
15 O 0 5.8616002676648016e-12
B27 O 0 2.6027718647014808e-08
- O 0 2.197459103570054e-08
positive O 0 2.7793933821129713e-10
dizygotic O 0 2.3696792084137996e-08
( O 0 2.1693747492834703e-11
DZ O 0 9.84107714430138e-07
) O 0 2.9534794748764526e-13
twin O 0 1.009199321333476e-11
pairs O 0 4.2961895976509346e-13
( O 0 1.0613987119767465e-11
27 O 0 5.295214267064807e-11
% O 0 1.9417330428001672e-13
) O 0 2.9004283783745644e-13
and O 0 1.1282266353801473e-12
4 O 0 4.213493228909411e-14
of O 0 8.326553253043111e-15
32 O 0 3.6295973171451834e-11
DZ O 0 0.00010980366641888395
twin O 0 8.98030746987466e-11
pairs O 0 3.1351854706124227e-12
overall O 0 3.7473212033400927e-11
( O 0 2.459921329134307e-11
12 O 0 5.298262696629141e-12
. O 0 1.3088374785016899e-13
5 O 0 7.918090011785339e-13
% O 0 1.5985649219271703e-12
) O 0 9.291259601973412e-12
. O 0 2.5410739484810208e-11

Nonsignificant O 0 5.497727215697523e-07
increases O 0 7.799871859504037e-12
in O 0 1.9218942098040738e-14
similarity O 0 2.685128662927201e-14
with O 0 9.8014907182454e-17
regard O 0 1.1691279827661782e-14
to O 0 2.135196757087083e-14
age O 0 2.8014352990157754e-12
at O 0 1.3547321901438703e-12
disease O 0 3.322013844564431e-11
onset O 0 1.3590937403273884e-11
and O 0 4.8844476775939186e-14
all O 0 7.322717354834858e-16
of O 0 1.3134770506482984e-16
the O 0 2.9896326028937964e-14
disease O 0 5.785253179291239e-11
severity O 0 1.1776253583395402e-11
scores O 0 1.6543782403038998e-12
assessed O 0 6.636677969337756e-13
were O 0 5.818021303442833e-14
noted O 0 1.862783365058629e-12
in O 0 7.2163720311879676e-12
disease O 0 1.900879276206524e-08
- O 0 1.4280082041295827e-06
concordant O 0 0.0026202343869954348
MZ O 1 0.9999771118164062
twins O 0 1.7590676861800603e-06
compared O 0 1.0505919467718172e-09
with O 0 1.0413732593264613e-12
concordant O 0 9.445852811040822e-06
DZ O 1 0.9988318085670471
twins O 0 1.020124454953475e-05
. O 0 5.131439162475715e-10

HLA O 0 0.0005513846408575773
- O 0 5.210610652284231e-06
B27 O 0 3.289176575549391e-08
and O 0 2.282581404704914e-13
B60 O 0 1.476456110149904e-11
were O 0 2.16906418363692e-15
associated O 0 4.083892328127968e-16
with O 0 2.037101168692914e-17
the O 0 2.071125575594168e-15
disease O 0 2.4746545958242994e-12
in O 0 2.0437991576915948e-13
probands O 0 2.1740327316166486e-09
, O 0 8.064606111819056e-14
and O 0 1.6599711243157206e-14
the O 0 1.578003068383564e-14
rate O 0 4.149457513702437e-11
of O 0 6.975455022284276e-16
disease O 0 3.6745103487723085e-12
concordance O 0 2.5281226764817255e-11
was O 0 8.062656445262384e-13
significantly O 0 1.0888382209750525e-12
increased O 0 2.891243017569267e-13
among O 0 2.2730188770688636e-13
DZ O 0 0.0004085033724550158
twin O 0 2.5892665789228886e-10
pairs O 0 4.884804583396574e-13
in O 0 4.621753283903796e-13
which O 0 1.7366003951088042e-15
the O 0 7.0871979380266684e-15
co O 0 2.3956104655553645e-07
- O 0 2.925805908660095e-08
twin O 0 2.9460379025181282e-08
was O 0 1.5345089643403753e-09
positive O 0 3.660043188663531e-13
for O 0 6.637820277970424e-16
both O 0 5.563484345254537e-15
B27 O 0 7.841856053403262e-10
and O 0 1.1716209599721417e-11
DR1 O 0 5.787639020127244e-05
. O 0 7.083239550453868e-11

Additive O 0 6.551975628710238e-11
genetic O 0 2.6557436805241252e-11
effects O 0 3.5506187833628244e-12
were O 0 8.533153906240855e-15
estimated O 0 1.6591052713551695e-16
to O 0 9.947979276208743e-18
contribute O 0 2.692500422430891e-16
97 O 0 2.327965294493528e-13
% O 0 9.960486584560235e-15
of O 0 2.423062153585054e-16
the O 0 1.1829537203993839e-15
population O 0 3.3870092056642934e-16
variance O 0 7.792893392220834e-13
. O 0 1.4054733071811043e-11

CONCLUSION O 0 4.775503950615878e-11
Susceptibility O 0 1.22182316347752e-11
to O 0 1.2440687586004473e-12
AS B-Disease 1 1.0
is O 0 5.634068236023949e-16
largely O 0 4.8924427157039335e-16
genetically O 0 1.0095165805731887e-12
determined O 0 2.942725577104177e-11
, O 0 1.5091380835968726e-12
and O 0 4.597870681736192e-14
the O 0 2.9446287259666387e-15
environmental O 0 1.0065301321365502e-13
trigger O 0 2.4425060932142806e-11
for O 0 2.4438584429785706e-14
the O 0 1.2980800245462887e-13
disease O 0 1.096379764753408e-09
is O 0 2.6558879336231744e-13
probably O 0 2.386577602209172e-10
ubiquitous O 0 5.849100759292014e-09
. O 0 7.313119554375191e-11

HLA O 0 1.5082976460689679e-05
- O 0 1.321130582709884e-08
B27 O 0 4.808997644545343e-10
accounts O 0 4.3109951914678535e-14
for O 0 5.3575144933744816e-17
a O 0 1.0290509043777113e-15
minority O 0 4.0411166031322984e-14
of O 0 1.3166323807257187e-16
the O 0 4.9232053641614336e-15
overall O 0 2.3175641093720056e-12
genetic O 0 1.3523266707837767e-11
susceptibility O 0 2.1916584866388256e-11
to O 0 4.3172823649406666e-10
AS B-Disease 1 1.0
. O 0 2.221404657443138e-11

Cell O 0 3.4566605222607905e-07
cycle O 0 2.833802525969986e-09
- O 0 9.31234589440777e-10
dependent O 0 2.981796753953603e-10
colocalization O 0 2.2498150897831692e-08
of O 0 3.260646215378672e-14
BARD1 O 0 1.3117649189098302e-08
and O 0 6.983355679748143e-14
BRCA1 O 0 6.031646709869776e-11
proteins O 0 3.110423973506221e-13
in O 0 8.100046647958534e-14
discrete O 0 5.8046146014789635e-12
nuclear O 0 1.864150084296412e-10
domains O 0 1.587113662715467e-09
. O 0 3.006827425933167e-11

Germ O 0 7.341146556427702e-06
- O 0 4.864262882620096e-05
line O 0 6.688511411390152e-10
mutations O 0 1.6279576298128262e-10
of O 0 3.3029645319949128e-15
the O 0 2.6988157412669413e-15
BRCA1 O 0 8.738233470140244e-10
gene O 0 1.2139236837960254e-10
predispose O 0 2.4657416733409043e-11
women O 0 1.2191799219490873e-13
to O 0 2.5733032461757463e-15
early O 0 6.267155683303827e-09
- O 0 9.277620165448752e-07
onset O 0 4.218594040139578e-05
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9999980926513672
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 2.3775220412748134e-14
compromising O 0 9.517969745687083e-11
the O 0 6.936025109193996e-16
genes O 0 7.273452131383029e-13
presumptive O 0 3.536303845239064e-12
function O 0 3.731156009156855e-13
as O 0 4.685303794244033e-13
a O 0 8.868183097587856e-12
tumor B-Disease 0 1.4852318486191507e-07
suppressor O 0 4.0317431739822496e-06
. O 0 1.5830806665562136e-09

Although O 0 1.0914538587161737e-12
the O 0 1.591140168230652e-15
biochemical O 0 3.6400624268267956e-13
properties O 0 2.5608009636413076e-13
of O 0 6.190008781833652e-16
BRCA1 O 0 7.483707542554896e-10
polypeptides O 0 3.1381123394291777e-11
are O 0 9.074801829856826e-15
not O 0 2.515437184532444e-16
understood O 0 1.731871177230223e-14
, O 0 6.400793460153477e-16
their O 0 2.0768682736880948e-16
expression O 0 1.0509786265008522e-13
pattern O 0 3.345379528951753e-12
and O 0 3.082369496904165e-14
subcellular O 0 4.131798375661688e-11
localization O 0 1.1923251448664463e-11
suggest O 0 4.285326705034259e-14
a O 0 1.8093652051349822e-14
role O 0 1.3772153990149194e-13
in O 0 2.3941022775364473e-12
cell O 0 1.7933208482645568e-06
- O 0 0.0009926154743880033
cycle O 0 7.247819233668906e-09
regulation O 0 4.386595975347518e-08
. O 0 5.150576840029508e-11

When O 0 5.6688344990396544e-11
resting O 0 3.630448719427193e-11
cells O 0 1.977737418279446e-11
are O 0 1.6920331848417798e-14
induced O 0 9.63160649326833e-13
to O 0 3.848204510581953e-15
proliferate O 0 3.7099913419158526e-11
, O 0 3.365232676804655e-15
the O 0 5.483625126075336e-16
steady O 0 1.1009845812814945e-11
- O 0 1.7330145023024268e-14
state O 0 1.395392336427841e-15
levels O 0 2.4171699594698927e-14
of O 0 1.8580165660751835e-17
BRCA1 O 0 2.7515470804595488e-11
increase O 0 1.2549331148900555e-13
in O 0 2.7712792997902636e-13
late O 0 1.813321437449389e-10
G1 O 0 1.3430914713730147e-10
and O 0 1.0944713458281314e-14
reach O 0 2.0448666224930426e-14
a O 0 1.8532767483733607e-14
maximum O 0 1.4811566415636607e-13
during O 0 6.401181668058697e-13
S O 0 6.815917275027061e-10
phase O 0 1.0058172177085378e-11
. O 0 5.666291220951525e-12

Moreover O 0 2.1689786078304962e-10
, O 0 5.471503783903431e-13
in O 0 7.124272959763145e-13
S O 0 5.248520507095122e-10
phase O 0 7.799555814570758e-13
cells O 0 2.639260121214959e-12
, O 0 1.8956136573627935e-13
BRCA1 O 0 2.0871688821699763e-09
polypeptides O 0 2.5837362804814745e-10
are O 0 2.4753097249870237e-13
hyperphosphorylated O 0 6.447942624276948e-09
and O 0 1.891006665491468e-12
accumulate O 0 6.486916559467204e-11
into O 0 1.916415295769372e-13
discrete O 0 2.328279513630349e-10
subnuclear O 0 2.8237934657227015e-07
foci O 0 6.729862889187643e-08
termed O 0 8.946465790415914e-09
" O 0 3.0181310228805103e-10
BRCA1 O 0 1.974639047830351e-07
nuclear O 0 1.0432541053262412e-08
dots O 0 3.903215656464454e-06
. O 0 1.1449181602785075e-09

" O 0 1.7326421408725423e-09
BRCA1 O 0 4.355125042820873e-07
associates O 0 3.4728884212853472e-09
in O 0 7.01830466572767e-13
vivo O 0 3.0763261382737994e-10
with O 0 2.1013428407127546e-15
a O 0 5.88255301674917e-13
structurally O 0 2.102363616529601e-09
related O 0 1.1158631527466434e-12
protein O 0 4.13975798085886e-11
termed O 0 1.6351064946462657e-09
BARD1 O 0 7.937076588859782e-06
. O 0 1.154309009487875e-10

Here O 0 7.403605506439703e-10
we O 0 2.1558872308896637e-14
show O 0 5.5211369330565585e-15
that O 0 3.474093721762692e-17
the O 0 2.572359916170301e-16
steady O 0 1.302612705200712e-11
- O 0 4.967767936923072e-14
state O 0 2.1212275744242597e-15
levels O 0 5.523604170625321e-14
of O 0 2.389941047765043e-16
BARD1 O 0 9.745559220730726e-11
, O 0 1.9533830460770346e-16
unlike O 0 7.846544764031783e-16
those O 0 1.1929499532566259e-16
of O 0 2.980541189159657e-17
BRCA1 O 0 1.1295692159407622e-10
, O 0 1.5664105754674418e-13
remain O 0 1.672611566394186e-13
relatively O 0 2.6372597817592505e-14
constant O 0 4.2037258548253964e-13
during O 0 2.7663906321945264e-12
cell O 0 1.5831478350492034e-08
cycle O 0 2.680963229195754e-10
progression O 0 5.794664748037803e-10
. O 0 1.4073644159784404e-11

However O 0 4.386873503348099e-11
, O 0 5.795363646442231e-13
immunostaining O 0 9.375006326806101e-10
revealed O 0 2.485502428872799e-11
that O 0 1.3639479323269196e-14
BARD1 O 0 7.165976256828799e-09
resides O 0 3.4803501226809974e-12
within O 0 2.5410083108814985e-13
BRCA1 O 0 3.457227037984012e-08
nuclear O 0 3.332474018957754e-10
dots O 0 1.9693791042385556e-09
during O 0 3.0394621281654155e-12
S O 0 2.4955305183427257e-11
phase O 0 4.117882182702419e-14
of O 0 5.740104055525978e-17
the O 0 5.966425541559933e-15
cell O 0 1.55941137780502e-09
cycle O 0 5.216986564970938e-12
, O 0 1.0739746223419055e-13
but O 0 8.169526388929552e-14
not O 0 2.1711999772134217e-15
during O 0 3.0889241766631978e-15
the O 0 4.743458196490493e-15
G1 O 0 1.085697975966582e-09
phase O 0 1.0363527744305934e-11
. O 0 5.61787595609875e-12

Nevertheless O 0 3.551111626975967e-09
, O 0 9.001631363046714e-13
BARD1 O 0 1.2910331692594923e-09
polypeptides O 0 2.4625409350553795e-11
are O 0 2.9311575139735063e-15
found O 0 3.927847206964012e-15
exclusively O 0 3.3390699466463378e-15
in O 0 1.9783996760714545e-13
the O 0 3.0398400996774688e-15
nuclear O 0 1.0433376168225705e-12
fractions O 0 3.850523198900557e-12
of O 0 3.319129838155906e-16
both O 0 1.6815416653504986e-14
G1 O 0 2.57458609986827e-10
- O 0 3.710371853510308e-12
and O 0 1.2024143616548577e-12
S O 0 8.666495299181065e-10
- O 0 4.6822712373995046e-11
phase O 0 4.746868696725581e-12
cells O 0 1.523710498052555e-11
. O 0 1.7615341477150714e-11

Therefore O 0 1.2463850264377019e-11
, O 0 2.876249314675422e-13
progression O 0 2.850407626944773e-12
to O 0 2.3627035386757783e-14
S O 0 4.239062989519482e-10
phase O 0 7.142096159276634e-13
is O 0 6.828104959021681e-15
accompanied O 0 5.15633881621215e-14
by O 0 3.178525280587448e-16
the O 0 3.655211441681849e-15
aggregation O 0 1.374218799735441e-13
of O 0 2.452120148236205e-16
nuclear O 0 3.838936547123639e-12
BARD1 O 0 7.59321583387873e-09
polypeptides O 0 5.242097866897666e-10
into O 0 5.8731275051626675e-12
BRCA1 O 0 9.447263948914042e-08
nuclear O 0 9.375905385411443e-09
dots O 0 8.218780180868634e-07
. O 0 3.8861119877608985e-10

This O 0 1.061550044915982e-12
cell O 0 4.145687793055686e-09
cycle O 0 4.833264344306087e-10
- O 0 3.057921693638832e-10
dependent O 0 2.659714115615941e-10
colocalization O 0 1.3806563892160284e-08
of O 0 6.061508039207839e-14
BARD1 O 0 3.612557364363056e-08
and O 0 1.2337300506291143e-13
BRCA1 O 0 2.6801913466378835e-10
indicates O 0 4.277457023565273e-13
a O 0 5.247126009784529e-15
role O 0 3.7109692489073476e-14
for O 0 2.235144611984017e-15
BARD1 O 0 1.837813234928376e-10
in O 0 8.060489125119585e-13
BRCA1 O 0 1.0983017091348302e-05
- O 0 4.3396150317676074e-07
mediated O 0 3.73012710497278e-07
tumor B-Disease 0 1.0785015547298826e-06
suppression O 0 5.712538886371021e-09
. O 0 4.0209714030625676e-11

Ethnic O 0 2.8153168685207675e-10
differences O 0 2.0274575351919566e-09
in O 0 1.6302313665672585e-11
the O 0 5.010057581474048e-13
HFE O 0 1.3786835779683315e-06
codon O 0 5.8061324637037615e-08
282 O 0 7.2882149204644975e-09
( O 0 8.094503400890574e-10
Cys O 1 0.9974338412284851
/ O 0 2.4388241399719846e-06
Tyr O 0 6.320734655673732e-07
) O 0 2.2446092207140111e-10
polymorphism O 0 3.987563843566022e-07
. O 0 1.8904569576427832e-10

Recent O 0 2.088221956464409e-11
studies O 0 1.628015105538394e-12
have O 0 5.879439493041653e-15
shown O 0 8.093869406080798e-14
that O 0 6.701187521551688e-11
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.6337301644853142e-07
HH B-Disease 0 8.7488311692141e-05
) O 0 1.5946751840030526e-13
is O 0 1.2061940598347316e-14
likely O 0 1.3151293205490577e-12
to O 0 1.7695283774168415e-15
be O 0 1.3081504839594898e-14
caused O 0 6.741579167031115e-16
by O 0 3.040986982288051e-16
homozygosity O 0 3.54858260831481e-11
for O 0 6.437278345565272e-16
a O 0 4.435480235594029e-14
Cys282Tyr O 0 6.242361627606385e-10
mutation O 0 1.1661826018749544e-12
in O 0 4.958493468251723e-13
the O 0 1.1157726150889773e-14
HFE O 0 2.0329484762271477e-09
gene O 0 1.1379509140541089e-10
located O 0 4.894006866429379e-10
4 O 0 1.308068986460853e-09
. O 0 2.639997942477379e-10

5 O 0 7.291663273178983e-09
Mb O 0 2.376628344791243e-06
telomeric O 0 3.476827714621322e-07
to O 0 4.435656356105433e-11
HLA O 0 5.842101700181956e-07
- O 0 2.0083032126194666e-08
A O 0 9.503190456783273e-10
. O 0 9.891531170536094e-12

Population O 0 2.510207482413901e-13
studies O 0 5.2589768477495635e-12
of O 0 7.326178543215576e-17
this O 0 1.1460808409581873e-16
polymorphism O 0 1.916460263054476e-12
are O 0 2.0539958694831665e-16
facilitated O 0 1.649870256419713e-14
by O 0 1.992730902850549e-16
the O 0 3.80026572802003e-16
fact O 0 2.2457767812961897e-15
that O 0 1.4696839551051803e-16
the O 0 1.5634570139320134e-15
Cys282Tyr O 0 5.341371234202086e-10
mutation O 0 9.531972433585167e-12
creates O 0 8.378405608189254e-12
a O 0 1.5636630879001245e-11
Rsal O 0 7.581956396052192e-09
restriction O 0 7.187953010578951e-11
site O 0 1.6355641840881674e-10
. O 0 9.36395318923422e-12

We O 0 8.646458549144143e-12
have O 0 6.3458751261061784e-15
studied O 0 4.2363164300292244e-13
the O 0 7.656222390014372e-15
codon O 0 1.0271656858407141e-09
282 O 0 6.567777571797606e-11
( O 0 7.24455009870617e-11
Cys O 0 0.4929428696632385
/ O 0 2.479564500390552e-07
Tyr O 0 1.9015210739325994e-08
) O 0 3.724794344489579e-12
polymorphism O 0 4.98094732126475e-10
in O 0 1.0149726111657875e-12
different O 0 5.809283311558958e-14
ethnic O 0 5.413961379902021e-13
groups O 0 4.809182566067882e-13
. O 0 7.524334454112047e-12

In O 0 4.2555872020733077e-11
agreement O 0 1.8239513632084536e-12
with O 0 3.740608032874607e-15
previous O 0 2.1243557856830825e-13
observations O 0 1.3296870928544008e-13
the O 0 2.2469818974218958e-14
Tyr O 0 7.233232346415264e-10
allele O 0 4.945124865152195e-11
appeared O 0 2.141039168179759e-08
to O 0 2.955546303030389e-14
be O 0 1.5346280358139765e-14
rare O 0 5.904652851732028e-13
or O 0 4.6843236754801065e-12
absent O 0 1.7535323887374332e-11
in O 0 2.974163883923131e-13
Asiatic O 0 4.0484674640461904e-11
( O 0 7.699518106418779e-13
Indian O 0 2.9301544914386857e-13
, O 0 2.5227092482582418e-14
Chinese O 0 8.21380215633525e-15
) O 0 1.0123480287567432e-14
populations O 0 1.141643420424221e-12
. O 0 6.0817223652975816e-12

The O 0 3.527349311076289e-13
highest O 0 7.402517048773691e-14
allele O 0 7.957214748222086e-12
frequency O 0 3.321176016493621e-12
( O 0 5.460338127830089e-13
7 O 0 2.6356405935772792e-14
. O 0 5.61855059243025e-16
5 O 0 3.605123842411861e-15
% O 0 3.894575752795863e-15
) O 0 1.1058824889902466e-14
was O 0 1.2874294512410511e-11
found O 0 3.1537918110391416e-11
in O 0 3.46989208199755e-11
Swedes O 0 1.0746740386480269e-08
. O 0 5.07209595504432e-12

Saamis O 0 7.269628099493275e-08
( O 0 1.0893294599689796e-10
2 O 0 1.0175235220372114e-12
% O 0 5.528536951696951e-14
) O 0 1.4206584822114895e-14
and O 0 7.699863221522808e-15
Mordvinians O 0 8.739441462179975e-12
( O 0 7.580141043659044e-15
1 O 0 3.2777104564307626e-15
. O 0 1.1087795746039168e-15
8 O 0 1.4026190521272252e-14
% O 0 3.860348845463211e-15
) O 0 9.635454631710342e-15
had O 0 9.010271912260337e-13
significantly O 0 2.330472186756749e-12
lower O 0 7.513979889683942e-12
frequencies O 0 4.14591104502815e-12
of O 0 2.005269356868209e-14
the O 0 8.280395683360475e-13
Tyr O 0 1.0978868481004156e-08
allele O 0 6.530672447269126e-09
. O 0 2.9632571396653873e-10

Comparisons O 0 3.8933750667879963e-10
with O 0 6.511649807685801e-14
allele O 0 2.9841563248256264e-11
frequencies O 0 5.884093125935186e-12
based O 0 1.086477262324248e-12
on O 0 9.570940394387772e-12
prevalence O 0 4.050161039881317e-10
estimates O 0 6.895517577071297e-12
of O 0 1.2716988107095567e-13
HH B-Disease 1 0.8724603056907654
showed O 0 1.1738887195633652e-08
some O 0 7.902304434729765e-14
disagreements O 0 2.1494717897946325e-12
with O 0 3.6890108620739337e-16
the O 0 2.948652979499044e-15
RFLP O 0 7.692906034417746e-11
data O 0 2.60684572886416e-12
, O 0 1.3776823174567639e-14
particularly O 0 1.5102092753432883e-12
in O 0 1.9009814555825955e-11
Finns O 0 3.7648142381385696e-08
. O 0 2.0048058699262405e-11

The O 0 5.522069346924896e-13
newly O 0 8.087211456064836e-12
described O 0 1.1981019475137966e-11
HFE O 0 1.5798146790757528e-08
marker O 0 1.2174893038174872e-11
provides O 0 1.9414516923364072e-13
a O 0 1.0300593521585591e-13
new O 0 1.5148300636872586e-13
approach O 0 4.0986159778599873e-13
to O 0 2.4561283081426123e-15
the O 0 6.076843062498109e-15
screening O 0 1.9155501837508915e-12
of O 0 3.5402398481027605e-15
HH B-Disease 0 6.0295017867417755e-09
as O 0 2.875989919305655e-14
well O 0 4.127859214381538e-15
as O 0 2.316278933386191e-15
studies O 0 3.4981488327779156e-14
of O 0 1.7063652430366516e-17
the O 0 3.4730219603866194e-16
relationship O 0 3.510188016989102e-13
between O 0 3.8519660144941195e-14
the O 0 3.554357058243446e-13
HFE O 0 1.901797332948263e-07
Tyr O 0 1.3823850508742908e-08
allele O 0 1.25487586988271e-09
and O 0 1.0349996901193315e-11
different O 0 5.581732558795904e-12
disorders O 0 1.1546342904011908e-07
including O 0 1.665135260578432e-12
cancer B-Disease 0 1.7211796432548e-07

Autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9999958276748657
neurohypophyseal I-Disease 1 0.9999997615814209
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.8356963396072388
associated O 0 2.0747812357058137e-09
with O 0 6.814369218639121e-14
a O 0 1.8329105594405704e-12
missense O 0 4.726830127310677e-07
mutation O 0 8.286838437676636e-10
encoding O 0 6.019502118981279e-10
Gly23 O 0 6.024767884582616e-08
- O 0 4.082756177581359e-08
- O 0 9.265916389722406e-08
> O 0 2.1082412204886936e-10
Val O 0 1.6081830978009748e-08
in O 0 1.1579143893714061e-10
neurophysin O 0 4.092044946446549e-06
II O 0 8.248711935721076e-09
. O 0 3.939573493816351e-12

Autosomal B-Disease 1 0.9999992847442627
dominant I-Disease 1 0.9999890327453613
neurohypophyseal I-Disease 1 0.9999995231628418
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9995445609092712
( O 0 8.834334153107193e-08
ADNDI B-Disease 0 1.5439503840752877e-05
) O 0 1.8033583524049157e-12
is O 0 6.241491698477653e-14
an O 0 5.155014327733187e-13
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.9444034923821185e-11
by O 0 3.5091287514665837e-14
progressive O 0 1.9261513217738724e-10
degeneration O 0 4.5496295797420316e-07
of O 0 3.4520355544480916e-15
the O 0 3.24385243194664e-15
magnocellular O 0 1.412267247591359e-10
neurons O 0 5.013615824583928e-12
of O 0 7.130692338714348e-16
the O 0 6.839911221877867e-16
hypothalamus O 0 6.991182806281859e-13
leading O 0 4.438817206593032e-13
to O 0 3.104126512242281e-15
decreased O 0 7.142767280421403e-12
ability O 0 9.358694239491525e-14
to O 0 9.979465204776414e-15
produce O 0 3.2689920648892867e-13
the O 0 3.0728967547605235e-13
hormone O 0 2.6375705439174446e-11
arginine O 0 1.5043832846117766e-10
vasopressin O 0 8.339094692555449e-11
( O 0 1.9626274563866453e-11
AVP O 0 5.425512128454102e-08
) O 0 5.439219387393113e-12
. O 0 1.1210026830410502e-11

Affected O 0 1.4458795272176417e-10
individuals O 0 1.8458260771627225e-14
are O 0 2.552206620074957e-15
not O 0 2.076425672503375e-15
symptomatic O 0 3.7770628638633674e-12
at O 0 5.857909101368575e-13
birth O 0 2.1339582878532326e-11
, O 0 1.6518138582204828e-13
but O 0 9.584252879182853e-13
usually O 0 8.050839183683378e-13
develop O 0 8.335309525930867e-11
diabetes B-Disease 0 7.538513102645084e-08
insipidus I-Disease 0 1.8425675207822678e-08
at O 0 9.36534617218543e-12
1 O 0 1.6828790097567214e-11
- O 0 1.8233939044876024e-05
6 O 0 1.4877595821971568e-09
yr O 0 8.010129931790289e-06
of O 0 1.0433057412786995e-12
age O 0 9.598274952615782e-11
. O 0 3.947636488532691e-12

The O 0 1.7756496685332468e-13
genetic O 0 4.024147681747081e-11
locus O 0 3.9728904194236137e-11
of O 0 4.288998762267196e-14
the O 0 3.414021723744526e-13
disease O 0 2.381906893944574e-10
is O 0 3.0255180430888194e-15
the O 0 1.3718978447566695e-14
AVP O 0 2.0692677082934097e-07
- O 0 6.369634819591852e-10
neurophysin O 0 3.3645257246917026e-08
II O 0 1.6260956470226517e-10
( O 0 5.011548359461215e-13
NPII O 0 6.345164949017601e-10
) O 0 2.7269763256863e-14
gene O 0 4.178055471038e-11
, O 0 4.202892374405298e-13
and O 0 1.240146528492473e-14
mutations O 0 1.7744925537646616e-12
that O 0 1.090440993658506e-15
cause O 0 2.0959999686397113e-14
ADNDI B-Disease 0 2.9854803074158553e-09
have O 0 1.0104965502593169e-13
been O 0 7.349044197626706e-14
found O 0 2.9403215973111685e-13
in O 0 2.612552338907611e-14
both O 0 1.0504284277796337e-15
the O 0 6.65059406421061e-16
signal O 0 7.758722592350609e-13
peptide O 0 4.016090506485902e-14
of O 0 5.333475301284711e-16
the O 0 1.1845710027572239e-14
prepro O 0 7.62031859835588e-09
- O 0 2.6574185074679235e-09
AVP O 0 2.943168908586813e-07
- O 0 2.8080235359162486e-10
NPII O 0 7.227550224975232e-10
precursor O 0 5.621841967645702e-12
and O 0 8.339686498890289e-14
within O 0 1.9655989075967328e-14
NPII O 0 7.98033017446187e-09
itself O 0 6.0732833692678234e-12
. O 0 4.19768733661563e-12

An O 0 1.2305297839715346e-12
affected O 0 7.212425795488642e-11
girl O 0 5.784577297163196e-07
who O 0 6.048400034942489e-14
presented O 0 1.4107324419157952e-14
at O 0 1.233649955193622e-13
9 O 0 1.4306413584179445e-13
months O 0 6.04224515473456e-13
of O 0 3.638363321086251e-16
age O 0 1.866866687280644e-12
and O 0 1.5671779873176542e-14
her O 0 1.4393746069173152e-14
similarly O 0 4.852791345849594e-14
affected O 0 3.5407432736646316e-13
younger O 0 4.9405778947131385e-12
brother O 0 6.451328186940497e-12
and O 0 8.611542062124736e-14
father O 0 2.098717250334503e-13
were O 0 6.106707072526044e-14
all O 0 1.8898985884248148e-17
found O 0 1.8508737159020003e-15
to O 0 2.890174618913995e-16
have O 0 1.8933073560540095e-14
a O 0 4.924006149109768e-14
novel O 0 2.8283080738544797e-11
missense O 0 3.261333603177263e-08
mutation O 0 2.701650292369351e-10
( O 0 3.949037277739542e-12
G1758 O 0 5.83561476918959e-10
- O 0 2.874120386131551e-10
- O 0 8.895772452000017e-10
> O 0 2.2449249056921694e-11
T O 0 4.487035049072219e-11
) O 0 1.972982409094654e-15
encoding O 0 8.908284130975871e-14
the O 0 3.353684547239145e-16
amino O 0 2.148109977655882e-13
acid O 0 4.6813352754795576e-14
substitution O 0 1.5646899127383894e-14
Gly23 O 0 1.9452836563793596e-10
- O 0 3.914173429819812e-09
- O 0 4.5832099004883275e-08
> O 0 1.8214291186424703e-10
Val O 0 9.307395743007874e-09
within O 0 4.118744581504963e-11
NPII O 0 1.8439321138430387e-05
. O 0 5.370810740590315e-11

The O 0 9.939740003295228e-12
mutation O 0 3.5999453418256167e-10
was O 0 1.7612292180224642e-10
confirmed O 0 1.1186718868946843e-12
by O 0 2.279950749069638e-15
restriction O 0 7.356919760892477e-12
endonuclease O 0 3.008139870530613e-08
analysis O 0 1.3874447424289116e-10
. O 0 6.095472217249043e-12

A O 0 3.3081444250626646e-09
T1 O 0 9.506545211479533e-06
- O 0 1.4923922098120102e-09
weighted O 0 5.909875366860717e-11
magnetic O 0 1.3356662781002782e-12
resonance O 0 5.4705913410391105e-11
imaging O 0 6.523180218209745e-07
of O 0 8.32198486554539e-14
the O 0 2.68259074892932e-13
fathers O 0 4.882527021576877e-11
pituitary O 0 3.940972895244421e-11
gland O 0 6.891668485886626e-11
demonstrates O 0 4.451996063470354e-12
an O 0 1.481116390558007e-14
attenuated O 0 4.0769414511032664e-09
posterior O 0 2.427272818295023e-07
pituitary O 0 3.476078563835472e-05
bright O 1 0.967118501663208
spot O 0 4.711353903985582e-05
. O 0 1.5807000153245099e-09

This O 0 7.678414111131349e-13
mutation O 0 1.3455008808505031e-11
may O 0 5.655073631594121e-12
be O 0 1.9513573138441167e-16
valuable O 0 7.818613005563125e-15
for O 0 2.1047420434870902e-17
developing O 0 3.0710771924645497e-15
models O 0 8.147542970154964e-13
of O 0 1.852562064324115e-15
dominantly B-Disease 0 3.412388371870634e-09
inherited I-Disease 0 3.6444529541768134e-05
neurodegeneration I-Disease 1 1.0
, O 0 5.553217391138232e-13
as O 0 2.964566822753821e-15
the O 0 1.018976135684391e-16
early O 0 2.2313060687312314e-12
age O 0 1.4253431673328688e-14
of O 0 1.4291629576997187e-17
onset O 0 4.2246084018190966e-13
of O 0 5.098776368234835e-17
symptoms O 0 1.4000244377438548e-13
suggests O 0 1.7059636369230898e-15
that O 0 2.6136746760915686e-17
this O 0 2.0945552480690507e-16
mutation O 0 6.455805399811776e-13
may O 0 6.06163244598612e-11
be O 0 4.451490174736672e-14
particularly O 0 2.850509541948987e-13
deleterious O 0 3.7301852578996986e-11
to O 0 6.860222161392607e-14
the O 0 2.641367552740255e-14
magnocellular O 0 1.9023291830677636e-09
neuron O 0 7.025959675166504e-11
. O 0 3.516455572907806e-12
. O 0 1.5114548501671266e-11

Frequent O 0 1.1448707759598165e-08
inactivation O 0 2.1290015084218794e-08
of O 0 1.6293593536019502e-13
PTEN O 0 1.819539647840429e-05
/ O 0 5.246171440376202e-06
MMAC1 O 0 1.1545517736522015e-05
in O 0 1.489909196017436e-09
primary O 0 0.00021843564172741026
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.436134154988224e-10

Sporadic B-Disease 1 0.9998273253440857
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 6.915119171724271e-11
the O 0 2.5434497817080053e-15
most O 0 3.462586408597328e-15
common O 0 1.0222057575393073e-12
male B-Disease 0 1.1313497014220353e-11
cancer I-Disease 0 1.9417870089633027e-11
in O 0 4.879440493148202e-13
the O 0 4.0149543811937496e-15
Western O 0 4.250936408434214e-12
world O 0 1.3989528285796027e-11
, O 0 5.076952313415317e-13
yet O 0 9.038638435800161e-13
many O 0 3.414146817805341e-16
of O 0 4.410870719677259e-18
the O 0 2.9415158004761404e-17
major O 0 9.787821459361287e-16
genetic O 0 2.3713717350448e-14
events O 0 1.3393267756628256e-16
involved O 0 4.880068517256614e-15
in O 0 1.393728611253503e-13
the O 0 5.852497916088335e-15
progression O 0 6.157717022912956e-13
of O 0 3.3918302789720485e-17
this O 0 5.539340306367764e-16
often O 0 2.944856272897589e-13
fatal O 0 3.228686415446269e-11
cancer B-Disease 0 6.550107567449004e-09
remain O 0 3.9332928580826376e-10
to O 0 1.1947188301598272e-13
be O 0 1.2510286860265007e-12
elucidated O 0 4.344718362858657e-09
. O 0 1.646942478228386e-11

Numerous O 0 5.009317266546631e-11
cytogenetic O 0 3.362605127676943e-07
and O 0 9.217090632396285e-12
allelotype O 0 7.283684322345607e-09
studies O 0 1.391865789290847e-10
have O 0 1.3189525426698934e-12
reported O 0 4.7779731560115835e-11
frequent O 0 1.1567173434368083e-11
loss O 0 1.356926376816503e-10
of O 0 5.3195420751704983e-14
heterozygosity O 0 4.4739159932305483e-08
on O 0 3.7264538677028725e-10
chromosomal O 0 0.002846928546205163
arm O 1 0.6839463710784912
10q O 0 4.613090823113453e-06
in O 0 4.900959638121094e-09
sporadic B-Disease 1 0.9999679327011108
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.728098716519582e-11

Deletion O 0 2.5269116576964734e-08
mapping O 0 1.6287226012323686e-09
studies O 0 3.050831809403576e-10
have O 0 1.1615757184238462e-13
unambiguously O 0 2.584857675125285e-12
identified O 0 8.368786349674529e-13
a O 0 3.768409263566093e-14
region O 0 2.736387505475335e-13
of O 0 2.5900355350158078e-15
chromosome O 0 1.0228703439807418e-09
10q23 O 0 5.121201795965646e-10
to O 0 8.367309937366146e-15
be O 0 8.766485542825405e-16
the O 0 1.050267650338333e-16
minimal O 0 6.23580370283025e-14
area O 0 5.298704725854864e-13
of O 0 4.2646997587027224e-13
loss O 0 1.4635133993579075e-08
. O 0 4.969092498585681e-11

A O 0 2.5449373719510504e-09
new O 0 8.957282138233325e-11
tumor B-Disease 0 4.292348254608669e-09
suppressor O 0 1.2222609591105993e-08
gene O 0 6.731144086558061e-09
, O 0 2.0586841259495614e-11
PTEN O 0 1.62031519721495e-05
/ O 0 2.757673973974306e-05
MMAC1 O 0 3.933875996153802e-05
, O 0 3.1843327887720596e-12
was O 0 1.834022734029106e-12
isolated O 0 2.6039435364888508e-12
recently O 0 1.8906227972070866e-10
at O 0 1.196588943382093e-13
this O 0 5.571613320449337e-17
region O 0 1.4501603856544726e-14
of O 0 1.2295707080471163e-15
chromosome O 0 4.965438060722249e-10
10q23 O 0 1.0676332040659986e-09
and O 0 2.998622942833318e-13
found O 0 1.7527147268270316e-13
to O 0 4.952115128046815e-16
be O 0 6.494749001640884e-16
inactivated O 0 4.3178171948250396e-14
by O 0 4.806534516611034e-16
mutation O 0 1.3135473611591841e-12
in O 0 5.281479142915657e-10
three O 0 1.6905374877751456e-09
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 1.4271979864588502e-07
lines O 0 2.4129075626433405e-08
. O 0 7.825372294600896e-11

We O 0 3.634864353951883e-10
screened O 0 4.3914429426195056e-08
80 O 0 6.719771961094523e-11
prostate B-Disease 0 7.775138897159195e-07
tumors I-Disease 1 1.0
by O 0 6.5935331603232325e-15
microsatellite O 0 8.293665060277178e-11
analysis O 0 1.9094511128497915e-12
and O 0 1.8876893253280506e-14
found O 0 6.618307518777705e-14
chromosome O 0 6.222474202566275e-10
10q23 O 0 4.299310629729547e-10
to O 0 5.650517488804685e-14
be O 0 3.557470073731195e-13
deleted O 0 2.5769064659897367e-09
in O 0 8.60004845115725e-11
23 O 0 3.0130505729308865e-11
cases O 0 3.19548510915868e-12
. O 0 1.1905406131426655e-12

We O 0 3.501765891145148e-11
then O 0 4.965532447568678e-14
proceeded O 0 8.013164106866408e-14
with O 0 6.0492872112957425e-18
sequence O 0 1.9342162521976663e-15
analysis O 0 9.559778167103801e-15
of O 0 3.7376946762874156e-17
the O 0 1.6022620284654563e-15
entire O 0 3.746268486398696e-12
PTEN O 0 4.763594461110188e-06
/ O 0 3.469411922196741e-07
MMAC1 O 0 6.651862918261031e-07
coding O 0 1.6549275727584245e-08
region O 0 6.889538939347517e-11
and O 0 1.9963490496127667e-12
tested O 0 1.6446344069595553e-12
for O 0 2.9546528844413605e-16
homozygous O 0 1.5241573194518798e-12
deletion O 0 6.771684341738693e-12
with O 0 2.3019386655891757e-15
new O 0 7.58332958060437e-13
intragenic O 0 9.910785525590882e-10
markers O 0 6.501942040326725e-11
in O 0 1.0477267924774436e-12
these O 0 9.390695144238792e-15
23 O 0 1.249983460922116e-13
cases O 0 1.0949975226949658e-14
with O 0 7.256314206934857e-16
10q23 O 0 1.5300433142684255e-09
loss O 0 2.2390461706933706e-10
of O 0 8.798455806155805e-14
heterozygosity O 0 6.116143680401365e-08
. O 0 1.2445090791235458e-10

The O 0 2.6963902031301723e-13
identification O 0 3.4333005188846855e-12
of O 0 1.3174017778094013e-15
the O 0 3.213291991429473e-14
second O 0 4.2410077186194606e-12
mutational O 0 4.215294224785282e-10
event O 0 7.423159580511457e-14
in O 0 9.894149301942212e-13
10 O 0 6.417571552300161e-14
( O 0 2.3131111826293904e-13
43 O 0 8.318295705023182e-12
% O 0 2.454937728796347e-12
) O 0 1.7826633225137556e-10
tumors B-Disease 1 1.0
establishes O 0 3.1358016627791585e-08
PTEN O 0 4.154226917307824e-05
/ O 0 3.542361446307041e-05
MMAC1 O 0 2.278829924762249e-06
as O 0 6.03027122594163e-13
a O 0 2.804367354384673e-14
main O 0 7.43829639809207e-14
inactivation O 0 2.149279235488799e-12
target O 0 2.992537858140243e-13
of O 0 1.2517530821555198e-14
10q O 0 3.0378264348485118e-09
loss O 0 3.473179965851614e-09
in O 0 3.3413354305622534e-09
sporadic B-Disease 1 0.9999990463256836
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.2322035593022065e-12
. O 0 1.3904581696103091e-12

Risk O 0 2.5569127259927882e-08
reversals O 0 1.58050705856283e-09
in O 0 2.6254416392659796e-13
predictive O 0 4.3515746561695323e-10
testing O 0 1.9182018820562696e-11
for O 0 2.5033415011060933e-13
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 6.080774772598829e-11

The O 0 8.553755441583974e-14
first O 0 1.6386147132100085e-14
predictive O 0 9.905823557254667e-12
testing O 0 8.139977949496446e-13
for O 0 3.19820768989159e-14
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.0813262098111638e-12
HD B-Disease 0 7.046825345469188e-08
) O 0 2.0012927404687575e-13
was O 0 3.4288159334386337e-13
based O 0 8.075668870329965e-15
on O 0 4.368230901779721e-14
analysis O 0 1.5880363430503808e-14
of O 0 5.472484326713227e-17
linked O 0 4.08870203319478e-12
polymorphic O 0 5.115468465488604e-11
DNA O 0 1.181531088245702e-11
markers O 0 9.211057480987273e-13
to O 0 1.119075577715148e-15
estimate O 0 1.3858795296257942e-13
the O 0 8.870093024746775e-16
likelihood O 0 4.163405731283376e-13
of O 0 1.2253891181447586e-15
inheriting O 0 1.1551651128705043e-11
the O 0 1.4767553567257737e-14
mutation O 0 1.8737945223223917e-12
for O 0 5.919797529778392e-13
HD B-Disease 0 3.690560390623432e-07
. O 0 4.2098286662239914e-11

Limits O 0 3.082390245823241e-12
to O 0 1.3597191203377525e-14
accuracy O 0 1.522964968112689e-13
included O 0 1.1772545650929017e-15
recombination O 0 7.941343844455537e-15
between O 0 2.534713060373551e-15
the O 0 4.790263966606345e-15
DNA O 0 4.405387513117809e-11
markers O 0 1.4827918407012142e-11
and O 0 3.3928707689505e-14
the O 0 1.9569266878212118e-15
mutation O 0 5.939952306063812e-13
, O 0 1.6849777053230125e-13
pedigree O 0 1.5972620448501118e-10
structure O 0 7.810630939762697e-13
, O 0 1.0240234461984018e-14
and O 0 4.791632030695279e-16
whether O 0 2.1647893671708051e-16
DNA O 0 4.3347023561714215e-13
samples O 0 7.465184273156532e-15
were O 0 5.688904937270955e-15
available O 0 5.547314909807926e-15
from O 0 5.186195711163327e-14
family O 0 8.166570176180998e-13
members O 0 4.8413550458089455e-14
. O 0 1.4616330064678995e-12

With O 0 1.768116496313546e-13
direct O 0 1.8752963591717187e-12
tests O 0 1.2281621032672607e-11
for O 0 2.724717055881912e-16
the O 0 1.0059647037629401e-15
HD B-Disease 0 1.3802510245852773e-08
mutation O 0 1.490986425035229e-13
, O 0 1.950348113262737e-13
we O 0 1.6212025957264807e-14
have O 0 1.486418282118271e-16
assessed O 0 3.730248396413213e-15
the O 0 5.811978109822956e-17
accuracy O 0 4.233031460076919e-12
of O 0 2.0802788253804346e-15
results O 0 1.1992118994878787e-13
obtained O 0 6.583005896041577e-14
by O 0 4.3941168215708756e-15
linkage O 0 3.832873254894231e-11
approaches O 0 3.1986438237679993e-12
when O 0 1.5139576875142224e-13
requested O 0 3.195721411022173e-13
to O 0 1.1059964149216523e-14
do O 0 5.280705343488346e-13
so O 0 1.1657916682177093e-15
by O 0 4.0270374914747894e-17
the O 0 4.407748969823986e-15
test O 0 6.929923486182626e-14
individuals O 0 1.4890239936920418e-15
. O 0 3.2994605853910175e-13

For O 0 2.20747668733777e-13
six O 0 7.135240376245511e-15
such O 0 1.8411958483189177e-17
individuals O 0 2.0262749957485954e-16
, O 0 5.100252699016296e-14
there O 0 1.6643778979271058e-14
was O 0 2.1969873023695158e-14
significant O 0 2.292142306037706e-15
disparity O 0 2.784801469285503e-13
between O 0 3.9627047303258944e-14
the O 0 6.616998073603886e-13
tests O 0 3.148100530259157e-11
. O 0 6.92019195853294e-13

Three O 0 1.5131972064263977e-11
went O 0 4.1386898248785275e-12
from O 0 9.868280271988026e-15
a O 0 8.011101412233254e-14
decreased O 0 5.085757856515549e-11
risk O 0 4.101452454031117e-14
to O 0 6.081985081883535e-17
an O 0 1.7118754239691124e-16
increased O 0 7.040748734900293e-13
risk O 0 4.875833677780994e-12
, O 0 7.617988000401671e-14
while O 0 2.23508193154592e-14
in O 0 5.0842366612364326e-14
another O 0 7.826494308324147e-14
three O 0 4.22652432258315e-14
the O 0 9.041353345802701e-15
risk O 0 2.6453545950988477e-11
was O 0 3.2418238232745367e-11
decreased O 0 2.825360223557283e-10
. O 0 3.2740166914374536e-12

Knowledge O 0 6.557851484068067e-11
of O 0 4.3194457850727255e-15
the O 0 4.0631167275141883e-16
potential O 0 8.569329836385139e-15
reasons O 0 4.475777573949768e-15
for O 0 5.311159622719255e-17
these O 0 5.461827262573339e-17
changes O 0 3.883048904933153e-15
in O 0 6.9265470095669635e-12
results O 0 1.3455702697895422e-11
and O 0 8.549889583212705e-14
impact O 0 8.941581334945617e-14
of O 0 1.109824323569906e-16
these O 0 2.03859569877134e-15
risk O 0 5.69409699512774e-14
reversals O 0 2.0594723842970453e-12
on O 0 1.6528152205707268e-14
both O 0 1.5490082835661022e-14
patients O 0 9.316821673963777e-14
and O 0 1.152763772093346e-15
the O 0 1.3756308460101613e-15
counseling O 0 9.50763556425982e-13
team O 0 9.27466772409095e-16
can O 0 6.288110549597869e-16
assist O 0 1.4128267097020578e-15
in O 0 1.789213444286855e-14
the O 0 5.351368342899866e-16
development O 0 2.4542739412628358e-15
of O 0 1.263427726679614e-17
strategies O 0 8.305869555504108e-15
for O 0 3.9543035002130017e-17
the O 0 5.715831797026814e-16
prevention O 0 9.488355332551782e-14
and O 0 1.3335920714423384e-15
, O 0 8.119400413773097e-17
where O 0 2.4388907509146238e-17
necessary O 0 1.810846326946551e-14
, O 0 5.949266771630929e-15
management O 0 4.0129526221108214e-13
of O 0 2.4426337431864263e-17
a O 0 1.4968932939962015e-13
risk O 0 7.262199522295454e-12
reversal O 0 7.873516942591419e-12
in O 0 2.950032457356942e-14
any O 0 2.715795829595722e-14
predictive O 0 2.2287903467255177e-10
testing O 0 4.32084715229486e-11
program O 0 4.1740708112136815e-12
. O 0 1.3001813438818371e-13
. O 0 1.4773765977943443e-12

A O 0 1.1726500326325606e-10
novel O 0 7.890478548322477e-11
common O 0 1.217733830438661e-10
missense O 0 1.3080767757855938e-06
mutation O 0 4.883267568089877e-09
G301C O 0 9.47904599257754e-09
in O 0 5.269778753994037e-13
the O 0 1.798496078355815e-14
N O 0 8.626596659233599e-11
- O 0 1.0039892528457273e-10
acetylgalactosamine O 0 1.4102772638580063e-07
- O 0 6.650259787299717e-10
6 O 0 1.6683439352238594e-11
- O 0 3.281845975533493e-11
sulfate O 0 6.283786685434833e-11
sulfatase O 0 1.126067683543397e-09
gene O 0 5.343817055525335e-10
in O 0 3.5556627087096615e-11
mucopolysaccharidosis B-Disease 0 1.8471178009349387e-07
IVA I-Disease 0 4.9778836910263635e-06
. O 0 2.1160768970407418e-10

Mucopolysaccharidosis B-Disease 0 3.9809627196518704e-05
IVA I-Disease 0 0.3151479959487915
( O 0 0.00046948104863986373
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 7.970601262341503e-11
is O 0 5.568395137350857e-13
an O 0 2.0089388052396684e-12
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 0.9999998807907104
lysosomal I-Disease 1 0.9999992847442627
storage I-Disease 1 0.9999953508377075
disorder I-Disease 1 0.9999996423721313
caused O 0 4.77525831377168e-11
by O 0 1.795695618025603e-14
a O 0 2.0855065230307446e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 4.699482990255799e-12
N O 0 1.3371211915469416e-09
- O 0 6.636081129052229e-10
acetylgalactosamine O 0 1.2956974387634546e-05
- O 0 1.0471275402323954e-08
6 O 0 1.8816397051590883e-10
- O 0 5.119678014864348e-10
sulfate O 0 4.5687692518114886e-10
sulfatase O 0 3.713777374514393e-08
( O 0 7.31900477723979e-12
GALNS O 0 2.90216224385631e-08
) O 0 3.3557197819111817e-12
. O 0 4.045879516828554e-12

In O 0 5.834287220007894e-11
previous O 0 1.1221273476386129e-12
studies O 0 6.602113387238484e-12
, O 0 3.7630082426812206e-14
we O 0 3.830877181096445e-15
have O 0 6.493609742326827e-16
found O 0 1.632547077395647e-14
two O 0 9.553903781856356e-16
common O 0 8.69392414776151e-15
mutations O 0 5.8703915209804e-13
in O 0 1.4095398025854022e-12
Caucasians O 0 7.746342456371735e-10
and O 0 1.1363967492711291e-12
Japanese O 0 3.0680739199206997e-11
, O 0 3.823557884695926e-14
respectively O 0 1.6701003644273293e-12
. O 0 1.4952704872894795e-12

To O 0 1.5316351702557296e-12
characterize O 0 1.2000259119737677e-10
the O 0 1.6694848628540093e-13
mutational O 0 2.380237118515538e-09
spectrum O 0 2.255602388895328e-12
in O 0 5.2874049675253124e-14
various O 0 5.811072181616088e-16
ethnic O 0 5.21040543745516e-15
groups O 0 2.734433264940748e-15
, O 0 4.642708201392509e-14
mutations O 0 1.4496363094293474e-12
in O 0 8.832610207468172e-13
the O 0 9.24792774097908e-15
GALNS O 0 1.0564992630746062e-10
gene O 0 4.982196079306167e-12
in O 0 4.083852125826709e-13
Colombian O 0 1.9822865571228476e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.007235628236458e-08
were O 0 9.531417132337475e-14
investigated O 0 9.885793355798866e-13
, O 0 2.8807649828425062e-15
and O 0 1.1306785526639927e-15
genetic O 0 2.1710291984305963e-12
backgrounds O 0 7.174759484446236e-12
were O 0 6.801692354143924e-15
extensively O 0 1.0356324901383135e-13
analyzed O 0 2.0476074178224501e-13
to O 0 4.452309573234022e-16
identify O 0 4.819188871205658e-14
racial O 0 3.4179165167612727e-14
origin O 0 2.8798212187326755e-14
, O 0 7.30221936926954e-15
based O 0 8.572697639383422e-15
on O 0 4.0505698296368353e-14
mitochondrial O 0 2.49063595268717e-12
DNA O 0 2.0595726513139567e-10
( O 0 1.2465412816548005e-12
mtDNA O 0 1.7222896442348201e-09
) O 0 1.6241667732952436e-11
lineages O 0 5.320884621795585e-09
. O 0 1.7566800791790627e-10

Three O 0 1.3178417558601385e-11
novel O 0 4.6149140064954963e-11
missense O 0 1.1636946339876886e-07
mutations O 0 4.741934844787465e-09
never O 0 7.84267512043968e-11
identified O 0 8.125897524302594e-12
previously O 0 4.241731613304975e-14
in O 0 2.5247153187388715e-15
other O 0 7.408523380578495e-17
populations O 0 8.506016664676722e-15
and O 0 6.669833549398721e-14
found O 0 9.603105637079334e-12
in O 0 2.9408081525517105e-10
16 O 0 5.724418768865425e-12
out O 0 1.3775910750676856e-13
of O 0 3.7789019689035e-15
19 O 0 8.525390463032245e-12
Colombian O 0 4.727037605789519e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 0.9999998807907104
unrelated O 0 4.3596995458194954e-10
alleles O 0 6.12503103791795e-11
account O 0 1.696683071816807e-11
for O 0 2.5043492670254186e-13
84 O 0 1.589650980293733e-11
. O 0 4.575977183979285e-12

2 O 0 8.460050021641408e-11
% O 0 7.934841477451327e-13
of O 0 2.3387675522566743e-16
the O 0 3.598487762786597e-15
alleles O 0 8.629106001793729e-13
in O 0 4.307023834804191e-11
this O 0 1.4471933308841944e-13
study O 0 2.1498696919919347e-12
. O 0 2.1285263048648195e-12

The O 0 1.7956571993216208e-11
G301C O 0 4.844157075467592e-09
and O 0 4.939049386490368e-13
S162F O 0 3.14868305040239e-11
mutations O 0 6.552521979868997e-12
account O 0 1.7231478830620484e-12
for O 0 4.3906925214750106e-14
68 O 0 1.5195688457536605e-11
. O 0 2.056308899198167e-12

4 O 0 1.874969957071926e-09
% O 0 1.0289553237230464e-10
and O 0 2.6465355948412927e-11
10 O 0 3.812237851785749e-12
. O 0 2.7378088945234635e-12

5 O 0 3.317380536937975e-10
% O 0 2.2297107736546362e-12
of O 0 5.8125799002622e-16
mutations O 0 4.281451061738384e-12
, O 0 1.4215889479040483e-13
respectively O 0 5.870456031009663e-14
, O 0 1.8256223931949287e-15
whereas O 0 4.3782651928860744e-14
the O 0 2.0988193178046472e-15
remaining O 0 1.2077099303259287e-12
F69V O 0 3.138518422929337e-08
is O 0 3.7082594211024916e-14
limited O 0 7.95468834031976e-14
to O 0 4.927867602909711e-14
a O 0 1.3648711501279553e-11
single O 0 3.1744863682181546e-11
allele O 0 4.30988000843513e-09
. O 0 9.656490052023514e-10

The O 0 8.717744408304196e-13
skewed O 0 3.4351510524999185e-10
prevalence O 0 9.980403170573027e-10
of O 0 2.929123364350675e-15
G301C O 0 2.2150664982789614e-11
in O 0 8.598210271754721e-15
only O 0 1.6098467849916449e-15
Colombian O 0 1.0712848793822949e-12
patients O 0 1.1011058601365087e-12
and O 0 3.682587123020635e-15
haplotype O 0 3.890802610651001e-12
analysis O 0 1.7778650662661315e-14
by O 0 2.461060051598882e-16
restriction O 0 3.2657825554081865e-13
fragment O 0 8.155771197282391e-12
length O 0 1.3933040918928663e-12
polymorphisms O 0 3.3997960002807304e-10
in O 0 1.2489259843331824e-12
the O 0 1.8693483515145638e-14
GALNS O 0 9.829720371001827e-10
gene O 0 1.0134004746475966e-11
suggest O 0 4.747554346179461e-13
that O 0 2.4124938293812806e-15
G301C O 0 1.0893144025692081e-11
originated O 0 5.669134432728651e-12
from O 0 3.533611933875108e-13
a O 0 6.907400541301956e-13
common O 0 8.922420094426009e-13
ancestor O 0 1.9600760250981786e-11
. O 0 5.747352593843402e-11

Investigation O 0 3.579123802888162e-11
of O 0 8.555835330985957e-16
the O 0 2.0551647220108183e-15
genetic O 0 1.701031503154038e-11
background O 0 7.16863070640561e-12
by O 0 8.964318028590527e-16
means O 0 7.559843593143989e-14
of O 0 2.42406059367163e-16
mtDNA O 0 2.7776642097521176e-11
lineages O 0 3.184794442057104e-12
indicate O 0 1.7501367109012955e-12
that O 0 9.504326308178851e-15
all O 0 2.553443499936185e-15
our O 0 2.419894991516152e-15
patients O 0 6.845079181647302e-16
are O 0 6.760474768092297e-18
probably O 0 3.004850735637346e-14
of O 0 3.009802207020353e-17
native O 0 3.7525744230743063e-13
American O 0 2.5182425589242996e-11
descent O 0 4.0999552197718e-08

Low O 0 4.661498209657111e-08
frequency O 0 7.460106976608927e-10
of O 0 1.3041999392341547e-13
BRCA1 O 0 1.104795842366002e-06
germline O 0 1.9306037657429442e-08
mutations O 0 4.2518413789771614e-10
in O 0 2.6604473832292364e-12
45 O 0 1.1227596109775195e-11
German O 1 0.9999502897262573
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.313699809519676e-08
. O 0 2.585899376572609e-11

In O 0 7.854081274238922e-11
this O 0 6.1893743541561585e-15
study O 0 6.7746063580731e-15
we O 0 7.961328316296581e-16
investigated O 0 5.791757861067087e-14
45 O 0 6.955467289366385e-14
German O 0 0.019337384030222893
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.7521883249882464e-11
for O 0 9.05205221895947e-15
germline O 0 4.09582634475214e-09
mutations O 0 5.465911057100925e-10
in O 0 2.9226432472079233e-12
the O 0 7.331767436008149e-14
BRCA1 O 0 2.5678113857452445e-08
gene O 0 2.2397019350250957e-08
. O 0 2.369391904899487e-10

We O 0 1.4949005575082275e-11
identified O 0 3.4158488537716636e-11
four O 0 1.0893777470811356e-13
germline O 0 3.474876386633241e-09
mutations O 0 1.5592953594989467e-09
in O 0 2.6553498289061395e-10
three O 0 8.28907515543209e-12
breast B-Disease 0 1.5930625352211791e-07
cancer I-Disease 0 1.4284664118235924e-08
families O 0 1.7044472387303666e-12
and O 0 3.5904683089518774e-14
in O 0 2.1598653855009475e-12
one O 0 5.595878178610292e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 6.761823306139503e-12
. O 0 4.3939635615469817e-16
among O 0 3.652921898390531e-17
these O 0 1.011508795791793e-17
were O 0 3.4235256959929327e-15
one O 0 3.367955464213604e-15
frameshift O 0 2.3213013733425214e-09
mutation O 0 8.60930077228872e-12
, O 0 3.0712164582336055e-12
one O 0 1.7361063758478124e-12
nonsense O 0 4.828119131161657e-07
mutation O 0 8.841265913828167e-11
, O 0 1.5120769220056118e-12
one O 0 1.3953477824948154e-14
novel O 0 5.042932217647067e-13
splice O 0 2.5486535104590757e-09
site O 0 1.53037443828552e-11
mutation O 0 3.4661568060201375e-10
, O 0 2.1262316907133538e-10
and O 0 1.135690933656841e-11
one O 0 4.7410959706783995e-12
missense O 0 4.430684839462629e-06
mutation O 0 5.0933174122747005e-08
. O 0 1.4668326553390898e-09

The O 0 1.5015379347879665e-12
missense O 0 4.569765454931485e-09
mutation O 0 4.872228662189393e-11
was O 0 2.162927392745928e-09
also O 0 1.7760501186056543e-12
found O 0 1.3955762760697876e-11
in O 0 2.286353745217795e-10
2 O 0 1.7296159296464886e-11
. O 0 3.403115983457994e-11

8 O 0 1.8392581901949256e-10
% O 0 1.704222022834087e-13
of O 0 1.3483021650737812e-17
the O 0 4.7095928531123106e-17
general O 0 1.1193611866370504e-16
population O 0 2.1325111583949854e-17
, O 0 6.506106125276788e-16
suggesting O 0 4.4825653063539084e-13
that O 0 9.106914542953131e-15
it O 0 6.605091771921465e-14
is O 0 5.517318508530336e-14
not O 0 1.6796168405761036e-12
disease O 0 2.2818826689308125e-11
associated O 0 6.170912305453191e-12
. O 0 1.984259111187381e-11

The O 0 1.7896377739121117e-13
average O 0 4.459936239764595e-11
age O 0 7.731836004776227e-13
of O 0 1.487820253994875e-15
disease O 0 3.054911879019073e-11
onset O 0 1.1058736391900137e-11
in O 0 5.6438825103222526e-14
those O 0 3.291870094451776e-15
families O 0 3.7495514302481915e-15
harbouring O 0 7.851955197146765e-11
causative O 0 2.8562898712891638e-09
mutations O 0 2.6479962667025347e-10
was O 0 8.682705943119373e-11
between O 0 2.500451018114247e-12
32 O 0 1.29240229629346e-10
. O 0 7.710280330863739e-12

3 O 0 1.965050167029858e-08
and O 0 4.053729227293523e-11
37 O 0 1.9670282069839118e-10
. O 0 5.7602559874747605e-12

4 O 0 8.383561067581979e-10
years O 0 7.764925312979398e-13
, O 0 2.481679268754775e-15
whereas O 0 7.706533605982436e-15
the O 0 3.4767332881845733e-16
family O 0 4.469910092020843e-14
harbouring O 0 5.966949850888525e-11
the O 0 8.050109651146567e-15
missense O 0 4.3100420454855737e-10
mutation O 0 2.9156221707793417e-12
had O 0 1.2396322033106366e-12
an O 0 3.3224615893143715e-16
average O 0 2.638324021059235e-12
age O 0 1.848428094614052e-12
of O 0 1.0440172354018659e-14
onset O 0 3.9334505097521344e-10
of O 0 1.7537714173693902e-13
51 O 0 3.499564249498377e-10
. O 0 2.2487390421987996e-11

2 O 0 2.943589194615015e-08
years O 0 9.424969832361185e-11
. O 0 5.278613483816752e-12

These O 0 1.0591285742314258e-13
findings O 0 1.5925809119816253e-13
show O 0 7.228183438075242e-14
that O 0 5.6950497377868115e-15
BRCA1 O 0 1.3823566291648604e-07
is O 0 5.646254405862472e-13
implicated O 0 1.4320290829886173e-12
in O 0 1.7109110081372364e-14
a O 0 1.1278742383338705e-15
small O 0 1.435621234521442e-14
fraction O 0 1.9457612604467656e-11
of O 0 2.124453057916753e-09
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.566691646889053e-12
suggesting O 0 5.885796407548161e-13
the O 0 1.0171745495451403e-15
involvement O 0 8.96723491359934e-14
of O 0 3.4194908016091277e-16
another O 0 1.1144502611330417e-13
susceptibility O 0 1.0503264057104555e-11
gene O 0 1.8580745830831802e-08
( O 0 2.962710521359213e-09
s O 0 7.64196386171534e-07
) O 0 4.51990356253873e-09

Paternal O 0 1.8406817616778426e-05
transmission O 0 9.481808774580713e-06
of O 0 9.040682091843166e-11
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 4.629502470265834e-08

We O 0 2.742987614823278e-09
report O 0 2.2118369635837354e-11
a O 0 5.016748464130999e-14
rare O 0 3.0291776031976525e-12
case O 0 4.6508692730373724e-11
of O 0 6.197362637178419e-14
paternally O 0 0.0011071822373196483
transmitted O 1 0.9995883107185364
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.7926174402236938
DM B-Disease 1 1.0
) O 0 4.026186495309503e-09
. O 0 6.003308961055609e-11

The O 0 3.606847622222159e-13
proband O 0 2.030196150082375e-10
is O 0 9.755991655269365e-15
a O 0 9.553403397142765e-14
23 O 0 4.3864950734218144e-12
year O 0 2.8252764711078626e-12
old O 0 8.213960995817615e-07
, O 0 2.953151889695249e-10
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 1.158924622934876e-09
who O 0 1.7426594889347058e-11
suffers O 0 4.8090939230860386e-08
severe O 0 3.0093571012912435e-07
muscular B-Disease 0 0.0006289584562182426
weakness I-Disease 1 0.5405826568603516
. O 0 9.47029454856363e-10

He O 0 1.0862587912496835e-10
presented O 0 4.156512807551582e-12
with O 0 1.4250536514714973e-12
respiratory O 0 1.580444586579688e-05
and O 0 5.177770105030399e-12
feeding O 0 1.006059038161089e-11
difficulties O 0 4.70626926318829e-10
at O 0 6.343186392809841e-12
birth O 0 7.925909928374608e-11
. O 0 5.877822534250399e-12

His O 0 8.15671363785242e-10
two O 0 4.4331531501295984e-11
sibs O 0 0.00042016265797428787
suffer O 0 9.733943073797491e-08
from O 0 8.113738847459473e-12
childhood O 0 3.4125079650948464e-07
onset O 0 0.0016720718704164028
DM B-Disease 1 1.0
. O 0 1.0823051344033274e-09

Their O 0 5.996039168648659e-12
late O 0 1.3279713995117959e-09
father O 0 3.362324958386398e-12
had O 0 1.217274436630944e-13
the O 0 5.4348499249477793e-17
adult O 0 2.2666059567438834e-14
type O 0 1.2134183415002386e-11
of O 0 3.0118540040452446e-12
DM B-Disease 1 1.0
, O 0 5.474228383962887e-13
with O 0 3.99850838948986e-15
onset O 0 2.362026893520941e-11
around O 0 6.0859229981946594e-12
30 O 0 6.209793096401128e-12
years O 0 9.054271004824144e-13
. O 0 2.712530449821421e-13

Only O 0 3.213908089313988e-12
six O 0 4.806154050586951e-14
other O 0 8.594397961747587e-17
cases O 0 6.930365340919562e-16
of O 0 1.9685449358328866e-17
paternal O 0 1.5206401693390603e-09
transmission O 0 1.278401668969309e-06
of O 0 8.864416145559773e-11
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 3.614112786820556e-09
been O 0 1.8401202436790776e-11
reported O 0 9.921112820165945e-10
recently O 0 1.5399449493358475e-09
. O 0 6.710187960834446e-12

We O 0 7.163864640391537e-11
review O 0 7.022897346130319e-13
the O 0 1.1065148202611956e-15
sex O 0 2.6483356523401835e-13
related O 0 4.824780982723431e-14
effects O 0 3.1360046937739527e-12
on O 0 2.310040700392868e-11
transmission O 0 6.681045050527246e-08
of O 0 7.444595634398254e-11
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.732979315605121e-09

Decreased O 0 1.40519933466976e-08
fertility O 0 8.467056916705573e-11
of O 0 7.178782634294711e-16
males O 0 1.6312064275280508e-13
with O 0 8.210543620587162e-15
adult O 0 4.866139158288263e-10
onset O 0 7.931000141070399e-07
DM B-Disease 1 1.0
and O 0 2.4389074093633667e-11
contraction O 0 1.0629355173819022e-09
of O 0 6.359535941130598e-17
the O 0 2.1710083095393258e-16
repeat O 0 9.304515301679708e-14
upon O 0 2.610716479697732e-16
male O 0 3.406221363451943e-14
transmission O 0 1.0073911106342481e-12
contribute O 0 2.052602659103611e-15
to O 0 6.3293872062714e-15
the O 0 2.8223220811742118e-14
almost O 0 8.032433767603264e-13
absent O 0 6.823060454304308e-13
occurrence O 0 1.0247155229382854e-13
of O 0 1.5467932288815611e-15
paternal O 0 1.6224223076122257e-09
transmission O 0 3.267367389980791e-07
of O 0 2.1654071591381552e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 4.3899417434545285e-09

Also O 0 4.311421011871097e-11
the O 0 6.61116288057091e-15
fathers O 0 3.4260243838950266e-13
of O 0 2.229165062302214e-17
the O 0 7.377560620587206e-16
reported O 0 2.5785487078877622e-09
congenitally O 0 2.7640806976592103e-08
affected O 0 8.409883033022592e-12
children O 0 1.0062566231650028e-11
showed O 0 5.753187509727198e-11
, O 0 1.5231299023681782e-14
on O 0 1.9753803627564626e-12
average O 0 9.2059511055953e-12
, O 0 7.134372845100934e-14
shorter O 0 2.772537976980516e-09
CTG O 0 7.906383103772896e-08
repeat O 0 6.756996073775667e-10
lengths O 0 7.69812391610003e-09
and O 0 9.612115790813558e-13
hence O 0 4.739764353570153e-13
less O 0 4.368691552177756e-13
severe O 0 1.2362287582501352e-10
clinical O 0 4.550694543414835e-11
symptoms O 0 1.1890509410417138e-10
than O 0 2.1032194422073965e-15
the O 0 1.4534713739178186e-15
mothers O 0 3.215165113312768e-12
of O 0 5.599571231060241e-16
children O 0 1.2191944502581986e-12
with O 0 5.334727885136781e-12
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.0304529673987872e-08

We O 0 2.010841319843859e-11
conclude O 0 2.015428622603732e-12
that O 0 7.9565621677815e-16
paternal O 0 2.738767268528619e-10
transmission O 0 3.134695703010948e-08
of O 0 2.0166871644855533e-11
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 1.362951973504778e-10
rare O 0 5.862665908296094e-11
and O 0 7.583731277509276e-14
preferentially O 0 2.870036239915885e-12
occurs O 0 1.4551309443955503e-14
with O 0 2.256165428636027e-16
onset O 0 1.1000253659354531e-11
of O 0 1.0511329897851598e-13
DM B-Disease 1 1.0
past O 0 6.4777640716717766e-12
30 O 0 5.740094272295437e-13
years O 0 7.656780754133202e-14
in O 0 1.1194519568052605e-14
the O 0 2.973570994741371e-15
father O 0 3.3393043104984477e-12
. O 0 4.633941071575248e-14
. O 0 2.0125773877305297e-13

The O 0 7.982951973073416e-12
RB1 O 0 4.418858878807441e-08
gene O 0 3.8002628821587336e-10
mutation O 0 2.6510066711282754e-11
in O 0 1.0299405425739927e-11
a O 0 2.228114498459277e-10
child O 0 7.423729584843386e-06
with O 0 1.7822689157842575e-10
ectopic B-Disease 1 1.0
intracranial I-Disease 1 0.9999935626983643
retinoblastoma I-Disease 1 0.9998739957809448
. O 0 7.874733398693934e-08

The O 0 3.0199200778957547e-11
RB1 O 0 1.0698111196916216e-07
gene O 0 1.8062321638367962e-09
mutation O 0 5.464615912553761e-11
was O 0 4.193773800453826e-12
investigated O 0 1.4938565792363412e-12
in O 0 1.485406036453446e-13
a O 0 4.34919912584153e-11
child O 0 3.3845803955045994e-06
with O 0 4.84783116427856e-11
ectopic B-Disease 1 0.9999772310256958
intracranial I-Disease 0 3.3864969736896455e-05
retinoblastoma I-Disease 0 3.8625280751602986e-08
using O 0 1.5465427549710142e-11
DNA O 0 2.1734013200269686e-10
obtained O 0 1.4475446665981884e-12
from O 0 2.7759544812019747e-14
both O 0 7.468602051098703e-15
the O 0 7.774742628125983e-15
pineal B-Disease 0 6.1948965957014934e-09
and I-Disease 0 9.410735302139983e-09
retinal I-Disease 1 0.9999852180480957
tumours I-Disease 1 1.0
of O 0 3.1132388333965366e-12
the O 0 1.4938196079422594e-12
patient O 0 3.662339043142282e-10
. O 0 2.034035049766625e-12

A O 0 2.2607398175722437e-09
nonsense O 0 4.619879234724067e-08
mutation O 0 2.8293008560997812e-11
in O 0 1.2460088299678929e-12
exon O 0 9.276075463304778e-10
17 O 0 1.9662656919328114e-11
( O 0 4.665340162801623e-12
codon O 0 4.598108283015989e-10
556 O 0 1.7516937553252454e-11
) O 0 1.545234243566316e-14
of O 0 1.0531883919940332e-16
the O 0 6.60617131541274e-15
RB1 O 0 2.409584198836967e-10
gene O 0 6.734857897067181e-12
was O 0 5.012007519081263e-13
found O 0 5.458312499358707e-15
to O 0 4.5222308195408845e-17
be O 0 3.4682158425043393e-16
present O 0 8.290196269606352e-16
homozygously O 0 3.109953961022427e-10
in O 0 1.9601835345856022e-12
both O 0 2.0989255526768918e-13
the O 0 4.587396543360989e-13
retinal B-Disease 0 1.40178144647507e-07
and I-Disease 0 3.067888443286648e-10
the I-Disease 0 3.0702617098005147e-12
pineal I-Disease 0 1.20945633170777e-05
tumours I-Disease 1 1.0
. O 0 8.542881402284763e-10

The O 0 7.815157619358096e-14
same O 0 1.4401050881310273e-14
mutation O 0 2.447260059532108e-13
was O 0 1.6199328933385465e-13
present O 0 4.456236947373085e-15
heterozygously O 0 1.8713097044154026e-11
in O 0 1.0018370275076752e-14
the O 0 1.3848917219202886e-16
DNA O 0 3.955752283894831e-13
from O 0 5.673601381254675e-16
the O 0 1.2028294014462652e-16
constitutional O 0 5.8024141284666094e-15
cells O 0 5.204587506953649e-14
of O 0 7.362828600052085e-16
the O 0 2.2817182103690263e-14
patient O 0 1.675160227546102e-12
, O 0 1.1339830399494685e-15
proving O 0 2.917996248276433e-13
it O 0 8.510037318319101e-16
to O 0 2.9489229712509812e-15
be O 0 2.4149858003121027e-14
of O 0 1.1748186042157167e-15
germline O 0 4.4890235972872006e-10
origin O 0 1.181576642084181e-10
. O 0 8.080616037409172e-11

The O 0 1.0091020629775932e-13
initial O 0 6.02662668033882e-13
mutation O 0 4.610510107375121e-13
was O 0 1.1608720712139031e-12
shown O 0 1.1939117432863654e-14
to O 0 6.102814786726821e-15
have O 0 3.201895942394478e-13
occurred O 0 2.6117031714373296e-12
in O 0 1.701909284074904e-13
the O 0 1.222005539157833e-14
paternally O 0 5.346957321350487e-10
derived O 0 4.2974826475195016e-10
RB1 O 0 4.845933858632634e-07
allele O 0 3.9232642023989683e-08
. O 0 1.5323241564502155e-09

The O 0 4.700269578931937e-13
mutation O 0 4.274335659720796e-12
is O 0 1.8691022037400917e-14
in O 0 7.703476664075795e-15
an O 0 5.3957451269254575e-17
area O 0 1.8015206636038707e-14
of O 0 4.7036163077504925e-16
the O 0 1.8367363124958524e-15
gene O 0 4.4631507691017536e-12
that O 0 1.5255219022354007e-15
encodes O 0 2.952667068636082e-14
the O 0 2.1401973537340526e-16
protein O 0 1.2750073349540592e-12
- O 0 1.8896844158899917e-11
binding O 0 4.155306198953823e-13
region O 0 8.021441041776434e-13
known O 0 4.548531690184987e-12
as O 0 1.0120845134187206e-12
the O 0 1.67155836562757e-14
pocket O 0 1.5121069736778736e-05
region O 0 1.221488910019275e-09
and O 0 7.910679222788985e-09
has O 0 6.231886534591169e-12
been O 0 2.7893358738213803e-13
detected O 0 1.1300211634479584e-11
in O 0 9.528841474551464e-13
other O 0 3.211078609635003e-15
cases O 0 6.9443949593831714e-15
of O 0 9.5166520669295e-17
retinoblastoma B-Disease 0 2.3834783105525226e-11
. O 0 2.2749328462690066e-12
. O 0 1.714784911288625e-11

Low O 0 1.1467201233017477e-07
levels O 0 1.881228896619125e-12
of O 0 1.7370898742731988e-16
beta O 0 8.879320022303627e-12
hexosaminidase O 0 2.5293477382004603e-11
A O 0 8.707773543024933e-13
in O 0 1.3732808293309695e-13
healthy O 0 4.2297282755281163e-13
individuals O 0 7.017884689322367e-18
with O 0 7.875118758762916e-17
apparent O 0 1.2553773125201229e-11
deficiency O 0 9.456479347136337e-06
of O 0 3.872620235286558e-15
this O 0 8.28470321859176e-14
enzyme O 0 6.485407350043104e-11
. O 0 2.014425735594183e-12

Appreciable O 0 6.791836426600639e-07
beta O 0 3.9183888134175504e-07
hexosaminidase O 0 1.1758275064721602e-07
A O 0 1.6215118137097306e-10
( O 0 1.169265725908808e-11
hex O 0 7.892408948606544e-10
A O 0 6.62562756395535e-12
) O 0 4.060532969975619e-14
activity O 0 4.819763945590472e-12
has O 0 1.2204495396337268e-14
been O 0 1.1314169748115853e-14
detected O 0 2.8421194217531642e-11
in O 0 4.595563166120975e-11
cultured O 1 0.9932259917259216
skin O 1 0.9999927282333374
fibroblasts O 0 8.064053690759465e-05
and O 0 3.1416313994725442e-09
melanoma B-Disease 0 1.0429026588099077e-05
tissue O 0 1.2068420929267631e-08
from O 0 5.811890140157427e-13
healthy O 0 4.518017904242555e-12
individuals O 0 4.202723374391662e-17
previously O 0 1.763646093587163e-14
reported O 0 7.0872765121909875e-12
as O 0 1.276617700440852e-13
having O 0 2.2710970257189267e-11
deficiency B-Disease 0 1.5905281543382443e-05
of I-Disease 0 1.2815004980982645e-15
hex I-Disease 0 7.563666915011424e-10
A I-Disease 0 2.696586877404261e-12
activity O 0 8.634291740784727e-13
indistinguishable O 0 8.357042542792709e-14
from O 0 1.7506749063186185e-15
that O 0 5.903188338118973e-17
of O 0 1.5511760685182305e-17
patients O 0 3.466564498834108e-15
with O 0 4.2858034829396097e-13
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 0 0.43059903383255005
( O 0 1.7176599031998308e-10
TSD B-Disease 0 3.767238922591787e-06
) O 0 3.203426066078485e-11
. O 0 2.5589580801566036e-11

Identification O 0 7.317155215069704e-10
and O 0 4.822428264009138e-13
quantitation O 0 3.5038591472691394e-10
of O 0 8.12238273737104e-15
hex O 0 7.598673912312393e-10
A O 0 3.1319655202644014e-11
, O 0 3.9359489924012045e-14
amounting O 0 2.0413731469104412e-12
to O 0 3.2371739837333546e-13
3 O 0 1.8690765948847776e-11
. O 0 3.9047143990389444e-11

5 O 0 1.2190682907586847e-09
% O 0 5.348711473729395e-10
- O 0 1.113766757043777e-05
6 O 0 1.7604737112542068e-10
. O 0 5.9889870840379444e-12

9 O 0 4.847685586284456e-10
% O 0 4.14074075591811e-13
of O 0 1.0222542855391632e-16
total O 0 3.1628275895528987e-15
beta O 0 2.3103326196594054e-10
hexosaminidase O 0 9.311688642377192e-10
activity O 0 4.0670810469434215e-11
, O 0 1.578282928069337e-14
has O 0 1.5751964670644844e-15
been O 0 6.181513570768283e-16
obtained O 0 7.024403997514918e-15
by O 0 1.7782414877078913e-14
cellulose O 0 3.750823651671453e-08
acetate O 0 1.5215737003693164e-10
gel O 0 8.839382559244768e-10
electrophoresis O 0 6.91722998324984e-11
, O 0 5.046347996591483e-13
DEAE O 0 1.7031281274171306e-08
- O 0 2.4856458558097927e-10
cellulose O 0 2.170565949199954e-08
ion O 0 5.17756532092406e-11
- O 0 1.5054539559411495e-10
exchange O 0 1.2067648269553644e-10
chromatography O 0 7.203128718491492e-12
, O 0 9.598989016298097e-15
radial O 0 2.3313892483223242e-11
immunodiffusion O 0 4.9862180162563163e-08
, O 0 5.5730515688412474e-12
and O 0 2.55134411861202e-12
radioimmunoassay O 0 6.978942224122875e-08
. O 0 7.983820202173142e-12

Previous O 0 2.031028956128722e-10
family O 0 7.035862777809987e-13
studies O 0 2.122193073399517e-13
suggested O 0 4.621592347643817e-14
that O 0 1.0856795832339731e-16
these O 0 4.4676021575266575e-17
individuals O 0 3.2103650505513903e-17
may O 0 1.3441376104598307e-13
be O 0 3.7640524225469483e-16
compound O 0 4.766778538187709e-14
heterozygotes O 0 2.1752365533811435e-12
for O 0 2.438845289068158e-16
the O 0 6.102835327275792e-16
common O 0 6.579983411435231e-13
mutant O 0 1.1866228000201318e-09
TSD B-Disease 0 5.525296842279204e-08
gene O 0 5.462159058389204e-10
and O 0 4.062148187267134e-12
a O 0 1.6344586274696926e-12
rare O 0 1.2220802148021903e-10
( O 0 5.4498662527269204e-11
allelic O 0 1.0060445809756402e-09
) O 0 5.735752584695719e-12
mutant O 0 6.317008249823175e-09
gene O 0 6.454565095737053e-07
. O 0 1.826767070944868e-09

Thus O 0 3.922942266171292e-12
, O 0 1.015140594739887e-13
the O 0 5.525540657349334e-15
postulated O 0 2.3057762643663438e-10
rate O 0 1.9045780577653382e-11
mutant O 0 6.642899771924782e-12
gene O 0 6.4235089469733e-11
appears O 0 1.891497375394735e-12
to O 0 4.915133669569692e-16
code O 0 1.67630920402213e-14
for O 0 4.3518246650378154e-17
the O 0 1.0945077841267311e-16
expression O 0 3.4782161146499485e-14
of O 0 8.755628803903091e-15
low O 0 3.186874028560105e-11
amounts O 0 4.0132743591055065e-13
of O 0 2.357199721872427e-13
hex O 0 5.2254918614380585e-08
A O 0 3.4798242065647855e-09
. O 0 4.59838625510578e-11

Heterozygotes O 0 3.130095294068269e-08
for O 0 3.312784887989778e-13
the O 0 2.1599649322010406e-15
rare O 0 4.908602278981544e-13
mutant O 0 2.5810680259752417e-09
may O 0 2.6424675780845064e-09
be O 0 6.451736456821074e-15
indistinguishable O 0 7.487008517499671e-13
from O 0 1.2552771627325713e-14
heterozygotes O 0 8.728196984608694e-12
for O 0 1.763221370091586e-15
the O 0 1.5846587779973806e-15
common O 0 1.6236210509737448e-12
TSD B-Disease 0 3.061823505845496e-08
mutant O 0 2.7454059026155164e-09
. O 0 3.0669988770881673e-10

However O 0 1.5836701524815644e-12
, O 0 3.0223111763505147e-15
direct O 0 8.12356434833246e-14
visualization O 0 3.796348999052235e-11
and O 0 3.713364251506368e-13
quantitation O 0 1.5292846988756992e-09
of O 0 7.847300825640502e-14
hex O 0 9.559035785144943e-10
A O 0 1.1035279677898413e-12
by O 0 5.384459273171131e-16
the O 0 5.224514041741101e-16
methods O 0 2.305412263002571e-13
described O 0 8.829359769355061e-13
may O 0 2.890266964563487e-13
prevent O 0 2.1837686756012546e-14
false O 0 1.5487633397981426e-10
- O 0 8.048932631510297e-10
positive O 0 6.037873673259142e-11
prenatal O 0 1.450519278023421e-07
diagnosis O 0 2.2408642053051153e-08
of O 0 5.7809172792982425e-15
TSD B-Disease 0 6.156038789839613e-09
in O 0 5.968742210551992e-13
fetuses O 0 1.1157089835345246e-10
having O 0 1.6451042730760562e-13
the O 0 3.6855823162254206e-14
incomplete O 0 1.429277113329519e-10
hex B-Disease 0 1.5143319842536584e-07
A I-Disease 0 2.6562746668901127e-08
deficiency I-Disease 0 0.08997321873903275
of O 0 2.198537118553107e-15
the O 0 1.7181512763637767e-14
type O 0 3.844562446175814e-09
described O 0 1.5579657008935044e-10
in O 0 6.41652911359536e-11
the O 0 1.5873656555864812e-12
four O 0 4.036539158480679e-11
healthy O 0 4.890601257301341e-10
individuals O 0 2.3161323119830213e-12

The O 0 1.751890993384464e-11
tumor B-Disease 0 6.919970729768465e-08
suppressor O 0 2.7282911219117523e-07
gene O 0 3.138518991363526e-07
Smad4 O 0 3.972289960074704e-06
/ O 0 3.513533499699406e-07
Dpc4 O 0 3.569323947516523e-09
is O 0 2.564925370349396e-14
required O 0 3.2540894603889188e-15
for O 0 3.1018151313827916e-17
gastrulation O 0 5.353827732708372e-13
and O 0 2.4258762723215407e-14
later O 0 3.149274189952894e-13
for O 0 1.062770015458484e-15
anterior O 0 2.1471689443802733e-12
development O 0 8.185486793585439e-13
of O 0 1.0878987936739117e-14
the O 0 1.9321093932666428e-13
mouse O 0 1.1628555007803243e-08
embryo O 0 2.522460906817514e-09
. O 0 1.634522656113191e-10

Mutations O 0 1.8556158831728453e-09
in O 0 2.436534914801447e-12
the O 0 3.129525989482157e-13
SMAD4 O 0 0.00027442825376056135
/ O 0 5.162434717931319e-06
DPC4 O 0 2.795479304040782e-06
tumor B-Disease 0 1.2986829744932038e-07
suppressor O 0 1.0444606068915618e-08
gene O 0 1.601949128904323e-09
, O 0 5.012418431704635e-13
a O 0 5.421794198497143e-13
key O 0 4.4522552311576646e-10
signal O 0 1.4190345565268103e-09
transducer O 0 4.056332603141755e-09
in O 0 7.833088344622041e-12
most O 0 3.634311276402846e-13
TGFbeta O 0 3.660547776007661e-08
- O 0 2.9522112532376354e-10
related O 0 1.6434240036541925e-12
pathways O 0 6.133134500480378e-14
, O 0 2.0585768618899342e-16
are O 0 2.0140354854660566e-18
involved O 0 3.023138343728178e-17
in O 0 3.1161211340501125e-15
50 O 0 4.7612812943600286e-14
% O 0 8.265215768743506e-13
of O 0 6.640923488204775e-12
pancreatic B-Disease 0 8.742807153794274e-07
cancers I-Disease 0 9.913724596799511e-08
. O 0 1.1778369946036094e-10

Homozygous O 0 1.06128936749883e-05
Smad4 O 0 3.698558884934755e-06
mutant O 0 2.001117138661357e-07
mice O 0 0.004477695096284151
die O 0 0.00086919468594715
before O 0 1.0860309179738792e-10
day O 0 1.4254629421284193e-10
7 O 0 8.314758603855665e-12
. O 0 2.5441228984623976e-12

5 O 0 9.683012169858785e-10
of O 0 2.1203885544086865e-13
embryogenesis O 0 1.5028325250909802e-09
. O 0 1.8997780779073103e-11

Mutant O 0 2.8827182307900046e-10
embryos O 0 1.6568429961338893e-10
have O 0 3.2218071526618486e-12
reduced O 0 2.8161075359654786e-13
size O 0 9.444057515184401e-12
, O 0 1.341779812258359e-11
fail O 0 1.1409904132619886e-08
to O 0 8.961540819314717e-14
gastrulate O 0 2.910455343396734e-08
or O 0 2.166867596811728e-12
express O 0 1.1891064305089016e-12
a O 0 6.19360790952983e-13
mesodermal O 0 5.627404653374413e-10
marker O 0 1.2347329825246334e-09
, O 0 7.122497036604614e-12
and O 0 2.1998649104605639e-13
show O 0 3.6758297794481365e-11
abnormal O 0 2.2902395535595588e-09
visceral O 0 2.6558261145837037e-10
endoderm O 0 1.2552043848756966e-08
development O 0 6.344822583992382e-11
. O 0 9.17753199825011e-12

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 4.023018981884558e-15
the O 0 4.87101077043515e-15
Smad4 O 0 2.4190731195972148e-08
- O 0 7.956711733925204e-09
deficient O 0 1.267092120116331e-08
embryos O 0 2.147702501953397e-11
results O 0 3.4163425127048397e-12
from O 0 2.8262221596765495e-14
reduced O 0 1.213767259443388e-12
cell O 0 5.870207792080251e-11
proliferation O 0 1.2322214429372202e-11
rather O 0 1.7985004490458228e-13
than O 0 3.017186923481158e-14
increased O 0 7.242384453655729e-14
apoptosis O 0 2.6019228004797723e-12
. O 0 3.908221836435022e-12

Aggregation O 0 1.2351969447266242e-09
of O 0 2.3763434796320038e-14
mutant O 0 5.247539625052866e-10
Smad4 O 0 3.731172881771272e-08
ES O 0 4.264862685232629e-09
cells O 0 1.1125187576732642e-11
with O 0 2.0470324857391718e-14
wild O 0 3.09547699972601e-11
- O 0 1.119024073403807e-08
type O 0 1.8906127774442893e-09
tetraploid O 0 2.071543647730323e-08
morulae O 0 6.144174221844878e-06
rescues O 0 4.6345252258106484e-07
the O 0 1.1732282896928514e-12
gastrulation B-Disease 0 2.5771830891585523e-08
defect I-Disease 0 4.004842679705689e-08
. O 0 2.289795957011176e-11

These O 0 2.9810813648341317e-13
results O 0 1.260618806607841e-13
indicate O 0 5.970629535483746e-14
that O 0 9.9316455362227e-16
Smad4 O 0 3.1821259516284783e-10
is O 0 2.527828164820031e-15
initially O 0 4.989066410975192e-14
required O 0 7.595622900110721e-16
for O 0 2.050456165118705e-17
the O 0 3.9074592695073886e-17
differentiation O 0 3.498108852822805e-14
of O 0 5.301241396302499e-17
the O 0 5.55550804774848e-16
visceral O 0 3.9488995840636365e-13
endoderm O 0 5.5172744845011223e-11
and O 0 4.833226917647093e-14
that O 0 1.7161514845148685e-16
the O 0 1.1255361097620934e-15
gastrulation B-Disease 0 4.598631891949978e-11
defect I-Disease 0 1.0751199236436193e-10
in O 0 1.0735097028978166e-13
the O 0 1.1655165730922647e-14
epiblast O 0 6.961600185206862e-10
is O 0 1.4139011413494967e-13
secondary O 0 4.2343822892476624e-11
and O 0 3.5745510284374005e-12
non O 0 6.129000951204944e-08
- O 0 1.2910170710256352e-07
cell O 0 6.824768661317648e-07
autonomous O 0 9.496237574069255e-09
. O 0 2.358153450288114e-09

Rescued O 0 2.016017930372982e-07
embryos O 0 6.6530030373712634e-09
show O 0 1.9250652183444572e-09
severe O 0 1.4372876933066436e-07
anterior O 0 7.918197866274568e-07
truncations O 0 5.174503030502819e-07
, O 0 3.297733960905269e-11
indicating O 0 5.981664052967517e-10
a O 0 1.9695189489715714e-12
second O 0 1.6092375099575201e-13
important O 0 1.598179223780572e-14
role O 0 1.0580665982034762e-13
for O 0 8.272888633636868e-15
Smad4 O 0 7.932129397758558e-10
in O 0 7.514796077079389e-12
anterior O 0 1.4398897185685655e-08
patterning O 0 1.555646065298788e-07
during O 0 1.8223847431109164e-10
embryogenesis O 0 7.502033660955476e-09
. O 0 2.4535628737054616e-11

Prevalence O 0 3.4296235185138357e-07
of O 0 4.464772328975977e-14
p16 O 0 2.3655863934379795e-09
and O 0 5.341651166529404e-12
CDK4 O 0 1.7044450828507252e-07
germline O 0 2.3252820113839334e-08
mutations O 0 4.531520436668046e-10
in O 0 3.993423647319361e-12
48 O 0 1.0437606334789962e-10
melanoma B-Disease 0 0.011716959998011589
- O 0 0.022467179223895073
prone O 0 9.359717660117894e-05
families O 0 3.253080027576516e-10
in O 0 5.246108547574124e-10
France O 0 2.001398797801812e-06
. O 0 1.5975758216324465e-10

The O 0 7.976452831570668e-12
French O 0 2.3685222672042983e-08
Familial B-Disease 0 0.010794459842145443
Melanoma I-Disease 1 0.9989676475524902
Study O 0 7.99451349564606e-09
Group O 0 1.9083500057970326e-10
. O 0 1.4372808498919198e-11

Germline O 0 1.588115446793381e-05
mutations O 0 3.4407872107067305e-08
in O 0 7.055917048554017e-12
the O 0 6.70176152460923e-15
p16 O 0 1.62877766829439e-10
and O 0 1.058454132717504e-13
CDK4 O 0 7.234433052616396e-10
genes O 0 1.1591334662941488e-11
have O 0 1.7723168310550264e-13
been O 0 9.638217144964517e-14
reported O 0 7.504497891164252e-12
in O 0 1.2453138529871979e-14
a O 0 1.5161937189697022e-14
subset O 0 2.9444464444763896e-13
of O 0 2.2383882399522326e-14
melanoma B-Disease 0 1.971116248000726e-08
pedigrees O 0 3.431867057201998e-08
, O 0 1.5232970050280126e-12
but O 0 2.0298290771738475e-13
their O 0 9.361152329104457e-15
prevalence O 0 1.117248047549646e-11
is O 0 6.499808964709544e-15
not O 0 1.9409953109844266e-14
well O 0 5.4002727853733057e-14
known O 0 2.194497621815783e-12
. O 0 8.926799403841112e-12

We O 0 4.955848231791293e-12
searched O 0 1.3867534724709696e-11
for O 0 1.5913275478004525e-16
such O 0 4.814020699677986e-16
germline O 0 1.3659012809696947e-09
mutations O 0 2.1023023599742174e-10
in O 0 5.599582863363706e-12
48 O 0 3.00353734938863e-11
French O 0 2.0081011825823225e-05
melanoma B-Disease 1 1.0
- O 1 0.9999228715896606
prone O 0 3.3497042750241235e-05
families O 0 1.52292512368285e-12
selected O 0 9.395962842137767e-15
according O 0 1.9288239557521507e-14
to O 0 6.209401601161039e-16
two O 0 1.8994552905917707e-15
major O 0 8.768050033854807e-14
criteria O 0 1.278189115964598e-13
families O 0 2.9799513762956823e-16
with O 0 9.236988919270221e-17
at O 0 2.295479344799345e-12
least O 0 2.2214828175777523e-13
three O 0 1.492618928575131e-14
affected O 0 8.782993050297089e-15
members O 0 5.561487570960504e-16
( O 0 9.982667497536804e-14
n O 0 2.541611886230921e-11
= O 0 2.7903515609217777e-10
20 O 0 8.323327270465253e-12
) O 0 2.391764358181808e-13
or O 0 4.026709955057273e-12
families O 0 7.057332826855903e-15
with O 0 9.118585624644891e-17
two O 0 4.651481006330517e-15
affected O 0 5.685455395593262e-15
members O 0 3.8530916656944833e-17
, O 0 8.548723430602573e-16
one O 0 4.1659015286855375e-16
of O 0 9.760555038655253e-18
them O 0 1.9665119244105782e-16
affected O 0 8.524235178701859e-16
before O 0 7.280492233018639e-16
the O 0 3.458809012229488e-16
age O 0 1.5516608519437237e-14
of O 0 5.4421085175409934e-18
50 O 0 7.984290320705461e-16
( O 0 4.30424942107592e-14
n O 0 1.5633766850542408e-11
= O 0 8.607027313090043e-10
28 O 0 1.1542391487040504e-09
) O 0 4.2969616580179615e-12
, O 0 4.634821172688763e-12
and O 0 5.5666080333574217e-14
one O 0 4.552803785557759e-15
additional O 0 5.096450537522661e-14
minor O 0 6.421336986445203e-12
criterion O 0 1.853498778070506e-11
. O 0 1.959717110810999e-11

Sixteen O 0 1.2939266325062704e-10
different O 0 2.0375481900661296e-13
p16 O 0 3.093001632592518e-09
germline O 0 4.078909210392112e-09
mutations O 0 5.5370832918733015e-11
were O 0 2.0277395485369248e-13
found O 0 4.1127959192607463e-14
in O 0 5.3269946098536206e-14
21 O 0 8.830197180008034e-14
families O 0 2.5678805412474243e-15
, O 0 3.407331061316141e-15
while O 0 2.8417194744795142e-14
one O 0 4.114090185604151e-14
germline O 0 1.2621418354896718e-09
mutation O 0 2.956745959181717e-11
, O 0 1.373174143837197e-12
Arg24His O 0 1.5161253363871197e-09
, O 0 1.0239678029100308e-12
was O 0 4.4719015816763186e-12
detected O 0 3.281503402341457e-10
in O 0 1.2930329550131514e-11
the O 0 6.924852943672455e-13
CDK4 O 0 9.741187056988565e-08
gene O 0 6.808852148765254e-09
. O 0 1.3734950676802526e-10

The O 0 3.8816907045428894e-13
frequency O 0 4.769930544296086e-12
of O 0 2.0286811781237285e-15
p16 O 0 3.57052082344822e-10
gene O 0 3.1747299233941817e-10
mutation O 0 3.131748766566078e-12
in O 0 5.636717628028018e-14
our O 0 9.841472526240375e-16
sample O 0 9.202250642265444e-15
( O 0 8.807019648065725e-14
44 O 0 1.3893810960671077e-13
% O 0 2.6598406636935135e-14
) O 0 3.307707365928121e-14
is O 0 7.817956555029003e-15
among O 0 3.7728236604740034e-15
the O 0 7.371656589186606e-15
highest O 0 6.192016951261925e-12
rates O 0 2.1546953110629374e-10
yet O 0 3.7692811654006786e-13
reported O 0 7.987067951464866e-11
and O 0 1.1963737292508547e-14
the O 0 3.187329711618124e-15
CDK4 O 0 2.2019011058915794e-09
mutation O 0 6.116642023608343e-13
is O 0 2.7353578861059706e-14
the O 0 1.4461937303624807e-14
second O 0 8.22924454274565e-12
mutation O 0 1.6923778350941276e-11
detected O 0 3.928940373043588e-08
in O 0 2.014942657169172e-10
this O 0 3.5505676361253374e-14
gene O 0 1.1319680748300698e-09
worldwide O 0 1.5458002933232962e-10
. O 0 3.1599275279736716e-11

In O 0 6.958476156393445e-11
summary O 0 2.1911172876087903e-09
, O 0 5.6583691454125534e-14
our O 0 2.5528785289603666e-15
results O 0 1.4457304033403326e-14
show O 0 6.550753591915565e-14
frequent O 0 1.7479407136110348e-13
involvement O 0 1.7959602988809609e-13
of O 0 3.567609864908711e-16
the O 0 1.6437915244737426e-15
p16 O 0 9.104188236630506e-11
gene O 0 2.516673536234748e-10
in O 0 6.095355557095283e-12
familial B-Disease 0 7.090278586474597e-08
melanoma I-Disease 0 1.1706001714628655e-05
and O 0 8.385979627725804e-13
confirm O 0 9.332068538064897e-13
the O 0 3.9838296790908575e-16
role O 0 1.1137745321290402e-13
of O 0 3.5759621391642305e-16
the O 0 1.3774353226493445e-14
CDK4 O 0 9.439528048105217e-10
gene O 0 2.2377898145631292e-11
as O 0 1.6078844256462582e-13
a O 0 1.588171217800638e-12
melanoma B-Disease 0 9.56960548137431e-07
- O 0 1.9813235496712878e-08
predisposing O 0 1.740798438731872e-08
gene O 0 7.2304771059350514e-09
. O 0 1.1838184078849512e-11
. O 0 5.1657844668540065e-12

Progression O 0 9.141717782767955e-08
of O 0 2.2175077258376058e-13
somatic O 0 3.0428890518408025e-09
CTG O 0 1.971752396912052e-07
repeat O 0 6.966966448196388e-10
length O 0 1.4490289176882776e-11
heterogeneity O 0 2.438415580563458e-10
in O 0 4.8881437092473945e-12
the O 0 1.6902205343346556e-14
blood O 0 4.514718893872116e-12
cells O 0 6.07846689648639e-11
of O 0 2.3945990047617716e-13
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.00017884864064399153
. O 0 3.193201952855773e-11

The O 0 2.8702428346398523e-13
genetic O 0 2.2388356793467956e-11
basis O 0 2.86898001015945e-12
of O 0 1.7609913906865143e-13
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.437403499148786e-05
DM B-Disease 1 1.0
) O 0 4.520724506545948e-12
is O 0 3.2788986318975236e-15
the O 0 3.449754428546687e-17
expansion O 0 3.0095826004938875e-14
of O 0 4.831682395419422e-16
an O 0 7.282246332373284e-15
unstable O 0 2.0097465913693213e-09
CTG O 0 2.2497376406249714e-08
repeat O 0 4.952902671329085e-11
in O 0 1.276581244142802e-13
the O 0 2.7167578049139187e-15
34 O 0 1.2831844419490535e-13
UTR O 0 2.6602253386243113e-11
of O 0 1.0501800353678514e-15
the O 0 8.078357861124319e-13
DM B-Disease 1 1.0
protein O 0 4.315059698445367e-10
kinase O 0 2.71631006576456e-09
gene O 0 3.2522009529856177e-09
on O 0 1.7495244142295974e-10
chromosome O 0 8.763793744037685e-07
19 O 0 2.6636806094160193e-09
. O 0 3.182962227121777e-11

One O 0 3.5539793764166605e-12
of O 0 2.5837675970852444e-16
the O 0 2.603059037156757e-16
principal O 0 8.498171784332431e-14
features O 0 4.393532114727386e-14
of O 0 2.771990070547293e-15
the O 0 1.2061412979491593e-10
DM B-Disease 1 1.0
mutation O 0 1.5599533383786612e-12
is O 0 1.7774174940568023e-14
an O 0 1.3811730884631646e-15
extraordinarily O 0 7.071199181751808e-11
high O 0 2.448496405627054e-10
level O 0 3.1599378062102668e-12
of O 0 2.796290175254598e-15
somatic O 0 3.2115261838772113e-11
mosaicism O 0 7.146263025781252e-10
, O 0 7.952927867042187e-14
due O 0 1.597496515225085e-14
to O 0 3.64075115990412e-16
an O 0 1.0552600095898907e-15
extremely O 0 1.3832804346414207e-10
high O 0 1.4626970468167855e-10
degree O 0 2.316294711590672e-09
of O 0 4.643779867477375e-14
somatic O 0 3.280683502637771e-10
instability O 0 6.01682453860164e-11
both O 0 3.265718926293189e-14
within O 0 2.376075986627261e-14
and O 0 2.8051711886516173e-13
between O 0 1.4259848794937087e-14
different O 0 7.555720236756755e-14
tissues O 0 9.997045725962384e-12
. O 0 1.2581357396873605e-12

This O 0 6.486542206141088e-12
instability O 0 3.2284154516393215e-11
appears O 0 3.4083369807036412e-12
to O 0 2.3743669706012332e-15
be O 0 1.6672969005182862e-15
biased O 0 5.46910444449572e-13
towards O 0 2.0497623458732303e-15
further O 0 7.80073722224427e-15
expansion O 0 2.9116679634835427e-14
and O 0 4.4855027827336684e-15
continuous O 0 5.128275428823489e-15
throughout O 0 3.120260795821581e-15
the O 0 1.631472277288876e-15
life O 0 1.0364658519737991e-14
of O 0 2.2905392167756885e-18
an O 0 5.1253144729551286e-18
individual O 0 5.748099996917222e-18
, O 0 1.4826022134024333e-15
features O 0 4.984928824434444e-14
that O 0 3.354468328001063e-14
could O 0 3.0567813905091334e-12
be O 0 1.9192299100201328e-15
associated O 0 9.42378194522444e-15
with O 0 3.055149108468347e-16
the O 0 1.3380540504260609e-14
progressive O 0 8.01317901464628e-14
nature O 0 1.2423418684851667e-13
of O 0 7.684315423556187e-14
the O 0 5.7361788929899404e-12
disease O 0 2.091153694649961e-09
. O 0 5.796692986725915e-12

Although O 0 4.283256041515138e-12
increasing O 0 8.398813464366786e-14
measured O 0 7.31876365067663e-13
allele O 0 8.48193824204424e-12
size O 0 4.4562010331761215e-12
between O 0 1.773957933673409e-12
patients O 0 1.8113845492995218e-11
clearly O 0 3.882769892280327e-14
correlates O 0 9.40586126915938e-15
with O 0 2.1348472818809576e-17
an O 0 1.0048022304521724e-16
increased O 0 2.191723094246284e-13
severity O 0 1.8004722712738896e-11
of O 0 1.066645297071291e-14
symptoms O 0 2.105812746400204e-11
and O 0 6.786786374217261e-16
an O 0 2.2388716959182788e-17
earlier O 0 3.930139200192251e-12
age O 0 8.874235981476408e-13
of O 0 5.844887325057255e-16
onset O 0 1.4221238119407897e-12
, O 0 6.679681175619323e-16
this O 0 2.0802768533818543e-17
correlation O 0 2.362392677584136e-14
is O 0 3.2323399836440333e-15
not O 0 1.4806249420420102e-14
precise O 0 1.725793292994826e-11
and O 0 4.821177636803176e-13
measured O 0 1.88659621236896e-13
allele O 0 1.7650005805849855e-12
length O 0 6.08634106655237e-12
cannot O 0 1.2888715268666306e-11
be O 0 1.2155291252431265e-14
used O 0 2.2628737601716915e-14
as O 0 7.738407455787615e-15
an O 0 1.9510743519001746e-16
accurate O 0 3.1427846436393736e-11
predictor O 0 4.5316414509777303e-10
of O 0 1.9755639452893187e-13
age O 0 2.7495547505473894e-10
of O 0 9.660081437025403e-14
onset O 0 3.8451986039689245e-10
. O 0 7.917399375001466e-12

In O 0 1.2317279141083048e-11
order O 0 5.175955336940907e-15
to O 0 9.561847230365927e-17
further O 0 1.0665632407545257e-15
characterize O 0 1.5084984585252148e-13
the O 0 3.6335519621876096e-15
dynamics O 0 3.614598897971888e-11
of O 0 4.594973273402969e-12
DM B-Disease 1 1.0
CTG O 0 7.3115224950015545e-06
repeat O 0 1.3460985215374421e-08
somatic O 0 3.844510931827472e-09
instability O 0 7.334831075844761e-10
, O 0 1.770954937601113e-13
we O 0 9.407618862524933e-15
have O 0 5.662790064474158e-16
studied O 0 7.665972755676806e-14
repeat O 0 3.5380560785801263e-13
length O 0 2.0703377163686087e-13
changes O 0 2.045741370358331e-13
over O 0 1.6757217358512322e-13
time O 0 2.874927672227162e-13
in O 0 1.2382285951781369e-12
111 O 0 2.2426621670845748e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.508392877269671e-08
with O 0 8.662536071351581e-16
varying O 0 2.209342734801889e-13
clinical O 0 1.1378510633708316e-10
severity O 0 9.951316159995116e-11
and O 0 4.988202776182171e-13
CTG O 0 1.9245815607860095e-08
repeat O 0 1.2710847652197543e-10
size O 0 2.1372237746924982e-12
over O 0 7.335548184508878e-13
time O 0 4.4460534429427434e-13
intervals O 0 4.390814101196128e-12
of O 0 8.149224576194818e-16
1 O 0 4.9622610708011106e-12
- O 0 1.5620891247181135e-07
7 O 0 1.1867036520119e-10
years O 0 1.078382695640645e-11
. O 0 4.0125395410831044e-13

We O 0 5.272857671323461e-12
have O 0 5.720284119834938e-15
found O 0 2.384123519604182e-15
a O 0 5.18842567362774e-16
direct O 0 4.20254515865956e-14
progression O 0 1.750992406623908e-11
of O 0 3.060012930470159e-16
the O 0 2.5810404686324407e-15
size O 0 1.1463018034785222e-12
heterogeneity O 0 1.2961886772244746e-11
over O 0 4.705355571323067e-13
time O 0 1.6783062027798945e-13
related O 0 1.572010615213601e-13
to O 0 1.4653573637501646e-15
initial O 0 2.766452160667815e-13
CTG O 0 8.637352499896167e-10
repeat O 0 9.7374157348451e-12
size O 0 1.32560065355114e-12
and O 0 2.9119138740887895e-13
the O 0 9.87950515260504e-15
time O 0 4.3442623088273125e-13
interval O 0 4.39637638360163e-13
and O 0 4.0726641758461954e-14
always O 0 4.6169756792681024e-14
biased O 0 9.738228019112727e-13
towards O 0 1.2640757174721753e-14
further O 0 1.2628568709423943e-13
expansion O 0 1.7762374904251033e-11
. O 0 7.75760185256491e-12

Attempts O 0 4.3656970399874595e-11
to O 0 5.2787892871990205e-14
mathematically O 0 4.610239707353303e-12
model O 0 6.808863911057783e-13
the O 0 6.0406489211454594e-15
dynamics O 0 3.420282460031565e-11
have O 0 1.3030393821236719e-12
proved O 0 2.6224715107825425e-11
only O 0 5.253635457984178e-15
partially O 0 1.0232897293188312e-13
successful O 0 4.7531148803089604e-14
suggesting O 0 3.184106353148336e-13
that O 0 7.422412735679995e-17
individual O 0 3.3711508050172534e-18
specific O 0 1.3815313833998532e-15
genetic O 0 9.556237745567131e-12
and O 0 3.773766715786664e-11
/ O 0 9.039346160477635e-09
or O 0 7.410068218749455e-12
environmental O 0 2.5128291374770795e-12
factors O 0 1.0108228273505993e-12
also O 0 9.168888738531056e-12
play O 0 1.5122306185055834e-11
a O 0 1.1839668785304513e-12
role O 0 7.891558066741577e-12
in O 0 3.3034861738473476e-12
somatic O 0 6.934746527020863e-11
mosaicism O 0 1.2384814951360568e-08
. O 0 1.397856656815133e-11
. O 0 2.084373992849997e-11

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 1.0386334015066723e-09
Palestinian O 0 4.9210541419597575e-08
Arabs O 0 1.5007023179691714e-08
. O 0 6.85683107515267e-11

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 0.0006150320987217128
AGU B-Disease 1 1.0
) O 0 3.171496398834961e-11
is O 0 2.5358795941485095e-14
a O 0 1.3068718199629736e-13
rare O 0 1.339873323402685e-09
disorder B-Disease 0 7.18420642442652e-06
of I-Disease 0 1.473856174705559e-15
glycoprotein I-Disease 0 7.667830259627806e-10
metabolism I-Disease 0 2.013825772806399e-09
caused O 0 4.356748184333563e-14
by O 0 7.35404275080669e-16
the O 0 9.355986037989927e-13
deficiency B-Disease 0 1.416602299286751e-05
of I-Disease 0 1.1402292726607585e-15
the I-Disease 0 4.6904161463004815e-14
lysosomal I-Disease 0 3.864029096689592e-09
enzyme I-Disease 0 3.30158705930117e-10
aspartylglucosaminidase I-Disease 0 1.7209762503966886e-09
( O 0 6.4188389846397964e-12
AGA O 0 5.720476536907881e-09
) O 0 3.516966926020437e-11
. O 0 3.933680811640805e-11

AGU B-Disease 1 1.0
is O 0 1.0177497039576267e-10
inherited O 0 3.551978933202804e-09
as O 0 1.941367422722551e-12
an O 0 4.0579803514857737e-13
autosomal O 0 0.0008593163220211864
recessive O 0 1.5139958122745156e-05
trait O 0 1.8898207443385218e-08
and O 0 3.855294208876536e-11
occurs O 0 4.2019522355964817e-14
with O 0 4.259100828569724e-16
a O 0 2.48007430564412e-12
high O 0 3.473867304926159e-10
frequency O 0 1.1513186237710471e-10
in O 0 5.074777504887606e-07
Finland O 0 1.906117006456043e-07
because O 0 7.422969357240294e-12
of O 0 3.3444875693769763e-15
a O 0 1.3984319344878537e-12
founder O 0 1.0041577291897141e-10
effect O 0 1.6540421809985162e-10
. O 0 2.794184675303235e-11

While O 0 2.9234434317793045e-10
very O 0 6.382230161028346e-11
few O 0 2.4634463306055787e-12
patients O 0 9.55076133197369e-14
with O 0 3.4735139806498557e-15
AGU B-Disease 1 1.0
have O 0 1.6729753162230548e-13
been O 0 5.825238701779797e-14
reported O 0 1.0125961484239165e-12
from O 0 1.1912685769744583e-14
non O 0 8.182342303708623e-11
- O 0 1.8046186073261694e-11
Finnish O 0 8.708209500718489e-12
origin O 0 4.153657669550559e-13
, O 0 7.730630371960423e-12
we O 0 2.1476698891520485e-11
diagnosed O 0 1.1550077561039984e-09
the O 0 2.937774874170636e-14
disorder O 0 2.303078616705534e-09
in O 0 1.708338874008286e-13
8 O 0 1.1099954099315704e-13
patients O 0 5.187264327929583e-14
originating O 0 2.5833038507817874e-13
from O 0 3.627531218117208e-13
3 O 0 1.3101863615295334e-13
unrelated O 0 6.555196923468953e-12
families O 0 7.974041349098626e-14
, O 0 5.250209209712534e-15
all O 0 4.006079381730656e-16
Palestinian O 0 3.564365816388637e-12
Arabs O 0 3.6229970846318738e-12
from O 0 1.5071274306679983e-12
the O 0 1.5037182111467262e-13
region O 0 2.979396243607546e-11
of O 0 4.5374118416534326e-13
Jerusalem O 0 4.1476761225567316e-07
. O 0 9.95224666566763e-11

The O 0 2.116833834955867e-12
clinical O 0 6.314860301337433e-10
diagnosis O 0 1.134998015572819e-07
of O 0 1.1963880949296402e-13
AGU B-Disease 1 1.0
is O 0 1.1691894197599084e-12
often O 0 2.1326296035118625e-13
difficult O 0 3.8675629539242085e-12
, O 0 8.264025280876799e-15
in O 0 2.247569230067522e-14
particular O 0 2.50985179633869e-14
early O 0 2.0565500691294147e-10
in O 0 5.132409796639037e-13
the O 0 2.0733386609271065e-15
course O 0 1.7463053572641662e-12
of O 0 1.5717384550573187e-16
the O 0 1.701476755170718e-14
disease O 0 3.204519982702436e-11
, O 0 4.275668496556487e-14
and O 0 7.96187931122877e-15
most O 0 1.763126343582816e-16
of O 0 5.49899538262749e-18
the O 0 1.2663144679034158e-15
patients O 0 1.973450055984833e-14
are O 0 1.2389401629931697e-15
diagnosed O 0 3.852918418340012e-12
after O 0 6.508541874395736e-15
the O 0 9.787115880916224e-15
age O 0 7.771423088387408e-11
of O 0 4.372415244539157e-14
5 O 0 1.5268611028296242e-11
years O 0 5.402558261868862e-11
. O 0 1.409308542262011e-12

However O 0 4.248766269365767e-11
, O 0 1.806710705522241e-13
since O 0 3.1219171263982895e-14
these O 0 1.8163766050591744e-15
patients O 0 2.6733530838395298e-15
excrete O 0 1.757081927059121e-14
early O 0 6.8128587894875775e-15
large O 0 1.564709140386292e-16
amounts O 0 7.497336627394768e-14
of O 0 6.469361179574362e-14
aspartylglucosamine O 0 4.662298280777577e-08
in O 0 3.1025227525960375e-11
urine O 0 2.5272776493084903e-12
, O 0 1.7379523655717405e-15
biochemical O 0 3.5037665585720135e-13
screening O 0 9.210675624982123e-12
is O 0 5.1755037836767256e-14
easy O 0 2.503186373459254e-11
by O 0 9.233269666420255e-14
urine O 0 1.717177441906692e-11
chromatography O 0 5.2205625239443165e-11
. O 0 2.7175069377931294e-13
. O 0 1.2231400788043079e-12

Detection O 0 4.337057379899534e-10
of O 0 1.8016856656219958e-14
heterozygous O 0 4.4591792064396785e-11
carriers O 0 3.294100409112488e-11
of O 0 2.1711265394568947e-14
the O 0 1.0315059223442447e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 9.9846308998508e-10
ATM O 0 5.1726054550726985e-09
) O 0 1.0571648808091472e-13
gene O 0 7.797506564044543e-12
by O 0 6.467325589995521e-14
G2 O 0 1.1536564592518062e-08
phase O 0 3.6357777899453936e-11
chromosomal O 0 1.460503824546322e-07
radiosensitivity O 0 5.080238807408932e-08
of O 0 5.297512645566216e-13
peripheral O 0 6.502336304947676e-07
blood O 0 1.574195884757046e-08
lymphocytes O 0 1.602060706318298e-07
. O 0 7.038231802924955e-11

In O 0 5.314010991241958e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 6.063642103981692e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.136088611022103e-12
patients O 0 5.741764702582586e-11
, O 0 4.092440531692099e-15
mutations O 0 8.604880046350627e-13
in O 0 2.710105089561571e-13
a O 0 3.377052598067115e-14
single O 0 7.131322001831513e-15
gene O 0 1.998025009330995e-12
, O 0 2.5324768933927995e-14
ATM O 0 2.027796680570404e-10
, O 0 1.8848687056136938e-14
result O 0 1.4243981157329583e-13
in O 0 2.8029989440625513e-10
an O 0 1.187865564133972e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.3168222068316027e-10
embraces O 0 1.612828273711564e-11
a O 0 1.6007791067088745e-13
variety O 0 1.935096505777112e-13
of O 0 1.4998784032737504e-15
clinical O 0 5.392710475220219e-13
features O 0 1.709522280679554e-13
and O 0 6.826871424940595e-14
manifests O 0 3.302176023942116e-12
extreme O 0 9.051197833766234e-13
radiosensitivity O 0 3.7357304449869844e-07
and O 0 1.7295621315346899e-12
a O 0 1.4168282432697188e-12
strong O 0 4.066693509718888e-11
pre O 0 5.79577594805869e-08
- O 0 4.262222219608702e-08
disposition O 0 3.450518981651385e-09
to O 0 4.40434364326614e-12
malignancy B-Disease 0 6.155102028060355e-08
. O 0 3.5579626050941116e-11

Heterozygotes O 0 6.70957405191075e-08
for O 0 6.21150754529648e-13
the O 0 1.1251717161881846e-14
ATM O 0 1.5034804512481514e-09
gene O 0 1.1130287663752014e-10
have O 0 2.0327504599276097e-13
no O 0 1.4164863367264937e-14
clinical O 0 2.275421875658906e-13
expression O 0 4.639129995410128e-15
of O 0 1.400624713052915e-14
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 9.026734915096313e-09
may O 0 1.5581322343471982e-10
be O 0 3.0527582415076915e-14
cancer B-Disease 0 1.7584012588015008e-12
prone O 0 7.724819048315901e-13
with O 0 4.320118964507556e-16
a O 0 2.143232856813282e-12
moderate O 0 4.465558589572538e-09
increase O 0 1.1690724777135841e-10
in O 0 9.801638389816958e-10
in O 0 1.762422291440302e-10
vitro O 0 1.9200935952312648e-08
radiosensitivity O 0 9.855881444309489e-08
. O 0 1.488286056894328e-11

We O 0 1.2873735411034204e-10
performed O 0 4.671706597958458e-12
a O 0 3.7796914036103413e-13
blind O 0 2.1612149569971706e-10
chromosomal O 0 1.3775044749309018e-07
analysis O 0 1.57764190600318e-10
on O 0 2.194686966883186e-11
G2 O 0 1.8406115032121306e-07
- O 0 1.5485426274608471e-09
phase O 0 4.16047300777489e-11
lymphocytes O 0 5.973737476905328e-11
from O 0 3.3081946470420176e-13
7 O 0 3.451281686654706e-13
unrelated O 0 3.6009001336267943e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.8101272303283622e-07
, O 0 1.5681915469423387e-14
13 O 0 1.164570013773708e-14
obligate O 0 7.613482760904233e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.6540566250000666e-08
( O 0 1.7969687153215896e-12
parents O 0 1.620983756294228e-13
of O 0 2.009132868693516e-17
the O 0 1.4614210163558166e-16
patients O 0 8.360482851811277e-15
) O 0 8.8284364737964e-16
, O 0 1.8097631412136023e-13
and O 0 1.3966573557400164e-11
14 O 0 4.0505120958711505e-12
normal O 0 6.559011146711757e-12
controls O 0 3.25563742631374e-10
following O 0 6.515725052601631e-14
X O 0 1.81846707830724e-11
- O 0 1.6545989838662178e-12
irradiation O 0 1.875608349188873e-11
with O 0 1.086563835867721e-13
1 O 0 1.5645900373895127e-12
Gy O 0 1.370889624041638e-08
in O 0 4.014987330775398e-14
order O 0 1.5154758797227279e-15
to O 0 6.442780883348872e-16
evaluate O 0 5.746018081915355e-14
this O 0 1.9457081334815226e-16
cytogenetic O 0 1.5365663602606716e-11
method O 0 1.6614163658116438e-13
as O 0 2.1276757821418225e-14
a O 0 5.5986587436419877e-14
tool O 0 2.952254760102413e-11
for O 0 3.058100647712614e-15
detection O 0 4.884478238542656e-13
of O 0 1.2503594588474023e-14
ATM O 0 4.546155807361174e-08
carriers O 0 2.9557849501316014e-09
. O 0 2.5502117778630762e-11

Both O 0 9.789885568878276e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 4.4479579628387e-06
and O 0 2.07772330156758e-13
heterozygotes O 0 9.893140473504758e-11
showed O 0 3.921580074561781e-12
significantly O 0 1.5485371231832579e-12
increased O 0 4.541340380462798e-14
levels O 0 1.1826520496152192e-14
of O 0 1.5433738362828343e-16
radiation O 0 3.382997215695127e-10
- O 0 1.516641390253426e-07
induced O 0 2.8338456026233416e-09
chromatid O 0 1.4467671860529663e-07
damage O 0 4.144806373118648e-11
relative O 0 5.680258238598135e-13
to O 0 8.478189938293523e-15
that O 0 4.053025547557515e-15
of O 0 5.287997467071917e-15
normal O 0 9.144581619713321e-11
controls O 0 3.182952070801548e-07
. O 0 1.4417295135515928e-10

These O 0 6.210311128199142e-13
results O 0 1.1850552006711923e-13
show O 0 1.635236576409769e-14
that O 0 3.523168693144238e-16
the O 0 2.6233679332045116e-14
G2 O 0 7.349023434244373e-08
- O 0 3.930645253724663e-10
phase O 0 2.1443707920454358e-11
chromosomal O 0 4.315804957855107e-08
radiosensitivity O 0 1.5705092781814756e-09
assay O 0 2.1490547189029208e-11
can O 0 5.208835461887424e-15
be O 0 1.6702872643117838e-17
used O 0 1.2102855413133692e-16
for O 0 1.2324949768009485e-17
the O 0 2.5222101724752526e-17
detection O 0 6.383633313795933e-14
of O 0 1.9505863666901407e-13
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 3.3856649679364637e-06
. O 0 1.7325818557623052e-10

In O 0 9.464109183843217e-12
combination O 0 1.3553711972202898e-11
with O 0 1.517058539608849e-14
molecular O 0 1.5325468758625727e-12
genetic O 0 2.8905568910664314e-11
analyses O 0 4.643335368981205e-11
, O 0 2.7266695303528043e-14
this O 0 4.968671975187676e-16
test O 0 3.0034769159595354e-13
may O 0 5.5091056770737584e-14
be O 0 4.4500828030250293e-17
of O 0 8.346061612131279e-19
value O 0 9.916805518986804e-16
in O 0 3.98121273903658e-14
studies O 0 3.606572505920891e-13
of O 0 2.616879914938428e-15
familial B-Disease 0 8.14113998437449e-10
and I-Disease 0 1.6555248491534336e-11
sporadic I-Disease 0 3.217943245203969e-09
cancers I-Disease 0 3.4605218690586526e-10
aimed O 0 5.365054320943807e-12
at O 0 2.6913560356028876e-12
determination O 0 6.904459642909089e-14
of O 0 1.1855320456774341e-17
the O 0 3.099780597948156e-17
potential O 0 5.215734545242811e-15
involvement O 0 1.666392582732809e-13
of O 0 6.0724401852382814e-15
ATM O 0 1.0196396971196009e-07
mutations O 0 1.5225637417515259e-10
in O 0 6.794986014829751e-12
tumor B-Disease 0 3.835875617141937e-09
risk O 0 2.5311974738428944e-10
or O 0 3.710456854960631e-12
development O 0 2.6611781354934916e-12
. O 0 6.953547438369456e-13
. O 0 4.21425307844947e-12

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 3.6087177690546923e-10
identification O 0 8.871194577542152e-12
and O 0 1.346864230692866e-15
detection O 0 7.13709199026821e-15
of O 0 8.276663330087188e-18
founder O 0 3.329586172745591e-12
- O 0 4.2841261094217487e-10
effect O 0 2.3926929881845638e-11
mutations O 0 1.2431940026036425e-11
in O 0 5.276537128236225e-13
the O 0 3.482190562645055e-15
ATM O 0 1.6096482480243424e-10
gene O 0 8.701385098563996e-12
in O 0 5.024105589022942e-13
ethnic O 0 3.644230371028373e-13
populations O 0 6.401050262755392e-12
. O 0 1.8556069875108605e-11

To O 0 7.809852482602853e-14
facilitate O 0 1.7603601139715847e-13
the O 0 3.86972592370579e-15
evaluation O 0 1.0279377040322765e-13
of O 0 2.932194798461648e-17
ATM O 0 1.1132246235945331e-09
heterozygotes O 0 2.7535052363192314e-11
for O 0 1.0265258991619462e-15
susceptibility O 0 2.1727185209406003e-13
to O 0 1.920659235766977e-14
other O 0 1.7916835278863202e-13
diseases O 0 1.593089216100907e-08
, O 0 3.6381013761473124e-15
such O 0 2.586954876186644e-15
as O 0 8.686825564430123e-12
breast B-Disease 0 4.752953031150753e-10
cancer I-Disease 0 6.492118509449085e-10
, O 0 9.47868411364794e-13
we O 0 4.9745946836647625e-14
have O 0 2.262060248553325e-16
attempted O 0 1.6856455399799457e-14
to O 0 1.785012351450887e-16
define O 0 6.078535434326723e-15
the O 0 6.223677282695826e-16
most O 0 2.0622090715166587e-15
common O 0 8.00997045384208e-14
mutations O 0 1.3627791386680577e-12
and O 0 1.5162002241827371e-13
their O 0 6.88772506708007e-15
frequencies O 0 2.4887283206487254e-11
in O 0 1.1959508050551904e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 6.855218998680357e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.0083546844730229e-11
homozygotes O 0 8.03704747198708e-09
from O 0 3.0990969339395047e-12
10 O 0 1.3375342771283077e-13
ethnic O 0 1.780672506147829e-13
populations O 0 4.233935684688772e-12
. O 0 8.66387517284295e-12

Both O 0 1.5464829937472668e-12
genomic O 0 8.186935573917253e-10
mutations O 0 1.616839995222108e-09
and O 0 2.356908722009332e-12
their O 0 8.385651588805991e-15
effects O 0 4.4899416758344135e-13
on O 0 3.494962836931431e-13
cDNA O 0 3.7926797119558486e-11
were O 0 8.642782670098548e-12
characterized O 0 2.2969961002705652e-11
. O 0 7.818325847841479e-12

Protein O 0 5.850450790489958e-09
- O 0 1.8427528392095383e-09
truncation O 0 1.7292077492125912e-10
testing O 0 1.8689161329632498e-11
of O 0 1.3915537683993417e-16
the O 0 1.7036409402328205e-16
entire O 0 1.0652302438296079e-14
ATM O 0 3.9990812744639115e-11
cDNA O 0 7.420166911464854e-12
detected O 0 7.558313003253048e-11
92 O 0 2.634934588227611e-12
( O 0 3.3593874210202657e-13
66 O 0 3.22297505524205e-12
% O 0 1.7830345761058602e-13
) O 0 2.2677964107292725e-13
truncating O 0 6.062456647804026e-10
mutations O 0 1.3212533289674866e-09
in O 0 9.485795829378141e-12
140 O 0 2.9894301010330304e-12
mutant O 0 1.4215240096149273e-09
alleles O 0 3.937310477653e-09
screened O 0 6.56513122976321e-07
. O 0 7.270716806395683e-10

The O 0 1.651770625658855e-12
haplotyping O 0 6.997920909412869e-09
of O 0 8.367246409895102e-15
patients O 0 3.5906089299736488e-12
with O 0 4.627903208968983e-16
identical O 0 6.880566429112722e-12
mutations O 0 4.952354498710676e-11
indicates O 0 2.7295316007425185e-10
that O 0 5.347680848491465e-14
almost O 0 3.216457590722588e-13
all O 0 3.651266015153098e-16
of O 0 1.6665568658648075e-18
these O 0 5.253466670125825e-18
represent O 0 5.4790852280014e-17
common O 0 5.241786822304806e-14
ancestry O 0 3.065775064370335e-11
and O 0 2.85432760760429e-10
that O 0 7.108161173378924e-13
very O 0 1.8891799583031776e-11
few O 0 8.327630252047413e-12
spontaneously O 0 4.2244094507204455e-12
recurring O 0 6.10604400375081e-10
ATM O 0 1.8452338679253444e-07
mutations O 0 1.5248980966831027e-09
exist O 0 4.523834362668566e-10
. O 0 8.785121935472873e-11

Assays O 0 1.0748954615280581e-08
requiring O 0 9.295088136684893e-12
minimal O 0 3.409884570884647e-12
amounts O 0 5.6232735210891976e-14
of O 0 4.596129414930698e-16
genomic O 0 4.8332778751492e-12
DNA O 0 3.655876157360183e-10
were O 0 4.572246918642213e-14
designed O 0 1.511631430109201e-14
to O 0 3.765186917300677e-16
allow O 0 5.331563124406284e-16
rapid O 0 1.1699651393092675e-13
screening O 0 6.089728330979649e-13
for O 0 3.44108167143464e-16
common O 0 1.3289112106747158e-13
ethnic O 0 2.675479412669879e-12
mutations O 0 9.810877665827888e-10
. O 0 1.36966521457893e-10

These O 0 2.6876419926408213e-12
rapid O 0 9.735596009918801e-12
assays O 0 2.1986863441014748e-09
detected O 0 5.64192130514396e-11
mutations O 0 1.2431086542086245e-11
in O 0 4.871072078679872e-13
76 O 0 3.548181496879077e-12
% O 0 2.2116945048392816e-14
of O 0 5.431598774268201e-16
Costa O 0 7.269739064202918e-12
Rican O 0 6.282273312674391e-12
patients O 0 4.438872533429894e-11
( O 0 4.3871932589633136e-14
3 O 0 1.1961227533885833e-14
) O 0 7.829356771466098e-15
, O 0 5.2471658203330496e-15
50 O 0 7.660575292330312e-15
% O 0 3.6216669040915056e-14
of O 0 1.358990587299819e-14
Norwegian O 0 2.103482802340295e-05
patients O 0 4.563454128470035e-11
( O 0 5.321703703251891e-14
1 O 0 2.0292475043522627e-14
) O 0 1.0060919281116177e-14
, O 0 3.264410768609449e-14
25 O 0 9.031356662959206e-15
% O 0 6.681952388588267e-15
of O 0 1.0136844561650974e-15
Polish O 0 8.657403960388166e-11
patients O 0 7.672719339220369e-13
( O 0 1.3158529780653468e-14
4 O 0 1.873185071952447e-14
) O 0 1.4585209396570514e-14
, O 0 4.5852417593058095e-14
and O 0 9.248885565835835e-14
14 O 0 5.523362258015585e-14
% O 0 8.462712105248345e-15
of O 0 8.554268849429128e-16
Italian O 0 1.7647575623058742e-09
patients O 0 9.405211852386852e-12
( O 0 2.4764475951670473e-13
1 O 0 1.199159911993708e-12
) O 0 9.399234862650374e-13
, O 0 6.203409097169099e-13
as O 0 3.507790100596743e-14
well O 0 2.388948642788216e-15
as O 0 7.482942636533073e-16
in O 0 1.4753109961441156e-14
patients O 0 4.796554456789129e-15
of O 0 1.291195981319672e-16
Amish O 0 3.492506834845699e-07
/ O 0 1.591520594956819e-05
Mennonite O 0 9.871320071397349e-05
and O 0 1.1484657669313947e-09
Irish O 0 2.0741124373557795e-09
English O 0 9.509886211844787e-09
backgrounds O 0 3.1839670899813655e-09
. O 0 1.711305229468163e-11

Additional O 0 5.218190896744135e-12
mutations O 0 2.4472764093008692e-11
were O 0 4.1248490625749035e-13
observed O 0 4.482492427639127e-15
in O 0 7.608124471137484e-15
Japanese O 0 9.153974507656454e-14
, O 0 3.909009736847558e-17
Utah O 0 1.5188441062374846e-15
Mormon O 0 2.731344881171105e-13
, O 0 9.304515301679708e-14
and O 0 2.3414257322275714e-14
African O 0 1.1177243484060406e-13
American O 0 7.136475872054904e-12
patients O 0 2.127577454491547e-11
. O 0 1.2806276221757895e-12

These O 0 9.793905053276375e-13
assays O 0 8.779459798047284e-11
should O 0 5.995881535817175e-15
facilitate O 0 6.44762834702689e-15
screening O 0 1.187018826330835e-13
for O 0 6.2964909876988846e-15
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
heterozygotes O 0 8.330609535533995e-10
in O 0 1.7872429068383627e-13
the O 0 1.3896016221537165e-16
populations O 0 1.2171206154477227e-14
studied O 0 6.0583118383084056e-12
. O 0 1.0566387039423128e-13
. O 0 8.260062013716596e-13

The O 0 8.681479840566553e-11
von B-Disease 1 0.9911584258079529
Hippel I-Disease 1 0.9999692440032959
- I-Disease 1 0.9999979734420776
Lindau I-Disease 1 0.9999517202377319
tumor I-Disease 0 0.0006452223169617355
suppressor O 0 5.317164308848987e-08
gene O 0 1.0883995926747048e-09
is O 0 1.1394760189662595e-13
required O 0 1.066193659103815e-14
for O 0 1.246006852992994e-15
cell O 0 1.4534757841744295e-09
cycle O 0 2.5818729099125193e-11
exit O 0 7.96845402162294e-12
upon O 0 1.5034229015799955e-13
serum O 0 6.8229116800822e-11
withdrawal O 0 9.296373670864e-10
. O 0 1.604770309693304e-11

The O 0 9.066091519009667e-13
inactivation O 0 5.813437231605434e-11
of O 0 7.614015161769164e-16
the O 0 4.652903089945662e-14
von B-Disease 1 0.9554036259651184
Hippel I-Disease 1 0.9999270439147949
- I-Disease 1 0.9999918937683105
Lindau I-Disease 1 0.9999926090240479
( I-Disease 0 9.974608872198587e-08
VHL I-Disease 0 0.0008788798586465418
) I-Disease 0 5.366000976891883e-10
tumor I-Disease 0 2.6809668725036317e-06
suppressor O 0 1.578095634613419e-06
gene O 0 1.5060219027418498e-07
predisposes O 0 6.793780471525679e-08
affected O 0 6.259312512746362e-11
individuals O 0 1.6893599488602452e-14
to O 0 2.6499902210883617e-15
the O 0 3.5578619450539126e-14
human O 0 3.910934687212375e-09
VHL B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
and O 0 5.172124447477833e-12
is O 0 3.7112596118016664e-14
associated O 0 9.323729288635008e-12
with O 0 1.8357454445450117e-11
sporadic B-Disease 1 0.999997615814209
renal I-Disease 1 0.9999969005584717
cell I-Disease 1 0.9999991655349731
carcinomas I-Disease 1 1.0
( O 0 9.134762990470335e-08
RCC B-Disease 0 0.005321823060512543
) O 0 5.749131726240364e-10
and O 0 3.1380661957847167e-10
brain B-Disease 0 5.437175900624425e-07
hemangioblastomas I-Disease 0 3.408335714993882e-06
. O 0 2.1841927572152642e-11

VHL O 0 0.0035189324989914894
- O 0 1.6261743439827114e-05
negative O 0 9.10428852307632e-08
786 O 0 1.7638541294218157e-07
- O 0 3.8666934187858715e-07
0 O 0 1.4942847306742557e-11
RCC B-Disease 0 5.086849164115392e-09
cells O 0 2.7917180719927437e-11
are O 0 1.9619929866963176e-13
tumorigenic O 0 1.0093043067982421e-09
in O 0 2.922832765747674e-12
nude O 0 3.5571918033383554e-07
mice O 0 2.94644934228927e-07
which O 0 1.4834182872954654e-13
is O 0 4.493807305506786e-16
suppressed O 0 7.696104089302894e-15
by O 0 2.088571224994495e-16
the O 0 2.7472306622243394e-15
reintroduction O 0 2.8649227087895746e-12
of O 0 5.2343939187411703e-14
VHL B-Disease 0 5.34264010809693e-08
. O 0 2.757573162870397e-11

Remarkably O 0 3.029079562111292e-05
, O 0 2.386587563858733e-13
this O 0 2.2170730052356688e-16
occurs O 0 3.447493710845355e-16
without O 0 1.0648350288443309e-16
affecting O 0 1.522177329115696e-14
the O 0 1.984210593140162e-14
growth O 0 5.059642376181728e-07
rate O 0 1.4982359797244271e-09
and O 0 8.316874885181194e-14
cell O 0 2.40615832813873e-10
cycle O 0 1.331763909220851e-12
profile O 0 6.645633479282487e-13
of O 0 3.729791263319492e-16
these O 0 7.350536563800649e-16
cells O 0 8.914148309476302e-14
in O 0 1.459012056136133e-12
culture O 0 1.140544776678798e-11
. O 0 6.090416799359177e-12

The O 0 2.043558464809303e-12
786 O 0 1.9410224538773946e-09
- O 0 5.710970363281831e-09
0 O 0 1.4921678259324778e-12
cell O 0 1.6439500871712198e-09
line O 0 5.004182068724106e-10
, O 0 6.861347698772918e-14
like O 0 5.94696682306925e-14
many O 0 1.963581825687789e-15
cancer B-Disease 0 1.0433310709519542e-13
cells O 0 6.114959206311374e-14
, O 0 6.24436144610295e-14
fails O 0 2.255942177856185e-12
to O 0 9.10031615629402e-15
exit O 0 5.2481977097507126e-11
the O 0 6.372930612050243e-13
cell O 0 2.568227586152716e-08
cycle O 0 8.650352135985973e-12
upon O 0 3.3026763290346095e-14
serum O 0 2.6994132623636702e-11
withdrawal O 0 2.515819219617299e-10
. O 0 1.2155958531434585e-11

Here O 0 4.810786213838014e-10
, O 0 7.258176535924338e-14
it O 0 2.1243201181844648e-16
is O 0 9.606886387538827e-18
shown O 0 7.2702472371727e-17
that O 0 7.306223638118347e-17
reintroduction O 0 6.75796156773649e-14
of O 0 1.6126672194175445e-16
the O 0 3.92157450447312e-15
wild O 0 9.005276559170827e-12
- O 0 2.669906518093512e-09
type O 0 5.367590372173936e-09
VHL B-Disease 0 3.287753003178295e-08
gene O 0 3.1912263942501795e-09
restores O 0 1.131780802410276e-08
the O 0 5.464669989847619e-14
ability O 0 2.8169146702727854e-12
of O 0 1.917878155550598e-13
VHL O 0 2.187657810281962e-05
- O 0 5.4170628573047e-05
negative O 0 1.6643026583551546e-06
RCC B-Disease 0 1.8746241039480083e-05
cancer I-Disease 0 2.8490911851974943e-09
cells O 0 1.586891035243454e-11
to O 0 5.61565293506934e-14
exit O 0 5.2264481804897844e-12
the O 0 3.118061093609209e-14
cell O 0 5.874906339187191e-09
cycle O 0 3.5316007063190824e-11
and O 0 3.723471184158278e-13
enter O 0 3.691696670582445e-10
G0 O 0 5.2960986067773774e-06
/ O 0 1.475468138778524e-07
quiescence O 0 7.593567374897248e-08
in O 0 8.436978893300306e-10
low O 0 4.389288932316049e-09
serum O 0 1.4868198339179628e-10
. O 0 5.819602612311403e-12

Both O 0 3.0819524710068436e-10
VHL O 0 3.35265722242184e-05
- O 0 5.634613444271963e-06
positive O 0 1.0081653289972792e-09
and O 0 2.696046727881929e-12
VHL O 0 4.7477661269113014e-07
- O 0 9.215363583336966e-09
negative O 0 1.372047808700927e-09
RCC B-Disease 0 6.260693652393456e-08
cells O 0 1.3314122027097142e-10
exit O 0 3.2764749247071734e-10
the O 0 2.371671923521307e-13
cell O 0 3.5518907814946488e-09
cycle O 0 5.21091026231546e-12
by O 0 1.7501814884510192e-14
contact O 0 2.2517454567605455e-09
inhibition O 0 3.4813112392839685e-09
. O 0 3.878586687933172e-11

The O 0 8.50534746799081e-12
cyclin O 0 5.07149628958814e-08
- O 0 1.0288498941690705e-09
dependent O 0 7.837295812329614e-10
kinase O 0 2.7355071097190375e-08
inhibitor O 0 1.5885287751871147e-08
, O 0 1.305974913715785e-13
p27 O 0 1.6400125701920842e-10
, O 0 1.6230928344515734e-14
accumulates O 0 6.299125175461551e-14
upon O 0 8.164560504751552e-17
serum O 0 4.843035897989477e-14
withdrawal O 0 1.5662104046413466e-13
, O 0 3.60665104281576e-15
only O 0 4.0135896522970453e-16
in O 0 2.331250876003621e-15
the O 0 2.997576146694574e-17
presence O 0 1.7154072284278517e-14
of O 0 2.1609292792114897e-15
VHL B-Disease 0 9.776949388973222e-11
, O 0 3.1900300526539705e-15
as O 0 1.753107373184896e-15
a O 0 5.734967012459118e-15
result O 0 2.163882247823855e-15
of O 0 1.116891556200212e-16
the O 0 4.371712376599526e-15
stabilization O 0 1.3169465518103607e-12
of O 0 2.7273582104905695e-16
the O 0 7.86611969544283e-15
protein O 0 4.223015600407498e-12
. O 0 2.7341245587009233e-12

We O 0 2.1448357413050845e-12
propose O 0 6.670524050657323e-13
that O 0 1.8640529132865668e-15
the O 0 1.6461509347483194e-15
loss O 0 2.033550411395524e-12
of O 0 6.733919342209976e-16
wild O 0 2.9669940115883975e-11
- O 0 5.33177853867528e-07
type O 0 5.5831385736837547e-08
VHL B-Disease 0 2.547473876290951e-08
gene O 0 6.34601204918539e-10
results O 0 9.585829525982081e-12
in O 0 9.955092678752119e-15
a O 0 3.636902993933537e-14
specific O 0 6.504329410142451e-13
cellular O 0 3.264713299699906e-08
defect O 0 5.742249453710713e-10
in O 0 1.3769080276990198e-13
serum O 0 1.6647582617990153e-11
- O 0 9.203748319031035e-10
dependent O 0 3.808331705545953e-10
growth O 0 1.1449466930102403e-09
control O 0 5.879639223410615e-12
, O 0 6.699157830032665e-14
which O 0 1.846002090609162e-14
may O 0 1.3176073730344906e-12
initiate O 0 2.2585557556131786e-12
tumor B-Disease 0 1.114626307918698e-10
formation O 0 1.7736872083909394e-12
. O 0 8.613801512347141e-12

This O 0 2.1979618645973087e-12
is O 0 1.3148577821149587e-13
corrected O 0 3.874606364917543e-12
by O 0 1.807225128748141e-16
the O 0 1.5111347299889312e-15
reintroduction O 0 8.246901425645881e-13
of O 0 1.950472508521371e-15
wild O 0 2.7115556328061174e-11
- O 0 7.511478656851978e-07
type O 0 1.682964096971773e-07
VHL B-Disease 0 3.039915270619531e-07
, O 0 2.0150404782259823e-12
implicating O 0 4.950223009281274e-10
VHL B-Disease 0 2.2784940156839184e-08
as O 0 5.722909667861542e-13
the O 0 1.1304980287671091e-14
first O 0 2.515772150064183e-13
tumor B-Disease 0 3.4598224285531387e-10
suppressor O 0 1.8997717288193883e-10
involved O 0 2.924053794234327e-12
in O 0 9.430030541157652e-13
the O 0 1.6585343870305878e-14
regulation O 0 2.8076900179807573e-11
of O 0 7.864949095909724e-15
cell O 0 3.327039532763365e-09
cycle O 0 4.04483781538123e-12
exit O 0 6.3150951482016104e-12
, O 0 9.309840767225686e-14
which O 0 5.692226153457139e-15
is O 0 5.016171888803803e-15
consistent O 0 3.980827982790619e-13
with O 0 1.4580131645809962e-16
its O 0 1.871120132681983e-15
gatekeeper O 0 4.086926283508596e-11
function O 0 4.3030591703784385e-14
in O 0 2.284037108751802e-12
the O 0 1.1851417200045566e-12
kidney O 0 2.333832849199524e-10
. O 0 5.950203437604662e-13
. O 0 1.0086624244176612e-11

Piebaldism B-Disease 1 1.0
with O 0 1.565932689118199e-05
deafness B-Disease 1 1.0
: O 0 2.9024317129387744e-13
molecular O 0 1.3634595839515096e-13
evidence O 0 7.12384795251153e-14
for O 0 5.310169719136601e-16
an O 0 5.671894398107721e-15
expanded O 0 1.5585773383008927e-07
syndrome O 1 0.9998821020126343
. O 0 1.2321091369393855e-10

In O 0 7.264107934959463e-13
a O 0 1.4079510398268963e-13
South O 0 3.8791002745022785e-13
African O 0 4.193461983909019e-12
girl O 0 6.757620241160112e-08
of O 0 1.0726720211943e-14
Xhosa O 0 1.0640337677614298e-07
stock O 0 9.770615427839857e-10
with O 0 2.970834570101971e-14
severe O 0 4.513466267397348e-10
piebaldism B-Disease 0 6.504221516934194e-08
and O 0 1.3687496231915008e-12
profound O 0 2.4069043647045874e-08
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 6.358467086187147e-10
identified O 0 1.6053212578692744e-11
a O 0 2.3721410103674963e-14
novel O 0 2.2538379853848794e-13
missense O 0 1.6357451504411813e-10
substitution O 0 1.2940488524487703e-12
at O 0 3.607542324764179e-13
a O 0 2.396877760559111e-14
highly O 0 9.929289514079911e-14
conserved O 0 1.5280052613822481e-12
residue O 0 2.1894451529558268e-10
in O 0 1.1250714444278886e-13
the O 0 2.670091795234364e-15
intracellular O 0 2.813070523050021e-12
kinase O 0 6.64166152630763e-11
domain O 0 2.249999232067923e-12
of O 0 4.579873264486112e-15
the O 0 7.822632515711025e-13
KIT O 0 3.613908745592198e-07
proto O 0 3.959781679441221e-06
- O 0 8.659691630441557e-09
oncogene O 0 1.1255572474055953e-08
, O 0 9.785246397886471e-12
R796G O 0 5.11268405389842e-09
. O 0 1.025565223022884e-11

Though O 0 7.659786693814397e-11
auditory B-Disease 0 1.3181856495236843e-08
anomalies I-Disease 0 6.678560993123028e-08
have O 0 1.1275440352448776e-13
been O 0 7.06291104703334e-14
observed O 0 5.878523172799313e-14
in O 0 4.353868069024991e-13
mice O 0 2.3784851865826795e-09
with O 0 4.121928967311221e-14
dominant O 0 4.589801594345744e-10
white O 0 6.623245840664538e-10
spotting O 0 4.087572449407162e-07
( O 0 1.4877481469000031e-09
W O 0 4.3369713239371777e-05
) O 0 9.782236869496086e-13
due O 0 2.922208265296322e-12
to O 0 2.0663542491666798e-12
KIT O 0 0.00013469188706949353
mutations O 0 1.251402892421538e-07
, O 0 8.333444156960468e-07
deafness B-Disease 1 1.0
is O 0 1.7510382250077172e-12
not O 0 4.3049721095865176e-14
typical O 0 5.401875561444891e-12
in O 0 3.185875825303941e-12
human O 0 1.001788387487712e-12
piebaldism B-Disease 0 4.2434521674294956e-08
. O 0 1.2864966036918446e-11

Thus O 0 2.400590793857904e-12
, O 0 3.0194318996045605e-14
the O 0 3.0898298137024903e-16
occurrence O 0 4.54838380500866e-12
of O 0 2.7718053546843535e-11
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 9.90243798071333e-09
this O 0 2.0976087891384082e-13
patient O 0 6.860856934659543e-12
extends O 0 1.5268092440844615e-14
considerably O 0 4.2338284570939133e-13
the O 0 1.7648354972516975e-16
phenotypic O 0 5.900997138846842e-12
range O 0 1.0433873817022876e-12
of O 0 1.2208080886802995e-14
piebaldism B-Disease 0 1.2101005752995775e-09
due O 0 7.130186198411881e-13
to O 0 5.224701422369693e-13
KIT O 0 1.023152265133831e-07
gene O 0 5.31672261772087e-10
mutation O 0 1.7312927133583678e-11
in O 0 4.581555404156723e-13
humans O 0 3.0741407683332334e-12
and O 0 5.969940687633457e-12
tightens O 0 2.0878028195170373e-08
the O 0 7.483513854376878e-16
clinical O 0 2.042002770217058e-13
similarity O 0 2.2656995637276856e-13
between O 0 2.130816139853109e-13
piebaldism B-Disease 0 6.932111773494398e-08
and O 0 3.940801474749435e-14
the O 0 6.460473151685748e-17
various O 0 1.3377394623894506e-15
forms O 0 3.745282729783472e-12
of O 0 1.3329309878074014e-11
Waardenburg B-Disease 1 0.824726939201355
syndrome I-Disease 1 0.9835154414176941
. O 0 3.512058482577074e-12
. O 0 7.585504273321941e-12

Cycloheximide O 0 1.335770871691011e-08
facilitates O 0 1.3414496943808807e-11
the O 0 6.491879465773823e-15
identification O 0 3.2078007784763773e-13
of O 0 5.53410246638018e-16
aberrant O 0 6.120055850988848e-11
transcripts O 0 2.2516855047172157e-09
resulting O 0 1.7450026612488706e-13
from O 0 4.3444668842247333e-14
a O 0 2.4423684103803966e-13
novel O 0 1.4903455206050076e-11
splice O 0 1.7661028550719493e-07
- O 0 1.2040088925857617e-09
site O 0 1.432138956036777e-11
mutation O 0 1.4716969309880312e-10
in O 0 2.683505917477902e-10
COL17A1 O 0 5.624053301289678e-06
in O 0 8.291066617982512e-12
a O 0 2.0755905674740838e-11
patient O 0 1.361668278132555e-10
with O 0 7.008214402684163e-14
generalized O 0 4.112126106292635e-08
atrophic B-Disease 1 0.6271163821220398
benign I-Disease 1 0.9961995482444763
epidermolysis I-Disease 1 0.8979936838150024
bullosa I-Disease 1 0.5847830176353455
. O 0 4.745122339500085e-07

Patients O 0 4.883028395852307e-06
with O 0 7.520273466454785e-12
generalized O 0 6.761925988030271e-07
atrophic B-Disease 1 0.9994137287139893
benign I-Disease 1 0.9997047781944275
epidermolysis I-Disease 1 0.9445670247077942
bullosa I-Disease 0 0.024896353483200073
often O 0 2.5323009467115298e-08
show O 0 1.4058519626214405e-10
decreased O 0 3.2652516801512377e-10
expression O 0 4.1051645589818e-13
of O 0 1.4691016728935022e-15
type O 0 1.475646133064501e-10
XVII O 0 5.583303264167228e-10
collagen O 0 1.1478935857400785e-10
, O 0 5.430609439785808e-14
a O 0 4.5884442214727886e-14
transmembrane O 0 3.8568166021990535e-11
hemidesmosomal O 0 6.220848280946711e-10
protein O 0 6.057988312380136e-12
encoded O 0 5.517586821462972e-12
by O 0 2.915514780554157e-13
COL17A1 O 0 5.2577938447484485e-08
. O 0 4.7288314757032435e-12

This O 0 8.07497298194182e-12
report O 0 3.166056999903688e-11
documents O 0 1.7012999082438585e-12
a O 0 4.944645292715745e-14
novel O 0 3.6635933002571175e-12
splice O 0 3.607531482430204e-07
- O 0 3.4379712410270713e-09
site O 0 2.628400448678736e-11
mutation O 0 1.9223711511529018e-10
in O 0 2.0722845661680367e-10
COL17A1 O 0 2.5330361950182123e-06
in O 0 6.416501011075049e-12
a O 0 1.2276093336316407e-11
patient O 0 1.0054072852039297e-10
with O 0 1.9396185436319595e-14
generalized O 0 8.202085233222078e-09
atrophic B-Disease 0 0.33622506260871887
benign I-Disease 0 0.2067626267671585
epidermolysis I-Disease 0 0.0075948103331029415
bullosa I-Disease 0 0.0007319161086343229
, O 0 5.300401229035856e-10
and O 0 7.687583615479873e-14
applies O 0 2.0075732864847408e-14
a O 0 3.475554906536265e-15
new O 0 3.011443362472416e-14
methodology O 0 1.684479649950027e-13
to O 0 3.39513304572185e-16
define O 0 7.13818381573722e-14
and O 0 5.063430143920078e-14
characterize O 0 7.795781381547684e-12
the O 0 5.197583560919393e-14
resulting O 0 1.9751457143012824e-13
mRNA O 0 2.0163537506334706e-10
splice O 0 6.937985119748191e-08
variants O 0 2.641159113636604e-08
. O 0 5.657819213134019e-10

Mutational O 0 5.502736826201726e-07
analysis O 0 1.196499427313924e-10
of O 0 1.8554837774207265e-14
COL17A1 O 0 9.040173942764795e-09
identified O 0 2.4336286458259693e-11
a O 0 4.4599995354874244e-13
maternally O 0 3.900760248143342e-08
inherited O 0 2.315660019291954e-08
G O 0 3.562801165202245e-09
- O 0 2.321362269075422e-10
to O 0 1.6277697505867605e-12
- O 0 8.582212274177436e-09
T O 0 1.7667480811667247e-09
transversion O 0 2.1877491138133642e-11
at O 0 2.8346928279622714e-14
the O 0 1.1449714924950801e-15
- O 0 1.1467939228446133e-12
1 O 0 7.0856029749869886e-15
position O 0 1.3838772792637566e-13
of O 0 4.279933392149207e-15
exon O 0 5.536040514897422e-10
32 O 0 4.852542256905679e-10
. O 0 2.054608393142754e-11

This O 0 1.0726205514066667e-11
acceptor O 0 3.060436626345364e-10
splice O 0 8.012332131102085e-08
- O 0 1.7576328170676447e-09
site O 0 2.367785655044141e-12
mutation O 0 6.667181997460636e-12
led O 0 2.55926763071887e-13
to O 0 2.7817250202100867e-15
the O 0 1.0424009906593863e-15
formation O 0 2.0976186486019142e-15
of O 0 1.695879471458011e-16
aberrant O 0 4.201243519741382e-12
transcripts O 0 1.1592446447217242e-10
present O 0 6.326276308366019e-14
at O 0 1.008391287138366e-11
extremely O 0 5.375015432740327e-10
low O 0 6.811450070642877e-09
levels O 0 1.943558161632275e-11
. O 0 6.1189790213911355e-12

Based O 0 6.739179353454361e-11
on O 0 2.90366966582134e-11
our O 0 1.1146495341042128e-14
recent O 0 1.2680577887638073e-14
finding O 0 1.199671736734284e-13
that O 0 3.5395105527351745e-15
cycloheximide O 0 2.003741395029124e-09
stabilized O 0 1.8690865744019902e-08
mutant O 0 1.523679959980484e-09
COL17A1 O 0 8.696076747582993e-08
transcripts O 0 1.1077008199578131e-09
in O 0 1.6570647848671016e-13
keratinocytes O 0 4.261118541348807e-11
homozygous O 0 9.406862441774244e-12
for O 0 3.912713269295419e-15
a O 0 1.3716577786787587e-13
frameshift O 0 4.8717808454057376e-08
mutation O 0 1.470529080449534e-11
, O 0 9.303201384171927e-14
the O 0 1.485738776406116e-15
effects O 0 7.320722153481007e-12
of O 0 1.7581571718581893e-15
the O 0 2.3414209888430668e-14
splice O 0 4.69196024255325e-08
- O 0 1.7446658007180815e-10
site O 0 3.242292285349224e-12
mutation O 0 7.054463783962017e-12
on O 0 1.995267883206364e-12
splicing O 0 2.3390947165302656e-11
of O 0 1.4989698122070544e-14
COL17A1 O 0 1.2711072194804274e-09
transcripts O 0 3.675227136512582e-11
were O 0 1.804911844711498e-14
determined O 0 1.0251764274462043e-14
using O 0 5.60154238260762e-14
reverse O 0 2.0367615580219045e-11
transcriptase O 0 4.4603298832157634e-10
polymerase O 0 1.6209514633325206e-11
chain O 0 3.5405287642648053e-12
reaction O 0 5.842819717633008e-14
of O 0 3.2308838281285847e-16
total O 0 1.2414710974395656e-15
RNA O 0 6.26504542688977e-11
from O 0 1.178471816659643e-12
keratinocytes O 0 7.011116687216656e-10
incubated O 0 8.887864055839856e-11
for O 0 2.511074302050803e-13
2 O 0 1.2313233115415767e-12
. O 0 3.758069810205766e-12

5 O 0 2.7431953930623365e-10
h O 0 3.7201261515740214e-10
in O 0 5.398205753931462e-13
the O 0 1.5007140012762168e-15
presence O 0 2.15538673606179e-13
or O 0 2.7849533443258245e-11
absence O 0 2.2097327440073755e-11
of O 0 9.690045058127934e-15
10 O 0 2.027952323213275e-13
microg O 0 1.687567086072761e-09
cycloheximide O 0 3.013618155023323e-08
per O 0 1.6029945149043101e-09
ml O 0 2.2619631181441946e-06
. O 0 2.5664166972139135e-11

Using O 0 3.1996370071681046e-13
this O 0 6.853103865910471e-15
approach O 0 3.1471680730227325e-12
, O 0 6.886993145910347e-14
an O 0 2.1887392343423323e-14
abnormally O 0 1.4530655567668305e-09
spliced O 0 6.495455977528763e-07
transcript O 0 3.161970312248741e-07
was O 0 1.1943053317142738e-11
identified O 0 4.627469197757139e-13
that O 0 6.938085913884887e-17
contains O 0 4.4504901067586505e-17
an O 0 1.0596807010113904e-16
extra O 0 2.8547970194400807e-13
264 O 0 1.9468099549981022e-13
bases O 0 8.274719071835884e-15
upstream O 0 3.6229537165449743e-13
from O 0 5.791150707850495e-14
exon O 0 1.9872105350149383e-10
32 O 0 3.757943262128194e-11
, O 0 3.291721143708001e-14
resulting O 0 2.970120690734025e-14
in O 0 6.75319771891586e-13
a O 0 1.8380403102313814e-11
premature O 0 3.7423089627175443e-10
termination O 0 1.629834323058077e-10
codon O 0 2.4704231993410986e-09
27 O 0 1.2497176904435747e-11
bp O 0 1.977712299483514e-10
downstream O 0 2.9609561330579126e-11
from O 0 2.4367020987764443e-12
the O 0 6.976516261393562e-13
cryptic O 0 2.3708997431981516e-08
splice O 0 1.6871889840786025e-07
site O 0 6.473299118958664e-10
. O 0 4.9606929675150013e-11

Three O 0 1.705491997627817e-11
other O 0 2.4045247740069227e-14
splice O 0 2.965673040478123e-09
variants O 0 1.2551265582416704e-10
, O 0 2.6029723962741648e-14
including O 0 7.88374856865756e-16
one O 0 3.787053072834047e-16
derived O 0 1.0010921467338597e-14
from O 0 1.0461027660432776e-13
the O 0 6.145801708799976e-15
skipping O 0 4.731501648813641e-12
of O 0 8.100008256190199e-16
exon O 0 1.6793422555339e-11
32 O 0 5.492914109672675e-11
, O 0 4.794071498288865e-13
were O 0 3.4801111645221816e-12
also O 0 7.533042115440147e-14
identified O 0 3.2975767949583457e-11
. O 0 1.8185321954897193e-12

These O 0 5.270602747645126e-13
results O 0 3.718134198964218e-13
indicate O 0 1.0023377933860919e-14
the O 0 1.2046938003725107e-16
usefulness O 0 1.2816508379760727e-13
of O 0 2.2362524781394664e-16
cycloheximide O 0 1.9847625279401093e-11
treatment O 0 2.449193463056193e-13
in O 0 1.1801457003001174e-15
evaluating O 0 4.189172541301488e-14
the O 0 4.741266922255946e-16
abnormal O 0 5.011808676402829e-12
processing O 0 5.592548993349489e-12
of O 0 4.481037225035744e-16
mRNA O 0 2.1840706326825554e-12
due O 0 3.968604823023289e-14
to O 0 2.5192523373939076e-14
splice O 0 2.9551662450444383e-08
- O 0 1.427767626349663e-10
site O 0 1.2017219901475085e-12
mutations O 0 4.213250581752703e-11
, O 0 1.3905105636802945e-13
because O 0 1.618876473846731e-13
( O 0 6.5753075727259525e-12
i O 0 2.337705584665173e-09
) O 0 1.6522131495518184e-14
aberrant O 0 1.0726347761391697e-11
splicing O 0 6.46858122621552e-11
often O 0 2.1481766018793813e-12
generates O 0 7.600319679168521e-12
a O 0 1.1397597275697446e-11
premature O 0 3.738130693875519e-09
termination O 0 1.7435945742771963e-10
codon O 0 3.5622760297115974e-10
, O 0 9.066467195062433e-14
( O 0 1.9899080755565735e-13
ii O 0 6.063861218708055e-12
) O 0 6.57592808873432e-14
transcripts O 0 3.9473543878010275e-10
with O 0 4.763479514264743e-14
premature O 0 4.4730899539935365e-11
termination O 0 5.5047628781668134e-12
codons O 0 2.284804984098443e-11
can O 0 5.5710691864840206e-14
occur O 0 7.938591326190139e-14
at O 0 1.063594958633507e-12
low O 0 1.0060254851396166e-09
or O 0 1.1435770733148054e-11
undetectable O 0 3.7108798256468845e-09
levels O 0 1.1353200280936337e-12
due O 0 2.5904022579303215e-14
to O 0 5.346943336904291e-15
nonsense O 0 7.385904665646592e-10
- O 0 8.441686585869412e-12
mediated O 0 2.543135979582445e-10
mRNA O 0 3.815147416735831e-12
decay O 0 1.3083016657880475e-12
, O 0 1.2662226707077571e-15
and O 0 7.579240224119639e-16
( O 0 4.4867009108375596e-15
iii O 0 1.145674484101522e-12
) O 0 7.65674755044167e-15
the O 0 1.766895142566241e-14
levels O 0 1.0240473833494912e-13
of O 0 3.7349007910504565e-17
these O 0 2.2874940009814113e-16
transcripts O 0 3.1010066476461207e-12
can O 0 2.7285773026599052e-15
be O 0 4.511687641627733e-16
increased O 0 3.1268735820407954e-15
by O 0 8.013313692884893e-15
cycloheximide O 0 2.0417003199213468e-08
. O 0 1.5068120362560222e-11

A O 0 6.946134778473834e-10
deletion O 0 9.438004155981616e-09
mutation O 0 3.205357507196638e-11
in O 0 1.436272281662987e-11
COL17A1 O 0 5.398259759203938e-07
in O 0 1.5062517205732817e-11
five O 0 6.040804792148413e-13
Austrian O 0 1.2444313357562464e-09
families O 0 1.6960503910600638e-13
with O 0 3.950298746967229e-14
generalized O 0 3.003072279739172e-08
atrophic B-Disease 0 0.49891072511672974
benign I-Disease 1 0.7426402568817139
epidermolysis I-Disease 0 0.020612433552742004
bullosa I-Disease 0 0.0018135466380044818
represents O 0 1.8736981743927572e-08
propagation O 0 2.6463464752879418e-09
of O 0 1.3840832776765288e-13
an O 0 2.957113991609167e-14
ancestral O 0 9.063650385776612e-10
allele O 0 2.028662038355833e-07
. O 0 2.2233481722366832e-09

Patients O 0 4.6571622078772634e-06
with O 0 3.8480412432873035e-12
generalized O 0 4.0033083337220887e-07
atrophic B-Disease 1 0.9993166923522949
benign I-Disease 1 0.9996243715286255
epidermolysis I-Disease 1 0.8908708095550537
bullosa I-Disease 0 0.49436673521995544
, O 0 2.479165317481602e-09
a O 0 9.23667739516354e-12
usually O 0 4.065107354466607e-13
nonlethal O 0 1.8848376193147942e-09
form O 0 8.588033756362634e-11
of O 0 8.86696532170772e-12
junctional B-Disease 0 0.0005122139700688422
epidermolysis I-Disease 0 0.019004279747605324
bullosa I-Disease 0 0.006526910699903965
, O 0 9.900980035837392e-10
have O 0 1.6421519092452153e-12
generalized O 0 2.1647918180267567e-10
blistering B-Disease 0 1.7817073683090712e-07
, O 0 2.580774829952226e-11
nail B-Disease 1 0.9999489784240723
dystrophy I-Disease 0 0.0802210196852684
, O 0 6.777735317431421e-11
patchy B-Disease 1 0.9899987578392029
alopecia I-Disease 1 0.9998551607131958
, O 0 7.73763453310039e-09
and O 0 3.987949082073783e-09
dental B-Disease 1 0.9999977350234985
abnormalities I-Disease 1 0.9999901056289673
. O 0 1.3843176605021768e-10

Skin B-Disease 1 1.0
fragility I-Disease 0 0.00016368149954359978
in O 0 2.7776576611709958e-12
most O 0 4.2210764607762945e-15
cases O 0 1.0179281971099598e-14
is O 0 2.336591736373415e-16
due O 0 6.403946857936986e-15
to O 0 1.4218845285213222e-13
mutations O 0 1.177068997826325e-10
in O 0 6.256396876264114e-12
the O 0 1.5838376007308412e-14
gene O 0 1.0343311623861595e-10
encoding O 0 1.1233063090809736e-10
type O 0 2.1872006428225177e-09
XVII O 0 4.766527617050542e-09
collagen O 0 7.259524092972924e-09
( O 0 7.439546201304381e-10
COL17A1 O 0 7.727755360065203e-07
) O 0 4.9356262132871365e-11
. O 0 2.263136379687669e-11

Recently O 0 9.073274753745864e-08
, O 0 4.068917945632133e-12
we O 0 7.969236300595442e-14
reported O 0 2.1498460997526614e-11
five O 0 3.899617377601215e-14
Austrian O 0 1.4895454869545688e-09
families O 0 9.947506143456741e-14
with O 0 1.421753780515584e-14
generalized O 0 6.576145406000933e-09
atrophic B-Disease 0 0.051394153386354446
benign I-Disease 0 0.01867399923503399
epidermolysis I-Disease 0 0.005486942827701569
bullosa I-Disease 0 0.006685633212327957
who O 0 4.026318833894038e-08
share O 0 3.382576163613038e-11
the O 0 8.099335817909198e-14
same O 0 3.931518739036521e-12
COL17A1 O 0 4.6249397200881504e-07
mutation O 0 8.41868630363507e-10
. O 0 1.47344955681028e-10

Affected O 0 1.0400844629998574e-09
individuals O 0 1.6451668857515173e-13
in O 0 4.166911607428325e-12
three O 0 2.3645158503697236e-14
families O 0 6.075009236167304e-16
are O 0 6.286836029710047e-17
homozygous O 0 3.342641647415684e-13
for O 0 2.6104191711332457e-15
4003delTC O 0 1.2276374361519515e-11
, O 0 3.950025494138445e-15
whereas O 0 3.046679594265016e-14
those O 0 1.0951311844940425e-14
in O 0 3.5057853430171815e-13
two O 0 2.5345256966856182e-14
others O 0 4.285057348557032e-14
are O 0 9.722771446594525e-16
compound O 0 6.160583653457008e-13
heterozygotes O 0 4.624396976460332e-10
. O 0 1.2210473951390632e-11

To O 0 2.9417909623054295e-13
determine O 0 1.1233967586472132e-13
if O 0 2.6405451684517658e-15
the O 0 2.0608868795557743e-16
occurrence O 0 1.8319728871916963e-13
of O 0 3.123821722331838e-15
4003delTC O 0 1.5194015490216373e-10
in O 0 6.789719204621306e-14
these O 0 1.939631466178361e-16
unrelated O 0 1.3033711852579021e-14
families O 0 8.153453388183986e-16
signifies O 0 1.2690473773560845e-14
propagation O 0 6.293900676242886e-14
of O 0 9.864507322543159e-17
an O 0 5.201028994487292e-16
ancestral O 0 3.4200538234774314e-11
allele O 0 6.698203769417432e-09
or O 0 1.3892361927503316e-08
a O 0 5.410403502992267e-08
mutational O 0 0.0004975664778612554
hot O 0 1.4419872968574055e-05
spot O 0 4.4717361902257835e-07
, O 0 8.374300385083355e-12
haplotypes O 0 6.08908756749571e-10
were O 0 3.481664609394919e-12
determined O 0 2.9893660246846365e-13
for O 0 3.9638047614265818e-16
polymorphisms O 0 1.0106266518095097e-11
both O 0 7.616375927296457e-14
within O 0 4.411479319864353e-13
and O 0 8.009505385320193e-12
flanking O 0 8.09812448210323e-08
COL17A1 O 0 4.903721492155455e-05
. O 0 1.4528071801134246e-10

Five O 0 3.6861156488265934e-11
intragenic O 0 9.909878473379763e-10
polymorphisms O 0 2.429655088231897e-10
were O 0 2.1085235879340913e-13
chosen O 0 5.93095730744308e-15
based O 0 2.7384653789389035e-13
on O 0 5.1511368087675535e-11
their O 0 1.2158411213589182e-12
informativeness O 0 9.294605973764192e-09
. O 0 9.12339301328835e-12

One O 0 2.112920732474932e-12
of O 0 1.4770917876245112e-16
these O 0 6.701090065710074e-17
, O 0 1.8285559329890664e-16
not O 0 6.875197026273705e-17
previously O 0 7.927662568291485e-15
reported O 0 5.84152518023906e-11
, O 0 3.574322166911316e-14
was O 0 1.336056157201504e-12
2988 O 0 2.162264291227789e-12
A O 0 9.608742837854956e-13
or O 0 2.0627273760592812e-12
C O 0 4.605544390301475e-09
that O 0 1.628842663504125e-14
introduces O 0 2.9339239913418746e-13
a O 0 1.3549355864714285e-13
new O 0 3.0330325382320333e-13
restriction O 0 4.4261697172004455e-13
site O 0 7.709452108824177e-13
for O 0 7.012386548169158e-14
Eco0109 O 0 1.3078875760186293e-08
I O 0 5.334718480298761e-07
. O 0 6.376459690121683e-12

All O 0 1.4062683580551988e-13
the O 0 9.851167665354647e-15
4003delTC O 0 4.0157287217734705e-11
alleles O 0 2.242450149181341e-12
showed O 0 5.997471963503642e-11
the O 0 3.335414311264666e-16
same O 0 3.7400803313484676e-15
haplotype O 0 1.2143954244980826e-11
for O 0 1.0784859706409588e-14
these O 0 3.592247247547701e-15
five O 0 8.887342088387956e-14
polymorphic O 0 9.311008908330365e-11
markers O 0 1.133322657942415e-09
. O 0 6.941085206602082e-11

Fourteen O 0 3.3112423913905786e-10
microsatellite O 0 1.3408243404455789e-09
polymorphisms O 0 1.2388422510056785e-09
were O 0 9.34182744181944e-13
selected O 0 1.2875526755613386e-14
based O 0 8.23889499917789e-14
on O 0 2.489971119915002e-12
their O 0 1.1313225475786254e-13
high O 0 4.089294441261826e-12
heterozygosity O 0 7.174503352525008e-11
and O 0 5.70540319090769e-14
their O 0 2.2834573595921525e-16
location O 0 2.0457248362752006e-14
within O 0 1.4064881800456702e-13
10q23 O 0 3.06957694817811e-08
- O 0 5.580750528366707e-09
q25 O 0 1.3225625927759666e-08
near O 0 7.105655175365655e-09
COL17A1 O 0 1.637252171349246e-05
. O 0 5.359451771269619e-11

Three O 0 2.96315368075728e-11
families O 0 2.5311404448086217e-13
shared O 0 4.4682397430488574e-14
microsatellite O 0 5.177113737708794e-10
polymorphisms O 0 8.136983531414899e-09
covering O 0 1.1912580921702443e-09
at O 0 2.753321355630778e-11
most O 0 2.0237868184665858e-13
19 O 0 4.536823661974859e-13
cM O 0 2.9866750739238057e-10
, O 0 6.651768030699681e-14
whereas O 0 1.5737266362021024e-13
the O 0 6.813585967272795e-15
others O 0 3.882821730696699e-14
shared O 0 3.039098098815674e-15
smaller O 0 1.1120726735314168e-12
regions O 0 1.2603893623230888e-11
consistent O 0 5.428200555712692e-09
with O 0 6.587804168281183e-14
cross O 0 1.423661466493087e-10
- O 0 7.041045524402989e-09
over O 0 1.778788569347864e-13
events O 0 3.9566310805776075e-15
during O 0 1.0213705390076013e-14
passage O 0 4.927811021108834e-14
of O 0 5.386860545402148e-17
this O 0 8.726743551033621e-17
mutation O 0 3.3219181647391486e-15
through O 0 2.176055932396736e-14
several O 0 5.217491477922664e-13
generations O 0 9.11083274796054e-13
. O 0 7.748399903466374e-13

These O 0 3.790296527160508e-13
results O 0 3.120073372841342e-13
indicate O 0 9.759179548469651e-14
that O 0 3.495979411993408e-15
4003delTC O 0 1.023709561565056e-09
occurs O 0 2.1800492184045894e-13
on O 0 1.0051109250452939e-12
a O 0 3.4717226923136613e-13
single O 0 2.7456251790354547e-13
ancestral O 0 7.419826905663562e-12
allele O 0 1.9298149744884086e-09
. O 0 5.5991905556496135e-11
. O 0 6.111657013807559e-11

The O 0 8.404126353167563e-12
haptoglobin O 0 1.425769511342878e-07
- O 0 2.809219523669526e-09
gene O 0 2.221305139826768e-09
deletion O 0 2.7264266400095494e-09
responsible O 0 2.4586068857884724e-12
for O 0 6.204767060390137e-14
anhaptoglobinemia B-Disease 0 7.231056198264696e-09
. O 0 1.6605626596000178e-11

We O 0 1.7796862941676928e-11
have O 0 5.6310195526885435e-15
found O 0 3.256473646377203e-15
an O 0 1.0180746411656062e-16
allelic O 0 5.190277894973061e-12
deletion O 0 1.537431987275184e-10
of O 0 2.0418800690243186e-15
the O 0 1.833251364840964e-14
haptoglobin O 0 2.212466737594454e-10
( O 0 5.19724942336236e-13
Hp O 0 1.2261444463923521e-11
) O 0 3.1864545148253733e-15
gene O 0 5.560607529986328e-12
from O 0 2.840728954150995e-13
an O 0 3.215000795697264e-15
individual O 0 2.4951777975604564e-15
with O 0 3.0327606745372826e-13
anhaptoglobinemia B-Disease 0 4.118327296964708e-07
. O 0 7.258160045209294e-11

The O 0 4.561152887674891e-13
Hp O 0 1.5005167247617024e-11
gene O 0 3.379414369869549e-12
cluster O 0 1.145392699956893e-12
consists O 0 2.0733860947721528e-15
of O 0 3.269429650580168e-16
coding O 0 6.260796325818774e-10
regions O 0 1.637726759762259e-11
of O 0 2.388777923297697e-13
the O 0 4.033195489822755e-13
alpha O 0 1.0754412985147788e-11
chain O 0 1.2415470561355502e-11
and O 0 7.203437878740976e-14
beta O 0 1.7811829485306352e-12
chain O 0 2.458061694726038e-13
of O 0 5.930815508833754e-17
the O 0 8.062583164206952e-16
haptoglobin O 0 5.573222005422762e-12
gene O 0 2.944666862778056e-12
( O 0 1.9146872130317016e-13
Hp O 0 1.5441257647519357e-11
) O 0 1.7411983652322084e-14
and O 0 1.0510167091021608e-13
of O 0 4.00380298068491e-16
the O 0 3.4023822713218077e-15
alpha O 0 7.039996840693674e-13
chain O 0 7.680366759243995e-12
and O 0 5.007074331433818e-14
beta O 0 1.3044568680439794e-12
chain O 0 9.82784478255859e-14
of O 0 8.982558750760751e-17
the O 0 3.373304265517278e-15
haptoglobin O 0 4.910594708640303e-10
- O 0 2.3500597301495674e-11
related O 0 4.388637023233777e-12
gene O 0 8.717586374995534e-11
( O 0 1.624370559935584e-12
Hpr O 0 3.5647045315556625e-09
) O 0 9.503864709103915e-13
, O 0 3.186372606739374e-13
in O 0 2.601961343867004e-13
tandem O 0 3.06464680022156e-11
from O 0 8.212623289760579e-12
the O 0 1.4382844741589462e-11
5 O 0 3.6571579098421125e-11
side O 0 1.2299145035754577e-09
. O 0 5.2464962929654746e-11

Southern O 0 6.551594378123582e-09
blot O 0 1.8973386204379494e-06
and O 0 1.795841253482422e-12
PCR O 0 4.2433828673082985e-10
analyses O 0 9.307573158381932e-13
have O 0 4.4879845892691235e-15
indicated O 0 3.6102455118307286e-14
that O 0 6.337546171726488e-17
the O 0 9.06787151216151e-17
individual O 0 1.5425085391876549e-16
with O 0 4.5457060729762414e-15
anhaptoglobinemia B-Disease 0 2.299944457107017e-09
was O 0 2.5897678099240373e-12
homozygous O 0 1.9220610346371014e-12
for O 0 2.392633447867009e-15
the O 0 5.72135127546936e-16
gene O 0 1.456688242251758e-11
deletion O 0 2.7947496747393608e-11
and O 0 8.09861008007999e-14
that O 0 1.2965215686266355e-16
the O 0 3.1673415340079353e-16
gene O 0 2.136752233483641e-11
deletion O 0 3.5233857498262466e-11
was O 0 9.423790957654998e-13
included O 0 1.489546718899616e-15
at O 0 2.0392267383170445e-14
least O 0 2.8435450845907314e-15
from O 0 6.5054891676538315e-15
the O 0 7.604842324345992e-16
promoter O 0 3.453463209845964e-12
region O 0 1.5180558633060004e-12
of O 0 5.872762671131626e-14
Hp O 0 1.390533937994931e-10
to O 0 1.2449623343140873e-14
Hpr O 0 6.732630009054219e-10
alpha O 0 7.932000542498763e-12
but O 0 3.790267253701851e-13
not O 0 1.135559220033543e-14
to O 0 1.856018255210444e-14
Hpr O 0 6.674355734759274e-09
beta O 0 2.368819140841083e-09
( O 0 2.0194894367886462e-11
Hpdel O 0 1.3029874068593017e-08
) O 0 1.2744342040016399e-11
. O 0 2.6228014551876733e-11

In O 0 3.4359535616007575e-12
addition O 0 1.1919458645190829e-14
, O 0 1.5795658441712483e-14
we O 0 1.9562399558592253e-15
found O 0 3.5352734821747717e-15
seven O 0 2.325627159569004e-16
individuals O 0 6.239333404595873e-19
with O 0 5.2183367231010044e-17
hypohaptoglobinemia B-Disease 0 1.0174275311136682e-10
in O 0 2.0535103565505475e-12
three O 0 4.0712506472638174e-14
families O 0 5.948219521270768e-16
, O 0 1.2084454945843572e-15
and O 0 1.4864814125426212e-15
the O 0 5.091101587988221e-16
genotypes O 0 1.5147759348937972e-12
of O 0 2.340044983820252e-15
six O 0 6.014075955990128e-13
of O 0 2.785024478237438e-17
the O 0 1.5590557248589616e-15
seven O 0 2.144938779474986e-15
individuals O 0 5.64367754356914e-18
were O 0 1.5324518387658907e-14
found O 0 1.569888492748868e-14
to O 0 2.2116254716540804e-15
be O 0 6.67156759524834e-13
Hp2 O 0 1.0687959957067505e-06
/ O 0 2.5401775474165333e-06
Hpdel O 0 5.477372269524494e-06
. O 0 3.7329558888465897e-10

The O 0 4.2787808886279866e-12
phenotypes O 0 1.1519101228429918e-09
and O 0 7.85257601131073e-13
genotypes O 0 6.818318826207204e-11
in O 0 1.1812036808736548e-12
one O 0 1.6485775147356135e-14
of O 0 6.135675721083127e-17
these O 0 4.356594056100898e-16
three O 0 1.9866370037208668e-15
families O 0 6.86202036998798e-16
showed O 0 7.499560868151622e-12
the O 0 6.20431432127983e-15
father O 0 7.718383224220027e-13
to O 0 6.352996132093745e-15
be O 0 3.4314378731048825e-14
hypohaptoglobinemic B-Disease 0 8.417621460976576e-11
( O 0 2.404181996713828e-13
Hp2 O 0 6.475608382849884e-10
) O 0 1.667254252409392e-13
and O 0 4.3367945953137754e-13
Hp2 O 0 2.5728265740099232e-08
/ O 0 1.6397889268660037e-08
Hpdel O 0 1.408771233002426e-08
, O 0 3.4157802996682973e-13
the O 0 4.552352316996872e-15
mother O 0 1.5616890376365933e-12
to O 0 2.8339925117093934e-16
be O 0 2.2194687849874184e-15
Hp2 O 0 1.565352708565726e-10
- O 0 1.3464610502944563e-11
1 O 0 5.919421989250898e-14
and O 0 2.097476787523908e-13
Hp1 O 0 7.846468363936765e-09
/ O 0 1.4563951156176813e-09
Hp2 O 0 2.1181372211742655e-09
, O 0 4.025922526124451e-14
one O 0 2.154582884854187e-15
of O 0 2.139608533486813e-17
the O 0 1.876159131685199e-15
two O 0 3.0533057636047967e-14
children O 0 2.5780208385271265e-14
to O 0 3.4709025251339115e-16
be O 0 1.3048710264976053e-14
hypohaptoglobinemic B-Disease 0 1.6367157629204598e-10
( O 0 4.1961798077048973e-13
Hp2 O 0 5.98602389878522e-10
) O 0 1.0033826932298248e-13
and O 0 3.7358419309463375e-13
Hp2 O 0 2.1067156907861317e-08
/ O 0 1.4646807322549193e-08
Hpdel O 0 5.507189371201093e-08
, O 0 1.3631013635537204e-12
and O 0 1.5366431271954945e-14
the O 0 3.31382900009287e-16
other O 0 6.495049910095396e-15
child O 0 4.652044808400868e-13
to O 0 1.3123401736144056e-16
be O 0 9.532829813886905e-15
Hp1 O 0 4.919141483039624e-11
and O 0 2.3293598495378876e-13
Hp1 O 0 1.4311935636612816e-08
/ O 0 1.9347693225313378e-08
Hpdel O 0 1.2537711313598265e-08
, O 0 1.76108219261846e-13
showing O 0 1.2868174407987265e-12
an O 0 4.3597029317151174e-16
anomalous O 0 2.7348182312508795e-12
inheritance O 0 3.654954464082927e-11
of O 0 6.575000418250487e-14
Hp O 0 1.3634095241688016e-10
phenotypes O 0 1.646895467222187e-11
in O 0 1.502702129396738e-11
the O 0 1.835968660088283e-12
child O 0 2.168235146982056e-09
with O 0 1.9221984640387275e-14
Hp1 O 0 3.737961051797356e-08
. O 0 3.683971530610286e-11

The O 0 1.724976281605728e-12
Hp2 O 0 6.900767601791813e-08
/ O 0 2.509103147474434e-08
Hpdel O 0 9.373450904348601e-10
individuals O 0 1.0946597767775776e-13
had O 0 1.3792127162570722e-10
an O 0 6.408419191898489e-15
extremely O 0 4.0908748610846146e-10
low O 0 2.9075006291456873e-10
level O 0 1.5258784904007006e-13
of O 0 5.702676845960363e-16
Hp O 0 2.0732996916517088e-11
( O 0 6.355545023638623e-14
mean O 0 1.568496027504196e-11
+ O 0 2.4929530662021193e-10
/ O 0 4.898622840698863e-09
- O 0 1.3948119104156831e-08
SD O 0 6.462424266828748e-07
= O 0 4.3300155128100926e-10
0 O 0 2.071247253571107e-12
. O 0 2.1764679631035982e-13
049 O 0 4.775493422926047e-08
+ O 0 4.372810114006143e-09
/ O 0 1.7269977448108875e-08
- O 0 5.191889584921228e-09
0 O 0 2.5717960747129176e-12
. O 0 1.4394796390027748e-13
043 O 0 1.2131610382937197e-08
mg O 0 1.4519281648972537e-05
/ O 0 6.263118734750606e-08
ml O 0 1.547743089247433e-08
; O 0 1.7660570542869097e-13
n O 0 2.123021203281894e-11
= O 0 9.087811059238504e-11
6 O 0 7.998982335874483e-13
) O 0 2.0174112353539206e-14
, O 0 4.0602367625539645e-15
compared O 0 4.314203074645695e-14
with O 0 6.689188591056661e-17
the O 0 7.720745971804416e-15
level O 0 1.517774214686643e-13
( O 0 7.29464604768814e-15
1 O 0 3.774853151415625e-15
. O 0 9.786257836540656e-15
64 O 0 2.583702837181262e-13
+ O 0 1.5093575694846706e-11
/ O 0 5.408499759163021e-10
- O 0 4.701908862259074e-10
1 O 0 4.2510236324989903e-13
. O 0 2.0395154749081046e-13
07 O 0 7.729985401772055e-11
mg O 0 2.204098166203039e-07
/ O 0 4.894625593721003e-09
ml O 0 3.5727892866432853e-10
) O 0 5.407265635275953e-16
obtained O 0 6.987100243001365e-14
from O 0 2.7879743869432816e-13
52 O 0 9.427464017774945e-12
healthy O 0 3.18410367516897e-11
volunteers O 0 1.782822750106411e-14
having O 0 5.1930451583880044e-14
phenotype O 0 1.1645900910295381e-10
Hp2 O 0 5.123614865709669e-10
, O 0 1.0628394933359826e-14
whereas O 0 2.7845930314178424e-14
the O 0 4.174412356920871e-16
serum O 0 1.5426118498904073e-12
Hp O 0 1.0565798930217696e-10
level O 0 1.4596459349362767e-13
of O 0 1.5762889410430954e-17
an O 0 6.165943252313177e-17
individual O 0 2.250131907073616e-16
with O 0 8.85515890215044e-14
Hp1 O 0 1.549617991258856e-05
/ O 0 1.0115403711097315e-05
Hpdel O 0 1.4274743989517447e-05
was O 0 1.0771020697575295e-07
0 O 0 2.5593435357129657e-11
. O 0 1.8246933478072158e-11

50 O 0 3.674485993254706e-10
mg O 0 0.00014206698688212782
/ O 0 1.1366437320248224e-06
ml O 0 1.2081736144864408e-07
, O 0 1.3757653971938327e-14
which O 0 1.9406528026242925e-16
was O 0 1.5552549821455132e-14
approximately O 0 1.2705184512393165e-16
half O 0 2.4341263732277976e-14
the O 0 5.74446945157789e-15
level O 0 2.082002749186334e-14
of O 0 3.5369170966693595e-16
Hp O 0 1.4360504972665833e-11
in O 0 1.0626818435638397e-13
control O 0 3.49664672216754e-11
sera O 0 4.2426265167705424e-08
from O 0 1.0509806593799256e-13
the O 0 6.660388115597299e-14
Hp1 O 0 9.235899156578853e-09
phenotype O 0 1.9750281965436045e-10
( O 0 3.938346773268292e-13
1 O 0 6.26663773498938e-14
. O 0 2.1002219196620056e-14
26 O 0 5.355011681480726e-13
+ O 0 3.096882819630942e-11
/ O 0 2.633068207913425e-10
- O 0 1.0735625582958264e-10
0 O 0 7.843859161369218e-14
. O 0 9.9332417698118e-15
33 O 0 1.2652595984818937e-11
mg O 0 3.7005875128670596e-06
/ O 0 2.1123851112747616e-08
ml O 0 5.028323979416882e-09
; O 0 1.6338958926608547e-14
n O 0 9.18553514500653e-12
= O 0 1.2176339103664446e-10
9 O 0 1.9170023207726317e-11
) O 0 2.0200113554514482e-13
, O 0 5.07522626355672e-14
showing O 0 2.0777561528934063e-12
a O 0 2.1356988443368974e-13
gene O 0 1.9554402541643867e-09
- O 0 7.0276953145764764e-09
dosage O 0 1.6968991545240897e-08
effect O 0 3.3653249631449e-10
. O 0 1.874710629790055e-11

The O 0 6.047825543316343e-13
other O 0 5.702422312559713e-14
allele O 0 1.1991999060434466e-10
( O 0 7.497387259636223e-12
Hp2 O 0 1.2927826587016966e-09
) O 0 2.5581877314737565e-14
of O 0 9.768605987557231e-17
individuals O 0 2.458470513060448e-16
with O 0 3.028219866432324e-15
Hp2 O 0 2.0808338163647022e-08
/ O 0 8.423957531533688e-09
Hpdel O 0 2.7093869370276025e-09
was O 0 4.348890605271327e-12
found O 0 8.652009908212757e-14
to O 0 4.1278885428973366e-16
have O 0 2.3663251127450588e-14
, O 0 1.2199507431069124e-15
in O 0 2.781705326694063e-14
all O 0 2.2699883710605067e-15
exons O 0 4.134113624348901e-12
, O 0 3.292677274498862e-13
no O 0 2.049592320949728e-13
mutation O 0 9.615522082988964e-14
, O 0 3.3013771922517582e-15
by O 0 9.353187678301424e-16
DNA O 0 8.403036079462911e-12
sequencing O 0 2.2957698242453972e-11
. O 0 1.0901810704178061e-11

On O 0 4.4933705194150075e-12
the O 0 5.981874257847549e-16
basis O 0 5.717077676613107e-15
of O 0 6.919897287549642e-18
the O 0 5.920824490523093e-17
present O 0 4.3917014541822207e-16
study O 0 8.452130122638297e-15
, O 0 1.742134167232335e-15
the O 0 5.69761105954019e-16
mechanism O 0 8.527853851683295e-14
of O 0 2.0351069818198364e-15
anhaptoglobinemia B-Disease 0 8.487935909684552e-10
and O 0 2.8094817054388765e-13
the O 0 4.109226183607838e-15
mechanism O 0 2.0153931962977462e-13
of O 0 1.4620455708055187e-16
anomalous O 0 2.3924133073921494e-12
inheritance O 0 2.2884076578133516e-11
of O 0 1.5454235384893683e-13
Hp O 0 5.373375078221443e-10
phenotypes O 0 4.5224692046819115e-11
were O 0 4.2810855555019955e-11
well O 0 1.964075820384825e-12
explained O 0 1.2425972750751413e-10
. O 0 2.2177203649886845e-12

However O 0 5.0797661216295253e-11
, O 0 2.0363204666310614e-13
the O 0 4.132601328336741e-15
mechanism O 0 1.2162492150566417e-12
of O 0 2.183002280190579e-14
hypohaptoglobinemia B-Disease 0 2.3158769124620449e-07
remains O 0 5.864759788920537e-10
unknown O 0 2.760464967721532e-09

ATM O 0 9.292530194215942e-06
mutations O 0 8.621576341738546e-08
and O 0 7.287092804175721e-12
phenotypes O 0 1.1017046830374966e-08
in O 0 9.56274348595798e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 3.254728824231279e-07
in O 0 8.53895892796025e-13
the O 0 1.9619123237487506e-15
British O 0 2.0617256166199915e-11
Isles O 0 1.5099811401242391e-09
: O 0 3.4384722276219453e-15
expression O 0 3.3770638212536662e-15
of O 0 1.3569707697391532e-17
mutant O 0 1.5018895686575578e-13
ATM O 0 5.1193924099912635e-11
and O 0 5.94801866858315e-15
the O 0 2.4735122300169083e-16
risk O 0 5.067103962981545e-13
of O 0 2.4081736225371048e-14
leukemia B-Disease 0 2.5465018552495167e-05
, O 0 2.617134668980725e-06
lymphoma B-Disease 1 1.0
, O 0 3.687351579628739e-08
and O 0 3.7014164178117426e-08
breast B-Disease 0 2.5929446564987302e-05
cancer I-Disease 0 3.069243632580765e-07
. O 0 3.42948169862467e-10

We O 0 1.3200007753511045e-10
report O 0 1.554387586526207e-12
the O 0 2.1215423795130627e-16
spectrum O 0 8.471485503109416e-14
of O 0 8.182528005856726e-15
59 O 0 3.4571935158406175e-12
ATM O 0 1.1023184143255094e-08
mutations O 0 8.49857406670651e-11
observed O 0 8.948500794525582e-12
in O 0 4.3296952689786394e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 5.645741566695506e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.441321801493034e-11
patients O 0 6.666664442711578e-11
in O 0 1.4122078039033228e-14
the O 0 4.884109711447964e-15
British O 0 2.289425871104811e-10
Isles O 0 1.1040464187317411e-07
. O 0 3.449712390746207e-11

Of O 0 9.52607892741597e-13
51 O 0 1.0123211297008439e-10
ATM O 0 1.257140347377117e-08
mutations O 0 6.444850209064157e-11
identified O 0 1.661662127339092e-11
in O 0 3.279069181981453e-14
families O 0 5.398176971751914e-16
native O 0 3.3799250985494913e-15
to O 0 8.475238293170138e-17
the O 0 1.7928883814318126e-15
British O 0 3.2991195886289404e-10
Isles O 0 8.19017298425706e-09
, O 0 9.814868102281382e-13
11 O 0 7.596528251276394e-14
were O 0 2.5651991313979487e-14
founder O 0 1.862242456594776e-13
mutations O 0 3.7034568120541955e-12
, O 0 6.288875670223959e-13
and O 0 1.8617736746804475e-13
2 O 0 7.736842985934037e-15
of O 0 1.8581664842894026e-16
these O 0 5.0277233006219835e-15
11 O 0 5.306102372803004e-15
conferred O 0 1.9943146797613692e-14
a O 0 4.0471180009701846e-14
milder O 0 1.975179797497617e-09
clinical O 0 8.577065446768728e-11
phenotype O 0 2.8653064296224606e-11
with O 0 5.62136168302395e-15
respect O 0 4.44367502524883e-15
to O 0 5.706009497091335e-15
both O 0 5.803504920555425e-13
cerebellar B-Disease 0 2.0009663614928286e-07
degeneration I-Disease 0 0.005534623749554157
and O 0 4.5480567228972646e-11
cellular O 0 2.387621433896925e-09
features O 0 5.060457053396306e-10
. O 0 7.155342984788149e-11

We O 0 2.0955447099790803e-10
report O 0 1.996677476134856e-11
, O 0 8.087534107855104e-16
in O 0 3.668118106215637e-15
two O 0 2.379378703613877e-13
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.0210486969808308e-11
, O 0 7.864499321414732e-15
an O 0 5.134849780922721e-16
ATM O 0 9.182991256295736e-09
mutation O 0 5.04514702584502e-12
( O 0 2.0386561091611383e-13
7271T O 0 3.2682173634057676e-10
- O 0 3.60720370240486e-10
- O 0 1.6899700527872596e-09
> O 0 6.8249642048989756e-12
G O 0 6.381387605836064e-12
) O 0 2.3277496653161455e-15
that O 0 1.102571140737898e-15
may O 0 6.85091523441872e-13
be O 0 9.854728062469312e-17
associated O 0 1.7300081494385608e-15
with O 0 2.3803773178716027e-17
an O 0 2.7934847491937326e-16
increased O 0 1.7520948233928912e-11
risk O 0 1.5317485058119473e-09
of O 0 1.38807335851171e-12
breast B-Disease 0 1.2104566167181474e-06
cancer I-Disease 0 1.57062984840195e-08
in O 0 1.1340718295005381e-11
both O 0 1.320359620249345e-12
homozygotes O 0 1.1608256578199416e-08
and O 0 5.961674025539015e-14
heterozygotes O 0 2.6402685593396313e-11
( O 0 1.5843337926313428e-13
relative O 0 1.2124142835523433e-11
risk O 0 7.026619841532522e-10
12 O 0 1.597530837000108e-13
. O 0 1.0572626072354366e-15
7 O 0 2.2826628215118043e-14
; O 0 4.771484314429475e-13
P O 0 2.05039327738632e-06
= O 0 1.778078795311444e-10
. O 0 3.7475103857771697e-13
0025 O 0 2.3102502133554026e-09
) O 0 9.94128417823939e-14
, O 0 7.001210117836727e-15
although O 0 6.000823973064404e-15
there O 0 1.8784435795439437e-15
is O 0 1.2605062571049747e-16
a O 0 7.478752046905651e-15
less O 0 1.2058916148624532e-12
severe O 0 1.5099018924047414e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.0400156291723306e-08
in O 0 6.348363132922807e-13
terms O 0 9.506090169588213e-14
of O 0 1.7312542804877597e-17
the O 0 3.8626891445569156e-16
degree O 0 1.7019564577114288e-11
of O 0 8.705808697637846e-14
cerebellar B-Disease 0 3.969177342355579e-08
degeneration I-Disease 0 8.957566024037078e-06
. O 0 1.5792255003699296e-10

This O 0 2.4252219156528643e-12
mutation O 0 2.0325973543178222e-11
( O 0 2.2459859493062506e-12
7271T O 0 3.830507300239816e-10
- O 0 4.729873714914845e-10
- O 0 1.5258292407338558e-09
> O 0 1.5834352926069606e-11
G O 0 7.052068998203431e-12
) O 0 3.7926789597905915e-15
also O 0 9.651966903742354e-16
allows O 0 1.5048176906172066e-16
expression O 0 4.337261852568799e-15
of O 0 3.3527379879205884e-16
full O 0 2.426821764378584e-13
- O 0 5.943851097076069e-13
length O 0 3.5754270366877144e-14
ATM O 0 5.8451472828569e-11
protein O 0 2.793238459541242e-13
at O 0 2.813165553370439e-13
a O 0 1.648486373990489e-14
level O 0 9.590460241552193e-15
comparable O 0 6.509427193232206e-14
with O 0 1.3302081748180574e-15
that O 0 1.0995139023697257e-14
in O 0 7.775581394031672e-13
unaffected O 0 5.671040720356402e-11
individuals O 0 4.790421599437829e-14
. O 0 2.897952711133911e-12

In O 0 6.196207284238364e-13
addition O 0 2.796972883810085e-15
, O 0 1.8053378599323195e-15
we O 0 2.673708731798258e-16
have O 0 6.810461209790815e-17
studied O 0 5.758805758648844e-12
18 O 0 2.0405593447597736e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.734859863717247e-09
, O 0 3.819014908186622e-15
in O 0 1.87583103347308e-14
15 O 0 4.4672318585449195e-15
families O 0 3.2264620514461213e-16
, O 0 1.4530057175550655e-15
who O 0 8.659191392352758e-14
developed O 0 1.604591237658326e-09
leukemia B-Disease 1 0.7539493441581726
, O 0 1.5357635447799112e-06
lymphoma B-Disease 1 1.0
, O 0 1.485158176994794e-11
preleukemic O 0 1.5816364111742587e-06
T O 0 4.535831612884067e-05
- O 0 5.260753255242889e-08
cell O 0 5.416712411943081e-08
proliferation O 0 1.4787447355502081e-07
, O 0 5.0633122694598853e-11
or O 0 4.198306669422891e-06
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 1.2545227877358567e-11
mostly O 0 1.4795253780799933e-12
in O 0 3.4412087762669685e-11
childhood O 0 3.5419931432301155e-09
. O 0 6.2729817000561905e-12

A O 0 3.062883557891638e-10
wide O 0 7.252703645987957e-12
variety O 0 7.736295111471225e-12
of O 0 5.6345465131776157e-14
ATM O 0 6.980926059441117e-08
mutation O 0 2.3065846108116794e-11
types O 0 2.307517371624712e-11
, O 0 9.279896458474352e-14
including O 0 7.153094306114327e-14
missense O 0 1.7791772677355766e-07
mutations O 0 8.006981744301811e-09
and O 0 1.9131522754900487e-11
in O 0 1.5246930454293484e-11
- O 0 5.7680733078768753e-08
frame O 0 3.3384175424089335e-09
deletions O 0 1.9732867784227892e-08
, O 0 9.417651554433082e-12
were O 0 1.6512289582534811e-12
seen O 0 7.656656558774344e-12
in O 0 1.3739777002773346e-13
these O 0 6.1990622934903795e-15
patients O 0 2.4887530526555325e-14
. O 0 3.011552460316022e-14

We O 0 7.56567898607674e-12
also O 0 2.2077818478976772e-15
show O 0 1.6041580058387666e-15
that O 0 4.038575668403169e-17
25 O 0 1.296388690333035e-15
% O 0 3.987737412653456e-16
of O 0 4.925738522069316e-16
all O 0 8.620535383620231e-13
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.3160209305927992e-09
carried O 0 1.152077565291787e-12
in O 0 2.309444736142696e-12
- O 0 3.778040991164744e-09
frame O 0 9.980922754948551e-09
deletions O 0 4.809121492144186e-07
or O 0 1.776492564165011e-10
missense O 0 5.847185491347773e-08
mutations O 0 2.546824973137518e-10
, O 0 1.1431267987315613e-13
many O 0 8.882074835181279e-17
of O 0 3.487835590560974e-18
which O 0 1.0192254280686798e-15
were O 0 1.1288788914071146e-12
also O 0 9.12457941506812e-15
associated O 0 8.147954662048647e-15
with O 0 1.0452321982855838e-15
expression O 0 1.9674790496890943e-13
of O 0 3.6388645528327886e-15
mutant O 0 1.0703810754408849e-10
ATM O 0 3.264532821845023e-08
protein O 0 2.433408363700096e-09
. O 0 7.609939761676898e-11

The O 0 1.0587641006976067e-11
DMPK O 0 3.628800016031164e-08
gene O 0 3.0585416421757827e-09
of O 0 1.5157664077884714e-13
severely O 0 1.4118477054125833e-07
affected O 0 3.4703442897132675e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0010253095533698797
is O 0 2.9900675034902346e-13
hypermethylated O 0 5.644497091950029e-10
proximal O 0 1.9883794610819905e-09
to O 0 1.9969763960948211e-13
the O 0 2.9794827764934376e-14
largely O 0 1.1905883180382548e-12
expanded O 0 5.097753885685563e-10
CTG O 0 3.09751908389444e-06
repeat O 0 5.385015455772191e-08
. O 0 9.049343219214023e-11

Using O 0 2.2781569686269876e-10
methylation O 0 6.977224842330543e-08
- O 0 7.227060905279359e-08
sensitive O 0 1.6231589405890645e-09
restriction O 0 1.075209626194562e-11
enzymes O 0 5.1998895640725795e-12
, O 0 6.776282636275716e-16
we O 0 1.3357500466941463e-16
characterized O 0 1.5405278320498395e-15
the O 0 5.504877712117539e-16
methylation O 0 4.294792646519774e-11
pattern O 0 1.5692540322742587e-10
on O 0 1.7634805074551174e-11
the O 0 3.6404005623793395e-14
5 O 0 1.1945070041603778e-13
side O 0 1.010425792515035e-12
of O 0 1.8580044627684606e-15
the O 0 6.635244111964644e-14
CTG O 0 1.4139585502448426e-08
repeat O 0 3.9141696828171035e-11
in O 0 1.22626951995497e-13
the O 0 2.5961288782801184e-15
DMPK O 0 3.4027997086738537e-10
gene O 0 4.8564351325108834e-12
of O 0 7.278214773181709e-16
normal O 0 1.3607057104333964e-13
individuals O 0 4.538426354190183e-16
and O 0 1.0733515110245874e-14
of O 0 3.761382680576321e-16
patients O 0 3.826804392576162e-14
affected O 0 6.3802460290398634e-15
with O 0 1.6135887859702013e-14
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.1120643251746887e-12
showing O 0 2.25164765305097e-12
expansions O 0 2.3580609687101628e-11
of O 0 1.2930696976083374e-15
the O 0 9.486613155185869e-15
repetitive O 0 4.615030579913082e-10
sequence O 0 9.32949290738394e-12
. O 0 2.0431347586002957e-11

The O 0 2.8960723250960607e-13
gene O 0 2.8296138002148474e-11
segment O 0 2.2885254455373705e-11
analyzed O 0 2.5413779154020988e-12
corresponds O 0 3.6049542664158205e-14
to O 0 5.147835960674432e-15
the O 0 8.982430345859903e-15
genomic O 0 6.986514144990963e-10
SacI O 0 1.2579362191900145e-06
- O 0 8.293072006892999e-09
HindIII O 0 4.456615965153787e-09
fragment O 0 6.623675496975068e-10
carrying O 0 2.897898761233808e-11
exons O 0 5.403573588580457e-09
11 O 0 7.237468957477233e-10
- O 0 4.6333187952996013e-08
15 O 0 5.471624542341402e-11
. O 0 2.3118510144443105e-12

There O 0 3.698480324082487e-12
is O 0 1.0759593899439118e-13
constitutive O 0 9.893140473504758e-11
methylation O 0 2.853565717053641e-10
in O 0 3.532063964223342e-12
intron O 0 6.2658171984253386e-09
12 O 0 1.8058676299129162e-12
at O 0 1.3071827488172517e-14
restriction O 0 4.743802091867078e-15
sites O 0 1.0492195423573124e-14
of O 0 8.900563976233064e-16
SacII O 0 2.539559895708976e-09
and O 0 8.217915822665567e-13
HhaI O 0 7.331236728802537e-10
, O 0 1.0057964830196154e-14
localized O 0 6.383988932108509e-13
1 O 0 9.819993803577079e-14
, O 0 4.895023730973336e-14
159 O 0 1.65824888542776e-11
- O 0 2.992569733684114e-11
1 O 0 4.976967392356611e-14
, O 0 2.3738789525686727e-14
232 O 0 2.90436430331123e-13
bp O 0 4.7069106424990625e-12
upstream O 0 8.924717518829506e-13
of O 0 7.198856785749046e-16
the O 0 1.78222457543906e-14
CTG O 0 1.038047781065643e-08
repeat O 0 1.8945636726108717e-11
, O 0 7.758063702361599e-15
whereas O 0 1.0257670635203248e-14
most O 0 1.0022110772571827e-15
, O 0 1.754726582542691e-15
if O 0 6.851008941673674e-16
not O 0 6.20147464332416e-15
all O 0 9.294430061541578e-16
, O 0 1.8144100063138867e-15
of O 0 3.0094791102730897e-18
the O 0 2.8079277859100515e-17
other O 0 3.292067664886723e-17
sites O 0 1.9868189040462897e-15
of O 0 2.0455119080741287e-16
SacII O 0 7.300910570551267e-11
, O 0 1.4891390800585852e-13
HhaI O 0 6.980267475142909e-10
, O 0 3.1100203792475134e-13
and O 0 2.8345373465944734e-13
HpaII O 0 2.926344166986894e-10
in O 0 1.2901690078694766e-13
this O 0 3.0041942533394885e-16
region O 0 1.517525254762786e-13
are O 0 3.238494270928899e-14
unmethylated O 0 2.2051277470680475e-10
, O 0 5.725898677725813e-14
in O 0 1.6779693885987483e-14
normal O 0 7.956888593103548e-14
individuals O 0 1.4142334726087696e-16
and O 0 1.1939117432863654e-14
most O 0 1.4527618779453747e-15
of O 0 9.064516467596995e-17
the O 0 2.8222573678570416e-14
patients O 0 3.0334548349782164e-13
. O 0 1.8430725424577882e-13

In O 0 2.2267113500284985e-11
a O 0 4.911046612779413e-13
number O 0 1.9847518471934576e-14
of O 0 4.7069036426187864e-15
young O 0 2.4678367682717806e-10
and O 0 5.712505121713285e-13
severely O 0 9.99983984506514e-10
affected O 0 1.9448577134612705e-13
patients O 0 3.0478142796011576e-13
, O 0 1.024546383164213e-15
however O 0 1.674308851013894e-14
, O 0 1.1768555490472739e-14
complete O 0 9.846771564358398e-15
methylation O 0 1.6171213673699114e-12
of O 0 1.7469380881229081e-16
these O 0 5.3394167741885565e-17
restriction O 0 2.848550202276057e-15
sites O 0 1.3438266646648937e-14
was O 0 4.152408451807421e-12
found O 0 1.8428626680222493e-12
in O 0 5.026664306150008e-13
the O 0 4.309359062626937e-14
mutated O 0 1.5339537640102208e-08
allele O 0 4.011929988223528e-08
. O 0 1.6426587867712783e-09

In O 0 1.280398703729091e-11
most O 0 3.335759530130231e-15
of O 0 1.2114306570661631e-17
these O 0 1.502265342119113e-16
patients O 0 2.062854087105993e-15
, O 0 7.426968515621692e-18
the O 0 5.1814021161337767e-17
onset O 0 2.863435129198816e-13
of O 0 2.374954387950154e-16
the O 0 3.1034547219414843e-13
disease O 0 1.6772929711805773e-08
was O 0 2.6381667961317135e-09
congenital O 0 0.0032388854306191206
. O 0 1.4743435639008595e-10

Preliminary O 0 7.001311974619284e-09
in O 0 1.0476134716663754e-11
vivo O 0 2.3106565549824154e-08
footprinting O 0 2.7716616557427187e-08
data O 0 1.4641860857436684e-12
gave O 0 4.4136315289393727e-14
evidence O 0 3.9988747312395476e-15
for O 0 9.560935346458648e-17
protein O 0 2.3821534480238105e-13
- O 0 6.3308937085782e-12
DNA O 0 1.0281470813611193e-10
contact O 0 6.768549609681429e-11
in O 0 9.870705815206993e-12
normal O 0 2.8021140095757513e-12
genes O 0 6.908603029931459e-12
at O 0 1.2581261987082426e-12
an O 0 3.062420092227137e-15
Sp1 O 0 1.791381105953338e-11
consensus O 0 5.045835236726533e-14
binding O 0 5.543763893583152e-14
site O 0 1.844106329229253e-13
upstream O 0 4.242674354199005e-12
of O 0 3.0682900305516094e-15
the O 0 1.1064927592880844e-13
CTG O 0 1.8575326166114792e-08
repeat O 0 2.3774305440982246e-11
and O 0 4.3340863260495424e-15
for O 0 6.1932617192233535e-18
a O 0 8.508085304422374e-17
significant O 0 8.094694712632955e-16
reduction O 0 7.135186166136887e-15
of O 0 5.580377464475459e-17
this O 0 2.5902910742680826e-16
interaction O 0 2.8749685246262082e-15
in O 0 5.783633121037024e-14
cells O 0 4.205199421103076e-14
with O 0 3.359512239795373e-15
a O 0 2.118796891409369e-12
hypermethylated O 0 2.0575175341264185e-08
DMPK O 0 3.0892294944351306e-08
gene O 0 1.0343237377696823e-09
. O 0 5.659745675595795e-12
. O 0 4.906788950848062e-12

The O 0 6.980770128617309e-11
hemochromatosis B-Disease 1 0.9999995231628418
gene O 0 3.663492009753355e-10
product O 0 2.8421544089572703e-13
complexes O 0 1.4059893115210553e-13
with O 0 9.211092210396901e-17
the O 0 2.121202507542977e-16
transferrin O 0 8.306765106498581e-13
receptor O 0 8.547855890987666e-13
and O 0 1.3390077891958785e-12
lowers O 0 4.306512611795821e-12
its O 0 1.4685968412569386e-16
affinity O 0 2.5670885230900942e-14
for O 0 6.124150911393446e-16
ligand O 0 1.8741152835351216e-13
binding O 0 9.943683897117861e-12
. O 0 1.89915132231544e-11

We O 0 8.776480237004947e-11
recently O 0 9.929151945087256e-11
reported O 0 1.4662942734999795e-11
the O 0 5.869845150848103e-16
positional O 0 1.8636229712210017e-11
cloning O 0 2.2871409627311934e-12
of O 0 1.2728719852228218e-15
a O 0 3.843418096803608e-13
candidate O 0 1.704893518028605e-11
gene O 0 2.0432917153812014e-06
for O 0 3.740564693544002e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 5.12851897838118e-07
HFE O 0 0.0001375806168653071
. O 0 9.600733541503814e-10

The O 0 3.014552312202018e-14
gene O 0 1.2100625189359615e-11
product O 0 1.1218427445683354e-12
, O 0 3.1805541680180946e-14
a O 0 1.3699407276981934e-12
member O 0 1.5577384217604906e-12
of O 0 2.999259227630548e-16
the O 0 5.24186127650087e-16
major O 0 1.780688565892509e-14
histocompatibility O 0 5.16714221323461e-13
complex O 0 5.872351216407168e-13
class O 0 2.4329788184118684e-11
I O 0 5.0083071023721e-10
- O 0 3.507646647096796e-12
like O 0 3.819912932517301e-14
family O 0 1.9453316114546003e-14
, O 0 5.522419235059583e-16
was O 0 1.6743823734737158e-14
found O 0 8.760038457426497e-15
to O 0 2.814191793078344e-16
have O 0 2.4773723179762237e-14
a O 0 5.747124645757648e-14
mutation O 0 5.264205737987027e-12
, O 0 1.9679830681740285e-12
Cys O 0 3.574657966964878e-06
- O 0 5.213460219088972e-10
282 O 0 5.0760231573576675e-09
- O 0 1.579236297288844e-08
- O 0 1.145840755611971e-08
> O 0 1.6543601558116627e-11
Tyr O 0 2.1343134204432346e-10
( O 0 5.644797644718466e-14
C282Y O 0 3.7967233523783506e-12
) O 0 2.438037378455155e-15
, O 0 1.8599109751140524e-16
in O 0 1.4498000154870632e-15
85 O 0 1.838391499578082e-14
% O 0 1.8433562984951184e-14
of O 0 1.82131074138352e-14
patient O 0 3.003995663330983e-11
chromosomes O 0 1.350201062066958e-10
. O 0 4.0561890651824584e-11

This O 0 7.865887845584507e-13
mutation O 0 1.5100544079049705e-11
eliminates O 0 4.187102053965219e-11
the O 0 8.540612031341429e-15
ability O 0 6.913344679712607e-13
of O 0 3.4515349579762643e-15
HFE O 0 2.582752012258993e-09
to O 0 3.0004465031248026e-14
associate O 0 4.025281843955675e-12
with O 0 1.7106858667798562e-14
beta2 O 0 2.5945101356228406e-07
- O 0 4.428849109672228e-08
microglobulin O 0 6.530848395414068e-08
( O 0 3.651691362488441e-12
beta2m O 0 3.440700391266205e-09
) O 0 5.050216429942911e-14
and O 0 1.3950736826330839e-14
prevents O 0 1.0024109770327347e-13
cell O 0 3.9610054125560623e-10
- O 0 7.611133945317761e-10
surface O 0 8.480110710862299e-12
expression O 0 8.399050205332159e-11
. O 0 2.6735525252008507e-11

A O 0 4.80814676961927e-09
second O 0 5.002974597101417e-12
mutation O 0 1.1875810664724318e-12
that O 0 6.85278046873121e-14
has O 0 5.885762255179727e-13
no O 0 7.784555335413335e-14
effect O 0 3.8781113737007544e-12
on O 0 1.5237867911910286e-10
beta2m O 0 4.916867357707133e-09
association O 0 2.3174214283661065e-13
, O 0 2.6719870314538454e-15
H63D O 0 6.549388809062862e-11
, O 0 5.414410358186043e-15
was O 0 5.929583538587246e-13
found O 0 3.067690686978791e-13
in O 0 1.4291067244528999e-12
eight O 0 6.314176070019994e-13
out O 0 1.3852294148981176e-13
of O 0 3.913131280054889e-15
nine O 0 1.2955830852590111e-11
patients O 0 1.9779959462874752e-13
heterozygous O 0 5.967684029231646e-13
for O 0 7.202073816882718e-15
the O 0 5.755417437124447e-14
C282Y O 0 1.7402465024574099e-09
mutant O 0 1.6643605604826917e-08
. O 0 7.47302442150044e-10

In O 0 1.8393694553586748e-11
this O 0 2.169520395582311e-14
report O 0 3.321593868010897e-12
, O 0 6.983015850129705e-16
we O 0 1.6780732507199494e-16
demonstrate O 0 5.917056120350098e-16
in O 0 1.5301822986870176e-14
cultured O 0 9.019502367202392e-10
293 O 0 7.946750028853256e-12
cells O 0 3.2409383336762243e-12
overexpressing O 0 1.656420445250717e-09
wild O 0 5.866054864078762e-11
- O 0 2.0567288316897248e-08
type O 0 5.14630071890565e-09
or O 0 7.357859981016457e-12
mutant O 0 3.8199571283925593e-10
HFE O 0 5.875982367342658e-09
proteins O 0 2.31729322145921e-13
that O 0 1.665008958648634e-15
both O 0 2.6558890114726e-16
the O 0 6.783783642419245e-16
wild O 0 5.704592614258486e-12
- O 0 3.169191487017997e-08
type O 0 1.2411536687295666e-08
and O 0 9.483407982513459e-12
H63D O 0 1.8639671139908387e-08
HFE O 0 9.642029397127772e-09
proteins O 0 6.7407568242472404e-12
form O 0 2.5489996398342374e-12
stable O 0 1.745593600221973e-11
complexes O 0 1.781066478112256e-13
with O 0 3.910816233130925e-16
the O 0 1.3736382010017456e-15
transferrin O 0 1.1443341933758955e-11
receptor O 0 3.567094883361044e-11
( O 0 2.1247590492601276e-11
TfR O 0 4.38068894936805e-07
) O 0 1.3113727118096996e-11
. O 0 1.73569665584683e-11

The O 0 6.649466133962223e-12
C282Y O 0 5.143700132492768e-09
mutation O 0 6.902468874248058e-11
nearly O 0 3.337196621475136e-12
completely O 0 2.8119223529493587e-12
prevents O 0 5.781650657364634e-13
the O 0 6.56064075339898e-15
association O 0 4.6831482647998607e-14
of O 0 1.6452200521567318e-17
the O 0 5.834706518426851e-16
mutant O 0 2.052990590029058e-11
HFE O 0 7.327745521479301e-09
protein O 0 2.5482910920304747e-11
with O 0 8.35873254292907e-14
the O 0 5.893423769831596e-13
TfR O 0 2.5876110498757043e-07
. O 0 2.346995861546297e-11

Studies O 0 1.826492734835483e-08
on O 0 3.414948445551458e-12
cell O 0 1.5504539319088906e-10
- O 0 2.0315391729974763e-11
associated O 0 3.6047408141131124e-14
transferrin O 0 1.447381819431881e-12
at O 0 4.325435409152645e-13
37 O 0 3.931449079046939e-13
degrees O 0 7.870847723578933e-11
C O 0 8.457783806647967e-09
suggest O 0 1.5452652178671311e-12
that O 0 3.921080684264871e-15
the O 0 1.120960353077731e-14
overexpressed O 0 8.453392985607877e-10
wild O 0 6.38775976558037e-11
- O 0 2.096657070183028e-09
type O 0 5.587958984420993e-10
HFE O 0 7.401279145113904e-09
protein O 0 9.508439174910066e-12
decreases O 0 3.282594194294747e-13
the O 0 9.457011683019936e-17
affinity O 0 1.3299458105978101e-13
of O 0 2.4195627428425914e-15
the O 0 9.864522664427416e-14
TfR O 0 3.2739531086178886e-09
for O 0 6.641495977445034e-15
transferrin O 0 1.0976679981622439e-10
. O 0 1.4188679745008592e-11

The O 0 3.5729082453056504e-12
overexpressed O 0 2.667306908676892e-08
H63D O 0 7.992547068624845e-09
protein O 0 3.718831232540909e-12
does O 0 2.3124219688608685e-14
not O 0 2.630871363979852e-16
have O 0 6.446833936001484e-17
this O 0 4.659056749896751e-18
effect O 0 3.3872047114564315e-15
, O 0 6.375158008004825e-16
providing O 0 1.5421555646766662e-16
the O 0 4.363178215253473e-17
first O 0 4.910991678457619e-16
direct O 0 7.374465773956175e-16
evidence O 0 9.359372543475686e-14
for O 0 1.0234638882925117e-16
a O 0 3.770233857237773e-15
functional O 0 7.199056346711419e-14
consequence O 0 1.8751664175413463e-13
of O 0 2.356581396291261e-15
the O 0 4.3426547080560596e-13
H63D O 0 3.5156585909135174e-07
mutation O 0 4.796804065065885e-10
. O 0 1.123869955432788e-10

Addition O 0 3.891300042607737e-12
of O 0 7.927450810054672e-15
soluble O 0 8.637813797562899e-10
wild O 0 4.5634218626133816e-10
- O 0 8.783925977695617e-07
type O 0 6.248334898373287e-07
HFE O 0 0.0027321588713675737
/ O 0 4.954355858899362e-07
beta2m O 0 2.772084783941864e-08
heterodimers O 0 5.563116634021981e-10
to O 0 2.0967727337381503e-13
cultured O 0 4.648958107367207e-09
cells O 0 1.9116942751029598e-10
also O 0 4.489342112033029e-13
decreased O 0 1.2156718773997932e-12
the O 0 6.609089052748456e-17
apparent O 0 1.3109329871912202e-14
affinity O 0 2.6123059878452315e-12
of O 0 6.14950705442774e-15
the O 0 3.0785385362903234e-14
TfR O 0 1.2684303607457537e-10
for O 0 6.427533496204907e-17
its O 0 8.789486193112503e-17
ligand O 0 2.5349510766317293e-14
under O 0 3.9694677801899517e-14
steady O 0 4.1896985880640614e-11
- O 0 1.129206212042988e-12
state O 0 1.8866598414839578e-14
conditions O 0 1.9974468259964517e-11
, O 0 2.7081578264608866e-16
both O 0 1.7777818664548874e-16
in O 0 4.7891334317316445e-14
293 O 0 1.5603959639155784e-13
cells O 0 3.076004620287953e-13
and O 0 8.728891632940605e-13
in O 0 5.382938018938521e-13
HeLa O 0 2.161665513256139e-09
cells O 0 8.542392349042416e-10
. O 0 1.0748738704657868e-10

Furthermore O 0 1.0694582372461348e-11
, O 0 3.9336525166746086e-14
at O 0 2.392398345402169e-13
4 O 0 6.775540550710626e-14
degrees O 0 1.0236792746809442e-07
C O 0 0.002791161648929119
, O 0 1.6239493473915734e-12
the O 0 6.923396589104264e-14
added O 0 1.8106496857406285e-10
soluble O 0 2.6265697516264508e-12
complex O 0 1.6287440688690646e-13
of O 0 9.190498060122291e-15
HFE O 0 3.072497634093452e-07
/ O 0 2.0013551704778365e-08
beta2m O 0 4.694303168406577e-09
inhibited O 0 2.8935259743789743e-10
binding O 0 2.466906887099718e-12
of O 0 2.211136310127041e-15
transferrin O 0 7.019754135612066e-12
to O 0 1.0252883204985366e-13
HeLa O 0 4.942828368825758e-09
cell O 0 5.327193974835609e-08
TfR O 0 2.3950073568812513e-07
in O 0 6.205704895269337e-13
a O 0 1.3008045161855275e-12
concentration O 0 9.228674491268407e-10
- O 0 4.166121059245853e-10
dependent O 0 8.274404772468102e-11
manner O 0 1.2830011497655391e-09
. O 0 3.5488466332278534e-11

Scatchard O 0 1.261815611997008e-07
plots O 0 2.974940294109274e-10
of O 0 4.7226881015908703e-14
these O 0 1.1513222278962377e-15
data O 0 8.866871673745072e-14
indicate O 0 1.3407059411773246e-14
that O 0 1.5835952222529844e-15
the O 0 7.739972772674141e-15
added O 0 2.4076674681738908e-11
heterodimer O 0 1.433939555636754e-12
substantially O 0 4.165499195574185e-11
reduced O 0 3.5766566574765846e-13
the O 0 7.074877102655026e-16
affinity O 0 6.000166184218225e-13
of O 0 2.3056265623382262e-14
TfR O 0 2.074931559903348e-09
for O 0 1.454559366562743e-14
transferrin O 0 2.315622277260232e-10
. O 0 3.1527332827741006e-11

These O 0 7.53776110539589e-13
results O 0 3.628292328042293e-13
establish O 0 1.5017856885369066e-14
a O 0 4.506283042028658e-14
molecular O 0 1.551706679814302e-12
link O 0 8.416754793127978e-11
between O 0 1.393134739513524e-11
HFE O 0 2.4756875518505694e-06
and O 0 8.292027546367986e-13
a O 0 1.3171243067565397e-13
key O 0 3.842167035916777e-12
protein O 0 1.7729828022394756e-13
involved O 0 2.137576411449099e-14
in O 0 4.6634049432388996e-14
iron O 0 1.4382790097799969e-11
transport O 0 9.061838735988093e-13
, O 0 7.399944101493111e-15
the O 0 8.609303862264911e-15
TfR O 0 6.829298015986751e-09
, O 0 1.334723211945596e-13
and O 0 9.79144845444143e-15
raise O 0 6.046205033762974e-15
the O 0 1.3186128496355177e-16
possibility O 0 6.1195534283139865e-15
that O 0 1.6032525276181517e-15
alterations O 0 3.5919874713519206e-11
in O 0 5.1386371828672506e-14
this O 0 2.2440640806768416e-15
regulatory O 0 8.371912607607612e-10
mechanism O 0 2.2008827052499846e-11
may O 0 2.372833596275825e-10
play O 0 4.114769289187414e-12
a O 0 6.177795498470487e-14
role O 0 1.290429894017231e-13
in O 0 1.2111182011702998e-14
the O 0 1.3982110503180665e-15
pathogenesis O 0 1.3804858298160916e-11
of O 0 1.6598714590310149e-12
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 4.684703180934946e-10
. O 0 1.6020943252592623e-11

Genomic O 0 7.672588786533652e-09
organization O 0 9.827991198640973e-11
of O 0 5.747958126177746e-14
the O 0 3.2755140830578733e-13
UBE3A O 0 1.273636257792532e-06
/ O 0 2.022418144065341e-08
E6 O 0 4.23476587130267e-09
- O 0 2.21071459804989e-07
AP O 0 2.3268316908797715e-06
gene O 0 9.430081160388681e-10
and O 0 6.663733692451046e-13
related O 0 2.1025247515238377e-12
pseudogenes O 0 4.200125802711341e-10
. O 0 1.0451944865152996e-11

The O 0 5.622195851234801e-12
UBE3A O 0 4.0258736788700844e-08
gene O 0 4.3848183417516395e-10
encodes O 0 7.745792202085156e-11
the O 0 1.941898756325968e-14
E6 O 0 2.279485974976403e-11
- O 0 1.7741119684444584e-10
AP O 0 4.3124126491989045e-09
ubiquitin O 0 1.7354980300088307e-11
- O 0 2.3252595595518732e-12
protein O 0 2.708973182493496e-13
ligase O 0 1.0200710718819006e-12
and O 0 2.4164233846301827e-14
has O 0 2.6618948456455472e-15
recently O 0 1.088858414240515e-13
been O 0 1.4248205903560603e-15
shown O 0 7.089655710002245e-16
to O 0 1.0175665140414823e-15
be O 0 2.7589314906544156e-14
mutated O 0 1.980085073682858e-07
in O 0 7.234604709083214e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 6.117139946582029e-06
who O 0 1.1452266001840683e-12
lack O 0 1.72787402875213e-12
15q11 O 0 9.646701215615394e-09
- O 0 1.3817761157497443e-08
q13 O 0 2.1658554061332325e-08
deletions O 0 9.744773166175946e-08
or O 0 1.997238485706987e-10
chromosome O 0 1.1434965017542709e-05
15 O 0 3.0645663784412136e-10
paternal O 0 2.9228479547782626e-07
uniparental B-Disease 0 0.0008381179068237543
disomy I-Disease 0 0.0001400924811605364
. O 0 1.00908104094799e-09

Previous O 0 6.355445336669874e-11
UBE3A O 0 8.06524180774204e-09
cDNA O 0 6.706787902821532e-11
analysis O 0 2.1792977578788397e-12
has O 0 3.3060907188449916e-15
shown O 0 3.7001185874464305e-15
a O 0 7.208343893571473e-14
coding O 0 6.411402658779153e-11
region O 0 1.0331174934638532e-12
of O 0 1.892007838106332e-14
approximately O 0 1.062597384214603e-12
2 O 0 2.119897313246355e-11
. O 0 4.087160124233158e-11

6 O 0 5.027892324704908e-09
kb O 0 2.577379731860674e-08
and O 0 3.911844264313513e-13
a O 0 4.263091615830383e-12
3 O 0 2.6788418705514516e-10
- O 0 5.587639316217974e-05
untranslated O 0 0.0004311043012421578
region O 0 4.573462053514277e-09
( O 0 1.5750442616813132e-10
UTR O 0 3.3146374533998824e-09
) O 0 1.028626104649169e-13
of O 0 3.4235386132453784e-15
< O 0 7.232000415191564e-11
50 O 0 6.501820837365863e-14
bp O 0 8.629637802959333e-12
, O 0 9.83888166421296e-16
whereas O 0 2.1745319930696833e-15
Northern O 0 1.8373083138451332e-14
analysis O 0 7.137942580753842e-13
has O 0 2.8208475662196315e-14
indicated O 0 8.260183986461e-14
mRNA O 0 2.3119117839760783e-13
sizes O 0 2.0778513458441505e-12
of O 0 2.5641512669389004e-15
5 O 0 5.005811737346377e-11
- O 0 8.551367500331253e-06
8 O 0 5.401685210237872e-10
kb O 0 6.062682018637133e-07
. O 0 4.2308059833295886e-11

We O 0 1.0289901743176788e-11
have O 0 1.432931142584257e-15
analyzed O 0 2.2993332769467162e-14
additional O 0 1.322219357106249e-16
cDNA O 0 3.631068427704942e-13
clones O 0 1.499143517658119e-11
and O 0 6.099463500871009e-15
provide O 0 4.809835827522958e-16
evidence O 0 2.874233723544465e-15
for O 0 1.3246323422147396e-16
an O 0 5.85294154959446e-16
additional O 0 8.251811235183981e-13
0 O 0 6.289395219905014e-12
. O 0 8.864230183203148e-11

5 O 0 5.850203099733164e-10
kb O 0 8.79237216366846e-09
of O 0 1.8425970181611996e-14
5 O 0 2.4886984834049386e-12
- O 0 1.669676175097834e-09
UTR O 0 8.014453101168328e-09
and O 0 2.553651734515938e-12
> O 0 1.0460600267936382e-11
2 O 0 3.9479129600866747e-13
kb O 0 3.340889342950959e-09
of O 0 1.6708962230320423e-13
3 O 0 2.545911814699764e-10
- O 0 8.563606002098823e-07
UTR O 0 8.991457889351295e-07
. O 0 1.7888861225667796e-10

We O 0 1.5099940395280065e-11
have O 0 6.192349980899863e-15
established O 0 1.5219994098451253e-15
the O 0 7.037915364163706e-17
genomic O 0 4.41083123801575e-13
organization O 0 6.948320364170632e-14
of O 0 5.339442860156354e-15
UBE3A O 0 1.7671525354145956e-09
and O 0 1.2644815478978638e-13
the O 0 2.699741230640935e-16
sequence O 0 1.2240536648242938e-14
of O 0 2.763501741624621e-15
intron O 0 5.275289538531069e-09
- O 0 1.1477458983222277e-08
exon O 0 1.0087312318773911e-08
borders O 0 1.101324365038181e-08
. O 0 4.861954727708451e-10

We O 0 9.104813430971248e-11
have O 0 7.86135344104863e-14
also O 0 2.5846168534939852e-15
mapped O 0 3.3940504486767997e-13
two O 0 7.004870147201813e-15
highly O 0 3.3726114349180714e-14
homologous O 0 4.0398552016672473e-13
processed O 0 8.976346575761962e-12
pseudogenes O 0 3.297085868214644e-11
, O 0 3.6529432907370096e-13
UBE3AP1 O 0 2.4311583857183905e-09
and O 0 2.692575098973103e-14
UBE3AP2 O 0 2.187291320288054e-10
, O 0 6.266821964655408e-16
to O 0 6.422337478469094e-17
chromosomes O 0 3.48679310251121e-13
2 O 0 4.5327474006194926e-14
and O 0 1.3016676495350432e-13
21 O 0 3.63847976270551e-13
, O 0 5.429840757386175e-15
respectively O 0 2.0864043728374e-13
, O 0 9.057272483013398e-14
and O 0 3.235783765497685e-14
determined O 0 1.470095475474692e-13
their O 0 6.346916129598354e-15
genomic O 0 8.710534897538036e-12
organization O 0 3.9119603389980995e-11
. O 0 3.351646737925762e-11

These O 0 7.105667508382207e-13
results O 0 1.1787887289546606e-12
will O 0 1.1239914393036568e-15
form O 0 5.485550537843564e-16
the O 0 1.0391097382637113e-15
basis O 0 2.5845936447912304e-14
for O 0 4.3067911657803054e-16
studies O 0 9.247280946620556e-14
of O 0 8.825070047226657e-16
mutation O 0 2.4472147398812982e-12
and O 0 4.246139464342269e-12
imprinting O 0 1.3031855594647368e-09
of O 0 5.944961862201781e-13
UBE3A O 0 6.130907195256441e-07
. O 0 1.7282120179373806e-10

Mutation O 0 1.2148166028680407e-08
spectrum O 0 5.718182594094401e-10
and O 0 1.6150848020091146e-11
genotype O 0 3.862288849632023e-06
- O 0 1.159110433945898e-05
phenotype O 0 5.285343718242075e-08
analyses O 0 1.1950630485202396e-09
in O 0 7.020503536153688e-12
Cowden B-Disease 0 1.1195342267455999e-05
disease I-Disease 0 3.443078355758189e-08
and O 0 6.2369996320366106e-12
Bannayan B-Disease 1 0.9999892711639404
- I-Disease 1 1.0
Zonana I-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
, O 0 3.3101592213785613e-12
two O 0 4.921238655301863e-13
hamartoma B-Disease 0 1.2332587175478693e-05
syndromes I-Disease 0 0.00010604401177261025
with O 0 6.7717871241046446e-12
germline O 0 0.0001227689062943682
PTEN O 0 0.0005403048126026988
mutation O 0 1.4756722066522343e-06
. O 0 2.58801868824321e-09

The O 0 1.3108588658994336e-09
tumour B-Disease 1 1.0
suppressor O 0 1.4094478046899894e-06
gene O 0 3.703775064423098e-08
PTEN O 0 1.970376359849979e-07
, O 0 9.533876509440486e-13
which O 0 7.149599278767366e-15
maps O 0 5.18068444047004e-12
to O 0 5.850271981265587e-13
10q23 O 0 6.786554251902999e-08
. O 0 5.357694149443759e-11

3 O 0 4.5902896067540055e-11
and O 0 1.2598153958573704e-14
encodes O 0 1.9727813404136346e-13
a O 0 1.0189926634147743e-14
403 O 0 8.870897451936782e-14
amino O 0 8.601373086003505e-12
acid O 0 1.0239429963643243e-11
dual O 0 1.354629429461962e-11
specificity O 0 3.473549226029604e-10
phosphatase O 0 1.0977099691444892e-06
( O 0 9.736381145764028e-11
protein O 0 1.629730128627216e-08
tyrosine O 0 5.6149200844402e-08
phosphatase O 0 4.7637303879355386e-08
; O 0 1.1002786138789022e-12
PTPase O 0 4.0395450873198513e-10
) O 0 2.369682141484253e-13
, O 0 2.6942859361199674e-14
was O 0 1.4858989418661123e-13
shown O 0 1.056529436692117e-14
recently O 0 7.377695676602514e-10
to O 0 4.654740473814846e-14
play O 0 3.6457898332231675e-12
a O 0 2.799131640449787e-13
broad O 0 1.2008839235522206e-11
role O 0 3.131905845776828e-11
in O 0 9.310471664469855e-12
human O 0 4.062210637312269e-12
malignancy B-Disease 0 1.6216063158935867e-08
. O 0 2.3009425961784125e-11

Somatic O 0 1.7961699995794334e-05
PTEN O 0 5.506421803147532e-05
deletions O 0 1.048418425853015e-06
and O 0 1.2293480469716123e-11
mutations O 0 6.689107601154376e-11
were O 0 4.0002061992699955e-13
observed O 0 1.1973514085598935e-13
in O 0 1.3202110845517145e-12
sporadic B-Disease 0 5.647491889249068e-06
breast I-Disease 1 0.5815209150314331
, I-Disease 0 7.881404684439985e-08
brain I-Disease 1 0.6944596171379089
, I-Disease 0 1.192936682770096e-08
prostate I-Disease 0 0.0004464229568839073
and I-Disease 0 2.836126333782829e-10
kidney I-Disease 0 1.242640546017526e-09
cancer I-Disease 0 4.2568068514547974e-10
cell O 0 2.7098440114059485e-07
lines O 0 6.30130944045959e-06
and O 0 5.812577974495525e-09
in O 0 4.4462787618382293e-11
several O 0 4.4952369192448327e-13
primary O 0 5.48309042613937e-09
tumours B-Disease 1 1.0
such O 0 2.715311482603955e-12
as O 0 1.6301419936137762e-10
endometrial B-Disease 0 0.2650200128555298
carcinomas I-Disease 1 1.0
, O 0 0.0003105432551819831
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 0 0.0016151637537404895
thyroid B-Disease 1 0.9999988079071045
tumours I-Disease 1 1.0
. O 0 3.226428846314633e-10

In O 0 5.545102137877178e-12
addition O 0 9.903017940187872e-14
, O 0 3.8380465526653e-14
PTEN O 0 8.895487901838806e-09
was O 0 2.388593663138483e-11
identified O 0 5.145390190308685e-12
as O 0 7.624860995142282e-15
the O 0 1.224243850190732e-16
susceptibility O 0 2.287641647294447e-13
gene O 0 3.872820467099025e-11
for O 0 2.492221923625082e-13
two O 0 1.409830932552758e-11
hamartoma B-Disease 0 0.4293309152126312
syndromes I-Disease 1 0.9999983310699463
Cowden B-Disease 1 0.9999667406082153
disease I-Disease 1 0.9999278783798218
( O 0 3.430944062188246e-08
CD B-Disease 0 2.196128207287984e-06
; O 0 3.104872955961291e-11
MIM O 0 0.0017390993889421225
158350 O 0 3.982422835946409e-09
) O 0 8.59538297742074e-13
and O 0 1.6813445167379593e-12
Bannayan B-Disease 0 9.880019206320867e-06
- I-Disease 0 1.6503527149325237e-06
Zonana I-Disease 0 2.943937033705879e-06
( I-Disease 0 7.032794051980984e-12
BZS I-Disease 0 8.745691282285861e-09
) I-Disease 0 7.461842558773024e-14
or I-Disease 0 1.6606940161142253e-13
Ruvalcaba I-Disease 0 7.715366123761669e-09
- I-Disease 0 8.461999101427864e-08
Riley I-Disease 1 0.6003719568252563
- I-Disease 1 0.999995231628418
Smith I-Disease 0 0.01901804655790329
syndrome I-Disease 0 0.14546215534210205
( O 0 8.54940944428062e-12
MIM O 0 2.6544354113866575e-05
153480 O 0 1.3557714062528703e-08
) O 0 1.544818092891198e-11
. O 0 1.046343393873439e-11

Constitutive O 0 1.4359622824144935e-08
DNA O 0 2.079237892971264e-09
from O 0 5.758739405475888e-12
37 O 0 3.018319275072123e-11
CD B-Disease 0 5.013162107658786e-10
families O 0 6.055060424413339e-14
and O 0 9.650978204534671e-15
seven O 0 4.8369802900429665e-14
BZS B-Disease 0 5.38706723673954e-09
families O 0 1.198205759871812e-13
was O 0 3.145354256998273e-13
screened O 0 2.4717923888251114e-11
for O 0 1.8637953051563183e-13
germline O 0 9.482159413209956e-08
PTEN O 0 2.799112735374365e-06
mutations O 0 5.247274614816888e-08
. O 0 5.186473472917896e-10

PTEN O 0 2.1558134903898463e-05
mutations O 0 9.850802840105644e-09
were O 0 2.3965465029140987e-12
identified O 0 1.3429747765247857e-12
in O 0 1.4841394511467577e-14
30 O 0 2.204886689283962e-15
of O 0 1.3793287999519715e-17
37 O 0 6.707161274944681e-14
( O 0 2.121193574521757e-13
81 O 0 3.3385273712216446e-12
% O 0 7.094576120157681e-13
) O 0 1.831931958559685e-12
CD B-Disease 0 1.3333552040251107e-08
families O 0 1.5329429484687088e-14
, O 0 1.0404822492756185e-15
including O 0 4.959869185283336e-15
missense O 0 1.3093802486707773e-08
and O 0 3.725477912275288e-11
nonsense O 0 1.9262898831584607e-07
point O 0 2.31407566719799e-11
mutations O 0 8.840422838218842e-11
, O 0 3.723009314032799e-13
deletions O 0 6.280470588038156e-10
, O 0 1.4261486956657077e-13
insertions O 0 2.4671870102466187e-10
, O 0 9.76895634156004e-14
a O 0 8.899084811067604e-13
deletion O 0 1.1412709000069299e-06
/ O 0 2.2722753101334092e-07
insertion O 0 7.553131453619244e-09
and O 0 6.91666307561789e-11
splice O 0 2.0608715658454457e-06
site O 0 3.186737540517015e-09
mutations O 0 2.3202983356895857e-07
. O 0 7.106966126713132e-10

These O 0 8.013107321777624e-13
mutations O 0 1.3425092634800073e-11
were O 0 8.277031946120339e-13
scattered O 0 1.0413489460927433e-13
over O 0 2.7334740001279823e-15
the O 0 5.604507844955958e-16
entire O 0 1.8242345297108525e-14
length O 0 4.109716310752437e-13
of O 0 1.3421967615161396e-15
PTEN O 0 8.442355148297054e-10
, O 0 2.3230581615795408e-14
with O 0 5.978608681138088e-17
the O 0 1.1375959531068633e-16
exception O 0 1.8088786694100793e-14
of O 0 8.03755188477771e-17
the O 0 1.6705797037603123e-14
first O 0 1.0310181181028e-10
, O 0 1.0293832453101004e-10
fourth O 0 3.9494298675890604e-07
and O 0 1.5870978142817904e-10
last O 0 1.0349118229058263e-09
exons O 0 4.682615628581743e-09
. O 0 8.228621256600732e-11

A O 0 2.637634999302918e-08
hot O 0 2.973103763181939e-09
spot O 0 3.7067537927981675e-10
for O 0 3.5014818735440434e-13
PTEN O 0 3.6815683301938407e-07
mutation O 0 1.104139557561723e-10
in O 0 5.641243722154243e-11
CD B-Disease 0 4.0380432331232896e-10
was O 0 3.998505086061366e-13
identified O 0 5.105463035844082e-13
in O 0 5.922008489058633e-14
exon O 0 9.33467192432147e-12
5 O 0 1.645744494458909e-13
that O 0 1.270974843179209e-15
contains O 0 4.408102182562991e-15
the O 0 1.5245918812351392e-14
PTPase O 0 2.7750124420578004e-10
core O 0 1.262284330880159e-12
motif O 0 1.4301920108275579e-12
, O 0 3.7828250019987086e-15
with O 0 7.621247102603042e-17
13 O 0 2.985653284459243e-15
of O 0 1.0564833501588525e-17
30 O 0 3.8282039451149105e-15
( O 0 7.129366541569482e-14
43 O 0 3.3816196370883844e-12
% O 0 9.061285792880125e-13
) O 0 3.0013194620565065e-12
CD B-Disease 0 2.9663518308353787e-09
mutations O 0 7.33933053220781e-12
identified O 0 8.90406845477365e-11
in O 0 3.2897016816364755e-13
this O 0 3.146468545781045e-14
exon O 0 2.022482847863216e-09
. O 0 7.625370473940407e-11

Seven O 0 2.39535366368393e-12
of O 0 1.2863191891258555e-16
30 O 0 8.807552770602727e-15
( O 0 7.42973255618215e-14
23 O 0 4.814891432607105e-13
% O 0 2.016253341315024e-14
) O 0 6.110572337974249e-15
were O 0 1.5999490144205653e-13
within O 0 2.1322439790571308e-16
the O 0 5.725280978949028e-16
core O 0 1.1625909382331073e-13
motif O 0 2.0875429206437812e-13
, O 0 2.1223930917596816e-15
the O 0 2.146927162848886e-16
majority O 0 1.0430141789857274e-14
( O 0 1.42929743561504e-12
five O 0 2.387157745781243e-12
of O 0 1.6368957233710269e-15
seven O 0 2.133541010963108e-13
) O 0 5.558796017891485e-15
of O 0 1.871697438575096e-16
which O 0 4.8553927534372016e-14
were O 0 2.359247562935818e-12
missense O 0 4.352016969022543e-09
mutations O 0 2.4960207511970367e-11
, O 0 2.3603974067735838e-14
possibly O 0 5.973078477140847e-14
pointing O 0 3.761217899633795e-12
to O 0 1.6038153810116022e-15
the O 0 4.100751989547473e-16
functional O 0 3.423520825553486e-14
significance O 0 3.915148912535249e-14
of O 0 6.072185228321158e-15
this O 0 1.0428575456531211e-13
region O 0 9.919649823775245e-11
. O 0 2.1080119594341085e-10

Germline O 0 0.00020166127069387585
PTEN O 0 1.8346690922044218e-05
mutations O 0 3.524377456542993e-09
were O 0 4.598296569902072e-12
identified O 0 1.7168033487890977e-12
in O 0 2.7086050280933013e-14
four O 0 2.274235182499803e-15
of O 0 1.5210923368202894e-17
seven O 0 5.467672552239046e-14
( O 0 4.511479623041381e-13
57 O 0 7.047339101173833e-11
% O 0 1.052638228318803e-12
) O 0 2.9399865788398705e-12
BZS B-Disease 0 2.2905184948740498e-07
families O 0 9.886758946253682e-12
studied O 0 1.3382031038844389e-09
. O 0 1.882805716890701e-11

Interestingly O 0 9.790842803170108e-09
, O 0 1.724630854793574e-12
none O 0 7.805106387592797e-13
of O 0 9.549927226866793e-17
these O 0 5.311952723490571e-16
mutations O 0 8.713604924409646e-13
was O 0 4.261142827477471e-11
observed O 0 6.658114679166868e-14
in O 0 2.8860803178744343e-13
the O 0 8.311245843026921e-14
PTPase O 0 1.0973510100598105e-08
core O 0 3.593051411954207e-10
motif O 0 3.1127327382307612e-09
. O 0 8.546723745395113e-11

It O 0 3.3695153871943218e-12
is O 0 1.2860555448270666e-14
also O 0 4.323072356636395e-15
worthy O 0 3.2516717318959235e-14
of O 0 1.857940511780943e-15
note O 0 1.3124249464979698e-09
that O 0 4.619175169722238e-15
a O 0 2.2354112918371305e-13
single O 0 2.776820657093837e-12
nonsense O 0 3.871251319509383e-09
point O 0 6.380803437705529e-12
mutation O 0 1.5450205134368011e-12
, O 0 1.7215635655324496e-13
R233X O 0 4.356871113886385e-11
, O 0 2.6202425510357327e-14
was O 0 2.1430111103639543e-13
observed O 0 1.375678915129918e-14
in O 0 1.1772551791917885e-14
the O 0 1.3379232685390048e-15
germline O 0 5.296689128964083e-11
DNA O 0 1.2710192620613014e-10
from O 0 1.2472112914923422e-13
two O 0 3.903881680270872e-14
unrelated O 0 8.676377324934315e-12
CD B-Disease 0 1.4052529806463099e-08
families O 0 2.7597959724803833e-13
and O 0 9.617209372619895e-14
one O 0 2.8407831642596193e-13
BZS B-Disease 0 1.2732095910905628e-07
family O 0 1.1270277072705781e-10
. O 0 2.8088791709235394e-11

Genotype O 0 0.0002830172306858003
- O 0 0.016794675961136818
phenotype O 0 3.9372675786353284e-08
studies O 0 2.5262274050419364e-08
were O 0 1.558196800754974e-11
not O 0 3.250938074308659e-15
performed O 0 2.0128028679010888e-14
on O 0 3.5475823532060344e-14
this O 0 6.635006275700967e-17
small O 0 1.855240543439593e-13
group O 0 3.278883241308872e-13
of O 0 4.315347246750846e-14
BZS B-Disease 0 1.6578663064592547e-07
families O 0 1.9595564754171235e-11
. O 0 1.7853878098161857e-11

However O 0 1.8656253625293218e-11
, O 0 1.0083714462386095e-12
genotype O 0 2.450980041146522e-08
- O 0 1.081360991861402e-07
phenotype O 0 7.794366041480316e-09
analysis O 0 3.7270062036576235e-11
inthe O 0 5.277614789633844e-09
group O 0 1.5762635988125773e-11
of O 0 2.889130449636179e-14
CD B-Disease 0 8.150173869125865e-08
families O 0 6.211659198075356e-14
revealed O 0 1.2398167345203936e-12
two O 0 2.809291495720241e-15
possible O 0 4.019735882181e-15
associations O 0 7.042273004570195e-15
worthy O 0 9.746734262782233e-14
of O 0 1.3792250185635981e-15
follow O 0 1.7946677130509237e-11
- O 0 1.5871727043759165e-07
up O 0 4.055664970525896e-10
in O 0 3.609560567108261e-12
independent O 0 4.9013072246639755e-12
analyses O 0 1.771660457228208e-10
. O 0 7.2606486795079306e-12

The O 0 2.2658042976575477e-12
first O 0 1.6193715205586878e-12
was O 0 6.655223247498121e-13
an O 0 4.0508596313718265e-16
association O 0 3.0821814555898747e-14
noted O 0 1.569637703233845e-13
in O 0 1.262984671273476e-13
the O 0 1.0118963060859725e-14
group O 0 1.2367362722028735e-13
of O 0 5.719498920292833e-15
CD B-Disease 0 3.228848868275236e-07
families O 0 2.272104352536372e-13
with O 0 3.5755377608345795e-13
breast B-Disease 0 2.089688905471121e-06
disease I-Disease 0 3.457481625446235e-07
. O 0 1.412762962171854e-10

A O 0 2.1543460071438147e-10
correlation O 0 4.234099529321078e-11
was O 0 9.586885322057648e-13
observed O 0 4.225200664196476e-15
between O 0 7.287105442754327e-16
the O 0 6.642506487751108e-16
presence O 0 3.552373022477906e-12
/ O 0 4.1072972578604094e-08
absence O 0 1.599910091562573e-12
of O 0 2.7733108066702993e-16
a O 0 3.290768536574201e-13
PTEN O 0 3.435108553162536e-08
mutation O 0 1.6258156279591596e-11
and O 0 2.032064295477698e-13
the O 0 5.705965874894551e-15
type O 0 4.477464621288618e-09
of O 0 2.6854015430614886e-13
breast O 0 4.330176395228591e-08
involvement O 0 6.174179500995081e-10
( O 0 6.460295493004864e-11
unaffected O 0 6.335508260235656e-07
versus O 0 2.3148754735302646e-06
benign O 0 0.04953628033399582
versus O 0 4.508787242230028e-06
malignant O 1 0.6098078489303589
) O 0 3.5362619499323955e-09
. O 0 1.5083453930309076e-10

Specifically O 0 8.114219365862319e-12
and O 0 1.1325618584244121e-13
more O 0 1.8607200239275783e-16
directly O 0 1.5308084995570108e-16
, O 0 1.0383812475774253e-14
an O 0 8.407972495152918e-16
association O 0 1.7212985594164398e-12
was O 0 7.928657730360555e-12
also O 0 1.0464016331483868e-14
observed O 0 9.597957965443052e-16
between O 0 4.2545215566986306e-16
the O 0 7.851036156234599e-16
presence O 0 1.1371588417544327e-14
of O 0 3.454918748721427e-16
a O 0 9.463184359390087e-13
PTEN O 0 6.347183443722315e-06
mutation O 0 1.0085008028681841e-07
and O 0 1.1009762346247953e-07
malignant B-Disease 1 0.9999995231628418
breast I-Disease 1 0.9997909665107727
disease I-Disease 0 0.0788259506225586
. O 0 4.611950821242772e-10

Secondly O 0 1.1976625273746322e-06
, O 0 7.729863624184041e-12
there O 0 6.453438315418697e-14
appeared O 0 1.8002876966960457e-10
to O 0 2.44135054782834e-15
be O 0 8.066679309660756e-15
an O 0 6.324725666325304e-16
interdependent O 0 1.1930099269585881e-11
association O 0 1.2316790789319507e-14
between O 0 3.979669953226451e-15
mutations O 0 3.741170567783669e-12
upstream O 0 5.918987956016197e-12
and O 0 3.963778429289834e-14
within O 0 8.566841465344342e-16
the O 0 1.844745601935205e-14
PTPase O 0 5.068899744387068e-10
core O 0 6.0673670948530045e-12
motif O 0 1.3799856223017937e-11
, O 0 1.4337527476024348e-13
the O 0 1.3276633702071503e-15
core O 0 2.061220118199092e-13
motif O 0 1.3655155023210852e-13
containing O 0 2.6311099837490054e-14
the O 0 9.899839025536827e-15
majority O 0 1.546001418247303e-13
of O 0 4.985765354173152e-14
missense O 0 9.755131458177857e-08
mutations O 0 2.5261295277800855e-09
, O 0 4.6860414854021926e-11
and O 0 4.806465758711541e-14
the O 0 4.089067699435692e-16
involvement O 0 5.607186671354944e-14
of O 0 2.460262252441687e-16
all O 0 5.626142654615608e-16
major O 0 2.6098130343561905e-14
organ O 0 1.610184728606523e-11
systems O 0 1.0422824409106468e-10
( O 0 1.489396279918953e-11
central O 0 2.5273743986531372e-08
nervous O 1 0.9999984502792358
system O 0 2.5638691170115635e-10
, O 0 1.7989508537333276e-12
thyroid O 0 2.896869766289001e-08
, O 0 6.164947892461914e-12
breast O 0 0.0002711675479076803
, O 0 1.4850215848127846e-05
skin O 1 1.0
and O 0 5.570784196606837e-06
gastrointestinal O 0 0.005312758963555098
tract O 0 0.0034066170919686556
) O 0 3.0119604033096437e-10
. O 0 1.2380102498710244e-10

However O 0 3.580789484369795e-11
, O 0 3.6219569281726455e-14
these O 0 6.603292171015684e-17
observations O 0 9.535739372060724e-15
would O 0 1.17366633447559e-13
need O 0 2.821396274162863e-14
to O 0 6.97620041127786e-16
be O 0 5.930980177332656e-15
confirmed O 0 4.183910433819965e-14
by O 0 1.9188922615115335e-16
studying O 0 8.884681049680862e-14
a O 0 2.246650919297756e-15
larger O 0 2.626822641783183e-14
number O 0 2.1377039407296378e-13
of O 0 2.311752948357809e-13
CD B-Disease 0 1.1822902479252662e-06
families O 0 2.699509886461282e-12
. O 0 6.069485192217172e-12

Molecular O 0 7.431553967762738e-07
defects O 0 3.917896901839413e-05
leading O 0 7.809021983738729e-13
to O 0 2.5176944743973174e-15
human O 0 7.945923243381572e-14
complement B-Disease 0 1.9851214005939255e-08
component I-Disease 1 0.9990697503089905
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.2478461069819784e-13
an O 0 1.5818382641621422e-15
African O 0 1.9557645162659315e-13
- O 0 1.4039702560253442e-11
American O 0 2.2792412488620295e-12
family O 0 3.793574829269453e-12
. O 0 1.5916313406139082e-12

Complement B-Disease 0 4.4833379320152744e-07
component I-Disease 1 0.9492998719215393
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 7.984254368764709e-10
C6D B-Disease 0 1.5076227555255173e-07
) O 0 8.025531628153004e-12
was O 0 1.785348868743597e-09
diagnosed O 0 4.841443868031092e-08
in O 0 1.745417775155661e-14
a O 0 1.176086409249849e-13
16 O 0 3.441585937676711e-13
- O 0 3.1175645832243193e-12
year O 0 2.98319745642428e-13
- O 0 4.027760113281542e-13
old O 0 1.9588839231254873e-11
African O 0 7.090067600948671e-14
- O 0 1.9608068695196185e-13
American O 0 6.602824434128254e-14
male O 0 3.559650837980932e-12
with O 0 3.3015146606169e-12
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 7.931853091003305e-11

The O 0 4.8781963711552745e-12
patients O 0 4.782242379874901e-10
father O 0 5.533691126852203e-12
and O 0 8.984594345633548e-14
two O 0 2.8053839633279676e-14
brothers O 0 2.486051295380598e-12
also O 0 6.244683318622907e-14
had O 0 1.4713361822307758e-12
C6D B-Disease 0 1.4186157137885402e-08
, O 0 1.0978171090291269e-13
but O 0 4.33546292399542e-13
gave O 0 8.395714679032551e-12
no O 0 2.567091287805634e-12
history O 0 5.952612534831925e-12
of O 0 7.236795255931294e-13
meningitis B-Disease 1 1.0
or O 0 7.364448634250564e-11
other O 0 1.5471918884957248e-11
neisserial B-Disease 0 8.779136805969756e-06
infection I-Disease 0 5.820507340104086e-06
. O 0 6.815185221720199e-11

By O 0 4.316581881974764e-14
using O 0 8.625091201149016e-13
exon O 0 2.383065966782283e-10
- O 0 2.4385819752392734e-11
specific O 0 1.920806721143753e-13
polymerase O 0 5.861399473422457e-12
chain O 0 3.456289941750068e-12
reaction O 0 8.534801554729854e-14
( O 0 4.490684422085202e-14
PCR O 0 5.917297207780337e-11
) O 0 5.86157234945886e-14
/ O 0 1.6299950972298305e-11
single O 0 8.670086675509336e-13
- O 0 5.484708798242366e-10
strand O 0 1.0378873760430452e-08
conformation O 0 1.0007580875104338e-10
polymorphism O 0 2.2559402956812136e-10
as O 0 3.549673846959395e-14
a O 0 1.2586816422574705e-14
screening O 0 6.942653374940322e-13
step O 0 8.71587331252371e-15
and O 0 1.0884040514739268e-16
nucleotide O 0 5.759299410297537e-16
sequencing O 0 6.07508123396782e-15
of O 0 4.992171646994716e-17
target O 0 1.9993011966031732e-13
exons O 0 1.2004578754665207e-11
, O 0 2.566796059554066e-13
we O 0 4.6398906309967625e-15
determined O 0 2.055297917941774e-15
that O 0 5.0959765272974653e-17
the O 0 1.8496738937322146e-15
proband O 0 1.9826258690347487e-10
was O 0 1.872325265748348e-13
a O 0 4.430776831044515e-15
compound O 0 8.241739674627949e-14
heterozygote O 0 1.0610142105182963e-11
for O 0 1.5457860685907931e-13
two O 0 3.706735873104661e-12
C6 O 0 2.0390306332274122e-08
gene O 0 1.5235412931247083e-08
mutations O 0 6.13357329370956e-08
. O 0 3.409484916616634e-10

The O 0 5.548431722748881e-13
first O 0 7.337838968174068e-14
, O 0 1.3636454356856314e-15
1195delC O 0 2.963167905489783e-13
located O 0 2.6348211739041054e-14
in O 0 4.797620634100497e-13
exon O 0 1.3585398084270395e-10
7 O 0 2.004989403669999e-11
, O 0 1.9602161148608854e-13
is O 0 1.347501411227438e-15
a O 0 6.0941140642926245e-15
novel O 0 2.5791730405046176e-13
mutation O 0 2.9203346013119413e-13
, O 0 1.3021245052254743e-13
while O 0 2.580579047434424e-14
the O 0 2.3237662811234454e-15
second O 0 6.623134657900154e-13
, O 0 9.496557321986634e-14
1936delG O 0 3.5071466564229326e-11
in O 0 3.9249606711456997e-13
exon O 0 1.1121459309038073e-10
12 O 0 4.799217620532481e-11
, O 0 1.9861429124620744e-13
has O 0 1.3809972655991383e-14
been O 0 4.893658313862362e-15
described O 0 8.581994164792717e-14
before O 0 4.235304666114388e-14
to O 0 2.1935610117462248e-15
cause O 0 3.240819071437251e-13
C6D B-Disease 0 2.1432208896499105e-08
in O 0 1.358244978077669e-13
an O 0 2.994092061954501e-16
unrelated O 0 1.1598451149161249e-12
African O 0 7.261863636462418e-13
- O 0 6.760370041547503e-11
American O 0 9.043621971085991e-13
individual O 0 6.152372990404775e-14
. O 0 1.7040278693300492e-12

Both O 0 6.313722114570375e-12
mutations O 0 6.708518740516922e-10
result O 0 1.0651445003784232e-11
in O 0 3.398368045304245e-11
premature O 0 3.431497030970121e-10
termination O 0 3.4482536270807884e-10
codons O 0 4.467620051684662e-09
and O 0 1.1359205243088866e-11
C6 O 0 7.959173586868928e-08
null O 0 1.122115094176479e-07
alleles O 0 1.7657921347336014e-08
. O 0 1.2775068780612742e-09

Allele O 0 3.841104856405764e-08
- O 0 4.531263364526694e-09
specific O 0 1.1157269769537792e-12
PCR O 0 4.51974624393614e-10
indicated O 0 1.0896131002677278e-12
that O 0 6.035967370045985e-17
the O 0 9.93456356472599e-16
probands O 0 2.187851677604158e-09
two O 0 3.1592369237158635e-13
brothers O 0 2.017641435869688e-11
also O 0 2.1099666949069874e-14
inherited O 0 3.573732889478043e-12
the O 0 2.3886628962234598e-14
1195delC O 0 4.609822246148809e-10
mutation O 0 1.418601998023905e-12
from O 0 5.06647566782259e-13
their O 0 5.2300225511069803e-14
heterozygous O 0 1.0315925197401654e-10
mother O 0 1.0269789185723965e-10
and O 0 4.079425446941063e-15
the O 0 8.53057839668561e-16
1936delG O 0 5.056373028611283e-11
mutation O 0 3.02785487654722e-12
from O 0 2.9085568589021227e-12
their O 0 9.29084215703195e-14
homozygous O 0 1.9932842876269063e-10
father O 0 1.0721178805850329e-10
. O 0 2.0905988799922032e-13
. O 0 1.4807478160294707e-12

PAX6 O 0 0.00025296330568380654
mutations O 0 3.351273335283622e-06
reviewed O 0 4.450073731732118e-07
. O 0 1.411892824876304e-10

Mutations O 0 2.9072160145915404e-07
in O 0 4.3250607956180076e-11
PAX6 O 0 5.892528065487568e-08
are O 0 3.496554716771183e-14
responsible O 0 9.384787089431693e-15
for O 0 4.136069028283241e-16
human O 0 1.0838067775057261e-13
aniridia B-Disease 1 1.0
and O 0 1.2043682891260676e-11
have O 0 4.3325345616901725e-14
also O 0 7.826486494445209e-16
been O 0 1.0284622164793695e-15
found O 0 3.284847301934443e-14
in O 0 2.459698568955948e-13
patients O 0 4.880359896590469e-14
with O 0 1.0530046784887077e-14
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 4.219636098867774e-11
with O 0 4.8976090544217143e-11
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 3.1591212978909766e-10
with O 0 7.84214793797533e-12
autosomal B-Disease 0 0.1904076337814331
dominant I-Disease 0 0.002271779580041766
keratitis I-Disease 1 0.9999992847442627
, O 0 1.4081028609780333e-07
and O 0 1.041689651204436e-11
with O 0 2.8462394116926526e-13
isolated B-Disease 0 0.0002685993385966867
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 1.962947804301507e-09

No O 0 1.7597409640579542e-11
locus O 0 1.1583688001859382e-11
other O 0 2.7752292515925356e-14
than O 0 2.4790787505517622e-14
chromosome O 0 1.0334684219515111e-08
11p13 O 0 6.5486336353615116e-09
has O 0 4.1378036522328465e-13
been O 0 1.535735649977124e-13
implicated O 0 7.946659823232505e-12
in O 0 7.407810476145471e-11
aniridia B-Disease 1 1.0
, O 0 8.229334639946184e-13
and O 0 9.633249804948639e-15
PAX6 O 0 3.010639515466096e-10
is O 0 2.0904453383298544e-15
clearly O 0 5.275746829555778e-15
the O 0 1.2320302005583672e-16
major O 0 2.968421881455012e-14
, O 0 1.418601293292493e-13
if O 0 3.049923730453e-14
not O 0 1.1222568217067984e-14
only O 0 1.701032232279999e-14
, O 0 2.39525535365194e-14
gene O 0 1.5051926371967284e-10
responsible O 0 1.478485216199754e-11
. O 0 9.105452503099798e-12

Twenty O 0 7.625901687902115e-09
- O 0 4.7248740031591296e-08
eight O 0 8.966016817879563e-11
percent O 0 2.850115803088027e-11
of O 0 1.3579916760511661e-16
identified O 0 2.1554176846128037e-11
PAX6 O 0 1.663951287866894e-08
mutations O 0 6.908870003874412e-11
are O 0 8.045297826379805e-13
C O 0 5.464040100378043e-07
- O 0 9.781062999536516e-07
T O 0 8.479997859467403e-08
changes O 0 2.222929305906174e-12
at O 0 6.618853685622095e-13
CpG O 0 1.3468189064003155e-10
dinucleotides O 0 4.0779815635438865e-10
, O 0 2.126543807311112e-14
20 O 0 5.266497229771761e-15
% O 0 6.407829127571608e-16
are O 0 4.653217847388862e-16
splicing O 0 2.7143187003586533e-11
errors O 0 2.7850355355241163e-09
, O 0 3.810254893446118e-15
and O 0 2.9871103928867573e-16
more O 0 7.796531306614459e-18
than O 0 9.908142092472067e-17
30 O 0 5.1142485632169575e-15
% O 0 2.800656418339457e-15
are O 0 3.504700463218338e-14
deletion O 0 4.191320901458795e-11
or O 0 4.617805703793776e-13
insertion O 0 2.7538044761188374e-11
events O 0 7.916720230760621e-12
. O 0 3.8319375450512894e-11

There O 0 4.522052437366808e-12
is O 0 1.1891845371110338e-14
a O 0 4.477037230526948e-13
noticeably O 0 8.809985274638166e-08
elevated O 0 6.012977876029835e-12
level O 0 1.2789652149847175e-12
of O 0 2.205516299461568e-16
mutation O 0 3.5871279498210853e-14
in O 0 1.5328122343442885e-13
the O 0 2.778955487170361e-16
paired O 0 1.8299997747630442e-13
domain O 0 7.951351030507578e-14
compared O 0 2.962998227849789e-13
with O 0 1.4127082309685606e-15
the O 0 5.974297526958536e-14
rest O 0 1.0459198611367793e-12
of O 0 1.6798610461040277e-15
the O 0 3.06961487478441e-14
gene O 0 4.827395705397919e-10
. O 0 2.9831494913201695e-11

Increased O 0 2.015104194619255e-10
mutation O 0 5.07192447762872e-11
in O 0 1.651014719904198e-12
the O 0 9.791410337958804e-15
homeodomain O 0 1.0345481415985347e-10
is O 0 4.338330977554823e-14
accounted O 0 3.5229607859427192e-12
for O 0 1.6803407843895288e-16
by O 0 5.891380434136452e-16
the O 0 4.5212717982500913e-14
hypermutable O 0 9.672052492248895e-09
CpG O 0 1.0464686894806619e-08
dinucleotide O 0 5.290555549208875e-09
in O 0 2.5390342606179672e-11
codon O 0 6.0685447778041635e-09
240 O 0 9.98954044484357e-11
. O 0 2.355506631759874e-12

Very O 0 4.85814499739945e-10
nearly O 0 1.7917697490640871e-12
all O 0 2.167740694656835e-15
mutations O 0 3.083429236765134e-13
appear O 0 6.756022390835836e-12
to O 0 2.3449070376407866e-14
cause O 0 1.5946091018806396e-12
loss O 0 4.0246542210020664e-11
of O 0 1.1797047137719532e-15
function O 0 2.1187057032303995e-14
of O 0 3.562523696758245e-16
the O 0 5.350044748040662e-15
mutant O 0 3.6713174167424256e-11
allele O 0 2.04960232813578e-11
, O 0 2.523620418540262e-13
and O 0 2.444425700943347e-15
more O 0 1.5429964103129386e-17
than O 0 4.745209265055374e-17
80 O 0 5.268684692358045e-16
% O 0 1.3040021401003118e-15
of O 0 1.8517775000567206e-15
exonic O 0 7.336608542907186e-10
substitutions O 0 1.1292627423442614e-11
result O 0 1.2140891590683989e-12
in O 0 3.2997344440177656e-11
nonsense O 0 2.7573469196795486e-07
codons O 0 5.303589123428765e-09
. O 0 1.0936654359916531e-11

In O 0 7.645671595835069e-11
a O 0 2.892125287087127e-13
gene O 0 3.465637499200369e-12
with O 0 8.545886929020455e-16
such O 0 2.1508383639526124e-15
extraordinarily O 0 3.182015068103894e-11
high O 0 1.0708042119016506e-13
sequence O 0 2.5155826095015757e-15
conservation O 0 1.151814248159474e-15
throughout O 0 1.1880102106329605e-14
evolution O 0 3.238673164287359e-14
, O 0 1.1660901838041453e-14
there O 0 3.828028609294829e-15
are O 0 4.2426436136792835e-15
presumed O 0 1.8840665139130408e-11
undiscovered O 0 4.277008969211238e-09
missense O 0 1.6209514797083102e-07
mutations O 0 1.6167136518419056e-09
, O 0 7.06707912676019e-13
these O 0 6.464100173235671e-16
are O 0 1.7310834842348797e-16
hypothesized O 0 1.9248107136480598e-14
to O 0 2.245665396463626e-15
exist O 0 1.0847498301078812e-13
in O 0 9.549623244953231e-12
as O 0 2.4323014088944994e-11
- O 0 4.992170010709174e-10
yet O 0 4.689546320713056e-11
unidentified O 0 3.1004674383439124e-09
phenotypes O 0 3.27074312078679e-10
. O 0 5.598297975369093e-13
. O 0 2.4114072284114885e-12

Genetic O 0 1.659622199667865e-07
heterogeneity O 0 3.7884557713141476e-08
and O 0 3.831294309586397e-11
penetrance O 0 2.471890603317206e-08
analysis O 0 5.144153332470314e-12
of O 0 1.628587071312291e-15
the O 0 3.4850628513691945e-14
BRCA1 O 0 4.134097252972424e-06
and O 0 4.695381930486242e-11
BRCA2 O 0 1.218074066855479e-05
genes O 0 1.4214968757642055e-07
in O 0 2.7909237587664393e-08
breast B-Disease 0 0.00010495230526430532
cancer I-Disease 0 5.946478722762549e-06
families O 0 3.879158105846159e-10
. O 0 2.4225507017083814e-11

The O 0 4.4034536017534265e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 4.277494554116856e-06
Consortium O 0 1.1467704297274395e-07
. O 0 4.622650873198353e-10

The O 0 4.287787843965801e-14
contribution O 0 3.4939814306774244e-14
of O 0 1.2538552485240155e-15
BRCA1 O 0 8.725313804802681e-09
and O 0 3.1445521100209595e-12
BRCA2 O 0 0.0001943772949744016
to O 0 2.928643141331122e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 1.7543747787840402e-08
assessed O 0 1.466688576146069e-11
by O 0 2.97688522290574e-15
linkage O 0 6.794008133859109e-10
and O 0 1.4095175764408663e-13
mutation O 0 2.1808145296130926e-13
analysis O 0 4.0532152829377e-13
in O 0 1.978878893431693e-13
237 O 0 1.7322495434596297e-12
families O 0 1.1165092796432043e-14
, O 0 1.2462446574929356e-15
each O 0 2.808966724759418e-17
with O 0 2.609254500830771e-15
at O 0 1.3421611044783788e-11
least O 0 3.4836955369044187e-13
four O 0 3.5325336948145714e-13
cases O 0 8.02198064919768e-12
of O 0 7.50743935876326e-14
breast B-Disease 0 4.796918915417336e-07
cancer I-Disease 0 8.908375370708654e-09
, O 0 1.2178155890402859e-13
collected O 0 3.177200933986504e-14
by O 0 1.0599653072580414e-13
the O 0 9.956831803492605e-09
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 2.741012039564339e-08
Consortium O 0 7.058444495555705e-09
. O 0 1.5618693838259645e-10

Families O 0 2.8608395166718203e-11
were O 0 1.1784869683850036e-13
included O 0 3.3205102371621344e-16
without O 0 1.079015750044797e-16
regard O 0 5.725477384713672e-16
to O 0 7.760631006285167e-17
the O 0 2.4632485729763503e-16
occurrence O 0 1.046163156104285e-12
of O 0 3.0558240942009374e-13
ovarian B-Disease 0 1.1273657563037887e-09
or I-Disease 0 3.3202211813243565e-11
other I-Disease 0 1.2776516823687079e-11
cancers I-Disease 0 2.941506771492186e-08
. O 0 6.689324094644178e-11

Overall O 0 1.4051665857550688e-06
, O 0 1.742976041274602e-10
disease O 0 5.138728553788496e-09
was O 0 8.319005206924857e-13
linked O 0 5.191862564868366e-12
to O 0 1.0589503415586645e-14
BRCA1 O 0 1.8023010861512034e-10
in O 0 3.606595985674189e-15
an O 0 5.369070950994399e-18
estimated O 0 7.213315638158677e-16
52 O 0 3.924225039971668e-14
% O 0 3.922875970596576e-15
of O 0 3.3697143810681367e-16
families O 0 6.507723217052215e-15
, O 0 5.745474773807162e-16
to O 0 5.998990146733598e-16
BRCA2 O 0 7.244720379162572e-10
in O 0 2.771253007887581e-13
32 O 0 5.726403509362377e-13
% O 0 2.26180378815272e-14
of O 0 1.4686478749920107e-15
families O 0 5.4504090043344666e-14
, O 0 1.4905506435245255e-14
and O 0 2.7129882965404003e-15
to O 0 1.3877581343533564e-16
neither O 0 1.3912022338443634e-14
gene O 0 2.7408496479364164e-12
in O 0 3.812214216178389e-13
16 O 0 1.0657653145423884e-13
% O 0 6.349773595245916e-15
( O 0 2.460768405449648e-13
95 O 0 9.401646822171372e-11
% O 0 9.939915557310997e-11
confidence O 0 5.4450847386533496e-08
interval O 0 2.1890348908537582e-11
[ O 0 1.805517367559073e-11
CI O 0 1.6005603953317404e-08
] O 0 1.038493770144644e-11
6 O 0 1.5600091747905442e-13
% O 0 4.106456385870316e-13
- O 0 1.4950368054655883e-08
28 O 0 1.8306160406988958e-11
% O 0 1.0487278227907723e-13
) O 0 3.0550123655869246e-14
, O 0 5.647045416050595e-15
suggesting O 0 5.970188536250087e-13
other O 0 3.953251419118063e-15
predisposition O 0 5.0530565842699104e-11
genes O 0 7.289476244842774e-10
. O 0 6.73244723858879e-11

The O 0 3.3553258641568634e-14
majority O 0 3.471065462509228e-14
( O 0 8.688396139697185e-13
81 O 0 1.5575006562240645e-12
% O 0 9.871067010384493e-15
) O 0 2.22012925892804e-15
of O 0 7.006844475122744e-16
the O 0 2.771690654768122e-10
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.5895999754277366e-12
were O 0 1.0608465942176827e-14
due O 0 1.579703635255943e-15
to O 0 3.259044761949034e-16
BRCA1 O 0 1.99637389952656e-10
, O 0 4.387985997098649e-15
with O 0 1.842052972869645e-17
most O 0 2.250097496360134e-16
others O 0 2.7253318959225004e-15
( O 0 1.1211277945507442e-13
14 O 0 7.370047497637366e-13
% O 0 1.941618388420427e-13
) O 0 2.9705922509164207e-13
due O 0 5.843739554756144e-12
to O 0 5.151979537432183e-12
BRCA2 O 0 5.982154107186943e-06
. O 0 2.1038025488362422e-10

Conversely O 0 1.5422368937478836e-10
, O 0 1.7146613312144995e-14
the O 0 8.589678400044604e-17
majority O 0 1.1365295386262702e-15
of O 0 9.28673556130916e-17
families O 0 2.2079165261362907e-15
with O 0 1.181745004383652e-15
male B-Disease 0 1.3943376453440237e-09
and I-Disease 0 4.399667119514561e-08
female I-Disease 0 2.0976420600504753e-08
breast I-Disease 0 2.0477519058204052e-07
cancer I-Disease 0 4.6836898803803706e-08
were O 0 5.984263085068164e-11
due O 0 1.3603995588449408e-13
to O 0 2.0413048489498382e-14
BRCA2 O 0 6.062762736291916e-08
( O 0 4.020396168757934e-11
76 O 0 4.681612875145902e-10
% O 0 1.2567668260243803e-11
) O 0 7.304723666223811e-12
. O 0 4.0785159971523655e-11

The O 0 4.144805379040781e-15
largest O 0 3.150220139407729e-15
proportion O 0 2.4328265164669412e-14
( O 0 6.391067688092666e-13
67 O 0 9.899930701606774e-12
% O 0 6.218996536277652e-14
) O 0 3.113864892388511e-14
of O 0 1.198108622133421e-15
families O 0 5.775605112169537e-15
due O 0 2.063853585983753e-15
to O 0 3.1834277484674785e-16
other O 0 1.330076355315641e-15
genes O 0 1.4527973008632289e-12
was O 0 2.373665326793617e-11
found O 0 1.6696863076176571e-12
in O 0 4.5282129283209793e-13
families O 0 3.2334004688939957e-15
with O 0 8.457157051422015e-16
four O 0 1.0438008015431835e-13
or O 0 3.709959043533134e-13
five O 0 1.9880795685926766e-13
cases O 0 5.831043655736556e-13
of O 0 2.4753838234292495e-14
female O 0 1.2744531652231217e-08
breast B-Disease 0 1.3173709021430113e-06
cancer I-Disease 0 1.5472996039989084e-07
only O 0 6.687605469402058e-10
. O 0 1.7627617421300812e-10

These O 0 1.1220454361644816e-13
estimates O 0 9.839253977544926e-13
were O 0 1.8689526177216066e-14
not O 0 1.2109281481527596e-15
substantially O 0 2.5101979956448917e-13
affected O 0 2.507190418818417e-15
either O 0 5.811670398635086e-16
by O 0 9.98006829223486e-16
changing O 0 1.0222446803972995e-12
the O 0 1.4474329395643137e-14
assumed O 0 6.488856327258041e-12
penetrance O 0 2.390595776891047e-10
model O 0 1.3319215522167305e-12
for O 0 3.715266501158653e-15
BRCA1 O 0 1.3265631648717857e-10
or O 0 2.264273837870867e-13
by O 0 1.2572798027297646e-15
including O 0 3.560224489350394e-14
or O 0 1.5671913636619572e-12
excluding O 0 9.095861841501574e-10
BRCA1 O 0 2.483819798726472e-07
mutation O 0 3.549567750837923e-09
data O 0 7.279323810394089e-09
. O 0 4.2017587326137473e-11

Among O 0 6.860329903983498e-13
those O 0 1.0850597086413047e-14
families O 0 4.9594528685897605e-15
with O 0 6.235155108526714e-16
disease O 0 2.8161856527320062e-11
due O 0 2.599192088230569e-14
to O 0 2.935969719905095e-15
BRCA1 O 0 3.949103710709778e-09
that O 0 1.5562549892430416e-14
were O 0 4.3978082758583045e-14
tested O 0 1.4986316766545105e-15
by O 0 6.576617333340135e-18
one O 0 2.263916309498996e-16
of O 0 7.89918442063229e-18
the O 0 2.0271949529386524e-16
standard O 0 1.2042895977323886e-12
screening O 0 2.1251489134535735e-14
methods O 0 9.58618560508058e-14
, O 0 9.947955579138554e-15
mutations O 0 1.866432355890346e-12
were O 0 1.0503218303772877e-12
detected O 0 4.5901844825113614e-11
in O 0 4.1175466898926705e-13
the O 0 4.592707846516088e-14
coding O 0 7.219005254688327e-11
sequence O 0 2.555580259130247e-13
or O 0 5.727888866338682e-13
splice O 0 1.1834419555434295e-10
sites O 0 1.7199684330861803e-13
in O 0 1.1138674685840129e-14
an O 0 7.070394445479478e-17
estimated O 0 1.1802408856275651e-14
63 O 0 1.0728450463085015e-12
% O 0 5.1530062497844725e-14
( O 0 3.865775971903518e-13
95 O 0 1.8046186073261694e-11
% O 0 3.0065448828470176e-12
CI O 0 2.428004393095762e-07
51 O 0 4.4035081137039356e-10
% O 0 2.735054370484047e-11
- O 0 1.6916808931455307e-07
77 O 0 4.370306616596764e-10
% O 0 1.5344019457796954e-11
) O 0 1.2593991821630013e-11
. O 0 2.059677775556601e-11

The O 0 5.664232307473448e-14
estimated O 0 7.912998056282261e-14
sensitivity O 0 1.5287282073908615e-12
was O 0 7.016885445083887e-13
identical O 0 4.652654401072348e-14
for O 0 7.618397630828919e-17
direct O 0 4.5384635177607435e-15
sequencing O 0 1.1864444973350152e-12
and O 0 3.3704392358654967e-13
other O 0 1.2399525579475518e-14
techniques O 0 7.738142765445488e-11
. O 0 5.992894982348451e-12

The O 0 7.43722618212761e-12
penetrance O 0 3.877179466371672e-08
of O 0 1.5453431720033328e-14
BRCA2 O 0 7.243313948634977e-09
was O 0 1.0337147804406754e-12
estimated O 0 3.542818269333762e-16
by O 0 2.8941117339319514e-17
maximizing O 0 1.1677379169964391e-13
the O 0 3.6573683263787377e-14
LOD O 0 4.4167990154164727e-07
score O 0 5.6419296318166445e-12
in O 0 8.123661791002712e-13
BRCA2 O 0 9.422306902706623e-06
- O 0 4.387801055827367e-08
mutation O 0 2.125360026861145e-10
families O 0 2.234966031688934e-11
, O 0 8.640647469445109e-14
over O 0 1.7503251452388735e-14
all O 0 1.0918192009669835e-14
possible O 0 1.820982600819754e-12
penetrance O 0 2.901895168605506e-09
functions O 0 1.7909087841189164e-12
. O 0 4.687594496594061e-12

The O 0 1.76201199762532e-14
estimated O 0 3.6506845587985434e-14
cumulative O 0 3.618370360281009e-12
risk O 0 5.937990654736325e-10
of O 0 3.042801741907214e-13
breast B-Disease 0 2.724754722294165e-06
cancer I-Disease 0 1.1588766390957517e-08
reached O 0 5.78258274597232e-11
28 O 0 1.5737926370093525e-13
% O 0 4.263019838258433e-15
( O 0 1.884293570242508e-14
95 O 0 6.052811247006518e-13
% O 0 3.500954138136586e-13
CI O 0 3.0843427367699405e-08
9 O 0 1.5477104190267377e-12
% O 0 7.08469144895113e-13
- O 0 1.1705767466452244e-09
44 O 0 9.711221627198285e-13
% O 0 9.186888005701093e-15
) O 0 2.1995006450003883e-16
by O 0 5.038895771075386e-16
age O 0 2.681956490658416e-13
50 O 0 7.553494128292252e-16
years O 0 2.770952614005584e-16
and O 0 3.7285801385538163e-17
84 O 0 5.3592743366713e-16
% O 0 1.7886658427804112e-16
( O 0 1.2475342651551303e-14
95 O 0 1.0580671538570896e-12
% O 0 4.876212823280712e-13
CI O 0 1.988194497926088e-08
43 O 0 3.706502552797142e-12
% O 0 3.032835755537727e-13
- O 0 2.958315814538537e-10
95 O 0 2.4463233088550806e-12
% O 0 2.4924679697556004e-14
) O 0 1.5516985025582292e-15
by O 0 6.791477136800037e-15
age O 0 3.557548353128048e-11
70 O 0 7.335113961538797e-13
years O 0 6.378889387190223e-13
. O 0 2.5412893902947153e-13

The O 0 2.2671456725853467e-11
corresponding O 0 5.439538199425442e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 4.4582338887266815e-07
were O 0 5.900931826507971e-11
0 O 0 3.813437846750256e-12
. O 0 1.5168054529404729e-12

4 O 0 5.346372997094839e-11
% O 0 8.402806987543865e-13
( O 0 3.4213877933043924e-13
95 O 0 2.513476189333619e-12
% O 0 4.866020238657176e-13
CI O 0 9.404077516705911e-09
0 O 0 3.03559044220747e-13
% O 0 1.593654353447549e-12
- O 0 1.2133062332608802e-09
1 O 0 4.338829913842074e-13
% O 0 5.5897062830158675e-14
) O 0 2.7691034352026096e-16
by O 0 1.6727047823700313e-16
age O 0 6.996647998382816e-14
50 O 0 5.3724562869129455e-16
years O 0 5.080431619830777e-16
and O 0 1.7468049451315116e-16
27 O 0 3.1683701496432572e-15
% O 0 2.7248626396697215e-16
( O 0 7.440279810441361e-15
95 O 0 8.047876059145975e-13
% O 0 1.8834646299190072e-13
CI O 0 6.752773451523808e-09
0 O 0 3.419678548579469e-13
% O 0 1.3966086316943849e-12
- O 0 1.4574567108738279e-09
47 O 0 5.1890436392199035e-11
% O 0 3.960128394913526e-14
) O 0 1.1670508885729212e-15
by O 0 3.913668722459922e-15
age O 0 7.207695551514348e-11
70 O 0 1.1591949188732853e-12
years O 0 4.770146408948628e-13
. O 0 3.5157090455019413e-13

The O 0 5.380135356322646e-13
lifetime O 0 2.5516228019384357e-11
risk O 0 7.456820716456036e-10
of O 0 8.993955753766603e-14
breast B-Disease 0 6.762351745237538e-07
cancer I-Disease 0 6.023455512149667e-09
appears O 0 6.921620828576058e-12
similar O 0 2.403089561381095e-14
to O 0 9.672982426438444e-15
the O 0 4.497344472742873e-14
risk O 0 2.460145585511664e-12
in O 0 2.098612048842454e-14
BRCA1 O 0 5.170667019549491e-11
carriers O 0 1.657799938992177e-11
, O 0 1.4318124322895004e-13
but O 0 1.1880789050049828e-13
there O 0 3.940814434353528e-15
was O 0 2.871391546841601e-14
some O 0 4.172308935884822e-17
suggestion O 0 2.4111058811939097e-14
of O 0 5.845444249220075e-16
a O 0 3.429074732497206e-11
lower O 0 1.9660623351569484e-08
risk O 0 1.0769952638045588e-11
in O 0 1.2896769156084398e-13
BRCA2 O 0 1.9390020700171817e-09
carriers O 0 3.1786424187219e-11
< O 0 2.0813162304733623e-10
50 O 0 7.922727686578146e-13
years O 0 4.5389701112258374e-13
of O 0 7.497147061421173e-15
age O 0 1.0313677863138526e-11
. O 0 2.462708856287854e-12

Eye B-Disease 1 0.999659538269043
movement I-Disease 0 1.5709392187090998e-07
abnormalities I-Disease 0 0.011686526238918304
correlate O 0 2.1372098535366035e-10
with O 0 1.73197448136847e-13
genotype O 0 2.33510036196094e-07
in O 0 4.6331372072216936e-10
autosomal O 0 0.0006399514386430383
dominant O 0 6.176180249894969e-06
cerebellar B-Disease 0 0.0002915153745561838
ataxia I-Disease 1 0.9998735189437866
type I-Disease 1 1.0
I I-Disease 1 0.9999997615814209
. O 0 3.878558585412861e-10

We O 0 1.8648614596994406e-10
compared O 0 3.2501262098305617e-11
horizontal O 0 2.906389084955663e-08
eye O 1 0.8688709735870361
movements O 0 5.648282126458071e-07
( O 0 8.957589531233268e-11
visually O 0 1.1281739431545645e-10
guided O 0 5.38907599101357e-11
saccades O 0 1.851342723568905e-08
, O 0 2.4269188004730213e-13
antisaccades O 0 4.839352807373132e-10
, O 0 2.1335763830589854e-14
and O 0 4.561634951065832e-15
smooth O 0 1.626136562644237e-13
pursuit O 0 4.031980099187399e-13
) O 0 2.4611848407278362e-14
in O 0 1.8231816338760976e-13
control O 0 5.572690312677375e-12
subjects O 0 1.5107624352916904e-12
( O 0 1.6533835119156987e-13
n O 0 3.255636038534959e-11
= O 0 2.740491722441618e-10
14 O 0 1.7463962567743074e-11
) O 0 2.3674370298355785e-13
and O 0 6.078425523331488e-13
patients O 0 4.233495403739053e-14
with O 0 1.480769432627922e-17
three O 0 1.8318940368946364e-15
forms O 0 3.3590925180293496e-13
of O 0 3.29300361935278e-13
autosomal O 0 4.7798766900086775e-06
dominant O 0 7.687664265176863e-07
cerebellar B-Disease 0 1.0246037163597066e-05
ataxias I-Disease 1 0.8812039494514465
type I-Disease 1 0.9999517202377319
I I-Disease 0 0.3743407726287842
spinocerebellar B-Disease 0 0.03023802861571312
ataxias I-Disease 0 0.00016524718375876546
1 I-Disease 0 7.385760059097635e-11
and I-Disease 0 9.85629004628119e-13
2 I-Disease 0 2.3341186839234696e-13
( O 0 1.5864877770874197e-12
SCA1 B-Disease 0 1.1555416179476197e-08
, O 0 8.052709025855101e-14
n O 0 2.681601295184688e-11
= O 0 1.1633601026961315e-10
11 O 0 1.1799990238398061e-12
; O 0 1.9472890368330692e-13
SCA2 B-Disease 0 3.907236312272744e-09
, O 0 9.532834726678e-14
n O 0 2.5788558788431004e-11
= O 0 1.899380375203208e-10
10 O 0 1.3300632296930903e-12
) O 0 6.354141388401069e-13
and O 0 1.664740012508048e-10
SCA3 B-Disease 1 1.0
/ O 0 3.3121273190772627e-07
Machado B-Disease 0 3.7703980382275404e-08
- I-Disease 0 4.12269649530117e-08
Joseph I-Disease 0 2.5799963054851105e-08
disease I-Disease 0 7.701004847149306e-07
( O 0 8.456770873854769e-12
MJD B-Disease 1 1.0
) O 0 2.4849455717949887e-13
( O 0 6.923373549808098e-13
n O 0 5.498189126207365e-10
= O 0 1.01490691406525e-08
16 O 0 7.226020337647299e-10
) O 0 1.3443209219421437e-11
. O 0 2.979538490932576e-11

In O 0 1.5995485491693273e-10
SCA1 B-Disease 0 1.4291586580839066e-08
, O 0 1.905291008785174e-14
saccade O 0 7.377649879902748e-11
amplitude O 0 4.4645531846118636e-13
was O 0 8.371037153384608e-13
significantly O 0 2.9933656464989356e-13
increased O 0 1.1000326084059653e-13
, O 0 8.980305987228189e-15
resulting O 0 1.6514350650864706e-14
in O 0 2.022468997830984e-11
hypermetria B-Disease 0 6.903096618771087e-07
. O 0 3.8318133388504094e-11

The O 0 1.3676483990449073e-12
smooth O 0 3.07094280560527e-11
pursuit O 0 1.4049130782345376e-11
gain O 0 9.53398693326335e-09
was O 0 1.1847163250422454e-09
decreased O 0 1.8787862376967723e-09
. O 0 2.1062574427632708e-12

In O 0 2.1388939230870818e-10
SCA2 B-Disease 0 4.249250906696034e-08
, O 0 1.397945751128657e-13
saccade O 0 1.0472508416015103e-09
velocity O 0 8.202764856246603e-11
was O 0 9.540416373576832e-11
markedly O 0 1.9147542218433955e-08
decreased O 0 1.0836229691335575e-09
. O 0 4.074035813567134e-12

The O 0 1.0676151802890832e-12
percentage O 0 1.8229374953993016e-10
of O 0 3.38639071279412e-15
errors O 0 1.850010145076908e-10
in O 0 7.986374148810649e-13
antisaccades O 0 4.815140286495989e-09
was O 0 5.430964922573112e-13
greatly O 0 1.9781192404032776e-14
increased O 0 5.1679475721608595e-14
and O 0 4.671414656194726e-15
was O 0 7.806214137281216e-15
significantly O 0 8.24739717708925e-15
correlated O 0 1.0192648998040219e-14
with O 0 3.3381274107342805e-15
age O 0 3.4367335366436436e-12
at O 0 5.331716405182485e-12
disease O 0 1.049155623489284e-10
onset O 0 2.7683938474964975e-10
. O 0 9.604607040247792e-12

In O 0 2.7402067160481325e-12
addition O 0 1.6039232930090824e-14
, O 0 8.037156823317154e-16
a O 0 9.764288766504195e-16
correlation O 0 1.0442806965297799e-13
between O 0 3.7860024766937436e-14
smooth O 0 5.247554561021994e-12
pursuit O 0 1.6704890509061654e-12
gain O 0 4.056541325070384e-09
and O 0 1.703504741781825e-12
the O 0 8.275950657741192e-15
number O 0 2.07882027699691e-14
of O 0 4.667281982445072e-15
trinucleotide O 0 3.5610143722664134e-09
repeats O 0 1.0953951079528679e-09
was O 0 3.143841853514573e-10
found O 0 2.447715467812639e-11
. O 0 2.717420255829439e-12

In O 0 2.5440359152639758e-08
SCA3 B-Disease 1 1.0
, O 0 8.157533676333983e-11
gaze B-Disease 0 1.8209675545222126e-06
- I-Disease 0 4.321628210846029e-08
evoked I-Disease 0 3.677178284089422e-10
nystagmus I-Disease 0 4.818466070588556e-09
was O 0 2.189760308843325e-12
often O 0 6.455306277177277e-15
present O 0 5.765498103284662e-16
as O 0 8.48773599960908e-15
was O 0 1.37362126881313e-13
saccade O 0 2.0540255607492952e-10
hypometria O 0 4.16267553760008e-09
and O 0 4.745852690869745e-13
smooth O 0 1.0275623234246023e-11
pursuit O 0 3.1789805163273677e-12
gain O 0 3.6260792146691756e-09
was O 0 4.096715189305655e-10
markedly O 0 2.9075811980305843e-08
decreased O 0 9.482331586596615e-10
. O 0 1.2051788603542612e-12

Three O 0 2.0547953529653773e-12
major O 0 6.163251332902409e-13
criteria O 0 3.04439226649425e-13
, O 0 1.2472052987342404e-15
saccade O 0 3.133824102996563e-11
amplitude O 0 3.073664369898643e-13
, O 0 1.5580517155307574e-14
saccade O 0 2.7972613808602276e-11
velocity O 0 2.9321462792497588e-12
, O 0 9.244035116366678e-14
and O 0 2.9353200456345508e-15
presence O 0 3.4625748042459506e-14
of O 0 4.904940115093431e-14
gaze B-Disease 0 3.134007420158014e-05
- I-Disease 0 5.845301132012537e-08
evoked I-Disease 0 1.7194856649638268e-10
nystagmus I-Disease 0 2.0094542696469375e-10
, O 0 1.2539413282472802e-15
permitted O 0 1.628698985540447e-15
the O 0 2.5414794771935734e-16
correct O 0 1.7207700108573531e-12
assignment O 0 4.955826873008495e-13
of O 0 2.3505637433617215e-17
90 O 0 5.585962905608772e-15
% O 0 1.0813939406280012e-15
of O 0 4.440264830898515e-17
the O 0 2.268940591304753e-15
SCA1 B-Disease 0 9.683006479965783e-11
, O 0 2.946224324281029e-15
90 O 0 7.844005359255914e-15
% O 0 1.5112846548205952e-15
of O 0 8.59334843498638e-17
the O 0 5.643750457885776e-15
SCA2 B-Disease 0 1.5733696567821198e-09
, O 0 3.369099170450634e-15
and O 0 1.873277102082166e-15
93 O 0 1.7252180722427193e-14
% O 0 2.2279685488548785e-15
of O 0 1.0897209891835602e-16
the O 0 1.5170036518738668e-14
patients O 0 6.353826427669962e-13
with O 0 1.986797092947898e-14
SCA3 B-Disease 1 1.0
to O 0 1.6122291286832686e-14
their O 0 1.4292462316263456e-15
genetically O 0 5.391674520044409e-12
confirmed O 0 2.532669213239913e-11
patient O 0 1.3400208720426576e-10
group O 0 3.583560314809886e-13
and O 0 5.797806896037927e-13
, O 0 2.352320947621514e-14
therefore O 0 3.22171183773836e-14
, O 0 2.286346025698327e-13
may O 0 7.705990706652344e-11
help O 0 9.490699892644727e-12
orient O 0 6.196339199959766e-06
diagnoses O 0 1.2145905202487484e-05
of O 0 1.2422108324882265e-14
SCA1 B-Disease 0 2.778081764631679e-08
, O 0 3.509833211828156e-13
SCA2 B-Disease 0 7.497084730800907e-09
, O 0 1.1262888001796825e-13
and O 0 8.514627804906416e-13
SCA3 B-Disease 1 1.0
at O 0 6.464097920128031e-13
early O 0 1.1940245884037304e-12
clinical O 0 2.943042673713564e-13
stages O 0 4.515471994253652e-14
of O 0 1.6838443244176094e-16
the O 0 3.969733070909032e-14
diseases O 0 8.875286283682726e-09
. O 0 3.418120279007064e-13
. O 0 2.7302524390621086e-12

Genetic O 0 1.8597058115688014e-08
basis O 0 9.058150063356862e-11
and O 0 2.163756505782835e-13
molecular O 0 3.284889721344442e-11
mechanism O 0 2.472657856245064e-09
for O 0 7.671271617937236e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 1.862652680983956e-07

Ventricular B-Disease 1 0.9999557733535767
fibrillation I-Disease 1 0.9995177984237671
causes O 0 1.635998780891157e-09
more O 0 1.0133723965218347e-13
than O 0 9.714101640862904e-15
300 O 0 7.927088279953247e-15
, O 0 5.46010397404215e-15
000 O 0 3.674618321756161e-14
sudden O 0 3.615967388796021e-13
deaths O 0 1.927475106605625e-13
each O 0 1.0294749502469305e-15
year O 0 8.08431186577474e-12
in O 0 1.8937282297848412e-12
the O 0 1.6802408260314233e-13
USA O 0 4.961606236975058e-09
alone O 0 1.1245367831369535e-10
. O 0 5.100248348655079e-12

In O 0 7.423701410547157e-13
approximately O 0 4.3424868600072317e-14
5 O 0 4.629658744044474e-13
- O 0 9.29967658436226e-09
12 O 0 1.6486986472233345e-12
% O 0 1.0121279695970466e-14
of O 0 3.9300618143092776e-17
these O 0 2.468139923548948e-16
cases O 0 1.029377287348112e-14
, O 0 1.1756741869017824e-16
there O 0 1.31603551366548e-15
are O 0 1.2480430143190749e-15
no O 0 5.423128851371473e-13
demonstrable O 0 9.192876859742682e-07
cardiac O 0 1.2193084764078321e-08
or O 0 6.212405589955949e-10
non O 1 0.970268964767456
- O 1 0.9999866485595703
cardiac O 0 0.00012817050446756184
causes O 0 8.722871383537445e-12
to O 0 4.020213185246778e-14
account O 0 4.2200100293550424e-13
for O 0 1.1370931331735495e-15
the O 0 1.0754369696681985e-15
episode O 0 2.2107474271365612e-12
, O 0 2.5376747957769202e-14
which O 0 7.341121792591918e-16
is O 0 2.3775378384392797e-16
therefore O 0 2.0813435881467807e-14
classified O 0 9.165697645308057e-10
as O 0 6.04484213795331e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999994039535522
fibrillation I-Disease 1 1.0
( O 0 1.5128845006984193e-05
IVF B-Disease 1 1.0
) O 0 2.2572841373857955e-09
. O 0 8.740496520998065e-11

A O 0 4.7344652503999995e-11
distinct O 0 9.301011349993615e-12
group O 0 5.0852989354199796e-12
of O 0 1.341614672004457e-13
IVF B-Disease 1 1.0
patients O 0 6.0293179338088976e-09
has O 0 8.534423608628789e-15
been O 0 3.4192185334561446e-15
found O 0 2.079177216680883e-14
to O 0 5.932425533178027e-16
present O 0 7.6452738538964e-16
with O 0 1.8336838175121847e-15
a O 0 2.332557758055742e-12
characteristic O 0 1.7882550995551583e-10
electrocardiographic O 0 1.9758870166697307e-06
pattern O 0 3.3199512472492643e-07
. O 0 5.738811648114961e-10

Because O 0 5.140760213351303e-12
of O 0 3.4010310420127003e-16
the O 0 6.016266574832932e-17
small O 0 7.253882587101527e-15
size O 0 4.35445760395628e-13
of O 0 9.549677087449557e-16
most O 0 1.7073185720013415e-14
pedigrees O 0 2.551832183061986e-11
and O 0 2.1509368315327307e-15
the O 0 3.8473657891454933e-16
high O 0 4.981055932301581e-12
incidence O 0 1.092750681608301e-10
of O 0 7.176544921478831e-14
sudden B-Disease 0 4.987877333384461e-10
death I-Disease 0 3.376858168091523e-11
, O 0 7.497490109764811e-15
however O 0 4.015276253713706e-15
, O 0 1.206662225532591e-16
molecular O 0 4.920501634993798e-15
genetic O 0 7.270955755880881e-13
studies O 0 8.811060388247416e-12
of O 0 5.583558179071517e-14
IVF B-Disease 1 1.0
have O 0 4.8336123298353684e-11
not O 0 1.3253673603486754e-13
yet O 0 8.312601475213288e-12
been O 0 7.802103581255881e-12
done O 0 3.176933022208672e-11
. O 0 2.3176701443444747e-12

Because O 0 1.2803957893936513e-08
IVF B-Disease 1 1.0
causes O 0 4.742842065752484e-07
cardiac O 0 0.0019378064898774028
rhythm O 0 0.00022280478151515126
disturbance O 0 3.283516392116326e-08
, O 0 1.1974702642230522e-13
we O 0 3.559794874239547e-15
investigated O 0 4.3681058797167063e-14
whether O 0 9.048461646296059e-15
malfunction O 0 5.954401971486334e-10
of O 0 2.9517798545633923e-16
ion O 0 4.62953514499681e-13
channels O 0 3.025219796892742e-10
could O 0 1.7666545559791302e-08
cause O 0 3.445595891937714e-11
the O 0 6.26597081512803e-13
disorder O 0 5.525899529623679e-11
by O 0 9.582990628567272e-17
studying O 0 1.0920447489001783e-13
mutations O 0 1.5991443195681465e-12
in O 0 3.166542549004614e-13
the O 0 1.1960412857597164e-13
cardiac O 0 7.486459369099308e-11
sodium O 0 2.0265506286976098e-11
channel O 0 5.909881917176563e-09
gene O 0 5.693179332411091e-07
SCN5A O 0 1.3273373042466119e-05
. O 0 1.4206343046385683e-10

We O 0 6.484538600526335e-12
have O 0 1.4905364133710117e-14
now O 0 2.826943238824547e-15
identified O 0 1.4806367666219539e-13
a O 0 8.906092687334735e-14
missense O 0 4.3932526949674866e-08
mutation O 0 7.646940719530093e-11
, O 0 3.5768816294273753e-13
a O 0 5.701380665322497e-13
splice O 0 6.360644420055905e-07
- O 0 1.8819575231532326e-08
donor O 0 1.650733882918587e-09
mutation O 0 4.219825378015685e-09
, O 0 5.1420371433019696e-11
and O 0 5.487390056235775e-13
a O 0 1.4945347476952309e-12
frameshift O 0 3.989420065408922e-07
mutation O 0 2.0748385648472478e-11
in O 0 8.037996808950287e-13
the O 0 1.4101756024562703e-14
coding O 0 1.2133356819266083e-10
region O 0 7.569922987060718e-12
of O 0 1.6189506061702746e-13
SCN5A O 0 1.2595432963280473e-07
in O 0 8.234818209273964e-12
three O 0 1.3659076474048515e-11
IVF B-Disease 1 1.0
families O 0 9.472290139755923e-12
. O 0 1.1339241177965587e-12

We O 0 2.803525423963893e-12
show O 0 2.1689493259692723e-14
that O 0 3.499191374164286e-17
sodium O 0 1.4755262325099689e-16
channels O 0 8.469111100351673e-14
with O 0 1.6899713372415734e-15
the O 0 1.8363308378240017e-14
missense O 0 7.743127028447816e-09
mutation O 0 3.851119770303946e-11
recover O 0 8.781708138450028e-10
from O 0 6.73704866308196e-14
inactivation O 0 3.1245893459402874e-12
more O 0 2.058231166568336e-16
rapidly O 0 9.342602307559587e-15
than O 0 2.170089278791555e-16
normal O 0 2.8811453006358234e-14
and O 0 5.430171947268551e-15
that O 0 9.316722909922127e-16
the O 0 6.181897170814271e-14
frameshift O 0 2.05808055397938e-06
mutation O 0 6.872123703427491e-11
causes O 0 1.1095896337159905e-12
the O 0 3.458680485567654e-14
sodium O 0 5.567365145286995e-13
channel O 0 2.3885525501921023e-11
to O 0 8.892683139340163e-14
be O 0 2.9096153654831203e-13
non O 0 3.2684671635863083e-10
- O 0 1.5560086552568464e-10
functional O 0 2.2783904971013236e-11
. O 0 1.2325809643776164e-11

Our O 0 1.6688839980100179e-12
results O 0 1.4013496038491752e-13
indicate O 0 1.7691318516480786e-13
that O 0 5.07017320380658e-15
mutations O 0 3.353566868646851e-10
in O 0 2.3290024422917277e-11
cardiac O 0 1.377246372502583e-10
ion O 0 9.145588800163473e-12
- O 0 6.366898674947663e-11
channel O 0 3.7743856651228924e-11
genes O 0 2.3435694357365477e-11
contribute O 0 5.979290955589189e-14
to O 0 1.3281091212956429e-15
the O 0 1.3400277218964581e-15
risk O 0 8.293430368453911e-14
of O 0 1.320565922323429e-16
developing O 0 3.4648245644114395e-12
IVF B-Disease 1 1.0
. O 0 1.838330269260391e-12
. O 0 1.8130428798904252e-12

Molecular O 0 6.011263709027048e-10
heterogeneity O 0 1.4913449364328812e-09
in O 0 2.6087918283956846e-11
mucopolysaccharidosis B-Disease 0 9.420435276297212e-08
IVA I-Disease 0 2.578499049832317e-07
in O 0 6.161471333143709e-11
Australia O 0 2.5941826811703983e-12
and O 0 1.837956802269551e-14
Northern O 0 2.781686990124821e-12
Ireland O 0 1.8910147048245562e-07
: O 0 4.863224758880694e-14
nine O 0 1.8494666247700214e-14
novel O 0 2.9919141708405206e-14
mutations O 0 3.7719493869471654e-13
including O 0 1.230031006926478e-14
T312S O 0 3.874918788615567e-11
, O 0 5.9678371219665325e-15
a O 0 6.639368230681531e-15
common O 0 1.9868324650437752e-13
allele O 0 1.47493059432513e-11
that O 0 1.1130525212448006e-13
confers O 0 7.980596045120691e-11
a O 0 3.5022218458635734e-10
mild O 0 0.008036326617002487
phenotype O 0 7.608174200868234e-06
. O 0 9.7965546785872e-10

Mucopolysaccharidosis B-Disease 0 2.1204614313319325e-05
IVA I-Disease 0 0.006598935928195715
( O 0 0.0003456633712630719
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.43884218376067e-11
is O 0 1.5896551924191732e-13
an O 0 7.98853821634693e-13
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 0.9999997615814209
lysosomal I-Disease 1 0.9999992847442627
storage I-Disease 1 0.999990701675415
disorder I-Disease 1 0.9999995231628418
caused O 0 1.1571675041788243e-11
by O 0 1.793655454468846e-14
a O 0 1.0246360204746452e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 7.68732820455309e-12
N O 0 1.7777407324004457e-09
- O 0 1.6000681890560031e-09
acetylgalactosamine O 0 1.341034203505842e-05
- O 0 2.8192856049713555e-08
6 O 0 2.8378957517283254e-10
- O 0 1.482109102113327e-09
sulfate O 0 8.91627494059577e-10
sulfatase O 0 8.341460500105313e-08
( O 0 1.3957945042830655e-11
GALNS O 0 5.421643223257888e-08
) O 0 7.1373202487068355e-12
. O 0 7.52820982635738e-12

Previous O 0 5.278888090542999e-11
studies O 0 2.140219251822728e-11
of O 0 1.4003462086198577e-15
patients O 0 2.999147832210072e-14
from O 0 2.5515239644590293e-16
a O 0 1.611528124216121e-14
British O 0 1.6460169338650132e-10
- O 0 6.201395508220742e-10
Irish O 0 1.2883800797058864e-11
population O 0 9.514551689918105e-16
showed O 0 4.663498320151005e-12
that O 0 2.1945894420930895e-16
the O 0 1.1066583923457552e-15
I113F O 0 4.546703638586003e-11
mutation O 0 2.7682733492670475e-13
is O 0 1.8550238385303675e-14
the O 0 3.5641817637524953e-16
most O 0 2.212671980860413e-15
common O 0 2.6987347225655364e-14
single O 0 2.6074761382173517e-13
mutation O 0 5.650364204301539e-11
among O 0 3.16695540902856e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 1 0.7297157645225525
and O 0 1.3983999505237654e-12
produces O 0 3.365372867533689e-12
a O 0 1.1957162690534595e-11
severe O 0 3.327723732127197e-07
clinical O 0 9.02244856604284e-09
phenotype O 0 3.5874953141501464e-07
. O 0 4.3639261648742433e-10

We O 0 3.283511657015126e-11
studied O 0 3.7951034675964834e-11
mutations O 0 7.250490572513479e-12
in O 0 2.663588750603796e-13
the O 0 8.233817544878869e-15
GALNS O 0 2.492102080253744e-10
gene O 0 6.547824348696052e-12
from O 0 6.712219755705684e-13
23 O 0 1.964311742777558e-12
additional O 0 3.711782270432451e-11
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 5.281555104375002e-07
( O 0 1.8334071240355687e-12
15 O 0 6.305267180768681e-14
from O 0 3.193617787757008e-14
Australia O 0 4.002938659795202e-13
, O 0 3.788225684070402e-15
8 O 0 2.9552291315432895e-15
from O 0 6.061886154715493e-15
Northern O 0 9.063887834726003e-11
Ireland O 0 1.1568026820896193e-06
) O 0 4.90049136252918e-13
, O 0 1.1196868390415341e-14
with O 0 5.4115760403607423e-17
various O 0 1.4678701505156655e-14
clinical O 0 1.4017013244549403e-11
phenotypes O 0 5.665829264089872e-11
( O 0 5.7469144026933705e-11
severe O 0 3.806141467066482e-05
, O 0 4.949594553660397e-12
16 O 0 6.565554306822707e-13
cases O 0 1.3038417459414198e-13
; O 0 9.122178076662654e-15
intermediate O 0 6.348375059146705e-13
, O 0 4.158395768569592e-14
4 O 0 1.8585060248578478e-13
cases O 0 2.5967878888866203e-11
; O 0 1.6723197479584506e-11
mild O 1 0.894631028175354
, O 0 5.323125273903884e-10
3 O 0 1.2323389704527177e-11
cases O 0 3.6977625822443017e-11
) O 0 9.93734608489838e-13
. O 0 1.9906199952290926e-11

We O 0 1.7910804783749512e-11
found O 0 2.658939149587092e-13
two O 0 7.654086172921397e-16
common O 0 1.4292081151437192e-15
mutations O 0 5.166370735626251e-14
that O 0 3.0910678052944616e-16
together O 0 5.75732211776129e-16
accounted O 0 7.848558500160585e-14
for O 0 4.0222037126728255e-16
32 O 0 1.3882288602082987e-13
% O 0 2.681228753831453e-14
of O 0 1.7893217374491616e-15
the O 0 9.979812657691378e-14
44 O 0 7.75242012512195e-13
unrelated O 0 6.80606352526647e-12
alleles O 0 6.007693040960271e-12
in O 0 6.663512103211033e-11
these O 0 1.3510756098969456e-12
patients O 0 9.720825706882597e-12
. O 0 7.245538262250217e-13

One O 0 4.298953987930121e-12
is O 0 1.8176842545231456e-14
the O 0 3.2192960997727907e-15
T312S O 0 2.4501453643743787e-10
mutation O 0 3.8578376604370135e-12
, O 0 2.302920224309113e-13
a O 0 4.626963891782125e-14
novel O 0 8.27592660200549e-13
mutation O 0 8.845288867673218e-13
found O 0 9.5622316488575e-13
exclusively O 0 2.421846089558505e-13
in O 0 6.050205475505166e-12
milder O 0 1.959501787496265e-06
patients O 0 3.462697861777997e-08
. O 0 3.7104229411166756e-11

The O 0 2.0336267663335211e-13
other O 0 3.5495027886556967e-15
is O 0 5.165399612352224e-16
the O 0 1.1979572414638789e-16
previously O 0 1.5206342044923882e-13
described O 0 1.7691655974406972e-13
I113F O 0 2.135399496117074e-11
that O 0 1.072196856886714e-15
produces O 0 2.4038976646940935e-13
a O 0 1.2904704214944385e-11
severe O 0 9.453338378762055e-08
phenotype O 0 7.163136217513966e-08
. O 0 4.3927955717393274e-10

The O 0 1.9141368177988394e-12
I113F O 0 2.2293780155280274e-09
and O 0 1.7074235363241652e-13
T312S O 0 2.076342917045615e-11
mutations O 0 4.3276883812670697e-13
accounted O 0 5.038192627850047e-13
for O 0 7.867401494520042e-17
8 O 0 4.2409283719610936e-15
( O 0 1.5182490952381916e-13
18 O 0 2.4767498165226276e-13
% O 0 3.639530744245804e-15
) O 0 3.0120101969207183e-15
and O 0 2.9231140891063795e-14
6 O 0 2.1065406160419332e-14
( O 0 1.7579073776068793e-13
14 O 0 2.5235144377779017e-13
% O 0 1.5064936670643354e-14
) O 0 1.0125565682683572e-14
of O 0 2.8095055832976596e-15
44 O 0 1.3343846698172374e-13
unrelated O 0 3.6283287572352885e-12
alleles O 0 1.582650330234081e-11
, O 0 1.3410736063312889e-11
respectively O 0 6.350320269632448e-11
. O 0 2.6923123452871067e-11

The O 0 9.60200126874644e-13
relatively O 0 5.029112543075698e-12
high O 0 1.108240669372984e-11
residual O 0 2.5969723593810556e-10
GALNS O 0 6.680585897811397e-07
activity O 0 1.0550634671480097e-10
seen O 0 6.3822519318079696e-12
when O 0 1.796606856070259e-14
the O 0 4.629157347126511e-16
T312S O 0 1.4488872341483772e-12
mutant O 0 1.0570525574640777e-12
cDNA O 0 1.0406947872909633e-11
is O 0 1.4596180167303352e-13
overexpressed O 0 2.568739387864838e-10
in O 0 1.8401781292330666e-13
mutant O 0 6.3625133807365675e-12
cells O 0 8.808300768457789e-13
provides O 0 6.9327224218535335e-15
an O 0 5.624057894774179e-17
explanation O 0 8.796476459564662e-14
for O 0 1.4226914671640182e-15
the O 0 7.634032159675383e-14
mild O 0 1.7664162044184195e-07
phenotype O 0 2.0009732537573655e-08
in O 0 1.0165100705616936e-10
patients O 0 4.317716670310112e-11
with O 0 1.2836727140914982e-15
this O 0 2.5827703216689708e-14
mutation O 0 9.117395033397813e-11
. O 0 9.678612772345829e-11

The O 0 7.280416232987447e-14
distribution O 0 9.909177563780305e-14
and O 0 2.427365398594461e-15
relative O 0 8.697340231637787e-15
frequencies O 0 1.2637388694097113e-13
of O 0 6.859272806865324e-16
the O 0 2.408182770492935e-14
I113F O 0 2.93304991405563e-10
and O 0 1.0887628689240647e-13
T312S O 0 1.5813196238556593e-11
mutations O 0 7.784366684235322e-13
in O 0 8.911410698990777e-14
Australia O 0 2.6541785872542974e-15
corresponded O 0 3.8139483806126206e-15
to O 0 8.081916558879134e-17
those O 0 2.463651575370786e-17
observed O 0 4.359303767438724e-16
in O 0 1.1212640143893216e-14
Northern O 0 7.699683772510735e-12
Ireland O 0 2.249073247639899e-07
and O 0 1.3033718798249189e-13
are O 0 4.7197003384532186e-17
unique O 0 1.3940129101860128e-17
to O 0 5.013089324150508e-16
these O 0 6.930731947367045e-17
two O 0 2.0911701603046877e-16
populations O 0 1.2015596461187718e-15
, O 0 2.8753524423095513e-15
suggesting O 0 1.0959383221894811e-13
that O 0 5.34282178046207e-16
both O 0 2.6557686798545305e-15
mutations O 0 6.934038304477752e-13
were O 0 6.408550773384647e-12
probably O 0 9.0455366721226e-13
introduced O 0 1.0445256584581258e-13
to O 0 9.486173968602718e-16
Australia O 0 2.595197989071086e-15
by O 0 5.538030581673072e-16
Irish O 0 7.723998524111764e-12
migrants O 0 7.830533964303665e-12
during O 0 1.847774083534818e-14
the O 0 6.834016931356161e-16
19th O 0 1.795099138779399e-11
century O 0 7.810821989195915e-10
. O 0 3.6682025472689617e-11

Haplotype O 0 4.0719393723520625e-07
analysis O 0 1.4507633983029677e-10
using O 0 8.053300214194703e-12
6 O 0 3.1324899271711892e-12
RFLPs O 0 1.0528020122357873e-10
provides O 0 1.4152150588572776e-13
additional O 0 2.01173204884917e-14
data O 0 4.596092928986495e-13
that O 0 1.4744458684555256e-16
the O 0 3.867217012116023e-15
I113F O 0 5.962319526986448e-11
mutation O 0 2.892588783515865e-13
originated O 0 4.08937467222259e-11
from O 0 1.6077136366990374e-12
a O 0 3.509317673695139e-13
common O 0 4.31001100694578e-13
ancestor O 0 1.4200077745607498e-11
. O 0 5.3551094114645537e-11

The O 0 6.147753747048901e-13
other O 0 7.148034470100609e-14
9 O 0 1.557675158563726e-13
novel O 0 2.4614820815296867e-13
mutations O 0 1.4916307772283588e-11
identified O 0 6.04667843573381e-11
in O 0 4.0128455571462884e-13
these O 0 2.7396747048183574e-15
23 O 0 3.676104695172003e-14
patients O 0 1.8809183133542892e-14
were O 0 3.5849626583221955e-16
each O 0 3.4040256508971015e-18
limited O 0 9.926916127761705e-15
to O 0 1.7374097562657294e-14
a O 0 5.6136692516695064e-11
single O 0 8.901997194943334e-11
family O 0 1.3202122728372956e-10
. O 0 6.177863776102299e-11

These O 0 1.2965037301127663e-13
data O 0 1.2885016404534655e-13
provide O 0 1.2800445543410528e-15
further O 0 7.179220973844915e-16
evidence O 0 1.2174688306923389e-14
for O 0 1.4063090823405116e-16
extensive O 0 1.785941322130294e-13
allelic O 0 1.7629803172880543e-10
heterogeneity O 0 1.6807700786714008e-09
in O 0 9.847218507275102e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 6.857534071841309e-12
British O 0 6.194019186445132e-10
- O 0 1.530306725783248e-08
Irish O 0 2.6344246228937607e-10
patients O 0 5.123587643561522e-13
and O 0 3.46025896058162e-17
provide O 0 2.5776727979830556e-17
evidence O 0 9.293934547267434e-16
for O 0 1.0741901768745096e-16
their O 0 4.084390754077868e-16
transmission O 0 9.082742153873613e-13
to O 0 3.4256159615485195e-15
Australia O 0 3.772967232558563e-15
by O 0 3.669249848112287e-16
British O 0 9.461700312130006e-10
- O 0 6.555904152882874e-10
Irish O 0 4.956531365896133e-11
migrants O 0 1.4806136872103082e-10
. O 0 4.2000050762573335e-14
. O 0 3.14656016086462e-13

Identification O 0 3.1453170623585436e-10
of O 0 1.4756599737183844e-14
constitutional O 0 2.7051071885969558e-12
WT1 O 0 1.8177937377572562e-08
mutations O 0 9.232442588213985e-10
, O 0 2.039960214639258e-12
in O 0 1.414867572060996e-12
patients O 0 1.3711222912257681e-12
with O 0 2.4609864656115893e-15
isolated O 0 1.1629402507651321e-07
diffuse B-Disease 1 0.9717571139335632
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 7.26546947604767e-12
and O 0 1.7706356612371397e-15
analysis O 0 1.6955578583418944e-14
of O 0 1.6716786019544327e-15
genotype O 0 7.235929047055834e-07
/ O 0 4.75301646929438e-07
phenotype O 0 2.1214283663084643e-09
correlations O 0 1.247503489398838e-10
by O 0 5.811651446272891e-15
use O 0 3.6320382465482304e-13
of O 0 2.4721268546921147e-15
a O 0 1.303178593682619e-12
computerized O 0 4.995763802639885e-09
mutation O 0 9.423621605275656e-11
database O 0 3.623527922158587e-09
. O 0 1.2933042657647942e-11

Constitutional O 0 5.887893506084652e-10
mutations O 0 4.552276888780682e-10
of O 0 9.781331492919425e-15
the O 0 3.787618784963694e-15
WT1 O 0 8.979473276049532e-10
gene O 0 2.414183436494355e-11
, O 0 2.247363401061339e-14
encoding O 0 1.7426819536037197e-12
a O 0 1.1907586461995523e-12
zinc O 0 1.1494268619571812e-05
- O 0 2.744564881140832e-06
finger O 0 6.898977062519407e-06
transcription O 0 6.221017478935664e-09
factor O 0 4.229593671828402e-12
involved O 0 3.5806240784863608e-12
in O 0 7.025038328833944e-10
renal O 0 4.964893562942052e-08
and O 0 1.5595151851757055e-13
gonadal O 0 3.3958233447428654e-10
development O 0 1.925222812117558e-13
, O 0 1.4151549703399994e-14
are O 0 3.385252671089925e-16
found O 0 3.861897306394087e-14
in O 0 1.1864477736584552e-14
most O 0 7.261797157081553e-16
patients O 0 1.1157210096066658e-15
with O 0 9.0498027112098e-16
Denys B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.763651529377967e-07
DDS B-Disease 1 1.0
) O 0 2.5106661194485014e-10
, O 0 4.732241942057014e-12
or O 0 1.1603690230899133e-09
diffuse B-Disease 1 0.8833475112915039
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 3.953680050017283e-08
DMS B-Disease 0 0.0011268883245065808
) O 0 7.948166186625902e-14
associated O 0 1.5725292704278637e-13
with O 0 1.884690049424459e-13
pseudohermaphroditism B-Disease 1 1.0
and O 0 4.52830200003973e-08
/ O 0 9.29758243728429e-06
or O 0 1.1707175229247468e-09
Wilms B-Disease 0 2.5953491785912775e-05
tumor I-Disease 0 4.909963172394782e-05
( O 0 1.4610868959152867e-08
WT B-Disease 1 0.9999994039535522
) O 0 5.523886903446851e-11
. O 0 2.7211040712349366e-11

Most O 0 2.1870357955200426e-11
mutations O 0 1.1679145650589362e-08
in O 0 2.996297965296435e-08
DDS B-Disease 1 1.0
patients O 0 3.633897804888875e-08
lie O 0 9.768332843995697e-12
in O 0 2.1802488471295983e-13
exon O 0 9.235118780814844e-10
8 O 0 1.856088373275444e-11
or O 0 1.2414120946491192e-11
exon O 0 2.9819404723241405e-09
9 O 0 8.684196417529932e-11
, O 0 2.9389197239021447e-13
encoding O 0 1.3459335868049038e-09
zinc O 0 1.1929887477890588e-06
finger O 0 0.00018485644250176847
2 O 0 6.227172250072854e-11
or O 0 1.1088422402494302e-09
zinc O 0 0.0008173562819138169
finger O 0 0.08649016916751862
3 O 0 1.6657999632463394e-11
, O 0 9.065971172568521e-13
respectively O 0 1.0137561796963457e-11
, O 0 2.7987245902966543e-14
with O 0 3.021827097021159e-15
a O 0 4.9055745576787047e-11
hot O 0 6.273900954312239e-09
spot O 0 9.834282721499221e-09
( O 0 3.8939153984562935e-11
R394W O 0 1.7244066174981754e-09
) O 0 2.8922578308027136e-13
in O 0 2.0601216912941034e-11
exon O 0 1.0074180600838645e-08
9 O 0 1.828904139244969e-09
. O 0 4.01512365022505e-11

We O 0 1.6801400548605017e-11
analyzed O 0 2.7344897179926164e-12
a O 0 5.0353554062899236e-14
series O 0 1.647804885162446e-13
of O 0 6.287058852314734e-15
24 O 0 1.551598086124706e-11
patients O 0 4.377184378845378e-12
, O 0 9.969875944780549e-15
10 O 0 2.7576044864875996e-15
with O 0 1.5310369337549735e-15
isolated B-Disease 0 1.973358365603417e-08
DMS I-Disease 1 0.9957212209701538
( O 0 6.0633295259626685e-12
IDMS B-Disease 0 1.0367338099115386e-08
) O 0 3.4016780820107784e-13
, O 0 1.4974559949237215e-13
10 O 0 8.262862643453397e-14
with O 0 1.407522210762624e-12
DDS B-Disease 1 1.0
, O 0 1.8041997063011905e-10
and O 0 2.0514161116341745e-12
4 O 0 1.810387912715497e-13
with O 0 1.2483299170838041e-13
urogenital B-Disease 0 0.00010269178164890036
abnormalities I-Disease 1 0.9999997615814209
and O 0 1.0932000193975e-08
/ O 0 0.04070672765374184
or O 0 1.3954704627394676e-05
WT B-Disease 1 1.0
. O 0 3.714567264889723e-10

We O 0 6.608709135491608e-10
report O 0 7.78003980683728e-11
WT1 O 0 8.847115395838046e-08
heterozygous O 0 3.791273073261436e-09
mutations O 0 1.3631001882785654e-10
in O 0 6.3811317341233575e-12
16 O 0 6.288983548340121e-13
patients O 0 2.019288165497346e-12
, O 0 1.2038083915387899e-14
4 O 0 8.769338201560992e-14
of O 0 3.1571016468294596e-15
whom O 0 9.736357553524755e-12
presented O 0 4.235810053404565e-12
with O 0 1.3146953144194118e-12
IDMS B-Disease 0 2.6467066618351964e-06
. O 0 7.026267762055838e-11

One O 0 3.3634751234190574e-11
male O 0 1.6204360075988689e-10
and O 0 3.0134843730621197e-13
two O 0 6.433859657062682e-14
female O 0 4.17246315623232e-12
IDMS B-Disease 0 9.886888392429682e-07
patients O 0 3.935596570858735e-10
with O 0 7.580866950894841e-14
WT1 O 0 5.373275598685723e-06
mutations O 0 4.764425796111027e-07
underwent O 0 3.6662223124039883e-07
normal O 0 1.3479629501489399e-07
puberty O 0 6.825538093835348e-06
. O 0 1.5467559177917423e-10

Two O 0 9.009731155584788e-11
mutations O 0 5.07323294485218e-10
associated O 0 4.395523008071667e-12
with O 0 4.4003903710947145e-15
IDMS B-Disease 0 4.501766959208453e-09
are O 0 6.431685069377196e-15
different O 0 1.7953795053296875e-15
from O 0 6.138447768751915e-14
those O 0 8.293082746132358e-14
described O 0 1.909648827957966e-11
in O 0 1.1074668293531431e-08
DDS B-Disease 1 1.0
patients O 0 1.2967494633642218e-08
. O 0 3.725618338140668e-12

No O 0 4.147568122281342e-10
WT1 O 0 2.6358907234680373e-07
mutations O 0 1.9614767587938786e-09
were O 0 4.836367417659915e-12
detected O 0 2.2065949761840287e-11
in O 0 3.4759367151075693e-13
the O 0 6.809974218785703e-15
six O 0 1.2783257254383312e-13
other O 0 6.8937445067197324e-15
IDMS B-Disease 0 7.876445806687116e-08
patients O 0 4.443588726144032e-12
, O 0 7.976680259069973e-16
suggesting O 0 7.91535728020959e-13
genetic O 0 1.2740312971271095e-10
heterogeneity O 0 1.446569114493812e-10
of O 0 7.501656495425765e-14
this O 0 3.1642019733546523e-12
disease O 0 5.180869511178798e-09
. O 0 2.4092568218225807e-11

We O 0 1.0804606515035786e-10
analyzed O 0 1.8936696655202923e-09
genotype O 0 1.06675020106195e-06
/ O 0 1.3117733033141121e-06
phenotype O 0 6.078785919072516e-09
correlations O 0 2.913686181216235e-09
, O 0 6.733056495157597e-13
on O 0 5.700442965968569e-14
the O 0 2.4436132904678116e-16
basis O 0 6.951418556581804e-15
of O 0 4.224857734966846e-17
the O 0 3.288606688264242e-15
constitution O 0 4.0587677533135413e-14
of O 0 1.756936120925163e-16
a O 0 3.4722455488113424e-13
WT1 O 0 6.086071202560106e-09
mutation O 0 8.98576872632173e-12
database O 0 1.3766101106260642e-11
of O 0 2.944235490920876e-15
84 O 0 7.888062490517267e-13
germ O 0 6.121535278680312e-08
- O 0 3.1311155908042565e-06
line O 0 8.629942316318306e-10
mutations O 0 6.499920740532517e-11
, O 0 1.4705210248273926e-14
to O 0 2.0832717104204393e-16
compare O 0 1.6548782540170594e-14
the O 0 7.134770272959785e-17
distribution O 0 2.1335763830589854e-14
and O 0 7.209925473490586e-14
type O 0 1.0438098302367749e-11
of O 0 3.607543762602607e-16
mutations O 0 3.1033362728541403e-13
, O 0 8.746119334410857e-14
according O 0 4.861451156592438e-15
to O 0 8.021535947583009e-16
the O 0 9.59957431606465e-15
different O 0 3.722194861360828e-12
symptoms O 0 3.0625330049716126e-10
. O 0 5.2450730390896094e-12

This O 0 8.214902960353501e-14
demonstrated O 0 1.5181969180086408e-13
( O 0 2.647335746886609e-13
1 O 0 5.032638463408311e-14
) O 0 3.501264685826038e-15
the O 0 7.496885857636063e-16
association O 0 1.656157104360824e-14
between O 0 2.6941767535730663e-15
mutations O 0 1.2617796564529105e-11
in O 0 4.750355924593164e-12
exons O 0 2.3695681528046464e-10
8 O 0 6.518255119686289e-12
and O 0 8.277821245301908e-13
9 O 0 1.9312075810046236e-12
and O 0 8.77884841644222e-13
DMS B-Disease 0 3.830252353509422e-06
; O 0 6.142348186067431e-14
( O 0 6.410307939845594e-13
2 O 0 1.551149616738079e-13
) O 0 4.046014147633323e-14
among O 0 2.1745829421014606e-14
patients O 0 3.497968922979919e-14
with O 0 3.790926925078755e-16
DMS B-Disease 0 1.8544565136835445e-06
, O 0 2.5703108905313337e-15
a O 0 1.0939621096202421e-14
higher O 0 3.4724176659062245e-13
frequency O 0 9.084544097884284e-13
of O 0 1.6843119713077885e-14
exon O 0 3.30009519711183e-10
8 O 0 6.061918328414961e-12
mutations O 0 2.481401750742407e-10
among O 0 4.1423282989491716e-13
46 O 0 3.983662792000908e-12
, O 0 1.6917081613592594e-13
XY O 0 5.461987484522979e-08
patients O 0 5.6362751271743505e-11
with O 0 2.113136292195613e-14
female O 0 1.2979457786332915e-10
phenotype O 0 1.8932326817378e-09
than O 0 7.854508059582099e-13
among O 0 1.5196397200496758e-13
46 O 0 1.3836010245502073e-12
, O 0 1.2862965087599015e-13
XY O 0 8.518548355596067e-08
patients O 0 1.9099947318190758e-11
with O 0 1.7719465506021341e-15
sexual O 0 2.208817113588668e-12
ambiguity O 0 1.906049797162357e-11
or O 0 1.2525096411419856e-11
male O 0 1.1364673091485145e-10
phenotype O 0 7.164551729665902e-10
; O 0 5.3253946391551565e-12
and O 0 3.5566781724644114e-12
( O 0 1.8092290903284902e-12
3 O 0 2.6877829253707172e-14
) O 0 1.0332834221360226e-15
statistically O 0 1.5855219426871153e-13
significant O 0 4.507888592980179e-15
evidence O 0 1.3773704399255848e-13
that O 0 2.7371257709218324e-15
mutations O 0 1.0186677022738788e-11
in O 0 3.0026077110778537e-12
exons O 0 5.57207946449978e-10
8 O 0 5.7040049766809986e-12
and O 0 1.7321529681511155e-13
9 O 0 6.842084136673282e-14
preferentially O 0 1.0144385331756212e-12
affect O 0 3.0821062390641585e-13
amino O 0 2.1716867670482087e-13
acids O 0 4.4685294283168184e-14
with O 0 4.653925583120962e-17
different O 0 5.492628027513465e-16
functions O 0 7.96224353539609e-15
. O 0 5.45219726029271e-14
. O 0 2.939952751732089e-12

The O 0 1.3904376781892491e-11
185delAG O 0 1.7267968388523514e-08
BRCA1 O 0 3.5885555860204477e-08
mutation O 0 1.0776938369483346e-11
originated O 0 5.0156627982855806e-12
before O 0 2.736307579446432e-14
the O 0 7.35089734689662e-17
dispersion O 0 1.0333239526625487e-13
of O 0 1.0556655994052826e-17
Jews O 0 5.202321778523039e-15
in O 0 5.9524219693594515e-15
the O 0 2.5669881390979327e-16
diaspora O 0 3.096589824835849e-13
and O 0 6.167814197745314e-13
is O 0 3.443407888605596e-15
not O 0 4.882507972144706e-15
limited O 0 1.5085674408884392e-13
to O 0 6.614070727738175e-13
Ashkenazim O 0 1.3188351033477375e-07
. O 0 5.7560196192740776e-11

The O 0 3.4898024140611605e-12
185delAG O 0 8.182646560328521e-09
mutation O 0 1.2968470741725469e-10
in O 0 2.20573125736534e-12
BRCA1 O 0 6.451697487364072e-08
is O 0 1.8370779886461158e-13
detected O 0 9.062470218701435e-11
in O 0 1.2940758490828652e-12
Ashkenazi O 0 8.884339097736671e-11
Jews O 0 8.438020247802935e-15
both O 0 7.673088827697455e-16
in O 0 2.719321621179327e-13
familial B-Disease 0 0.0015715378103777766
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 6.158346055329389e-11
in O 0 1.2560299209127962e-13
the O 0 7.500947380618148e-16
general O 0 5.247566043400627e-15
population O 0 2.119254199415394e-15
. O 0 1.3639205867152504e-12

All O 0 7.746394671548362e-12
tested O 0 6.343225250615703e-11
Ashkenazi O 0 8.309630206149166e-10
mutation O 0 1.4356635455112232e-12
carriers O 0 7.001220783675599e-12
share O 0 3.4276080237982676e-12
the O 0 2.878695681352364e-14
same O 0 4.624893133395314e-13
allelic O 0 1.5151328802698316e-10
pattern O 0 1.9768080505855323e-09
at O 0 6.291762250087984e-11
the O 0 2.530315095904817e-13
BRCA1 O 0 3.497152079035004e-08
locus O 0 1.8011199198753047e-09
. O 0 5.606649866596314e-11

Our O 0 1.537219245124899e-12
previous O 0 1.2597799051768804e-13
study O 0 1.6347844302225245e-14
showed O 0 1.9671976992253343e-13
that O 0 5.633806714601484e-17
this O 0 6.704340951691856e-16
Ashkenazi O 0 1.0584259024781772e-09
mutation O 0 9.502360920690678e-13
also O 0 1.772229010679055e-13
occurs O 0 1.845966007005609e-15
in O 0 1.1237090596948659e-14
Iraqi O 0 2.382753282875738e-13
Jews O 0 3.653319779941405e-13
with O 0 2.272830166598545e-15
a O 0 1.1249727142675567e-13
similar O 0 1.3786747351390849e-12
allelic O 0 2.4021975519872285e-09
pattern O 0 9.312957161000668e-08
. O 0 8.430447451246437e-10

We O 0 3.1815720197281294e-11
extended O 0 3.627932643971571e-13
our O 0 2.011404882373293e-15
analysis O 0 3.744948229696338e-15
to O 0 2.0528364931366122e-16
other O 0 9.254421095552731e-15
non O 0 1.0071365963426615e-10
- O 0 5.744448319799922e-11
Ashkenazi O 0 2.0572640813121268e-10
subsets O 0 5.086181475988383e-12
354 O 0 1.8728879558338463e-11
of O 0 1.1317963185170131e-15
Moroccan O 0 4.415987714390113e-11
origin O 0 1.82755546807023e-12
, O 0 2.7333357474103315e-13
200 O 0 3.056749460755154e-14
Yemenites O 0 1.5535384090270554e-10
and O 0 1.0297033103295102e-14
150 O 0 1.2732514559831917e-14
Iranian O 0 5.01054493035058e-13
Jews O 0 6.610996472478092e-12
. O 0 5.061639041931132e-12

Heteroduplex O 0 6.586943612774121e-08
analysis O 0 4.491305764797726e-12
complemented O 0 6.151835768228309e-13
by O 0 1.5616799388086739e-16
direct O 0 2.552071645374812e-14
DNA O 0 1.1087501576578784e-11
sequencing O 0 9.851854575193553e-13
of O 0 4.217342316028324e-15
abnormally O 0 1.1292325581557794e-11
migrating O 0 5.276288520678074e-12
bands O 0 2.8406128144142784e-11
were O 0 1.1373730950114957e-11
employed O 0 5.713513689942218e-11
. O 0 1.1036183902510266e-12

Four O 0 2.884860319379845e-12
of O 0 1.5600842081453856e-16
Moroccan O 0 2.116930762630087e-12
origin O 0 2.7863038685647067e-14
( O 0 3.499730751510208e-14
1 O 0 3.2789363248636764e-15
. O 0 3.4028738680685704e-16
1 O 0 6.094765432629063e-15
% O 0 5.701745109718383e-15
) O 0 1.1059458470547012e-14
and O 0 1.9365577053737613e-14
none O 0 5.665507600278834e-14
of O 0 1.3887053885036276e-17
the O 0 8.825305628265112e-16
Yemenites O 0 1.2977025704019596e-11
or O 0 2.6040499915896617e-14
Iranians O 0 1.192376817941987e-12
was O 0 4.854043599358815e-13
a O 0 1.9569837354902093e-14
carrier O 0 3.2032044117863423e-12
of O 0 4.371162228700284e-15
the O 0 4.646927916247823e-13
185delAG O 0 2.5527414848625085e-08
mutation O 0 7.261514722856077e-10
. O 0 1.4246122337358003e-10

BRCA1 O 0 0.0001304522156715393
allelic O 0 9.47726022104689e-08
patterns O 0 5.8786615575456835e-09
were O 0 2.5588149221017487e-12
determined O 0 2.8041428906536506e-14
for O 0 4.359337119361022e-16
four O 0 8.411693616769324e-16
of O 0 6.764211556509505e-19
these O 0 4.51195880797614e-18
individuals O 0 8.704064243870887e-18
and O 0 7.978601435673464e-15
for O 0 1.7088227966365467e-15
12 O 0 9.677890982367782e-15
additional O 0 7.889593519510088e-14
non O 0 4.1101788639252845e-09
- O 0 2.366914664264641e-08
Ashkenazi O 0 4.845801981900877e-09
185delAG O 0 2.0519892729442546e-10
mutation O 0 4.080817281315596e-12
carriers O 0 3.0780986093326135e-10
who O 0 1.166593210921718e-10
had O 0 5.342732265489758e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.194556257886006e-09

Six O 0 9.241639120638467e-10
non O 0 5.4806150728836656e-08
- O 0 3.5782764484793006e-07
Ashkenazi O 0 2.231164808463859e-09
individuals O 0 5.973710448422794e-16
shared O 0 1.93212196323558e-15
the O 0 1.1912310057692917e-16
common O 0 4.1316047263116606e-13
Ashkenazi O 0 6.831994525668961e-09
haplotype O 0 2.2880344285880483e-09
, O 0 1.047665426634481e-11
four O 0 6.367207650882778e-13
had O 0 1.345418134540699e-12
a O 0 1.523272203903317e-14
closely O 0 5.076506706322426e-13
related O 0 9.112401805344561e-12
pattern O 0 2.519459363359289e-10
, O 0 8.303980766899421e-12
and O 0 1.5782896365702792e-13
the O 0 4.0316066254202955e-15
rest O 0 1.3695742131537847e-13
( O 0 3.2857508489199383e-13
n O 0 3.4615321720110614e-10
= O 0 5.550433002099453e-09
6 O 0 3.9571217830269845e-11
) O 0 2.5271896120920845e-13
displayed O 0 8.648554095103123e-12
a O 0 1.7693521344244734e-12
distinct O 0 5.2941134115469524e-11
BRCA1 O 0 2.6453969894646434e-06
allelic O 0 2.2409737709949695e-07
pattern O 0 4.95219239837752e-07
. O 0 1.7911028216133218e-09

We O 0 1.638826747918376e-11
conclude O 0 4.895439956187353e-12
that O 0 3.7648997201919986e-16
the O 0 4.926586719686873e-15
185delAG O 0 8.388459704633533e-09
BRCA1 O 0 9.01159751265368e-07
mutation O 0 6.060927454365483e-11
occurs O 0 3.60087421035285e-13
in O 0 1.0673941588999585e-14
some O 0 6.7612325548689015e-15
non O 0 7.631612009006972e-11
- O 0 8.986120736409475e-10
Ashkenazi O 0 1.3048238878266005e-10
populations O 0 6.820198160568947e-13
at O 0 2.2737269966127682e-12
rates O 0 2.1944598915801805e-12
comparable O 0 8.180878663301833e-14
with O 0 2.771576506710796e-16
that O 0 4.554402136729228e-15
of O 0 1.7012982006254368e-14
Ashkenazim O 0 3.155270533738985e-08
. O 0 1.637804822318678e-11

The O 0 5.443160570710315e-13
majority O 0 3.518217889329073e-13
of O 0 8.813832566994552e-16
Jewish O 0 6.459947594211757e-12
185delAG O 0 3.003974291537759e-10
mutation O 0 7.225774882949065e-13
carriers O 0 2.3192678680339363e-11
have O 0 8.852288476898784e-14
a O 0 3.6665112000114006e-14
common O 0 5.199489927151801e-13
allelic O 0 3.787489072371031e-11
pattern O 0 1.1253800669130953e-10
, O 0 9.828201214022794e-14
supporting O 0 1.1193281205883719e-14
the O 0 4.17892148387602e-16
founder O 0 2.1090625719390882e-13
effect O 0 1.3949094429446113e-13
notion O 0 1.339783725585672e-13
, O 0 1.7345166644124055e-13
but O 0 1.0604607198882315e-13
dating O 0 3.6746573665868976e-12
the O 0 1.5538953089767128e-16
mutations O 0 9.636446507291577e-15
origin O 0 1.3506928831419265e-14
to O 0 9.148977352080832e-15
an O 0 2.5104250258857442e-15
earlier O 0 9.985915740140516e-12
date O 0 5.48491287111208e-12
than O 0 4.270020480864195e-14
currently O 0 2.3850707989007437e-14
estimated O 0 1.5599495436710575e-13
. O 0 1.0904931471711343e-11

However O 0 2.029525332514215e-11
, O 0 2.4461293383101594e-14
the O 0 2.625657876189502e-16
different O 0 1.4876840934486039e-15
allelic O 0 8.690206540484802e-12
pattern O 0 1.5750532822433883e-10
at O 0 1.0012922782576261e-11
the O 0 2.736876785586987e-14
BRCA1 O 0 3.132243353576314e-09
locus O 0 4.635265435370961e-11
even O 0 2.0235455672201752e-11
in O 0 3.7569142133202227e-13
some O 0 1.4487329657317596e-15
Jewish O 0 2.1585245526742347e-14
mutation O 0 2.2677951910018285e-14
carriers O 0 1.602836136385677e-12
, O 0 3.010759637477392e-14
might O 0 7.349818995604218e-13
suggest O 0 1.0337541369795367e-12
that O 0 6.47792713906665e-15
the O 0 3.807406745160976e-15
mutation O 0 1.4605733343695665e-13
arose O 0 1.0229702284911268e-12
independently O 0 5.853779700554229e-12
. O 0 2.041018829640473e-12
. O 0 1.1022053061915393e-11

Crystal O 0 4.917711127205848e-09
structure O 0 3.541264937539923e-12
of O 0 2.065791385608834e-15
the O 0 1.434704677109877e-13
hemochromatosis B-Disease 1 1.0
protein O 0 2.7487681575344425e-10
HFE O 0 1.5446287804365966e-08
and O 0 3.428192720477362e-14
characterization O 0 1.070959943991201e-12
of O 0 2.8435113091519596e-16
its O 0 1.123948558260702e-15
interaction O 0 6.570833947886238e-15
with O 0 5.645017725053986e-16
transferrin O 0 7.40866916426608e-12
receptor O 0 1.074854788507551e-11
. O 0 1.3510480061096342e-11

HFE O 0 7.311703939194558e-06
is O 0 6.713077901725206e-13
an O 0 3.2494007095093926e-15
MHC O 0 9.179340620946164e-11
- O 0 4.223630126198863e-11
related O 0 4.1804586051533144e-13
protein O 0 3.9080557908723057e-13
that O 0 9.099512957301786e-16
is O 0 1.5892406703766547e-16
mutated O 0 2.056273554207344e-12
in O 0 9.732361401157408e-13
the O 0 2.386683244700455e-13
iron B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
overload I-Disease 1 0.9994814991950989
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.2040186625483784e-08

HFE O 0 1.5178873127297265e-06
binds O 0 4.927933616727387e-10
to O 0 1.1127299033358504e-13
transferrin O 0 1.721338870053213e-11
receptor O 0 4.431535867432945e-12
( O 0 2.3895950322649906e-12
TfR O 0 2.854831748777542e-08
) O 0 1.80786904001827e-13
and O 0 1.910170426781127e-14
reduces O 0 9.936047142933106e-15
its O 0 3.654636478364231e-17
affinity O 0 2.622087219388263e-14
for O 0 3.772391673670904e-15
iron O 0 7.318048944604527e-10
- O 0 3.0434259279399356e-11
loaded O 0 3.1096898060051226e-12
transferrin O 0 8.838109064046584e-12
, O 0 1.3761887950828472e-13
implicating O 0 1.769259461159578e-10
HFE O 0 8.93708929083914e-08
in O 0 8.143387353332088e-11
iron O 0 1.2375326718938595e-07
metabolism O 0 5.9434015042825195e-08
. O 0 1.7170693686341387e-11

The O 0 1.3302141332882655e-10
2 O 0 1.1181440495722228e-10
. O 0 9.59014638535205e-12

6 O 0 1.0791451066083368e-09
A O 0 9.058300116937534e-12
crystal O 0 9.96720150858721e-10
structure O 0 1.127110904608486e-11
of O 0 1.261469651203358e-14
HFE O 0 2.1047759091175067e-08
reveals O 0 4.127961861222218e-11
the O 0 2.4140771457179357e-15
locations O 0 2.987133327150837e-12
of O 0 1.7887444997422008e-12
hemochromatosis B-Disease 1 1.0
mutations O 0 2.2502698371340557e-08
and O 0 2.8872657303197213e-12
a O 0 1.343928007074835e-12
patch O 0 1.2323894793553336e-07
of O 0 1.1819439300713146e-14
histidines O 0 1.2039170771416252e-09
that O 0 3.406798065834081e-15
could O 0 1.0878059249815747e-13
be O 0 5.748061930065432e-16
involved O 0 3.4330332173093886e-15
in O 0 3.209821948166325e-12
pH O 0 1.7660531370644605e-10
- O 0 1.1932193080821385e-11
dependent O 0 2.1898366800443547e-11
interactions O 0 2.0763904484688567e-11
. O 0 1.0378481928030592e-11

We O 0 1.653962557190969e-11
also O 0 9.81455805434137e-15
demonstrate O 0 4.225104102440489e-15
that O 0 4.040274737086022e-15
soluble O 0 3.5523719521535213e-09
TfR O 0 8.011260206330917e-07
and O 0 3.180318963909301e-13
HFE O 0 5.480361497944841e-09
bind O 0 8.912270227368069e-12
tightly O 0 4.425952226244645e-12
at O 0 5.357341089848311e-13
the O 0 2.1277272817450156e-15
basic O 0 3.143866731617623e-13
pH O 0 1.6513317948295414e-13
of O 0 6.718056532690271e-18
the O 0 2.82326669231699e-16
cell O 0 6.412120834298207e-12
surface O 0 8.19637191234665e-14
, O 0 1.5798076551370305e-13
but O 0 7.549555192153459e-14
not O 0 5.853391112331215e-15
at O 0 5.94336049559302e-14
the O 0 7.78505948942354e-14
acidic O 0 1.9403181839017236e-10
pH O 0 2.8724420411685436e-11
of O 0 4.368962060619791e-15
intracellular O 0 3.312421864576365e-11
vesicles O 0 5.129494162758874e-09
. O 0 1.3034136270295704e-10

TfR O 0 0.008187290281057358
HFE O 0 1.9373952454770915e-05
stoichiometry O 0 5.7345359572025245e-09
( O 0 2.9686384461768967e-09
2 O 0 1.7206068167463506e-11
1 O 0 5.755827130020374e-13
) O 0 1.2513574161251984e-13
differs O 0 4.00344471115921e-12
from O 0 3.1536741534193835e-13
TfR O 0 7.883746988568419e-09
transferrin O 0 1.1723005378938556e-11
stoichiometry O 0 4.240619574241711e-12
( O 0 2.0962619660946924e-12
2 O 0 7.132063494473539e-13
2 O 0 2.760912158616957e-13
) O 0 5.142578935390593e-14
, O 0 4.11625443948768e-15
implying O 0 7.739714901963679e-13
a O 0 2.188655716893733e-14
different O 0 5.167629850102344e-15
mode O 0 6.863039325212539e-13
of O 0 5.658188028592607e-17
binding O 0 5.0797101171663056e-14
for O 0 6.3914027235046234e-15
HFE O 0 7.618817798871191e-10
and O 0 5.1231551146573365e-14
transferrin O 0 1.8723583881247174e-12
to O 0 2.4180337636695026e-13
TfR O 0 3.457352875102515e-07
, O 0 3.6519959690888004e-13
consistent O 0 4.9592053553981774e-12
with O 0 1.2597714560232316e-15
our O 0 2.3300862057011465e-15
demonstration O 0 9.46084133073271e-16
that O 0 1.7959198858802562e-16
HFE O 0 1.0357090879375974e-10
, O 0 1.6047884101097606e-15
transferrin O 0 9.12229168072154e-13
, O 0 1.4669388208495004e-13
and O 0 1.9120122152216368e-13
TfR O 0 5.939273517441279e-09
form O 0 4.4724965918285786e-13
a O 0 4.417569175046987e-12
ternary O 0 5.196543195751246e-10
complex O 0 5.168056538273902e-10
. O 0 9.089059366251817e-11

Identification O 0 1.5930846919420816e-10
of O 0 5.4968436046128315e-15
three O 0 4.440116639837415e-15
novel O 0 1.746707569165104e-13
mutations O 0 1.0309468556624068e-11
and O 0 1.0472792338206416e-12
a O 0 2.8718707099917307e-12
high O 0 4.546703638586003e-11
frequency O 0 8.928280857689597e-12
of O 0 5.444047617493997e-15
the O 0 9.833527357195129e-14
Arg778Leu O 0 2.105509544492179e-09
mutation O 0 3.0061951192261738e-12
in O 0 4.2283026038814064e-12
Korean O 0 2.970051635187154e-11
patients O 0 2.65897113355118e-12
with O 0 9.302629128712762e-15
Wilson B-Disease 0 3.6966238958768827e-09
disease I-Disease 0 1.3374636509411175e-08
. O 0 3.0184688082357525e-11

Four O 0 1.2392876655442642e-11
mutations O 0 2.3593127451704277e-10
- O 0 2.3346766298004695e-08
- O 0 4.596812708257403e-09
R778L O 0 1.2810057459233803e-09
, O 0 4.927576223575855e-14
A874V O 0 2.620801319019872e-11
, O 0 3.0068098381410505e-15
L1083F O 0 2.347164997085205e-12
, O 0 8.735307318828158e-16
and O 0 5.11274380918616e-16
2304delC O 0 6.5009594929499315e-12
- O 0 5.383133175329569e-13
- O 0 2.75658185514005e-13
in O 0 7.651170685516948e-15
the O 0 4.270782207005749e-16
copper O 0 5.8204682393259155e-12
- O 0 5.442181603911196e-14
transporting O 0 1.9030184871503264e-13
enzyme O 0 2.3594803411422505e-13
, O 0 3.243382328660914e-15
P O 0 6.320572398799129e-10
- O 0 1.9118791619310294e-11
type O 0 9.691931979194379e-11
ATPase O 0 1.523592807473051e-09
( O 0 1.0673144659745226e-11
ATP7B O 0 1.3492395645187116e-08
) O 0 5.3165903347559065e-14
, O 0 1.9579869613129373e-15
were O 0 3.989473936074446e-15
identified O 0 1.0751572158615441e-13
in O 0 3.431463961719658e-14
Korean O 0 3.066603828510983e-12
Patients O 0 1.611412148464983e-13
with O 0 9.978094705467757e-15
Wilson B-Disease 0 6.227095727950882e-09
disease I-Disease 0 2.614324934313572e-08
. O 0 3.839326426224865e-11

Arg778Leu O 0 1.4933716556697618e-06
, O 0 1.2205671586287825e-12
the O 0 5.513683678395431e-16
most O 0 1.4123787351520787e-16
frequently O 0 2.118527826311476e-14
reported O 0 2.28593294467061e-12
mutation O 0 7.898507016620634e-14
of O 0 3.380297263650691e-16
this O 0 1.2135310009903333e-16
enzyme O 0 5.558725205937094e-14
, O 0 1.2573133664102996e-15
was O 0 1.325857961831725e-13
found O 0 5.915305138076699e-13
in O 0 6.427558680612011e-13
six O 0 5.855460159711473e-14
of O 0 7.20877315928123e-17
eight O 0 8.787181628221261e-15
unrelated O 0 1.6928580932884518e-12
patients O 0 1.8057160584492027e-12
studied O 0 1.1035537934855899e-11
, O 0 7.0338429091626464e-15
an O 0 4.447420604941589e-16
allele O 0 3.6884013204785404e-11
frequency O 0 7.979352178999477e-10
of O 0 3.38741847072388e-11
37 O 0 3.396906755881446e-09
. O 0 3.217915170439234e-11

5 O 0 8.370523718603806e-10
% O 0 2.9654761719150047e-12
, O 0 2.6669171157480548e-14
which O 0 6.68911553446496e-16
is O 0 4.563668994809545e-16
considerably O 0 1.833267261955318e-12
higher O 0 2.2205677509441746e-13
than O 0 4.301013924623998e-15
those O 0 1.3816262510899457e-15
in O 0 4.676185992786609e-14
other O 0 6.03286553539314e-15
Asian O 0 3.619955897538052e-13
populations O 0 1.555208978092082e-12
. O 0 2.2434640950530493e-12

The O 0 1.2614269438021575e-13
novel O 0 8.594218544287491e-13
single O 0 9.085752441205519e-14
nucleotide O 0 1.0351180849965669e-11
deletion O 0 6.052679191181909e-11
, O 0 9.22365821416117e-14
2304delC O 0 1.1845824321454757e-10
, O 0 1.451613894191961e-13
was O 0 8.043521577960622e-12
found O 0 9.582283751197185e-12
in O 0 1.8238443741380728e-11
one O 0 1.555826995014442e-11
patient O 0 9.881881424256278e-11
. O 0 1.5125500678336845e-12

Since O 0 1.470753380194978e-11
a O 0 5.055577267584765e-13
mutation O 0 6.603737522092867e-12
at O 0 4.872521656984485e-13
cDNA O 0 1.9095004744063004e-10
nucleotide O 0 2.0299337766260805e-09
2302 O 0 8.362743386669536e-08
( O 0 3.684798993708327e-12
2302insC O 0 8.393029327091739e-11
) O 0 9.391739366456167e-14
had O 0 8.455105647738048e-13
been O 0 2.1432142627460238e-14
previously O 0 1.857657941589739e-14
described O 0 5.5870523593855304e-14
, O 0 3.277433847233925e-16
this O 0 4.781292951326468e-18
region O 0 5.067717231776016e-15
of O 0 3.996722579339252e-16
the O 0 1.234590839391432e-14
ATP7B O 0 2.0405546141688546e-09
gene O 0 7.455466799477506e-11
may O 0 1.457077167255072e-11
be O 0 1.6089328152657338e-14
susceptible O 0 8.14088293304982e-12
to O 0 2.953838684608724e-14
gene O 0 2.981879845265212e-07
rearrangements O 0 2.3313398855862033e-07
causing O 0 4.2178438519613337e-10
Wilson B-Disease 0 7.764722198544405e-08
disease I-Disease 0 2.123135345755145e-06
. O 0 1.350510259179316e-10

Disruption O 0 9.620646501673491e-09
of O 0 2.449252687599865e-14
splicing O 0 1.2578340279068012e-11
regulated O 0 4.101227820893505e-13
by O 0 2.2148425027877523e-15
a O 0 3.6299123971385294e-13
CUG O 0 2.503061224956582e-08
- O 0 1.608941625763638e-11
binding O 0 5.717718833120333e-12
protein O 0 7.79492304037177e-11
in O 0 2.1791919657676573e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 4.2315503878675997e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999998927116394
DM B-Disease 1 1.0
) O 0 1.2408269967068009e-08
is O 0 3.200247141940671e-13
caused O 0 1.1463487257156683e-14
by O 0 1.4083706811247898e-16
a O 0 7.714390514194577e-14
CTG O 0 7.073104324462065e-10
expansion O 0 2.385933247847638e-12
in O 0 1.9250918133900674e-12
the O 0 5.16382895915813e-14
3 O 0 1.0604632406582826e-12
untranslated O 0 5.218029563991422e-09
region O 0 4.621159011009013e-11
of O 0 2.0878585318961917e-12
the O 0 3.711084994861835e-09
DM B-Disease 1 1.0
gene O 0 1.7772398663851163e-08
. O 0 1.0145807805006513e-10

One O 0 1.16858291706462e-12
model O 0 3.629237535496266e-11
of O 0 7.035379223641058e-13
DM B-Disease 1 1.0
pathogenesis O 0 1.4431822403793149e-10
suggests O 0 2.196829279902876e-13
that O 0 2.249428075634007e-16
RNAs O 0 2.0581068099767563e-11
from O 0 4.350503518633225e-14
the O 0 3.099593191908576e-16
expanded O 0 9.950276280007442e-14
allele O 0 3.780058948146814e-13
create O 0 1.6079512734864555e-14
a O 0 1.160696565987232e-13
gain O 0 2.2609369931814172e-10
- O 0 3.907783818757338e-11
of O 0 9.705365173638333e-14
- O 0 1.4613864285362155e-10
function O 0 6.93758989668493e-15
mutation O 0 6.531050504419598e-15
by O 0 4.9836496352775e-16
the O 0 1.8689729041606934e-15
inappropriate O 0 4.822465126883002e-13
binding O 0 4.6839969918130095e-14
of O 0 1.4494177653998351e-16
proteins O 0 5.067021394209847e-15
to O 0 1.3569417840070003e-14
the O 0 3.918049424397191e-13
CUG O 0 6.502336447056223e-08
repeats O 0 1.0334678668399988e-09
. O 0 1.7360741316752026e-11

Data O 0 8.691387887171942e-11
presented O 0 7.904509295372786e-13
here O 0 3.0426624219280496e-13
indicate O 0 1.3044711253025476e-13
that O 0 5.522819458127161e-16
the O 0 5.806507732821571e-16
conserved O 0 1.6909476206403151e-12
heterogeneous O 0 3.915989494479577e-12
nuclear O 0 3.887131068414096e-12
ribonucleoprotein O 0 1.9117672722668289e-10
, O 0 8.488079894985665e-14
CUG O 0 9.374542253581808e-10
- O 0 3.5659296696022302e-12
binding O 0 1.0830841432052374e-12
protein O 0 4.604132613356127e-12
( O 0 1.0872023631846792e-13
CUG O 0 2.002499499553778e-09
- O 0 5.282040430043544e-11
BP O 0 1.299950813660189e-09
) O 0 2.867905159230702e-14
, O 0 1.3183424926006219e-14
may O 0 8.41823491340779e-14
mediate O 0 1.1401918905556974e-12
the O 0 2.491572825336942e-15
trans O 0 2.7954319414824624e-11
- O 0 3.308570431515001e-11
dominant O 0 4.553247015537387e-11
effect O 0 2.2749772551899916e-11
of O 0 3.1926596664387215e-15
the O 0 5.951108475368144e-14
RNA O 0 4.774122208672793e-10
. O 0 3.662461393189043e-12

CUG O 0 1.2748448170896154e-05
- O 0 1.4230649867386092e-06
BP O 0 1.5355205107425718e-07
was O 0 3.302408910568766e-12
found O 0 9.417062432853871e-15
to O 0 3.3882611600650046e-17
bind O 0 1.7903264455795473e-14
to O 0 5.760551430872697e-16
the O 0 1.841520989856655e-15
human O 0 2.2283619448369013e-13
cardiac O 0 3.714213103744868e-10
troponin O 0 6.100145277798674e-09
T O 0 3.674992088420481e-09
( O 0 6.550044794745302e-13
cTNT O 0 6.986058259661476e-11
) O 0 6.628667070535804e-14
pre O 0 3.9351236158502445e-10
- O 0 6.432483018459223e-11
messenger O 0 4.472595210858188e-11
RNA O 0 3.3693502848874957e-11
and O 0 1.4598345183516534e-14
regulate O 0 6.928125743455374e-14
its O 0 3.3458148700053238e-15
alternative O 0 3.9901171559539317e-13
splicing O 0 1.0501771674498173e-09
. O 0 4.6418830584871174e-11

Splicing O 0 1.380598568800906e-08
of O 0 5.450682223281933e-13
cTNT O 0 2.3589901143594716e-09
was O 0 1.0053185714453683e-11
disrupted O 0 3.848817708984598e-09
in O 0 1.852193065587926e-09
DM B-Disease 1 1.0
striated O 0 1.4896862410296308e-07
muscle O 0 6.883046808070503e-07
and O 0 1.2417318909219155e-11
in O 0 6.163980458863405e-13
normal O 0 4.135714774117227e-12
cells O 0 4.646939083530199e-12
expressing O 0 4.634686189518289e-13
transcripts O 0 5.327083912876063e-11
that O 0 3.043762073981493e-15
contain O 0 1.7645428304277622e-12
CUG O 0 1.2439862473456742e-07
repeats O 0 4.588508240033207e-09
. O 0 4.611438314539029e-11

Altered O 0 1.2331872412119083e-08
expression O 0 3.7300714600396745e-11
of O 0 1.859643386818103e-14
genes O 0 2.0552825066855185e-11
regulated O 0 2.3903027127070153e-11
posttranscriptionally O 0 5.1392133604277745e-11
by O 0 1.4376131172002052e-14
CUG O 0 1.1248559417254e-07
- O 0 4.874574077717853e-10
BP O 0 5.221102994390492e-10
therefore O 0 4.962350991818791e-14
may O 0 1.127655911356551e-13
contribute O 0 1.6784591430488507e-14
to O 0 4.4478283903193194e-12
DM B-Disease 1 1.0
pathogenesis O 0 4.568908584801079e-10
. O 0 5.836484724339175e-13
. O 0 1.2603646425135562e-12

Identification O 0 2.3179332064859892e-10
of O 0 7.210348481744445e-15
a O 0 2.5101595064677684e-13
novel O 0 4.14419748517858e-11
nonsense O 0 1.0540048833718174e-07
mutation O 0 4.791023133776662e-11
and O 0 6.369916530010733e-13
a O 0 4.143260712817509e-13
missense O 0 2.6541968622950662e-09
substitution O 0 2.055717748805641e-11
in O 0 4.1434897505264467e-13
the O 0 1.269768795317261e-14
vasopressin O 0 1.5215563531345566e-10
- O 0 1.257264514720191e-09
neurophysin O 0 5.4872259624971775e-08
II O 0 5.212344444949224e-11
gene O 0 1.734736833347572e-11
in O 0 1.4866821966205701e-12
two O 0 5.3381622310434e-14
Spanish O 0 9.964263789075112e-12
kindreds O 0 2.0028750213896274e-08
with O 0 3.954049761223377e-12
familial B-Disease 0 0.11529949307441711
neurohypophyseal I-Disease 1 0.9961064457893372
diabetes I-Disease 1 0.9999185800552368
insipidus I-Disease 1 0.9289510250091553
. O 0 1.6349046561003888e-08

Familial B-Disease 1 0.9999958276748657
neurohypophyseal I-Disease 1 0.9999847412109375
diabetes I-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.9999366998672485
( O 0 0.00016969090211205184
FNDI B-Disease 1 1.0
) O 0 3.245381047234375e-11
is O 0 2.0584425277584556e-13
an O 0 7.68853771339166e-14
autosomal B-Disease 1 0.9999940395355225
dominant I-Disease 1 0.9999829530715942
disease I-Disease 1 0.9999990463256836
caused O 0 4.095654482227928e-09
by O 0 3.406116014237348e-11
deficiency O 1 0.9997496008872986
in O 0 9.571756364942785e-13
the O 0 4.491018491879599e-14
antidiuretic O 0 4.6535383546597586e-08
hormone O 0 1.8644844002047023e-10
arginine O 0 5.436051053742119e-10
vasopressin O 0 8.287134867224211e-11
( O 0 7.892582420954142e-12
AVP O 0 1.6375627520659464e-09
) O 0 1.3368168741033012e-14
encoded O 0 7.661484836309074e-14
by O 0 1.5935637412509834e-15
the O 0 3.7048025102381574e-14
AVP O 0 3.561681793939897e-08
- O 0 1.4142162441110884e-10
neurophysin O 0 3.873902976181398e-09
II O 0 3.7967979454878176e-11
( O 0 4.322615128251467e-13
AVP O 0 1.0662458471699665e-08
- O 0 2.1117464721331913e-10
NPII O 0 6.556857279349515e-09
) O 0 4.9643865813976326e-14
gene O 0 6.062869650769187e-11
on O 0 8.247094847313452e-12
chromosome O 0 6.566973098642848e-08
20p13 O 0 8.201776324767707e-08
. O 0 7.872619223192601e-11

In O 0 2.3759843051363028e-11
this O 0 6.154599840023107e-15
study O 0 1.7740983107496916e-14
, O 0 4.187540308812129e-15
we O 0 7.576841003296541e-16
analyzed O 0 3.982724523440839e-14
two O 0 9.260101933771729e-16
families O 0 2.8191125251062995e-16
with O 0 5.880334065713072e-16
FNDI B-Disease 1 0.9999998807907104
using O 0 4.3471692581396534e-14
direct O 0 1.4360031176316457e-12
automated O 0 2.7891873255470045e-09
fluorescent O 0 4.808682965706801e-11
, O 0 4.239026664409895e-12
solid O 0 2.8582175515268204e-10
phase O 0 1.0482539586787604e-13
, O 0 3.831125785266464e-15
single O 0 1.2691544592612763e-13
- O 0 2.0147342127962986e-11
stranded O 0 4.767558917095904e-11
DNA O 0 4.657062929736e-12
sequencing O 0 3.4249854471632424e-13
of O 0 3.3014527899423007e-15
PCR O 0 1.6299657179530413e-09
- O 0 5.6765384059964674e-11
amplified O 0 8.294001596631517e-10
AVP O 0 1.348110743037978e-07
- O 0 4.1579206744302155e-10
NPII O 0 1.9218084901240218e-08
DNA O 0 1.5663988994774058e-09
. O 0 4.758871248455865e-12

In O 0 6.914020571346935e-12
one O 0 5.6363706833328225e-15
of O 0 7.97691540997451e-18
the O 0 1.4708729776048886e-16
families O 0 7.157727512808337e-16
, O 0 1.1399025297013552e-16
affected O 0 9.865039100415357e-16
individuals O 0 2.953738552079469e-17
presented O 0 2.0554714749926664e-14
a O 0 9.990478496563204e-14
novel O 0 2.3659272457843272e-11
nonsense O 0 5.2101825076533714e-09
mutation O 0 3.749178051348778e-12
in O 0 1.2615334124554956e-12
exon O 0 2.1362306021344146e-11
3 O 0 5.884797315246215e-13
of O 0 1.4843338663839763e-15
the O 0 2.42999649468687e-15
gene O 0 6.2558595456674304e-12
, O 0 1.296804901147492e-14
consisting O 0 5.22421440383601e-16
in O 0 1.648187710173287e-14
a O 0 7.564506204586763e-13
G O 0 1.2202571175734533e-09
to O 0 5.634291319091267e-13
T O 0 2.2258618059822766e-07
transition O 0 1.299596823385596e-12
at O 0 3.644717177803819e-13
nucleotide O 0 2.6674795185199773e-12
2101 O 0 8.632011772036208e-11
, O 0 7.507765466447953e-15
which O 0 3.5102096184468393e-16
produces O 0 1.28587402566647e-14
a O 0 2.123646717462277e-13
stop O 0 2.058742933075397e-11
signal O 0 2.4258268727095356e-09
in O 0 5.627233123917108e-10
codon O 0 8.696337872038384e-09
82 O 0 2.4775792528686225e-11
( O 0 6.052525668154285e-12
Glu O 0 2.4319156466390268e-08
) O 0 1.417655381107108e-12
of O 0 2.560893662927055e-13
NPII O 0 1.9993917703686748e-06
. O 0 6.460935952912195e-11

The O 0 6.40330011236756e-11
premature O 0 1.6134483749041806e-09
termination O 0 4.060028008234795e-11
eliminates O 0 1.696815778162719e-11
part O 0 4.02120285854235e-14
of O 0 8.857852869263358e-16
the O 0 1.547685218102491e-14
C O 0 3.249842894792465e-10
- O 0 1.6896774777952484e-12
terminal O 0 1.599232682045204e-12
domain O 0 2.2026106524623834e-13
of O 0 4.625415049686423e-16
NPII O 0 8.245289867536698e-11
, O 0 2.2942054135994215e-16
including O 0 2.6072218401330424e-17
a O 0 4.886271763045831e-15
cysteine O 0 6.332411808460114e-13
residue O 0 2.6560375426809557e-11
in O 0 8.517482780277114e-14
position O 0 6.287181333278907e-14
85 O 0 6.727889102900236e-15
, O 0 1.8305389959372663e-15
which O 0 6.021872212408081e-16
could O 0 7.025801517174593e-14
be O 0 1.0124247064142934e-15
involved O 0 2.6419355730346837e-15
in O 0 4.932045440456112e-13
the O 0 3.5065076927146e-13
correct O 0 1.47559897634153e-09
folding O 0 7.051965261739568e-11
of O 0 7.755963060652408e-15
the O 0 3.728303473241046e-13
prohormone O 0 1.5605881742430938e-07
. O 0 9.797241490305808e-11

In O 0 3.4800530512857364e-11
the O 0 2.8831134663920635e-14
second O 0 7.838793633294094e-13
family O 0 1.7967037905207428e-13
, O 0 2.5126669103388895e-15
a O 0 9.346736675375136e-15
G279A O 0 3.592801403606849e-12
substitution O 0 6.02387741467994e-14
at O 0 1.0780566435213135e-13
position O 0 2.9738234444409706e-13
- O 0 9.6816729980298e-12
1 O 0 4.1942411864578574e-14
of O 0 4.736675474286236e-16
the O 0 2.7626794843910738e-15
signal O 0 5.979692652494095e-13
peptide O 0 3.0575016260123156e-14
was O 0 1.3247027444169418e-13
observed O 0 1.778664580665045e-15
in O 0 1.66378429723767e-14
all O 0 4.647150973904153e-16
affected O 0 5.696027213807943e-15
individuals O 0 5.736977445159426e-16
. O 0 7.120292853587951e-13

This O 0 5.934938304696935e-12
missense O 0 1.2972719787285314e-07
mutation O 0 9.138745316050745e-10
, O 0 1.5256268470764667e-11
which O 0 1.114429620634183e-12
replaces O 0 7.869117979453222e-08
Ala O 0 1.206497927341843e-05
with O 0 1.0996031559254438e-12
Thr O 0 7.445469964295626e-05
, O 0 1.860131189704295e-12
is O 0 6.093672760127105e-15
frequent O 0 1.0608112695556504e-12
among O 0 7.792421222174717e-12
FNDI B-Disease 1 1.0
patients O 0 3.6237488565404874e-09
and O 0 1.0336855510277316e-15
is O 0 1.9736504600096864e-17
thought O 0 3.899689714214911e-15
to O 0 1.567875852468941e-16
reduce O 0 2.3082842129135313e-14
the O 0 9.880108240063485e-15
efficiency O 0 1.362929138038621e-13
of O 0 2.21419071093484e-16
cleavage O 0 6.432798738131851e-12
by O 0 1.4560977478015463e-13
signal O 0 1.3124149544907482e-09
peptidases O 0 4.8500766069992096e-08
. O 0 3.883307304192174e-12
. O 0 2.6535347270179033e-12

Genetic O 0 1.2229186552303872e-08
heterogeneity O 0 1.0594984889422676e-09
of O 0 6.151800531657703e-13
Saethre B-Disease 0 0.3533564805984497
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 0.9999990463256836
syndrome I-Disease 1 1.0
, O 0 6.126379785420522e-13
due O 0 8.053399527113703e-14
to O 0 1.3374672260002031e-14
TWIST O 0 8.556620656463565e-08
and O 0 3.332955786361502e-11
FGFR O 0 1.2179795305655716e-07
mutations O 0 1.8419515912526663e-09
. O 0 5.076473269527426e-11

Thirty O 0 6.958460119221854e-08
- O 0 3.305774498585379e-08
two O 0 3.148263578002866e-14
unrelated O 0 1.1819451667394176e-12
patients O 0 7.156246623930829e-14
with O 0 2.0634020380135275e-18
features O 0 1.467052763721565e-14
of O 0 2.4497244849514856e-14
Saethre B-Disease 1 0.963374137878418
- I-Disease 1 0.9999978542327881
Chotzen I-Disease 1 0.9999898672103882
syndrome I-Disease 1 1.0
, O 0 3.305657207382587e-14
a O 0 1.2150453169643138e-13
common O 0 1.0422605833948495e-10
autosomal B-Disease 0 5.077518289908767e-05
dominant I-Disease 0 4.075943797943182e-05
condition I-Disease 1 0.962226390838623
of O 0 4.565785683557921e-12
craniosynostosis B-Disease 0 0.0001263719896087423
and O 0 2.0913998310945203e-10
limb B-Disease 0 0.001111108111217618
anomalies I-Disease 0 0.00023737257288303226
, O 0 1.2465508226339184e-12
were O 0 4.426000852712081e-13
screened O 0 2.5055795979667117e-11
for O 0 1.936962968287375e-15
mutations O 0 9.907934932565365e-13
in O 0 2.0356603230332893e-13
TWIST O 0 2.4781441343435517e-09
, O 0 1.4604542618659733e-12
FGFR2 O 0 3.17306216857105e-08
, O 0 1.2159570225711569e-12
and O 0 9.032692671086251e-13
FGFR3 O 0 7.419868808256069e-08
. O 0 8.450643830537619e-12

Nine O 0 4.93235341458842e-10
novel O 0 2.1534945701673358e-11
and O 0 6.912224156767344e-13
three O 0 2.88308060151371e-14
recurrent O 0 3.3795596876551315e-10
TWIST O 0 2.7042460715165362e-08
mutations O 0 4.2465406191460886e-10
were O 0 3.652835672829369e-11
found O 0 2.3830101086863564e-11
in O 0 5.035293796501472e-12
12 O 0 4.105924042603626e-13
families O 0 1.5945444021159966e-13
. O 0 1.1198160454473083e-12

Seven O 0 1.1421274516421054e-11
families O 0 1.8043956628334412e-14
were O 0 1.5688518726521944e-15
found O 0 2.2576733590403764e-15
to O 0 1.9728600062163307e-17
have O 0 1.7769351511449883e-15
the O 0 1.0459461411810008e-15
FGFR3 O 0 1.7728352119661395e-08
P250R O 0 8.941714729759909e-11
mutation O 0 1.3828094485440756e-12
, O 0 1.5955544719649384e-13
and O 0 3.2898113808734744e-15
one O 0 2.7108865960400255e-16
individual O 0 1.3468730451294734e-17
was O 0 1.1664340283587538e-12
found O 0 4.2637237056969424e-13
to O 0 2.432138641010476e-15
have O 0 7.1038171479682714e-15
an O 0 1.0533175512835997e-15
FGFR2 O 0 1.592123233251641e-08
VV269 O 0 5.775214972914e-09
- O 0 1.0267915406814154e-09
270 O 0 1.159432619357581e-10
deletion O 0 4.4589135939077096e-08
. O 0 6.770279475931673e-11

To O 0 4.376975778347392e-12
date O 0 4.7440107397989095e-11
, O 0 5.644442568506977e-14
our O 0 5.7070106900349894e-15
detection O 0 4.2086681904286716e-13
rate O 0 2.877314001208803e-13
for O 0 4.8227124488568973e-17
TWIST O 0 4.2795669785711254e-11
or O 0 4.641482510836514e-12
FGFR O 0 1.0791971760681918e-08
mutations O 0 3.6598859359804337e-11
is O 0 3.9241898034010625e-13
68 O 0 9.490121362365489e-12
% O 0 6.788320583818799e-14
in O 0 7.760231801774709e-13
our O 0 9.238826717550275e-12
Saethre B-Disease 1 0.990847110748291
- I-Disease 1 0.9999994039535522
Chotzen I-Disease 1 0.9999862909317017
syndrome I-Disease 1 1.0
patients O 0 9.13230291388345e-09
, O 0 4.487162967310287e-15
including O 0 2.128474153046257e-15
our O 0 4.3908097508349106e-14
five O 0 3.0103923639914626e-14
patients O 0 1.9849563209469248e-14
elsewhere O 0 4.72127653812493e-13
reported O 0 1.319406667255052e-10
with O 0 6.274231893581284e-14
TWIST O 0 5.996634513394383e-07
mutations O 0 7.254433853631781e-08
. O 0 2.812794164253063e-10

More O 0 1.4740487476461173e-13
than O 0 2.687935179542986e-15
35 O 0 3.584623103989465e-15
different O 0 3.9215423172211245e-16
TWIST O 0 1.9572303500137167e-10
mutations O 0 3.331383779947572e-12
are O 0 5.2744314720919866e-14
now O 0 4.3662817095614995e-14
known O 0 6.332795751554446e-14
in O 0 1.892652050708432e-12
the O 0 4.508080107129553e-14
literature O 0 5.239575787130413e-11
. O 0 2.4206511361341e-12

The O 0 2.578561753767243e-14
most O 0 2.6237353760970306e-16
common O 0 7.28749401911888e-16
phenotypic O 0 2.3075061284481835e-13
features O 0 2.1459968676217078e-13
, O 0 1.2393567549724531e-14
present O 0 1.969478233791863e-15
in O 0 2.133471622024069e-13
more O 0 2.368486867881394e-15
than O 0 1.8178462072226606e-15
a O 0 1.1564204726189492e-13
third O 0 4.418319009269478e-12
of O 0 4.7950907838562734e-15
our O 0 1.5349193270564054e-12
patients O 0 3.043496783262413e-14
with O 0 4.71565370472216e-16
TWIST O 0 4.633572636691952e-09
mutations O 0 2.845755020519647e-10
, O 0 9.342361953490474e-13
are O 0 1.5228075216284533e-14
coronal B-Disease 0 3.5549185817274065e-10
synostosis I-Disease 0 3.93581096602702e-08
, O 0 1.55833267297123e-12
brachycephaly B-Disease 0 2.8571957955136895e-06
, O 0 3.898954076264616e-11
low B-Disease 0 0.0008764191879890859
frontal I-Disease 1 0.9999997615814209
hairline I-Disease 1 1.0
, O 0 1.0904318559212811e-09
facial B-Disease 1 0.886026918888092
asymmetry I-Disease 0 3.618416485551279e-06
, O 0 2.76315553771056e-10
ptosis B-Disease 0 0.0004985088016837835
, O 0 1.9638743756211774e-11
hypertelorism B-Disease 0 7.56699455450871e-06
, O 0 1.2904950545677973e-11
broad B-Disease 0 1.2469052457220187e-08
great I-Disease 0 2.295546011055194e-07
toes I-Disease 1 0.9999773502349854
, O 0 5.6712783774726105e-11
and O 0 2.0570736954106383e-12
clinodactyly B-Disease 0 1.2732552789884721e-08
. O 0 3.717412662418429e-12

Significant O 0 1.556891171539121e-09
intra O 0 0.000995864626020193
- O 0 4.0170772990677506e-05
and O 0 8.739736907271978e-13
interfamilial O 0 2.513862173980641e-10
phenotypic O 0 8.472322843289248e-11
variability O 0 1.4376591063458566e-11
is O 0 2.5239836940306806e-15
present O 0 1.5469045078350067e-16
for O 0 1.0913351163436717e-16
either O 0 5.019619905822191e-14
TWIST O 0 3.272112891750112e-08
mutations O 0 1.4577549833916237e-08
or O 0 2.05786565565802e-09
FGFR O 0 2.5394508611498168e-06
mutations O 0 2.0409020251577203e-08
. O 0 3.00987595958091e-10

The O 0 1.1666114309392267e-13
overlap O 0 5.30114363864187e-12
in O 0 1.6963673846702443e-13
clinical O 0 3.7532184391647627e-13
features O 0 4.324641231061299e-14
and O 0 1.1068236272979409e-14
the O 0 2.3506276017050106e-16
presence O 0 5.766559647325809e-14
, O 0 6.227780606753858e-14
in O 0 1.89326398796711e-14
the O 0 2.2447990405772623e-16
same O 0 2.9243897207249445e-15
genes O 0 1.2385214381849252e-12
, O 0 3.5328890420766035e-14
of O 0 3.043340741264683e-17
mutations O 0 3.504058751057498e-14
for O 0 1.2021190055013149e-15
more O 0 2.675361504836588e-16
than O 0 1.2436136672796454e-15
one O 0 2.607016978597304e-14
craniosynostotic B-Disease 0 2.6435932554136343e-08
condition I-Disease 0 3.838772077990882e-10
- O 0 1.2057489338565541e-12
such O 0 1.1897920291408046e-15
as O 0 9.729386350396108e-14
Saethre B-Disease 0 6.581537537186932e-10
- I-Disease 0 1.1853870662825727e-10
Chotzen I-Disease 0 1.2766251389351169e-09
, I-Disease 0 7.20991192096343e-14
Crouzon I-Disease 0 2.7562443993822683e-10
, I-Disease 0 2.4764038205043332e-14
and I-Disease 0 1.209323033423207e-13
Pfeiffer I-Disease 0 2.3156935924362188e-07
syndromes I-Disease 0 2.509553098661854e-08
- O 0 6.347001396678209e-11
support O 0 1.2479864113423746e-14
the O 0 7.372159197361684e-16
hypothesis O 0 9.910425073905021e-14
that O 0 7.542725163159098e-16
TWIST O 0 1.1840492475378994e-10
and O 0 5.752410808974873e-14
FGFRs O 0 5.9530097865079235e-12
are O 0 2.6976101486852024e-16
components O 0 1.3836997242173531e-14
of O 0 8.263665841122142e-18
the O 0 1.1429330547679535e-16
same O 0 2.229728683319273e-15
molecular O 0 2.779302802442471e-14
pathway O 0 2.8362881298151302e-14
involved O 0 6.3614355448637135e-15
in O 0 6.980063093275576e-15
the O 0 1.7383104487501922e-15
modulation O 0 4.775109994914484e-12
of O 0 1.211211307031862e-13
craniofacial O 0 1.0269040018329179e-07
and O 0 2.441591850574354e-12
limb O 0 1.4398678693794409e-08
development O 0 2.7129819658161525e-12
in O 0 7.513530813144098e-13
humans O 0 1.3146477179440397e-12
. O 0 1.2587358455898312e-12
. O 0 3.9639641395694536e-12

Mutation O 0 9.544066870148527e-09
analysis O 0 2.5636540113005424e-10
of O 0 3.924526448175619e-13
UBE3A O 0 0.0005449072341434658
in O 0 3.3647902455413714e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 7.784504123264924e-05
. O 0 2.9326960998554696e-11

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9996552467346191
AS B-Disease 1 1.0
) O 0 3.1099227359998594e-11
is O 0 1.2469443067073677e-14
caused O 0 6.580416431618526e-15
by O 0 2.0914344610540106e-15
chromosome O 0 8.788905603296371e-08
15q11 O 0 1.1836163338330152e-07
- O 0 2.415779576381283e-09
q13 O 0 2.5410957782412424e-09
deletions O 0 2.43305553482287e-09
of O 0 1.3649159215790418e-14
maternal O 0 1.1388986542043567e-12
origin O 0 1.6951900766361966e-13
, O 0 9.636521046190935e-15
by O 0 5.072184907056309e-15
paternal O 0 6.191860801862958e-09
uniparental B-Disease 0 3.474617642496014e-06
disomy I-Disease 0 4.98111376145971e-07
( O 0 1.2285967798675301e-09
UPD B-Disease 1 1.0
) O 0 4.1132885292283206e-11
15 O 0 9.236725967420867e-13
, O 0 1.6490420699555352e-15
by O 0 4.674641004690817e-15
imprinting O 0 1.805056308512576e-05
defects O 1 0.9461917877197266
, O 0 8.309042202111344e-14
and O 0 7.330435730808476e-15
by O 0 1.7249933967534601e-15
mutations O 0 5.952797976771507e-11
in O 0 9.721493575420848e-12
the O 0 2.4178860411235015e-13
UBE3A O 0 4.3008078876027866e-08
gene O 0 1.0121232740800679e-08
. O 0 1.2913477231979442e-10

UBE3A O 0 2.7426758606452495e-06
encodes O 0 1.332792654018533e-09
a O 0 2.869560275162164e-12
ubiquitin O 0 1.398134663599393e-10
- O 0 4.157910474256177e-11
protein O 0 5.2225519915627405e-12
ligase O 0 1.5253095661527105e-11
and O 0 5.0100548709686166e-14
shows O 0 1.0097533703276595e-12
brain O 0 2.009252320078758e-09
- O 0 1.572181718145771e-09
specific O 0 1.3688392433430785e-11
imprinting O 0 1.7720127232223604e-07
. O 0 1.7003479180210945e-10

Here O 0 3.2641556124701765e-10
we O 0 2.0878216961273816e-13
describe O 0 1.2796948830468002e-12
UBE3A O 0 1.1924228715542995e-07
coding O 0 3.6042368378730316e-07
- O 0 3.0996055500054354e-08
region O 0 3.5612707227627993e-10
mutations O 0 5.931948265924802e-09
detected O 0 1.6920527479147296e-10
by O 0 2.8107077348080503e-14
SSCP O 0 9.810241508034778e-10
analysis O 0 1.8463835603672873e-13
in O 0 2.766858736482497e-13
13 O 0 7.392432477791588e-13
AS B-Disease 1 0.9999998807907104
individuals O 0 4.578211491722717e-16
or O 0 2.295644956681192e-13
families O 0 1.2176669178173838e-13
. O 0 1.0353110512992258e-12

Two O 0 4.5975597461056505e-12
identical O 0 9.053947695736309e-12
de O 0 5.894354448976458e-10
novo O 0 2.4467109227543915e-08
5 O 0 2.915084493237963e-11
- O 0 1.3749085203684785e-09
bp O 0 1.475008004625522e-09
duplications O 0 1.6191608054327844e-09
in O 0 3.1798658758214193e-12
exon O 0 3.1805241773597004e-10
16 O 0 1.7907663199534518e-11
were O 0 1.062710791761845e-12
found O 0 1.4250862859568891e-12
. O 0 2.855940852732053e-13

Among O 0 8.9966196385044e-13
the O 0 1.4811663866777188e-15
other O 0 2.4604420351847416e-15
11 O 0 2.572527999270772e-15
unique O 0 3.3492498003646768e-15
mutations O 0 1.2948567565396196e-11
, O 0 3.057191305666507e-11
8 O 0 1.4142929449095787e-12
were O 0 1.8123019361257486e-13
small O 0 1.8316233675163412e-13
deletions O 0 3.925013647432252e-09
or O 0 1.0704336722566765e-11
insertions O 0 8.352856184501434e-09
predicted O 0 1.2012838501718193e-09
to O 0 3.4395500770473264e-14
cause O 0 3.308454855563414e-12
frameshifts O 0 2.2461367166215496e-07
, O 0 6.17570122644906e-13
1 O 0 7.633668274321243e-14
was O 0 2.5902420399542825e-12
a O 0 5.774109760204454e-14
mutation O 0 1.2181081881015854e-13
to O 0 6.014024134514415e-15
a O 0 7.859629559594378e-14
stop O 0 4.130551369690982e-12
codon O 0 7.802390677991156e-11
, O 0 4.94170371669652e-14
1 O 0 4.433983358969641e-14
was O 0 1.0912915536509527e-12
a O 0 8.320941049903829e-13
missense O 0 1.3042355639925063e-08
mutation O 0 5.5340107496526514e-11
, O 0 5.177355506119641e-12
and O 0 7.50874622895692e-13
1 O 0 3.611122089287183e-13
was O 0 3.85010634484928e-11
predicted O 0 5.1352352925526645e-11
to O 0 1.8314749673439823e-15
cause O 0 3.13528398393232e-14
insertion O 0 3.1480688281876334e-12
of O 0 1.2454896123237531e-14
an O 0 2.0736139042833168e-13
isoleucine O 0 3.921117297522869e-08
in O 0 3.4875249389776375e-13
the O 0 1.650761165673635e-14
hect O 0 1.717024439296111e-10
domain O 0 6.449983776246615e-13
of O 0 7.949826667664052e-16
the O 0 3.798542968884433e-15
UBE3A O 0 1.901319657271472e-10
protein O 0 1.6394384764681358e-12
, O 0 1.0890405940868104e-14
which O 0 1.230545907667202e-16
functions O 0 1.986583031840259e-16
in O 0 1.9869099600881195e-15
E2 O 0 8.137793390539105e-12
binding O 0 1.8051745265691005e-13
and O 0 6.114842654577832e-14
ubiquitin O 0 2.073638569882741e-12
transfer O 0 7.179837887422158e-12
. O 0 3.3910819031285344e-12

Eight O 0 3.5643134277396626e-11
of O 0 4.837140993368884e-16
the O 0 6.391472921360127e-16
cases O 0 1.2739559332854231e-14
were O 0 1.6384741057407642e-14
familial O 0 9.200860559555046e-12
, O 0 5.805323669699769e-12
and O 0 1.1787218770487051e-11
five O 0 6.487804217469861e-12
were O 0 3.760918659834189e-11
sporadic O 0 4.089365290838032e-08
. O 0 1.1272334628220637e-11

In O 0 2.8984420419320145e-10
two O 0 5.707386603256981e-13
familial O 0 4.361290439902632e-09
cases O 0 3.2131391991541136e-10
and O 0 4.72493409415381e-13
one O 0 1.56313059284513e-13
sporadic O 0 3.0629259129000275e-09
case O 0 5.1806080259009235e-11
, O 0 5.248509892213753e-14
mosaicism O 0 6.972656341197592e-10
for O 0 6.943391987670328e-14
UBE3A O 0 2.5442059126135064e-08
mutations O 0 1.5603389413865187e-10
was O 0 2.5954050106996585e-12
detected O 0 1.0640784260662617e-11
in O 0 6.630159203775687e-14
the O 0 1.220933195446609e-15
mother O 0 4.741441961275683e-11
of O 0 2.1063415791811962e-16
three O 0 7.721593546852756e-13
AS B-Disease 1 1.0
sons O 0 5.179284084944058e-11
, O 0 3.5461330798332823e-15
in O 0 2.7532528547210807e-15
the O 0 1.5776620740948232e-15
maternal O 0 5.828144824387982e-12
grandfather O 0 5.489479010245546e-11
of O 0 1.398072454552072e-15
two O 0 6.058516860939223e-13
AS B-Disease 1 1.0
first O 0 2.643812089826031e-14
cousins O 0 1.6007899866776754e-11
, O 0 2.7354674921693453e-14
and O 0 9.224603841743485e-15
in O 0 4.149316253001384e-14
the O 0 1.1202764586761178e-14
mother O 0 4.2963513302574086e-10
of O 0 1.1830395883644118e-15
an O 0 9.41559981024187e-13
AS B-Disease 1 1.0
daughter O 0 0.0001864693476818502
. O 0 1.9731482073237494e-11

The O 0 1.830732830956916e-13
frequencies O 0 1.1927316773130414e-12
with O 0 3.0588007204435195e-15
which O 0 2.935523121783655e-14
we O 0 1.2041711757500989e-14
detected O 0 3.6284652582888044e-13
mutations O 0 6.795539608459022e-13
were O 0 2.097312666420048e-13
5 O 0 1.6554455331576593e-15
( O 0 3.4024032777388996e-14
14 O 0 1.0347221668892403e-13
% O 0 1.083116106840535e-14
) O 0 1.0316100661970744e-14
of O 0 3.3092954680009282e-15
35 O 0 1.4628826578919063e-12
in O 0 6.672178543172536e-13
sporadic O 0 6.422311571441242e-10
cases O 0 2.7368466650953827e-13
and O 0 3.0005650877374182e-15
8 O 0 2.7281817382735375e-15
( O 0 7.24359621899007e-15
80 O 0 1.7727654197038922e-14
% O 0 1.507358826516661e-14
) O 0 5.596202686908129e-14
of O 0 6.063473833271826e-14
10 O 0 7.233414713557484e-13
in O 0 6.598043509123408e-13
familial O 0 6.06394823243761e-10
cases O 0 2.6938685657174055e-11
. O 0 9.776747689422063e-14
. O 0 2.9905481303132975e-12

The O 0 7.963839310232146e-11
hemochromatosis B-Disease 1 1.0
845 O 0 9.939716605344984e-09
G O 0 1.4774351742019576e-09
- O 0 3.212942967234511e-10
- O 0 3.8742112296041853e-10
> O 0 2.169899242926432e-12
A O 0 1.0651515205874901e-13
and O 0 1.4182373444108815e-15
187 O 0 6.586774176217322e-14
C O 0 4.632843414453802e-11
- O 0 1.3586745617466534e-10
- O 0 4.076241566508543e-09
> O 0 1.5130853514566667e-10
G O 0 4.552190013829005e-10
mutations O 0 2.2945362276871606e-10
: O 0 4.378977649238669e-13
prevalence O 0 9.922866694989096e-11
in O 0 9.705481860897147e-13
non O 0 5.733836072607801e-09
- O 0 2.596844739244375e-09
Caucasian O 0 4.429362654434499e-09
populations O 0 6.152983678120449e-10
. O 0 3.0041677478998e-11

Hemochromatosis B-Disease 0 0.0027255695313215256
, O 0 1.5260692015628408e-11
the O 0 8.209350733923149e-12
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 1.7739697311482984e-14
iron I-Disease 0 1.8967613257814264e-08
metabolism I-Disease 0 5.691046522926513e-10
, O 0 3.7863131683787965e-14
leads O 0 5.988844131981502e-14
, O 0 1.2848008518629578e-13
if O 0 9.026475313728133e-13
untreated O 0 9.750268370467552e-10
, O 0 4.2812097860974244e-14
to O 0 5.4616897891259994e-14
progressive O 0 2.006007998600623e-10
iron B-Disease 1 0.9444296956062317
overload I-Disease 1 0.9885411262512207
and O 0 1.4918670387942257e-07
premature B-Disease 0 3.403349069230899e-07
death I-Disease 0 1.8026235018564485e-11
. O 0 1.234648668024807e-12

The O 0 1.8510477872712983e-10
hemochromatosis B-Disease 1 1.0
gene O 0 7.143650115892797e-09
, O 0 2.854934604695769e-12
HFE O 0 8.364877679412075e-09
, O 0 3.099525302217854e-14
recently O 0 6.006845194861388e-12
has O 0 8.19246031419623e-15
been O 0 6.484231605293064e-15
identified O 0 4.650581135468013e-13
, O 0 1.814825264216278e-15
and O 0 1.0477471449851002e-15
characterization O 0 2.278918427665172e-13
of O 0 1.6527001140871509e-16
this O 0 2.0383380684064768e-16
gene O 0 6.274441469861225e-12
has O 0 1.5762319563721733e-13
shown O 0 3.578065374911822e-15
that O 0 3.023589719644836e-16
it O 0 1.1469949747967319e-16
contains O 0 3.02565489184936e-16
two O 0 1.8308602331825125e-15
mutations O 0 2.1419812538253646e-13
that O 0 1.5696420485128643e-15
result O 0 6.70183860460743e-15
in O 0 6.610892389069534e-13
amino O 0 1.3473396877350385e-11
acid O 0 2.6344924505816714e-12
substitutions O 0 8.931937763197173e-13
- O 0 8.399377656072293e-13
cDNA O 0 2.938821755393839e-11
nucleotides O 0 8.07865857543888e-11
845 O 0 1.9050040711565686e-10
G O 0 3.127621217569043e-10
- O 0 3.3499358842448146e-10
- O 0 9.280960444613129e-10
> O 0 5.983769035822206e-12
A O 0 5.804932814816588e-13
( O 0 1.2787720101575806e-13
C282Y O 0 1.3679231358754151e-11
) O 0 2.221569638454846e-15
and O 0 1.3898302945796956e-15
187 O 0 1.0501650682956734e-13
C O 0 4.8939297059291675e-11
- O 0 2.3290791517638354e-10
- O 0 2.783161257013944e-09
> O 0 5.751048248736623e-11
G O 0 1.8790288769388042e-10
( O 0 2.8648351052540377e-12
H63D O 0 8.728930112056332e-08
) O 0 5.487822002381293e-12
. O 0 9.869142829355138e-12

Although O 0 3.150896876746856e-09
hemochromatosis B-Disease 1 1.0
is O 0 1.1660936972968106e-12
common O 0 5.338042833279155e-13
in O 0 8.725163603770514e-13
Caucasians O 0 5.4477831135102406e-09
, O 0 1.272868529328397e-13
affecting O 0 3.1248690701007886e-12
> O 0 2.0582049953254966e-11
= O 0 5.735558555874931e-11
1 O 0 2.8186452737805068e-12
/ O 0 1.7109641481383164e-09
300 O 0 2.7710347444377323e-14
individuals O 0 4.714826259411811e-16
of O 0 2.3872791474666227e-17
northern O 0 3.018638670190116e-13
European O 0 2.9455769420816402e-12
origin O 0 6.170824078501405e-14
, O 0 1.0951261598945994e-12
it O 0 2.3887996073411466e-14
has O 0 2.317132827300318e-14
not O 0 7.251665054845615e-16
been O 0 2.8755167667013186e-15
recognized O 0 2.550289360998847e-15
in O 0 7.195898607884055e-14
other O 0 2.4575248537143978e-15
populations O 0 6.979640932054665e-14
. O 0 2.351874771322482e-12

The O 0 9.975929858661164e-14
present O 0 6.167431542141062e-15
study O 0 1.771703134508917e-15
used O 0 7.362298569185341e-15
PCR O 0 1.7089241480250372e-11
and O 0 1.4518698463727975e-15
restriction O 0 3.9807824462993746e-13
- O 0 7.513803489990478e-13
enzyme O 0 6.59131386623879e-13
digestion O 0 1.5635010647274683e-12
to O 0 5.038241967519224e-16
analyze O 0 1.3680860101467768e-13
the O 0 7.592956863909238e-16
frequency O 0 1.1998273197460357e-13
of O 0 6.349355002151295e-17
the O 0 1.545601877041248e-15
845 O 0 3.1494262493075853e-12
G O 0 8.362376763271229e-12
- O 0 2.284674359420702e-11
- O 0 5.476302050722026e-11
> O 0 4.742449922351399e-13
A O 0 3.71836621822913e-14
and O 0 1.4304843820369946e-15
187 O 0 5.2303118975617624e-14
C O 0 1.9495802541791285e-11
- O 0 4.436375572458573e-11
- O 0 1.0467875455333342e-09
> O 0 9.841609471816781e-11
G O 0 1.4002508874622066e-10
mutations O 0 1.0212011097854301e-10
in O 0 8.69685573556822e-12
HLA O 0 1.1261155563602188e-08
- O 0 5.4994765685822955e-11
typed O 0 2.113688807314773e-10
samples O 0 3.556378011092959e-13
from O 0 2.666154447282347e-14
non O 0 9.712583515231188e-11
- O 0 9.497422986948223e-11
Caucasian O 0 4.604564993182514e-11
populations O 0 5.816758750012974e-13
, O 0 2.3913468048201297e-15
comprising O 0 5.380886382320494e-16
Australian O 0 3.088560630122236e-14
Aboriginal O 0 3.5849869893436054e-14
, O 0 1.0922061044414655e-15
Chinese O 0 3.706744079159854e-15
, O 0 1.6934570472261143e-14
and O 0 4.9082621783125627e-14
Pacific O 0 6.918374293590768e-12
Islanders O 0 2.870188531289841e-09
. O 0 6.224355232620216e-12

Results O 0 1.8389924028028304e-09
showed O 0 7.36365829423491e-12
that O 0 7.67317286924769e-17
the O 0 1.7582703301659866e-16
845 O 0 1.025109034116789e-12
G O 0 1.1435355266875558e-11
- O 0 1.9565574854718548e-11
- O 0 1.0085070972776222e-10
> O 0 1.5777547454284835e-12
A O 0 1.481303415432761e-13
mutation O 0 4.1038727320932833e-13
was O 0 1.0599982263465035e-12
present O 0 7.012058492308687e-16
in O 0 4.061336634835974e-15
these O 0 2.3072462799157895e-17
populations O 0 1.974322626975447e-15
( O 0 6.504372354712877e-15
allele O 0 4.495453922309656e-12
frequency O 0 1.8269001762771797e-12
0 O 0 3.4764851181189396e-14
. O 0 2.752097501781026e-15
32 O 0 7.661996444209215e-14
% O 0 8.220667358372746e-15
) O 0 1.9805730948514733e-14
, O 0 1.8774855259882928e-13
and O 0 4.425365645764276e-14
, O 0 1.4214491874677514e-15
furthermore O 0 1.157143652408656e-14
, O 0 2.7900048943244396e-14
it O 0 2.710105089561571e-13
was O 0 4.713476275952644e-09
always O 0 2.3445249647952027e-12
seen O 0 4.092476140957202e-13
in O 0 2.710681402308553e-15
conjunction O 0 3.352997201178272e-14
with O 0 1.5325606994402718e-13
HLA O 0 2.7641334554573405e-08
haplotypes O 0 2.965343526284414e-10
common O 0 3.360281497499784e-11
in O 0 1.0578538045535879e-11
Caucasians O 0 3.7605496494563795e-09
, O 0 1.5438525634227547e-14
suggesting O 0 4.304071205343818e-13
that O 0 9.45240064741332e-16
845 O 0 2.1765853008837155e-12
G O 0 2.3779882576957512e-11
- O 0 1.0872040073772737e-10
- O 0 4.97010932409836e-10
> O 0 2.4345931087105255e-12
A O 0 3.51549670450646e-12
may O 0 7.971296366038327e-12
have O 0 1.9104147110831152e-14
been O 0 1.632500490583548e-14
introduced O 0 1.0531518419929636e-13
into O 0 1.9093060720101014e-15
these O 0 9.076488748910842e-17
populations O 0 9.920929510648748e-16
by O 0 2.227433224032214e-15
Caucasian O 0 1.0281868689787643e-09
admixture O 0 4.355224447749606e-08
. O 0 2.928248199474126e-10

187 O 0 6.449858425128241e-10
C O 0 5.123910629123429e-09
- O 0 1.132823390648241e-09
- O 0 2.0745596351900986e-09
> O 0 3.1559279495274595e-11
G O 0 2.439093545192339e-11
was O 0 1.0429232076471923e-13
present O 0 2.1193745045636837e-16
at O 0 6.34161582093091e-15
an O 0 8.363981839037266e-17
allele O 0 6.246690664735155e-12
frequency O 0 6.280479608600231e-11
of O 0 4.978187567034054e-12
2 O 0 7.241096611210196e-11
. O 0 3.9931818268668096e-11

68 O 0 6.738789437576997e-08
% O 0 1.1089278800779923e-11
in O 0 4.570610383225482e-13
the O 0 7.8550500336134e-16
two O 0 9.284508129355678e-16
populations O 0 1.0948591175113844e-15
analyzed O 0 2.5461558317459165e-13
( O 0 4.1693401118744755e-14
Australian O 0 1.4203022438707968e-12
Aboriginal O 0 3.719583235167745e-12
and O 0 4.712441916722432e-13
Chinese O 0 1.5701646254896728e-13
) O 0 1.4886023999832049e-13
. O 0 3.3612800043325564e-12

In O 0 3.0772500433234873e-12
the O 0 6.23937005035137e-15
Australian O 0 2.7740068136430582e-14
Aboriginal O 0 2.920379053601013e-13
samples O 0 5.053800734562512e-14
, O 0 4.1875704843608746e-16
187 O 0 4.342544797060824e-14
C O 0 2.1713989981075876e-11
- O 0 9.398849754038707e-11
- O 0 2.031099510801937e-09
> O 0 4.27237377420564e-11
G O 0 6.729802132232621e-11
was O 0 1.3211179112487814e-12
found O 0 1.0332530051828867e-13
to O 0 5.201307456568702e-16
be O 0 1.305200744660236e-16
associated O 0 8.868034311168473e-15
with O 0 3.229346653911731e-14
HLA O 0 5.435369487827302e-09
haplotypes O 0 5.49442297215208e-11
common O 0 2.042249399106244e-12
in O 0 1.2603838328920092e-12
Caucasians O 0 3.9590719591586776e-10
, O 0 1.2015557074155671e-14
suggesting O 0 3.518607117908995e-13
that O 0 4.426789846961789e-15
it O 0 1.736223740732984e-14
was O 0 1.0305569331930942e-12
introduced O 0 6.308202658150686e-14
by O 0 1.1906274153850342e-15
recent O 0 3.4683618824193907e-12
admixture O 0 5.373662070873308e-10
. O 0 6.308044364633503e-11

In O 0 1.3835778009396726e-11
the O 0 3.540428736449998e-15
Chinese O 0 5.089279302481322e-15
samples O 0 2.489531814747238e-14
analyzed O 0 1.4640988887839462e-13
, O 0 2.654531376476829e-16
187 O 0 2.5079376712844846e-14
C O 0 6.506591706395559e-12
- O 0 9.034661907492136e-12
- O 0 1.917244557558817e-10
> O 0 5.0551555129396686e-12
G O 0 1.6379985909309447e-11
was O 0 2.0629988602832716e-12
present O 0 8.546934285259735e-15
in O 0 3.0631257079416496e-12
association O 0 1.343637793258315e-13
with O 0 3.5942314486964237e-17
a O 0 8.083004175653188e-15
wide O 0 2.260946421403509e-13
variety O 0 1.1978590862271599e-12
of O 0 1.6115995799155514e-13
HLA O 0 1.2665895887664647e-08
haplotypes O 0 1.359981155468759e-10
, O 0 5.248242704140871e-13
showing O 0 6.3830065365200195e-12
this O 0 7.738699470396181e-16
mutation O 0 3.439799443546998e-14
to O 0 7.511947268108547e-15
be O 0 7.37511671877614e-15
widespread O 0 1.5637619034413776e-14
and O 0 1.0759942199387029e-13
likely O 0 6.237305593889686e-13
to O 0 5.034246089590552e-16
predate O 0 3.953438704878964e-12
the O 0 1.2224198441481587e-15
more O 0 4.571230881446158e-16
genetically O 0 5.245547648590615e-14
restricted O 0 1.349254231562333e-13
845 O 0 9.075749700382385e-12
G O 0 1.0014244988809651e-10
- O 0 8.314672284015501e-10
- O 0 8.612730084678333e-09
> O 0 1.0207455020116996e-10
A O 0 1.5758339078075778e-11
mutation O 0 2.0468490791181182e-10
. O 0 2.4586926244962726e-11

Genotype O 0 0.010415074415504932
- O 0 0.031715575605630875
phenotype O 0 6.364883120113518e-06
correlations O 0 3.962773917010054e-06
in O 0 1.4567070216742195e-08
attenuated B-Disease 1 0.9994539618492126
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999996423721313
coli I-Disease 1 1.0
. O 0 3.385149938139875e-08

Germ O 0 4.571446424961323e-06
- O 0 1.4383024790731724e-05
line O 0 4.4587988856648053e-10
mutations O 0 1.4464560105231783e-10
of O 0 2.4994553139440906e-15
the O 0 3.78435474350145e-15
tumor B-Disease 0 9.06805963651891e-10
suppressor O 0 1.0558879104394236e-08
APC O 0 4.732977898491697e-10
are O 0 8.45373033728225e-14
implicated O 0 3.8576941641110807e-10
in O 0 2.517470676366429e-10
attenuated B-Disease 1 0.9999034404754639
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 1.0
( O 0 5.225590939517133e-05
AAPC B-Disease 1 1.0
) O 0 5.010282466688665e-11
, O 0 3.905237271799658e-14
a O 0 2.7580701936723295e-13
variant O 0 5.775113550043898e-06
of O 0 2.1382873249820022e-09
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 4.9967678933171555e-05
FAP B-Disease 0 2.1362342522479594e-05
) O 0 1.306577845916479e-09
. O 0 8.672642465290537e-11

AAPC B-Disease 1 1.0
is O 0 9.885269686149556e-12
recognized O 0 2.7183559019755034e-14
by O 0 8.810471434380729e-16
the O 0 8.13589863035214e-16
occurrence O 0 2.9112861210309204e-13
of O 0 5.4193079026870674e-15
< O 0 3.1699737279566875e-10
100 O 0 1.257201943461253e-13
colonic B-Disease 0 9.086879582120844e-10
adenomas I-Disease 0 2.3703532292529417e-07
and O 0 6.413181617703767e-13
a O 0 1.2921292453973304e-13
later O 0 3.837611652068862e-12
onset O 0 2.1063501165485832e-08
of O 0 1.6172718719786872e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 6.411301611136677e-12
age O 0 3.536695242223331e-12
> O 0 1.220693511549964e-11
40 O 0 1.4304647960941552e-12
years O 0 6.217789954784947e-13
) O 0 1.3824104892496553e-13
. O 0 2.3690778071933094e-12

The O 0 4.069286547265724e-14
aim O 0 5.93036362205035e-13
of O 0 6.334383959506371e-16
this O 0 1.1227572064203889e-15
study O 0 6.053982490284663e-15
was O 0 1.6041810620755909e-13
to O 0 5.288562438047735e-15
assess O 0 2.0684728235798033e-11
genotype O 0 5.858996843244313e-08
- O 0 1.4847758222913399e-07
phenotype O 0 4.10195788447254e-08
correlations O 0 9.251276367194805e-08
in O 0 3.916301949402623e-09
AAPC B-Disease 1 1.0
families O 0 6.393125473458383e-10
. O 0 2.6318868959207542e-11

By O 0 6.144328210284933e-14
protein O 0 1.4858786423488368e-10
- O 0 1.0222261925818543e-10
truncation O 0 8.87595483223258e-11
test O 0 3.682410279481907e-12
( O 0 2.991475068960664e-14
PTT O 0 1.280398703729091e-11
) O 0 6.317928544560944e-15
assay O 0 7.712717725767704e-13
, O 0 4.662563797170629e-16
the O 0 6.61882728466392e-17
entire O 0 2.5588904300067987e-14
coding O 0 3.410965954131484e-11
region O 0 6.46842659730168e-13
of O 0 7.047352237638405e-15
the O 0 8.087141253974167e-14
APC B-Disease 0 1.0254438791157394e-11
gene O 0 2.1853012455164134e-11
was O 0 5.423783384223002e-12
screened O 0 9.193493188952573e-12
in O 0 4.1278534545574966e-14
affected O 0 1.7527137781501306e-14
individuals O 0 1.8630496292303236e-16
from O 0 4.3831306856603747e-13
11 O 0 3.9434542437044584e-11
AAPC B-Disease 1 1.0
kindreds O 0 2.726771981542697e-07
, O 0 4.09424273997705e-12
and O 0 1.2608153182516041e-14
their O 0 5.766377958758622e-16
phenotypic O 0 1.8859001166271483e-11
differences O 0 3.024802977535934e-11
were O 0 1.0816359613530224e-10
examined O 0 1.6108531175618168e-09
. O 0 7.16444828810503e-12

Five O 0 2.1338117037195126e-11
novel O 0 1.732825515021741e-11
germ O 0 2.0454545790471457e-07
- O 0 5.060877015239384e-07
line O 0 1.9798116479563532e-09
APC B-Disease 0 2.6215327131318134e-10
mutations O 0 4.530921818290956e-11
were O 0 9.158716320067928e-12
identified O 0 1.042101543946572e-10
in O 0 3.70399370897001e-12
seven O 0 7.78333040379886e-12
kindreds O 0 3.829378769637515e-08
. O 0 5.2971946273849824e-11

Mutations O 0 1.7676985430981063e-09
were O 0 4.811880061073026e-13
located O 0 3.239686554505454e-14
in O 0 4.2962605451305966e-14
three O 0 5.757893335605095e-16
different O 0 1.9558285890144354e-16
regions O 0 1.7087912234834378e-14
of O 0 2.5136543389971512e-15
the O 0 3.274094726888818e-14
APC B-Disease 0 6.1559945509215286e-12
gene O 0 9.89336130380325e-12
( O 0 2.2151657136197656e-13
1 O 0 2.895032914025826e-14
) O 0 5.546680058613959e-15
at O 0 2.427261408359527e-13
the O 0 5.474139733494627e-15
5 O 0 8.809068790171723e-14
end O 0 1.0771364269274164e-12
spanning O 0 6.296188397036939e-12
exons O 0 3.217657390530704e-11
4 O 0 2.999938622169629e-13
and O 0 7.282791313371548e-14
5 O 0 1.6638795037409414e-14
, O 0 1.3161718012666933e-14
( O 0 6.350649173203493e-14
2 O 0 1.0859997458061675e-14
) O 0 3.272201142383584e-15
within O 0 3.315512478075538e-15
exon O 0 1.1816121865682039e-11
9 O 0 6.3143362066808706e-12
, O 0 1.0512031918758283e-13
and O 0 8.282713029978891e-14
( O 0 1.754002216906858e-13
3 O 0 7.150965881724466e-14
) O 0 2.5042666304910845e-14
at O 0 2.1037041466470674e-12
the O 0 3.554226479644297e-14
3 O 0 4.764418026770301e-13
distal O 0 2.835067514084244e-09
end O 0 6.968720600575296e-10
of O 0 1.4062782344593638e-14
the O 0 1.3137747996699173e-13
gene O 0 9.96617455228943e-10
. O 0 4.1563488761831024e-11

Variability O 0 2.263303677807471e-08
in O 0 4.8407970340558215e-12
the O 0 1.3580811280243521e-14
number O 0 1.1686046011080697e-13
of O 0 3.625515165861515e-11
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 5.002518885244278e-11
most O 0 1.158524946093435e-16
apparent O 0 1.3206724896561053e-15
in O 0 1.2227841318429491e-14
individuals O 0 1.2570200547825332e-16
with O 0 4.830577017423256e-16
mutations O 0 5.2623482828251245e-12
in O 0 3.3843813168621395e-12
region O 0 2.0562980138083553e-11
1 O 0 1.934574549167234e-11
, O 0 7.666872345324371e-12
and O 0 8.040474536175068e-11
upper O 0 0.2783571481704712
- O 0 0.003066493896767497
gastrointestinal O 0 1.6302669791912194e-06
manifestations O 0 7.311045102653679e-10
were O 0 2.189853333389724e-11
more O 0 6.110517365535972e-14
severe O 0 8.586661937037832e-10
in O 0 1.9184352457318754e-12
them O 0 4.895960481650363e-13
. O 0 1.8705629493270814e-12

In O 0 5.049642995413883e-12
individuals O 0 7.987371614809335e-15
with O 0 2.6062799328782508e-15
mutations O 0 4.757455714099468e-12
in O 0 3.3876409164836085e-13
either O 0 9.351021476242116e-14
region O 0 1.660185704188688e-11
2 O 0 1.8270536993048037e-12
or O 0 7.731161197344072e-12
region O 0 6.172658217895588e-11
3 O 0 2.3768501056231628e-11
, O 0 8.77699009391858e-13
the O 0 9.511144923404248e-15
average O 0 4.5240346841987633e-13
number O 0 1.2915957544009965e-15
of O 0 4.2081478263254377e-16
adenomas B-Disease 0 3.83000298143088e-10
tended O 0 3.458763223745942e-12
to O 0 1.8652620528187723e-15
be O 0 6.23071210308101e-15
lower O 0 2.449665091001224e-13
than O 0 7.643757135525223e-16
those O 0 8.549501906820659e-17
in O 0 4.906668739932188e-15
individuals O 0 4.1651845947050255e-17
with O 0 4.165424807954911e-16
mutations O 0 4.858989729669694e-13
in O 0 8.207436466567408e-13
region O 0 4.970992692997223e-13
1 O 0 6.098364543384582e-13
, O 0 8.790371046080853e-14
although O 0 6.836086601305635e-13
age O 0 1.1175373777413955e-12
at O 0 8.521663192803675e-13
diagnosis O 0 1.4621644173207216e-10
was O 0 3.3848959876334184e-13
similar O 0 3.296485263579174e-13
. O 0 1.2729814598266831e-11

In O 0 2.6996067603590745e-09
all O 0 3.2807319361172205e-11
AAPC B-Disease 1 1.0
kindreds O 0 7.947174651690148e-08
, O 0 1.7935606884227073e-13
a O 0 6.213329547047342e-14
predominance O 0 9.23712287215217e-11
of O 0 7.176247443507755e-13
right O 1 0.9827477335929871
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 9.497472319708322e-08
rectal B-Disease 1 0.9738219976425171
polyp I-Disease 0 3.5706343624042347e-06
sparing O 0 2.587485559146785e-09
was O 0 3.041934412695291e-11
observed O 0 5.041540102057596e-12
. O 0 1.17921156780193e-12

No O 0 5.327191132664666e-09
desmoid B-Disease 0 0.0007404911448247731
tumors I-Disease 1 1.0
were O 0 9.946463652710236e-10
found O 0 1.0274133974141897e-11
in O 0 1.7968990824370618e-13
these O 0 7.465241024363998e-15
kindreds O 0 2.769916296330166e-09
. O 0 1.0660367553982919e-11

Our O 0 1.9232859662515756e-12
data O 0 6.643402733312598e-13
suggest O 0 5.497640239099724e-15
that O 0 3.6303218020432553e-16
, O 0 3.782074530807441e-15
in O 0 1.3424785588744825e-11
AAPC B-Disease 1 1.0
families O 0 1.3573307245957206e-13
, O 0 1.7103936457070094e-16
the O 0 5.606683131443625e-18
location O 0 1.224324461257531e-14
of O 0 7.833086998686688e-16
the O 0 3.288070770518514e-13
APC B-Disease 0 2.833175694050283e-09
mutation O 0 5.999360036534895e-11
may O 0 5.613830234008077e-11
partially O 0 1.9332023828977363e-11
predict O 0 1.0652725229709503e-11
specific O 0 6.910866193546306e-13
phenotypic O 0 1.6923634715837466e-09
expression O 0 1.393229198676238e-09
. O 0 1.5463605396170976e-10

This O 0 5.037865740895042e-13
should O 0 1.5178379115642765e-13
help O 0 2.794473331934385e-14
in O 0 2.0467084109335523e-14
the O 0 3.6156167806833286e-16
design O 0 8.954522236551132e-13
of O 0 1.7434296511856012e-16
tailored O 0 2.126684939263157e-11
clinical O 0 4.726257163412129e-10
- O 0 4.455765978406134e-09
management O 0 9.506739145903609e-11
protocols O 0 7.849300202866782e-12
in O 0 9.40517940763684e-15
this O 0 2.385541505697445e-16
subset O 0 1.9370536262237198e-13
of O 0 4.585712286108009e-15
FAP B-Disease 0 4.196394620681332e-10
patients O 0 5.256272153641994e-11
. O 0 1.6064375578470763e-13
. O 0 3.0240746972526322e-12

Wilms B-Disease 0 0.06000247970223427
' I-Disease 0 4.0829672798281536e-07
tumor I-Disease 0 1.27319026432815e-07
1 O 0 2.192519776844648e-11
and O 0 1.2598647168918231e-12
Dax O 1 0.9999752044677734
- O 0 8.91545892667267e-10
1 O 0 2.829529958860849e-13
modulate O 0 2.2077580041912626e-10
the O 0 5.096851760089116e-13
orphan O 0 4.24720703051662e-09
nuclear O 0 3.022494581006452e-12
receptor O 0 1.1467135400955453e-11
SF O 0 9.751671115054705e-08
- O 0 2.733230308749057e-10
1 O 0 3.662696502430146e-13
in O 0 2.1281027883911924e-13
sex O 0 6.9326003271363845e-12
- O 0 3.293041566428817e-13
specific O 0 2.8050949556863644e-14
gene O 0 9.852390431275282e-11
expression O 0 4.492147626100618e-11
. O 0 1.3900558655521866e-11

Products O 0 6.806281316329432e-09
of O 0 9.558506601243383e-14
steroidogenic O 0 1.478794775522374e-08
factor O 0 1.3173567271762554e-11
1 O 0 3.6009221862989826e-13
( O 0 1.7217910040431827e-12
SF O 0 1.9932516806875356e-05
- O 0 1.0529677574311336e-08
1 O 0 6.044715509384568e-12
) O 0 2.3810098857823814e-12
and O 0 2.308697157060724e-11
Wilms B-Disease 0 1.3587307989837427e-07
tumor I-Disease 0 1.4207603094007482e-08
1 O 0 3.047269684849918e-12
( O 0 1.0147539275875972e-12
WT1 O 0 1.3800292020249572e-09
) O 0 6.070138288500823e-14
genes O 0 8.046326192140407e-13
are O 0 2.6720279007935504e-15
essential O 0 4.91414295865876e-15
for O 0 3.98781159421079e-17
mammalian O 0 1.612968873049292e-12
gonadogenesis O 0 1.57821380963874e-10
prior O 0 1.1968816779686642e-12
to O 0 4.213324499946318e-14
sexual O 0 1.28418900947197e-12
differentiation O 0 6.640901717425152e-11
. O 0 8.539027991638637e-12

In O 0 1.0600229895241231e-11
males O 0 7.0156315652714074e-12
, O 0 3.323195397249984e-13
SF O 0 1.5090658962435555e-05
- O 0 1.2435089402629274e-08
1 O 0 6.890596491830603e-13
participates O 0 1.5548226226479167e-13
in O 0 7.01261423062538e-14
sexual O 0 9.734206814898932e-15
development O 0 1.601412004433107e-16
by O 0 8.269061871130071e-17
regulating O 0 1.5930305848326637e-13
expression O 0 1.717626793562837e-14
of O 0 1.8967535995971643e-16
the O 0 1.2580329208989921e-15
polypeptide O 0 6.549476239126051e-11
hormone O 0 2.5434775813293342e-12
Mullerian O 0 3.5076100357578355e-10
inhibiting O 0 4.752932075691163e-11
substance O 0 5.967146776697518e-10
( O 0 7.614180119741576e-11
MIS O 0 2.946886297650053e-06
) O 0 6.033119837045575e-11
. O 0 2.2446764932904095e-11

Here O 0 1.1781708053604234e-08
, O 0 3.86729493914717e-13
we O 0 4.1161917590495836e-15
show O 0 1.435555504764735e-14
that O 0 6.452056211758662e-15
WT1 O 0 9.669732037309586e-08
- O 0 4.495211758381856e-09
KTS O 0 3.3882835737131245e-07
isoforms O 0 1.2601285570568166e-09
associate O 0 9.988340016198194e-11
and O 0 2.07667626720082e-14
synergize O 0 4.4787586833683335e-11
with O 0 1.3854058179797128e-14
SF O 0 1.8566932340036146e-05
- O 0 9.083868768300363e-09
1 O 0 1.5558172155108463e-12
to O 0 1.3921558404770412e-13
promote O 0 8.320945495132737e-12
MIS O 0 4.981047254659643e-07
expression O 0 2.1003424000021198e-10
. O 0 2.6374145922769543e-11

In O 0 8.213552060709617e-11
contrast O 0 5.241105466291529e-11
, O 0 4.63471492087586e-12
WT1 O 0 5.181861411074351e-07
missense O 0 1.9379037041744596e-07
mutations O 0 1.0183093257509768e-09
, O 0 7.349899362090254e-14
associated O 0 7.353265132209463e-14
with O 0 9.530066792412962e-15
male B-Disease 0 5.766153665653917e-10
pseudohermaphroditism I-Disease 1 1.0
in O 0 2.1091068891365694e-09
Denys B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.3022550052199655e-11
fail O 0 6.38932240448753e-10
to O 0 1.3987398953386847e-14
synergize O 0 7.542158564355361e-10
with O 0 9.699300824311807e-13
SF O 1 0.9821065664291382
- O 0 6.027715244272258e-06
1 O 0 1.7071689895065134e-10
. O 0 4.2114908782586724e-11

Additionally O 0 1.1556021417558071e-10
, O 0 5.936110571190881e-14
the O 0 3.2365349143153102e-15
X O 0 4.066265191227103e-08
- O 0 5.134456859678949e-09
linked O 0 5.7645510587178705e-09
, O 0 2.711940643839589e-13
candidate O 0 8.101646090108439e-12
dosage O 0 7.670543311633082e-08
- O 0 7.908412258395003e-10
sensitive O 0 1.1624469165028017e-09
sex O 0 6.027724847035287e-11
- O 0 4.5762473671606685e-12
reversal O 0 6.696481910650753e-12
gene O 0 5.698122095693092e-12
, O 0 2.1577353890179368e-13
Dax O 1 0.8514377474784851
- O 0 6.99020286099028e-11
1 O 0 3.601078243649185e-14
, O 0 9.343207936116874e-15
antagonizes O 0 1.1894955853630762e-10
synergy O 0 1.2146965724935122e-11
between O 0 1.0698023413316382e-12
SF O 0 3.607289181672968e-05
- O 0 3.6052314467127644e-09
1 O 0 2.1840697111107088e-13
and O 0 3.075615933809117e-14
WT1 O 0 1.5925255558713047e-10
, O 0 7.960391074340444e-15
most O 0 1.1298377665847244e-15
likely O 0 7.410848803656063e-15
through O 0 1.304797609916902e-16
a O 0 4.816282701163629e-15
direct O 0 1.8885250080338117e-14
interaction O 0 1.534078718007023e-13
with O 0 4.987099058370581e-13
SF O 0 0.27786365151405334
- O 0 3.325087618577527e-07
1 O 0 7.890718634051552e-11
. O 0 4.730331404356747e-11

We O 0 2.493441737805302e-11
propose O 0 3.517396443553089e-11
that O 0 1.74504169252708e-14
WT1 O 0 1.2569294050024382e-08
and O 0 9.898684302789285e-12
Dax O 1 0.9998849630355835
- O 0 7.445564720320874e-10
1 O 0 3.568076145958263e-14
functionally O 0 4.160891683285817e-12
oppose O 0 1.1763803635638642e-13
each O 0 4.321143239099023e-15
other O 0 5.0560375791696213e-14
in O 0 5.790523767944256e-13
testis O 0 2.813844469928828e-11
development O 0 5.115773053115426e-14
by O 0 2.8016675215685946e-14
modulating O 0 2.5797586289399987e-09
SF O 0 2.0276286250009434e-06
- O 0 7.731434381597069e-10
1 O 0 1.313119665086182e-11
- O 0 1.0686369844581378e-10
mediated O 0 1.9635504333592735e-09
transactivation O 0 3.284681682202972e-08
. O 0 2.306134666910098e-12
. O 0 1.0878977840106385e-12

A O 0 1.206785504859198e-10
mouse O 0 1.4296459571738751e-09
model O 0 1.2081996514368143e-10
for O 0 8.888525332428898e-11
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 0 0.0018875135574489832
- O 0 0.0003955849970225245
centre O 0 4.886752336119571e-09
mutations O 0 7.715590299994801e-08
. O 0 6.542285463373432e-11

Imprinting O 0 2.7902726174033887e-07
in O 0 1.8838618165428755e-11
the O 0 6.000850315789064e-14
15q11 O 0 1.349182321419562e-09
- O 0 3.405643822507187e-10
q13 O 0 2.960528489026615e-10
region O 0 1.3080396141229578e-12
involves O 0 1.2840953072992128e-13
an O 0 5.073326707469208e-15
imprinting O 0 1.59088311968425e-10
centre O 0 1.823896415842352e-11
( O 0 3.1119906456454627e-13
IC O 0 2.7659977086536003e-10
) O 0 1.773956009214553e-14
, O 0 4.4458963691530046e-15
mapping O 0 1.4664493035686232e-13
in O 0 3.7546273598879076e-14
part O 0 7.270365848255095e-15
to O 0 5.238346513286238e-15
the O 0 2.8143863988979757e-15
promoter O 0 1.7124218709696493e-11
and O 0 2.0619711992540812e-13
first O 0 5.864871034568647e-14
exon O 0 2.2040164832093367e-11
of O 0 3.233070820611583e-13
SNRPN O 0 1.1766435363824712e-06
. O 0 3.308797680290354e-11

Deletion O 0 1.792648518517126e-08
of O 0 7.918810735179499e-14
this O 0 1.0875673327409921e-13
IC O 0 5.089044918804575e-08
abolishes O 0 3.8922743500480195e-11
local O 0 4.486840247757383e-14
paternally O 0 4.058905295201143e-11
derived O 0 6.337438711832843e-13
gene O 0 1.4432200226566216e-11
expression O 0 4.5119873007086475e-13
and O 0 2.4403554535219057e-14
results O 0 3.542999498385574e-13
in O 0 4.1948784001988315e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.544939878949663e-08
PWS B-Disease 1 1.0
) O 0 2.469371651603325e-10
. O 0 2.0584877552520808e-11

We O 0 1.733023793915045e-11
have O 0 1.2184678213503306e-14
created O 0 4.585694498416117e-15
two O 0 2.7960674479411175e-14
deletion O 0 1.0372629838384384e-10
mutations O 0 3.064389367257725e-11
in O 0 2.6206402499451276e-12
mice O 0 1.00412755887902e-09
to O 0 1.1449857988815593e-13
understand O 0 9.752625790282465e-11
PWS B-Disease 1 1.0
and O 0 5.137992895726251e-13
the O 0 6.082501666102242e-15
mechanism O 0 1.9864761691048421e-13
of O 0 1.536736194940574e-15
this O 0 1.2750602440200764e-13
IC O 0 2.597564652262463e-08
. O 0 1.0350213741627812e-11

Mice O 0 9.748314369062427e-06
harbouring O 0 8.756627778438997e-08
an O 0 7.103905679851918e-13
intragenic O 0 7.852232641880619e-09
deletion O 0 2.4934345699278992e-09
in O 0 4.309355389892078e-12
Snrpn O 0 2.928765141518852e-08
are O 0 1.2351709553163476e-13
phenotypically O 0 1.7763442938800722e-09
normal O 0 2.6324241397812642e-11
, O 0 2.212082445929124e-14
suggesting O 0 3.736383218880951e-13
that O 0 9.077323870457276e-16
mutations O 0 4.1938514835394847e-13
of O 0 1.0299737467737448e-15
SNRPN O 0 8.637385251475393e-10
are O 0 2.347841922099728e-15
not O 0 6.525244834719999e-16
sufficient O 0 4.9113502910316624e-15
to O 0 1.8467698412725532e-14
induce O 0 1.0780939474486217e-09
PWS B-Disease 1 1.0
. O 0 3.4727279385471377e-10

Mice O 0 5.282489382807398e-06
with O 0 1.7412257074557458e-13
a O 0 5.2233133725383685e-14
larger O 0 7.778663374232234e-14
deletion O 0 3.0015673974093104e-11
involving O 0 6.578035506707089e-14
both O 0 2.4222990150160606e-13
Snrpn O 0 4.700027922410754e-09
and O 0 2.1492564875719676e-14
the O 0 8.134910354660931e-15
putative O 0 5.710762973620831e-09
PWS O 1 1.0
- O 0 2.483886305526539e-07
IC O 0 2.4512605278914634e-08
lack O 0 2.2578150286889365e-12
expression O 0 1.9075535693125617e-13
of O 0 4.855999123148317e-16
the O 0 1.15537936748282e-14
imprinted O 0 2.0219534380139237e-10
genes O 0 1.810988303763139e-10
Zfp127 O 0 2.970859114270752e-09
( O 0 2.2097189529557415e-12
mouse O 0 2.6919864115626524e-09
homologue O 0 1.1618023876280859e-08
of O 0 2.8065627621400024e-13
ZNF127 O 0 2.033278967417118e-08
) O 0 7.730951295803479e-13
, O 0 1.5542030011063412e-13
Ndn O 0 5.699150040783252e-10
and O 0 7.563467538905522e-13
Ipw O 0 7.902219323341342e-09
, O 0 1.7132442383174795e-12
and O 0 1.531984988086682e-13
manifest O 0 5.434156271667823e-13
several O 0 3.1063772905413727e-15
phenotypes O 0 7.872496057825806e-12
common O 0 2.3679135041643207e-11
to O 0 5.462856833560181e-10
PWS B-Disease 1 1.0
infants O 0 0.1507294774055481
. O 0 3.215461230610117e-11

These O 0 2.5596617382085685e-14
data O 0 2.856228301833033e-14
demonstrate O 0 7.52263989439733e-16
that O 0 9.119763033528799e-18
both O 0 1.0520359639646244e-16
the O 0 1.881125285854951e-15
position O 0 2.380795213752229e-13
of O 0 2.528540519528672e-16
the O 0 1.0507135390696795e-14
IC O 0 7.766255416541412e-10
and O 0 1.646547515574224e-14
its O 0 2.797889320519455e-16
role O 0 4.828711893225049e-14
in O 0 1.4290507999495904e-14
the O 0 6.921620255134753e-16
coordinate O 0 4.5002277728953266e-14
expression O 0 5.93401602811891e-14
of O 0 1.3642698048468762e-15
genes O 0 7.242954066372098e-13
is O 0 5.501224882532504e-16
conserved O 0 4.341037756041069e-14
between O 0 3.832415884207768e-13
mouse O 0 2.00921768112039e-09
and O 0 6.751445648205123e-13
human O 0 1.1909233263451575e-14
, O 0 1.278985953739398e-14
and O 0 2.3187895390418527e-15
indicate O 0 1.2746510932252347e-14
that O 0 2.707414290351875e-16
the O 0 9.842485789403528e-16
mouse O 0 4.456976801514578e-11
is O 0 1.905290077048932e-15
a O 0 2.4006605673499012e-15
suitable O 0 5.373753877860668e-14
model O 0 2.9575907695145176e-12
system O 0 1.3246142464146127e-13
in O 0 3.9202771888111054e-13
which O 0 7.1046849332227335e-15
to O 0 8.053852372103128e-16
investigate O 0 6.449005622599126e-15
the O 0 6.472587972762751e-16
molecular O 0 4.9651726279726846e-14
mechanisms O 0 2.055323549158758e-13
of O 0 1.919647497263129e-15
imprinting O 0 2.8937673438034217e-11
in O 0 2.9227213097643423e-12
this O 0 5.619517692297777e-15
region O 0 3.4076851041474343e-13
of O 0 1.1316149475871823e-15
the O 0 6.1158425769720654e-15
genome O 0 2.8047006449087586e-13
. O 0 2.973040921522979e-13
. O 0 1.2245780561456754e-12

Mutations O 0 1.2274801619582831e-08
of O 0 6.231451986360437e-14
the O 0 3.357906265327379e-14
ATM O 0 2.2642827612884275e-09
gene O 0 2.389182462980699e-10
detected O 0 6.539094266067025e-10
in O 0 1.3982086322084086e-11
Japanese O 0 5.475390594256169e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999920129776001
: O 0 3.295062858091509e-14
possible O 0 5.511499392182699e-15
preponderance O 0 1.509116581699388e-10
of O 0 5.651377142542853e-15
the O 0 1.8702362114498758e-14
two O 0 3.176940386651929e-14
founder O 0 4.138034533085477e-12
mutations O 0 1.5151040144711914e-10
4612del165 O 0 1.1507418351541787e-09
and O 0 1.2813557723548308e-12
7883del5 O 0 3.2104392477805277e-09
. O 0 7.909294746921702e-12

The O 0 1.23356294796928e-13
ATM O 0 1.94402716147124e-09
( O 0 7.247065447746337e-11
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 4.568555603268187e-12
mutated O 0 2.3150568961849416e-10
) O 0 9.04598119501332e-14
gene O 0 7.429007409243127e-11
on O 0 2.7725551889068445e-12
human O 0 4.968149914900966e-13
chromosome O 0 5.150909032636264e-08
11q22 O 0 2.496591946510307e-07
. O 0 1.887542205869508e-10

3 O 0 1.0449463516692958e-09
has O 0 4.2890010661968125e-13
recently O 0 2.4158726234790873e-12
been O 0 4.6973631717206824e-14
identified O 0 2.002610181633599e-13
as O 0 9.450525528226336e-16
the O 0 1.6383559419976443e-17
gene O 0 1.5760064423202963e-13
responsible O 0 2.543992941585432e-15
for O 0 9.22776155410107e-17
the O 0 1.747925437371831e-15
human O 0 2.4384284522116495e-11
recessive B-Disease 1 0.999998927116394
disease I-Disease 1 0.9999839067459106
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.07620193064212799
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.890593816701653e-11
. O 0 2.4945691345923393e-11

In O 0 9.013027303661492e-12
order O 0 2.6826496939521194e-15
to O 0 1.326356716006892e-16
define O 0 3.7215925667252216e-15
the O 0 1.0235815067581719e-15
types O 0 2.8872713681710183e-12
of O 0 2.0666951697635542e-14
disease O 0 3.2725235854513812e-09
- O 0 5.08202946392089e-09
causing O 0 3.097203049584607e-10
ATM O 0 6.711211852916676e-08
mutations O 0 6.877198116539418e-11
in O 0 7.963117470109748e-13
Japanese O 0 3.4468203291559973e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.1726185675797751e-06
as O 0 1.227781439884501e-13
well O 0 2.0543074823165496e-14
as O 0 6.538628484682209e-15
to O 0 1.5968437704601073e-15
look O 0 7.905689991538623e-12
for O 0 2.4308389748320326e-16
possible O 0 5.987131092548975e-14
mutational O 0 9.643458254160464e-10
hotspots O 0 2.470441073931795e-10
, O 0 5.370600340316722e-13
reverse O 0 3.614648858007996e-10
- O 0 5.830482624480382e-11
transcribed O 0 1.3913324659053927e-10
RNA O 0 3.874532639169814e-12
derived O 0 1.3564404590868384e-13
from O 0 3.856759204536042e-14
ten O 0 1.357833116777396e-13
patients O 0 4.668902779989643e-15
belonging O 0 2.6848712496145306e-15
to O 0 1.0798767987403503e-15
eight O 0 1.2763296584168086e-14
unrelated O 0 1.99431682106066e-12
Japanese O 0 1.4893325461784457e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 5.911611478115475e-11
was O 0 3.8139248703661366e-12
analyzed O 0 1.9239354033528944e-12
for O 0 2.003042602541084e-16
mutations O 0 5.178367432664803e-14
by O 0 4.424339486524501e-16
the O 0 6.191330682626961e-16
restriction O 0 8.397776289463532e-13
endonuclease O 0 1.325170417842969e-09
fingerprinting O 0 4.6016787602631837e-10
method O 0 2.6937401961801832e-11
. O 0 6.08686278463777e-12

As O 0 4.2177691894629277e-11
has O 0 8.220278570249956e-14
been O 0 4.46028449431154e-15
reported O 0 1.0504355089750728e-13
by O 0 1.6897255123984124e-16
others O 0 1.759688721776273e-13
, O 0 6.558310354002846e-16
mutations O 0 3.3816807860909126e-14
that O 0 2.1905174106085033e-15
lead O 0 4.410879688300333e-14
to O 0 2.2071937105707512e-14
exon O 0 9.816718549160441e-10
skipping O 0 2.538016552477984e-08
or O 0 4.5149556315848827e-10
premature O 0 1.23085958092517e-10
protein O 0 1.9474571694849674e-12
truncation O 0 4.633002315124202e-11
were O 0 4.4693268183571e-12
also O 0 1.9556451185016865e-13
predominant O 0 1.1435121599623344e-10
in O 0 1.2308831731644432e-10
our O 0 4.0089234015772135e-12
mutants O 0 1.8077070951250107e-09
. O 0 1.3516947977576521e-11

Six O 0 6.467397450915513e-11
different O 0 6.071412226053494e-14
mutations O 0 1.0119745753184306e-12
were O 0 1.354367193482503e-13
identified O 0 9.499551752861768e-13
on O 0 5.506128105542407e-12
12 O 0 2.3576000635246175e-13
of O 0 7.465350821009786e-16
the O 0 2.4366218678156804e-13
16 O 0 6.511383446317076e-12
alleles O 0 1.1679714140289121e-10
examined O 0 1.4503754641737032e-07
. O 0 4.939063394382437e-11

Four O 0 6.356569350746133e-12
were O 0 4.8025616144510563e-14
deletions O 0 8.796921524556467e-12
involving O 0 3.25653776677131e-14
a O 0 4.786067917851577e-13
loss O 0 5.92687314157625e-12
of O 0 5.518502237074124e-16
a O 0 2.266140291910801e-13
single O 0 6.775181544266262e-13
exon O 0 1.2913181635099136e-10
exon O 0 1.7643031480218951e-09
7 O 0 7.104834776061608e-11
, O 0 5.804589664828996e-13
exon O 0 4.987782409315855e-10
16 O 0 2.1564540084173522e-11
, O 0 2.1657961611198234e-13
exon O 0 5.827783811085396e-10
33 O 0 1.8774741483706947e-10
or O 0 3.282371943691409e-11
exon O 0 5.628870525242746e-08
35 O 0 1.2195433995998428e-08
. O 0 2.243427804637932e-10

The O 0 1.6302460683487174e-12
others O 0 2.0182484156139324e-12
were O 0 1.3788082275315722e-13
minute O 0 4.952586192714936e-13
deletions O 0 4.658737839946525e-10
, O 0 8.274123438267375e-14
4649delA O 0 3.609906817914066e-11
in O 0 7.691588387254492e-14
exon O 0 9.385343197054752e-11
33 O 0 1.6343846415134422e-11
and O 0 7.855972410141313e-14
7883del5 O 0 5.6236893614114436e-11
in O 0 7.134947472252351e-13
exon O 0 3.006928039894774e-09
55 O 0 7.021127013118189e-10
. O 0 2.106142170388292e-11

The O 0 1.5509905642793753e-12
mutations O 0 4.3548298300777333e-10
4612del165 O 0 2.9419977565225963e-10
and O 0 2.285337582152644e-14
7883del5 O 0 6.689613706728492e-12
were O 0 9.885806908326022e-14
found O 0 1.0783837337642252e-13
in O 0 7.913311289066156e-15
more O 0 6.38998214337296e-17
than O 0 2.3643409327721597e-17
two O 0 1.7228084355613483e-17
unrelated O 0 3.1115717200904097e-15
families O 0 4.566400940762236e-17
; O 0 3.055988200481721e-16
44 O 0 2.7906330539581234e-14
% O 0 6.036460258517992e-14
( O 0 3.0569912920497266e-12
7 O 0 1.5994126596058367e-12
of O 0 2.8124880286565894e-14
16 O 0 6.713871537715466e-13
) O 0 5.081810589468907e-15
of O 0 1.3695302500262398e-16
the O 0 3.208297429892253e-16
mutant O 0 2.4836105394498986e-12
alleles O 0 1.5205798859635467e-12
had O 0 1.6733744390151628e-09
one O 0 2.1680861316333844e-13
of O 0 2.7264338857868782e-15
the O 0 1.751792206303518e-13
two O 0 1.0984230018606933e-12
mutations O 0 2.506001517410539e-10
. O 0 3.4182018326944785e-11

The O 0 2.5425900534309376e-12
4612del165 O 0 5.539589342795637e-10
mutations O 0 7.230769368676837e-12
in O 0 2.7464998591381073e-13
three O 0 3.8714517003962613e-16
different O 0 1.7202021548873162e-16
families O 0 5.237144891171439e-16
were O 0 4.664062918432327e-14
all O 0 2.984864696785349e-17
ascribed O 0 1.4353884698675365e-14
to O 0 2.855479090603275e-16
the O 0 4.101049509870196e-16
same O 0 1.8708570866002132e-14
T O 0 5.631979327347381e-10
- O 0 4.7598449487429306e-11
- O 0 8.138635598786692e-11
> O 0 6.477500827384297e-13
A O 0 1.3155400163319952e-13
substitution O 0 5.0500043328929184e-14
at O 0 8.43470868779235e-14
the O 0 1.632430906826931e-15
splice O 0 7.91527468568809e-11
donor O 0 5.442038963562879e-13
site O 0 2.010046643019514e-12
in O 0 6.4959517799556554e-12
intron O 0 1.1057150004489813e-06
33 O 0 7.636603527316765e-08
. O 0 2.142376692715331e-10

Microsatellite O 0 3.94543206994058e-07
genotyping O 0 7.111257360747913e-08
around O 0 1.5021603752551904e-11
the O 0 1.6296195621233467e-14
ATM O 0 2.0725890448325401e-10
locus O 0 2.4567648262974195e-12
also O 0 1.5611402687069897e-13
indicated O 0 7.091991924279561e-13
that O 0 2.720157901043316e-16
a O 0 3.124067573644779e-14
common O 0 1.0366691012564377e-11
haplotype O 0 2.78221112814947e-09
was O 0 4.7240742567788985e-11
shared O 0 1.8646120820866967e-14
by O 0 9.69614073073285e-16
the O 0 3.2270420043171944e-15
mutant O 0 1.2982571614972294e-11
alleles O 0 1.1930417591343723e-11
in O 0 1.878490418771861e-11
both O 0 4.5333810490266746e-13
mutations O 0 3.471588572168116e-10
. O 0 1.4409864794451277e-11

This O 0 1.498810434487699e-13
suggests O 0 7.731555738514639e-13
that O 0 1.2610552403339139e-15
these O 0 3.898185913096179e-16
two O 0 5.317507142042191e-16
founder O 0 6.229791530733275e-13
mutations O 0 9.555331526023281e-11
may O 0 2.881486715899939e-10
be O 0 2.9339838935119045e-14
predominant O 0 2.6209812098443308e-11
among O 0 1.616140083088649e-13
Japanese O 0 1.504876084856832e-11
ATM O 0 1.0394464844409868e-08
mutant O 0 3.721845720505712e-09
alleles O 0 7.537229507192933e-09
. O 0 4.588015800610634e-10

W474C O 0 3.5189650304801035e-08
amino O 0 1.186745035575143e-09
acid O 0 7.656675293787885e-11
substitution O 0 1.917985301830294e-12
affects O 0 3.499839307252728e-13
early O 0 2.59437924702427e-13
processing O 0 1.6741053259373279e-13
of O 0 2.699532466797939e-18
the O 0 7.926354325904451e-17
alpha O 0 3.0377450229747416e-13
- O 0 4.0731225900772494e-14
subunit O 0 5.301646708449903e-13
of O 0 9.728373510749428e-16
beta O 0 1.7851470301977201e-10
- O 0 1.1918596665161374e-10
hexosaminidase O 0 5.252789758714016e-09
A O 0 8.456823435976091e-11
and O 0 3.65315044111459e-14
is O 0 8.736569794966261e-17
associated O 0 7.428397632257278e-15
with O 0 9.226151370938119e-15
subacute O 0 3.117783586858991e-09
G B-Disease 0 3.79985154452811e-09
( I-Disease 0 1.557026209353385e-11
M2 I-Disease 0 1.0748860859166598e-06
) I-Disease 0 5.759865917553952e-10
gangliosidosis I-Disease 0 3.496440285744029e-06
. O 0 2.445821600804976e-10

Mutations O 0 4.0374693810463214e-08
in O 0 6.467122410508397e-12
the O 0 4.566364444230121e-14
HEXA O 0 1.693995343998722e-08
gene O 0 1.636215468669988e-11
, O 0 1.2391676125153312e-14
encoding O 0 1.8044541081068018e-14
the O 0 7.593330087801622e-17
alpha O 0 7.813219607974778e-14
- O 0 2.550027924279677e-14
subunit O 0 2.647840714048444e-13
of O 0 3.4038603967543257e-16
beta O 0 1.1989301218484627e-10
- O 0 1.606249334928922e-11
hexosaminidase O 0 2.5360491484605063e-10
A O 0 2.5630012435301497e-12
( O 0 2.0149780823909558e-13
Hex O 0 8.286213729058467e-12
A O 0 8.117373418402296e-13
) O 0 1.2395364106605657e-14
, O 0 3.654876863667684e-15
that O 0 3.337208962321661e-16
abolish O 0 1.4548666958658085e-11
Hex O 0 1.5846929324325743e-10
A O 0 1.336328834047884e-12
enzyme O 0 1.640894919940905e-10
activity O 0 1.9432291886722908e-10
cause O 0 1.3752370797703861e-08
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 0 0.005469865631312132
( O 0 2.94603334782817e-11
TSD B-Disease 0 2.305449413597671e-07
) O 0 3.3124311670310047e-13
, O 0 3.5598236733597535e-14
the O 0 1.3705404744586945e-14
fatal O 0 5.059154206676908e-10
infantile B-Disease 0 1.1240816633062423e-07
form I-Disease 0 2.4137402146462428e-12
of I-Disease 0 3.1936238863942285e-14
G I-Disease 0 1.2556204964653261e-09
( I-Disease 0 6.639893712981348e-13
M2 I-Disease 0 2.9761974218445175e-08
) I-Disease 0 5.9454528973656995e-12
gangliosidosis I-Disease 0 3.4788968150678556e-08
, I-Disease 0 2.866310921251225e-12
Type I-Disease 0 6.709251376690872e-09
1 I-Disease 0 2.4529217199087405e-11
. O 0 1.9432318601464438e-11

Less O 0 4.501409023305314e-08
severe O 0 1.987168843697873e-06
, O 0 1.480236723125361e-12
subacute O 0 3.7295225752131955e-07
( O 0 1.5743962800129907e-09
juvenile O 0 0.0306098535656929
- O 0 2.7604837669059634e-05
onset O 0 2.189720362366643e-06
) O 0 1.3900432194180468e-10
and O 0 3.7797473484424415e-10
chronic O 0 3.474399136393913e-06
( O 0 6.522159982230713e-12
adult O 0 2.2527062810695497e-06
- O 0 9.779206493476522e-07
onset O 0 1.0425991181506333e-09
) O 0 1.797820484877085e-14
variants O 0 5.14152479272334e-12
are O 0 3.613040635853373e-15
characterized O 0 8.9183107987857e-15
by O 0 1.0127298500335418e-15
a O 0 3.1782874400886063e-13
broad O 0 2.918689595565738e-11
spectrum O 0 2.70767306145836e-12
of O 0 2.3234127295712614e-14
clinical O 0 3.429321280071229e-12
manifestations O 0 1.649952960716683e-13
and O 0 5.742694917553392e-15
are O 0 2.4173645335257888e-17
associated O 0 9.23484447007579e-16
with O 0 7.889314633912205e-16
residual O 0 5.97807137125983e-10
levels O 0 2.220248117301704e-11
of O 0 5.701440601373845e-15
Hex O 0 6.330622137618036e-10
A O 0 1.285615971319265e-11
enzyme O 0 8.430540293646871e-11
activity O 0 5.903555422293039e-11
. O 0 2.4658766781954222e-12

We O 0 6.1759642538961046e-12
identified O 0 1.7614022219947234e-12
a O 0 7.469033529682034e-14
1422 O 0 4.184405599794161e-10
G O 0 5.1381742610656644e-11
- O 0 6.858792700459304e-11
- O 0 6.229444737826384e-10
> O 0 1.7396341311926022e-11
C O 0 1.4768654355012956e-10
( O 0 1.640736022523112e-13
amino O 0 2.334752183252853e-12
acid O 0 3.257744551551922e-13
W474C O 0 6.350312528428936e-13
) O 0 5.596432444595072e-16
substitution O 0 5.684869672310236e-15
in O 0 9.02873933115219e-15
the O 0 7.50054715755057e-16
first O 0 2.0211742639253925e-14
position O 0 6.760127939202387e-14
of O 0 1.2009226773424366e-15
exon O 0 7.26353352464848e-11
13 O 0 1.2179886439700471e-11
of O 0 2.889990018671053e-14
HEXA O 0 6.31450447485804e-08
of O 0 8.571520263586738e-15
a O 0 1.9686025812953867e-12
non O 0 2.1747708078834194e-09
- O 0 6.195330914948727e-10
Jewish O 0 1.3882540082776895e-11
proband O 0 2.6249883831042098e-06
who O 0 1.3318452243837875e-12
manifested O 0 4.9455084125127335e-12
a O 0 2.162811623589514e-13
subacute O 0 4.1114023296984215e-09
variant O 0 5.1594311045732866e-09
of O 0 1.5752770182037024e-12
G B-Disease 0 4.224030902832965e-08
( I-Disease 0 2.835308203497089e-11
M2 I-Disease 0 1.5355658433691133e-06
) I-Disease 0 4.689021393389226e-10
gangliosidosis I-Disease 0 2.4817368284857366e-06
. O 0 1.0645052200830563e-10

On O 0 8.550701813270223e-11
the O 0 5.041861974577552e-14
second O 0 3.859118320043153e-12
maternally O 0 3.8651154454782954e-07
inherited O 0 1.15869802641555e-07
allele O 0 1.5315264612070223e-09
, O 0 1.2313474025138493e-11
we O 0 2.1597310664043037e-14
identified O 0 1.1275354293901335e-13
the O 0 3.0596176837211463e-15
common O 0 3.252000613240824e-10
infantile O 0 0.00012042780144838616
disease O 0 1.5754596915940056e-06
- O 0 1.9755694324885553e-07
causing O 0 7.387387146451374e-09
4 O 0 4.3123914161835586e-11
- O 0 1.608912447714772e-09
bp O 0 1.7695404030959594e-09
insertion O 0 1.1937047184051863e-10
, O 0 1.5389795557721464e-12
+ O 0 1.0650089143915409e-10
TATC O 0 8.772539139556557e-09
1278 O 0 1.4362901978870468e-09
, O 0 1.0748537747785197e-13
in O 0 2.1420139154158108e-13
exon O 0 1.916594660755777e-09
11 O 0 1.0616948986630348e-10
. O 0 5.982411181021385e-12

Pulse O 0 3.6870219446427654e-06
- O 0 2.516259201001958e-07
chase O 0 3.18318371661519e-09
analysis O 0 1.4603818371608512e-12
using O 0 4.588376662124916e-13
proband O 0 2.4822266464497034e-09
fibroblasts O 0 9.534486394846553e-11
revealed O 0 1.457816679872881e-11
that O 0 2.0469092477393022e-16
the O 0 1.1031804750643291e-16
W474C O 0 1.7768837616560784e-12
- O 0 1.1116177490761055e-14
containing O 0 2.7884500382948122e-15
alpha O 0 7.911760032926554e-14
- O 0 5.394618586340499e-15
subunit O 0 3.139796297848933e-14
precursor O 0 1.0870032765607565e-13
was O 0 2.693629553348481e-13
normally O 0 1.1082981422525211e-14
synthesized O 0 1.9556937720741768e-13
, O 0 6.433476544060639e-15
but O 0 1.1894017587103572e-15
not O 0 8.535457041763998e-17
phosphorylated O 0 3.675459594879374e-14
or O 0 1.632705980776552e-14
secreted O 0 1.0456565084290825e-12
, O 0 1.5942129073017591e-13
and O 0 2.386672707610591e-14
the O 0 7.65598860892093e-15
mature O 0 1.0070150442686998e-11
lysosomal O 0 2.5762256911088244e-11
alpha O 0 3.3785637048450168e-12
- O 0 6.27913476422548e-12
subunit O 0 6.410730279959864e-11
was O 0 2.5478452680971486e-10
not O 0 6.780171584765127e-13
detected O 0 1.0667619010362728e-09
. O 0 2.437512344743986e-11

When O 0 2.8959965935743126e-12
the O 0 7.16436899226864e-15
W474C O 0 1.9727794051127567e-11
- O 0 1.7033056009477937e-13
containing O 0 4.331229114511864e-14
alpha O 0 1.5036560321521342e-12
- O 0 2.4774445190646477e-13
subunit O 0 8.122019224711396e-13
was O 0 3.388539449034056e-13
transiently O 0 2.346189215129968e-12
co O 0 8.001015648628762e-12
- O 0 4.437124224900696e-13
expressed O 0 3.25399035753409e-15
with O 0 1.0867983946432879e-16
the O 0 3.1305601870646013e-16
beta O 0 5.710718898634115e-13
- O 0 2.4156537704943075e-14
subunit O 0 1.0611750058319921e-13
to O 0 5.009593830935426e-15
produce O 0 1.2012744585957608e-13
Hex O 0 5.1977307874429e-11
A O 0 4.719163428090756e-12
( O 0 8.077156565117205e-13
alphabeta O 0 1.2655232417557727e-10
) O 0 9.787303075197568e-15
in O 0 2.64611927204908e-13
COS O 0 8.049109112562292e-08
- O 0 1.988856163093189e-10
7 O 0 5.358076721022342e-13
cells O 0 5.78606336020665e-13
, O 0 8.224524746414542e-15
the O 0 4.053193471839308e-16
mature O 0 7.685311534302158e-14
alpha O 0 2.0927524443199383e-14
- O 0 7.676752774589922e-15
subunit O 0 1.48092428348557e-14
was O 0 5.3021694294223126e-14
present O 0 1.0327075323761183e-16
, O 0 4.935519635027735e-16
but O 0 1.0679842444026632e-15
its O 0 5.544474848040452e-17
level O 0 3.815592895079715e-15
was O 0 3.4228157553281915e-14
much O 0 6.8725292960063276e-15
lower O 0 4.985169178503557e-13
than O 0 2.303123082347233e-16
that O 0 6.276244809146918e-17
from O 0 4.984488621411756e-15
normal O 0 3.91846792643577e-13
alpha O 0 1.4192948032121233e-12
- O 0 3.398280192402209e-13
subunit O 0 6.825273310938351e-13
transfections O 0 2.108774960207782e-11
, O 0 6.186420538510846e-16
although O 0 2.2426510179625846e-16
higher O 0 2.9718928107146233e-15
than O 0 4.338483697595213e-16
in O 0 1.9425174291906426e-14
those O 0 1.2202580043085289e-15
cells O 0 1.0305049423107917e-14
transfected O 0 7.647501338789442e-13
with O 0 2.9578779623880313e-16
an O 0 3.973842366549341e-16
alpha O 0 4.682893829655033e-12
- O 0 6.596599568670092e-12
subunit O 0 1.5555064181160816e-11
associated O 0 1.206044118740035e-11
with O 0 1.966433526429112e-12
infantile O 0 1.3478785376719316e-06
TSD B-Disease 0 3.0722592327947496e-06
. O 0 1.9895657343838025e-10

Furthermore O 0 1.0578719324139119e-11
, O 0 5.021321849123109e-15
the O 0 6.212952257396811e-17
precursor O 0 2.4072473073059875e-13
level O 0 2.8142803503729795e-14
of O 0 6.422750572467003e-18
the O 0 1.166761018016503e-16
W474C O 0 5.09784380507694e-13
alpha O 0 7.072482519337314e-14
- O 0 1.5774042160898553e-14
subunit O 0 3.3488684237801755e-14
was O 0 6.010953724783913e-14
found O 0 2.1598425359401624e-14
to O 0 1.1419704547629582e-15
accumulate O 0 8.647278856507845e-13
in O 0 2.332718572342976e-15
comparison O 0 7.780291540963446e-15
to O 0 6.492767473939901e-16
the O 0 3.15250416375e-15
normal O 0 1.0810780439254875e-12
alpha O 0 6.945041330225221e-12
- O 0 9.736686283623452e-13
subunit O 0 5.2954845369823644e-12
precursor O 0 4.3429655705029546e-11
levels O 0 5.920726148939126e-12
. O 0 1.1423207215213727e-12

We O 0 1.9761652383931683e-11
conclude O 0 2.6273965642031882e-12
that O 0 3.886871141107638e-16
the O 0 9.955125289520588e-16
1422 O 0 1.212262373817552e-10
G O 0 1.835503797564808e-11
- O 0 4.726777996788556e-11
- O 0 5.008097270220446e-10
> O 0 2.503043258772486e-11
C O 0 3.818578092618097e-11
mutation O 0 3.859653482235492e-13
is O 0 3.414096525224098e-15
the O 0 6.471551416193549e-16
cause O 0 6.731782151029111e-14
of O 0 9.66221409658e-15
Hex B-Disease 0 1.489705994117685e-07
A I-Disease 0 1.1558830692592892e-06
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.74459907526159e-11
the O 0 2.2145067897494375e-13
proband O 0 1.0420354357165706e-07
. O 0 1.88954372981609e-11

The O 0 7.689905569957523e-13
resulting O 0 9.130822183414655e-13
W474C O 0 1.4663675829140743e-10
substitution O 0 1.8065738792080732e-12
clearly O 0 8.59313651051935e-13
interferes O 0 6.482482194265782e-13
with O 0 2.0156514820543524e-16
alpha O 0 2.2983744356504243e-13
- O 0 7.327168385917737e-14
subunit O 0 3.635413638961721e-13
processing O 0 7.79750233565607e-13
, O 0 4.621411230823871e-16
but O 0 1.064120344795085e-16
because O 0 2.2423248441034427e-17
the O 0 5.1305567300871834e-18
base O 0 4.470588014840178e-16
substitution O 0 6.5122671252977604e-15
falls O 0 8.70121943247204e-12
at O 0 5.799274770254201e-14
the O 0 8.587815059909543e-16
first O 0 7.801053504346775e-14
position O 0 7.019348210318688e-13
of O 0 2.5729794678316584e-15
exon O 0 8.20451762084673e-11
13 O 0 3.4276342614908417e-12
, O 0 2.850758163059665e-14
aberrant O 0 5.7277936733879375e-12
splicing O 0 4.8375872752082216e-11
may O 0 4.987463567140971e-12
also O 0 2.720014011321401e-15
contribute O 0 3.6189702370610676e-16
to O 0 3.565558764039023e-14
Hex B-Disease 0 1.0284251317216331e-07
A I-Disease 0 3.617659771748549e-08
deficiency I-Disease 0 2.7858615794684738e-05
in O 0 3.6352281861801172e-12
this O 0 8.352771463859474e-14
proband O 0 4.238701389880362e-09
. O 0 4.77949982109066e-13
. O 0 1.7830796518111813e-12

Two O 0 3.504705900492233e-11
frequent O 0 1.043854669369182e-09
missense O 0 0.0003955872671213001
mutations O 0 0.0012062875321134925
in O 0 0.016068333759903908
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 6.253992879123871e-10

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 3.844110096906661e-08
an O 0 3.683282159272494e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 2.6422230803291313e-06
by O 0 3.461132205492823e-12
early O 0 6.698819561279379e-07
childhood O 1 0.9749899506568909
deafness B-Disease 1 1.0
and O 0 7.944004778437375e-07
goiter B-Disease 1 1.0
. O 0 1.5615297943583073e-10

A O 0 2.341314364606717e-10
century O 0 1.1559542385797261e-11
after O 0 1.012568663898844e-13
its O 0 7.345711917072648e-17
recognition O 0 1.5237778825728278e-14
as O 0 1.0504481399303822e-12
a O 0 2.0272243606012097e-10
syndrome O 0 3.1761858281242894e-06
by O 0 1.972215759574094e-14
Vaughan O 0 3.17375059566416e-09
Pendred O 0 2.0581836235322726e-09
, O 0 2.5959964023271678e-14
the O 0 8.449486532809917e-15
disease O 0 6.952808120908038e-12
gene O 0 1.9396891037803954e-10
( O 0 1.7548875547168663e-11
PDS O 0 1.9333680256750085e-07
) O 0 1.5511258998155558e-13
was O 0 1.8808771814343705e-12
mapped O 0 6.023426896151207e-11
to O 0 6.781905224038931e-13
chromosome O 0 4.4431996570892807e-07
7q22 O 0 3.3944006645469926e-06
- O 0 1.3983500366521184e-06
q31 O 0 2.0599860306447226e-07
. O 0 3.790423183658298e-11

1 O 0 9.417835955538578e-11
and O 0 1.6551221656245507e-13
, O 0 4.589684870630632e-15
recently O 0 1.653154284471381e-12
, O 0 9.564843212370145e-16
found O 0 5.664499376961717e-15
to O 0 7.623166161624165e-17
encode O 0 7.35385710659564e-13
a O 0 4.975109950747236e-13
putative O 0 3.9847158905814695e-10
sulfate O 0 2.7140107938805613e-09
transporter O 0 1.4168423945193354e-07
. O 0 1.0761456309404949e-10

We O 0 2.6676537714931392e-11
performed O 0 2.1964437105052859e-13
mutation O 0 6.831469797404649e-14
analysis O 0 1.3668132923215504e-13
of O 0 2.0734801418990776e-16
the O 0 2.2909544270324766e-14
PDS B-Disease 0 6.522903994721219e-09
gene O 0 8.990744954084917e-11
in O 0 2.5512578161190902e-11
patients O 0 1.754288381228264e-11
from O 0 9.782045372287371e-14
14 O 0 2.74584012211615e-13
Pendred B-Disease 0 6.225450016605905e-11
families O 0 2.1668642273146637e-15
originating O 0 3.501635559201993e-13
from O 0 1.0140844327460874e-12
seven O 0 3.36737419632388e-13
countries O 0 1.313711339961509e-14
and O 0 4.5970111127013186e-14
identified O 0 9.704763902218527e-12
all O 0 9.031908081407868e-15
mutations O 0 3.770399617519793e-11
. O 0 5.6425320145436775e-12

The O 0 3.522246513551486e-13
mutations O 0 3.199760768846094e-12
include O 0 2.3898978702605565e-14
three O 0 6.5064569027960695e-15
single O 0 9.863237884853021e-15
base O 0 5.874275133162243e-14
deletions O 0 5.561294535993966e-09
, O 0 7.494813797359612e-12
one O 0 3.519533568665384e-13
splice O 0 5.506191413928718e-08
site O 0 3.208129872867005e-10
mutation O 0 9.078914509075275e-09
and O 0 2.5030266748160557e-09
10 O 0 1.4313743766647402e-11
missense O 0 1.7159708249891992e-06
mutations O 0 5.065850814389705e-07
. O 0 7.060352857912733e-10

One O 0 7.746590174884105e-11
missense O 0 2.3990699560272333e-07
mutation O 0 7.604226692770055e-10
( O 0 3.122678504663412e-11
L236P O 0 1.7250964545745262e-10
) O 0 3.289689213311492e-13
was O 0 1.617540845190446e-12
found O 0 6.700388399498436e-13
in O 0 2.495883714818698e-14
a O 0 7.372697592678782e-15
homozygous O 0 1.916708979032844e-12
state O 0 1.9337821478121985e-14
in O 0 1.1131656577414994e-12
two O 0 8.136186494499265e-14
consanguineous O 0 4.060301539432487e-10
families O 0 2.0086504074617872e-13
and O 0 9.649216376004383e-14
in O 0 7.961397518888372e-14
a O 0 1.0031071025901062e-13
heterozygous O 0 7.562217345380429e-12
state O 0 1.323500499732927e-13
in O 0 1.9760294095449993e-11
five O 0 6.37260209879198e-13
additional O 0 1.2312739803427286e-12
non O 0 2.6800405450444487e-08
- O 0 2.554149602929101e-07
consanguineous O 0 3.0170812692631443e-07
families O 0 1.4149661997642227e-10
. O 0 5.5642894805640886e-12

Another O 0 9.014097107629127e-11
missense O 0 8.311776014124916e-07
mutation O 0 2.4061779235751146e-09
( O 0 5.682886106139762e-11
T416P O 0 3.834045025907784e-10
) O 0 2.4274327123027795e-13
was O 0 1.394221326930789e-12
found O 0 3.096359702924739e-13
in O 0 1.0125218399175198e-14
a O 0 4.7387016829751865e-15
homozygous O 0 6.074056188576371e-13
state O 0 4.649547230111935e-15
in O 0 1.5138949122084355e-12
one O 0 6.819622855791171e-14
family O 0 2.5144337024822494e-13
and O 0 6.858559943936915e-14
in O 0 2.3026600835503522e-14
a O 0 2.855618099297831e-14
heterozygous O 0 2.464503861404621e-12
state O 0 2.1630757623437857e-13
in O 0 3.5320876778932586e-10
four O 0 1.6747202583045073e-11
families O 0 1.4732786930531094e-13
. O 0 7.93564324495788e-13

Pendred B-Disease 0 0.00023853716265875846
patients O 0 9.070408850675449e-06
in O 0 4.037068422613199e-12
three O 0 2.865899249686332e-13
non O 0 1.3155074807258416e-09
- O 0 4.31867652750384e-09
consanguineous O 0 6.209980085714051e-09
families O 0 4.90554828474956e-14
were O 0 2.314265112554094e-15
shown O 0 6.272801487867432e-16
to O 0 1.581976304062765e-16
be O 0 2.2888992815804654e-16
compound O 0 1.6164382048047647e-14
heterozygotes O 0 3.1360526155099766e-12
for O 0 9.116194635923249e-15
L236P O 0 4.387746277423332e-10
and O 0 2.80786006424949e-12
T416P O 0 8.537559104127013e-09
. O 0 1.3658503147939705e-11

In O 0 6.516912443715883e-12
total O 0 1.5851794703258815e-14
, O 0 1.327294360303679e-14
one O 0 2.0136772600125395e-15
or O 0 2.9401516486206314e-14
both O 0 1.1308128709136035e-14
of O 0 8.940817231817855e-17
these O 0 1.9231500579093645e-16
mutations O 0 1.4064633111583388e-14
were O 0 4.780721716939051e-13
found O 0 1.3713674835470757e-13
in O 0 1.5172270991653525e-13
nine O 0 1.6692079847242108e-13
of O 0 5.946265257442774e-17
the O 0 2.0163302519066346e-14
14 O 0 7.812508777925442e-13
families O 0 8.563970658927861e-15
analyzed O 0 6.842117584310303e-12
. O 0 5.268956711906858e-12

The O 0 3.608774249482666e-13
identification O 0 1.783236102184671e-12
of O 0 5.734789453177549e-16
two O 0 5.088754989086971e-15
frequent O 0 1.7640592112067033e-11
PDS B-Disease 0 1.24420500924316e-06
mutations O 0 1.8188184292000642e-10
will O 0 1.132505750961986e-13
facilitate O 0 1.5072531168048436e-13
the O 0 3.2260329763187778e-15
molecular O 0 4.593022143173364e-11
diagnosis O 0 1.5666349781895406e-06
of O 0 9.696424912997159e-11
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 9.831333525056607e-10

Insertional O 0 3.5640067608255777e-07
mutation O 0 7.074774099891101e-11
by O 0 3.978791241246969e-14
transposable O 0 6.811112118754181e-09
element O 0 1.2934184279167482e-10
, O 0 9.153703836584093e-12
L1 O 0 2.9917100619059056e-07
, O 0 4.749202875582725e-13
in O 0 5.18560454992878e-13
the O 0 2.121838078503191e-12
DMD B-Disease 1 1.0
gene O 0 6.603634084001442e-09
results O 0 4.290944335960667e-11
in O 0 5.411373172475864e-12
X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 0.9999997615814209
dilated I-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
. O 0 5.181146622845745e-09

X B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
linked I-Disease 1 0.9999990463256836
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 0 4.471251813242816e-09
XLDCM B-Disease 0 7.755826203492688e-08
) O 0 7.448234466255615e-14
is O 0 1.521070638218461e-15
a O 0 1.1052077425444638e-14
clinical O 0 6.5144890350199436e-12
phenotype O 0 2.924875272536376e-11
of O 0 3.771628920501901e-15
dystrophinopathy B-Disease 0 1.3021526079626256e-08
which O 0 2.3507107379887836e-14
is O 0 8.610777064318423e-16
characterized O 0 2.3873647335284978e-14
by O 0 3.6135729960607224e-14
preferential O 0 1.2182018949147277e-08
myocardial B-Disease 0 2.0566532921151293e-09
involvement I-Disease 0 2.4256069375283573e-11
without O 0 9.558634672625008e-14
any O 0 2.3842659481942627e-14
overt O 0 1.223320889032209e-10
clinical O 0 2.8965423393145784e-09
signs O 0 2.3736950183206318e-09
of O 0 5.116988430198255e-12
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 2.7932602897351444e-09

To O 0 3.612446496450983e-12
date O 0 1.9064726186623915e-10
, O 0 3.027251368960433e-14
several O 0 5.873476804609456e-15
mutations O 0 7.292514682399887e-12
in O 0 2.2369053224308155e-12
the O 0 5.284796038285133e-13
Duchenne B-Disease 0 8.979067160908016e-07
muscular I-Disease 0 1.0214265699914904e-07
dystrophy I-Disease 0 8.20261846001813e-07
gene O 0 9.908711184891672e-09
, O 0 2.576000801557399e-10
DMD O 1 1.0
, O 0 2.689414988453487e-13
have O 0 1.8156631915593495e-15
been O 0 3.0183707790798877e-15
identified O 0 6.560972468441784e-13
in O 0 4.293379616670395e-13
patients O 0 2.1278837795523503e-13
with O 0 1.0215336987290662e-15
XLDCM B-Disease 0 2.3773493467160733e-06
, O 0 5.435151569262164e-13
but O 0 5.842083815408433e-14
a O 0 2.345327674202393e-14
pathogenic O 0 3.471520987341492e-11
correlation O 0 1.5414470914965062e-12
of O 0 2.148001227095784e-15
these O 0 2.3843294756653068e-14
cardiospecific O 0 1.086798095961683e-09
mutations O 0 1.4226055056187903e-10
in O 0 1.9794253736105105e-10
DMD O 1 1.0
with O 0 2.1427809206902085e-14
the O 0 5.5125636043776294e-14
XLDCM B-Disease 0 4.1405229467272875e-07
phenotype O 0 1.8134338475306322e-08
has O 0 5.981869444227073e-10
remained O 0 4.695205335636388e-10
to O 0 1.4952860659194454e-14
be O 0 3.787528559014153e-13
elucidated O 0 1.1398848531740668e-09
. O 0 6.0667764215094344e-12

We O 0 7.009910013566767e-11
report O 0 3.381658234685725e-12
here O 0 2.8764823842611885e-15
the O 0 2.1743142195754552e-17
identification O 0 3.1048863431476156e-14
of O 0 3.682230479136449e-18
a O 0 4.800251755603894e-15
unique O 0 2.8263946155846105e-14
de O 0 2.0804360456594395e-09
novo O 0 2.7562364834921027e-08
L1 O 0 4.023455346668925e-08
insertion O 0 6.819893261234e-11
in O 0 5.883697392142229e-13
the O 0 1.9451608496124338e-14
muscle O 0 3.078678284529346e-11
exon O 0 3.8312963912545683e-10
1 O 0 1.6505243352615828e-11
in O 0 1.686556783120352e-09
DMD O 1 1.0
in O 0 3.205051848920171e-11
three O 0 1.8383013752724942e-13
XLDCM B-Disease 0 7.393505363495478e-09
patients O 0 1.6096158694106633e-12
from O 0 8.981917043893867e-15
two O 0 6.024333372515447e-15
unrelated O 0 4.9160441342732675e-12
Japanese O 0 1.6667797697600406e-10
families O 0 4.889222707249452e-13
. O 0 1.8780094666881464e-12

The O 0 6.15985263014221e-14
insertion O 0 7.843089892822785e-12
was O 0 2.7347191351723144e-12
a O 0 8.137148723927345e-14
5 O 0 1.1189316075251032e-13
- O 0 5.6594546757327e-12
truncated O 0 1.4308038261134914e-11
form O 0 9.731395377021723e-13
of O 0 8.607230113851796e-16
human O 0 1.566105135386662e-14
L1 O 0 5.110770695537781e-10
inversely O 0 1.1552718959424724e-13
integrated O 0 8.756088844437404e-13
in O 0 2.3293687942058106e-13
the O 0 4.158871801085949e-14
5 O 0 4.581846187179384e-12
- O 0 5.199302322012045e-09
untranslated O 0 2.0876561279692396e-07
region O 0 8.133529960652197e-11
in O 0 9.275022590238269e-12
the O 0 1.8634636748168093e-14
muscle O 0 3.0605153827911735e-12
exon O 0 1.0560816977867038e-11
1 O 0 1.7450292242020965e-13
, O 0 7.737965304589148e-15
which O 0 4.1931974301086033e-16
affected O 0 4.9895301615138134e-15
the O 0 4.681723682437521e-16
transcription O 0 1.5484603616694459e-12
or O 0 1.3589880462009773e-14
the O 0 9.509076468947053e-15
stability O 0 6.056876463052252e-13
of O 0 2.3829210636913258e-17
the O 0 4.459091130767977e-16
muscle O 0 7.248081258445782e-13
form O 0 6.653493945033007e-14
of O 0 7.747087743551959e-16
dystrophin O 0 1.501730684250191e-11
transcripts O 0 6.984939016074776e-11
but O 0 9.604995326927077e-15
not O 0 8.659425607550586e-17
that O 0 7.059879821841072e-18
of O 0 9.825894035240816e-18
the O 0 4.716753365245933e-15
brain O 0 5.83516637786552e-11
or O 0 2.9484325137635325e-12
Purkinje O 0 5.733843955191276e-10
cell O 0 6.848708267170878e-09
form O 0 4.019892196893693e-10
, O 0 6.184362466576943e-10
probably O 0 2.20793303640221e-08
due O 0 4.0431159397009975e-13
to O 0 1.969440752583947e-15
its O 0 3.588903479109296e-16
unique O 0 4.67373171482194e-15
site O 0 6.886707458637897e-13
of O 0 2.7164483837782867e-14
integration O 0 5.004294201249593e-11
. O 0 8.048647685832133e-12

We O 0 1.602441812055544e-12
speculate O 0 3.243224645007453e-13
that O 0 2.890470815747738e-17
this O 0 4.640273132546897e-18
insertion O 0 9.224462387241294e-15
of O 0 6.57935554932187e-17
an O 0 9.393270336156682e-16
L1 O 0 1.173658148445611e-08
sequence O 0 1.7140646541013993e-12
in O 0 1.7983051714409726e-09
DMD O 1 1.0
is O 0 5.76787966347081e-14
responsible O 0 1.5398815459110845e-15
for O 0 3.037727162755653e-17
some O 0 1.369363225716953e-16
of O 0 3.2521240643642417e-18
the O 0 3.0108699317550364e-17
population O 0 2.819820988757339e-17
of O 0 1.0597292068825106e-16
Japanese O 0 1.1521769649469604e-11
patients O 0 4.959493441467934e-14
with O 0 3.0439249160656026e-15
XLDCM B-Disease 0 1.9558440200739824e-08
. O 0 1.1023982291261114e-12
. O 0 1.3044376342974395e-11

Severe O 0 0.18865284323692322
early O 0 0.00024033673980738968
- O 1 0.8739159107208252
onset O 0 0.0005335567984730005
obesity B-Disease 1 1.0
, O 0 1.0179986853486866e-09
adrenal B-Disease 1 0.9999998807907104
insufficiency I-Disease 1 1.0
and O 0 7.551443359510301e-10
red O 0 2.1178611859795637e-06
hair O 1 1.0
pigmentation O 1 0.9891400337219238
caused O 0 6.585229028743811e-10
by O 0 4.189526330022897e-13
POMC O 0 9.137704637396382e-07
mutations O 0 4.331213165897907e-10
in O 0 6.165285296177991e-13
humans O 0 4.030267439225632e-12
. O 0 6.2043946369438885e-12

Sequential O 0 3.5012353016838915e-09
cleavage O 0 1.666802917910104e-09
of O 0 4.691666366930629e-15
the O 0 1.2333522866401331e-15
precursor O 0 1.0348115593583618e-12
protein O 0 7.712795679903905e-12
pre O 0 1.2720750008909931e-09
- O 0 8.232801107510568e-10
pro O 0 2.1603259181546264e-09
- O 0 3.6353999810501136e-09
opiomelanocortin O 0 1.6760711929464378e-08
( O 0 9.93482531484735e-13
POMC O 0 6.2077183393682844e-09
) O 0 4.72599525703013e-14
generates O 0 2.1873965854769806e-13
the O 0 5.7998912408332125e-15
melanocortin O 0 6.874946167911844e-10
peptides O 0 1.2408825356136077e-10
adrenocorticotrophin O 0 1.3313697921901735e-09
( O 0 3.4160428392243647e-12
ACTH O 0 2.0955165380698304e-10
) O 0 6.909491696242137e-14
, O 0 5.4733486894251865e-14
melanocyte O 0 1.7067767643652587e-08
- O 0 6.958908116416751e-09
stimulating O 0 1.1061046523153095e-09
hormones O 0 8.297525860845312e-11
( O 0 3.929215080470533e-13
MSH O 0 8.78260042469492e-09
) O 0 1.3602145499086015e-14
alpha O 0 7.050922345985811e-13
, O 0 3.428832145649244e-15
beta O 0 1.0061390739654619e-12
and O 0 5.472925511764738e-16
gamma O 0 2.0754617913610468e-13
as O 0 2.8908707211779605e-15
well O 0 5.092578072294403e-16
as O 0 1.7692710382195538e-16
the O 0 4.083781419751437e-17
opioid O 0 1.622456238369735e-13
- O 0 5.96158322360707e-14
receptor O 0 1.6529547099564806e-13
ligand O 0 2.5689438423737165e-11
beta O 0 1.819705097716451e-08
- O 0 1.9246293447849894e-08
endorphin O 0 1.2642466344914283e-06
. O 0 9.592326932761353e-11

While O 0 1.1957390806671686e-11
a O 0 3.971408705366608e-13
few O 0 7.194090700761435e-13
cases O 0 9.789828588633101e-14
of O 0 7.314872241556507e-16
isolated O 0 3.775010526396727e-08
ACTH B-Disease 0 0.0004889008705504239
deficiency I-Disease 0 0.0005194534314796329
have O 0 1.1504366253037301e-13
been O 0 1.1592761256160045e-13
reported O 0 4.110245477306762e-11
( O 0 2.2209374096748835e-12
OMIM O 0 2.3368401969037222e-07
201400 O 0 3.213077859332003e-10
) O 0 2.6922480087301914e-13
, O 0 8.865328040901996e-15
an O 0 7.498830857041196e-16
inherited O 0 9.092643438179948e-08
POMC O 0 0.0003326007863506675
defect O 0 2.467840204189997e-06
has O 0 1.7977201324792524e-11
not O 0 1.0018490214942083e-13
been O 0 1.1374028888871957e-12
described O 0 4.5088585642893975e-12
so O 0 5.652353043082703e-13
far O 0 4.261856059034619e-12
. O 0 2.592827211614357e-12

Recent O 0 6.791076728740464e-11
studies O 0 2.169565048448785e-11
in O 0 5.481989103113538e-14
animal O 0 2.682836591771931e-13
models O 0 3.0225925928828445e-12
elucidated O 0 6.476108711794826e-12
a O 0 4.607509916675946e-14
central O 0 6.140742889225795e-14
role O 0 2.0261003703773983e-13
of O 0 8.561842912164358e-16
alpha O 0 4.545663151445112e-11
- O 0 3.565239770075834e-10
MSH O 0 1.262253874756425e-07
in O 0 5.341913435034928e-13
the O 0 4.278953798545707e-15
regulation O 0 1.4161500748108291e-12
of O 0 4.7335480036518463e-17
food O 0 6.406292292167933e-15
intake O 0 2.405188593727686e-15
by O 0 4.3361320562009494e-17
activation O 0 1.1935793675578628e-14
of O 0 8.641973287765799e-16
the O 0 3.4796164295183493e-14
brain O 0 4.357702393376073e-11
melanocortin O 0 5.108266032394226e-10
- O 0 2.2676169969537696e-11
4 O 0 4.665409226480011e-13
- O 0 2.070026875605757e-12
receptor O 0 7.127711506953183e-13
( O 0 1.6699944378750775e-13
MC4 O 0 5.3766818552958284e-08
- O 0 3.8194908347222167e-10
R O 0 1.6349350762112635e-09
; O 0 3.4952230454528277e-13
refs O 0 2.346720817669734e-09
3 O 0 6.277646588323527e-13
- O 0 3.452491903477295e-10
5 O 0 3.693705768765404e-13
) O 0 1.4528817331074112e-14
and O 0 3.855139592837597e-15
the O 0 2.6286042273569667e-16
linkage O 0 4.48845387940322e-12
of O 0 1.948360643625629e-15
human O 0 6.901145236867801e-13
obesity B-Disease 1 1.0
to O 0 3.345484696562484e-14
chromosome O 0 3.3799979481941023e-10
2 O 0 4.867431327784666e-13
in O 0 9.554496408457902e-14
close O 0 2.684136550176741e-13
proximity O 0 3.064468167071621e-13
to O 0 1.356108642400081e-14
the O 0 1.0116569345750785e-14
POMC O 0 7.368906040916556e-10
locus O 0 9.543682033888445e-13
, O 0 4.6686111465459035e-14
led O 0 2.406785674349734e-15
to O 0 2.391345269572913e-16
the O 0 2.083391883219831e-15
proposal O 0 3.650827903878273e-12
of O 0 2.2812905434339576e-15
an O 0 1.7450283094065135e-14
association O 0 3.9543414658178844e-13
of O 0 1.2262869730688482e-15
POMC O 0 1.0010817064198818e-08
with O 0 2.3083865006122417e-13
human O 0 2.2683274703005907e-10
obesity B-Disease 1 1.0
. O 0 2.5188334057402173e-11

The O 0 5.856289303322881e-13
dual O 0 2.550562018532876e-11
role O 0 1.05780076538331e-12
of O 0 8.806947989078388e-15
alpha O 0 1.3208980575996065e-09
- O 0 9.153787949855996e-09
MSH O 0 4.800534725291072e-07
in O 0 2.275895129907196e-13
regulating O 0 3.4222121664262417e-12
food O 0 1.6115697101456994e-12
intake O 0 2.3269808389209112e-12
and O 0 2.0699496397534947e-14
influencing O 0 6.680347941490083e-11
hair O 1 0.9047726988792419
pigmentation O 0 2.8719956389977597e-05
predicts O 0 1.3686970445903057e-09
that O 0 4.94343356973305e-16
the O 0 1.886967589729519e-16
phenotype O 0 1.9828015097866913e-12
associated O 0 1.0615271682501426e-13
with O 0 8.73131387611921e-15
a O 0 4.349373639023213e-11
defect O 0 3.197898390538967e-09
in O 0 5.152419289833343e-13
POMC O 0 5.97496230270167e-09
function O 0 1.2484632739510199e-13
would O 0 4.76343411329877e-14
include O 0 2.5882456442839763e-13
obesity B-Disease 1 1.0
, O 0 2.6982111206788617e-13
alteration O 0 1.5794251462253328e-09
in O 0 1.3492852390939447e-09
pigmentation O 0 0.47411882877349854
and O 0 6.224925641618029e-08
ACTH B-Disease 0 2.6592595531838015e-05
deficiency I-Disease 0 2.6792904463945888e-05
. O 0 3.715982729857181e-11

The O 0 5.220039895129092e-13
observation O 0 1.8799278106440553e-11
of O 0 3.356924554141511e-15
these O 0 1.699904323207435e-13
symptoms O 0 3.9051463451844626e-11
in O 0 3.209930693644225e-13
two O 0 3.623898666500931e-14
probands O 0 1.718626629898523e-10
prompted O 0 4.577904353340878e-13
us O 0 1.5943253932771545e-13
to O 0 1.5350252942662387e-15
search O 0 3.3828823531485697e-13
for O 0 9.82129408385441e-16
mutations O 0 8.682912245108754e-13
within O 0 1.3560214149471728e-13
their O 0 2.3632198628553702e-12
POMC O 0 5.9208741021166134e-08
genes O 0 2.1191679522303275e-09
. O 0 1.450730230390107e-10

Patient O 0 0.0001490897557232529
1 O 0 2.8327243328796214e-11
was O 0 4.245993747570287e-12
found O 0 9.423715199028196e-14
to O 0 4.674781188643588e-16
be O 0 3.4759908108667457e-16
a O 0 2.1764240529156126e-15
compound O 0 1.5229881429341258e-13
heterozygote O 0 1.6847192044200376e-11
for O 0 2.61641192923507e-14
two O 0 6.245159689952443e-14
mutations O 0 1.1817452398588113e-11
in O 0 4.719874231035037e-12
exon O 0 2.1554927287503745e-10
3 O 0 3.227157907223499e-12
( O 0 4.7222425622606146e-12
G7013T O 0 8.851192001557706e-10
, O 0 2.1731742924288588e-13
C7133delta O 0 1.1539105781999126e-10
) O 0 1.1338322045573862e-14
which O 0 1.3399458773379297e-15
interfere O 0 2.779498975273055e-14
with O 0 6.320577322466126e-16
appropriate O 0 5.947794882478485e-14
synthesis O 0 3.4074576927417555e-13
of O 0 1.722814362145001e-14
ACTH O 0 2.1934284943903037e-10
and O 0 1.069632988952296e-12
alpha O 0 3.923531721738982e-09
- O 0 1.2873557864168106e-07
MSH O 0 3.2622774597257376e-05
. O 0 5.83117235053443e-11

Patient O 0 0.011128639802336693
2 O 0 3.4482982441685905e-11
was O 0 1.1595840390329903e-12
homozygous O 0 1.0134970987452085e-11
for O 0 3.028335486429624e-15
a O 0 2.7292656863361388e-14
mutation O 0 5.858512459877563e-13
in O 0 3.3473519095439386e-12
exon O 0 2.4028698475397903e-10
2 O 0 1.27623909704222e-11
( O 0 2.6130845751093368e-11
C3804A O 0 3.7373819594677116e-09
) O 0 1.2859440075285722e-12
which O 0 4.560404788175876e-13
abolishes O 0 1.9939623285836205e-09
POMC O 0 4.02280392108878e-07
translation O 0 1.391426707186838e-08
. O 0 9.552179186522736e-11

These O 0 3.524072784348402e-14
findings O 0 2.4696492409697485e-14
represent O 0 2.1538750829476374e-16
the O 0 2.7665273962517725e-16
first O 0 1.791302312238079e-15
examples O 0 3.4947745923292334e-14
of O 0 8.900123519100492e-16
a O 0 1.8303306092981586e-10
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 4.849564760184277e-13
the O 0 3.224552108617093e-14
POMC O 0 1.220557321879312e-09
gene O 0 9.221416165383634e-12
and O 0 2.095392307203351e-14
define O 0 3.0990539453233656e-13
a O 0 2.3662508584487707e-12
new O 0 8.483241331624924e-10
monogenic B-Disease 0 0.0063148257322609425
endocrine I-Disease 0 6.594440492335707e-05
disorder I-Disease 0 2.0205538930895273e-06
resulting O 0 6.839138630421182e-13
in O 0 1.2107105682584995e-12
early O 0 2.0482611944316886e-05
- O 1 0.9355103373527527
onset O 0 0.3894578516483307
obesity B-Disease 1 1.0
, O 0 2.8166555754438605e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.6046700079819232e-10
red O 0 4.0620790286993724e-08
hair O 1 0.9999899864196777
pigmentation O 0 0.0001432737917639315
. O 0 3.8267663343694025e-11
. O 0 7.94234122913906e-12

A O 0 6.670941576913947e-10
European O 0 9.467002876073494e-11
multicenter O 0 1.8065594575844557e-09
study O 0 1.7158884035861632e-10
of O 0 2.7638985544697903e-10
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 5.3784480341656504e-11
classification O 0 1.8170215332347084e-11
of O 0 1.7699198125175914e-15
105 O 0 8.188630329364344e-12
mutations O 0 4.930300959160583e-11
and O 0 8.699638774124774e-13
a O 0 5.259824219509997e-14
general O 0 6.1312598471615146e-15
system O 0 1.3725992727402908e-14
for O 0 2.393061040686695e-16
genotype O 0 1.0970772033880305e-11
- O 0 2.445904416503719e-11
based O 0 1.1520709516585348e-12
prediction O 0 2.0263595246206023e-09
of O 0 1.7383784570255273e-13
metabolic O 0 5.474521724835313e-09
phenotype O 0 1.3448564928353335e-08
. O 0 1.640710206585183e-10

Phenylketonuria B-Disease 1 0.5551592111587524
( O 0 1.2848821597799542e-06
PKU B-Disease 0 0.0010408052476122975
) O 0 3.153642902375964e-10
and O 0 2.6059770660835646e-11
mild B-Disease 1 0.9999353885650635
hyperphenylalaninemia I-Disease 1 1.0
( O 0 0.014135505072772503
MHP B-Disease 1 1.0
) O 0 5.3175009534500717e-11
are O 0 1.0549099788148553e-11
allelic B-Disease 0 1.1096022944911965e-06
disorders I-Disease 0 0.08618605136871338
caused O 0 5.432021477590199e-13
by O 0 4.15265525687946e-15
mutations O 0 3.944116214182891e-11
in O 0 7.347127463711023e-13
the O 0 1.9656888624957312e-14
gene O 0 1.1619070505730633e-07
encoding O 0 1.637804842857804e-07
phenylalanine O 0 4.35822585131973e-06
hydroxylase O 0 5.9320613218005747e-05
( O 0 5.217382081923461e-09
PAH O 0 1.00460522389767e-06
) O 0 1.0223451252233673e-10
. O 0 4.5178999430461886e-11

Previous O 0 6.665236505082328e-12
studies O 0 1.4210528370348086e-12
have O 0 5.930369043061212e-15
suggested O 0 9.820700737274857e-15
that O 0 4.209590627837077e-17
the O 0 7.345939821875019e-16
highly O 0 7.350534026936972e-13
variable O 0 2.2866460114290277e-10
metabolic O 0 1.0786409543328546e-09
phenotypes O 0 1.3406171728291838e-09
of O 0 6.019782762545223e-12
PAH B-Disease 0 2.241519723611418e-06
deficiency I-Disease 0 3.1550835046800785e-06
correlate O 0 2.0091335262151233e-09
with O 0 1.6331630492416593e-11
PAH O 0 7.65373079048004e-06
genotypes O 0 3.4490736311454384e-07
. O 0 1.537297095177692e-10

We O 0 9.199141448590353e-12
identified O 0 3.0680020156326204e-12
both O 0 1.808185288239457e-14
causative O 0 9.558562830136452e-10
mutations O 0 1.4552366256470606e-10
in O 0 2.9048496247296995e-11
686 O 0 2.3218371669742055e-09
patients O 0 1.4360271860525131e-09
from O 0 1.0935152089386335e-11
seven O 0 4.5281660365770193e-11
European O 0 1.7344069236369108e-10
centers O 0 2.1706837716184424e-10
. O 0 8.639716546354759e-12

On O 0 6.768420546254816e-11
the O 0 5.241044313223243e-15
basis O 0 1.4189848298110097e-14
of O 0 9.238322830726024e-18
the O 0 8.858017114245787e-17
phenotypic O 0 2.3568412846342035e-12
characteristics O 0 1.216378614585928e-13
of O 0 1.6817844461690054e-15
297 O 0 7.93051822128854e-12
functionally O 0 2.6940910613504343e-10
hemizygous O 0 2.9602039930409774e-08
patients O 0 1.3966906520224143e-09
, O 0 2.4347252255215064e-14
105 O 0 6.334368793381451e-13
of O 0 1.1508430190063285e-16
the O 0 1.0584166896260706e-15
mutations O 0 1.086914737900846e-12
were O 0 1.3418968627249006e-12
assigned O 0 1.7552330235418544e-14
to O 0 1.7199536565964155e-15
one O 0 3.30236157159141e-14
of O 0 4.1368107115076806e-16
four O 0 8.410162350607278e-14
arbitrary O 0 8.384379887420301e-13
phenotype O 0 1.5187503477065434e-09
categories O 0 1.0642545511529988e-08
. O 0 5.1852345334113537e-11

We O 0 2.024015720650252e-12
proposed O 0 3.087488625224191e-14
and O 0 6.907538438265769e-15
tested O 0 3.927557267586167e-14
a O 0 3.648747309744878e-15
simple O 0 2.1050223941872746e-14
model O 0 1.1320910436310103e-13
for O 0 1.613159424969238e-16
correlation O 0 2.809931920391001e-13
between O 0 1.6870970495196785e-13
genotype O 0 3.3205269089897627e-10
and O 0 1.052770826244498e-12
phenotypic O 0 1.1476949390853974e-09
outcome O 0 3.704772946755419e-11
. O 0 1.1866623135514676e-11

The O 0 1.3450838479058674e-13
observed O 0 9.350206156208407e-13
phenotype O 0 7.278011526778982e-11
matched O 0 1.1386580914263256e-11
the O 0 6.076263268445714e-15
predicted O 0 1.6113246154025873e-11
phenotype O 0 1.6927233920105422e-11
in O 0 8.828399708331325e-13
79 O 0 1.617131428766072e-11
% O 0 2.353353141971038e-14
of O 0 8.821934834181734e-17
the O 0 7.29278257520418e-15
cases O 0 2.159321549691229e-12
, O 0 3.497988912957474e-14
and O 0 9.665038273832735e-14
in O 0 3.057339537787529e-13
only O 0 2.5929333617833068e-14
5 O 0 7.677133092383239e-15
of O 0 1.7298827885623672e-15
184 O 0 8.081502047424527e-13
patients O 0 3.23456517646592e-12
was O 0 1.4953239113515288e-13
the O 0 5.351082998675759e-16
observed O 0 8.817188109190924e-14
phenotype O 0 2.9357391084089413e-12
more O 0 6.447037965062654e-15
than O 0 3.3518830140394536e-15
one O 0 3.650919525738112e-15
category O 0 7.88033787529896e-12
away O 0 5.674273117345363e-12
from O 0 9.029993766618283e-12
that O 0 1.3725620466586985e-11
expected O 0 9.36637434278964e-10
. O 0 6.806452537005958e-12

Among O 0 7.353243881846883e-12
the O 0 1.473632007436068e-14
seven O 0 1.6565616472964326e-14
contributing O 0 1.2651025755141317e-15
centers O 0 3.41415060827778e-14
, O 0 1.5568211460649864e-15
the O 0 2.6341250292884926e-16
proportion O 0 1.6047410524976796e-13
of O 0 3.1648428926926535e-15
patients O 0 6.112114530861315e-14
for O 0 5.275217963359336e-17
whom O 0 1.5831821666362558e-14
the O 0 1.6791946429327753e-15
observed O 0 2.0019837838284454e-13
phenotype O 0 3.283398899989187e-11
did O 0 9.388421984279915e-11
not O 0 4.840228830802276e-14
match O 0 6.027948864888166e-13
the O 0 2.046589995727526e-15
predicted O 0 6.882381470285637e-11
phenotype O 0 5.1055458472060167e-11
was O 0 4.898681287002216e-12
4 O 0 1.1305546613899625e-13
% O 0 9.138208852815799e-13
- O 0 1.1864423221652487e-08
23 O 0 1.348612367613189e-11
% O 0 7.601170669453705e-13
( O 0 2.8298080892441568e-11
P O 0 2.4917184418882243e-05
< O 0 2.4445079294110883e-09
. O 0 2.1082903489417354e-13
0001 O 0 1.035816210581686e-09
) O 0 1.1447843405653843e-14
, O 0 1.2091370969857904e-15
suggesting O 0 1.817972855588934e-13
that O 0 5.471255798067463e-16
differences O 0 4.4843591188482856e-14
in O 0 4.5994121969969e-15
methods O 0 7.396445008388004e-15
used O 0 4.530385364542779e-15
for O 0 2.9532330454635255e-16
mutation O 0 2.1075666439916013e-13
detection O 0 4.133956198193456e-12
or O 0 2.3750374930631146e-11
phenotype O 0 1.9672702578077406e-08
classification O 0 1.2968897067366925e-09
may O 0 1.3147619104536545e-10
account O 0 3.453592934635902e-13
for O 0 4.561127895967782e-16
a O 0 7.946404019282434e-15
considerable O 0 2.387056481298333e-13
proportion O 0 1.1628004982500162e-11
of O 0 3.3232208760010373e-13
genotype O 0 0.0002180203446187079
- O 1 0.9179823398590088
phenotype O 0 3.1497320378548466e-06
inconsistencies O 0 4.137366886425298e-06
. O 0 7.277067143318661e-11

Our O 0 5.485508748626078e-12
data O 0 1.137541775185491e-12
indicate O 0 2.1223215174756387e-14
that O 0 1.2010274711998797e-16
the O 0 6.454620095786706e-14
PAH O 0 5.927876856048897e-09
- O 0 5.4432385682146034e-11
mutation O 0 1.8142683536059856e-11
genotype O 0 1.0544886075436466e-09
is O 0 2.939445223142621e-14
the O 0 2.434262840823512e-16
main O 0 3.2157629559432035e-14
determinant O 0 4.2959867434244625e-12
of O 0 1.4516408298396836e-14
metabolic O 0 3.742573195797405e-10
phenotype O 0 1.624629319962878e-10
in O 0 1.6461878518322925e-12
most O 0 1.9001929207635576e-13
patients O 0 1.548272274276563e-11
with O 0 4.394089692799641e-12
PAH B-Disease 0 0.00010339167056372389
deficiency I-Disease 0 0.014196336269378662
. O 0 9.695444447288537e-11

In O 0 7.211267173679037e-12
the O 0 2.1422157803078004e-15
present O 0 5.456207728363899e-16
study O 0 5.272527680839738e-15
, O 0 3.4642096413616224e-16
the O 0 3.5260456934891465e-16
classification O 0 4.695750759802289e-14
of O 0 4.0214977636508482e-16
105 O 0 4.503308490000357e-11
PAH O 0 4.0412254098676215e-10
mutations O 0 1.5328779912060497e-11
may O 0 9.307927692492335e-13
allow O 0 1.7595862223193258e-15
the O 0 1.4976715648087977e-15
prediction O 0 2.3684916874988637e-11
of O 0 1.1264159122964946e-16
the O 0 6.686797417046562e-15
biochemical O 0 1.0590251592335065e-10
phenotype O 0 4.2058256877197664e-10
in O 0 2.5224777128185494e-11
> O 0 1.7103729543777035e-10
10 O 0 8.813173715122025e-13
, O 0 2.2564617546422944e-13
000 O 0 3.160731767461178e-13
genotypes O 0 3.325044059532267e-11
, O 0 6.041896854786649e-14
which O 0 1.3270919194292852e-14
may O 0 6.233404634473083e-13
be O 0 1.8598966814330675e-16
useful O 0 2.128636571613893e-15
for O 0 5.841919401019415e-17
the O 0 7.642911161369152e-16
management O 0 4.754443800464303e-12
of O 0 2.761669270546531e-14
hyperphenylalaninemia B-Disease 1 1.0
in O 0 9.331766470666025e-09
newborns O 0 5.652734103023249e-08
. O 0 9.068235528805757e-13

Somatic O 0 2.034223371083499e-06
instability O 0 2.4505405704644545e-08
of O 0 2.384347602170378e-14
the O 0 9.876213751978599e-14
CTG O 0 5.186349838481874e-08
repeat O 0 3.321344033135887e-10
in O 0 7.389472605860703e-13
mice O 0 1.5826691346365607e-10
transgenic O 0 3.693300526519394e-11
for O 0 2.8354538023620847e-15
the O 0 7.33642543959169e-14
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 1.7580241429282495e-10
is O 0 2.4323095620948365e-12
age O 0 3.2240429401718396e-13
dependent O 0 9.31676814148151e-14
but O 0 1.2283055161096262e-14
not O 0 1.3892305158437007e-16
correlated O 0 1.1757779749076006e-15
to O 0 7.633961861234717e-17
the O 0 2.432592068335053e-16
relative O 0 3.7282110450058414e-13
intertissue O 0 2.121893993844992e-09
transcription O 0 1.3959290390275214e-09
levels O 0 2.135329239816297e-12
and O 0 4.914119783837323e-13
proliferative O 0 4.282349408413211e-08
capacities O 0 9.770951825416319e-10
. O 0 1.42947815043315e-11

A O 0 1.2121704751066886e-09
( O 0 7.999157586313643e-11
CTG O 0 2.9706225035397438e-08
) O 0 1.5414470914965062e-12
nexpansion O 0 9.11423603255912e-10
in O 0 3.6429380020387703e-13
the O 0 4.772319150102289e-14
3 O 0 1.2982942845796153e-11
- O 0 2.6589612289740217e-08
untranslated O 0 3.5625248528958764e-07
region O 0 8.961435066234813e-11
( O 0 6.334880103125995e-12
UTR O 0 3.3999256188188554e-10
) O 0 2.8978613264432976e-14
of O 0 1.4111085033685525e-15
the O 0 3.009557013322617e-12
DM O 1 1.0
protein O 0 4.2742176464827253e-10
kinase O 0 2.0524915100850194e-09
gene O 0 2.610188065688135e-09
( O 0 3.0299766168306874e-11
DMPK O 0 2.1418561146901993e-08
) O 0 3.131615789169623e-13
is O 0 1.1796197563673436e-14
responsible O 0 7.432325832253464e-14
for O 0 1.3223745388361418e-14
causing O 0 1.2100147273041983e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.017499404028058052
DM B-Disease 1 1.0
) O 0 2.745667693204723e-09
. O 0 9.689325730644072e-11

Major O 0 6.669723884300538e-09
instability O 0 1.7206774316491646e-07
, O 0 1.7217754999521162e-11
with O 0 1.3795827841046947e-15
very O 0 5.773270265850431e-15
large O 0 8.928445256832022e-17
expansions O 0 7.987364567495214e-13
between O 0 2.0648539318944602e-15
generations O 0 2.6792761734814423e-14
and O 0 3.267251378301361e-14
high O 0 2.6806115378634476e-13
levels O 0 1.5420809093102776e-14
of O 0 1.24888999432677e-16
somatic O 0 2.578318418142156e-12
mosaicism O 0 8.489323827243211e-11
, O 0 2.6611752488052073e-14
is O 0 1.7404470893596412e-15
observed O 0 2.7841576564829537e-14
in O 0 1.0798955479840444e-11
patients O 0 2.79698790170424e-12
. O 0 1.1964366129768589e-12

There O 0 6.614279263184031e-11
is O 0 6.494978844031121e-14
a O 0 1.4413864795736336e-13
good O 0 6.3290826572692804e-12
correlation O 0 8.294289734200877e-13
between O 0 4.15739694731819e-14
repeat O 0 2.716819174145013e-12
size O 0 2.6630656230555716e-13
( O 0 2.614667380176905e-13
at O 0 1.3303650715779103e-12
least O 0 2.2275743397212264e-14
in O 0 2.4148060599206954e-14
leucocytes O 0 2.293095748007179e-11
) O 0 2.2145297358719786e-15
, O 0 1.385109144689937e-15
clinical O 0 1.5587955459837183e-13
severity O 0 6.56172327844623e-13
and O 0 2.6432084602664996e-13
age O 0 8.32735573205734e-13
of O 0 3.75247030578443e-15
onset O 0 3.238764464952304e-11
. O 0 2.727093507612355e-12

The O 0 1.0847452797113633e-10
trinucleotide O 0 1.6220213865381083e-06
repeat O 0 7.608282004412104e-08
instability O 0 1.2850601138758577e-10
mechanisms O 0 2.4407815178706382e-12
involved O 0 4.486312038011475e-13
in O 0 3.429472172911119e-08
DM B-Disease 1 1.0
and O 0 6.459032527578179e-13
other O 0 5.900807593202037e-15
human O 0 8.981857141723837e-13
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.1864619529899922e-13
unknown O 0 4.586768465042468e-12
. O 0 4.967260977539745e-12

We O 0 3.4250891012277407e-10
studied O 0 1.2900903678669806e-09
somatic O 0 3.1201630168453676e-09
instability O 0 2.452369557426337e-11
by O 0 5.719738630616906e-15
measuring O 0 5.594981509343677e-12
the O 0 6.624922083766109e-15
CTG O 0 8.06888866833333e-09
repeat O 0 1.133178880591279e-11
length O 0 4.787674705471201e-13
at O 0 7.342588451315912e-13
several O 0 1.2245533295598791e-14
ages O 0 1.123478805646616e-12
in O 0 4.992100059475783e-15
various O 0 2.455116527287117e-15
tissues O 0 4.80764191478078e-13
of O 0 3.636698107251508e-16
transgenic O 0 3.707699425259392e-11
mice O 0 2.2303170421622553e-10
carrying O 0 1.0760255533814878e-12
a O 0 4.4972866034519166e-13
( O 0 4.667698953048083e-12
CTG O 0 1.8100887899663576e-08
) O 0 6.646165822549177e-13
55expansion O 0 2.451832903371809e-10
surrounded O 0 8.151661854208236e-13
by O 0 2.0400515790010808e-14
45 O 0 2.471667618839102e-13
kb O 0 7.932882128969254e-11
of O 0 1.9236856738996048e-16
the O 0 7.241800509141891e-15
human O 0 3.1035170960924674e-11
DM B-Disease 1 1.0
region O 0 1.386105639988866e-11
, O 0 7.168609916828952e-14
using O 0 1.7072575178665034e-13
small O 0 1.89515736437329e-10
- O 0 4.40317649008648e-08
pool O 0 4.099044437211319e-10
PCR O 0 1.138924776711292e-08
. O 0 5.069542442087682e-12

These O 0 5.287397581398012e-13
mice O 0 1.70017278033896e-10
have O 0 8.975203460753929e-15
been O 0 4.4161449721554077e-16
shown O 0 3.4931914030475204e-16
to O 0 4.941321810716427e-16
reproduce O 0 4.36288982372246e-12
the O 0 2.0733518322894363e-14
intergenerational O 0 1.2190327913774723e-10
and O 0 7.161111439078771e-13
somatic O 0 1.3693776668155522e-10
instability O 0 1.8339255461463644e-11
of O 0 6.833078312971485e-16
the O 0 4.639766964186463e-15
55 O 0 2.8366032938341446e-13
CTG O 0 1.0188688781553878e-09
repeat O 0 1.6326670917998776e-12
suggesting O 0 9.378493126413825e-14
that O 0 2.7155532181838047e-17
surrounding O 0 4.405897196982611e-16
sequences O 0 8.080233530882719e-14
and O 0 7.965585927405955e-15
the O 0 3.5163744301160745e-16
chromatin O 0 5.072189955372675e-13
environment O 0 8.741082537693304e-14
are O 0 2.695234221268154e-16
involved O 0 9.60734516572935e-14
in O 0 7.334279017445766e-12
instability O 0 6.737713859061856e-11
mechanisms O 0 1.5132872732692704e-10
. O 0 8.459529084181572e-12

As O 0 2.4675658651801546e-12
observed O 0 1.1558737636734734e-13
in O 0 3.083863324209943e-14
some O 0 6.356992857055365e-16
of O 0 8.83590690734449e-18
the O 0 8.24814743652228e-16
tissues O 0 4.1149106691507065e-12
of O 0 2.224354381241689e-12
DM B-Disease 1 1.0
patients O 0 6.374447636403602e-10
, O 0 1.019334864725465e-14
there O 0 1.7195214368592553e-14
is O 0 1.440593296746001e-15
a O 0 2.7527132523820323e-14
tendency O 0 8.041067811603853e-12
for O 0 4.793209015460653e-14
repeat O 0 2.8092634555415552e-12
length O 0 1.545922569644309e-12
and O 0 3.627448276651013e-13
somatic O 0 6.417247809531457e-12
mosaicism O 0 5.279310669181747e-11
to O 0 2.029501741291381e-15
increase O 0 4.214640280926583e-15
with O 0 4.2720064343123275e-15
the O 0 1.5358183474978304e-12
age O 0 1.5142141707169543e-10
of O 0 4.038487074050842e-15
the O 0 2.0806301831172852e-13
mouse O 0 3.93471495385711e-08
. O 0 8.09341829666188e-11

Furthermore O 0 5.340444753088036e-10
, O 0 2.744820213132493e-12
we O 0 9.381207528196597e-15
observed O 0 3.0120792301059195e-15
no O 0 1.0245698883284992e-15
correlation O 0 1.5471893650151683e-14
between O 0 1.6155259503205718e-14
the O 0 1.2451481902833739e-13
somatic O 0 4.1529513161719933e-10
mutation O 0 5.846800266162688e-10
rate O 0 1.0837563024779229e-07
and O 0 3.242630773267474e-13
tissue O 0 4.2283211654225994e-11
proliferation O 0 4.2727016369425996e-10
capacity O 0 2.73071105658107e-12
. O 0 2.4421042445210706e-12

The O 0 8.136784648837825e-12
somatic O 0 1.7203994673309353e-08
mutation O 0 1.4773703371773195e-09
rates O 0 1.9008249196872384e-08
in O 0 5.552441237908004e-14
different O 0 6.775455720360959e-16
tissues O 0 2.84780310227592e-13
were O 0 1.9984052390328855e-13
also O 0 1.9238701682634286e-15
not O 0 4.438926783539649e-17
correlated O 0 1.486804661491117e-15
to O 0 3.2791472360675427e-16
the O 0 5.478839919318941e-15
relative O 0 3.4937851223215688e-12
inter O 0 1.6371451749819244e-08
- O 0 5.7592348667867554e-08
tissue O 0 6.2178977522364676e-09
difference O 0 2.9258559550854324e-12
in O 0 1.2984489243354769e-13
transcriptional O 0 3.0137157960158367e-12
levels O 0 1.1877525601510647e-13
of O 0 3.079637757415755e-17
the O 0 3.9918770214853654e-16
three O 0 1.0373037581410467e-15
genes O 0 2.353188173834231e-13
( O 0 5.314453846612388e-13
DMAHP O 0 4.5416377325580015e-09
, O 0 2.200783907327017e-13
DMPK O 0 1.149388939580831e-08
and O 0 2.3098886627222204e-13
59 O 0 1.8547168737902825e-13
) O 0 1.3089410833366333e-15
surrounding O 0 1.5926955324800478e-14
the O 0 8.256313926806313e-13
repeat O 0 1.0618189660860367e-09
. O 0 1.1905270606155094e-12
. O 0 4.3482019200513644e-12

A O 0 4.796776864601782e-10
novel O 0 2.882003247162146e-10
missense O 0 7.735623057669727e-07
mutation O 0 5.951611203869334e-09
in O 0 2.0606572004311374e-10
patients O 0 4.0158511932508745e-11
from O 0 1.835466017184855e-14
a O 0 2.4107484671714863e-13
retinoblastoma B-Disease 0 1.2244823821561113e-08
pedigree O 0 5.742567168454116e-07
showing O 0 3.6403058345513273e-09
only O 0 1.123020296547872e-12
mild O 0 8.521111816151006e-09
expression O 0 2.1124614644346673e-12
of O 0 4.939213016315119e-15
the O 0 3.86509536398974e-14
tumor B-Disease 0 1.4817134186273506e-09
phenotype O 0 1.822515116600698e-08
. O 0 7.729720336024926e-11

We O 0 9.892173018222206e-12
have O 0 2.9577778536815777e-15
used O 0 2.6232665433607253e-15
single O 0 1.4751675087628507e-14
strand O 0 2.2162341406506414e-10
conformation O 0 5.899713877155488e-12
polymorphism O 0 4.6190967717407716e-11
analysis O 0 7.774054295271726e-13
to O 0 5.340542732438364e-15
study O 0 1.812177523926456e-13
the O 0 1.6383460343591394e-14
27 O 0 1.664179536363386e-12
exons O 0 1.6579296963081802e-11
of O 0 3.197827626208157e-15
the O 0 1.5690323118457833e-14
RB1 O 0 2.2310701897065854e-10
gene O 0 1.9418563979023418e-12
in O 0 1.7776073988435767e-14
individuals O 0 7.684771926669154e-17
from O 0 4.5960621816905096e-15
a O 0 4.4712256358318825e-13
family O 0 3.6323934311799366e-12
showing O 0 6.97117974457484e-10
mild O 0 1.833242890825204e-08
expression O 0 4.525061423656107e-13
of O 0 2.150739896372494e-15
the O 0 1.568739069039444e-14
retinoblastoma B-Disease 0 2.745819349669887e-09
phenotype O 0 2.7225723897572607e-08
. O 0 7.720230704721942e-11

In O 0 8.897867685708771e-12
this O 0 1.8066054447378856e-15
family O 0 5.929306016712408e-15
affected O 0 3.2956019098591416e-15
individuals O 0 4.1259345437671393e-17
developed O 0 3.14445436919511e-13
unilateral B-Disease 0 4.1732596400834154e-07
tumors I-Disease 1 1.0
and O 0 2.903499385364938e-10
, O 0 1.8077992106220984e-14
as O 0 6.036733087830303e-15
a O 0 1.062750216063342e-14
result O 0 1.8042718266165526e-14
of O 0 5.34104936401994e-16
linkage O 0 1.4298714989813277e-10
analysis O 0 7.28429903201766e-12
, O 0 1.0572797384767949e-13
unaffected O 0 2.1188705304209243e-11
mutation O 0 5.956585051591912e-13
carriers O 0 5.0514474547735944e-11
were O 0 1.1221515036630159e-11
also O 0 3.441262438853496e-14
identified O 0 6.986117413732007e-13
within O 0 2.7732292373974787e-14
the O 0 1.6169394382453683e-12
pedigree O 0 1.776335807335272e-07
. O 0 8.399594908503616e-11

A O 0 3.3740161775597244e-09
single O 0 3.8585146362735134e-12
band O 0 1.6270869200585292e-12
shift O 0 2.367948285370014e-12
using O 0 1.5465891371399532e-12
SSCP O 0 9.641771825386058e-09
was O 0 1.7339553187376011e-12
identified O 0 3.880032688370616e-13
in O 0 1.1903328596776265e-14
exon O 0 3.5015237237479013e-12
21 O 0 6.950073112507726e-13
which O 0 4.041153533768799e-15
resulted O 0 3.793050129628078e-14
in O 0 2.4307780181059835e-13
a O 0 3.71755447606259e-12
missense O 0 2.825115927862498e-07
mutation O 0 1.5457088387016427e-10
converting O 0 1.118124828836109e-10
a O 0 4.041377302255178e-11
cys O 0 0.00024046235193964094
- O 0 2.779062313607028e-08
- O 0 9.80736558631179e-09
> O 0 2.6048439447090566e-11
arg O 0 8.006740236099485e-12
at O 0 5.474915022751249e-14
nucleotide O 0 5.31226484242614e-13
position O 0 1.344407441275508e-12
28 O 0 6.974481213915806e-13
in O 0 1.546381837684574e-13
the O 0 9.344638235951608e-14
exon O 0 2.3870476706377985e-09
. O 0 7.257634077051378e-11

The O 0 5.1628692640526275e-12
mutation O 0 1.2237193897091103e-11
destroyed O 0 8.629394421255654e-11
an O 0 1.465171571308349e-13
NdeI O 0 4.361091043847409e-09
restriction O 0 1.474326771777612e-10
enzyme O 0 1.661403098429659e-10
site O 0 3.4883002736352253e-11
. O 0 4.541006893427069e-12

Analysis O 0 1.7362040971580228e-10
of O 0 4.695784641120179e-15
all O 0 4.195469595989613e-16
family O 0 1.5209198663538497e-15
members O 0 3.59308001328375e-17
demonstrated O 0 1.2226529899668904e-15
that O 0 9.723397589231003e-17
the O 0 2.927492402410737e-15
missense O 0 4.687664478808529e-09
mutation O 0 7.899377679754238e-11
co O 0 3.346286092664741e-08
- O 0 1.1182043069268843e-09
segregated O 0 3.1156518337516204e-11
with O 0 7.518742166411421e-15
patients O 0 9.129206939018086e-12
with O 0 3.785533220440965e-14
tumors B-Disease 1 1.0
or O 0 2.5678197346223897e-09
who O 0 2.3689716854846665e-10
, O 0 5.5987868150236125e-14
as O 0 5.247518863665465e-14
a O 0 4.416157720001264e-14
result O 0 1.3189436318832883e-14
of O 0 2.407509834580077e-16
linkage O 0 1.6565925714528973e-11
analysis O 0 6.264360991742324e-12
had O 0 2.511619245915142e-10
been O 0 4.61698908271746e-12
predicted O 0 1.1654694570539803e-11
to O 0 2.682076464405065e-15
carry O 0 1.3594068362307588e-12
the O 0 1.1574069610706395e-13
predisposing O 0 3.001936699220664e-09
mutation O 0 2.471586268981696e-10
. O 0 1.4194859176974717e-10

These O 0 2.383912294998125e-13
observations O 0 1.250112752031185e-12
point O 0 5.931460834648905e-13
to O 0 4.0622953702531476e-16
another O 0 4.7703692802577094e-15
region O 0 1.6236201294018981e-13
of O 0 1.6927650636598549e-15
the O 0 3.734928084040204e-14
RB1 O 0 4.1225034497216484e-10
gene O 0 1.855255749375062e-12
where O 0 7.155028759959266e-15
mutations O 0 4.2097198665359825e-13
only O 0 3.0991690401602386e-15
modify O 0 1.1338938685559463e-12
the O 0 9.80052377719655e-16
function O 0 3.71723712331044e-15
of O 0 4.028837304138807e-16
the O 0 1.0314644612334414e-14
gene O 0 1.722163939232857e-10
and O 0 4.276626795751692e-12
raise O 0 8.49625952275071e-14
important O 0 1.0699503349281825e-14
questions O 0 2.8794041397094475e-14
for O 0 1.1437616912183846e-16
genetic O 0 1.1849275900754908e-11
counseling O 0 1.359996837368982e-10
in O 0 8.490087701883836e-14
families O 0 2.0378037229656573e-14
with O 0 1.3560406680060639e-15
these O 0 1.2021288099076793e-14
distinctive O 0 7.635965471042283e-11
phenotypes O 0 2.2252605313966e-10
. O 0 2.480154970285753e-12
. O 0 1.0909008071879889e-11

Maternal B-Disease 0 3.919408300134819e-06
disomy I-Disease 0 8.456917566945776e-05
and O 0 3.018445511315804e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 1.4481572607749627e-09
with O 0 3.742829546185371e-14
gamete O 0 5.64259139412826e-10
complementation O 0 5.283338211370392e-08
in O 0 7.606013800558198e-13
a O 0 1.829905449174038e-13
case O 0 5.810892674158741e-13
of O 0 4.857370257731685e-16
familial O 0 2.54417903411408e-10
translocation O 0 3.608793264220367e-10
( O 0 3.2949924039238354e-11
3 O 0 4.10791539673383e-12
; O 0 3.2948021481266077e-12
15 O 0 9.758867975870333e-13
) O 0 5.689960763839708e-14
( O 0 1.529410007927029e-13
p25 O 0 1.2566596374607997e-10
; O 0 7.387114601660819e-14
q11 O 0 1.3021611566799152e-10
. O 0 2.2019469852075507e-13
2 O 0 1.0951449165921834e-12
) O 0 1.4946031608523147e-12
. O 0 4.917206832683041e-12

Maternal B-Disease 0 0.00010783853940665722
uniparental I-Disease 0 0.0024224973749369383
disomy I-Disease 0 6.404351734090596e-05
( I-Disease 0 8.037020648998805e-08
UPD I-Disease 1 1.0
) I-Disease 0 3.9505894215696724e-12
for I-Disease 0 1.457441989088839e-14
chromosome I-Disease 0 1.4767287837003096e-08
15 I-Disease 0 1.6355313370991498e-12
is O 0 2.647876873884962e-16
responsible O 0 1.4351240844149188e-16
for O 0 4.300039684533423e-18
an O 0 1.5438140163099014e-18
estimated O 0 3.203932827933729e-15
30 O 0 1.6730671007132193e-14
% O 0 4.237467818855086e-15
of O 0 1.0757242197164361e-15
cases O 0 3.434125596737947e-12
of O 0 1.3699708034664582e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.5565720445920306e-07
PWS B-Disease 1 1.0
) O 0 8.490931291404991e-10
. O 0 9.792439081834914e-11

We O 0 4.4034745294574407e-10
report O 0 7.046865695137239e-12
on O 0 2.336512644671965e-15
an O 0 6.195483112758365e-18
unusual O 0 1.7675693807922555e-14
case O 0 5.950509724718389e-13
of O 0 6.051694124898537e-16
maternal B-Disease 0 2.7580937533855376e-11
disomy I-Disease 0 1.5631345107181005e-08
15 I-Disease 0 3.159534049321233e-12
in O 0 2.928191022988358e-11
PWS B-Disease 1 1.0
that O 0 5.462471092316547e-14
is O 0 1.1140496018434962e-15
most O 0 2.326674304050047e-16
consistent O 0 4.2582417254029715e-15
with O 0 5.7289015484901725e-18
adjacent O 0 6.980785442972995e-14
- O 0 1.4004787329824353e-09
1 O 0 7.532242516337939e-13
segregation O 0 6.9542141142853175e-12
of O 0 1.5723561273643243e-16
a O 0 3.7332401167829155e-14
paternal O 0 1.0567536845584868e-09
t O 0 1.7908577731873265e-08
( O 0 3.72382810351346e-12
3 O 0 9.849994084265568e-13
; O 0 1.2776900848096573e-12
15 O 0 7.199691689184495e-13
) O 0 7.945589851213533e-14
( O 0 2.082543799951722e-13
p25 O 0 8.409598017955489e-11
; O 0 5.72651057432691e-14
q11 O 0 2.8906007795703736e-11
. O 0 1.3185235882447448e-14
2 O 0 8.725720070535542e-15
) O 0 1.5929681712099453e-15
with O 0 3.031628062314279e-16
simultaneous O 0 9.145707195040709e-13
maternal O 0 1.2580265995598694e-10
meiotic O 0 2.1192567700722975e-09
nondisjunction O 0 7.886513664345784e-09
for O 0 5.460629778214487e-13
chromosome O 0 1.1396684840292437e-07
15 O 0 1.0072004341665775e-09
. O 0 4.240783418874017e-11

The O 0 1.2416252921643167e-11
patient O 0 7.719866967903499e-10
( O 0 5.110969807098353e-12
J O 0 2.231446671885351e-08
. O 0 6.351303082638773e-14
B O 0 2.630235959588667e-11
. O 0 8.579891066687979e-16
) O 0 1.9288081585876844e-15
, O 0 1.2079707326174212e-15
a O 0 6.110645436917597e-14
17 O 0 7.307241834189626e-13
- O 0 5.909196309356046e-12
year O 0 2.9556396392849127e-12
- O 0 4.782960832949712e-11
old O 0 3.444876606195635e-09
white O 0 6.39053480272489e-12
male O 0 2.3909628617257983e-12
with O 0 4.5425966997301656e-14
PWS B-Disease 1 1.0
, O 0 1.2093738554000422e-13
was O 0 5.053550012810125e-14
found O 0 3.862617623212432e-15
to O 0 4.9379463182471696e-17
have O 0 1.1870498446773636e-14
47 O 0 3.0634965863998026e-14
chromosomes O 0 3.095627324357225e-13
with O 0 1.646534810080015e-14
a O 0 1.7834796139926112e-10
supernumerary O 0 0.00019988039275631309
, O 0 2.8644363356949976e-12
paternal O 0 1.1892267615110086e-08
der O 0 0.0905262902379036
( O 0 1.0040466374983126e-10
15 O 0 2.528010353136656e-12
) O 0 7.0577101800339045e-15
consisting O 0 6.582374771792578e-15
of O 0 1.2247589044561778e-14
the O 0 4.4149072418731006e-12
short O 0 5.129700639372459e-06
arm O 1 0.8804500102996826
and O 0 4.722630272957495e-12
the O 0 7.701097348526958e-15
proximal O 0 5.061817631712984e-10
long O 0 5.498723698593722e-10
arm O 0 4.78364336231607e-06
of O 0 2.313067272441405e-13
chromosome O 0 4.649905804399168e-06
15 O 0 3.672163373380499e-08
, O 0 6.3099300090518895e-12
and O 0 1.002583541361013e-12
distal O 0 7.65798660040673e-08
chromosome O 0 0.0005238867597654462
arm O 1 0.9994397759437561
3p O 0 0.0040511563420295715
. O 0 1.4516036372924646e-08

The O 0 2.8869298444866853e-12
t O 0 5.312275508373432e-09
( O 0 2.0915094742918194e-12
3 O 0 9.233269666420255e-14
; O 0 4.828205367522591e-14
15 O 0 4.082152300108159e-14
) O 0 2.939309147299645e-15
was O 0 4.304102037343098e-14
present O 0 1.3798820514328714e-16
in O 0 5.313110299892112e-15
the O 0 3.9193590897995765e-16
balanced O 0 1.3880428009511048e-14
state O 0 9.114381561899651e-16
in O 0 7.502132053603672e-13
the O 0 7.048821162175534e-14
patients O 0 1.1093736606432314e-12
father O 0 1.4190783964584952e-12
and O 0 2.998439983716711e-13
a O 0 3.1248276535777997e-12
sister O 0 8.825711006466008e-08
. O 0 3.431914127882685e-11

Fluorescent O 0 2.3929325188021267e-09
in O 0 2.3805829269668566e-12
situ O 0 3.933664158295436e-12
hybridization O 0 8.777470395480991e-14
analysis O 0 6.015472814964104e-14
demonstrated O 0 1.0224932811791869e-14
that O 0 1.67646097644441e-16
the O 0 1.4648496310257567e-14
PWS B-Disease 1 1.0
critical O 0 3.0543046390663076e-12
region O 0 8.227639489849503e-13
resided O 0 8.634498671611368e-11
on O 0 2.098413131625121e-13
the O 0 2.1793816802091878e-15
derivative O 0 8.305849931444786e-12
chromosome O 0 5.4451387843101884e-11
3 O 0 4.479967015847547e-13
and O 0 4.564753048751265e-14
that O 0 1.5190411472768396e-15
there O 0 3.7875918493159716e-14
was O 0 1.0613334213219194e-12
no O 0 1.1759311819919353e-14
deletion O 0 3.1002850026801143e-12
of O 0 2.925894527695301e-16
the O 0 4.414475512568017e-13
PWS B-Disease 1 1.0
region O 0 5.73035369155761e-11
on O 0 6.284434084236068e-11
the O 0 1.349364955709198e-13
normal O 0 4.407671710254801e-12
pair O 0 6.595077348819922e-12
of O 0 3.212671455092315e-15
15s O 0 8.286260566592318e-12
present O 0 8.352628484697977e-14
in O 0 7.244452954191516e-11
J O 0 1.7173204469145276e-05
. O 0 7.425025871921065e-11

B O 0 0.0011665122583508492
. O 0 1.7982159095097927e-09

Methylation O 0 2.152478195682761e-09
analysis O 0 1.930508877756587e-11
at O 0 2.0220312240987887e-13
exon O 0 7.101741937576289e-12
alpha O 0 6.0726111639208824e-12
of O 0 4.972995548987817e-16
the O 0 1.36462375873971e-15
small O 0 2.1675744966281885e-12
nuclear O 0 9.378543081028923e-11
ribonucleoprotein O 0 1.792897386110326e-09
- O 0 2.414045352505667e-11
associated O 0 1.0175118126537486e-12
polypeptide O 0 2.9231925213757393e-10
N O 0 5.4465616045051846e-11
( O 0 2.2080200081514567e-13
SNRPN O 0 3.640317769448842e-10
) O 0 4.646756680067206e-14
gene O 0 9.260797684262911e-11
showed O 0 7.174352778527293e-11
a O 0 9.574563635417893e-14
pattern O 0 1.5337028522188767e-11
characteristic O 0 1.472650126843611e-12
of O 0 5.8147337991679496e-15
only O 0 2.702165036595327e-14
the O 0 6.16780847180259e-15
maternal O 0 6.057506579670857e-11
chromosome O 0 6.52079137353212e-08
15 O 0 3.3887597172821415e-09
in O 0 1.6636998445562767e-09
J O 0 0.0002707544481381774
. O 0 8.193710987480785e-11

B O 0 0.0011945642763748765
. O 0 2.491205242094452e-09

Maternal B-Disease 0 2.5805489713093266e-05
disomy I-Disease 0 4.90216443722602e-05
was O 0 6.181462008925109e-10
confirmed O 0 5.268974275982052e-13
by O 0 1.5221437495532933e-16
polymerase O 0 1.7225136247911443e-12
chain O 0 4.302905688008396e-13
reaction O 0 4.625823107808763e-15
analysis O 0 3.5099185249866036e-14
of O 0 3.978893859288529e-16
microsatellite O 0 1.3019427202998202e-10
repeats O 0 1.1040469233281058e-10
at O 0 1.3447151378520594e-12
the O 0 1.2334140565178116e-14
gamma O 0 2.9063931261674725e-09
- O 0 1.6459172913485531e-09
aminobutyric O 0 5.9025371257348525e-09
acid O 0 4.1558336633107373e-11
receptor O 0 1.4938422677676644e-12
beta3 O 0 3.7083661141856794e-10
subunit O 0 1.17362564111545e-10
( O 0 1.7987321701551373e-11
GABRB3 O 0 1.7646744510102508e-08
) O 0 1.2373975542129267e-12
locus O 0 3.553637106801233e-10
. O 0 8.918226573895183e-11

A O 0 6.795589091446175e-10
niece O 0 5.425636118161492e-08
( O 0 4.4199227611230185e-11
B O 0 3.4417946270792754e-10
. O 0 6.577505602895287e-15
B O 0 1.453897874488519e-12
. O 0 9.866464762744705e-17
) O 0 2.597940311177381e-16
with O 0 2.2494196053045345e-16
45 O 0 8.987742936505082e-15
chromosomes O 0 1.1575416731905708e-13
and O 0 1.0862109958232127e-14
the O 0 1.1144874119981083e-15
derivative O 0 4.432094014711341e-12
3 O 0 3.642991466758401e-14
but O 0 5.252255133093332e-14
without O 0 1.07760175294732e-14
the O 0 6.52761324471964e-15
der O 0 9.465890798310284e-06
( O 0 1.852059521370575e-12
15 O 0 9.902904776586119e-14
) O 0 2.6403135049406917e-15
demonstrated O 0 1.2943535030948434e-14
a O 0 6.875915310212977e-14
phenotype O 0 5.189983859343883e-11
consistent O 0 5.972719714641972e-12
with O 0 4.510741611704768e-16
that O 0 1.053454029467226e-15
reported O 0 9.936934088072835e-12
for O 0 1.4364776695344108e-15
haploinsufficiency O 0 7.262234702487547e-10
of O 0 1.2349912318655992e-14
distal O 0 1.692783229145789e-07
3 O 0 1.0260514660132003e-09
p O 0 1.8293108951183967e-05
. O 0 7.936094559291007e-10

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 5.1935340472653024e-09
with O 0 1.5800254984585371e-12
unbalanced O 0 9.213756584358634e-07
segregation O 0 1.0580399750770297e-10
of O 0 4.643219470479472e-15
non O 0 4.871209546841726e-10
- O 0 1.872525468016306e-09
Robertsonian O 0 9.611164308864772e-09
translocations O 0 4.051138446925506e-08
has O 0 1.10422272454197e-12
been O 0 4.523471373407521e-14
reported O 0 4.548696488915205e-12
previously O 0 1.4629906986383945e-13
but O 0 1.307819412661726e-13
has O 0 1.4053210025256717e-14
not O 0 5.013165557115761e-16
, O 0 1.0815212470329956e-16
to O 0 4.479513889219666e-17
our O 0 1.4751095981790382e-16
knowledge O 0 5.995352669620733e-16
, O 0 6.119433467272832e-16
been O 0 2.81908192604108e-15
observed O 0 4.511827719701385e-15
in O 0 1.2955867661253867e-13
a O 0 8.622459300375307e-13
case O 0 2.2463425217167377e-11
of O 0 9.17379995753198e-13
PWS B-Disease 1 1.0
. O 0 1.5737409986282813e-10

Furthermore O 0 4.915580165132383e-10
, O 0 2.413602087289468e-12
our O 0 5.174296846430183e-15
findings O 0 5.907793243324633e-14
are O 0 4.8487432271639e-16
best O 0 2.2413062684555236e-14
interpreted O 0 4.7112355385176344e-14
as O 0 7.447719300817095e-15
true O 0 3.586532655065755e-14
gamete O 0 1.2323489451127045e-10
complementation O 0 1.3214532579297611e-08
resulting O 0 2.6682033318903287e-11
in O 0 1.0261155120039334e-10
maternal B-Disease 0 3.64334050573234e-06
UPD I-Disease 1 1.0
15 I-Disease 0 1.1237343500170027e-07
and O 0 2.8088391612612895e-09
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999661445617676
- I-Disease 1 0.9999998807907104
Jampel I-Disease 1 0.9999855756759644
syndrome I-Disease 1 0.9999997615814209
type I-Disease 0 1.1867415850019825e-07
2 I-Disease 0 2.1233117260960332e-12
and O 0 1.0672609714393322e-12
Stuve B-Disease 1 0.9997939467430115
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
: O 0 2.1354544922722735e-13
a O 0 3.8592119409007475e-13
case O 0 7.088087495416007e-12
for O 0 5.9689526643580664e-15
" O 0 1.5317315558288636e-12
lumping O 0 5.395833779786585e-11
" O 0 2.3325900239123953e-11
. O 0 2.0097398138047007e-12

Recent O 0 8.982838778370805e-12
studies O 0 4.595516675531819e-12
demonstrated O 0 3.003681830170135e-14
the O 0 7.064921818546828e-17
existence O 0 3.8344592834303835e-15
of O 0 7.756280036263138e-17
a O 0 2.45839793292478e-14
genetically O 0 2.1502016746971497e-12
distinct O 0 5.826441217514355e-13
, O 0 2.6840750217034526e-13
usually O 0 6.0115008233645444e-15
lethal O 0 1.5098448682168523e-14
form O 0 1.9327274223862774e-14
of O 0 3.3208538678409236e-15
the O 0 4.257484989556026e-12
Schwartz B-Disease 1 1.0
- I-Disease 1 1.0
Jampel I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 0 3.1728304428213505e-09
SJS B-Disease 1 0.9999887943267822
) O 0 2.6405594290984657e-12
of O 0 3.5763611446219465e-14
myotonia B-Disease 0 2.8559225029312074e-05
and O 0 3.256256722594664e-11
skeletal B-Disease 0 0.0020665526390075684
dysplasia I-Disease 1 0.9999984502792358
, O 0 3.874311028245758e-12
which O 0 8.735399963056764e-14
we O 0 6.241542113878673e-13
called O 0 2.1913711123477952e-10
SJS B-Disease 1 0.9999858140945435
type I-Disease 0 4.520462368873268e-07
2 I-Disease 0 9.438624187785294e-11
. O 0 2.7431468554994787e-11

This O 0 1.0326043492492332e-10
disorder O 0 4.160521712037735e-06
is O 0 7.373291701587986e-14
reminiscent O 0 1.2461187463841394e-11
of O 0 6.01239232554153e-16
another O 0 8.222238943303081e-14
rare O 0 2.3332131365849662e-11
condition O 0 2.493900641553637e-09
, O 0 3.302498452115686e-15
the O 0 5.085187032203252e-14
Stuve B-Disease 1 0.9997914433479309
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 7.785006417293516e-09
SWS B-Disease 0 0.002027378650382161
) O 0 3.745768886037615e-12
, O 0 6.312391066668269e-14
which O 0 2.4053719763607664e-15
comprises O 0 4.658583801109718e-15
campomelia B-Disease 0 6.775554006743789e-10
at O 0 2.0699952169023206e-12
birth O 0 9.501114305032754e-12
with O 0 7.207904791691616e-14
skeletal B-Disease 0 0.00010550580191193148
dysplasia I-Disease 1 0.9999741315841675
, O 0 1.7125712740290178e-12
contractures B-Disease 0 1.0813008266552515e-08
, O 0 1.0699152501458808e-11
and O 0 1.2513300291783214e-11
early B-Disease 0 3.011699334365403e-08
death I-Disease 0 7.745567208450321e-12
. O 0 7.861687646368298e-13

To O 0 2.8902136760267094e-12
test O 0 2.789634029418814e-13
for O 0 1.114159477898623e-16
possible O 0 8.20027758126644e-15
nosologic O 0 2.1289678908686938e-09
identity O 0 2.6933396485295802e-11
between O 0 2.172661356381056e-12
these O 0 6.880274345047455e-13
disorders O 0 2.649503061391556e-09
, O 0 1.5093718426674582e-15
we O 0 7.783523395173695e-16
reviewed O 0 4.668495611251898e-14
the O 0 4.667918501235154e-17
literature O 0 1.6907017506926497e-13
and O 0 1.4356012021922394e-15
obtained O 0 2.3349278036760047e-14
a O 0 3.4249187687296345e-14
follow O 0 3.7122526732290273e-13
- O 0 1.5053591706504221e-10
up O 0 1.7462021412173456e-12
of O 0 1.18334142326121e-16
the O 0 3.6237083276097713e-16
only O 0 7.690821991843816e-15
two O 0 2.7354556337080838e-15
surviving O 0 1.7336775461410103e-12
patients O 0 6.497456923621608e-14
, O 0 2.410064168311641e-16
one O 0 2.045606590475764e-15
with O 0 2.40672824551591e-13
SJS B-Disease 1 0.9995893836021423
type I-Disease 0 3.365178802283708e-09
2 I-Disease 0 8.921211751104774e-13
at O 0 7.405861340847864e-11
age O 0 1.9029050557506366e-10
10 O 0 1.4168489515312133e-13
years O 0 2.6801243922748227e-14
and O 0 2.930686881292188e-16
another O 0 1.9839711792776207e-15
with O 0 4.889217743636381e-15
SWS B-Disease 0 1.5962774568833993e-07
at O 0 4.090310729010227e-11
age O 0 6.327227630720245e-11
7 O 0 5.238794207468311e-12
years O 0 3.0637332948391105e-12
. O 0 1.3390589635384198e-12

Patients O 0 1.2907310519949533e-05
reported O 0 2.1956774176601357e-09
as O 0 3.1494243519537835e-13
having O 0 2.0699045776007008e-12
either O 0 6.4554250833737115e-09
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 1.735437926697614e-08
SWS B-Disease 0 9.819243132369593e-05
presented O 0 1.3407840376150615e-12
a O 0 1.49548640615213e-13
combination O 0 6.778649690175609e-12
of O 0 9.79077591028131e-15
a O 0 5.139965709999306e-12
severe O 0 1.0641774572661689e-08
, O 0 3.4693480727154835e-12
prenatal O 1 0.7451685070991516
- O 0 1.9463344870018773e-05
onset O 0 1.8971069266626728e-06
neuromuscular B-Disease 1 0.9999732971191406
disorder I-Disease 1 0.9999926090240479
( O 0 6.252474926693452e-11
with O 0 2.163522399428741e-12
congenital B-Disease 1 0.9999986886978149
joint I-Disease 0 5.5450245781685226e-06
contractures I-Disease 1 0.999993085861206
, O 0 1.0257377653033473e-05
respiratory O 1 0.9999991655349731
and O 0 4.314495809232266e-12
feeding O 0 2.095119910894283e-11
difficulties O 0 1.3783081620477589e-10
, O 0 5.543063227929183e-15
tendency O 0 3.107128486792843e-12
to O 0 1.974343404693643e-13
hyperthermia B-Disease 0 1.6601314101194475e-08
, O 0 2.826827313895386e-13
and O 0 3.6733992719384725e-14
frequent O 0 1.2381630443147884e-11
death O 0 3.7009728615089443e-11
in O 0 3.858796268629838e-11
infancy O 0 2.627641215724452e-09
) O 0 1.2082933462912067e-15
with O 0 1.9582922637508633e-16
a O 0 2.0478691171218338e-13
distinct O 0 7.122744755116983e-11
campomelic B-Disease 1 0.9038026332855225
- I-Disease 0 0.2739335596561432
metaphyseal I-Disease 0 0.0011051100445911288
skeletal I-Disease 1 0.9224919080734253
dysplasia I-Disease 1 0.9999834299087524
. O 0 1.1001208832794873e-09

The O 0 5.691229958007873e-14
similarity O 0 7.145965676830235e-13
of O 0 5.486722090288735e-16
the O 0 2.2420619065477692e-15
clinical O 0 9.77283792086281e-13
and O 0 1.0942208781856283e-14
radiographic O 0 3.9491920844625383e-10
findings O 0 1.0476818718130332e-10
is O 0 1.2151634950011148e-13
so O 0 3.235512376141385e-14
extensive O 0 4.816487513730275e-14
that O 0 1.17133314834106e-14
these O 0 1.6364034489979064e-14
disorders O 0 7.435159432578331e-11
appear O 0 1.4880573173409878e-13
to O 0 1.88265185098414e-14
be O 0 2.2169536985274657e-13
a O 0 5.742349954915293e-13
single O 0 9.97917026790418e-13
entity O 0 6.910824690287143e-10
. O 0 1.5735976965913778e-09

The O 0 1.201643358384949e-13
follow O 0 3.449802943311653e-12
- O 0 2.2012701383911093e-10
up O 0 5.575547619082744e-13
observation O 0 1.3278420518073736e-13
of O 0 1.728482563691217e-17
an O 0 3.080766031771277e-17
identical O 0 5.712851659832666e-14
and O 0 2.6642720436120164e-15
unique O 0 1.7868329428918917e-14
pattern O 0 2.2853825498714286e-09
of O 0 1.090665752156994e-11
progressive O 0 3.211727062080172e-08
bone B-Disease 1 0.9999974966049194
dysplasia I-Disease 1 1.0
in O 0 5.317929430148638e-10
the O 0 6.072802037713348e-14
two O 0 4.3656511782355634e-13
patients O 0 2.841959252566223e-13
( O 0 2.8828317432338067e-15
one O 0 3.500091248732559e-14
with O 0 1.5974554578440658e-12
SJS B-Disease 1 0.9999997615814209
type I-Disease 0 5.791378043795703e-07
2 I-Disease 0 1.0517598077186552e-11
, O 0 6.19480107402065e-13
one O 0 1.5948363235509383e-13
with O 0 2.802182043262075e-13
SWS B-Disease 0 6.741592642356409e-06
) O 0 4.024663496351652e-14
surviving O 0 7.995187845111218e-12
beyond O 0 6.416072534376482e-12
infancy O 0 8.048721689135618e-09
adds O 0 5.719551134791834e-12
to O 0 4.527014173412707e-16
the O 0 3.128840974879471e-16
evidence O 0 1.2685639756530864e-13
in O 0 1.834854289990348e-13
favor O 0 3.974545844352695e-13
of O 0 6.109686341511421e-15
identity O 0 7.721497746748796e-11
. O 0 1.5464601821335577e-11

The O 0 1.238320643942581e-12
hypothesis O 0 2.1290023563547145e-11
that O 0 1.7438457362156656e-12
SWS B-Disease 0 0.0031992322765290737
and O 0 7.063811341412318e-11
SJS B-Disease 1 0.9995360374450684
type I-Disease 0 4.5900487855021765e-09
2 I-Disease 0 2.9299422588634216e-13
are O 0 8.38341203369345e-15
the O 0 5.2221059270720575e-15
same O 0 2.0927955549088217e-11
disorder O 0 1.3460804915155222e-08
should O 0 4.271322031690946e-15
be O 0 2.8720385847220964e-17
testable O 0 5.803535007165711e-14
by O 0 1.811345414640941e-16
molecular O 0 5.686412712230249e-14
methods O 0 2.364518303377139e-12
. O 0 4.0209209659775036e-13
. O 0 4.689588994910565e-12

A O 0 4.232236505696818e-10
mouse O 0 5.867414998306231e-09
model O 0 3.606873411055034e-10
of O 0 4.399572340555574e-13
severe O 1 0.9900957345962524
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9984637498855591
defects O 1 0.9999996423721313
in O 0 4.696244504387437e-10
hemostasis O 0 8.243651973316446e-05
and O 0 6.905105376375786e-10
thrombosis B-Disease 0 4.79751979582943e-05
. O 0 2.796649301028964e-10

von B-Disease 0 0.0036540713626891375
Willebrand I-Disease 0 0.00027308615972287953
factor I-Disease 0 4.2857246285166184e-07
( I-Disease 0 4.0125804900981166e-08
vWf I-Disease 0 0.0003917996946256608
) I-Disease 0 2.1251773887343006e-06
deficiency I-Disease 1 1.0
causes O 0 0.0004122815444134176
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 7.091765041877807e-07
humans O 0 7.880800012571854e-09
. O 0 2.666068199541627e-10

We O 0 4.689222100895396e-12
generated O 0 1.8949004556212054e-14
a O 0 4.961707246778878e-14
mouse O 0 2.816939181915501e-10
model O 0 7.386135973674879e-12
for O 0 2.821254989067261e-15
this O 0 4.285324333342007e-15
disease O 0 1.416589556161446e-13
by O 0 2.761297761895865e-16
using O 0 4.4100660623325183e-13
gene O 0 1.8781043387150476e-10
targeting O 0 2.682473576598454e-09
. O 0 1.0549809636994922e-10

vWf B-Disease 0 0.0006923704058863223
- I-Disease 1 0.9999672174453735
deficient I-Disease 1 0.9972359538078308
mice O 0 4.97883083880879e-05
appeared O 0 2.460257331193816e-09
normal O 0 3.3920459757003085e-12
at O 0 6.077332647541622e-14
birth O 0 3.297892625761696e-14
; O 0 4.834466486837929e-16
they O 0 2.889206089678369e-15
were O 0 2.336149665643078e-13
viable O 0 4.560565466937838e-11
and O 0 1.857187770541377e-13
fertile O 0 1.2386259552743528e-11
. O 0 2.855540456869754e-11

Neither O 0 1.542391458997372e-08
vWf O 0 3.2692644253984326e-06
nor O 0 1.5308592082874384e-07
vWf O 0 1.3518445484805852e-05
propolypeptide O 0 2.5657958758529276e-05
( O 0 6.325616475066909e-09
von B-Disease 0 3.3149517548736185e-05
Willebrand I-Disease 0 1.079455387298367e-06
antigen O 0 2.370595719725088e-09
II O 0 9.528914546308442e-09
) O 0 1.4628491560447765e-12
were O 0 8.44549907438874e-13
detectable O 0 6.88387818970071e-11
in O 0 3.690804443751833e-13
plasma O 0 1.8059548648197143e-11
, O 0 2.721117059976963e-13
platelets O 0 4.860660918898363e-12
, O 0 1.4868225127104805e-14
or O 0 1.972657199264885e-13
endothelial O 0 3.0876313333351446e-13
cells O 0 9.182518027200937e-13
of O 0 9.721732772442955e-16
the O 0 1.365410673523533e-14
homozygous O 0 1.3520005115452705e-09
mutant O 0 2.2295663981708458e-08
mice O 0 6.088633199397009e-06
. O 0 1.35048180971431e-10

The O 0 9.456310517616529e-13
mutant O 0 1.0232728442360894e-08
mice O 0 3.1150057111517526e-06
exhibited O 0 3.844007068209976e-08
defects O 0 8.374777098651975e-05
in O 0 3.8310275633259006e-13
hemostasis O 0 2.617876360133664e-09
with O 0 4.153204134229281e-14
a O 0 6.997353391158256e-11
highly O 0 3.234047341038604e-08
prolonged O 0 1.7435453628422692e-05
bleeding O 1 0.9999990463256836
time O 0 1.892156875626938e-09
and O 0 8.063460489593499e-12
spontaneous O 0 1.6681328627449199e-12
bleeding O 0 2.4530926179267e-09
events O 0 2.913975980034045e-16
in O 0 1.1356713883715831e-15
approximately O 0 2.8779748563142506e-15
10 O 0 4.300154863808893e-14
% O 0 2.4085595307478738e-14
of O 0 5.824338813976634e-14
neonates O 0 2.0876547157655523e-09
. O 0 2.74308809174173e-12

As O 0 1.504540242391883e-11
in O 0 1.8620009505608548e-13
the O 0 1.3600712742855734e-15
human O 0 7.09526296223395e-14
disease O 0 1.6744775704902182e-11
, O 0 1.3530437595595597e-15
the O 0 4.698630989460309e-16
factor O 0 1.809407522901027e-13
VIII O 0 1.5982746237597212e-09
level O 0 3.838372761993947e-12
in O 0 2.9986402900680775e-13
these O 0 2.727682412351131e-15
mice O 0 1.3062358139581676e-10
was O 0 5.944942454982893e-12
reduced O 0 1.676597025817607e-14
strongly O 0 1.2661019685127734e-15
as O 0 8.811681632704118e-16
a O 0 6.8370974843062066e-15
result O 0 1.540910648590351e-14
of O 0 8.368933805405151e-16
the O 0 4.9775938579244006e-14
lack O 0 1.1894671445716876e-12
of O 0 8.785970476985806e-16
protection O 0 2.8789426761597833e-14
provided O 0 1.6240652282750213e-14
by O 0 1.195569115713599e-13
vWf O 0 2.0163209768497836e-08
. O 0 1.9026656639109518e-10

Defective O 0 0.00011931994959013537
thrombosis B-Disease 0 0.0005330624408088624
in O 0 3.126695430344384e-11
mutant O 0 6.7170877748878866e-09
mice O 0 9.578000026522204e-05
was O 0 4.2111980569359275e-09
also O 0 5.736449726692627e-13
evident O 0 9.342036828364e-14
in O 0 2.091555247952289e-14
an O 0 4.1324733734221465e-16
in O 0 1.587461580373692e-13
vivo O 0 8.997611544714346e-10
model O 0 1.0806481404168622e-10
of O 0 1.5041866406953486e-12
vascular B-Disease 0 0.032962899655103683
injury I-Disease 0 0.00022336567053571343
. O 0 5.5869329995683614e-11

In O 0 2.3525432903820365e-12
this O 0 1.4274427926025228e-15
model O 0 2.2795445544197823e-13
, O 0 1.4161613725362796e-15
the O 0 2.461887708667468e-15
exteriorized O 0 5.787816337310403e-10
mesentery O 0 2.164953993855079e-09
was O 0 2.0143000115102616e-11
superfused O 0 2.9312433036388086e-10
with O 0 8.217468961963913e-15
ferric O 0 7.560965742392511e-11
chloride O 0 1.5388444641814547e-12
and O 0 3.6637866677145803e-13
the O 0 3.2229410519514154e-14
accumulation O 0 1.814551221952787e-12
of O 0 5.185104986837148e-15
fluorescently O 0 1.4286428706711263e-09
labeled O 0 2.7653976886199416e-09
platelets O 0 9.654745447562618e-09
was O 0 2.7989213377543898e-11
observed O 0 1.1823323624402665e-13
by O 0 1.9411211800803886e-14
intravital O 0 1.4246400725781427e-09
microscopy O 0 1.4226028688391068e-10
. O 0 6.98327029882706e-12

We O 0 2.6132554453717205e-10
conclude O 0 5.1375279030985155e-11
that O 0 1.8337818615758294e-15
these O 0 8.248210434597732e-16
mice O 0 3.0524135302689714e-11
very O 0 1.3520854900105073e-13
closely O 0 1.1152929708241333e-12
mimic O 0 1.296088569802123e-09
severe O 0 1.1187471216089762e-07
human O 0 6.387595341550423e-09
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.8889838457107544
will O 0 1.608746802439498e-09
be O 0 4.1586498784537684e-14
very O 0 8.80426035353675e-15
useful O 0 3.92979580625917e-15
for O 0 1.934406199336088e-17
investigating O 0 1.3739737319279767e-15
the O 0 4.433139497101983e-17
role O 0 1.5243184589997655e-14
of O 0 2.0595350679115156e-16
vWf O 0 5.446236777534308e-12
in O 0 1.2494071532573314e-12
normal O 0 8.771559173448296e-11
physiology O 0 3.2284416806582783e-10
and O 0 1.6077280294828772e-13
in O 0 9.413067113966944e-13
disease O 0 1.6258156279591596e-11
models O 0 2.8332213311554888e-11
. O 0 2.7002811336766797e-13
. O 0 4.474282055966228e-12

Oral O 0 3.11754142501286e-08
contraceptives O 0 3.2858272334124194e-06
and O 0 5.531841803206594e-13
the O 0 5.151069932467049e-14
risk O 0 4.685688725913906e-09
of O 0 1.5515425055845355e-10
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.602836528062483e-10

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 0.9999940395355225
Cancer I-Disease 0 0.0007326007471419871
Clinical O 0 6.873070219626243e-07
Study O 0 2.468162563218357e-09
Group O 0 7.92544474492729e-10
. O 0 5.82653578162784e-11

BACKGROUND O 0 5.088529178465251e-06
Women O 0 4.194640121357729e-11
with O 0 1.843419656559573e-14
mutations O 0 1.7259513263034876e-11
in O 0 3.2149608496234716e-13
either O 0 5.3094054624841167e-14
the O 0 3.6859692408757264e-14
BRCA1 O 0 8.148010266495476e-09
or O 0 1.443657042868307e-12
the O 0 1.8089372840900293e-14
BRCA2 O 0 5.560676918925367e-10
gene O 0 1.8134828708160633e-11
have O 0 6.530331966370442e-14
a O 0 6.349800785003523e-14
high O 0 1.0870168480614506e-11
lifetime O 0 2.4061204417780147e-11
risk O 0 1.2289534652154543e-06
of O 0 7.587139094766826e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.797060083548075e-10

Oral O 0 7.048021188893472e-08
contraceptives O 0 4.722018275060691e-06
protect O 0 5.522449164629961e-09
against O 0 5.523757135961205e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 9.636865958007057e-12
general O 0 2.5736384594646222e-14
, O 0 1.2789891216426208e-13
but O 0 4.315299745143164e-13
it O 0 2.890815452278152e-15
is O 0 8.377393414616956e-17
not O 0 1.0834868266917686e-16
known O 0 2.400147477142102e-15
whether O 0 3.589288561462942e-15
they O 0 4.1543845593445747e-14
also O 0 1.2747768564420783e-15
protect O 0 7.2491207796303e-16
against O 0 3.4570975503958254e-14
hereditary B-Disease 0 1.5192958002785417e-08
forms I-Disease 0 7.660805181330943e-07
of I-Disease 0 0.0013260891428217292
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.96896099319477e-10

METHODS O 0 4.556498511831819e-10
We O 0 3.416614322189482e-13
enrolled O 0 7.163437377999404e-12
207 O 0 3.848476398671252e-11
women O 0 9.027473863928992e-13
with O 0 2.190576019189816e-11
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 5.960880660599299e-13
161 O 0 1.8762648498673457e-13
of O 0 3.2835142864806797e-17
their O 0 2.0197009348169384e-15
sisters O 0 3.643509539213996e-12
as O 0 1.118197162197198e-14
controls O 0 2.5283301494094523e-11
in O 0 6.683387025231691e-13
a O 0 3.0613209450053303e-12
case O 0 2.585530678445025e-10
- O 0 4.1427297703400257e-10
control O 0 1.6508912015211763e-09
study O 0 1.9848316046289227e-10
. O 0 2.010864218193742e-11

All O 0 4.814212179946042e-13
the O 0 2.8157138689329127e-14
patients O 0 1.9718632922240825e-13
carried O 0 1.0742409295005223e-13
a O 0 2.3530266277105305e-13
pathogenic O 0 1.7258313667056768e-09
mutation O 0 7.0836951755748334e-12
in O 0 5.319402687428698e-13
either O 0 2.189600632968372e-13
BRCA1 O 0 8.361209502538713e-09
( O 0 1.933511293780721e-12
179 O 0 5.71359799750315e-12
women O 0 1.0909101313266722e-13
) O 0 1.454154315407366e-14
or O 0 7.239449924950625e-12
BRCA2 O 0 6.247647888812935e-06
( O 0 8.393945538642811e-10
28 O 0 9.742849860217007e-10
women O 0 1.7583653283415046e-11
) O 0 7.668784227435332e-13
. O 0 4.808158211855318e-12

The O 0 1.645439969173712e-13
control O 0 3.280273839015302e-12
women O 0 1.8878849221762306e-13
were O 0 2.3223893443643888e-14
enrolled O 0 3.7390975190197684e-14
regardless O 0 4.546448814991865e-16
of O 0 8.301327374411682e-18
whether O 0 3.614364124833458e-15
or O 0 3.1870957695884217e-13
not O 0 7.996785200171941e-13
they O 0 3.014559088465596e-13
had O 0 9.89954862876119e-13
either O 0 7.340638920284512e-14
mutation O 0 6.518083989215384e-11
. O 0 5.7171108125420034e-11

Lifetime O 0 1.6947603320716098e-09
histories O 0 1.519567360830365e-09
of O 0 7.988803947523142e-15
oral O 0 2.4499759859741843e-11
- O 0 6.743589714419684e-11
contraceptive O 0 3.426265104966575e-10
use O 0 1.6207952406414872e-13
were O 0 3.5248542908268565e-13
obtained O 0 3.694647940453294e-14
by O 0 7.460027748331884e-16
interview O 0 2.335752147253345e-10
or O 0 3.445294993308784e-14
by O 0 6.655035693227775e-16
written O 0 4.640282299031573e-14
questionnaire O 0 1.7304844148889782e-14
and O 0 3.39185608700716e-17
were O 0 4.0150751363282925e-16
compared O 0 9.002665327695098e-16
between O 0 3.0407315489148947e-16
patients O 0 8.228168851560219e-14
and O 0 5.881051396740278e-16
control O 0 2.9313061851964084e-13
women O 0 4.0736993856330117e-13
, O 0 2.7738624368771987e-15
after O 0 4.921095405089823e-14
adjustment O 0 1.5902020368899206e-12
for O 0 2.0412248625698378e-16
year O 0 3.608772352128864e-14
of O 0 9.456908980275082e-16
birth O 0 2.668529112959117e-11
and O 0 2.281546479521168e-12
parity O 0 2.183714875592102e-10
. O 0 7.915372459040004e-13

RESULTS O 0 1.7883037273236368e-09
The O 0 2.496183564482026e-14
adjusted O 0 1.724589776541663e-10
odds O 0 3.0042106580197014e-09
ratio O 0 6.683627816528315e-06
for O 0 3.8355526044142607e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 5.162576269257535e-11
with O 0 7.330183314990194e-15
any O 0 2.604030171018696e-14
past O 0 8.975482304000165e-14
use O 0 5.43541821523396e-14
of O 0 5.196646128380843e-16
oral O 0 4.13030677368087e-12
contraceptives O 0 2.7764448518041718e-08
was O 0 4.846751333609234e-10
0 O 0 8.153998309889943e-12
. O 0 2.5237482242923548e-11

5 O 0 1.919285216867017e-11
( O 0 7.065613285422989e-12
95 O 0 2.0295999603181514e-10
percent O 0 1.0292296792613342e-07
confidence O 0 5.556139437423724e-10
interval O 0 1.0150902471015022e-13
, O 0 1.1626206945005444e-15
0 O 0 6.058900787092895e-16
. O 0 6.313324073459669e-16
3 O 0 2.4735229767474266e-15
to O 0 9.614086531549958e-15
0 O 0 1.5800516006258397e-13
. O 0 8.122019224711396e-13
8 O 0 1.1946494141157338e-11
) O 0 1.827618351796234e-12
. O 0 9.723681929085792e-12

The O 0 4.563843660626565e-12
risk O 0 1.1822506862380067e-10
decreased O 0 4.854548360522237e-11
with O 0 4.127053950746495e-16
increasing O 0 3.650891573650852e-15
duration O 0 4.575928801457338e-14
of O 0 8.50619850544514e-18
use O 0 7.603051760222967e-14
( O 0 1.1752193185624038e-12
P O 0 1.0340752698567712e-09
for O 0 1.167951115189263e-14
trend O 0 1.1855408321714833e-10
, O 0 7.118021721087137e-14
< O 0 4.5932230241518823e-11
0 O 0 3.204301244914137e-14
. O 0 6.027299258380258e-15
001 O 0 1.1960281940184836e-12
) O 0 8.433055390652384e-17
; O 0 2.1677713863662833e-17
use O 0 7.867045608333297e-16
for O 0 4.200337388458365e-16
six O 0 5.719695431936596e-15
or O 0 2.881997415780761e-14
more O 0 1.36086591824504e-14
years O 0 1.4365799064111444e-14
was O 0 1.8418229571023513e-15
associated O 0 4.249071693776437e-16
with O 0 3.211197855992109e-17
a O 0 2.4303872309854382e-14
60 O 0 2.5571648206053343e-13
percent O 0 7.915938043945303e-11
reduction O 0 3.5355485900057104e-12
in O 0 3.273295801076159e-10
risk O 0 1.8169192816941404e-09
. O 0 1.1134783199640008e-11

Oral O 0 1.0508333048164786e-07
- O 0 2.3755756473065048e-08
contraceptive O 0 1.7915001038204537e-08
use O 0 1.5946615555817445e-11
protected O 0 5.381688339411994e-08
against O 0 0.00011973355867667124
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 1.6908805212313325e-15
for O 0 6.259289757259174e-18
carriers O 0 4.059400317518551e-15
of O 0 8.651991569949449e-18
the O 0 5.7277303864742505e-15
BRCA1 O 0 5.521719685930293e-07
mutation O 0 1.8109009083944194e-11
( O 0 1.2065242468300985e-12
odds O 0 4.957309562847456e-10
ratio O 0 3.1999405902816136e-10
, O 0 6.992685917068739e-14
0 O 0 2.1745912430243437e-14
. O 0 9.041176739433198e-16
5 O 0 5.402650576262838e-15
; O 0 2.409317455829077e-14
95 O 0 1.3366717455109978e-10
percent O 0 1.3263136224850314e-06
confidence O 0 1.19795977582271e-08
interval O 0 4.4595064945494867e-13
, O 0 3.836273628003402e-15
0 O 0 1.2183045345739237e-15
. O 0 6.597278634136873e-16
3 O 0 2.6269917942627497e-15
to O 0 3.7189244129413705e-15
0 O 0 4.31664795054465e-14
. O 0 6.942332857673081e-14
9 O 0 7.096118939849128e-13
) O 0 6.39774488269719e-15
and O 0 6.337187638561783e-16
for O 0 4.040869936550146e-18
carriers O 0 1.197236517010928e-14
of O 0 2.1338214124852694e-17
the O 0 4.172824466606301e-14
BRCA2 O 0 7.432106485794066e-07
mutation O 0 1.0273154722739708e-11
( O 0 2.9974865905363357e-12
odds O 0 3.737738119014011e-09
ratio O 0 4.660782315646372e-10
, O 0 1.568314841058141e-13
0 O 0 2.0584296528576573e-14
. O 0 2.2797245912727212e-15
4 O 0 1.5118794413561572e-14
; O 0 1.1404980150390986e-13
95 O 0 2.973862267552363e-10
percent O 0 2.245810719614383e-05
confidence O 0 7.790460188061843e-08
interval O 0 8.395053315707335e-13
, O 0 2.9861888210401446e-15
0 O 0 1.458264309849857e-15
. O 0 8.223234609356755e-16
2 O 0 8.596997320574253e-15
to O 0 2.846297687559424e-14
1 O 0 1.5126018926975293e-12
. O 0 1.291373475167945e-12
1 O 0 2.5718841119293234e-12
) O 0 2.877595297462454e-12
. O 0 1.7580869052236103e-11

CONCLUSIONS O 0 8.18093059962166e-09
Oral O 0 1.4145972171419885e-09
- O 0 8.79443073920072e-10
contraceptive O 0 2.511170382746286e-09
use O 0 8.123940430961041e-13
may O 0 2.696905632842972e-12
reduce O 0 2.782203890286817e-14
the O 0 1.4997218080576268e-14
risk O 0 1.5277082709985734e-08
of O 0 1.3042217306136195e-10
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.6226179471237612e-12
women O 0 4.167829343909753e-14
with O 0 1.3348994403266458e-16
pathogenic O 0 6.191559764889831e-11
mutations O 0 5.435983260748678e-12
in O 0 4.70697103256007e-13
the O 0 1.6665102186685238e-13
BRCA1 O 0 7.926659577606188e-07
or O 0 3.4047362706957074e-09
BRCA2 O 0 0.0004009279946330935
gene O 0 8.560864080209285e-05

A O 0 3.463989095564557e-10
Japanese O 0 3.792534689073257e-11
family O 0 1.9656749372740784e-13
with O 0 2.136431053497822e-14
adrenoleukodystrophy B-Disease 1 1.0
with O 0 2.2565725126704773e-14
a O 0 3.070554444387086e-12
codon O 0 1.2105763058656294e-09
291 O 0 5.857311857759839e-11
deletion O 0 3.0649230375878744e-10
: O 0 3.8572447238214083e-14
a O 0 4.802213653316324e-14
clinical O 0 4.409395158028184e-12
, O 0 1.1916230602628843e-14
biochemical O 0 1.9151375364040435e-12
, O 0 7.638867701364668e-14
pathological O 0 4.5944612003800955e-10
, O 0 1.3537892595144596e-12
and O 0 7.355962085113521e-13
genetic O 0 2.3214341560162666e-09
report O 0 9.65305169131625e-09
. O 0 1.0589620326462157e-11

We O 0 7.704462068325313e-11
report O 0 4.17666725857635e-12
a O 0 2.051280694782831e-14
Japanese O 0 4.0664720939512233e-13
family O 0 1.0565540006475874e-13
with O 0 3.510522764409857e-13
adrenoleukodystrophy B-Disease 1 1.0
( O 0 2.254593255202053e-06
ALD B-Disease 1 1.0
) O 0 1.0323788265237388e-12
with O 0 5.669731499476907e-15
a O 0 2.2612009378635e-13
three O 0 2.4153911902806587e-14
base O 0 3.9895671944019384e-14
pair O 0 9.690041304077912e-12
deletion O 0 1.7317501876945585e-09
( O 0 6.957597258744341e-12
delGAG O 0 3.448229257685398e-09
291 O 0 4.3417006101442723e-10
) O 0 1.2275268692144015e-12
in O 0 8.803954093528077e-12
the O 0 3.3587372466614696e-11
ALD B-Disease 1 1.0
gene O 0 3.322880814948803e-08
. O 0 1.8617765662476415e-10

A O 0 9.389837518636313e-11
variety O 0 1.1635076582749981e-12
of O 0 1.5198700748948464e-15
phenotypes O 0 1.4855483379885848e-12
were O 0 1.4563284118137426e-13
observed O 0 3.3415672115330803e-15
within O 0 2.2960890560554375e-15
this O 0 9.259122467223171e-14
family O 0 5.80982050663037e-12
. O 0 5.253162054658089e-12

While O 0 8.226294645474752e-12
the O 0 1.1741970514390215e-13
proband O 0 1.3608648430363246e-08
( O 0 9.905318926195505e-11
patient O 0 1.3098291340440937e-09
1 O 0 2.7227105661199735e-13
) O 0 5.86739993613597e-14
was O 0 2.094375671155002e-12
classified O 0 1.8873674324793033e-12
as O 0 4.646284882715585e-15
having O 0 5.928084595202467e-15
a O 0 4.437119837270029e-15
rare O 0 2.8079494567186114e-13
intermediate O 0 1.092070336071449e-12
type O 0 1.7365983651096428e-10
of O 0 8.857676284069679e-14
adult O 0 7.174346006166843e-09
cerebral O 0 7.027523452052264e-08
and O 0 3.7330034896587705e-11
cerebello O 0 0.026731951162219048
- O 0 2.7290216166875325e-05
brain O 0 1.0326924382297875e-07
stem O 0 7.535831958449535e-10
forms O 0 3.037568460650952e-11
, O 0 3.4039192905316318e-12
his O 0 1.7168163592151675e-12
younger O 0 4.606462433720537e-11
brother O 0 1.8702605436571318e-11
( O 0 2.376863809938623e-11
patient O 0 3.247091762137444e-10
2 O 0 1.4515889575419938e-13
) O 0 2.846092773348824e-13
and O 0 2.5459675600386644e-12
nephew O 0 6.586614365033938e-09
( O 0 1.1077868483644338e-10
patient O 0 6.112875983177446e-09
3 O 0 5.430964922573112e-13
) O 0 8.958964212851805e-13
had O 0 4.369508754820117e-09
a O 0 5.170008865462705e-10
childhood O 0 2.486071707608062e-06
ALD B-Disease 1 1.0
type O 0 2.6559384878055425e-06
. O 0 4.299958722420172e-10

Another O 0 9.933186911892378e-11
nephew O 0 1.938233928910904e-08
( O 0 1.2293727147394407e-09
patient O 0 2.8619393521722714e-09
4 O 0 2.090722614565138e-13
) O 0 1.474403010705977e-13
of O 0 9.093224627053018e-14
patient O 0 1.7614384395514548e-09
1 O 0 1.585134882511538e-13
was O 0 8.085638061872125e-12
classified O 0 1.3120531570931515e-11
as O 0 2.565944418747579e-13
having O 0 1.14508467811969e-12
an O 0 1.020136666113336e-13
adolescent O 0 3.0994740107814778e-09
form O 0 6.130290025607721e-11
. O 0 2.793376085996613e-10

The O 0 4.1505058938351436e-13
tau O 0 5.208209905016581e-11
level O 0 3.3899743906093405e-13
in O 0 5.99604526728588e-14
the O 0 7.959944010350883e-13
cerebrospinal O 0 7.355348685678109e-08
fluid O 0 1.9953165786290583e-09
( O 0 3.6005293191365695e-10
CSF O 1 0.6910542249679565
) O 0 9.320185682254456e-13
in O 0 1.4144858895281942e-10
patient O 0 9.671345946316023e-10
1 O 0 2.25426353473758e-13
was O 0 1.2923284664623225e-10
as O 0 4.580052699945658e-13
high O 0 6.044493247939209e-13
as O 0 2.0796598560542286e-15
that O 0 1.0683138196284839e-16
of O 0 3.459270909883538e-16
patients O 0 5.067393987062685e-13
with O 0 4.460473806175251e-14
Alzheimers B-Disease 0 1.708425952529069e-05
disease I-Disease 0 6.381240780228836e-08
( O 0 8.169035760341448e-12
AD B-Disease 0 6.795607419007865e-07
) O 0 1.0459887123115408e-10
. O 0 1.3430657974655702e-10

His O 0 3.5962122169053146e-10
brain O 0 6.8891257143377516e-09
magnetic O 0 9.088136493362597e-12
resonance O 0 8.055994066280547e-11
image O 0 4.855875146425603e-10
( O 0 2.8368443011350664e-11
MRI O 0 0.0005273743881843984
) O 0 1.8123107181633458e-11
showed O 0 1.7552960684952268e-07
abnormalities B-Disease 1 0.8576052188873291
in I-Disease 0 2.636833622542828e-13
the I-Disease 0 6.058233748646932e-15
bilateral I-Disease 0 3.678649398985989e-11
cerebellar I-Disease 0 1.1134964061909614e-09
hemispheres I-Disease 0 6.473305234067084e-07
and O 0 8.494085296240073e-11
brain O 0 4.985794554990264e-10
stem O 0 3.6273292702837523e-10
, O 0 2.467272805332932e-13
but O 0 2.17474049022965e-14
not O 0 8.662700713380704e-16
in O 0 4.8126304645016577e-14
the O 0 8.002442025006884e-14
cerebral O 0 3.829473627092739e-08
white O 0 2.708394504224998e-07
matter O 0 1.0119292209731512e-10
, O 0 3.943822248349228e-15
where O 0 1.1278950435806374e-16
marked O 0 5.2726483830347216e-15
reductions O 0 6.288000176969677e-13
of O 0 1.7102501795015682e-16
the O 0 1.195707622541134e-14
cerebral O 0 1.8665409495799423e-10
blood O 0 3.61838545237525e-11
flow O 0 1.1142628486560113e-10
and O 0 4.7546820647337285e-11
oxygen O 0 1.4746682607674755e-12
metabolism O 0 2.8202010171618497e-11
were O 0 3.013426910346978e-13
clearly O 0 5.209076103947739e-14
demonstrated O 0 2.4412014700296233e-15
by O 0 1.2731051310415535e-15
positron O 0 3.7600456082031997e-10
emission O 0 2.096885109992286e-09
tomography O 0 1.8888603108280222e-06
( O 0 4.22632551178026e-09
PET O 0 3.660583445252996e-07
) O 0 1.1751802309056814e-10
. O 0 5.3045345893565354e-11

In O 0 5.137236747110308e-10
patients O 0 2.446149505175299e-09
2 O 0 5.969778165727802e-13
and O 0 9.404111604022214e-13
3 O 0 3.5458119188210013e-13
, O 0 5.075313338543698e-14
the O 0 1.8819625355716643e-14
autopsy O 0 4.2401790412149865e-10
findings O 0 3.0975352491302566e-13
showed O 0 1.334815613075746e-12
massive O 0 2.84165161019978e-12
demyelination B-Disease 1 1.0
of I-Disease 0 7.29046272136824e-14
the I-Disease 0 3.6387852366676077e-13
cerebral I-Disease 0 1.8740134066774772e-07
white I-Disease 0 1.7079938574582343e-09
matter I-Disease 0 1.0731929667856521e-12
with O 0 1.9226072950786317e-16
sparing O 0 3.962916827375887e-14
of O 0 4.456878257193275e-17
the O 0 6.640200440552208e-16
U O 0 2.7506681377076347e-09
- O 0 4.091453842391957e-09
fibers O 0 4.848924595179938e-10
, O 0 1.5563647647130058e-14
compatible O 0 9.895993665362882e-14
with O 0 4.590783247370094e-17
the O 0 5.541054912811243e-15
findings O 0 2.639350760516579e-12
of O 0 1.2084837254164316e-13
childhood O 0 4.362840044791483e-08
ALD B-Disease 1 1.0
. O 0 2.109733637789546e-10

Oleic O 0 0.008702153339982033
and O 0 1.4203199727447213e-10
erucic O 0 5.2278647189041294e-08
acids O 0 2.4827795375159667e-10
( O 0 8.222556750064891e-13
Lorenzos O 0 1.880332868575696e-11
Oil O 0 4.900725008097351e-13
) O 0 6.622117134161276e-15
were O 0 1.3935092763069762e-15
administered O 0 1.718019139224005e-15
to O 0 3.5320113465366586e-15
patients O 0 2.970088096906215e-13
1 O 0 4.773919195339652e-15
and O 0 1.442448699547072e-12
4 O 0 8.926177532580029e-14
, O 0 3.177619368262448e-14
but O 0 2.4496906459852428e-15
sufficient O 0 1.8908524004629824e-15
effectiveness O 0 1.0404872764161605e-13
was O 0 6.43169111719244e-13
not O 0 1.0669219380318642e-14
obtained O 0 6.439354258147567e-12
. O 0 4.746995765220197e-12

The O 0 1.0382653937990316e-12
findings O 0 4.523433277253686e-12
in O 0 6.034215960020947e-14
this O 0 3.9860642578848327e-16
family O 0 6.143598576104168e-15
suggest O 0 2.6891620644154367e-14
that O 0 6.466566627298957e-16
delGAG291 O 0 7.84329892700164e-12
is O 0 5.288458676511697e-16
part O 0 2.327101473353259e-15
of O 0 7.075443555938502e-16
the O 0 3.0520480890847135e-14
cause O 0 4.4661030516174316e-13
of O 0 2.8113296263979244e-14
Japanese O 0 8.126091466387209e-10
ALD B-Disease 1 0.9999160766601562
with O 0 4.8754565922654036e-14
phenotypic O 0 6.041736000383935e-10
variations O 0 1.2097959301016203e-09
. O 0 1.3600408299563327e-10

Moreover O 0 1.1267976829376636e-10
, O 0 5.095760375077238e-14
although O 0 2.8695557723350164e-15
the O 0 1.0352200438559114e-16
scale O 0 5.954718868602521e-14
of O 0 3.105094406203197e-17
the O 0 9.555945131259238e-16
study O 0 6.147067599539648e-15
is O 0 1.6547061263342655e-16
limited O 0 1.173856035974457e-14
, O 0 6.549504048911775e-14
there O 0 7.587898001983409e-14
is O 0 1.000003709396638e-15
a O 0 1.113697469071499e-14
possibility O 0 2.0335881416311263e-13
that O 0 9.466591329191851e-14
PET O 0 6.037900179833855e-10
can O 0 3.3319811753446116e-12
detect O 0 1.93400004344646e-10
an O 0 3.463779014046403e-13
insidious B-Disease 0 1.7246562720174552e-06
lesion I-Disease 0 0.07221449911594391
which O 0 3.690139166456774e-11
is O 0 1.2006193294330364e-13
undetectable O 0 1.4820113886093722e-11
by O 0 4.873761933447832e-15
computed O 0 3.176987839470513e-11
tomogram O 0 7.4189321352946536e-09
( O 0 1.0718699365586115e-11
CT O 1 0.9997617602348328
) O 0 9.056948442089097e-13
or O 0 1.071476891587042e-12
MRI O 0 1.6350675480225618e-07
analysis O 0 1.613698215850723e-12
, O 0 1.1437324103481892e-14
and O 0 1.2523112133402893e-15
that O 0 1.6294430708973854e-17
the O 0 5.039549045235956e-16
higher O 0 1.7921833721928904e-12
level O 0 1.2574819047909795e-14
of O 0 3.23352048287471e-17
tau O 0 1.3853879794658436e-13
reflects O 0 1.0433086923414877e-14
the O 0 1.1559694741613484e-15
process O 0 6.004285203796769e-14
of O 0 2.2488460051805657e-15
neuronal B-Disease 0 5.61047153180283e-10
degeneration I-Disease 0 1.4024820416125294e-07
in O 0 6.32433838632096e-09
ALD B-Disease 1 1.0
. O 0 2.986469960220006e-10

Lorenzos O 0 3.2674169148094734e-08
Oil O 0 6.312377009987102e-11
should O 0 9.977147553226137e-14
be O 0 7.020570114637408e-16
given O 0 6.275601461153699e-16
in O 0 1.101668330671067e-13
the O 0 3.3173865808229855e-14
early O 0 2.459942693988637e-09
stage O 0 4.298218378440133e-11
. O 0 7.573067064940708e-13
. O 0 4.765338297574306e-12

Nonsense O 0 1.9574285943235736e-06
mutation O 0 1.3397608578102904e-09
in O 0 9.803498290938961e-12
exon O 0 5.15523790323158e-10
4 O 0 2.8547659028377304e-12
of O 0 7.46469595866244e-16
human O 0 2.0074582594105037e-14
complement O 0 4.084025218703546e-12
C9 O 0 1.4392766978232885e-09
gene O 0 1.1311818842729693e-10
is O 0 9.896107506590993e-14
the O 0 2.498673502533775e-15
major O 0 4.2357428870799796e-13
cause O 0 2.122234679657886e-12
of O 0 5.268368749068719e-14
Japanese O 0 3.762821998432031e-10
complement B-Disease 0 6.464222046531631e-09
C9 I-Disease 0 6.111797119956464e-05
deficiency I-Disease 0 0.0008552003419026732
. O 0 1.7613234482016793e-10

Deficiency B-Disease 1 0.9999994039535522
of I-Disease 0 4.4641528429596733e-13
the I-Disease 0 8.54643301116155e-14
ninth I-Disease 0 3.973342922042322e-12
component I-Disease 0 4.979096562135465e-13
of I-Disease 0 1.1946805474469848e-16
human I-Disease 0 4.036069218502905e-15
complement I-Disease 0 4.472095437024759e-13
( O 0 1.0316327870088515e-12
C9 O 0 8.338526535922597e-10
) O 0 3.248150785340777e-14
is O 0 8.307354510139764e-16
the O 0 1.2009725464072062e-16
most O 0 2.157939041149445e-15
common O 0 7.429994987318e-12
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 6.36406968790304e-11
Japan O 0 1.900654330103113e-12
but O 0 4.521022092937241e-14
is O 0 7.583867670989607e-16
rare O 0 1.1958290531844523e-13
in O 0 6.849638477940401e-12
other O 0 3.721296274600272e-14
countries O 0 5.687239416386769e-13
. O 0 3.878199844598029e-12

We O 0 6.325658746808571e-11
studied O 0 6.331267975168142e-12
the O 0 6.183353220450601e-16
molecular O 0 1.231848959859852e-13
basis O 0 1.0731192410379231e-12
of O 0 2.2272868228576104e-13
C9 B-Disease 0 0.0007647352758795023
deficiency I-Disease 0 0.0609123595058918
in O 0 6.812193170668834e-12
four O 0 8.551438637066644e-14
Japanese O 0 5.400299131486097e-12
C9 B-Disease 0 2.0036854664340353e-07
- I-Disease 0 1.7541347574479005e-07
deficient I-Disease 0 1.1766472198360134e-05
patients O 0 6.574693145466881e-08
who O 0 3.5490341134675196e-12
had O 0 6.190024881558287e-11
suffered O 0 1.0029270924860612e-06
from O 0 1.2073156918646077e-09
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.6094748584171157e-10

Direct O 0 1.7062859805627717e-11
sequencing O 0 1.049485845450171e-10
of O 0 6.173508156504665e-14
amplified O 0 1.9642425186372492e-10
C9 O 0 2.7418787240662823e-09
cDNA O 0 4.1877969841896956e-11
and O 0 8.082365614454912e-13
DNA O 0 5.6331904418893686e-11
revealed O 0 2.6135866474513714e-12
a O 0 2.0215377765850362e-13
nonsense O 0 8.613558477588157e-11
substitution O 0 5.503142971700903e-13
( O 0 1.0152644648380935e-13
CGA O 0 1.7840461552509623e-08
- O 0 2.2302786006900277e-10
- O 0 3.3968533541539614e-10
> O 0 8.377543450621694e-12
TGA O 0 1.5119783203232373e-09
) O 0 1.6663377627604628e-14
at O 0 8.340672445240893e-14
codon O 0 7.917928465661639e-12
95 O 0 1.0380411807897616e-13
in O 0 1.0754991630623507e-14
exon O 0 1.3929541547996749e-11
4 O 0 1.3197201578080131e-12
in O 0 8.769241843092912e-13
the O 0 1.1429805669635473e-13
four O 0 2.0649565390939983e-11
C9 B-Disease 0 1.0460281373525504e-05
- I-Disease 0 3.003031906700926e-06
deficient I-Disease 0 2.7802346380667586e-07
individuals O 0 5.939159212174638e-13
. O 0 4.3528323306896155e-12

An O 0 3.581716954276226e-12
allele O 0 4.4696832901536254e-09
- O 0 1.0433569563872425e-09
specific O 0 8.827220638468747e-13
polymerase O 0 1.227525112806882e-11
chain O 0 1.926612298516761e-12
reaction O 0 5.482313008512568e-14
system O 0 1.660145274289676e-14
designed O 0 1.557977515444578e-14
to O 0 1.7579157674682219e-15
detect O 0 1.7846642674963775e-13
exclusively O 0 6.96862306628996e-15
only O 0 4.0773276004405987e-14
one O 0 6.173622505952544e-15
of O 0 2.1883195453988356e-16
the O 0 2.2740801754704554e-14
normal O 0 8.473235134365265e-13
and O 0 2.3641595883121085e-14
mutant O 0 2.0836258066148083e-12
alleles O 0 1.6455287653316386e-12
indicated O 0 7.755445591284271e-11
that O 0 2.5757782764476234e-15
all O 0 2.593820819377969e-16
the O 0 3.9218117795774697e-16
four O 0 1.6740598233274014e-14
patients O 0 1.950591728408697e-15
were O 0 5.345737161987401e-16
homozygous O 0 4.652009029729176e-13
for O 0 9.07109394313022e-16
the O 0 6.260156344756109e-16
mutation O 0 1.0310991698046085e-13
in O 0 1.2904993913764873e-12
exon O 0 4.91867241381172e-11
4 O 0 2.6167739849980443e-12
and O 0 1.8922468030414114e-13
that O 0 1.906184120324759e-15
the O 0 7.522615648079215e-15
parents O 0 1.019340254565515e-11
of O 0 6.15133664559381e-15
patient O 0 3.3397774129584334e-11
2 O 0 8.963045149829041e-14
were O 0 2.8416966696420687e-11
heterozygous O 0 4.994346625153412e-08
. O 0 1.1461411680846467e-10

The O 0 3.364979464775403e-13
common O 0 1.4049552536990473e-12
mutation O 0 4.590269570697858e-12
at O 0 1.7537523083061002e-12
codon O 0 6.733037738460013e-11
95 O 0 5.921412448914309e-13
in O 0 5.072061748465778e-14
exon O 0 4.117260005154222e-11
4 O 0 2.0528524626722833e-12
might O 0 9.78922238409341e-12
be O 0 1.1428383670723623e-14
responsible O 0 3.3999688626968434e-15
for O 0 3.10024355439339e-16
most O 0 4.035253102258225e-15
Japanese O 0 3.581418148157489e-11
C9 B-Disease 0 2.417217217498546e-07
deficiency I-Disease 0 4.116434695333737e-07
. O 0 2.074718652086971e-12
. O 0 1.2347152814062845e-11

BRCA1 O 0 1.8241850341382815e-07
required O 0 2.4377541651965373e-11
for O 0 4.8348217112801836e-14
transcription O 0 3.8898511078855336e-09
- O 0 3.996164732456009e-09
coupled O 0 5.460679686208891e-10
repair O 0 8.47084820065902e-08
of O 0 5.673712130812528e-15
oxidative O 0 1.6911444033346212e-12
DNA O 0 9.25695187170561e-10
damage O 0 6.656908912994197e-10
. O 0 1.2941086570406046e-11

The O 0 4.747398585358553e-10
breast B-Disease 1 0.9999997615814209
and I-Disease 1 0.9999932050704956
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 8.486822800080063e-09
gene O 0 1.311794939340416e-08
BRCA1 O 0 1.8042089777736692e-07
encodes O 0 8.070885626487723e-10
a O 0 1.927061635265126e-11
zinc O 0 8.170530350071203e-07
finger O 0 7.264582109201001e-07
protein O 0 9.04351538100201e-10
of O 0 2.1020813263878182e-14
unknown O 0 2.3186485717530125e-11
function O 0 8.490922374926324e-12
. O 0 6.614389591597103e-12

Association O 0 8.68220426109012e-12
of O 0 1.9399718675440389e-16
the O 0 2.7876510744673146e-16
BRCA1 O 0 1.4227757860751922e-11
protein O 0 9.401095353578359e-14
with O 0 3.0099180784805594e-16
the O 0 9.815451674100723e-16
DNA O 0 1.9838353182421997e-11
repair O 0 1.138858590765679e-10
protein O 0 5.850720949385213e-12
Rad51 O 0 3.434104556276907e-09
and O 0 1.9259501762500242e-13
changes O 0 6.066701367614044e-14
in O 0 9.890893510580874e-15
the O 0 1.6713206775946586e-16
phosphorylation O 0 4.212553022337959e-14
and O 0 2.987455050592995e-14
cellular O 0 1.718212724877155e-11
localization O 0 1.5995409207228417e-12
of O 0 1.0894419480757216e-17
the O 0 5.4167601466957347e-17
protein O 0 2.2278081208146686e-14
after O 0 5.520947621192847e-15
exposure O 0 7.537225102946868e-14
to O 0 6.213429242825233e-16
DNA O 0 2.3177862407131045e-11
- O 0 3.829685266826255e-12
damaging O 0 4.297150309195974e-12
agents O 0 2.832733613650218e-12
are O 0 6.7007395793583675e-15
consistent O 0 3.5687842655021673e-14
with O 0 9.640807410098401e-18
a O 0 1.505358282926012e-15
role O 0 1.4626439572311065e-14
for O 0 5.618764468249431e-16
BRCA1 O 0 4.3618435252579246e-11
in O 0 5.7500800995646806e-12
DNA O 0 1.1520776332929472e-08
repair O 0 2.2382441500212735e-07
. O 0 3.401740347741544e-11

Here O 0 5.740007580357087e-09
, O 0 6.536001666106184e-14
it O 0 2.0767810557643072e-16
is O 0 2.0067737495865148e-17
shown O 0 5.950330221496207e-16
that O 0 5.703721343463446e-16
mouse O 0 1.3689756273027598e-10
embryonic O 0 3.4009309257676534e-10
stem O 0 3.063048703566551e-09
cells O 0 2.767677198534102e-09
deficient B-Disease 0 4.046497537046889e-08
in I-Disease 0 4.3664507773377714e-13
BRCA1 I-Disease 0 9.98593119305724e-09
are O 0 6.997012019262228e-13
defective O 0 3.0936075923193584e-10
in O 0 1.9993659776829792e-13
the O 0 1.081022728438867e-15
ability O 0 1.0063036016451365e-13
to O 0 1.9099627343024603e-14
carry O 0 1.4708487899861566e-11
out O 0 6.0509904378780455e-12
transcription O 0 4.483540649857787e-09
- O 0 8.286649144650937e-10
coupled O 0 1.873882160552398e-10
repair O 0 1.0281677731427408e-08
of O 0 9.026495540874913e-16
oxidative O 0 1.7989018749001856e-13
DNA O 0 9.63606278103768e-11
damage O 0 1.2075637711994602e-10
, O 0 1.2526397562447056e-13
and O 0 5.151198003848674e-14
are O 0 1.770525186964994e-14
hypersensitive O 0 4.370700690259355e-09
to O 0 2.55227594972169e-14
ionizing O 0 5.833207528116446e-11
radiation O 0 2.2360300278023715e-09
and O 0 2.4232440706817293e-11
hydrogen O 0 2.827416686196349e-12
peroxide O 0 3.540326787287995e-08
. O 0 7.405833585272248e-11

These O 0 6.317235688550749e-13
results O 0 6.853097733391933e-13
suggest O 0 1.96958185980263e-13
that O 0 2.0662733473558216e-14
BRCA1 O 0 2.699175460918468e-08
participates O 0 2.1193371493519186e-13
, O 0 4.956707634807709e-16
directly O 0 4.45989104750754e-16
or O 0 1.0862441148114504e-14
indirectly O 0 1.1225099490327559e-13
, O 0 1.6332113883955196e-13
in O 0 3.2553983380506635e-12
transcription O 0 1.815918970748953e-08
- O 0 1.1909012664901297e-09
coupled O 0 2.0548250601049034e-10
repair O 0 8.89387585800705e-09
of O 0 2.8941146456077076e-15
oxidative O 0 8.015078401327203e-13
DNA O 0 1.6647337675035345e-10
damage O 0 9.117116783752266e-11
. O 0 6.139715472142093e-13
. O 0 5.570883598177145e-12

Truncation O 0 1.312343442805286e-07
mutations O 0 7.802814394608504e-09
in O 0 1.476427270372116e-12
the O 0 1.1821243480890798e-14
transactivation O 0 1.7617206582443146e-09
region O 0 1.3122307927770915e-11
of O 0 3.212709571574941e-14
PAX6 O 0 1.6762406573889166e-08
result O 0 1.6183031477379206e-12
in O 0 6.190800476424396e-12
dominant O 0 4.229811523259741e-08
- O 0 1.568659172335174e-06
negative O 0 9.28603256511451e-08
mutants O 0 2.7853300821334415e-07
. O 0 1.4987955321288382e-10

PAX6 O 0 7.938439011923037e-06
is O 0 2.3506875265755234e-11
a O 0 2.169526711059966e-12
transcription O 0 5.145333811795716e-11
factor O 0 1.0071561911285248e-13
with O 0 1.0888858014626777e-16
two O 0 2.3224192869790742e-15
DNA O 0 7.625381229225958e-12
- O 0 1.0096402880410693e-11
binding O 0 1.4833710431857994e-12
domains O 0 3.345005175625637e-11
( O 0 4.953653047652662e-13
paired O 0 2.5826115551685902e-11
box O 0 1.1931863275194132e-09
and O 0 1.2768666332596545e-12
homeobox O 0 1.6941582858809312e-10
) O 0 1.336063014780245e-13
and O 0 1.7663189907555187e-14
a O 0 2.2825770678962243e-13
proline O 0 7.430696613575094e-10
- O 0 6.940277519351667e-11
serine O 0 7.351123709753438e-09
- O 0 1.3321395098131461e-09
threonine O 0 1.2992524389687787e-08
( O 0 1.112951744652868e-11
PST O 0 3.6853194274044654e-08
) O 0 7.755082383556489e-13
- O 0 3.108469731616381e-11
rich O 0 2.6875767236700376e-11
transactivation O 0 4.2152500157044415e-08
domain O 0 9.563376757171227e-10
. O 0 1.3329209264112407e-11

PAX6 O 0 0.00038483887328766286
regulates O 0 2.2160011212690733e-06
eye O 0 0.0012564905919134617
development O 0 1.554670836512173e-10
in O 0 8.779987370824416e-13
animals O 0 3.1537811506212807e-14
ranging O 0 2.948869447239044e-13
from O 0 1.129937547065911e-14
jellyfish O 0 2.444792144336988e-13
to O 0 1.1143472280453377e-15
Drosophila O 0 4.4339941332287303e-13
to O 0 2.2682915523089195e-15
humans O 0 3.926091494011602e-13
. O 0 2.069951848815421e-12

Heterozygous O 0 1.4796724826737773e-05
mutations O 0 6.529703000524023e-08
in O 0 6.3790387902495915e-12
the O 0 4.844696421379274e-15
human O 0 2.248911438475741e-14
PAX6 O 0 4.656430352412144e-09
gene O 0 7.507841015552685e-10
result O 0 3.3633319653642024e-12
in O 0 9.942479511134555e-14
various O 0 1.0106034796985783e-15
phenotypes O 0 4.992450897134404e-12
, O 0 1.31712606858507e-14
including O 0 3.4139761872532814e-13
aniridia B-Disease 1 1.0
, O 0 2.833014889347396e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 4.696047439800566e-10
autosomal B-Disease 0 0.00034025852801278234
dominant I-Disease 0 3.213546733604744e-05
keratitis I-Disease 1 0.9999748468399048
, O 0 7.902595910991295e-09
and O 0 1.5816853382588647e-10
familial B-Disease 1 0.6936353445053101
foveal I-Disease 1 0.9952813982963562
dysplasia I-Disease 1 0.9999997615814209
. O 0 2.202640292381375e-09

It O 0 2.869219347789026e-13
is O 0 4.760041407531838e-16
believed O 0 3.1468811355296524e-15
that O 0 1.5678041193662205e-16
the O 0 1.2702138899552194e-15
mutated O 0 7.157968107129875e-10
allele O 0 3.6543984505144067e-10
of O 0 1.6345170388617353e-13
PAX6 O 0 9.531841094201354e-09
produces O 0 2.743684402936597e-12
an O 0 1.5638872643175712e-14
inactive O 0 1.8222656023025863e-11
protein O 0 1.1086408180371876e-10
and O 0 1.0096426472649966e-10
aniridia B-Disease 1 1.0
is O 0 6.751626167866842e-13
caused O 0 6.510187896581476e-13
due O 0 6.012894717723205e-13
to O 0 2.0421742096855822e-13
genetic O 0 1.4636698075776167e-08
haploinsufficiency O 0 2.5816163997660624e-06
. O 0 1.0912718645395003e-10

However O 0 3.726487174393611e-11
, O 0 2.092999947347126e-14
several O 0 1.2123147410874149e-15
truncation O 0 2.322618659900133e-11
mutations O 0 1.6706620462048072e-11
have O 0 1.428631654165971e-13
been O 0 1.404503700434866e-14
found O 0 5.026729222755086e-14
to O 0 1.1004533466115254e-15
occur O 0 7.451924819400213e-15
in O 0 4.3109538562600275e-14
the O 0 6.484160539228789e-14
C O 0 2.344842897628041e-08
- O 0 1.205203020715473e-10
terminal O 0 9.79408290580075e-11
half O 0 3.4256603630156146e-12
of O 0 3.97032887388413e-15
PAX6 O 0 9.494675046184398e-10
in O 0 3.242531839819235e-13
patients O 0 1.2708022568280741e-12
with O 0 7.91980379660686e-15
Aniridia B-Disease 1 1.0
resulting O 0 8.42903654860172e-13
in O 0 1.204474413545216e-14
mutant O 0 4.631831485198135e-13
proteins O 0 2.2320529417265388e-14
that O 0 2.4352848390139336e-16
retain O 0 2.5691703606678558e-14
the O 0 4.0629150277936234e-16
DNA O 0 4.993689056015382e-12
- O 0 1.4568542769724524e-12
binding O 0 7.432056814589416e-14
domains O 0 9.839873056985415e-13
but O 0 3.093604365733693e-12
have O 0 9.12949837256205e-13
lost O 0 4.228498454161844e-11
most O 0 2.524619180499358e-15
of O 0 6.83440444892953e-17
the O 0 1.1720617660822882e-14
transactivation O 0 1.3913411534005604e-09
domain O 0 2.6704807809529996e-10
. O 0 3.2921530085383566e-11

It O 0 4.3038354997915196e-12
is O 0 1.7050732570647598e-14
not O 0 1.2981751886979127e-15
clear O 0 2.7630589551514437e-15
whether O 0 2.6162509929750916e-15
such O 0 2.3691882535133678e-14
mutants O 0 1.844367858439e-08
really O 0 6.784545369953321e-09
behave O 0 8.300081542206295e-13
as O 0 6.473702562242219e-15
loss O 0 3.560898321000594e-13
- O 0 3.2197185455967725e-12
of O 0 8.030024805901273e-14
- O 0 5.320912599415806e-10
function O 0 1.0666946790921158e-13
mutants O 0 5.1481707785683284e-11
as O 0 1.541235455232437e-12
predicted O 0 9.099982919980043e-12
by O 0 6.179587142560519e-14
haploinsufficiency O 0 4.841914957864901e-08
. O 0 6.712390192287199e-12

Contrary O 0 1.4621888769217328e-11
to O 0 1.0876912706018343e-14
this O 0 2.615820382600531e-16
theory O 0 5.2197160236113795e-15
, O 0 2.9112441929000313e-15
our O 0 5.08655937380857e-16
data O 0 8.243248748526777e-14
showed O 0 2.8871707542094116e-13
that O 0 2.88769347412303e-17
these O 0 1.2525016634045235e-16
mutants O 0 4.031720703817632e-12
are O 0 1.0093595271122406e-14
dominant O 0 1.365530605257348e-10
- O 0 1.859091325329132e-09
negative O 0 2.14187417801881e-10
in O 0 1.7538894598809196e-12
transient O 0 6.7946750656466826e-12
transfection O 0 2.0455884208736563e-10
assays O 0 2.3176271665703574e-11
when O 0 2.024909340409605e-14
they O 0 3.2360904337762385e-15
are O 0 1.4058424201261337e-16
coexpressed O 0 8.074310317573996e-12
with O 0 4.2147690299345654e-15
wild O 0 8.443563070947846e-10
- O 0 2.95622885460034e-06
type O 0 6.39102211152931e-08
PAX6 O 0 3.264457291152212e-06
. O 0 2.2008335431866755e-10

We O 0 7.699492952928377e-12
found O 0 1.0174667505009546e-13
that O 0 2.5860048228571798e-17
the O 0 7.326541840940609e-17
dominant O 0 1.7518876974098596e-11
- O 0 2.807232224455447e-09
negative O 0 1.528175919141006e-10
effects O 0 4.3787484055313186e-11
result O 0 4.312072617376761e-14
from O 0 3.5039904378503023e-15
the O 0 4.761964304671003e-17
enhanced O 0 1.1860993043039548e-14
DNA O 0 1.0655213690535792e-13
binding O 0 3.145825097202663e-15
ability O 0 2.3702729639056216e-14
of O 0 3.7522128077684645e-15
these O 0 4.525119699522878e-14
mutants O 0 5.300865857371662e-10
. O 0 1.4402940645696916e-11

Kinetic O 0 6.531549606725306e-11
studies O 0 6.682501774157856e-11
of O 0 3.056001488311081e-15
binding O 0 5.4777619072632344e-12
and O 0 5.502453527539419e-12
dissociation O 0 2.9214172313912767e-12
revealed O 0 1.6344212224947419e-12
that O 0 2.290078510261721e-16
various O 0 1.3096853076599146e-15
truncation O 0 3.210184895685586e-11
mutants O 0 2.31128907679512e-10
have O 0 7.023835181009519e-13
3 O 0 9.502809102763729e-14
- O 0 1.0613263740077983e-10
5 O 0 6.3353632236140545e-12
- O 0 2.3617590105828867e-09
fold O 0 5.214173884326989e-11
higher O 0 2.9386841809801723e-13
affinity O 0 1.8042991010774542e-14
to O 0 2.6756473784562865e-16
various O 0 1.9259619425964527e-16
DNA O 0 9.967751586148835e-14
- O 0 8.184620177236444e-15
binding O 0 1.2229608864432174e-15
sites O 0 1.7089409789085123e-14
when O 0 2.027344051913193e-14
compared O 0 3.896935400239665e-13
with O 0 3.00877034883703e-16
the O 0 2.102578704134446e-14
wild O 0 3.7484451653746476e-10
- O 0 1.1033622371314777e-07
type O 0 8.512128779614159e-09
PAX6 O 0 8.129802040457434e-07
. O 0 1.0068215705594241e-10

These O 0 4.031624413112188e-14
results O 0 1.0109162889659993e-14
provide O 0 2.4649217277449736e-16
a O 0 4.665762405337698e-14
new O 0 8.11736181743905e-12
insight O 0 1.964462620351881e-11
into O 0 2.3879202177353072e-14
the O 0 3.744262556525536e-15
role O 0 2.1828703124573967e-13
of O 0 9.083247807132135e-16
mutant O 0 5.862352964181028e-11
PAX6 O 0 6.276991371123586e-08
in O 0 7.188707962235696e-11
causing O 0 4.2702899549773576e-10
aniridia B-Disease 1 1.0
. O 0 2.180712728450107e-11
. O 0 5.984625121857601e-12

Reversal O 0 1.3468643089709076e-07
of O 0 1.3771137008511403e-12
severe O 0 1.1485406048450386e-06
hypertrophic B-Disease 1 0.9998801946640015
cardiomyopathy I-Disease 1 1.0
and O 0 5.180963644213499e-11
excellent O 0 1.6055342610954426e-09
neuropsychologic O 0 1.3893640016249265e-07
outcome O 0 1.8099443818697658e-11
in O 0 3.69117930665297e-12
very B-Disease 0 6.306143107703832e-11
- I-Disease 0 6.831375742866186e-11
long I-Disease 0 8.298618042745787e-11
- I-Disease 0 1.4205793659460841e-11
chain I-Disease 0 6.700731081110689e-10
acyl I-Disease 0 1.7034658128523006e-08
- I-Disease 0 2.970829138249087e-10
coenzyme I-Disease 0 1.4292117489489442e-10
A I-Disease 0 6.126339713308226e-11
dehydrogenase I-Disease 0 6.998503749855445e-07
deficiency I-Disease 0 2.166663034586236e-05
. O 0 7.199341817143434e-11

Very B-Disease 0 7.718281125335125e-09
- I-Disease 0 2.3143340577291838e-09
long I-Disease 0 9.951239832162173e-11
- I-Disease 0 2.5021458863183632e-11
chain I-Disease 0 1.3390806519186782e-10
acyl I-Disease 0 1.9680499452334743e-09
- I-Disease 0 1.864106612126104e-11
coenzyme I-Disease 0 8.410395643809743e-12
A I-Disease 0 1.5406938420371719e-13
dehydrogenase I-Disease 0 2.6794860774614904e-10
( I-Disease 0 2.4377108404777248e-12
VLCAD I-Disease 0 3.462175968138581e-08
) I-Disease 0 1.5011207554760375e-11
deficiency I-Disease 0 2.222777482074889e-07
is O 0 2.126300370042071e-14
a O 0 4.416625485476056e-12
disorder O 0 9.343513056592201e-07
of O 0 1.2772447928130221e-15
fatty O 0 2.615000438410675e-10
acid O 0 7.812631618031585e-12
beta O 0 2.6302046478299257e-12
oxidation O 0 6.940501995957591e-15
that O 0 1.9550911674245117e-15
reportedly O 0 2.461504333695075e-10
has O 0 6.348838989256311e-12
high O 0 5.063114372205746e-09
rates O 0 1.9078270270256326e-05
of O 0 3.6078880768369848e-12
morbidity O 0 0.006793868727982044
and O 0 8.758373470918457e-10
mortality O 0 8.528766026749679e-10
. O 0 4.698425676297191e-12

We O 0 7.581160634158313e-13
describe O 0 7.05714851248658e-14
the O 0 2.985014251040099e-16
outcome O 0 7.387928939136309e-15
of O 0 6.779304955710638e-17
a O 0 1.7904707122311236e-13
5 O 0 2.0929369619771682e-13
- O 0 2.388939913944288e-11
year O 0 1.1984630302053212e-11
- O 0 2.1316648446401132e-10
old O 0 2.0414478285601945e-07
girl O 0 5.067097319511049e-08
with O 0 2.5695797486319227e-12
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 2.8669247531531994e-11
was O 0 1.0888542807197324e-13
first O 0 7.6729130683609e-16
seen O 0 1.3242935936221e-13
at O 0 1.1137575237074593e-13
5 O 0 1.468651453706213e-14
months O 0 8.5518186499281e-13
of O 0 6.413649302710429e-16
age O 0 9.675538365297442e-13
with O 0 2.0217641376698604e-14
severe O 0 1.0297559072114382e-07
hypertrophic B-Disease 0 0.0913732498884201
cardiomyopathy I-Disease 1 1.0
, O 0 7.293578505596088e-07
hepatomegaly B-Disease 1 1.0
, O 0 2.7412735192910986e-08
encephalopathy B-Disease 0 0.08354200422763824
, O 0 4.6196807490517244e-10
and O 0 1.1109162895150959e-10
hypotonia B-Disease 0 0.00043198384810239077
. O 0 4.640944573086614e-11

Biochemical O 0 2.383713848530533e-08
studies O 0 3.317187946549893e-08
indicated O 0 0.0008714304422028363
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 6.486347570167084e-11
by O 0 1.528336105675182e-14
a O 0 3.8686491510286913e-11
stable O 0 1.0420269980215835e-08
yet O 0 1.4489431356123905e-11
inactive O 0 2.341149218931804e-10
enzyme O 0 1.5245425755150421e-10
. O 0 3.4646922917463963e-12

Molecular O 0 1.2554521311436417e-10
genetic O 0 5.346896259084133e-10
analysis O 0 1.229714385875269e-10
of O 0 9.115399949612135e-14
her O 0 5.02589324324898e-11
VLCAD O 0 6.914416417203029e-07
gene O 0 5.541008096798805e-09
revealed O 0 6.716379674642781e-10
a O 0 3.3390748933187497e-12
T1372C O 0 6.720390910430751e-10
( O 0 2.697661972278498e-12
F458L O 0 1.5036927258904598e-09
) O 0 2.474305482724759e-12
missense O 0 1.9308953369545634e-07
mutation O 0 3.1399898237083335e-09
and O 0 4.8526505730395186e-11
a O 0 1.170759322821624e-10
1668 O 0 3.4582699299789965e-05
ACAG O 0 1.6927127944654785e-05
1669 O 0 2.7241989641879627e-07
splice O 0 6.469367690442596e-07
site O 0 5.997738417029552e-10
mutation O 0 1.0551993945284721e-08
. O 0 2.6043683876153523e-10

After O 0 1.9015036073488645e-11
initial O 0 4.866032056460856e-12
treatment O 0 2.992351158526141e-12
with O 0 1.0589059570322284e-14
intravenous O 0 7.382087718887931e-10
glucose O 0 2.562937773120666e-08
and O 0 8.035329671605973e-13
carnitine O 0 1.0883243611869986e-10
, O 0 1.0104112879228463e-14
the O 0 3.0745701445807896e-15
patient O 0 6.932812397081323e-12
has O 0 3.839406379358822e-15
thrived O 0 7.630836934557905e-12
on O 0 3.3178863302618655e-14
a O 0 1.4461510331256755e-12
low O 0 1.313497932642349e-07
- O 0 5.235225586375236e-09
fat O 0 1.1989854664662403e-09
diet O 0 1.6860084509073836e-11
supplemented O 0 2.234666444944633e-12
with O 0 7.301662021590247e-15
medium O 0 7.831262749391499e-09
- O 0 9.680883178431188e-11
chain O 0 2.0445040105343537e-10
triglyceride O 0 9.719446358857908e-10
oil O 0 1.346199957064087e-10
and O 0 4.290891101633998e-13
carnitine O 0 3.3376396091355787e-10
and O 0 4.559934786534103e-13
avoidance O 0 7.087563869134783e-11
of O 0 3.236332981660685e-14
fasting O 0 5.536991420918014e-10
. O 0 1.3749457301870383e-12

Her O 0 2.119580813086941e-06
ventricular O 0 1.2311904356465675e-05
hypertrophy O 0 4.228440175779724e-08
resolved O 0 4.591167446221789e-10
significantly O 0 2.2318520295772082e-11
over O 0 2.8976414366901904e-13
1 O 0 2.402481154555741e-13
year O 0 7.734460858235814e-13
, O 0 5.107230048216008e-15
and O 0 1.2814522595719184e-14
cognitively O 0 2.8128034623708942e-11
, O 0 1.6161105936365904e-15
she O 0 3.7026707654791435e-13
is O 0 3.264580122259341e-17
in O 0 6.829169785315498e-16
the O 0 1.4977051284893327e-16
superior O 0 4.729322741260124e-14
range O 0 2.9154885970716915e-12
for O 0 2.185495924858505e-12
age O 0 1.2404677111887974e-11
. O 0 7.0490566508873975e-12

Clinical O 0 5.4207509592174574e-09
recognition O 0 7.442210736563482e-11
of O 0 4.879699422311035e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 5.765639159681368e-13
important O 0 9.85436267363169e-15
because O 0 4.983481075720997e-15
it O 0 2.6196266310281368e-15
is O 0 6.926083589371191e-16
one O 0 2.8694901272816042e-15
of O 0 1.8339977226284812e-16
the O 0 1.1587338720638312e-14
few O 0 1.7415918967395028e-12
directly O 0 5.119970609588839e-14
treatable O 0 2.811190724649748e-10
causes O 0 4.2057554812922893e-13
of O 0 1.8501706243456706e-12
cardiomyopathy B-Disease 1 1.0
in O 0 1.673579497207811e-08
children O 0 5.944004316527085e-11
. O 0 1.5487490576029245e-13
. O 0 1.42083881552596e-12

Cloning O 0 3.2938254901360153e-10
of O 0 4.599867900722523e-15
a O 0 2.899497794097393e-14
novel O 0 3.2795524650998387e-13
member O 0 3.290691490457319e-14
of O 0 5.216147341455699e-17
the O 0 7.62413339384059e-15
low O 0 1.2731921295028314e-08
- O 0 1.2070785482265478e-09
density O 0 1.281922918511258e-12
lipoprotein O 0 9.940431811017447e-10
receptor O 0 3.92056560827303e-11
family O 0 1.0981517084562853e-10
. O 0 1.483578364325222e-11

A O 0 5.55394306933632e-11
gene O 0 4.221344662713733e-10
encoding O 0 2.482195698982892e-11
a O 0 9.230170203459662e-14
novel O 0 4.716398170449831e-13
transmembrane O 0 9.179965815286906e-12
protein O 0 3.435869991297302e-11
was O 0 2.3071993534434787e-12
identified O 0 7.194279080888905e-14
by O 0 2.023100607429862e-16
DNA O 0 5.603127011845344e-13
sequence O 0 1.02055654034529e-14
analysis O 0 2.3388546484194757e-14
within O 0 2.666956502780102e-15
the O 0 2.0868036031823634e-12
insulin B-Disease 1 0.9999916553497314
- I-Disease 1 1.0
dependent I-Disease 1 0.9999998807907104
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.2473185817540866e-09
IDDM B-Disease 0 3.8410396996368945e-07
) O 0 1.0416891958395236e-12
locus O 0 7.537829804782348e-10
IDDM4 O 0 2.8427533038666297e-07
on O 0 7.20896051187303e-11
chromosome O 0 7.669591468584258e-07
11q13 O 0 7.35397293283313e-07
. O 0 2.071762900124341e-10

Based O 0 5.168800717297861e-12
on O 0 2.54233185068356e-13
its O 0 6.001510916784627e-15
chromosomal O 0 6.027547350129225e-09
position O 0 4.541072518016165e-10
, O 0 7.690708150615705e-14
this O 0 1.7353478980776111e-16
gene O 0 3.4993672456268277e-12
is O 0 1.6351835521472707e-14
a O 0 4.015079487960059e-14
candidate O 0 3.913015744760884e-13
for O 0 2.755311991815856e-15
conferring O 0 4.775984295546376e-12
susceptibility O 0 1.3376747487470197e-09
to O 0 2.338453597428014e-10
diabetes B-Disease 0 0.0006621405482292175
. O 0 1.3946428734090688e-10

The O 0 4.118662062877615e-13
gene O 0 9.702307707248892e-11
, O 0 5.934310117958197e-14
termed O 0 7.089656119119159e-12
low O 0 7.947414282227783e-09
- O 0 2.279849198316697e-09
density O 0 2.220276696870971e-12
lipoprotein O 0 3.1992389293300505e-10
receptor O 0 9.189386447963632e-13
related O 0 2.1581480092597305e-12
protein O 0 6.488633415291378e-12
5 O 0 1.5949611423260457e-13
( O 0 2.322590091172888e-13
LRP5 O 0 7.589650019568239e-10
) O 0 1.1986669015489563e-14
, O 0 8.604440199081777e-16
encodes O 0 5.55435824287423e-14
a O 0 3.32622977419891e-15
protein O 0 2.543341839217339e-12
of O 0 3.767516152026508e-15
1615 O 0 1.2736961485515508e-10
amino O 0 3.6454262460246245e-13
acids O 0 9.679853218893392e-14
that O 0 1.5885791905844083e-17
contains O 0 3.237717266430559e-17
conserved O 0 5.394885825235358e-15
modules O 0 4.1431024193003263e-13
which O 0 8.758831011960186e-16
are O 0 4.320745504190728e-16
characteristic O 0 3.335341646425703e-14
of O 0 4.680848591523889e-16
the O 0 4.272693039219372e-14
low O 0 9.832692171585222e-08
- O 0 2.8667308527019486e-09
density O 0 3.2938220293626808e-12
lipoprotein O 0 2.207503335682759e-08
( O 0 1.935076404668834e-11
LDL O 0 1.7565309207157043e-08
) O 0 4.591668299920582e-13
receptor O 0 9.405462519929131e-12
family O 0 3.482436908286424e-11
. O 0 9.586103612291286e-12

These O 0 3.0363084550961983e-13
modules O 0 1.1201686279938006e-12
include O 0 2.503959835157589e-15
a O 0 4.251142826975328e-14
putative O 0 2.5699289918357238e-11
signal O 0 3.3994489081340395e-12
peptide O 0 9.613247968932176e-14
for O 0 3.025389664657751e-16
protein O 0 2.3177472650002563e-14
export O 0 9.1813310426625e-12
, O 0 3.5742472891987787e-14
four O 0 1.4492263454828763e-13
epidermal O 0 2.8163696375038683e-10
growth O 0 1.110378247681787e-10
factor O 0 1.0405592403353592e-12
( O 0 3.091999963358849e-12
EGF O 0 2.4680840482460553e-08
) O 0 6.686868398407542e-13
repeats O 0 8.22588611809616e-12
with O 0 2.506616553996652e-15
associated O 0 1.3825615999274454e-12
spacer O 0 4.419558763402165e-08
domains O 0 3.309367224701987e-10
, O 0 8.145907044601955e-14
three O 0 7.474619881375766e-14
LDL O 0 5.774782874112816e-10
- O 0 4.5492429268101375e-12
receptor O 0 8.872661719921959e-13
( O 0 4.810301462709887e-13
LDLR O 0 3.850572749541925e-09
) O 0 1.3051281518190738e-13
repeats O 0 5.477928874397797e-12
, O 0 6.816758105660263e-15
a O 0 3.914519567055439e-15
single O 0 1.3534057602653925e-14
transmembrane O 0 7.833248481282917e-13
spanning O 0 7.0585551292801085e-12
domain O 0 6.052433294129189e-12
, O 0 9.239350820880454e-13
and O 0 7.075464075311649e-14
a O 0 1.7535841214440934e-13
cytoplasmic O 0 6.824372733582607e-10
domain O 0 1.1295675506062253e-09
. O 0 3.878039209204154e-11

The O 0 5.260777300982247e-14
encoded O 0 4.8875469643716585e-12
protein O 0 8.174585140741097e-12
has O 0 2.857841052564605e-14
a O 0 1.3362400023145737e-15
unique O 0 4.575996394686529e-15
organization O 0 1.5611492133749127e-13
of O 0 3.205456597854192e-14
EGF O 0 2.7112236011817004e-08
and O 0 7.83857354025308e-12
LDLR O 0 3.7565509813930476e-08
repeats O 0 2.4120478184230798e-11
; O 0 1.2992212320361244e-14
therefore O 0 7.72569603234817e-15
, O 0 6.052135534943175e-15
LRP5 O 0 6.064040936060167e-10
likely O 0 5.411883574201089e-14
represents O 0 2.6025144479112318e-15
a O 0 5.427917569079434e-14
new O 0 2.32833956108347e-12
category O 0 2.4046429777935252e-11
of O 0 1.941920016852944e-15
the O 0 9.231618290986288e-13
LDLR O 0 1.9825445178867085e-06
family O 0 3.96721856754656e-11
. O 0 1.0138760490885357e-11

Both O 0 3.906947682041917e-12
human O 0 5.839959050200905e-13
and O 0 3.7819050733960136e-13
mouse O 0 7.586006489646024e-09
LRP5 O 0 1.2620154166143038e-07
cDNAs O 0 1.0004341799429994e-09
have O 0 7.121212663606033e-14
been O 0 1.4045947564766958e-14
isolated O 0 4.463216363333189e-13
and O 0 4.185320658973849e-15
the O 0 5.50489557921877e-17
encoded O 0 5.794653358493981e-14
mature O 0 4.483674716226904e-14
proteins O 0 1.3298067870801773e-16
are O 0 2.2684794678917568e-17
95 O 0 1.3564236327773412e-15
% O 0 1.3285593987164473e-16
identical O 0 1.1182894210258129e-13
, O 0 5.6317099692438505e-14
indicating O 0 3.261670794563187e-11
a O 0 1.0699484354059763e-10
high O 0 9.438561043850768e-09
degree O 0 9.014101687299103e-10
of O 0 8.796769617667706e-16
evolutionary O 0 1.8856608169446482e-13
conservation O 0 4.296637644198714e-14
. O 0 3.888382129300927e-13
. O 0 6.24126011289361e-12

The O 0 4.09189262334797e-12
APC B-Disease 0 1.683407191421793e-09
variants O 0 6.011424691365619e-10
I1307K O 0 2.1096984159640897e-09
and O 0 1.2943171653814062e-13
E1317Q O 0 1.9142985807629742e-11
are O 0 7.280325473407148e-16
associated O 0 6.072306828371066e-13
with O 0 1.5148445982049452e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 4.9372832211513895e-11
but O 0 5.366348438209413e-14
not O 0 5.540251925577246e-15
always O 0 2.3061764561275837e-14
with O 0 9.228605940070364e-17
a O 0 1.4053948976799902e-12
family O 0 3.5083893255849485e-12
history O 0 6.328264995358879e-11
. O 0 1.4262263245412576e-11

Classical O 0 0.00019515187887009233
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 4.725748567580013e-06
FAP B-Disease 0 4.326717473190911e-08
) O 0 1.2702836829289743e-12
is O 0 2.181142026431819e-14
a O 0 2.8005445185108613e-11
high O 1 0.9999651908874512
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 0.999997615814209
dominant I-Disease 0 0.4499944746494293
disease I-Disease 0 0.4928346276283264
that O 0 8.011360265501935e-14
predisposes O 0 9.15267861500979e-11
to O 0 7.533872715948225e-15
hundreds O 0 7.512549508534045e-15
or O 0 5.405487459009782e-14
thousands O 0 6.224657426870742e-14
of O 0 1.4524213429178978e-11
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 3.4994257021025987e-06
carcinoma I-Disease 1 1.0
and O 0 5.422270163250864e-13
that O 0 9.282526072259102e-16
results O 0 9.174665320272214e-15
from O 0 4.468595581589999e-15
truncating O 0 1.6495053933862636e-10
mutations O 0 1.3805524778920386e-10
in O 0 2.5099549175178204e-12
the O 0 4.651607468349542e-14
APC B-Disease 0 8.532861917043277e-11
gene O 0 8.090598191401455e-10
. O 0 6.65331331695107e-11

A O 0 9.886731433539353e-10
variant O 0 1.482503506622379e-07
of O 0 2.5362353276575655e-12
FAP B-Disease 0 7.782900723896091e-08
is O 0 1.190546411455884e-10
attenuated B-Disease 1 0.9995052814483643
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 2.2765411777925237e-10
which O 0 3.903844410821193e-14
results O 0 3.195189542093933e-14
from O 0 5.573106639535346e-15
germ O 0 8.033279073060839e-07
- O 0 3.1572273684332686e-08
line O 0 9.113900606427805e-11
mutations O 0 1.0388999556465439e-11
in O 0 1.406000749853975e-12
the O 0 1.7180857160136592e-14
5 O 0 4.309473920294585e-14
and O 0 5.968386592239416e-14
3 O 0 4.827153098492217e-15
regions O 0 1.7426643082133625e-13
of O 0 1.757011623324499e-14
the O 0 8.076832930768718e-13
APC B-Disease 0 2.194663201171565e-10
gene O 0 7.387440104089649e-10
. O 0 5.1261245248568343e-11

Attenuated B-Disease 1 0.9999966621398926
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 1.0
have O 0 6.306434818803552e-10
" O 0 6.197239336286353e-12
multiple O 0 7.870817886335146e-11
" O 0 0.3019426167011261
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 4.7620879461973686e-11
typically O 0 1.2127445315340823e-12
fewer O 0 7.465131079487444e-14
than O 0 1.7019334541600538e-15
100 O 0 2.44075444839171e-15
) O 0 1.612262205319859e-15
without O 0 1.15225432412722e-14
the O 0 2.3119721943658765e-14
florid O 0 2.0406179856991002e-08
phenotype O 0 4.869518677175222e-10
of O 0 3.929917779003575e-14
classical O 0 7.518757144664434e-11
FAP B-Disease 0 1.1325647086835033e-08
. O 0 3.5943723691866936e-11

Another O 0 2.1964794566509127e-11
group O 0 5.2276347313473526e-12
of O 0 3.647244673296449e-15
patients O 0 1.5495912116404026e-13
with O 0 8.122621785950623e-17
multiple O 0 5.197586610238003e-13
adenomas B-Disease 0 2.3076895558915567e-06
has O 0 9.979485293687418e-11
no O 0 3.8664414551969895e-12
mutations O 0 5.408527792294393e-11
in O 0 4.386492796597252e-13
the O 0 1.1514941120570592e-14
APC B-Disease 0 2.257612499723116e-12
gene O 0 8.599666985464882e-12
, O 0 3.1550700637164586e-13
and O 0 1.5786773066095786e-14
their O 0 1.6482998573355036e-15
phenotype O 0 1.1632575111497623e-11
probably O 0 4.888052809737253e-11
results O 0 4.205875556682892e-13
from O 0 2.096407899707109e-14
variation O 0 6.797763740795659e-11
at O 0 4.5035342122190514e-10
a O 0 3.614203988172582e-12
locus O 0 3.49667343690907e-11
, O 0 1.7236015132510163e-12
or O 0 4.27680460490798e-13
loci O 0 7.378360075693813e-13
, O 0 3.2943417958841703e-13
elsewhere O 0 3.822929126040542e-11
in O 0 8.038487410433337e-13
the O 0 3.343660187594098e-14
genome O 0 7.676178269411249e-12
. O 0 9.49529951194128e-12

Recently O 0 3.760895594950853e-08
, O 0 4.447800634743704e-13
however O 0 4.0031044749649566e-14
, O 0 9.093752074469273e-16
a O 0 1.4155220744193394e-14
missense O 0 2.2544315303463236e-09
variant O 0 9.248626753333156e-09
of O 0 2.2801793547917726e-13
APC B-Disease 0 2.103337087833168e-10
( O 0 2.580591556416989e-12
I1307K O 0 8.435079856816685e-10
) O 0 1.153134987670612e-12
was O 0 7.802014242996869e-12
described O 0 7.122462206609823e-14
that O 0 5.510063803686001e-17
confers O 0 1.4172971166636055e-14
an O 0 7.60031413914953e-17
increased O 0 1.0735169697628777e-11
risk O 0 4.0892061292652215e-07
of O 0 5.757780400017509e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.1203929494232878e-12
including O 0 1.0001946094471254e-15
multiple O 0 2.353655193920029e-13
adenomas B-Disease 0 1.256932193882676e-07
, O 0 2.7960505438739958e-11
in O 0 2.034832718988966e-10
Ashkenazim O 0 6.18109479546547e-05
. O 0 1.2063160192976596e-10

We O 0 4.2345921907882556e-11
have O 0 1.662211899155705e-13
studied O 0 1.1489400576769615e-11
a O 0 2.5561359127436456e-13
set O 0 4.1931234417806607e-13
of O 0 1.13192146763497e-15
164 O 0 5.454761642376127e-12
patients O 0 7.392827669483459e-13
with O 0 7.742896730408063e-15
multiple O 0 0.0001757703721523285
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 6.881458375573857e-06
/ I-Disease 1 0.9980884194374084
or I-Disease 0 0.21229803562164307
carcinoma I-Disease 1 1.0
and O 0 2.4154880873261675e-10
analyzed O 0 1.4107360835069471e-09
codons O 0 5.708171268992146e-09
1263 O 0 6.719945488953272e-09
- O 0 1.454479758855598e-09
1377 O 0 3.2935254523636104e-09
( O 0 3.9955417446835284e-12
exon O 0 7.858101946922602e-10
15G O 0 1.1756992712719239e-08
) O 0 2.898774970061524e-13
of O 0 4.839226812001498e-16
the O 0 4.234688280238671e-15
APC B-Disease 0 1.740529378610467e-12
gene O 0 3.6190256520740594e-12
for O 0 2.245795034856203e-14
germ O 0 2.0377708409569095e-08
- O 0 2.1745893974411956e-08
line O 0 5.295803240379371e-10
variants O 0 6.626483806115857e-09
. O 0 4.231233419194069e-11

Three O 0 3.7776410471979105e-11
patients O 0 1.6382077985821475e-11
with O 0 4.0541212376143476e-16
the O 0 2.019832013165526e-15
I1307K O 0 9.208203644028856e-11
allele O 0 2.7993963050421122e-11
were O 0 2.51106102057419e-12
detected O 0 6.060207457386779e-12
, O 0 2.0695301890380144e-15
each O 0 7.955556448505533e-17
of O 0 1.7209709431660679e-15
Ashkenazi O 0 2.8118034567370387e-09
descent O 0 1.6772728761438316e-09
. O 0 9.826098268383987e-11

Four O 0 5.550631065887046e-10
patients O 0 6.353593762220555e-10
had O 0 7.691987780229781e-13
a O 0 1.1720489758847846e-13
germ O 0 1.2023852491438447e-07
- O 0 5.1495828046199676e-08
line O 0 1.1915716191523984e-09
E1317Q O 0 7.23972259919492e-09
missense O 0 8.378051141733067e-09
variant O 0 6.774533156672646e-10
of O 0 4.901056299623681e-15
APC O 0 1.4266990366884613e-12
that O 0 3.2412038657996943e-16
was O 0 2.2290420106495928e-13
not O 0 9.504973864867027e-16
present O 0 4.410925396315749e-16
in O 0 1.1339128420939648e-13
controls O 0 4.0307229776104236e-11
; O 0 1.4202602920229852e-14
one O 0 5.883747502611388e-15
of O 0 1.4563058968839112e-17
these O 0 4.852533964300659e-17
individuals O 0 6.826067130099485e-17
had O 0 5.941745793297537e-12
an O 0 7.00206191534431e-16
unusually O 0 6.209173800120205e-13
large O 0 3.1760076339704124e-14
number O 0 6.568359679944014e-13
of O 0 3.678896515766153e-14
metaplastic B-Disease 0 2.3439402241365315e-07
polyps I-Disease 0 1.0037473430202226e-07
of I-Disease 0 4.646907790744996e-14
the I-Disease 0 7.623690632778402e-13
colorectum I-Disease 0 1.542159679956967e-07
. O 0 2.7189667184401856e-11

There O 0 3.6944895927260024e-12
is O 0 3.3282476184375064e-15
increasing O 0 7.230892630605387e-16
evidence O 0 3.7246694986094175e-14
that O 0 6.361262432505118e-16
there O 0 1.0050441907075115e-15
exist O 0 1.554759637277959e-14
germ O 0 4.028050670790151e-10
- O 0 1.080227313848825e-11
line O 0 1.1892855407077962e-12
variants O 0 3.101574335903634e-12
of O 0 3.4736048249334487e-16
the O 0 6.754501184037072e-16
APC B-Disease 0 8.700762414151283e-14
gene O 0 8.469078574286498e-14
that O 0 2.833516849769951e-16
predispose O 0 1.55048107057347e-13
to O 0 8.495505938713361e-16
the O 0 3.219871870418687e-16
development O 0 1.1521796158212722e-14
of O 0 3.345163925185359e-15
multiple O 0 4.596149210556177e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.006687913555651903
carcinoma I-Disease 1 1.0
, O 0 4.78564106745627e-12
but O 0 4.052463456493717e-14
without O 0 6.784252792792905e-15
the O 0 2.663621522308525e-15
florid O 0 4.362016525760737e-08
phenotype O 0 2.700382972786741e-10
of O 0 5.466355924225834e-15
classical O 0 2.6216060572403777e-11
FAP B-Disease 0 2.9013455526971654e-10
, O 0 1.3120743640876453e-13
and O 0 9.821519606376615e-16
possibly O 0 3.3155376773057188e-15
with O 0 4.7547946339936384e-17
importance O 0 1.0395752184436113e-12
for O 0 1.2848331607528962e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 3.7548067433057497e-10
in O 0 1.573905970017695e-14
the O 0 7.08024649744723e-17
general O 0 5.965284588179982e-16
population O 0 2.2099969714036452e-16
. O 0 4.552927452368058e-14
. O 0 2.980048282794079e-12

Genomic O 0 1.0011500517492777e-09
structure O 0 1.477670416583088e-11
of O 0 7.879393548759252e-15
the O 0 1.1654971421564547e-13
human O 0 2.198593113122982e-10
congenital B-Disease 1 0.9999998807907104
chloride I-Disease 1 0.9993583559989929
diarrhea I-Disease 1 1.0
( O 0 1.1509568764722644e-07
CLD B-Disease 0 0.005280041601508856
) O 0 5.656780599494482e-11
gene O 0 2.474541638264327e-08
. O 0 1.5294443489466403e-10

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999991655349731
diarrhea I-Disease 1 1.0
( O 0 4.722558878711425e-05
CLD B-Disease 1 0.983256459236145
) O 0 6.396611018644194e-11
is O 0 1.8660541048574203e-13
caused O 0 7.565498385099859e-14
by O 0 8.874937629688596e-15
mutations O 0 4.411056797604118e-10
in O 0 2.3285260438571376e-12
a O 0 8.474734043868726e-14
gene O 0 2.003257802696279e-11
which O 0 2.2489072033110048e-14
encodes O 0 1.0746376011283587e-11
an O 0 3.443219084961653e-14
intestinal O 0 7.322674022702813e-09
anion O 0 3.6164713446140695e-09
transporter O 0 8.773461104283342e-07
. O 0 2.048610586724564e-10

We O 0 3.0455121757810844e-10
report O 0 3.130938563966623e-11
here O 0 2.45273094369447e-14
the O 0 1.2083666146411442e-16
complete O 0 3.072073091452284e-15
genomic O 0 4.938662868415877e-13
organization O 0 6.393993949756205e-13
of O 0 3.121010631738138e-15
the O 0 3.3581044710370364e-14
human O 0 1.1142894332932807e-12
CLD B-Disease 0 4.152588939376756e-09
gene O 0 3.528764520172034e-12
which O 0 1.1160749211478523e-14
spans O 0 3.5328708816902143e-13
approximately O 0 3.716742625475833e-14
39kb O 0 7.54334195107731e-09
, O 0 1.8188860790788186e-12
and O 0 6.022983761039269e-13
comprises O 0 2.241127883316832e-13
21 O 0 5.50237980179169e-12
exons O 0 1.8081554031823543e-09
. O 0 2.7070803931827925e-11

All O 0 2.110834293814201e-12
exon O 0 2.233297990983374e-09
/ O 0 1.6843000327781965e-09
intron O 0 3.725801889231661e-09
boundaries O 0 8.782424093523034e-11
conform O 0 4.2832110080937014e-10
to O 0 1.8220822189918794e-14
the O 0 1.5433201862747464e-13
GT O 0 8.265440243349076e-08
/ O 0 7.589446227029839e-07
AG O 1 0.9999983310699463
rule O 0 2.2680561873045235e-09
. O 0 5.132845884436854e-11

An O 0 3.9591412288354777e-13
analysis O 0 1.1046566222513987e-12
of O 0 1.763906672685474e-16
the O 0 6.979553602957803e-16
putative O 0 3.0421823914161816e-12
promoter O 0 3.3303245577931406e-11
region O 0 5.438161206072767e-12
sequence O 0 7.428092429345723e-13
shows O 0 4.0763130718102225e-12
a O 0 3.122521989237792e-12
putative O 0 1.2627655587849063e-09
TATA O 0 2.487883250523737e-07
box O 0 1.5310131828982776e-08
and O 0 8.530275097395901e-11
predicts O 0 7.236986010461521e-10
multiple O 0 8.831228933900426e-13
transcription O 0 8.679758300988993e-11
factor O 0 9.564748082099839e-13
binding O 0 8.29367650945212e-12
sites O 0 3.5312389123909327e-10
. O 0 1.1887606177207743e-10

The O 0 4.32439423625388e-14
genomic O 0 2.1947707540270756e-11
structure O 0 1.8204235861796203e-12
was O 0 1.3021053419520756e-12
determined O 0 5.2445044428127766e-15
using O 0 3.2502205950506874e-14
DNA O 0 1.7152765319217167e-10
from O 0 8.48019910044441e-14
several O 0 6.371805769236948e-15
sources O 0 2.465620413459428e-14
including O 0 9.325754398722226e-16
multiple O 0 8.983184205182959e-15
large O 0 9.995614579094703e-12
- O 0 0.00024112171377055347
insert O 0 2.2437955067289295e-06
libaries O 0 6.208881586644566e-08
and O 0 1.0376175287908629e-13
genomic O 0 1.9200176171185745e-11
DNA O 0 6.103318961336868e-10
from O 0 4.5114047046712624e-12
Finnish O 0 9.978661097420627e-08
CLD B-Disease 0 0.0005074036307632923
patients O 0 1.906706046383988e-07
and O 0 1.2667880633365769e-11
controls O 0 1.3677926347099856e-07
. O 0 1.7559229070762683e-10

Exon O 0 8.25868085030379e-08
- O 0 1.0667502436945142e-08
specific O 0 7.079534874998572e-12
primers O 0 4.650146490092766e-09
developed O 0 1.1643319121346085e-11
in O 0 4.508015922360942e-12
this O 0 4.8309109601627105e-15
study O 0 3.9730127824808004e-14
will O 0 3.6936735137507726e-15
facilitate O 0 7.576761890419267e-14
mutation O 0 1.9048413020528177e-13
screening O 0 3.938506205197756e-12
studies O 0 6.596306617243086e-13
of O 0 7.810887853325929e-16
patients O 0 9.3363359578158e-14
with O 0 4.085606246357178e-16
the O 0 2.623649453074861e-13
disease O 0 1.6874448505177497e-09
. O 0 2.324834942613041e-11

Genomic O 0 4.107904294503584e-10
sequencing O 0 4.5825909039676205e-11
of O 0 1.2737130042361506e-14
a O 0 4.245977267697265e-12
BAC O 0 3.4639047044038307e-06
clone O 0 2.89061645730726e-08
H O 1 0.9999997615814209
_ O 0 2.8394088295857767e-12
RG364P16 O 0 1.0870857686251512e-10
revealed O 0 1.1630749531879592e-12
the O 0 8.940101224279629e-17
presence O 0 5.661907032626645e-15
of O 0 8.398127192978965e-17
another O 0 1.2306317226926707e-14
, O 0 1.1677677960836535e-15
highly O 0 3.514351344861117e-15
homologous O 0 3.43460679276715e-14
gene O 0 2.3317004577139144e-11
3 O 0 3.057911454433515e-13
of O 0 2.651901339175604e-15
the O 0 5.737793053184337e-14
CLD B-Disease 0 2.4927180319878062e-08
gene O 0 7.393074347161743e-11
, O 0 1.3951994670257511e-13
with O 0 1.523793610915867e-16
a O 0 4.627429082276757e-15
similar O 0 3.723623328216264e-15
genomic O 0 2.6655418323973112e-12
structure O 0 2.6444919171142445e-11
, O 0 1.4217869503257985e-13
recently O 0 6.641860672562672e-12
identified O 0 1.4078772002379392e-11
as O 0 5.794324438659904e-13
the O 0 6.499561305828294e-11
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 7.568407056623982e-08
( O 0 2.5245003310025993e-10
PDS B-Disease 0 3.347799690800457e-07
) O 0 4.284432617712719e-12
. O 0 1.199459585474183e-12
. O 0 6.811556527153151e-12

The O 0 2.445195608491435e-11
APCI1307K O 0 4.989432909496827e-06
allele O 0 5.117135515320115e-07
and O 0 2.636245666209902e-09
cancer B-Disease 0 2.1646743064707152e-08
risk O 0 1.5892909210890593e-10
in O 0 1.8629175079724197e-13
a O 0 2.6280003563930454e-14
community O 0 4.053829381824459e-15
- O 0 3.761776046912191e-13
based O 0 3.4351441504688884e-14
study O 0 7.373600699207145e-14
of O 0 2.9962644897059713e-15
Ashkenazi O 0 2.0932754141167464e-10
Jews O 0 4.14710540214136e-12
. O 0 2.40460039033219e-12

Mutations O 0 3.708511187028307e-08
in O 0 1.873691826692614e-11
APC O 0 1.229888135778623e-10
are O 0 7.33113453298996e-15
classically O 0 1.844127739403234e-09
associated O 0 1.032366067632573e-10
with O 0 2.111578245589385e-09
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.179949435936578e-06
FAP B-Disease 0 2.2510388930641057e-07
) O 0 5.925234261572321e-12
, O 0 4.3962815836741734e-14
a O 0 4.0136366452614425e-12
highly O 0 7.64707692724187e-06
penetrant O 1 0.9999998807907104
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 2.8425574782886542e-08
by O 0 2.5397289523179656e-13
multiple O 0 7.897705406323396e-11
intestinal O 0 2.164432544304873e-06
polyps B-Disease 0 0.00017459644004702568
and O 0 2.8953282913551925e-12
, O 0 2.681831036608598e-15
without O 0 9.256923442637157e-16
surgical O 0 3.45556049052842e-11
intervention O 0 1.1847168211731596e-12
, O 0 3.588125161709888e-15
the O 0 3.726107993487916e-16
development O 0 1.067090513173774e-11
of O 0 1.1029582225319245e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.4258598735625867e-10
CRC B-Disease 0 2.888407379941782e-07
) O 0 5.662693838143218e-12
. O 0 8.268705165015433e-12

APC B-Disease 0 4.678332743424107e-08
is O 0 2.3750634705471674e-12
a O 0 1.5969786604230762e-10
tumour O 1 1.0
- O 0 8.16254782876058e-07
suppressor O 0 1.0626683533132564e-08
gene O 0 3.1630238428448365e-09
, O 0 2.1093090381979485e-12
and O 0 4.9220623779024086e-14
somatic O 0 1.5694665012055964e-10
loss O 0 9.22320220198003e-10
occurs O 0 1.079257169744885e-11
in O 0 1.1299280622267815e-08
tumours B-Disease 1 1.0
. O 0 3.778089785466676e-10

The O 0 4.073585219144249e-12
germline O 0 2.9745859109198136e-08
T O 0 1.1134566157977588e-08
- O 0 3.360993428014325e-11
to O 0 4.383554744235088e-14
- O 0 5.6387130208113145e-12
A O 0 2.4028478859405844e-13
transversion O 0 1.1430165841597173e-11
responsible O 0 1.7494598375557822e-15
for O 0 2.7800991139980525e-17
the O 0 3.1867325004507503e-16
APC O 0 1.4058406348771424e-11
I1307K O 0 2.8633505289032968e-11
allele O 0 1.3293942335845799e-11
converts O 0 9.436369220738872e-12
the O 0 2.9114680637079907e-14
wild O 0 7.748138068641719e-12
- O 0 4.808282105805972e-10
type O 0 3.555072555783134e-11
sequence O 0 3.174954873660929e-13
to O 0 4.380286891124581e-14
a O 0 4.034859252266543e-12
homopolymer O 0 3.0159128527884604e-08
tract O 0 3.9923429540067445e-07
( O 0 2.8898402767985054e-11
A8 O 0 1.3488999250910183e-08
) O 0 1.5065568557222006e-14
that O 0 6.808126839927741e-16
is O 0 8.937824743824544e-15
genetically O 0 9.882810125816377e-10
unstable O 0 7.32518128643278e-06
and O 0 6.081284781300766e-11
prone O 0 2.4593751479784487e-09
to O 0 1.3827724772499939e-12
somatic O 0 1.0215157608683967e-08
mutation O 0 2.478339311551281e-08
. O 0 7.115714684147179e-10

The O 0 1.8048517324772972e-12
I1307K O 0 4.697928712715793e-10
allele O 0 1.5527977514917524e-10
was O 0 3.3813779554137113e-10
found O 0 1.745231598127006e-10
in O 0 1.0286178853124994e-10
6 O 0 7.841533845864834e-12
. O 0 4.4999576981341605e-12

1 O 0 2.9785851562991184e-10
% O 0 4.8529166796207335e-12
of O 0 1.4480983686476767e-14
unselected O 0 4.0293002712132875e-07
Ashkenazi O 0 6.24709528551648e-08
Jews O 0 5.4236797344953125e-12
and O 0 7.600557417599893e-14
higher O 0 2.4315103966734974e-13
proportions O 0 1.140990405455733e-12
of O 0 4.6419976254530575e-15
Ashkenazim O 0 1.012623318530359e-08
with O 0 4.8046876671486646e-14
family O 0 1.8890132513771363e-12
or O 0 1.5766598096544904e-12
personal O 0 1.4171855529376831e-11
histories O 0 7.664087142700282e-10
of O 0 4.7320024146920575e-14
CRC B-Disease 0 3.846677287810962e-08
( O 0 1.0460879558416014e-11
ref O 0 2.1958675233690883e-07
. O 0 9.806222674157983e-13
2 O 0 1.4005887378695792e-12
) O 0 7.854118288901091e-13
. O 0 4.439996547506153e-12

To O 0 3.564853219475278e-13
evaluate O 0 7.233510665449749e-13
the O 0 3.141470500820829e-16
role O 0 4.294548522137606e-14
of O 0 5.050056488946646e-16
I1307K O 0 1.2247801384202006e-10
in O 0 1.1157893185786971e-11
cancer B-Disease 0 1.220628875753249e-10
, O 0 7.040976959457601e-13
we O 0 4.8565345538501e-13
genotyped O 0 9.498841713195816e-10
5 O 0 5.540151670757609e-13
, O 0 8.179680890951779e-13
081 O 0 3.817962834773425e-09
Ashkenazi O 0 3.4278091476380723e-09
volunteers O 0 3.556922334793655e-12
in O 0 6.020410949283961e-13
a O 0 9.071488135323214e-13
community O 0 1.2027034099540423e-12
survey O 0 4.785262741613394e-10
. O 0 4.331382041228293e-12

Risk O 0 3.034405793300721e-08
of O 0 3.412094825433476e-13
developing O 0 1.5354780771303922e-06
colorectal B-Disease 1 1.0
, I-Disease 0 1.0145299000896557e-07
breast I-Disease 0 2.803093047987204e-05
and I-Disease 0 3.1120293841890856e-11
other I-Disease 0 7.832109120324907e-14
cancers I-Disease 0 6.541336222687377e-11
were O 0 3.4349950726701717e-13
compared O 0 6.238206565895021e-14
between O 0 1.1130858265802866e-14
genotyped O 0 2.277393607030831e-09
I1307K O 0 1.5722050050737124e-10
carriers O 0 7.071410731279704e-12
and O 0 2.783408879357581e-14
non O 0 8.886227799605184e-13
- O 0 2.474856528478925e-13
carriers O 0 1.1565534771204589e-12
and O 0 1.9854182927163573e-14
their O 0 7.881403346184849e-16
first O 0 2.4674283883446835e-13
- O 0 1.5060850136472403e-11
degree O 0 1.2629552958998147e-10
relatives O 0 2.983496436015365e-11
. O 0 8.464658010978732e-13

Sperm O 0 1.863415199920837e-09
DNA O 0 1.445326081039866e-09
analysis O 0 1.4412751374315302e-11
in O 0 1.3626880656855689e-12
a O 0 4.1435889441832074e-11
Friedreich B-Disease 0 1.1550165254448075e-05
ataxia I-Disease 0 0.00022349732171278447
premutation O 0 4.4575890569831245e-06
carrier O 0 1.1739626160078842e-08
suggests O 0 3.778327650749702e-10
both O 0 4.3950349544637224e-13
meiotic O 0 9.210491813682609e-10
and O 0 3.455734776027647e-13
mitotic O 0 1.3244438532011849e-11
expansion O 0 3.4424544378269806e-12
in O 0 1.7962455524725418e-12
the O 0 1.457820816104169e-13
FRDA B-Disease 0 4.1524085503397146e-08
gene O 0 1.8611029384274502e-09
. O 0 3.673040344098766e-11

Friedreich B-Disease 0 0.009276783093810081
ataxia I-Disease 1 0.9984499216079712
is O 0 3.24107816140895e-07
usually O 0 1.221779483140395e-10
caused O 0 1.7972830255313932e-13
by O 0 5.777496854378111e-16
an O 0 1.092797862834241e-15
expansion O 0 4.303712334424725e-12
of O 0 2.965988186390961e-14
a O 0 9.624564339949515e-11
GAA O 0 7.530177725811882e-08
trinucleotide O 0 6.070744351660551e-09
repeat O 0 1.2552150985278843e-10
in O 0 3.828185869431816e-13
intron O 0 4.042026990891401e-10
1 O 0 1.5560249486470945e-12
of O 0 5.082741055161466e-15
the O 0 1.9909445728334696e-13
FRDA B-Disease 0 4.412979848211762e-08
gene O 0 2.154038947210779e-09
. O 0 2.980561630838707e-11

Occasionally O 0 9.829387970228254e-09
, O 0 1.179996747015244e-12
a O 0 6.827249540448249e-14
fully O 0 3.270855334085339e-14
expanded O 0 3.496076312562574e-13
allele O 0 1.1303832869735686e-11
has O 0 4.471583693599346e-13
been O 0 4.522548107495014e-14
found O 0 5.212962629922921e-14
to O 0 1.3344826207072578e-15
arise O 0 1.8238553977636615e-14
from O 0 1.0409670697588032e-14
a O 0 2.8753388559010773e-13
premutation O 0 3.7538328001573973e-10
of O 0 2.5510677842773737e-15
100 O 0 9.957870438599345e-14
or O 0 1.4398565889930937e-12
less O 0 3.6507182693545914e-11
triplet O 0 2.0613617834897013e-07
repeats O 0 5.173703598870816e-08
. O 0 1.7338314117765208e-10

We O 0 1.4074423050625118e-11
have O 0 1.9205054145837556e-14
examined O 0 1.1175985131913965e-13
the O 0 6.684851517668923e-17
sperm O 0 6.707830363210376e-13
DNA O 0 1.1336977363829437e-11
of O 0 7.554243752450572e-16
a O 0 1.7817265674999194e-12
premutation O 0 9.153563951258548e-08
carrier O 0 1.659054937874771e-08
. O 0 3.3405628263594167e-10

This O 0 2.384959634296746e-12
mans O 0 5.255492707689768e-10
leucocyte O 0 3.693501504642427e-09
DNA O 0 6.050792311640407e-09
showed O 0 1.8752838171209874e-10
one O 0 6.912761243418539e-14
normal O 0 2.8253196223543275e-12
allele O 0 1.0112654463823034e-10
and O 0 2.96492192776443e-12
one O 0 2.1869240427363663e-14
allele O 0 5.766720000827119e-12
of O 0 1.0895891326234523e-14
approximately O 0 8.11155396324148e-13
100 O 0 6.125237470011591e-12
repeats O 0 1.694773321680998e-09
. O 0 3.790726760266594e-11

His O 0 4.1269522521591995e-12
sperm O 0 1.533800031428001e-10
showed O 0 4.181529254798644e-12
an O 0 1.885845006376611e-16
expanded O 0 1.0830531350231043e-12
allele O 0 1.899021773166254e-10
in O 0 6.794687834599245e-08
a O 0 1.2226434087381222e-08
tight O 0 2.2399716215204535e-07
range O 0 3.3159983005986993e-12
centering O 0 2.2367699706316024e-11
on O 0 1.9696026060112004e-11
a O 0 2.1709371767712066e-13
size O 0 3.3827145728623775e-13
of O 0 2.5657265364625566e-15
approximately O 0 3.64489092120196e-13
320 O 0 1.080444733680963e-09
trinucleotide O 0 2.8207330160512356e-07
repeats O 0 1.049969853283983e-07
. O 0 2.629093609485267e-10

His O 0 2.549449540367732e-10
affected O 0 4.668362363347001e-10
son O 0 3.5010347954056442e-09
has O 0 2.96427568905952e-13
repeat O 0 2.961960104269634e-12
sizes O 0 1.2520271278071426e-11
of O 0 7.47270592572815e-15
1040 O 0 5.252874177297251e-11
and O 0 1.3125180196166264e-12
540 O 0 4.62993060557082e-10
. O 0 6.475219232332519e-12

These O 0 5.549815435771516e-14
data O 0 9.644580056464291e-14
suggest O 0 1.8857740144277192e-15
that O 0 5.382711076577337e-17
expansion O 0 1.284227579964256e-13
occurs O 0 3.4900366288354717e-15
in O 0 6.970767414899229e-14
two O 0 9.245988035529867e-15
stages O 0 2.2557117577894775e-14
, O 0 5.5559554929028674e-15
the O 0 6.357356551827092e-16
first O 0 2.5670592157501192e-14
during O 0 9.882634092312197e-15
meiosis O 0 6.307549426341763e-15
followed O 0 9.127051057208208e-15
by O 0 9.750665300338793e-16
a O 0 1.2504705387481052e-12
second O 0 2.0945354825552265e-12
mitotic O 0 1.172576202801423e-10
expansion O 0 2.783584474030931e-10
. O 0 3.561323458356469e-11

We O 0 3.276017304654211e-11
also O 0 1.2571077703381773e-14
show O 0 3.471177948484623e-14
that O 0 7.788839585708899e-16
in O 0 6.891040608145507e-14
all O 0 3.371797288024994e-16
informative O 0 1.6566096910052008e-13
carrier O 0 1.078270570162472e-13
father O 0 9.685541214540794e-14
to O 0 2.798424486523442e-15
affected O 0 3.85251184252533e-13
child O 0 3.824358538184747e-11
transmissions O 0 6.821951892277411e-10
, O 0 5.352596434794266e-15
with O 0 5.5173416695874876e-17
the O 0 1.1921675065715997e-16
notable O 0 1.7567500595503868e-14
exception O 0 4.913442293004791e-14
of O 0 1.6390631483341526e-16
the O 0 4.0412611069531e-15
premutation O 0 2.9019142991359992e-11
carrier O 0 1.6555808373536207e-12
, O 0 1.8091029637345123e-14
the O 0 5.625735020009742e-16
expansion O 0 2.584767523714643e-13
size O 0 2.1212634513517736e-12
decreases O 0 2.693750604521039e-11
. O 0 1.4361593511647008e-12
. O 0 6.9612475506186655e-12

The O 0 3.6401735575494754e-13
R496H O 0 1.2933321080765836e-10
mutation O 0 7.661054082785945e-12
of O 0 6.474566959364892e-15
arylsulfatase O 0 3.2972923946772426e-08
A O 0 4.203879022668389e-09
does O 0 8.816226221286527e-11
not O 0 7.619914248191417e-12
cause O 0 1.4024621464159281e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 4.43095959923312e-09

Deficiency B-Disease 1 0.9999959468841553
of I-Disease 0 1.2153866238082123e-12
arylsulfatase I-Disease 0 1.4788518853947608e-07
A I-Disease 0 6.390199480676984e-10
( O 0 3.582948868152691e-11
ARSA O 0 2.210365664723213e-06
) O 0 8.144796469211624e-12
enzyme O 0 2.0278132506490465e-09
activity O 0 1.733366006284598e-09
causes O 0 1.1436938063269508e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.9208398953196593e-05
MLD B-Disease 1 1.0
) O 0 1.013803596627838e-09
. O 0 6.17292883475784e-11

A O 0 1.1600591598437404e-09
number O 0 4.2552579840836324e-13
of O 0 1.677838098491924e-14
ARSA O 0 2.482243417034624e-06
gene O 0 5.128897306860836e-09
mutations O 0 5.548704828939321e-10
responsible O 0 2.7993148164068282e-12
for O 0 8.666482245386908e-13
MLD B-Disease 1 1.0
have O 0 4.74904230524098e-12
been O 0 1.266265629677743e-12
identified O 0 8.220495117949866e-11
. O 0 2.4581380767690897e-12

Recently O 0 3.3984750569260314e-09
, O 0 1.659272220490282e-13
the O 0 2.8506807018966384e-15
R496H O 0 4.165181394233386e-11
mutation O 0 7.202218422347473e-13
of O 0 1.30605882079954e-14
ARSA O 0 1.6160177196411496e-08
was O 0 1.9621651037911997e-13
proposed O 0 2.1841756749324103e-15
to O 0 3.157932586150716e-15
be O 0 2.5326412177845668e-14
a O 0 1.8224062937974989e-13
cause O 0 4.284448663904872e-12
of O 0 1.727855185318372e-11
MLD B-Disease 1 1.0
( O 0 2.4642652501905005e-11
Draghia O 0 7.122561651584647e-09
et O 0 2.3479744815091408e-09
al O 0 4.135683795425393e-08
. O 0 3.4339701221464125e-11
, O 0 2.899345910925555e-12
1997 O 0 4.137101089225076e-13
) O 0 3.715943297424168e-13
. O 0 4.624903758576604e-12

We O 0 7.621382691613832e-12
have O 0 4.962916386311083e-15
investigated O 0 6.530855093918667e-14
the O 0 9.722660273520198e-16
R496H O 0 1.6044979581075758e-11
mutation O 0 1.263912341757309e-13
and O 0 1.1792418102662787e-14
found O 0 2.7662979667900968e-14
this O 0 6.265767408636077e-17
mutation O 0 5.005085921590139e-15
at O 0 1.7273656734585058e-13
a O 0 7.149602497492566e-14
relatively O 0 2.38702113630751e-12
high O 0 8.559786560113913e-12
frequency O 0 8.941069727045475e-14
in O 0 2.3360816319567546e-14
an O 0 8.586271077665376e-17
African O 0 2.592971562969228e-15
American O 0 5.817751354042543e-15
population O 0 8.688183170203257e-16
( O 0 2.9380566989728463e-13
f O 0 7.292049186702343e-10
= O 0 1.6613840858603623e-10
0 O 0 2.0253865858771425e-12
. O 0 9.298382376565772e-13
09 O 0 3.490549863038872e-11
, O 0 9.43689909744562e-14
n O 0 4.069967973752142e-11
= O 0 7.141930380427652e-10
61 O 0 1.1856313153479903e-10
subjects O 0 9.494494079831384e-10
) O 0 9.31926584513132e-12
. O 0 2.956430239509089e-11

The O 0 1.573163994905702e-11
ARSA O 0 8.50412220643193e-07
enzyme O 0 3.8509309630008204e-10
activity O 0 4.60681388869677e-11
in O 0 1.581091757085068e-13
subjects O 0 1.0638059443762726e-12
with O 0 7.836976679859598e-15
and O 0 5.168321960723546e-14
without O 0 1.974872351358215e-15
the O 0 3.011801667997016e-16
R496H O 0 5.619698283110264e-12
mutation O 0 8.131067704992417e-14
was O 0 4.3925479573103665e-12
determined O 0 2.546976572790488e-13
and O 0 2.1071553925550504e-14
found O 0 1.1345034612274263e-13
to O 0 6.092417457299274e-15
be O 0 1.0193703384652961e-13
normal O 0 7.531584730879892e-12
. O 0 3.890104818132789e-12

It O 0 2.7714130903383483e-12
is O 0 8.605461720816165e-15
therefore O 0 1.1977795498334127e-15
concluded O 0 1.3175741151328496e-13
that O 0 1.5125469986098001e-16
the O 0 1.1303809264621512e-15
R496H O 0 3.3698772938794974e-11
mutation O 0 9.20354070732543e-13
of O 0 1.2595558649623317e-14
ARSA O 0 3.135580683988337e-08
does O 0 2.0295929921507888e-13
not O 0 3.3280808588260157e-16
negatively O 0 6.226981769981302e-15
influence O 0 9.731161731453553e-15
the O 0 1.3461200063695847e-14
activity O 0 2.9230613155656338e-12
of O 0 1.2272463437607321e-15
ARSA O 0 1.896262169509555e-08
and O 0 3.3137454911146003e-13
is O 0 3.5237078825547247e-15
not O 0 8.523003910433907e-15
a O 0 4.1334177833945995e-13
cause O 0 3.5747571569544334e-11
of O 0 4.906971495799439e-10
MLD B-Disease 1 1.0

Down O 0 1.056676097732634e-07
- O 0 8.531780615328444e-09
regulation O 0 1.4857766406084494e-10
of O 0 5.9047030977264596e-15
transmembrane O 0 7.732717799413535e-10
carbonic O 0 1.2065352450463251e-07
anhydrases O 0 4.786408567269973e-07
in O 0 2.232365181598084e-09
renal B-Disease 1 0.6181046366691589
cell I-Disease 1 0.9998626708984375
carcinoma I-Disease 1 1.0
cell O 0 9.711699931358453e-06
lines O 0 7.124297263239043e-10
by O 0 2.38811303631542e-13
wild O 0 1.434959484569731e-09
- O 0 9.84608141152421e-06
type O 0 0.00033250756678171456
von B-Disease 1 0.9999934434890747
Hippel I-Disease 1 0.9999696016311646
- I-Disease 1 0.9998656511306763
Lindau I-Disease 1 0.9927175045013428
transgenes O 0 0.0008457590010948479
. O 0 1.1441067648831904e-08

To O 0 7.12213979198878e-13
discover O 0 2.3786460648378416e-11
genes O 0 2.5331231903735763e-11
involved O 0 1.5487025724347792e-12
in O 0 3.9027187731521806e-11
von B-Disease 1 0.9999792575836182
Hippel I-Disease 1 0.9999798536300659
- I-Disease 1 0.9999874830245972
Lindau I-Disease 1 0.9999637603759766
( O 0 9.361324160295226e-09
VHL B-Disease 0 2.1366063265304547e-06
) O 0 7.813082819607686e-11
- O 0 1.1305401947936389e-08
mediated O 0 2.4901897432982878e-08
carcinogenesis O 0 7.291472314818748e-08
, O 0 1.6510808562367196e-12
we O 0 2.999870046382219e-13
used O 0 1.5587734228383887e-11
renal B-Disease 0 6.561045302078128e-05
cell I-Disease 1 0.9996113181114197
carcinoma I-Disease 1 1.0
cell O 0 0.09812556207180023
lines O 0 1.3536341612052638e-06
stably O 0 1.7116233266278869e-06
transfected O 0 3.96684605163955e-08
with O 0 1.2337494307429475e-12
wild O 0 5.64382984791223e-10
- O 0 4.989728040527552e-06
type O 0 2.956910066131968e-05
VHL O 0 0.0006251241429708898
- O 0 3.0543753837264376e-07
expressing O 0 5.469811825697946e-10
transgenes O 0 3.2380413017563114e-07
. O 0 1.8736892593018695e-10

Large O 0 1.7047830161431854e-11
- O 0 2.9805418133577177e-09
scale O 0 3.0488757352120643e-11
RNA O 0 5.954254311824059e-10
differential O 0 1.2975145263771637e-11
display O 0 1.4867729443424071e-12
technology O 0 6.540841201996273e-10
applied O 0 3.6009806247960796e-11
to O 0 1.0224391049518805e-13
these O 0 9.32825018130131e-15
cell O 0 3.6098173061827055e-11
lines O 0 2.146129975122424e-11
identified O 0 1.6455357909617163e-11
several O 0 2.3161341754555052e-14
differentially O 0 3.462954749344771e-12
expressed O 0 4.079643557924981e-15
genes O 0 1.4149917132097456e-12
, O 0 1.082632705137537e-14
including O 0 1.032101599416366e-15
an O 0 3.0736320555917055e-15
alpha O 0 1.3078937932675672e-10
carbonic O 0 4.686368182404976e-09
anhydrase O 0 1.2082309375216482e-08
gene O 0 2.105353003045707e-09
, O 0 1.2199253759948014e-11
termed O 0 2.2674073729689326e-09
CA12 O 0 4.293540314392885e-06
. O 0 9.56680221153583e-11

The O 0 1.1722725925828598e-13
deduced O 0 8.877423102182647e-12
protein O 0 1.7492022370488303e-12
sequence O 0 5.488276798087596e-14
was O 0 8.6538415322579e-14
classified O 0 4.150654226244867e-14
as O 0 1.1424759216742322e-15
a O 0 3.006140597409425e-14
one O 0 1.1551161503003948e-12
- O 0 5.3572195568563075e-09
pass O 0 5.548302928204407e-10
transmembrane O 0 6.948258413075337e-09
CA O 0 1.725361542526116e-08
possessing O 0 1.4502538059346648e-11
an O 0 2.681411755299707e-15
apparently O 0 1.5406066179723954e-12
intact O 0 4.028922594850881e-12
catalytic O 0 1.7526387242547403e-12
domain O 0 7.37267723000673e-13
in O 0 1.8536075452324496e-12
the O 0 2.3682905679958677e-13
extracellular O 0 9.76096647953284e-10
CA O 0 5.400191730586812e-05
module O 0 1.1082888384805756e-08
. O 0 4.9498051490903805e-11

Reintroduced O 0 2.15607052211908e-08
wild O 0 5.156283400253869e-09
- O 0 1.3812301631332957e-06
type O 0 3.915668500553693e-08
VHL B-Disease 0 2.1472905586961133e-07
strongly O 0 9.522813960993748e-12
inhibited O 0 1.4715059726277957e-10
the O 0 1.8315527249685402e-14
overexpression O 0 2.8106408259814808e-12
of O 0 2.9595934688040173e-16
the O 0 2.8148374439423886e-15
CA12 O 0 2.430818601961704e-10
gene O 0 3.636568476905744e-11
in O 0 3.1822259671104858e-12
the O 0 4.688354739157408e-12
parental O 0 0.0001259896089322865
renal B-Disease 0 0.00013103180390316993
cell I-Disease 1 0.8131028413772583
carcinoma I-Disease 1 1.0
cell O 0 0.042362280189991
lines O 0 2.8342657969915308e-05
. O 0 2.794762865576672e-09

Similar O 0 5.24638362267571e-12
results O 0 4.874631514412142e-13
were O 0 2.487944983223852e-15
obtained O 0 1.1746443695384665e-14
with O 0 1.2702526417125563e-15
CA9 O 0 1.617658966779345e-07
, O 0 3.9514137811389946e-14
encoding O 0 5.61519526622728e-13
another O 0 1.2038869792556361e-13
transmembrane O 0 1.5553677790158815e-10
CA O 0 4.913316615784424e-07
with O 0 6.9626713892860775e-15
an O 0 6.240631705926305e-15
intact O 0 5.726693078078604e-11
catalytic O 0 1.3260623155098017e-10
domain O 0 2.1624600721192877e-10
. O 0 3.7618300835484675e-11

Although O 0 1.4907255117824203e-12
both O 0 7.39399030690686e-15
domains O 0 2.225525753268842e-12
of O 0 1.3291981144982363e-16
the O 0 2.526642530452112e-15
VHL B-Disease 0 8.19533677032247e-11
protein O 0 2.35141143752407e-13
contribute O 0 1.269146564914208e-14
to O 0 1.811768745826111e-14
regulation O 0 2.5377512591351348e-11
of O 0 1.0927526312748577e-14
CA12 O 0 3.7125433838269828e-09
expression O 0 4.5087870069460134e-13
, O 0 2.772721356442305e-14
the O 0 3.296783732578798e-15
elongin O 0 6.521330003783632e-11
binding O 0 1.6944797344778384e-12
domain O 0 2.139721212712775e-11
alone O 0 1.674100788551236e-11
could O 0 9.571852858936136e-12
effectively O 0 1.3031817812370061e-11
regulate O 0 2.5270836534474483e-09
CA9 O 0 6.711328296660213e-06
expression O 0 2.4366408890585944e-09
. O 0 1.0234357805671834e-10

We O 0 3.9161426879097405e-10
mapped O 0 8.957410813081879e-09
CA12 O 0 1.3708356618735706e-06
and O 0 2.6610562711693042e-12
CA9 O 0 1.213582692116688e-07
loci O 0 2.8930498621737577e-11
to O 0 4.157034417216765e-13
chromosome O 0 1.1701398960894949e-08
bands O 0 1.8946992863533296e-09
15q22 O 0 4.998253899657357e-08
and O 0 1.672134999908259e-11
17q21 O 0 8.810065565967307e-09
. O 0 1.3763003757494285e-11

2 O 0 1.986437403456165e-10
respectively O 0 8.630789659347382e-12
, O 0 4.171296757982633e-14
regions O 0 3.824488035292228e-12
prone O 0 1.1159207780053748e-08
to O 0 1.0220575471023285e-12
amplification O 0 3.4834082840440317e-10
in O 0 4.277377497335921e-12
some O 0 9.317301433425101e-14
human O 0 4.000603017265125e-13
cancers B-Disease 0 9.986497184755194e-10
. O 0 6.0245038124850936e-12

Additional O 0 1.6052561840548818e-12
experiments O 0 2.3499780680419358e-12
are O 0 5.747604320515678e-15
needed O 0 1.829108865509122e-14
to O 0 9.250458728365035e-17
define O 0 1.3195903415385169e-14
the O 0 1.6472753709857995e-15
role O 0 9.327281785473374e-13
of O 0 4.17312702677506e-14
CA O 0 5.815309478407471e-08
IX O 0 3.899449207978023e-09
and O 0 4.716598639431524e-12
CA O 0 1.9182844201992566e-09
XII O 0 3.301976053693423e-11
enzymes O 0 2.701996612564095e-13
in O 0 1.9567623634294444e-15
the O 0 4.954212063986861e-16
regulation O 0 7.822980110927524e-12
of O 0 1.5190187432553848e-14
pH O 0 6.651508337174317e-12
in O 0 2.4016462172389737e-14
the O 0 1.7348657775119458e-15
extracellular O 0 3.973932185923068e-13
microenvironment O 0 5.829504240439931e-11
and O 0 1.4715647388249993e-14
its O 0 1.2550557324382913e-16
potential O 0 1.2221174322101652e-14
impact O 0 1.5671675112141625e-12
on O 0 1.4724073349459132e-10
cancer B-Disease 0 7.773264809607383e-10
cell O 0 2.5182853846672515e-07
growth O 0 8.269978479802376e-09
. O 0 4.629157734220568e-12

A O 0 6.37087049781826e-11
gene O 0 4.0970901671322224e-10
encoding O 0 2.8999778273197663e-11
a O 0 6.916599319109137e-14
transmembrane O 0 5.911969698513264e-12
protein O 0 2.5181223425874144e-11
is O 0 3.900375980308776e-14
mutated O 0 3.407263360344359e-09
in O 0 4.840589595822564e-10
patients O 0 1.0636320979529046e-07
with O 0 9.043291115951035e-10
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 1.1861255089229417e-08
optic B-Disease 1 0.9933081865310669
atrophy I-Disease 1 0.9484080076217651
( O 0 0.00013572875468526036
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 2.2499082596993958e-09
. O 0 6.021680376555594e-11

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.20062473899452e-06
WFS B-Disease 0 0.0033590870443731546
; O 0 2.490800066201615e-10
OMIM O 0 2.580951786512742e-06
222300 O 0 1.976589336649681e-09
) O 0 2.655737392151525e-12
is O 0 6.724547134406844e-13
an O 0 1.3390339184682354e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999876022338867
defined O 0 1.8198690818205243e-11
by O 0 2.3865192591218665e-13
young O 0 6.528318330367711e-09
- O 0 4.519748575404492e-09
onset O 0 1.0265279826171536e-07
non O 0 1.0056503185751353e-07
- O 0 1.7102374627597783e-08
immune O 0 4.678832397075894e-07
insulin B-Disease 1 0.9712862372398376
- I-Disease 1 0.9709798097610474
dependent I-Disease 0 0.46015316247940063
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 9.527995753488838e-11
progressive O 0 7.079700714562875e-11
optic B-Disease 0 3.440404907451011e-05
atrophy I-Disease 0 6.670045422652038e-06
. O 0 9.726938143828079e-10

Linkage O 0 1.4648203539024962e-08
to O 0 4.096060513339439e-13
markers O 0 6.770409233247676e-11
on O 0 2.1230849110015493e-12
chromosome O 0 4.6781895690628517e-08
4p O 0 8.684388603796833e-07
was O 0 1.114998982032489e-09
confirmed O 0 1.58495896962485e-10
in O 0 1.1043159442447603e-11
five O 0 1.2674519636948767e-12
families O 0 6.570261777130368e-14
. O 0 5.878391848811171e-13

On O 0 1.163124371122981e-11
the O 0 2.0152756111840083e-15
basis O 0 5.944778089933545e-14
of O 0 2.765906256403639e-15
meiotic O 0 1.1754682560649599e-08
recombinants O 0 1.5392753311971319e-06
and O 0 3.253295549621171e-11
disease O 0 1.2144939498526242e-09
- O 0 3.684365312839333e-11
associated O 0 2.737516376777327e-12
haplotypes O 0 4.779372453356245e-09
, O 0 2.4160098292640153e-13
the O 0 1.828725159584016e-14
WFS B-Disease 0 1.169046726090528e-08
gene O 0 1.871102578432371e-11
was O 0 3.703765538622811e-13
localized O 0 1.3616618683293114e-12
to O 0 2.8100751706030408e-14
a O 0 2.7203413133225496e-11
BAC O 0 0.006108512170612812
/ O 0 1.235156105394708e-06
P1 O 0 4.697996700997464e-06
contig O 0 9.013353263753743e-08
of O 0 2.877806296757747e-14
less O 0 4.141625193840315e-13
than O 0 2.5290448852971145e-14
250 O 0 1.9984891291759815e-13
kb O 0 2.22991509701842e-08
. O 0 1.479026796868954e-11

Mutations O 0 1.0262441207942175e-07
in O 0 4.284302079771152e-12
a O 0 8.146731038253044e-14
novel O 0 4.408568779132316e-13
gene O 0 1.631597912332694e-10
( O 0 5.175943441210196e-12
WFS1 O 0 1.6341494823990388e-09
) O 0 8.230727568687285e-14
encoding O 0 2.2463370139697014e-12
a O 0 2.673222090194237e-14
putative O 0 2.0809764501861228e-12
transmembrane O 0 1.7185069556627242e-12
protein O 0 1.5129923355838848e-11
were O 0 2.026839416788273e-12
found O 0 5.777494368336411e-13
in O 0 1.4552864596446662e-14
all O 0 6.482048669039092e-17
affected O 0 6.67601299356212e-16
individuals O 0 3.562290696523301e-17
in O 0 5.980902080017503e-13
six O 0 6.910922788899709e-12
WFS B-Disease 0 3.8865167084622954e-07
families O 0 5.199331633634618e-13
, O 0 1.016807081241633e-13
and O 0 1.4699602890163102e-14
these O 0 8.075044342350043e-17
mutations O 0 1.2293585474696528e-13
were O 0 8.144167577741473e-14
associated O 0 2.7489304032395946e-14
with O 0 1.5830154282005888e-15
the O 0 2.625321563875377e-13
disease O 0 1.8215030594959103e-09
phenotype O 0 5.856781282176371e-09
. O 0 8.999494899297744e-11

WFS1 O 0 1.5437416323038633e-06
appears O 0 1.0497841484991e-10
to O 0 5.7631041764174846e-15
function O 0 1.4821450273691528e-14
in O 0 2.188907421204339e-13
survival O 0 2.2271913480143013e-11
of O 0 2.701708729358729e-16
islet O 0 1.0277633188948698e-09
beta O 0 5.136320879728373e-08
- O 0 1.4565153527712482e-08
cells O 0 9.364529290900592e-11
and O 0 1.298751904632578e-12
neurons O 0 3.9889471933896026e-12
. O 0 1.7424017957623494e-13
. O 0 1.4838492847640827e-12

Stable O 0 5.940508529533872e-09
interaction O 0 2.2211069788946602e-12
between O 0 3.525861040306645e-14
the O 0 8.287002425999611e-16
products O 0 1.1908882083591643e-12
of O 0 5.758615034145935e-17
the O 0 5.831838782504803e-15
BRCA1 O 0 1.3632471151936443e-08
and O 0 1.1577525396710975e-11
BRCA2 O 0 9.977062376265167e-08
tumor B-Disease 0 9.094236474993522e-09
suppressor O 0 9.486787355683646e-09
genes O 0 1.4147510940532015e-09
in O 0 4.8988611778266744e-11
mitotic O 0 1.2202709953612612e-09
and O 0 3.954388899662931e-12
meiotic O 0 4.479540738344667e-09
cells O 0 1.9140520279847806e-09
. O 0 9.699235858917632e-11

BRCA1 O 0 0.000490691396407783
and O 0 4.029047581677325e-11
BRCA2 O 0 9.18090758972312e-09
account O 0 6.237305593889686e-13
for O 0 7.509880401838128e-16
most O 0 5.486010582613041e-16
cases O 0 2.4551728549781094e-15
of O 0 7.98498819644466e-17
familial O 0 3.048516716841476e-10
, O 0 3.161370904641858e-13
early O 0 7.135662893897887e-11
onset O 0 6.41396269429606e-10
breast B-Disease 0 5.390070967337124e-08
and I-Disease 0 1.996166247408837e-06
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.2206549790047538e-13
encode O 0 1.521519048990408e-13
products O 0 5.51625856538146e-13
that O 0 5.08723587520074e-17
each O 0 3.326429409276666e-17
interact O 0 1.3127971373015374e-14
with O 0 1.0102595165593573e-13
hRAD51 O 0 3.236929302374847e-08
. O 0 3.581192634105612e-11

Results O 0 1.8197067463976424e-10
presented O 0 1.9281195563769504e-12
here O 0 2.54855110539548e-13
show O 0 2.501312958841373e-13
that O 0 5.683590652559882e-15
BRCA1 O 0 1.9586513744229705e-08
and O 0 1.7320084168964689e-12
BRCA2 O 0 3.3096783091934867e-09
coexist O 0 1.712512510271269e-12
in O 0 2.3068715313641006e-14
a O 0 1.4211517094966757e-14
biochemical O 0 1.4730238513324667e-12
complex O 0 1.0630249935514313e-12
and O 0 2.660730251576038e-13
colocalize O 0 9.520335630952559e-10
in O 0 1.7921012980884332e-12
subnuclear O 0 1.936371596400477e-08
foci O 0 1.111527758723696e-08
in O 0 4.337020326206087e-12
somatic O 0 2.1413176787277166e-11
cells O 0 6.746497110965421e-11
and O 0 3.606936797850846e-13
on O 0 2.2367068795519328e-14
the O 0 5.0979597755341225e-17
axial O 0 7.553095281653214e-15
elements O 0 2.613660156358666e-13
of O 0 2.8982482510936033e-14
developing O 0 2.3759888154173403e-11
synaptonemal O 0 1.4165554063083619e-08
complexes O 0 6.71808386698558e-10
. O 0 2.098871597355778e-11

Like O 0 2.6026216737307095e-09
BRCA1 O 0 3.29204999616195e-06
and O 0 1.9921658073185355e-11
RAD51 O 0 1.9298313702620362e-07
, O 0 1.2005925767444303e-12
BRCA2 O 0 4.889944094088605e-08
relocates O 0 7.8044823936807e-09
to O 0 5.381441819940491e-12
PCNA O 0 4.7660753921263677e-07
+ O 0 2.877433569192789e-10
replication O 0 1.7397468882185407e-11
sites O 0 1.0145022842633633e-12
following O 0 1.4244035367438207e-13
exposure O 0 1.3685389627093869e-11
of O 0 4.794068584495527e-14
S O 0 4.0040595838952697e-10
phase O 0 2.994577676107557e-12
cells O 0 2.393275898640579e-12
to O 0 4.2802648361414675e-13
hydroxyurea O 0 6.253471074302297e-09
or O 0 3.193396935774473e-11
UV O 0 1.0353209844993216e-08
irradiation O 0 1.496817247925719e-08
. O 0 7.259488843391892e-11

Thus O 0 4.609609222105959e-11
, O 0 5.4061733388566235e-12
BRCA1 O 0 2.7776843936067053e-08
and O 0 3.0029727619493296e-13
BRCA2 O 0 3.2603975075318203e-10
participate O 0 1.945487465516895e-14
, O 0 1.4040162329737212e-14
together O 0 5.717077676613107e-15
, O 0 3.947615261887033e-15
in O 0 1.588105969158645e-14
a O 0 8.005891820794461e-14
pathway O 0 5.645535688242331e-12
( O 0 1.0088470857316789e-11
s O 0 6.677226827012106e-11
) O 0 1.9530497756699815e-14
associated O 0 5.810670954814467e-13
with O 0 4.33522685591302e-15
the O 0 1.750507934948891e-15
activation O 0 2.1514835065968886e-14
of O 0 4.593675666361621e-16
double O 0 2.85384164216973e-11
- O 0 1.5604334180352453e-07
strand O 0 8.929661271395162e-05
break O 0 4.075861943420023e-05
repair O 0 0.00909536611288786
and O 0 3.6902165351238025e-11
/ O 0 9.511568199727094e-10
or O 0 2.0907435938771757e-12
homologous O 0 1.445231712082773e-10
recombination O 0 7.44876105240877e-10
. O 0 1.9248623528422826e-10

Dysfunction O 0 1.8223347524326527e-06
of O 0 5.31201593332426e-15
this O 0 3.0555235499705926e-15
pathway O 0 6.860673921332827e-12
may O 0 1.1792261611631716e-10
be O 0 7.423439948416998e-15
a O 0 1.4676461950044115e-14
general O 0 3.953115893846502e-15
phenomenon O 0 6.942150305132289e-13
in O 0 4.071594678165674e-13
the O 0 2.8791609141986434e-15
majority O 0 3.4931534983231307e-15
of O 0 4.682062495616423e-16
cases O 0 3.940548245779524e-13
of O 0 2.0246931776014658e-14
hereditary B-Disease 0 0.00018280025688000023
breast I-Disease 1 0.9543430805206299
and I-Disease 1 0.9954872727394104
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1600580739068445e-11
. O 0 2.3928103422277136e-12

A O 0 1.3738567228305243e-10
novel O 0 1.0713492593072971e-10
Arg362Ser O 0 7.953312675113011e-09
mutation O 0 1.5248588849936517e-11
in O 0 2.4541032725942935e-13
the O 0 4.12650734979772e-14
sterol O 0 1.8814981572745637e-08
27 O 0 2.3218635902821916e-09
- O 0 9.289359503839023e-09
hydroxylase O 0 1.3272381238493836e-07
gene O 0 1.2732328524833747e-09
( O 0 6.6856342510746014e-12
CYP27 O 0 2.539787491429024e-09
) O 0 5.427896901475521e-14
: O 0 1.5626400506543866e-15
its O 0 3.8321324309847167e-16
effects O 0 2.280827436640376e-13
on O 0 2.581259587585566e-13
pre O 0 1.7398009422020522e-10
- O 0 9.349532432978425e-12
mRNA O 0 3.940354986742278e-12
splicing O 0 1.415943473581649e-10
and O 0 3.94597088294521e-13
enzyme O 0 7.2053825579676545e-12
activity O 0 1.9577818533011992e-11
. O 0 1.019777253093157e-12

A O 0 7.018003539416284e-11
novel O 0 1.5593712085482103e-11
C O 0 1.886891309865746e-09
to O 0 7.832344256671064e-15
A O 0 8.435163917179522e-13
mutation O 0 7.775492489453528e-13
in O 0 1.006748937687485e-13
the O 0 1.866683247049323e-14
sterol O 0 1.1646622333216783e-08
27 O 0 1.3889706051983808e-09
- O 0 1.1904727870160059e-08
hydroxylase O 0 1.770153090774329e-07
gene O 0 1.7151562392569986e-09
( O 0 2.3425235709528813e-11
CYP27 O 0 1.0548431461643304e-08
) O 0 1.3353752240270744e-13
was O 0 2.284985894072944e-13
identified O 0 1.305762359268001e-14
by O 0 1.200454929867095e-16
sequencing O 0 2.2695155216939655e-12
amplified O 0 4.404203043928412e-11
CYP27 O 0 8.474945190073413e-10
gene O 0 1.1496179702641385e-10
products O 0 1.429887874770941e-10
from O 0 1.4756417658981502e-12
a O 0 5.53371480582765e-11
patient O 0 2.5931969904746666e-09
with O 0 1.9869282000956057e-12
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.1838104940764538e-09
CTX B-Disease 0 7.8520324677811e-06
) O 0 3.9670065843377955e-11
. O 0 3.257766278963459e-11

The O 0 8.767570003342939e-13
mutation O 0 2.3887896868912684e-11
changed O 0 1.3766573818407846e-11
the O 0 2.1273510297098452e-14
adrenodoxin O 0 4.746239512520845e-10
cofactor O 0 3.612264098951101e-10
binding O 0 6.6735054982114406e-12
residue O 0 4.264852637714256e-10
362Arg O 0 6.186061662916131e-10
to O 0 1.568129442486646e-13
362Ser O 0 6.140755126615716e-10
( O 0 7.757538101477168e-13
CGT O 0 5.098514943568944e-09
362Arg O 0 3.824112415617975e-10
to O 0 1.0513576229227717e-13
AGT O 0 6.36450137037059e-09
362Ser O 0 2.990047792694739e-11
) O 0 1.8844553535354337e-14
, O 0 2.862230843165398e-15
and O 0 1.0802229175784221e-15
was O 0 9.218271423429812e-15
responsible O 0 6.375817317275144e-15
for O 0 6.489625934617653e-15
deficiency O 0 3.969686038218789e-11
in O 0 2.7095544249722313e-15
the O 0 1.0377990818327774e-14
sterol O 0 1.4646975188270517e-08
27 O 0 1.5971501898803808e-09
- O 0 9.934978173475884e-09
hydroxylase O 0 1.698239771030785e-08
activity O 0 1.3364551132433178e-10
, O 0 8.124086967660916e-15
as O 0 1.3962922030551802e-15
confirmed O 0 5.618746045282829e-15
by O 0 6.604376108490374e-17
expression O 0 1.311635770427557e-14
of O 0 8.307445036786001e-17
mutant O 0 9.702409231940323e-13
cDNA O 0 3.503127041920573e-12
into O 0 2.7978309773135646e-12
COS O 0 1.9085211988567607e-06
- O 0 9.024737401830407e-09
1 O 0 2.818215279198899e-12
cells O 0 7.793495709895737e-11
. O 0 1.9811844872985596e-11

Quantitative O 0 3.0544606843818656e-09
analysis O 0 2.2702222046699916e-11
showed O 0 3.1691242512177364e-12
that O 0 6.228257745707002e-17
the O 0 1.0976647023909275e-16
expression O 0 2.6415842237681626e-14
of O 0 1.3012292718683565e-15
CYP27 O 0 2.7586688489122935e-10
gene O 0 6.476998191257133e-12
mRNA O 0 1.7483883264779454e-12
in O 0 1.927710514002326e-13
the O 0 1.2216419926168714e-14
patient O 0 2.6358845661711428e-12
represented O 0 2.315424327964388e-13
52 O 0 1.1797120225143232e-10
. O 0 3.566060988169362e-11

5 O 0 6.099452887209367e-11
% O 0 8.089536527623731e-13
of O 0 2.7980401453236254e-15
the O 0 2.784201363383032e-13
normal O 0 8.089656722276573e-10
level O 0 1.7963022735933976e-10
. O 0 4.927496344980797e-12

As O 0 1.7707126997307254e-12
the O 0 4.149187503993401e-15
mutation O 0 1.9029203668537165e-13
occurred O 0 2.307567927972015e-13
at O 0 1.1307697569365883e-14
the O 0 1.6783356985847003e-16
penultimate O 0 6.678353616645927e-13
nucleotide O 0 6.089702716703324e-14
of O 0 3.929269110584656e-16
exon O 0 1.35917666010954e-11
6 O 0 1.7495092831040782e-12
( O 0 1.6977990194289028e-12
- O 0 5.814027592698778e-10
2 O 0 4.931970088405124e-13
position O 0 1.8842273661473508e-12
of O 0 4.056289165503286e-15
exon O 0 7.714902328093132e-11
6 O 0 1.946500079175184e-11
- O 0 7.083539865782029e-10
intron O 0 1.927369730481132e-08
6 O 0 4.956075046885777e-12
splice O 0 5.691220272829867e-10
site O 0 2.530783471243331e-13
) O 0 8.226595741970578e-15
of O 0 7.784676815819839e-17
the O 0 9.029525801243716e-16
gene O 0 1.136692129311001e-11
, O 0 7.42382500959482e-14
we O 0 1.386261427135558e-15
hypothesized O 0 7.306008994675556e-15
that O 0 8.402228685328248e-17
the O 0 6.789582641734385e-16
mutation O 0 3.4378153535713496e-12
may O 0 1.930850444809007e-12
partially O 0 1.2685162165473884e-12
affect O 0 2.9080397486759557e-13
the O 0 1.6222006546482304e-15
normal O 0 6.394335473440538e-13
splicing O 0 1.7637060215069944e-11
efficiency O 0 9.579847765756044e-13
in O 0 4.5345397900985185e-13
exon O 0 1.194967347295517e-09
6 O 0 3.8464363638635035e-11
and O 0 2.9184413132682385e-13
cause O 0 7.363759701019355e-15
alternative O 0 1.932179324306768e-13
splicing O 0 1.0879502160277e-11
elsewhere O 0 1.1529249777098016e-10
, O 0 2.281161201502912e-14
which O 0 4.92352194272547e-16
resulted O 0 4.613962528964835e-15
in O 0 1.999335484496878e-13
decreased O 0 1.2795985104840923e-10
transcript O 0 1.6081148634938813e-09
in O 0 1.1076912824481422e-11
the O 0 1.7740053133083467e-12
patient O 0 5.252155932389257e-10
. O 0 4.287440628220063e-12

Transfection O 0 3.5503955331250836e-08
of O 0 4.222648638629693e-14
constructed O 0 4.094992574199541e-12
minigenes O 0 4.637966899423418e-09
, O 0 3.420355632836186e-14
with O 0 5.969063943311512e-16
or O 0 4.064580161160236e-13
without O 0 7.575721733960039e-14
the O 0 6.540275116731671e-15
mutation O 0 1.7336238239233637e-13
, O 0 2.883097203359476e-14
into O 0 6.347233936360164e-14
COS O 0 1.0386918347649043e-07
- O 0 8.931810846490862e-11
1 O 0 6.076648922546599e-14
cells O 0 7.62321033121599e-13
confirmed O 0 2.636507982420322e-12
that O 0 1.0834124466110878e-16
the O 0 2.308295012583609e-16
mutant O 0 2.4571688433949745e-11
minigene O 0 3.626874356399412e-09
was O 0 5.488739887940519e-13
responsible O 0 2.033469455374557e-15
for O 0 7.506067827133198e-17
a O 0 6.235345690939846e-16
mRNA O 0 2.368597668261224e-13
species O 0 4.638793723330068e-15
alternatively O 0 2.12068080110428e-12
spliced O 0 2.2817600253688397e-08
at O 0 1.0448606424517948e-09
an O 0 4.171555462173515e-12
activated O 0 5.0091717440636785e-08
cryptic O 0 1.4191929267326486e-06
5 O 0 3.550058511048171e-11
splice O 0 3.20154995847588e-08
site O 0 4.6511624413048125e-11
88 O 0 9.635101744231989e-12
bp O 0 4.145581100623019e-11
upstream O 0 3.788520278741325e-12
from O 0 5.883237690421095e-13
the O 0 1.4363339619245796e-13
3 O 0 4.677178783163427e-13
end O 0 1.1987509943023333e-11
of O 0 7.878311887685608e-15
exon O 0 1.1880268990793752e-09
6 O 0 1.2287203199345953e-10
. O 0 2.5224392019573827e-11

Our O 0 2.582418437077627e-12
data O 0 2.778578148815436e-13
suggest O 0 9.042043677654713e-15
that O 0 1.880199134736467e-16
the O 0 2.0506381779406913e-15
C O 0 1.6672790925653658e-10
to O 0 2.8584774284178775e-15
A O 0 1.4457236406292817e-12
mutation O 0 5.83467031200352e-13
at O 0 5.576227955945978e-13
the O 0 1.5219994098451253e-15
penultimate O 0 1.1662916726135064e-12
nucleotide O 0 2.7780905288883606e-13
of O 0 7.549000618507068e-16
exon O 0 2.2223623982742247e-11
6 O 0 7.845628985890529e-13
of O 0 6.823076442051188e-16
the O 0 8.700591991122296e-15
CYP27 O 0 5.677385783720013e-10
gene O 0 5.804027831263214e-12
not O 0 2.2758592834728683e-14
only O 0 1.149724723757716e-15
causes O 0 1.8577360380274757e-14
the O 0 8.713023249944107e-13
deficiency B-Disease 0 4.4391759956852184e-07
in I-Disease 0 5.868877839222339e-14
the I-Disease 0 3.232464751597164e-14
sterol I-Disease 0 4.2693088175838056e-08
27 I-Disease 0 2.8554021369586735e-09
- I-Disease 0 8.088149705542946e-09
hydroxylase I-Disease 0 9.43049993651357e-09
activity I-Disease 0 9.524598471033485e-11
, O 0 3.991089143201565e-14
but O 0 2.3155116062392733e-14
also O 0 4.564001984636934e-15
partially O 0 1.8889005485613064e-13
leads O 0 2.874273491741339e-14
to O 0 3.65239632768165e-15
alternative O 0 4.077065291277493e-13
pre O 0 3.0588959143429406e-10
- O 0 2.22170129515753e-11
mRNA O 0 4.975662677014769e-12
splicing O 0 4.206962903041678e-11
of O 0 9.980454539258807e-15
the O 0 1.0269220776472007e-14
gene O 0 2.2695566259667288e-10
. O 0 1.1487362276685342e-11

To O 0 2.3612137093655117e-13
our O 0 2.986803978718088e-15
knowledge O 0 5.38596190961956e-15
, O 0 3.785509672925031e-15
this O 0 1.0121616232748322e-16
is O 0 2.321009771215284e-16
the O 0 1.48814953805312e-15
first O 0 1.3095998894693817e-12
report O 0 5.945418636577049e-12
regarding O 0 6.70572563880238e-15
effects O 0 2.5647358043758006e-13
on O 0 1.7542732674499795e-13
pre O 0 2.968488302390604e-11
- O 0 8.570253881567957e-13
mRNA O 0 3.7816597726544887e-13
splicing O 0 1.9411601232671716e-12
of O 0 5.532962148274939e-16
a O 0 9.8976875618508e-15
mutation O 0 4.353458647179606e-14
at O 0 2.078615193379721e-13
the O 0 1.2051178197719503e-14
- O 0 5.853751927631379e-10
2 O 0 8.141717551882199e-13
position O 0 1.5912594852895978e-10
of O 0 8.288465400130285e-14
a O 0 9.813905244016041e-11
5 O 0 1.9000489116099972e-12
splice O 0 1.3141038479602685e-08
site O 0 7.34841465455105e-10
. O 0 7.761157688745968e-11

ATM O 0 5.423553375294432e-06
germline O 0 3.482336410343123e-07
mutations O 0 9.47214218172121e-09
in O 0 4.485614657490089e-11
classical O 0 4.398350199608103e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 1.0
in O 0 9.232331565911522e-11
the O 0 2.5102539675820462e-14
Dutch O 0 1.8489915154518144e-09
population O 0 2.3190561003103537e-14
. O 0 1.2236136583132495e-12

Germline O 0 5.790836894448148e-06
mutations O 0 5.069156117087914e-08
in O 0 3.7622103349344016e-11
the O 0 7.482147801991194e-15
ATM O 0 7.43199737862632e-11
gene O 0 2.027964818643313e-12
are O 0 4.917815587638936e-16
responsible O 0 1.966055373652008e-15
for O 0 7.872844290011081e-15
the O 0 5.3337618766136075e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0010221378179267049
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.030392993150997e-10
. O 0 1.1350738057802623e-11

In O 0 2.229269720210869e-11
our O 0 3.2029937648567555e-14
study O 0 2.6617234485286703e-14
, O 0 2.0031962860814516e-15
we O 0 9.352830865672393e-16
have O 0 1.799925292929585e-16
determined O 0 2.6398501779185436e-15
the O 0 2.060785632648798e-15
ATM O 0 1.714627373416988e-08
mutation O 0 2.0525157094775093e-12
spectrum O 0 1.41994196348888e-12
in O 0 5.6016979249617904e-12
19 O 0 1.8103475532896263e-12
classical O 0 2.3149906991370983e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 9.989359561757283e-09
, O 0 3.575579915546782e-16
including O 0 2.613016736632344e-17
some O 0 8.187140550240779e-17
immigrant O 0 1.5839350772824112e-13
populations O 0 6.051073355627318e-15
, O 0 2.5029378899067267e-15
as O 0 2.3201877786795328e-15
well O 0 7.761794035461306e-15
as O 0 9.080225720631274e-14
12 O 0 2.3581564964083278e-14
of O 0 9.07621637487874e-16
Dutch O 0 4.100983719279583e-10
ethnic O 0 2.11492769911642e-13
origin O 0 1.3358834871635139e-11
. O 0 1.3700204859468101e-10

Both O 0 5.410493559253327e-13
the O 0 7.579562520156069e-15
protein O 0 5.359160381093742e-13
truncation O 0 3.908246296036033e-11
test O 0 1.2527485993008014e-11
( O 0 6.250787647904543e-13
PTT O 0 7.513341615528191e-10
) O 0 1.1957721325703968e-13
and O 0 1.2453661149200435e-14
the O 0 6.8880899265221e-16
restriction O 0 6.100566232736249e-12
endonuclease O 0 7.175057437081023e-09
fingerprinting O 0 1.1040812708529302e-09
( O 0 2.3290177837524684e-13
REF O 0 2.4435509171638614e-10
) O 0 4.454908905590909e-16
method O 0 1.8398497938517224e-15
were O 0 1.0986329669287575e-15
used O 0 2.0487929166650978e-15
and O 0 1.894708094438884e-15
compared O 0 4.776888469336252e-15
for O 0 1.736307195977601e-17
their O 0 4.809154627744908e-17
detection O 0 1.8273295881001198e-15
efficiency O 0 5.554278791183778e-16
, O 0 4.259797182296596e-17
identifying O 0 2.8212510927157035e-14
76 O 0 1.7962652307419724e-13
% O 0 7.963520014047602e-15
and O 0 2.9056320067014085e-14
60 O 0 7.656780754133202e-14
% O 0 5.223821592306721e-14
of O 0 2.756205611575209e-15
the O 0 2.498104262511902e-13
mutations O 0 1.5765169725234784e-10
, O 0 1.0109640555255872e-11
respectively O 0 1.559296788911091e-11
. O 0 5.393351130283941e-12

Most O 0 2.2522747555875355e-12
patients O 0 1.2862193948803835e-11
were O 0 9.573925311388842e-14
found O 0 8.048301744023947e-14
to O 0 1.0943914494453816e-15
be O 0 4.852187580764791e-15
compound O 0 1.3253655985201451e-12
heterozygote O 0 6.860422008259093e-09
. O 0 5.280811551933162e-11

Seventeen O 0 1.1080896200610368e-09
mutations O 0 4.0775979814888785e-11
were O 0 1.693722744521009e-13
distinct O 0 1.060530905038241e-14
, O 0 1.0508979381422968e-14
of O 0 1.207164092553839e-16
which O 0 1.128716803182328e-13
10 O 0 1.514263839102678e-13
were O 0 6.518566068869358e-12
not O 0 2.1081695959247748e-13
reported O 0 4.781111617724321e-10
previously O 0 3.407961413071092e-11
. O 0 9.128736828956097e-12

Mutations O 0 5.041605799505078e-09
are O 0 9.542991397104572e-13
small O 0 1.4663381186358349e-12
deletions O 0 2.6711106215770997e-07
or O 0 1.8296100634529466e-08
point O 0 2.372246399318101e-09
mutations O 0 1.871808663622687e-08
frequently O 0 8.884173952061758e-10
affecting O 0 7.871238383305723e-11
splice O 0 1.4666186132217263e-07
sites O 0 2.4735871129166753e-09
. O 0 1.95240934530716e-10

Moreover O 0 2.4479698268464745e-09
, O 0 1.6649582754157954e-11
a O 0 4.133966086117269e-11
16 O 0 3.914856286368895e-11
. O 0 4.393201514379941e-12

7 O 0 1.2423514439419137e-09
- O 0 1.810305350069541e-09
kb O 0 2.160886358737457e-09
genomic O 0 1.0955304025062063e-10
deletion O 0 1.624338025196792e-10
of O 0 2.448606867329231e-15
the O 0 9.336117423315408e-15
3 O 0 1.1990083405299945e-13
end O 0 1.724696665865444e-12
of O 0 5.937788310525331e-17
the O 0 3.97887850681636e-16
gene O 0 5.463151090366603e-13
, O 0 7.754868694084555e-15
most O 0 1.3288084528727197e-15
likely O 0 4.359458012138419e-14
a O 0 1.86970122544039e-14
result O 0 4.409497669343593e-15
of O 0 6.554229772779449e-17
recombination O 0 1.8760277145234323e-14
between O 0 3.493614834817853e-14
two O 0 6.458293101696544e-13
LINE O 0 1.455761206026196e-10
elements O 0 2.812655707298828e-13
, O 0 3.2816878554886575e-12
was O 0 5.075630887807492e-11
identified O 0 1.499553259343145e-10
. O 0 4.3942657672324525e-12

The O 0 1.626456131234577e-13
most O 0 5.180972736603968e-15
frequently O 0 2.6984222690519533e-13
found O 0 6.593904025228858e-13
mutation O 0 7.606681669096449e-13
, O 0 9.529544850710864e-14
identified O 0 1.2732194638875871e-11
in O 0 3.005608728481185e-13
three O 0 4.779731958940185e-15
unrelated O 0 1.7453155891009042e-13
Turkish O 0 8.35335828286432e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 4.301430739372947e-12
, O 0 4.553173159685397e-13
was O 0 1.1502309521516096e-12
previously O 0 5.098862209730083e-14
described O 0 3.1435113843555906e-14
to O 0 2.4311357010613677e-16
be O 0 2.693815705779299e-16
a O 0 6.286914856713701e-15
Turkish O 0 1.6718358641920616e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 6.629315763007071e-09
mutation O 0 1.7587931111506805e-09
. O 0 2.0514884235822706e-10

The O 0 6.68210875087033e-14
presence O 0 1.2895809637161748e-13
of O 0 5.837244440895061e-16
a O 0 9.853240185569989e-14
founder O 0 8.107103530163862e-12
mutation O 0 6.059719241148509e-13
among O 0 1.0328229326742478e-14
relatively O 0 7.137663737507606e-15
small O 0 1.1465674296226493e-14
ethnic O 0 1.4065303961677614e-14
population O 0 2.9013313663183143e-16
groups O 0 3.534880511826805e-16
in O 0 3.999731250955811e-14
Western O 0 1.7199300794343286e-12
Europe O 0 1.6976988703731877e-08
could O 0 5.651919487981161e-10
indicate O 0 9.31102157181174e-12
a O 0 2.343523595668695e-12
high O 0 5.981270166655062e-12
carrier O 0 8.035089087143898e-12
frequency O 0 9.529045087719457e-12
in O 0 1.1943366217889717e-12
such O 0 8.700957062322563e-15
communities O 0 1.122759003824303e-12
. O 0 2.874123031584852e-12

In O 0 2.958240943873314e-11
patients O 0 2.4560301709053434e-11
of O 0 5.713605159166719e-17
Dutch O 0 1.7696196938365993e-11
ethnic O 0 6.228621202250713e-15
origin O 0 1.1788084343291455e-13
, O 0 2.405045346903778e-12
however O 0 3.2851369194397684e-13
, O 0 1.3317041832336743e-14
no O 0 4.16948071934372e-15
significant O 0 1.1583973882255344e-15
founder O 0 3.3167574589598736e-12
effect O 0 3.9156330955414376e-11
could O 0 7.03309216421033e-11
be O 0 1.8988994675717824e-13
identified O 0 3.071915291585903e-11
. O 0 7.590362800097283e-13

The O 0 2.303311079192294e-13
observed O 0 5.774575153986994e-13
genetic O 0 3.1595158347247354e-12
heterogeneity O 0 1.6345583740695613e-12
including O 0 3.687507113894761e-15
the O 0 2.0487772465555736e-15
relative O 0 3.866117495587851e-12
high O 0 2.6245305928540574e-09
percentage O 0 6.11490136304127e-10
of O 0 1.0914194861191742e-14
splice O 0 5.903147552999144e-07
- O 0 5.949353010237246e-09
site O 0 2.85463666593877e-11
mutations O 0 8.51597725670672e-09
had O 0 2.097446554216731e-07
no O 0 4.5999545318642365e-12
reflection O 0 6.869586822132179e-13
on O 0 2.1210004239047286e-12
the O 0 9.761338466045613e-14
phenotype O 0 1.6113570477926942e-09
. O 0 3.95797492003247e-11

All O 0 1.3852645159434518e-12
patients O 0 2.6910891050280217e-12
manifested O 0 8.176046645269608e-13
classical O 0 2.9450011873599635e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 4.712606173351563e-12
increased O 0 4.83352453114344e-13
cellular O 0 1.5749271331522152e-10
radioresistant O 0 2.2180778047609095e-10
DNA O 0 3.625570330068051e-11
synthesis O 0 2.604506194048284e-11
. O 0 4.991565320799918e-12

Determination O 0 2.424603226525157e-11
of O 0 4.0808088635021665e-16
the O 0 5.974550863925148e-17
genomic O 0 1.7215504195811082e-13
structure O 0 2.5848561572422435e-13
of O 0 2.567301276590621e-16
the O 0 6.4179847349718315e-15
COL4A4 O 0 4.125429442503048e-10
gene O 0 8.137684970321857e-12
and O 0 2.027661181048645e-14
of O 0 9.729520049252876e-17
novel O 0 3.056870381823451e-11
mutations O 0 7.918651135696564e-06
causing O 0 3.572779974092555e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.4319695651465736e-07

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 5.9178706379725554e-08
a O 0 4.743708093002397e-09
progressive O 0 1.0772890846055816e-07
hematuric B-Disease 1 0.9999537467956543
glomerulonephritis I-Disease 1 1.0
characterized O 0 1.7516020989205572e-07
by O 0 7.283534886326493e-12
glomerular B-Disease 0 0.0007313305395655334
basement I-Disease 0 0.1428709626197815
membrane I-Disease 0 0.0006383521831594408
abnormalities I-Disease 1 0.9999855756759644
and O 0 3.279876234973597e-14
associated O 0 2.0435527049852617e-14
with O 0 1.0617488113614506e-15
mutations O 0 8.894100733680688e-12
in O 0 8.570548784558873e-13
either O 0 1.8849021464744514e-13
the O 0 3.2650165665733255e-13
COL4A3 O 0 4.075971560268954e-08
or O 0 1.042444451072877e-12
the O 0 1.0551564640472536e-13
COL4A4 O 0 1.6774007738362684e-09
gene O 0 1.7901584728474695e-11
, O 0 3.5896056905983936e-14
which O 0 1.4694821230357174e-16
encode O 0 5.306735411346464e-13
the O 0 1.2513908908672738e-13
alpha3 O 0 3.109031965209397e-08
and O 0 1.0284466854526553e-11
alpha4 O 0 1.0140965400751156e-07
type O 0 1.8081429686844785e-07
IV O 0 2.787705000173446e-08
collagen O 0 6.91616486303559e-10
chains O 0 3.7228393701127516e-09
, O 0 1.9980707626626737e-12
respectively O 0 9.613899086546862e-12
. O 0 5.988278883178877e-12

To O 0 1.37189651999714e-12
date O 0 1.3251412987747013e-11
, O 0 2.3604919356504973e-14
mutation O 0 1.8580985003662648e-13
screening O 0 5.6035679568688934e-12
in O 0 9.83772864061351e-14
the O 0 1.4730692810975598e-15
two O 0 5.538053875079121e-15
genes O 0 3.266625251546751e-12
has O 0 1.138761827890189e-12
been O 0 6.532029149346197e-13
hampered O 0 7.887634295711266e-11
by O 0 1.7634231756912693e-15
the O 0 3.793981272946995e-15
lack O 0 4.0876295539582844e-14
of O 0 1.4442014321081777e-17
genomic O 0 2.690656670991526e-13
structure O 0 1.9388956586097184e-12
information O 0 8.990671922226579e-12
. O 0 5.408659631278567e-12

We O 0 1.759456608185772e-10
report O 0 5.7257185104298e-12
here O 0 8.768363097232112e-15
the O 0 2.8158975056758774e-17
complete O 0 3.576002902624817e-16
characterization O 0 4.386423475420849e-14
of O 0 4.9839325972214426e-17
the O 0 5.5393430592248424e-15
48 O 0 9.190573107241418e-14
exons O 0 1.7895635060632964e-12
of O 0 1.9074716104045854e-15
the O 0 2.9514002461601685e-14
COL4A4 O 0 2.8673321494920856e-09
gene O 0 3.512415011619474e-11
, O 0 1.3715661635951837e-13
a O 0 3.609164697790032e-14
comprehensive O 0 1.0040916665829402e-12
gene O 0 4.985088383757663e-11
screen O 0 2.0269634859459984e-08
, O 0 3.656876884639004e-12
and O 0 5.383376510954656e-14
the O 0 1.6871106952204588e-16
subsequent O 0 1.0433677728895587e-15
detection O 0 4.6477229752534335e-14
of O 0 2.6977851139283696e-16
10 O 0 4.086869119541975e-16
novel O 0 1.2787005883394681e-14
mutations O 0 2.2595380427814504e-12
in O 0 9.515329062875777e-13
eight O 0 6.116843143111339e-12
patients O 0 4.3712233832593483e-10
diagnosed O 0 4.0788185629025975e-07
with O 0 3.1594890592678837e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.7094718884891336e-07

Furthermore O 0 5.18517485892378e-11
, O 0 2.0506715086871657e-13
we O 0 4.6376963921469e-15
identified O 0 2.976687906580677e-14
a O 0 2.432630555394594e-15
glycine O 0 2.1949287005995632e-12
to O 0 2.4301819949023185e-15
alanine O 0 5.509584108387422e-12
substitution O 0 6.097117304310409e-14
in O 0 2.1108723425341917e-14
the O 0 4.682777179665669e-16
collagenous O 0 1.7273609626000663e-11
domain O 0 1.4650178856503993e-13
that O 0 4.409111422319645e-15
is O 0 6.930131348067883e-15
apparently O 0 4.50775788224389e-12
silent O 0 3.2983171315698057e-12
in O 0 3.576197497856537e-14
the O 0 4.793460563070164e-16
heterozygous O 0 3.3902928207873995e-12
carriers O 0 2.197468422504567e-11
, O 0 2.0737771309203845e-12
in O 0 5.3560589990953034e-11
11 O 0 1.602555761703872e-11
. O 0 4.501331165446265e-12

5 O 0 4.8836167748644854e-11
% O 0 3.0367716804743927e-13
of O 0 6.197731472381345e-17
all O 0 1.2318938811934184e-16
control O 0 5.435459211628607e-14
individuals O 0 1.6858311460745128e-15
, O 0 2.809181652487641e-13
and O 0 4.162389562797214e-13
in O 0 4.920732332887312e-13
one O 0 1.0019670470650787e-14
control O 0 2.0727400373322935e-13
individual O 0 3.3078171837497327e-16
homozygous O 0 3.1695761466832284e-13
for O 0 1.2227795578650339e-14
this O 0 7.904708398937367e-16
glycine O 0 2.4365268483372837e-11
substitution O 0 6.0138955447486264e-12
. O 0 3.385640075584395e-12

There O 0 2.166083631904847e-11
has O 0 1.711225155716714e-13
been O 0 3.1073210546512034e-14
no O 0 8.444621175560888e-15
previous O 0 4.368811712271653e-15
finding O 0 8.724688384405786e-15
of O 0 1.9116655153719027e-17
a O 0 2.539377882572317e-15
glycine O 0 2.9109695339965547e-13
substitution O 0 3.86680450707071e-15
that O 0 6.385478045675935e-16
is O 0 1.5918618403017127e-16
not O 0 7.160755655594771e-17
associated O 0 1.492424619217031e-15
with O 0 1.757981941917226e-16
any O 0 8.97359918035183e-14
obvious O 0 7.013356909113533e-12
phenotype O 0 8.675293816651219e-10
in O 0 3.8116853423586505e-12
homozygous O 0 8.081421642991415e-10
individuals O 0 2.9763162420759492e-12
. O 0 1.6793230001033166e-11

Founder O 0 1.1693143342483836e-08
BRCA1 O 0 0.0001410551485605538
and O 0 4.474131135023818e-11
BRCA2 O 0 6.654991011600941e-07
mutations O 0 4.706026679457409e-10
in O 0 2.6108264855606578e-12
French O 0 1.7266783558511634e-08
Canadian O 0 1.3176737411413342e-05
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 8.881932689330796e-11
. O 0 2.5888295413639684e-12

We O 0 7.489568860929996e-12
have O 0 6.359882509954923e-15
identified O 0 4.4720360769558154e-13
four O 0 2.4577967512904664e-15
mutations O 0 1.9055708684709467e-14
in O 0 1.3792572058155938e-14
each O 0 1.1456743974924032e-16
of O 0 2.0881100684942743e-15
the O 0 6.507447358750085e-12
breast B-Disease 0 2.0533950646495214e-06
cancer I-Disease 0 1.5851486523388303e-07
- O 0 7.343360142186839e-09
susceptibility O 0 4.579799650628047e-09
genes O 0 8.292281528099466e-09
, O 0 6.49659666340785e-12
BRCA1 O 0 5.044330109171824e-08
and O 0 1.2009062364329304e-12
BRCA2 O 0 1.0499434210942127e-08
, O 0 1.3370419138167278e-13
in O 0 2.91385296967428e-13
French O 0 3.2437895924886107e-08
Canadian O 0 2.3747156774334144e-07
breast B-Disease 1 0.9998507499694824
cancer I-Disease 1 0.9937800765037537
and O 1 0.92922443151474
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.741509572805171e-10
from O 0 9.3886686619582e-12
Quebec O 0 1.7852229694526045e-09
. O 0 8.50924677942011e-11

To O 0 3.5899514697762536e-12
identify O 0 1.1766306678984151e-11
founder O 0 3.52635767808529e-11
effects O 0 5.061588481680701e-09
, O 0 1.4023162839271741e-11
we O 0 6.832173173564049e-14
examined O 0 5.144739885845628e-13
independently O 0 1.1046766528865354e-14
ascertained O 0 3.4007265319740965e-12
French O 0 2.5587823526684872e-11
Canadian O 0 2.3083450081951007e-11
cancer B-Disease 0 2.2453500170271923e-10
families O 0 1.7916176626043417e-14
for O 0 7.94645746176745e-17
the O 0 2.83379670151479e-17
distribution O 0 7.20182648326212e-15
of O 0 2.987875263638128e-15
these O 0 1.3119091587816128e-13
eight O 0 1.4693842930596501e-12
mutations O 0 1.2225861989456632e-10
. O 0 3.02205205304773e-11

Mutations O 0 1.3441018298365748e-09
were O 0 4.044120507223914e-12
found O 0 1.6824600523532296e-13
in O 0 7.22786630893979e-14
41 O 0 5.025696113609979e-13
of O 0 1.5031088810554599e-15
97 O 0 2.3157446446542274e-11
families O 0 8.658897709089286e-13
. O 0 2.916973737207562e-12

Six O 0 4.0076658658350084e-10
of O 0 5.5209687970165285e-15
eight O 0 5.871911572426225e-14
mutations O 0 4.53007911131037e-13
were O 0 9.051681387935162e-13
observed O 0 3.402494418484024e-14
at O 0 9.005221156439813e-13
least O 0 3.9025957487316687e-13
twice O 0 1.0204456724061117e-10
. O 0 1.0861422872210369e-11

The O 0 1.49708041102814e-11
BRCA1 O 0 2.1749456209363416e-06
C4446T O 0 1.1193272086984507e-08
mutation O 0 3.689632627201789e-11
was O 0 2.7671558620878667e-12
the O 0 1.9890247366596175e-16
most O 0 1.2096486784161524e-16
common O 0 2.9801005599735175e-15
mutation O 0 4.7521360490351133e-14
found O 0 5.508339895321512e-10
, O 0 2.285238784229676e-13
followed O 0 2.5383088846412348e-14
by O 0 1.4262725107067726e-15
the O 0 4.389915893906332e-13
BRCA2 O 0 1.1120516319351736e-05
8765delAG O 0 9.771184039664149e-08
mutation O 0 5.421919357928573e-09
. O 0 3.312379259767795e-10

Together O 0 2.658632689001017e-11
, O 0 5.90648610208043e-14
these O 0 1.9890095165363465e-16
mutations O 0 6.810913324214324e-14
were O 0 9.843434254546216e-14
found O 0 7.425496713819521e-14
in O 0 7.533804445092676e-14
28 O 0 1.8255504800977068e-14
of O 0 4.4602117950618637e-17
41 O 0 5.1127684578449253e-14
families O 0 1.5437388545435417e-16
identified O 0 1.5617567731673193e-13
to O 0 5.3098886100772305e-15
have O 0 6.96379369100053e-13
a O 0 2.667657761357134e-12
mutation O 0 3.5264063891204955e-10
. O 0 2.6062368929657964e-10

The O 0 3.02785330445407e-13
odds O 0 2.893474869425372e-11
of O 0 1.4304188428627008e-15
detection O 0 1.4524030578482588e-13
of O 0 1.1906040690394255e-16
any O 0 3.1901031092456712e-15
of O 0 1.9153381642044137e-16
the O 0 2.507153318775327e-14
four O 0 3.921899968412773e-13
BRCA1 O 0 4.748143656030379e-09
mutations O 0 4.927200869531134e-10
was O 0 5.6858439734241983e-08
18 O 0 2.640656270036512e-11
. O 0 2.3854644388282553e-12

7x O 0 3.0395023713936098e-05
greater O 0 1.2638902424644272e-10
if O 0 5.174660179518842e-12
one O 0 1.0049067596118195e-14
or O 0 8.685106534780593e-15
more O 0 1.1216613575448786e-15
cases O 0 1.4064667670527636e-13
of O 0 8.035099820745406e-13
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 1.0754639366561403e-11
also O 0 7.105010193874479e-15
present O 0 3.144467673965129e-16
in O 0 4.77346894650621e-13
the O 0 4.783437304567949e-14
family O 0 2.299541850339648e-12
. O 0 1.6264663227349985e-12

The O 0 5.21311455375234e-13
odds O 0 6.286472037375646e-11
of O 0 1.2811827548639258e-15
detection O 0 3.0038951469475716e-13
of O 0 4.1589786225285097e-16
any O 0 1.630359530106068e-14
of O 0 1.2581865514998004e-15
the O 0 6.616919739996924e-14
four O 0 2.333461115305857e-12
BRCA2 O 0 1.3095042561417358e-07
mutations O 0 1.4678513959864858e-09
was O 0 3.477981280752829e-08
5 O 0 2.7810623595692086e-11
. O 0 2.3343348087845328e-11

3x O 0 1.0670059054973535e-05
greater O 0 1.9586494925949438e-10
if O 0 7.2099466154329495e-12
there O 0 4.119649771056749e-14
were O 0 1.607754931249282e-14
at O 0 2.0072503975252474e-15
least O 0 1.8681023131095935e-16
five O 0 6.058300452491529e-16
cases O 0 9.419540851257537e-15
of O 0 7.481058517621025e-16
breast B-Disease 0 1.0322268595430728e-09
cancer I-Disease 0 3.4912324142766238e-09
in O 0 1.370229624209074e-10
the O 0 1.0228142117985062e-12
family O 0 3.7466422325715953e-11
. O 0 8.888860134059762e-12

Interestingly O 0 5.2128066307943755e-09
, O 0 6.559142606225171e-14
the O 0 7.9503683717036e-17
presence O 0 3.1242403683660186e-14
of O 0 3.0029355094403094e-15
a O 0 4.830930100396813e-11
breast B-Disease 0 6.486552184270522e-09
cancer I-Disease 0 2.8598684184699685e-11
case O 0 1.1320959360933136e-12
< O 0 5.938157604523653e-11
36 O 0 8.955377129964137e-13
years O 0 1.696774367060741e-14
of O 0 1.5181425776687008e-16
age O 0 8.981475909134937e-14
was O 0 2.664537630792628e-14
strongly O 0 1.2167021599959553e-15
predictive O 0 4.714851556050781e-13
of O 0 6.99007520800058e-17
the O 0 2.779263066009333e-16
presence O 0 7.299684199658409e-15
of O 0 1.559013240862701e-16
any O 0 2.215494125234075e-14
of O 0 2.119601906440242e-15
the O 0 8.183172428522997e-14
eight O 0 1.2241249680577937e-12
mutations O 0 1.3166408067977198e-11
screened O 0 7.983588901083749e-09
. O 0 6.778226591119818e-11

Carriers O 0 5.044931694619947e-10
of O 0 1.4750035867117334e-15
the O 0 5.930434476356388e-16
same O 0 6.17013781240754e-15
mutation O 0 5.99103828612807e-14
, O 0 5.791622081685642e-15
from O 0 1.5420093985537057e-15
different O 0 3.4715933334419566e-15
families O 0 1.9947625907838773e-15
, O 0 1.0032510351930639e-16
shared O 0 6.414163345830294e-16
similar O 0 2.7861231117337626e-14
haplotypes O 0 4.381212753701291e-11
, O 0 6.828111752225918e-13
indicating O 0 1.6382954021176843e-11
that O 0 3.527514025103212e-15
the O 0 6.648666534860015e-16
mutant O 0 1.2365770733768766e-11
alleles O 0 3.872013387001827e-12
were O 0 1.1777038545768281e-11
likely O 0 9.487546382205836e-13
to O 0 3.034856581332298e-16
be O 0 3.8943657945040623e-16
identical O 0 1.0137701123718885e-14
by O 0 8.793078671600046e-16
descent O 0 6.9089716586701044e-12
for O 0 1.440074933758105e-14
a O 0 6.820587931249955e-13
mutation O 0 2.2413128211024036e-12
in O 0 4.7469979336245416e-11
the O 0 3.453795477154249e-14
founder O 0 1.0397304545106678e-11
population O 0 1.5672803766603183e-13
. O 0 1.6896074817029927e-11

The O 0 1.7333592785932772e-13
identification O 0 4.114722451653563e-12
of O 0 1.4068516334130076e-15
common O 0 1.8031805215645846e-11
BRCA1 O 0 5.469839015859179e-05
and O 0 1.7215597003517047e-10
BRCA2 O 0 3.4515455809014384e-06
mutations O 0 4.803524245033941e-10
will O 0 1.7987817995095828e-13
facilitate O 0 3.9970641813741326e-13
carrier O 0 3.541379646129772e-12
detection O 0 3.3149611528004996e-12
in O 0 1.0426692061832332e-12
French O 0 2.857746217443946e-08
Canadian O 0 5.391263968590465e-08
breast B-Disease 1 0.9824971556663513
cancer I-Disease 1 0.9287144541740417
and O 0 0.46907350420951843
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 9.052062210912482e-09
. O 0 1.8899656145654475e-11

Are O 0 1.2597602128128216e-10
Dp71 O 0 2.623504258281173e-07
and O 0 1.1987305245653168e-11
Dp140 O 0 6.8462266966662355e-09
brain O 0 1.1361904750373242e-09
dystrophin O 0 4.008875897909547e-09
isoforms O 0 1.2894869894086725e-10
related O 0 4.1127374943161765e-12
to O 0 2.817024567715494e-14
cognitive B-Disease 0 4.6517412144453374e-10
impairment I-Disease 0 2.656122788380344e-08
in O 0 1.9562580721999012e-12
Duchenne B-Disease 0 6.485922494903207e-05
muscular I-Disease 0 0.001543165766634047
dystrophy I-Disease 1 0.9995192289352417
? O 0 9.881997357297223e-06

Molecular O 0 3.896116484991552e-10
study O 0 1.3161066680922318e-10
and O 0 2.100023713952348e-12
neuropsychological O 0 8.558322106555494e-11
analysis O 0 2.0369342605859597e-13
were O 0 1.0169195672170284e-13
performed O 0 5.3415642541727523e-14
concurrently O 0 6.992195993212047e-13
on O 0 8.33845405917577e-12
49 O 0 8.360849512722979e-11
patients O 0 2.9106493690950197e-12
with O 0 8.793888435097621e-15
Duchenne B-Disease 0 8.096377541733091e-07
muscular I-Disease 0 1.1530161145856255e-06
dystrophy I-Disease 0 0.00038334241253323853
( O 0 2.9657650557624038e-08
DMD B-Disease 1 1.0
) O 0 1.3760700912079926e-10
in O 0 2.3743658948693902e-12
order O 0 2.2856384482555087e-14
to O 0 9.932516921367187e-16
find O 0 1.8201309600132665e-13
a O 0 6.179230287579841e-15
molecular O 0 2.7993920522590907e-14
explanation O 0 2.0271131507317713e-13
for O 0 6.947968273750282e-16
the O 0 7.307457421015361e-15
cognitive B-Disease 0 2.4100197532073153e-11
impairment I-Disease 0 1.1886881756684176e-10
observed O 0 1.7581991635165495e-13
in O 0 1.3705836595864773e-12
most O 0 7.659670120396811e-11
DMD B-Disease 1 1.0
patients O 0 1.0171897883992642e-06
. O 0 1.825779458175525e-11

Complete O 0 1.9994136554735142e-11
analysis O 0 5.13873058688441e-12
of O 0 8.828167540835647e-16
the O 0 8.508061402211393e-15
dystrophin O 0 1.33380917421988e-10
gene O 0 9.386327132210326e-11
was O 0 1.2881588157265256e-11
performed O 0 1.7805359305554137e-14
to O 0 5.1754560110185005e-17
define O 0 8.996285263778141e-15
the O 0 7.076662118712246e-15
localization O 0 4.141842771532289e-11
of O 0 1.6614684668082294e-15
deletions O 0 3.184871921746435e-09
and O 0 2.906022644744155e-12
duplications O 0 5.203237840589736e-10
in O 0 8.987478729988174e-13
relation O 0 1.953676749457539e-13
to O 0 6.513012514291344e-15
the O 0 2.99811817895939e-14
different O 0 7.69858222310349e-12
DMD B-Disease 1 1.0
promoters O 0 2.069647919711315e-08
. O 0 4.306539153065003e-11

Qualitative O 0 1.7956248710149225e-09
analysis O 0 2.3087634234975063e-11
of O 0 2.302307548437705e-15
the O 0 1.689379430618032e-14
Dp71 O 0 1.5579695311629393e-09
transcript O 0 1.1456003257137581e-08
and O 0 1.2833705181469063e-13
testing O 0 5.123663334425689e-14
for O 0 2.3928498780199223e-17
the O 0 9.068592813655656e-18
specific O 0 2.2532413120834275e-16
first O 0 9.687014374242658e-15
exon O 0 2.276834103198677e-12
of O 0 2.5512342686031565e-14
Dp140 O 0 2.8358950743267997e-09
were O 0 1.2354042233653217e-09
also O 0 1.3152019620946143e-12
carried O 0 1.6225196533548036e-11
out O 0 1.2526912666899204e-11
. O 0 2.115852848830202e-12

Neuropsychological O 0 2.4494388526363764e-06
analysis O 0 3.387626845707814e-10
assessed O 0 2.2201858407289166e-10
verbal O 0 1.898063262117944e-09
and O 0 2.338931728417676e-13
visuospatial O 0 4.6098072026268255e-09
intelligence O 0 1.0032579628171945e-10
, O 0 1.6003730729952786e-13
verbal O 0 2.3615323585524095e-10
memory O 0 2.2806860566770837e-11
, O 0 7.420105654042108e-13
and O 0 3.410118758553904e-12
reading O 0 2.674187538076467e-09
skills O 0 9.200852302271301e-10
. O 0 2.6473977090407663e-12

Comparison O 0 8.005476143102541e-11
of O 0 3.220155626456017e-15
molecular O 0 6.798949424291489e-13
and O 0 1.6368965915797978e-14
psychometric O 0 3.248359914387322e-11
findings O 0 3.9395112064015414e-13
demonstrated O 0 1.3118016872412652e-13
that O 0 1.9286169408998417e-15
deletions O 0 4.2776185371629083e-10
and O 0 1.8762290711956536e-13
duplications O 0 7.77986217115334e-11
that O 0 6.17875849022822e-15
were O 0 2.374449513961943e-14
localized O 0 2.0762219526092307e-13
in O 0 1.1304360767773469e-13
the O 0 3.7557068186758885e-15
distal O 0 3.2737937361027036e-11
part O 0 7.909048849868983e-13
of O 0 1.2853100711301881e-14
the O 0 1.6251653546669152e-14
gene O 0 1.0263719735226218e-10
seemed O 0 1.0827593266427016e-09
to O 0 4.262141888608604e-15
be O 0 4.163741065274447e-16
preferentially O 0 3.597268289452435e-14
associated O 0 6.823525983612119e-14
with O 0 3.6215842336758536e-14
cognitive B-Disease 0 1.3535280674048522e-09
impairment I-Disease 0 9.57867918316424e-09
. O 0 2.9161005207778423e-12

Two O 0 2.0732363742448356e-11
altered O 0 1.5435501765637127e-09
Dp71 O 0 3.373297019493293e-08
transcripts O 0 1.9627126590648913e-08
and O 0 8.111859030627763e-14
two O 0 2.5856720447880273e-15
deleted O 0 8.334160618572728e-12
Dp140 O 0 1.4243770008956491e-12
DNA O 0 1.5108969847812959e-13
sequences O 0 1.5103087034587688e-14
were O 0 7.854335773080628e-15
found O 0 2.868184002476938e-14
in O 0 9.913147776610676e-14
four O 0 1.4433945575223484e-13
patients O 0 7.566623244853812e-14
with O 0 4.668760054938031e-15
severe O 0 1.8846702687369543e-07
cerebral B-Disease 0 4.701991201727651e-05
dysfunction I-Disease 0 5.196594065637328e-05
. O 0 1.493060536317259e-10

These O 0 3.0857576286931823e-14
findings O 0 3.1067105133028225e-14
suggest O 0 7.277913758848079e-15
that O 0 2.011049942481169e-17
some O 0 1.48354545076365e-17
sequences O 0 8.923172344386466e-16
located O 0 2.5169324835579675e-14
in O 0 4.0062151187604533e-13
the O 0 4.53114557661294e-15
distal O 0 7.694091024024186e-12
part O 0 1.014540556600052e-13
of O 0 2.995910218175782e-15
the O 0 5.33712114284793e-15
gene O 0 1.5615588683237647e-11
and O 0 1.0700968756938156e-11
, O 0 5.478797991188052e-15
in O 0 1.3504861435753254e-15
particular O 0 1.4158589817741098e-15
, O 0 2.4804584825195448e-15
some O 0 1.8267834212557302e-14
DMD B-Disease 1 1.0
isoforms O 0 4.413798146418735e-11
expressed O 0 3.4155180582678274e-14
in O 0 4.4799331345296567e-13
the O 0 5.1571360436221056e-14
brain O 0 2.2754049755491224e-09
may O 0 6.448203516279394e-12
be O 0 9.464739799872448e-16
related O 0 8.606775468917357e-15
to O 0 1.4946572657170953e-16
the O 0 1.2948967053239176e-14
cognitive B-Disease 0 5.876133607474188e-11
impairment I-Disease 0 8.207773349866443e-11
associated O 0 2.536940384330333e-13
with O 0 3.932651079785465e-12
DMD B-Disease 1 1.0
. O 0 9.64746477150058e-11
. O 0 2.020922838796846e-11

I1307K O 0 2.2642464045929955e-06
APC O 0 9.57875627705107e-08
and O 0 2.3157567443504723e-12
hMLH1 O 0 1.5166689015799761e-09
mutations O 0 1.4016697524876776e-10
in O 0 7.348332554425741e-13
a O 0 5.659181348365017e-13
non O 0 2.414912159132143e-10
- O 0 2.4608320589591948e-11
Jewish O 0 2.521576697445127e-12
family O 0 5.422414904240891e-13
with O 0 3.7754094826553813e-14
hereditary B-Disease 1 0.9398974180221558
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.698686605410842e-10

We O 0 6.3160583534116466e-12
describe O 0 9.571884300799138e-13
a O 0 1.0173115063023819e-13
French O 0 2.639725937836346e-10
Canadian O 0 3.5509222229279658e-09
hereditary B-Disease 1 0.9999996423721313
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.7551679221128325e-08
HNPCC B-Disease 0 1.9823270122287795e-05
) O 0 3.166829992684583e-11
kindred O 0 2.1501574565263581e-07
which O 0 3.422262473407045e-13
carries O 0 5.235278356663375e-12
a O 0 1.3762255224314401e-13
novel O 0 1.4587261953913355e-11
truncating O 0 1.3483932193025794e-08
mutation O 0 1.2134752092052281e-09
in O 0 6.549204512040774e-10
hMLH1 O 0 1.2318947995026974e-07
. O 0 7.812545749219524e-11

Interestingly O 0 9.05748454016475e-09
, O 0 9.342927229398154e-14
the O 0 1.828731215869589e-15
I1307K O 0 8.994673061923919e-11
APC O 0 4.1871821981898094e-11
polymorphism O 0 4.324351293716333e-11
, O 0 1.5344750404878787e-15
associated O 0 5.659723275809505e-16
with O 0 1.145721828028727e-17
an O 0 1.017321509761489e-16
increased O 0 1.1761571751256472e-11
risk O 0 1.023481654982561e-08
of O 0 6.180085776463784e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.7636570372528415e-13
is O 0 1.3494561515114641e-15
also O 0 5.388880361639325e-15
present O 0 9.947457523765569e-16
in O 0 1.0691624668934807e-11
this O 0 3.0096357264003393e-13
family O 0 9.404870979223823e-12
. O 0 3.6171831589021375e-12

The O 0 9.683422683495757e-13
I1307K O 0 6.976846878004039e-10
polymorphism O 0 3.777096857504603e-09
has O 0 2.5267654179920995e-13
previously O 0 1.1152662587931086e-14
only O 0 3.300380763868432e-16
been O 0 9.638506491419299e-15
identified O 0 2.0678593657275784e-13
in O 0 5.7745916372481474e-15
individuals O 0 1.3722078005818495e-16
of O 0 5.194921886937588e-16
self O 0 1.4175108309366635e-10
- O 0 5.177668960243409e-09
reported O 0 8.601848833222903e-08
Ashkenazi O 0 3.8905839661040886e-10
Jewish O 0 9.310946111340535e-13
origins O 0 1.7093683413182958e-10
. O 0 3.595504102782421e-11

In O 0 1.4379876412881631e-12
addition O 0 1.4923770159653953e-14
, O 0 1.1280296053522206e-14
in O 0 5.488297804504688e-14
this O 0 1.6411349115137979e-15
family O 0 3.533470445491599e-13
, O 0 2.4631008292545255e-14
there O 0 4.147779311718591e-15
appears O 0 1.1949967924917981e-13
to O 0 1.9646308759929633e-15
be O 0 2.389779285647941e-14
no O 0 1.3040723591316392e-14
relationship O 0 1.2857463778013188e-14
between O 0 1.0766684496943879e-15
the O 0 3.5885084441185204e-15
I1307K O 0 5.3783939107932e-12
polymorphism O 0 2.330303268058276e-12
and O 0 4.2285540676346555e-15
the O 0 1.5673557212997677e-16
presence O 0 2.1435098433632976e-13
or O 0 5.331696455862511e-12
absence O 0 6.962283180533824e-12
of O 0 5.632437485842247e-15
cancer B-Disease 0 6.840238445104951e-12
. O 0 2.514318777051966e-13
. O 0 1.9509110039256372e-12

Identification O 0 1.7729720469539245e-10
of O 0 2.7733652285371604e-15
a O 0 5.071858460558437e-14
novel O 0 3.8017215786036174e-13
mutation O 0 7.923876940880981e-13
of O 0 2.8764275388778538e-15
the O 0 2.904368572357284e-14
CPO O 0 3.4849301222550366e-10
gene O 0 1.2782270034095156e-11
in O 0 1.2843162948070197e-12
a O 0 3.5772311762077846e-12
Japanese O 0 3.093341971460717e-10
hereditary B-Disease 0 1.2987648290163634e-07
coproporphyria I-Disease 0 2.5103412554017268e-05
family O 0 8.178710486639318e-10
. O 0 4.737934350407258e-11

Hereditary B-Disease 0 0.0035625663585960865
coproporphyria I-Disease 0 1.4555383131664712e-05
( O 0 3.644794022150677e-09
HCP B-Disease 0 4.2292335820093285e-06
) O 0 2.554518879413492e-12
is O 0 8.61942895530321e-14
an O 0 2.0221854518578247e-13
autosomal B-Disease 1 0.9999986886978149
dominant I-Disease 1 0.9995108842849731
disease I-Disease 1 0.9935770630836487
characterized O 0 2.9328151018859216e-10
by O 0 1.3918053721247853e-13
a O 0 4.2298395341866524e-10
deficiency B-Disease 0 0.0007266848697327077
of I-Disease 0 1.0394631627609532e-14
coproporphyrinogen I-Disease 0 1.5620548188266525e-09
oxidase I-Disease 0 9.393209543517855e-10
( O 0 2.679651856310472e-12
CPO O 0 6.915835126797276e-10
) O 0 3.6832282422584114e-14
caused O 0 5.093525563349202e-14
by O 0 2.5574402248978046e-15
a O 0 1.6886722055409198e-12
mutation O 0 1.7745815233949358e-11
in O 0 1.9101258769138596e-11
the O 0 4.132708444123251e-13
CPO O 0 1.9409567286743368e-08
gene O 0 1.8589565442539424e-09
. O 0 4.1097045905269525e-11

Only O 0 5.187034482490027e-11
11 O 0 4.000604968829036e-12
mutations O 0 5.412767022788811e-12
of O 0 1.0007747211368762e-15
the O 0 4.665944517421357e-16
gene O 0 7.836869174437933e-12
have O 0 2.6638630537534347e-13
been O 0 1.4322986969638601e-13
reported O 0 1.309683611561141e-10
in O 0 5.617568216154112e-11
HCP B-Disease 0 0.000125448961625807
patients O 0 1.5273898812395714e-09
. O 0 4.040080769929233e-12

We O 0 8.353485958512152e-11
report O 0 1.7799908682419874e-12
another O 0 1.1218887011879217e-14
mutation O 0 2.575220852535365e-13
in O 0 3.4142124891167747e-12
a O 0 7.136884399433496e-12
Japanese O 0 5.144669135148661e-10
family O 0 4.1446698503810886e-12
. O 0 3.788831227924394e-12

Polymerase O 0 6.324434309590288e-09
chain O 0 1.401386368060642e-10
reaction O 0 4.2775080352774886e-12
- O 0 8.024984149423986e-11
single O 0 1.8551024431878727e-13
strand O 0 8.501091497414848e-10
conformational O 0 4.0449248117635506e-11
polymorphism O 0 2.3808396920621533e-10
and O 0 5.198037062359353e-15
direct O 0 2.527201360439063e-15
sequence O 0 3.1906524948152604e-14
analyses O 0 2.8103767143322633e-13
demonstrated O 0 9.838586684989079e-15
a O 0 7.779820082425004e-14
C O 0 7.207063418279702e-11
to O 0 3.690020768869033e-14
T O 0 1.4616539922851501e-10
substitution O 0 1.1602426918527753e-13
in O 0 1.1820168596080732e-13
exon O 0 1.0890651228057102e-11
1 O 0 1.21390568495576e-13
of O 0 5.589519596954293e-16
the O 0 4.588371546045914e-15
CPO O 0 2.042086812148458e-11
gene O 0 1.6146918600367516e-13
at O 0 1.1217646108611489e-14
nucleotide O 0 3.569280965622437e-14
position O 0 4.5732064375648626e-14
85 O 0 3.494754602351678e-14
, O 0 3.7360446428712744e-15
which O 0 2.442282072312083e-15
lies O 0 9.745693428696647e-14
in O 0 8.40814614114227e-13
the O 0 1.7469866495805654e-14
putative O 0 1.987171711903546e-11
presequence O 0 2.4513327478992153e-10
for O 0 1.090487241657426e-14
targeting O 0 9.453068536280362e-12
to O 0 9.20117172557855e-13
mitochondria O 0 3.5989933255820006e-09
. O 0 1.1385457854284908e-10

This O 0 5.327688160430832e-13
mutation O 0 1.1198658320110688e-11
changes O 0 4.74705669738229e-13
the O 0 1.320660482964078e-14
codon O 0 1.4544171422770091e-11
for O 0 6.692535959385091e-16
glutamine O 0 2.8068638992934103e-12
to O 0 3.733309149968117e-15
a O 0 2.472365302937096e-13
termination O 0 2.0022454180756988e-11
codon O 0 2.7955492087894385e-11
at O 0 1.7409401557085674e-13
amino O 0 2.689498363600551e-12
acid O 0 1.431418004960161e-11
position O 0 1.45965305814455e-11
29 O 0 2.048098773910212e-10
. O 0 2.1263808422378183e-11

MaeI O 0 9.079853668936266e-08
restriction O 0 5.3055060345030824e-11
analysis O 0 3.745983124386898e-12
showed O 0 2.409232535693917e-12
two O 0 2.6289250410857392e-16
other O 0 4.8043870895663976e-17
carriers O 0 2.0006553651166076e-13
in O 0 4.414913530245701e-13
the O 0 1.2677173492816468e-13
family O 0 1.0325604954397605e-11
. O 0 4.017810823625512e-12

The O 0 1.2134507808292394e-11
C O 0 8.643219189252704e-05
- O 0 0.005473734810948372
T O 0 3.707521614160214e-07
mutation O 0 2.016901619675271e-12
is O 0 4.013438615734638e-15
located O 0 6.8074030502743126e-15
within O 0 1.654897227555078e-14
a O 0 4.144999502051633e-13
recently O 0 4.735203115030506e-12
proposed O 0 6.671233525453943e-14
putative O 0 1.0250528724442542e-11
alternative O 0 5.665805498378251e-12
translation O 0 8.396411343980503e-10
initiation O 0 4.9955775627275045e-11
codon O 0 1.0353343737889986e-09
( O 0 3.490707722875186e-12
TIC O 0 1.2905394441986573e-07
- O 0 6.384011097537723e-10
1 O 0 1.6043615817373097e-13
) O 0 2.7784902013845226e-15
, O 0 1.0720818589292344e-16
supporting O 0 2.720998581243466e-16
that O 0 2.464724263189145e-16
TIC O 0 4.6531475561550906e-08
- O 0 1.5715213852462995e-10
1 O 0 1.1454555294727886e-13
is O 0 3.7585443790491904e-15
the O 0 1.096096103251731e-15
real O 0 1.5263805844267786e-11
TIC O 0 3.0064348788272355e-09
rather O 0 5.99842051707657e-15
than O 0 5.740088597174691e-15
TIC O 0 1.3349201744006223e-08
- O 0 1.2457533615783944e-10
2 O 0 2.9134027547221553e-13
. O 0 5.607079606390411e-14
. O 0 8.855112823558109e-13

Human B-Disease 0 1.902366979222858e-11
complement I-Disease 0 2.7197888385899205e-09
factor I-Disease 0 2.485559207343613e-07
H I-Disease 1 1.0
deficiency I-Disease 1 0.8373323082923889
associated O 0 3.2625329104973844e-09
with O 0 1.1145971923198772e-09
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.701714585384707e-08

This O 0 4.3609904641465913e-13
study O 0 2.8259756730888985e-13
reports O 0 7.214317576491325e-13
on O 0 4.626937464354171e-14
six O 0 1.2186637061897126e-13
cases O 0 1.7630281999928e-13
of O 0 1.4316044348789726e-14
deficiency B-Disease 0 1.2641294233617373e-07
in I-Disease 0 2.0244161978277136e-13
the I-Disease 0 7.200340152197925e-16
human I-Disease 0 2.027474367932128e-15
complement I-Disease 0 2.2699385231715608e-13
regulatory I-Disease 0 8.772692641767499e-12
protein I-Disease 0 1.4311170521211225e-12
Factor I-Disease 0 9.49553044700402e-13
H I-Disease 1 0.999776303768158
( O 0 5.2682532815373495e-12
FH O 0 1.2689151844824664e-06
) O 0 7.68415414848303e-14
in O 0 2.1722862969682753e-14
the O 0 4.479806380284265e-16
context O 0 3.773076753918643e-14
of O 0 1.7991708248015978e-15
an O 0 5.609799734115906e-13
acute B-Disease 0 1.9386614440008998e-05
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 6.044190703491381e-10

Five O 0 1.456793886911445e-11
of O 0 1.112117069704556e-16
the O 0 9.680540369077896e-17
cases O 0 2.2370555183130227e-15
were O 0 3.2274608621096117e-15
observed O 0 1.1120582273845014e-15
in O 0 8.699567758882476e-14
children O 0 2.995557428953251e-14
presenting O 0 1.705418710981968e-13
with O 0 4.767102077668506e-12
idiopathic O 1 0.9999710321426392
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0004230980994179845
HUS B-Disease 1 1.0
) O 0 1.9125829453514598e-07
. O 0 2.365270646009776e-09

Two O 0 1.8922335486698527e-12
of O 0 3.9500084476003813e-16
the O 0 9.204106703211115e-16
children O 0 2.8023998662547907e-14
exhibited O 0 1.1454581857681112e-12
a O 0 2.0937217237726458e-11
homozygous O 0 0.2499590963125229
deficiency O 0 0.38166818022727966
characterized O 0 4.309034899729891e-12
by O 0 1.022536141046318e-14
the O 0 3.6684139748241126e-14
absence O 0 3.85751191189429e-13
of O 0 1.1587850778524707e-17
the O 0 3.596233887523292e-17
150 O 0 1.2126802358041551e-15
- O 0 1.1689680798863955e-13
kD O 0 2.4194431180735165e-11
form O 0 8.0517406977898e-14
of O 0 6.645500325703178e-15
Factor O 0 9.201579602435839e-12
H O 1 1.0
and O 0 1.9164447047533006e-13
the O 0 2.226684446906841e-16
presence O 0 7.03196461360211e-15
, O 0 1.1742719503273825e-15
upon O 0 1.700965639608477e-16
immunoblotting O 0 8.02568428381889e-12
, O 0 5.650447206245887e-16
of O 0 9.56658532091463e-18
the O 0 1.380720031715502e-15
42 O 0 5.41999550709299e-13
- O 0 4.980676027860342e-12
kD O 0 3.756821964628898e-09
Factor O 0 1.5183606108526426e-11
H O 1 0.9999921321868896
- O 0 6.964651078078532e-11
like O 0 5.746974077180944e-13
protein O 0 9.286847332812265e-12
1 O 0 3.285443748654582e-13
( O 0 2.4071139504387717e-13
FHL O 0 3.288142025326124e-08
- O 0 1.0396913191490498e-10
1 O 0 1.2235991300041382e-13
) O 0 6.442980677245306e-15
and O 0 3.2301950844633486e-15
other O 0 8.961416305471471e-15
FH O 0 7.109236577207412e-08
- O 0 9.268757636404779e-13
related O 0 1.2330083785580537e-12
protein O 0 1.0972635126893504e-11
( O 0 2.9622200959505962e-12
FHR O 0 2.2348841000052744e-08
) O 0 8.825369363259228e-13
bands O 0 1.5111818740809468e-10
. O 0 1.6820350667856587e-11

Southern O 0 1.5709108458494825e-09
blot O 0 4.996547886548797e-07
and O 0 2.8576842498254096e-13
PCR O 0 2.774122251358868e-11
analysis O 0 9.445771767568108e-15
of O 0 1.2482797335580529e-17
DNA O 0 1.6533214684463782e-12
of O 0 1.5397454912439317e-16
one O 0 3.828439504977542e-14
patient O 0 1.1305853172063896e-12
with O 0 7.226291335877665e-15
homozygous O 0 2.45593510044273e-05
deficiency O 1 0.997187077999115
ruled O 0 1.9450388522024298e-10
out O 0 4.738345675027456e-13
the O 0 6.391107109006032e-16
presence O 0 3.657515032485202e-14
of O 0 5.602346058055887e-17
a O 0 8.358277072137508e-16
large O 0 3.163949696449774e-15
deletion O 0 1.5031692904288185e-11
of O 0 1.4010889506354813e-15
the O 0 2.463735256932019e-14
FH O 0 1.9201930001599976e-07
gene O 0 1.0677481468435168e-11
as O 0 5.468924128121909e-14
the O 0 1.2464205227086093e-15
underlying O 0 1.6444180002059272e-12
defect O 0 1.806423240158228e-11
for O 0 1.2254880304171743e-14
the O 0 6.09240349142004e-12
deficiency O 0 3.485230263322592e-05
. O 0 6.924331941160489e-11

The O 0 2.611726752834581e-13
other O 0 1.9896641300677642e-14
four O 0 6.82341790220805e-15
children O 0 8.093089055802316e-16
presented O 0 4.725019136261714e-15
with O 0 6.651475973739468e-14
heterozygous O 0 0.0005693071871064603
deficiency O 0 9.830710769165307e-05
and O 0 2.609240609490436e-14
exhibited O 0 1.856781655512618e-12
a O 0 2.3262785469636837e-13
normal O 0 2.4866832551428963e-11
immunoblotting O 0 2.201061333195753e-09
pattern O 0 2.0176490686529824e-11
of O 0 1.7417145418163093e-16
proteins O 0 6.6447900885769056e-15
of O 0 8.153951020040497e-16
the O 0 1.8704083963073936e-13
FH O 0 2.3995804440346546e-05
family O 0 5.021598154658635e-12
. O 0 5.571914457602745e-12

Factor B-Disease 0 2.041883817582857e-05
H I-Disease 1 1.0
deficiency I-Disease 1 0.986533522605896
is O 0 5.205910572417261e-13
the O 0 1.5666997525156344e-14
only O 0 1.1558379947596009e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 6.87784065811492e-11
with O 0 1.866670880368293e-12
HUS B-Disease 1 0.6488710641860962
. O 0 7.71406410970954e-11

These O 0 4.232157159445027e-13
observations O 0 1.3438742306470797e-12
suggest O 0 2.4249385052049766e-13
a O 0 4.058241576446707e-14
role O 0 1.6382031907229144e-13
for O 0 3.4135902112798766e-14
FH O 0 1.0708864692787756e-06
and O 0 1.1735527914030763e-12
/ O 0 7.7815025534278e-09
or O 0 9.489040109222913e-11
FH O 0 1.8298618670087308e-05
receptors O 0 2.5689624039149095e-12
in O 0 3.5624473748545327e-13
the O 0 1.1555865517417184e-14
pathogenesis O 0 3.26232409142424e-11
of O 0 4.4258276175337084e-15
idiopathic O 0 4.3552970119264955e-09
HUS B-Disease 0 0.01415939349681139
. O 0 3.384234559256072e-11
. O 0 5.987699225329379e-11

Further O 0 1.0225611156433612e-11
evidence O 0 1.901325234407447e-12
for O 0 2.106101683568666e-15
a O 0 1.0123325280538085e-14
major O 0 4.900087293932022e-14
ancient O 0 6.2328970110159254e-12
mutation O 0 7.909716259746347e-08
underlying O 0 2.803932943606924e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 5.118125923075922e-10
linkage O 0 6.329263868565249e-08
disequilibrium O 0 2.27196714774891e-08
studies O 0 3.6860681174033516e-10
in O 0 3.0067842746867024e-13
the O 0 5.070694976102089e-15
Japanese O 0 3.670489693435863e-12
population O 0 5.410591086626873e-15
. O 0 1.2108584534348266e-12

The O 0 1.5833635791384637e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9015316963195801
DM B-Disease 1 1.0
) O 0 2.1995745502767505e-10
mutation O 0 1.0901255592665748e-10
is O 0 2.205578791434834e-13
an O 0 3.767812952371226e-14
unstable O 0 7.942307256314507e-09
( O 0 5.805411706916175e-12
CTG O 0 3.177592589054257e-08
) O 0 2.8065106662256145e-12
n O 0 1.360790785609467e-10
repeat O 0 1.6660552104585946e-10
, O 0 3.330154416656718e-14
present O 0 1.2830216633924149e-15
at O 0 7.855238540795811e-14
a O 0 1.1393733246917344e-14
copy O 0 9.802530315239366e-11
number O 0 8.352990845392812e-15
of O 0 6.263452361712112e-16
5 O 0 8.619516233578095e-13
- O 0 3.516487767640797e-09
37 O 0 8.409550139587552e-11
repeats O 0 7.711842275881509e-11
on O 0 4.7892662058401925e-12
normal O 0 9.512265974898071e-12
chromosomes O 0 5.424217932453734e-12
but O 0 3.483104104619328e-13
amplified O 0 1.0318413875068377e-12
to O 0 3.853948664513758e-15
50 O 0 6.956515577341907e-14
- O 0 1.679011530503205e-12
3000 O 0 4.706028318771094e-13
copies O 0 7.790617040370762e-10
on O 0 7.11485270699086e-08
DM B-Disease 1 1.0
chromosomes O 0 4.005527909356488e-09
. O 0 5.513213843788556e-11

Previous O 0 6.360089538359759e-11
findings O 0 2.87817708034821e-12
in O 0 6.462221030642187e-14
Caucasian O 0 3.3715502611997294e-10
populations O 0 9.89570231313408e-12
of O 0 8.733417228333831e-14
a O 0 5.836433203398883e-08
DM B-Disease 1 1.0
founder O 0 9.080429463903528e-11
chromosome O 0 1.2252766801168491e-08
raise O 0 4.718005153225846e-11
a O 0 2.369511704902738e-12
question O 0 2.965362981208197e-12
about O 0 8.56942809220702e-15
the O 0 5.16055187074152e-17
molecular O 0 3.808307141183907e-15
events O 0 1.151629171460499e-16
involved O 0 1.7983622471501488e-14
in O 0 6.388971383192166e-13
the O 0 2.4169072098496544e-14
expansion O 0 4.6954357069139974e-11
mutation O 0 1.9364103376329211e-10
. O 0 1.5957607457650624e-10

To O 0 7.379514208906424e-13
investigate O 0 2.2549559333499836e-13
whether O 0 6.817434037952172e-15
a O 0 1.6126873735077332e-14
founder O 0 6.716766357516002e-13
chromosome O 0 2.4110094476448296e-10
for O 0 2.763345921443644e-13
the O 0 1.2890387542097148e-11
DM B-Disease 1 1.0
mutation O 0 1.1756676361607266e-12
exists O 0 3.6136624427399525e-14
in O 0 6.976576282148204e-15
the O 0 1.5375621314734858e-16
Japanese O 0 7.729309813714336e-14
population O 0 1.9956130978897043e-17
, O 0 6.02734499815941e-15
we O 0 2.618344011387757e-14
genotyped O 0 5.394588595275529e-11
families O 0 7.739112398957968e-16
using O 0 3.491996324262239e-14
polymorphic O 0 1.9403476048118762e-10
markers O 0 1.7201736562943992e-11
near O 0 8.603739942714128e-11
the O 0 3.0936735920424063e-13
( O 0 3.327383290771535e-12
CTG O 0 1.835772600600194e-08
) O 0 2.7744488564213077e-12
n O 0 9.856981897371497e-10
repeat O 0 1.6439846151072857e-09
region O 0 6.23819260137104e-11
and O 0 1.0267351205350828e-12
constructed O 0 1.2385645460633032e-11
haplotypes O 0 3.644267465574558e-08
. O 0 7.932428325307939e-11

Six O 0 8.444859395106974e-12
different O 0 3.7575929916428344e-14
haplotypes O 0 4.984004528529873e-11
were O 0 8.73891996093501e-13
found O 0 3.6975297823538256e-11
and O 0 2.282780631190917e-10
DM B-Disease 1 1.0
alleles O 0 1.9285079089215174e-10
were O 0 8.434223458531065e-11
always O 0 2.943253279985569e-11
haplotype O 0 8.128591133527152e-09
A O 0 1.090885271004538e-09
. O 0 3.3503300828074956e-11

To O 0 9.174324711383464e-13
find O 0 3.426063686223779e-13
an O 0 6.062758757469842e-17
origin O 0 1.3547772760135867e-14
of O 0 4.030866477443073e-16
the O 0 8.415582345030169e-15
( O 0 8.98768418629986e-13
CTG O 0 3.4827325468000936e-09
) O 0 1.1196431152007968e-12
n O 0 2.5674562476041274e-10
repeat O 0 5.766065402923459e-10
mutation O 0 9.433759329269265e-12
and O 0 4.575198184718354e-13
to O 0 1.5410097937968272e-15
investigate O 0 2.2993244678040647e-14
the O 0 1.4244618719028981e-15
mechanism O 0 1.0719383551367062e-13
of O 0 5.5169628208669383e-17
the O 0 8.565828202181189e-16
expansion O 0 2.247939112414929e-13
mutation O 0 6.667086452144186e-14
in O 0 6.900852637806501e-14
the O 0 4.284227531554431e-16
Japanese O 0 9.448804314925868e-14
population O 0 2.0486345479737408e-17
we O 0 9.419787761361662e-16
have O 0 9.544724062290487e-16
studied O 0 4.78717271986534e-13
90 O 0 5.1503137014517406e-14
Japanese O 0 2.1046784315359446e-09
DM B-Disease 1 1.0
families O 0 1.2265245785160472e-13
comprising O 0 1.0069409769972865e-13
190 O 0 1.1405334142400303e-12
affected O 0 1.3753601122573622e-12
and O 0 5.53399150506409e-14
130 O 0 7.2296351847842e-13
unaffected O 0 8.604597590000651e-10
members O 0 4.5016207016364274e-13
. O 0 3.9626184278329646e-12

The O 0 1.4334410394778452e-13
results O 0 1.3513353576324189e-13
suggest O 0 3.845917182811187e-14
that O 0 1.008843133475947e-15
a O 0 1.903452947289632e-14
few O 0 7.281137905058507e-14
common O 0 1.6012730963237132e-14
ancestral O 0 1.5069865928057924e-12
mutations O 0 1.399801715512572e-11
in O 0 6.090680802588178e-13
both O 0 8.654518480989346e-14
Caucasian O 0 1.3151963962343416e-09
and O 0 2.128493778799645e-12
Japanese O 0 1.0176981870071988e-12
populations O 0 5.108165172589777e-15
have O 0 3.5210188176449883e-16
originated O 0 1.8105078525808282e-14
by O 0 1.0129958845534286e-16
expansion O 0 4.350022403919185e-14
of O 0 3.944931874745021e-17
an O 0 1.1827727200464674e-16
ancestral O 0 2.4600751123704523e-12
n O 0 7.531334444976778e-10
= O 0 3.1148472690034623e-09
5 O 0 1.6298738400588597e-11
repeat O 0 2.0944616874185584e-10
to O 0 1.6111263256672614e-13
n O 0 7.793852369042398e-11
= O 0 6.813083985868218e-10
19 O 0 2.9132585233071495e-09
- O 0 1.5526785546171595e-07
37 O 0 7.580098354553755e-11
copies O 0 1.9153523211912216e-09
. O 0 9.886570728756539e-12

These O 0 8.185388944339372e-14
data O 0 7.517670161513376e-14
support O 0 8.028056513090091e-16
multistep O 0 2.8026284418225522e-11
models O 0 1.4317763641358283e-10
of O 0 1.6122421052280206e-13
triplet O 0 1.1115596443289633e-08
repeat O 0 1.0642210723776913e-10
expansion O 0 6.13263454775359e-13
that O 0 2.87253478721051e-15
have O 0 1.230448022422235e-15
been O 0 3.9181928313103257e-16
proposed O 0 6.332934474375382e-16
for O 0 1.913710431577587e-15
both O 0 7.952485892026573e-11
DM B-Disease 1 1.0
and O 0 5.067089456356477e-11
Friedreichs B-Disease 0 1.6204840136424536e-08
ataxia I-Disease 0 1.3836952916790324e-07
. O 0 6.080562268973022e-12
. O 0 8.251027465433491e-12

The O 0 3.136683959987542e-14
molecular O 0 2.1790900247425915e-12
basis O 0 1.6730282090260395e-11
of O 0 1.9505222437210534e-10
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.8147242606195157e-12
the O 0 4.257508671326682e-16
western O 0 3.702550690088541e-13
Cape O 0 1.1156323781458255e-10
, O 0 1.9658511201271073e-13
South O 0 4.5432315678647917e-13
Africa O 0 1.897105736392568e-11
. O 0 2.3497629623309146e-12

Deficiency B-Disease 1 0.9999995231628418
of I-Disease 0 1.4155065737164046e-13
the I-Disease 0 5.0629666474913404e-14
sixth I-Disease 0 1.9613165258558496e-12
component I-Disease 0 2.820085202685785e-13
of I-Disease 0 5.783227296964083e-17
human I-Disease 0 1.4036085560162077e-15
complement I-Disease 0 1.3628908114918237e-12
( O 0 3.5309658842630487e-12
C6 O 0 1.1046535908221244e-10
) O 0 5.3021795938176797e-14
has O 0 4.78810140678871e-14
been O 0 6.446007464779024e-14
reported O 0 7.432748860836114e-11
in O 0 2.771135371951866e-14
a O 0 1.544948285243323e-14
number O 0 7.20687977594632e-16
of O 0 4.7676172569771904e-17
families O 0 6.699556141982155e-17
from O 0 1.4679693751314804e-16
the O 0 1.4009919653630207e-16
western O 0 1.6064591063652545e-13
Cape O 0 1.5853854340441842e-10
, O 0 1.1994641391233074e-12
South O 0 2.36514518907327e-12
Africa O 0 1.9634259496026374e-10
. O 0 3.7457901364001955e-12

Meningococcal B-Disease 1 0.7335094213485718
disease I-Disease 0 0.0004202493582852185
is O 0 4.512833249453729e-12
endemic O 0 1.233498286151713e-11
in O 0 1.159407205658658e-12
the O 0 4.554595090834612e-14
Cape O 0 7.580333583057097e-10
and O 0 2.98343625195277e-13
almost O 0 8.751454625539022e-15
all O 0 1.8403543078509307e-16
pedigrees O 0 1.0795042811040378e-11
of O 0 2.2113893612200333e-15
total O 0 3.136480519749796e-10
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 7.727892631370636e-11
C6Q0 O 0 1.3784382524306693e-08
) O 0 3.237042795270484e-14
have O 0 1.368972870583211e-14
been O 0 1.2858665717765342e-14
ascertained O 0 4.035051806572376e-12
because O 0 3.412464335086386e-14
of O 0 2.6012603732811744e-14
recurrent O 0 2.8573865620273864e-06
disease O 0 3.3669191452645464e-06
. O 0 8.913771110119484e-11

We O 0 4.620416028944252e-12
have O 0 4.367662288562229e-15
sequenced O 0 1.0614522905376053e-13
the O 0 5.648529206015948e-16
expressed O 0 1.0836154962904124e-15
exons O 0 3.449421304146938e-12
of O 0 2.0906528614019317e-15
the O 0 4.568254682955214e-14
C6 O 0 3.3131424687082855e-11
gene O 0 2.7044161181322135e-12
from O 0 4.5450754569470106e-14
selected O 0 5.223124314784541e-14
cases O 0 4.0058312434287577e-14
and O 0 1.6961004676479055e-15
have O 0 1.8833800875605418e-15
found O 0 1.9557981265332786e-13
three O 0 2.6843705684394085e-14
molecular O 0 2.323009978821844e-10
defects O 0 4.421512130647898e-06
leading O 0 1.2003016853015525e-12
to O 0 1.3615494907741332e-13
total O 0 1.955158604460827e-11
deficiency O 1 0.9226459264755249
879delG O 0 2.450479819060547e-08
, O 0 1.8972449750565695e-13
which O 0 1.3258312379422392e-15
is O 0 6.354492124627494e-17
the O 0 3.3075649267501285e-16
common O 0 2.3652265042362064e-12
defect O 0 3.510071053258734e-11
in O 0 1.7721714124386417e-13
the O 0 3.0830400081852116e-14
Cape O 0 1.7824151876677519e-10
and O 0 6.62173278449113e-13
hitherto O 0 3.7703704741653965e-11
unreported O 0 8.508824894670752e-11
, O 0 7.492193714389583e-13
and O 0 3.01065785799845e-13
1195delC O 0 5.214186304947077e-10
and O 0 9.77887408093285e-14
1936delG O 0 4.6708092255043354e-11
, O 0 2.8921281415881595e-15
which O 0 1.4159500378159396e-16
have O 0 8.277618889130809e-16
been O 0 6.27345084450062e-15
previously O 0 3.6134971019086484e-14
reported O 0 1.1797812726754842e-11
in O 0 2.554590924647854e-13
African O 0 2.1884577483533008e-12
- O 0 5.37540512102197e-10
Americans O 0 1.3333811485494174e-11
. O 0 2.6031243133273207e-12

We O 0 2.0511009557466764e-10
also O 0 1.2944133883242143e-13
show O 0 4.8786566827401304e-14
that O 0 1.5530952598882515e-16
the O 0 8.229608638163962e-15
879delG O 0 1.6865190133330543e-08
and O 0 5.3300010238732654e-11
1195delC O 0 1.909628281282494e-06
defects O 0 5.3504586503549945e-06
are O 0 4.518388201636106e-16
associated O 0 2.0027389306415816e-14
with O 0 1.387727789398021e-14
characteristic O 0 2.7647503841876642e-08
C6 O 0 9.169305121758953e-05
/ O 0 2.7610963115876075e-06
C7 O 0 4.1250089566347015e-08
region O 0 3.1387728527398906e-10
DNA O 0 1.5636652861417133e-08
marker O 0 2.5783812862556488e-09
haplotypes O 0 4.2006007561212755e-09
, O 0 5.995018392303264e-13
although O 0 2.379100741281906e-14
small O 0 2.0152931786473344e-13
variations O 0 8.178441257555846e-11
were O 0 7.635368726166547e-11
observed O 0 5.759750315581513e-12
. O 0 1.7850261199714446e-12

The O 0 1.7824710891317652e-12
1936delG O 0 3.1330202876489466e-09
defect O 0 1.7549360853408302e-09
was O 0 3.046390451098141e-13
observed O 0 4.37091193046437e-15
only O 0 7.387811836831351e-16
once O 0 4.837715599344478e-15
in O 0 2.2288452279552867e-14
the O 0 4.947303027994345e-15
Cape O 0 1.0829695473724144e-10
, O 0 9.936222986972956e-14
but O 0 1.181803555536131e-15
its O 0 2.8443991717342495e-17
associated O 0 1.2338170578534563e-13
haplotype O 0 3.950548221887118e-10
could O 0 6.633609633821536e-11
be O 0 3.2068830013373684e-13
deduced O 0 8.488125480266007e-11
. O 0 2.811761457346962e-12

The O 0 1.645456557466951e-12
data O 0 2.1560990839941674e-12
from O 0 9.062658765524988e-15
the O 0 1.943409524290691e-15
haplotypes O 0 2.7948775238595402e-11
indicate O 0 5.4366988341825184e-12
that O 0 2.6406760350421166e-15
these O 0 4.108267818767579e-16
three O 0 1.4449633514791228e-15
molecular O 0 1.74114357914118e-12
defects O 0 8.662627837274783e-10
account O 0 8.343850512858991e-15
for O 0 3.266601195811049e-15
the O 0 2.971352981370745e-12
defects O 0 0.3334523141384125
in O 0 3.384278100815319e-12
all O 0 4.548862964770658e-15
the O 0 5.5142751191508514e-15
38 O 0 9.603681240012707e-14
unrelated O 0 2.998388484113518e-13
C6Q0 O 0 2.614352068164294e-10
individuals O 0 1.2222705545912051e-15
we O 0 2.4870637301455285e-14
have O 0 3.2509878374943103e-15
studied O 0 9.902909655495895e-13
from O 0 8.900335573798837e-14
the O 0 1.6965939829242938e-13
Cape O 0 5.523215218516953e-10
. O 0 1.1677189597214532e-11

We O 0 3.175721838277745e-11
have O 0 3.2764247451201253e-14
also O 0 3.6738296493789725e-16
observed O 0 7.141036199187099e-16
the O 0 7.097583938388545e-16
879delG O 0 4.5689607652832365e-10
defect O 0 2.4597351933053346e-10
in O 0 2.9414377834477423e-13
two O 0 5.2312256089426246e-12
Dutch O 1 0.9999997615814209
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 1.2751822850987082e-06
, O 0 4.60818015690645e-13
but O 0 9.157601841549776e-15
the O 0 5.24586191898987e-16
879delG O 0 1.7243628747110051e-10
defect O 0 2.1944107989058104e-11
in O 0 9.256646251105168e-15
the O 0 1.1252398599887912e-15
Cape O 0 2.9335464613033935e-11
probably O 0 6.985061973274753e-10
did O 0 4.176077886275387e-12
not O 0 3.713112496373785e-15
come O 0 9.253362304368663e-15
from O 0 2.4325900248680678e-14
The O 0 1.014540556600052e-13
Netherlands O 0 1.172449959341293e-08
. O 0 3.2652594278599623e-13
. O 0 1.6224755913785138e-12

Complement B-Disease 1 0.7340613603591919
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 3.142880747319943e-11
seven O 0 1.4483283550335152e-13
further O 0 1.1933426218491052e-14
molecular O 0 5.156556293073322e-10
defects O 1 0.9994065761566162
and O 0 7.557555384458958e-13
their O 0 6.695731073541253e-15
associated O 0 2.2187271551260546e-12
marker O 0 1.0102254144328526e-08
haplotypes O 0 4.6614624693575024e-07
. O 0 1.0632192903869964e-09

Seven O 0 2.3430150181136256e-11
further O 0 4.119382447458596e-14
molecular O 0 4.799396557259028e-13
bases O 0 7.8324161392751e-12
of O 0 2.997253487069251e-11
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 7.665735407558216e-11
described O 0 1.0844888181926748e-10
. O 0 8.17184167556384e-12

All O 0 1.3071958608872752e-13
these O 0 2.3418667399315593e-15
new O 0 2.6806267166938624e-13
molecular O 0 3.861601316490493e-11
defects O 0 8.417931351978325e-10
involve O 0 1.046421623125942e-14
single O 0 6.693924928247164e-13
- O 0 1.307961100538435e-10
nucleotide O 0 3.0207828426165317e-12
events O 0 4.698904432871506e-14
, O 0 4.5506878972555176e-14
deletions O 0 1.3878179161430637e-10
and O 0 1.204118998520548e-13
substitutions O 0 1.0605477271125735e-13
, O 0 2.515966315426682e-15
some O 0 3.4153975148915213e-16
of O 0 2.4314405005734812e-17
which O 0 1.172799171790344e-15
alter O 0 5.517050358228026e-12
splice O 0 1.1213866502046699e-09
sites O 0 1.2506626290154088e-10
, O 0 2.168584582740163e-11
and O 0 1.5866149540022523e-12
others O 0 4.8835119975665364e-12
codons O 0 8.415314556309283e-10
. O 0 1.825528010007682e-12

They O 0 7.306782132468492e-13
are O 0 2.0477681920873773e-16
distributed O 0 1.760632757995438e-16
along O 0 6.092115490053578e-15
the O 0 1.2422913853215103e-14
C7 O 0 1.2398346238562397e-10
gene O 0 1.3708562930647705e-11
, O 0 1.5916941701298037e-13
but O 0 5.835376839125484e-15
predominantly O 0 7.312365129911753e-15
towards O 0 6.051815949412176e-14
the O 0 2.920352978538765e-12
3 O 0 4.001186881819052e-11
end O 0 1.68769598296592e-09
. O 0 1.1891364629090795e-11

All O 0 1.7090070135970803e-13
were O 0 1.503368420420828e-13
found O 0 8.797500352991303e-14
in O 0 8.25454189999934e-15
compound O 0 3.207923022271325e-13
heterozygous O 0 1.0861924554239621e-10
individuals O 0 1.6103520697908352e-13
. O 0 5.918558611955893e-12

The O 0 2.4244855012511835e-09
C6 O 0 0.052800022065639496
/ O 0 0.0031003879848867655
C7 O 0 1.5111451148186461e-06
marker O 0 2.1278809825275857e-08
haplotypes O 0 1.9372876636225556e-08
associated O 0 2.3035873208954172e-10
with O 0 4.2074641839161264e-13
most O 0 1.5341738296426044e-11
C7 B-Disease 0 6.579553155461326e-05
defects I-Disease 0 0.0005644269404001534
are O 0 3.279202267798126e-13
tabulated O 0 8.577965421308065e-11
. O 0 5.145661999793327e-13
. O 0 6.618566805727255e-12

A O 0 3.113722890635273e-10
genome O 0 1.7413447073177934e-10
- O 0 2.743369531543749e-09
wide O 0 4.943615655728095e-11
search O 0 3.4068695781153124e-11
for O 0 3.4282909762992433e-14
chromosomal O 0 1.192214824641269e-07
loci O 0 2.457643533126941e-10
linked O 0 1.3739470894336137e-08
to O 0 1.374542667187395e-11
mental O 0 7.409955316006744e-08
health O 0 2.2728303614161227e-11
wellness O 0 2.9795835937429516e-11
in O 0 3.9661833252336784e-14
relatives O 0 4.574011525440569e-13
at O 0 1.4865821247600497e-13
high O 0 1.8174398618009402e-12
risk O 0 4.010889276956364e-12
for O 0 4.5469311367278553e-14
bipolar B-Disease 0 7.39792312742793e-07
affective I-Disease 0 9.177899329415595e-08
disorder I-Disease 0 3.3787430311349453e-06
among O 0 6.844253896270969e-13
the O 0 4.674467735631127e-13
Old O 0 5.114392024552217e-06
Order O 0 4.700675178964664e-12
Amish O 0 6.750380521225452e-08
. O 0 2.9059246328677624e-11

Bipolar B-Disease 1 0.999951958656311
affective I-Disease 1 0.9913507699966431
disorder I-Disease 1 0.999924898147583
( O 0 3.8225709886319237e-07
BPAD B-Disease 1 1.0
; O 0 2.715840992095764e-07
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 0.9999805688858032
) O 0 2.4579691580706164e-12
is O 0 1.0108507286158818e-14
characterized O 0 1.1987446591735142e-14
by O 0 3.0609017856691838e-15
episodes O 0 3.186740454852455e-11
of O 0 4.1528239858425534e-14
mania B-Disease 0 1.1794101340001362e-07
and O 0 1.0131569194715695e-11
/ O 0 2.866546289226335e-08
or O 0 2.529231858672265e-11
hypomania B-Disease 0 1.9515462668096006e-07
interspersed O 0 3.4822411620893945e-09
with O 0 1.0202806617143692e-13
periods O 0 8.657900091302295e-11
of O 0 2.8558305351610025e-14
depression B-Disease 0 1.082656186923714e-09
. O 0 1.301554133567584e-12

Compelling O 0 2.3808248775236684e-11
evidence O 0 2.0064486639000123e-13
supports O 0 2.0777657209775785e-14
a O 0 5.039378897492676e-15
significant O 0 2.8075625320683056e-14
genetic O 0 2.5621910842987816e-11
component O 0 3.5810902854205295e-11
in O 0 6.022753910178702e-13
the O 0 1.557142679771764e-14
susceptibility O 0 3.2468533070484362e-12
to O 0 3.5734126161562907e-12
develop O 0 3.4867554177253623e-08
BPAD B-Disease 1 1.0
. O 0 1.5072418868555815e-09

To O 0 9.367592422246385e-13
date O 0 1.8253199299267386e-11
, O 0 7.78919978646972e-15
however O 0 1.7275878586709e-15
, O 0 4.502746679473871e-16
linkage O 0 1.1882856894643301e-12
studies O 0 1.8546329836471864e-12
have O 0 1.4827472677946506e-14
attempted O 0 2.025323675046084e-13
only O 0 2.5522165727120873e-15
to O 0 1.4978372656291043e-15
identify O 0 1.0841097984604087e-11
chromosomal O 0 2.72704703263571e-08
loci O 0 4.993097948990943e-12
that O 0 4.494832173021317e-14
cause O 0 5.53590539294907e-13
or O 0 1.2294693258266265e-12
increase O 0 7.950960853250755e-13
the O 0 3.223194823022413e-13
risk O 0 7.746309149680997e-11
of O 0 4.088385784973593e-14
developing O 0 7.3279835532957804e-09
BPAD B-Disease 1 1.0
. O 0 2.1118834458988545e-10

To O 0 2.576503192654872e-13
determine O 0 3.3480512063926646e-14
whether O 0 1.0513630439336341e-14
there O 0 1.6042177894241838e-13
could O 0 1.3007101905965213e-12
be O 0 8.446909011551422e-15
protective O 0 6.782444885670286e-14
alleles O 0 8.123750017954498e-14
that O 0 1.2543336103809774e-15
prevent O 0 3.399076132322085e-14
or O 0 9.422515935900155e-13
reduce O 0 4.833754924105094e-13
the O 0 1.8872608960633294e-14
risk O 0 1.5023056583463035e-12
of O 0 2.7281700386309535e-16
developing O 0 3.647071533663393e-11
BPAD B-Disease 1 1.0
, O 0 7.468773151754048e-15
similar O 0 4.225730377425865e-16
to O 0 3.069389055800672e-16
what O 0 1.4964265322554523e-15
is O 0 9.6556455413625e-17
observed O 0 2.1926908971511578e-15
in O 0 2.1554565315766439e-13
other O 0 1.2055655952691868e-11
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 7.221293333269097e-14
we O 0 8.236487392728614e-15
used O 0 8.610297804606537e-13
mental O 0 1.0192440225154087e-09
health O 0 6.435608990162933e-12
wellness O 0 1.649071296183635e-10
( O 0 3.0493919021823412e-12
absence O 0 3.4304874912960415e-11
of O 0 2.28045223492606e-14
any O 0 4.3032649665875056e-10
psychiatric B-Disease 0 3.210698196198791e-05
disorder I-Disease 0 3.8028029614167735e-09
) O 0 1.604275150495372e-14
as O 0 2.1581757106252375e-13
the O 0 5.210725785315812e-14
phenotype O 0 3.315219210264786e-09
in O 0 2.871061721698709e-11
our O 0 5.570668709306559e-13
genome O 0 1.588653687767394e-11
- O 0 6.5329892606769135e-09
wide O 0 1.3196742587595622e-09
linkage O 0 5.495263621924096e-07
scan O 0 5.5675550356681924e-06
of O 0 2.5156509227087717e-14
several O 0 6.782518916349876e-15
large O 0 1.1872135761460678e-13
multigeneration O 0 1.7665880136519263e-07
Old O 0 4.475287695981933e-09
Order O 0 2.0651198578882507e-13
Amish O 0 3.421367078537685e-10
pedigrees O 0 8.250407024235074e-10
exhibiting O 0 2.152833120105946e-11
an O 0 3.9061832381951517e-14
extremely O 0 9.225541997004427e-10
high O 0 2.235926443994174e-10
incidence O 0 9.722342930729155e-09
of O 0 9.971228009941768e-11
BPAD B-Disease 1 1.0
. O 0 6.635574312241488e-10

We O 0 9.02417376935638e-12
have O 0 3.310042466357112e-14
found O 0 9.932111150233805e-14
strong O 0 7.356336812489386e-14
evidence O 0 1.1629673427342082e-14
for O 0 1.152301503862382e-16
a O 0 1.4640478296378857e-14
locus O 0 7.361046668041826e-12
on O 0 1.0649926773798057e-10
chromosome O 0 9.190360401589714e-07
4p O 0 1.1986886647719075e-06
at O 0 4.540602269176297e-11
D4S2949 O 0 7.055301481928566e-11
( O 0 8.068898197169383e-14
maximum O 0 4.3280269233954283e-13
GENEHUNTER O 0 1.0958826734963623e-08
- O 0 3.342538468231737e-10
PLUS O 0 1.4771696366100429e-10
nonparametric O 0 3.5991511992961023e-09
linkage O 0 4.7866435259891205e-09
score O 0 2.2381153874651005e-10
= O 0 1.5114672013982755e-10
4 O 0 3.477965799473376e-13
. O 0 1.76638641457812e-14
05 O 0 1.1949160411139914e-11
, O 0 6.287997195413703e-14
P O 0 1.886079203927693e-08
= O 0 3.828620753765222e-11
5 O 0 3.279102250147714e-13
. O 0 2.7282976970840166e-14
22 O 0 3.4483535276373656e-13
x O 0 7.587924039098581e-11
10 O 0 7.331379427155671e-13
( O 0 4.742126830103999e-12
- O 0 1.0814184214780198e-08
4 O 0 3.9253200841658786e-13
) O 0 2.1275458472877137e-14
; O 0 4.838511725611602e-14
SIBPAL O 0 1.7595278567483774e-09
Pempirical O 0 1.0691120211347993e-10
value O 0 4.688450691049673e-13
< O 0 2.6498794478135856e-11
3 O 0 3.243346753277129e-14
x O 0 1.4654218810639108e-11
10 O 0 2.059703183834513e-13
( O 0 1.0932811730576808e-12
- O 0 2.5022628413751136e-09
5 O 0 2.6860826930763526e-13
) O 0 1.6641556364817463e-14
) O 0 2.2264701475711857e-14
and O 0 2.5707683730261457e-14
suggestive O 0 3.888556837639001e-11
evidence O 0 1.909008636390673e-14
for O 0 1.0133940562130872e-16
a O 0 4.338188083096621e-15
locus O 0 1.9667645984045024e-11
on O 0 5.057629315352585e-10
chromosome O 0 0.0004347496142145246
4q O 0 0.003339075483381748
at O 0 4.6446818613432583e-11
D4S397 O 0 2.3225846246255344e-10
( O 0 1.4767051784939783e-13
maximum O 0 7.389092050898161e-13
GENEHUNTER O 0 1.8057644268765216e-08
- O 0 4.578993573201018e-10
PLUS O 0 1.4171322448852663e-10
nonparametric O 0 3.784856872357523e-09
linkage O 0 1.7915230410281424e-09
score O 0 1.2395720561109158e-10
= O 0 5.40606275023503e-11
3 O 0 1.221959545268797e-13
. O 0 1.6213106771305504e-14
29 O 0 1.0202598314801303e-12
, O 0 3.70140523049331e-14
P O 0 3.809207527183389e-08
= O 0 1.849963411626465e-11
2 O 0 1.3121970144584078e-13
. O 0 6.644539790340992e-14
57 O 0 7.948493425946612e-12
x O 0 2.1160284635612925e-10
10 O 0 2.609721249866026e-12
( O 0 8.974087098434502e-12
- O 0 2.992482706076771e-08
3 O 0 5.805541594336439e-13
) O 0 6.097942653214214e-14
; O 0 6.228647968491846e-14
SIBPAL O 0 2.4966897438361e-09
Pempirical O 0 7.350274555673053e-11
value O 0 3.7401266979320003e-13
< O 0 6.324524237655282e-11
1 O 0 4.361229666250896e-14
x O 0 9.984740118040847e-11
10 O 0 2.30148560799448e-12
( O 0 1.515854802791594e-11
- O 0 2.1711710473937273e-07
3 O 0 1.0590120360504107e-12
) O 0 1.214713347811626e-14
) O 0 5.010450816519811e-16
that O 0 1.3009358014219125e-16
are O 0 2.2567337348040754e-16
linked O 0 1.7601058414570825e-12
to O 0 2.837631388544204e-13
mental O 0 2.020366096644466e-09
health O 0 3.193384792710141e-11
wellness O 0 5.3185589266036e-10
. O 0 3.817491461832745e-12

These O 0 2.0460769309307153e-13
findings O 0 5.245250306144811e-13
are O 0 3.627984414625307e-15
consistent O 0 5.998687332454955e-14
with O 0 3.6390136835710645e-17
the O 0 4.842495300386716e-16
hypothesis O 0 1.629744075966593e-14
that O 0 3.3180159898302665e-16
certain O 0 1.3959839889414981e-14
alleles O 0 7.673630827986777e-12
could O 0 3.7930700247379434e-11
prevent O 0 3.1469460284178075e-12
or O 0 7.89225108877023e-12
modify O 0 4.5830630956977814e-11
the O 0 1.0884383536613126e-14
clinical O 0 1.7410872006282108e-12
manifestations O 0 1.4863646338042491e-12
of O 0 3.3679715917209196e-13
BPAD B-Disease 1 1.0
and O 0 3.213152671450309e-13
perhaps O 0 1.1440143537350123e-13
other O 0 1.0697380684716006e-14
related O 0 2.720081625218196e-11
affective B-Disease 0 7.701986604047306e-09
disorders I-Disease 0 1.1010262142008287e-06
. O 0 2.371067925333037e-11

Segregation O 0 3.3548758437973447e-07
distortion O 0 1.6501829236403864e-07
in O 0 1.2193682730199384e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 3.6522120883120124e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999964237213135
DM B-Disease 1 1.0
) O 0 3.408275328631305e-10
is O 0 3.376088200234689e-13
an O 0 7.353236671902436e-14
autosomal B-Disease 0 0.013769282959401608
dominant I-Disease 0 0.001023313496261835
disease I-Disease 1 0.984636664390564
which O 0 3.7657137824664844e-11
, O 0 2.3854724619243317e-13
in O 0 4.681326466336906e-14
the O 0 9.541374046984096e-16
typical O 0 1.16868103736123e-12
pedigree O 0 3.012408655855836e-10
, O 0 3.2006180068462967e-14
shows O 0 2.572942943770973e-13
a O 0 2.2961582721997553e-12
three O 0 4.877189147337035e-13
generation O 0 2.19179101951239e-12
anticipation O 0 1.6630445284770978e-11
cascade O 0 1.5869200398199723e-09
. O 0 1.5834844546702698e-10

This O 0 6.788534578222594e-12
results O 0 2.2299884161469663e-11
in O 0 7.462309936645539e-11
infertility B-Disease 0 0.12543150782585144
and O 0 6.130105867363511e-10
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.16105938383771e-09
CDM B-Disease 0 7.390012513042166e-08
) O 0 1.2844822319495186e-13
with O 0 1.9377612968401623e-15
the O 0 4.555913667023603e-15
disappearance O 0 3.902376338738023e-11
of O 0 1.9133230156481718e-12
DM B-Disease 1 1.0
in O 0 1.802565041675308e-11
that O 0 5.5228672519612096e-14
pedigree O 0 3.7814511522071825e-09
. O 0 4.746397719301854e-12

The O 0 5.891970667869922e-14
concept O 0 2.378684814223486e-13
of O 0 4.48071450548284e-15
segregation O 0 1.4609315493463448e-11
distortion O 0 2.6624980432182754e-12
, O 0 2.152841173356395e-15
where O 0 8.900051785997771e-17
there O 0 3.4444176577578416e-16
is O 0 1.171877229366817e-16
preferential O 0 6.113728880791092e-12
transmission O 0 5.252924484278054e-11
of O 0 8.266637636365249e-16
the O 0 9.666927623173233e-16
larger O 0 2.7147443228950005e-14
allele O 0 5.342803022917453e-12
at O 0 1.8356122177820566e-11
the O 0 7.394424482443096e-12
DM B-Disease 1 1.0
locus O 0 4.0835733232380544e-12
, O 0 3.759898208749446e-12
has O 0 8.081270570260701e-13
been O 0 1.3427007986357986e-12
put O 0 4.444351570792593e-12
forward O 0 8.545606713580844e-13
to O 0 6.698362381391898e-15
explain O 0 1.463811168632423e-13
partially O 0 5.8925921867653e-13
the O 0 2.6984980615600736e-14
maintenance O 0 1.0077303574940188e-10
of O 0 6.853437630773007e-13
DM B-Disease 1 1.0
in O 0 6.873575493504536e-12
the O 0 1.0732737534000295e-14
population O 0 1.753305684773672e-14
. O 0 3.7576903394453964e-12

In O 0 3.851051855879861e-12
a O 0 5.890670438414569e-13
survey O 0 8.606049900494739e-12
of O 0 2.81168507530391e-13
DM B-Disease 1 1.0
in O 0 9.194351877073181e-12
Northern O 0 1.4628087630086384e-10
Ireland O 0 2.8807127705476887e-07
, O 0 1.0151100880012587e-12
59 O 0 1.2903246179862826e-12
pedigrees O 0 5.473944630907113e-10
were O 0 6.286669318802951e-13
ascertained O 0 6.686275144662801e-11
. O 0 1.5839027138475625e-12

Sibships O 0 1.2112420400001156e-08
where O 0 1.0374593030363158e-13
the O 0 6.516886737112967e-16
status O 0 2.817255638303505e-14
of O 0 1.4132356942666836e-16
all O 0 5.775094986577053e-16
the O 0 7.458889018413419e-16
members O 0 8.407459510824237e-16
had O 0 4.1801954150759435e-13
been O 0 5.110621144620341e-15
identified O 0 4.818407568015111e-14
were O 0 1.4660737630411286e-14
examined O 0 5.508769235587109e-14
to O 0 3.285995166573849e-17
determine O 0 3.868454791949757e-16
the O 0 1.0644416349798905e-15
transmission O 0 3.95056105884084e-11
of O 0 3.9415361064245886e-15
the O 0 1.1488655513036683e-11
DM B-Disease 1 1.0
expansion O 0 7.09115383600023e-13
from O 0 1.6941751278774786e-13
affected O 0 7.235856336849922e-13
parents O 0 2.6102175434104813e-13
to O 0 1.323279657067754e-15
their O 0 9.587424475469234e-15
offspring O 0 2.0445253563067256e-12
. O 0 1.6192726413205571e-12

Where O 0 7.700164833014667e-13
the O 0 9.953649334609998e-15
transmitting O 0 1.8315075844821394e-10
parent O 0 2.022096101672588e-10
was O 0 9.43268518849294e-11
male O 0 1.8451460845336776e-11
, O 0 1.9278034030234537e-12
58 O 0 2.294578936579139e-11
. O 0 6.395997446950741e-12

3 O 0 3.605454823585319e-11
% O 0 2.3613893501174543e-13
of O 0 7.85489650889171e-17
the O 0 3.0378564014545584e-16
offspring O 0 2.863592406276462e-14
were O 0 1.0660072271521243e-13
affected O 0 7.782784358927215e-15
, O 0 1.343277575556836e-15
and O 0 2.9370227936167687e-15
in O 0 1.0045157692033669e-14
the O 0 5.451692513359441e-16
case O 0 7.559526464008537e-14
of O 0 7.194652855352704e-17
a O 0 1.2537513345220463e-13
female O 0 1.6755979199631343e-12
transmitting O 0 2.500063711607936e-09
parent O 0 8.428522768610947e-09
, O 0 3.0482436019774184e-10
68 O 0 1.5756460580718112e-09
. O 0 4.1641648462764635e-11

7 O 0 2.8539863805576715e-09
% O 0 2.162013797157858e-11
were O 0 5.776957905101465e-12
affected O 0 4.70058627438652e-12
. O 0 1.2730147882014653e-12

Studies O 0 8.419188013419898e-09
on O 0 8.780292465315753e-12
meiotic O 0 1.104437208354625e-09
drive O 0 5.395988170175947e-11
in O 0 1.327145948692987e-09
DM B-Disease 1 1.0
have O 0 2.8019240031450232e-14
shown O 0 4.740853570177686e-15
increased O 0 2.050162103072687e-14
transmission O 0 1.3321018550380148e-12
of O 0 4.3263508108936323e-17
the O 0 2.9833980062976193e-16
larger O 0 6.080671990232878e-14
allele O 0 3.104588808255926e-11
at O 0 1.4284240457129727e-10
the O 0 9.566984704445503e-11
DM B-Disease 1 1.0
locus O 0 1.9779761162297405e-10
in O 0 4.028258282495756e-10
non O 0 0.01592814177274704
- O 1 0.9999828338623047
DM O 1 1.0
heterozygotes O 0 1.808156468996458e-08
for O 0 1.1939722214387993e-12
CTGn O 0 1.218583101092463e-08
. O 0 8.678230876968396e-12

This O 0 1.1456433674991717e-13
study O 0 2.8343575723217482e-14
provides O 0 3.803603567227804e-15
further O 0 6.325159770710772e-16
evidence O 0 1.6505092580751217e-14
that O 0 1.052105298905313e-14
the O 0 2.2926889553520624e-11
DM B-Disease 1 1.0
expansion O 0 2.996767764495978e-11
tends O 0 3.640316173503244e-11
to O 0 4.363484467956487e-14
be O 0 6.719454094701593e-14
transmitted O 0 5.70003835798083e-11
preferentially O 0 2.769914853040234e-10
. O 0 2.4939364809406506e-11

Diagnosis O 1 0.9960796236991882
of O 0 9.977243475844944e-10
hemochromatosis B-Disease 1 1.0
. O 0 2.6930546681569467e-09

If O 0 7.399656443141112e-09
untreated O 0 4.5247841740092554e-07
, O 0 1.328325366367622e-10
hemochromatosis B-Disease 1 1.0
can O 0 2.4854578395405724e-09
cause O 0 1.7053310985559733e-09
serious O 0 0.00017878964717965573
illness O 0 7.546549113612855e-06
and O 0 8.63872862133519e-12
early B-Disease 0 4.9026258608364515e-08
death I-Disease 0 9.20835716705648e-12
, O 0 8.638186838733335e-15
but O 0 1.2682464230011608e-14
the O 0 7.964578805231669e-16
disease O 0 1.2097048189552151e-11
is O 0 9.01174107396669e-15
still O 0 1.647145961292118e-12
substantially O 0 2.9658073219529513e-10
under O 0 9.226324237943118e-08
- O 1 0.9999905824661255
diagnosed O 0 0.0006768309394828975
. O 0 3.904356699058198e-11

The O 0 2.865653406843721e-13
cornerstone O 0 2.859595719939545e-11
of O 0 1.6272892050788607e-15
screening O 0 1.5902747868556943e-12
and O 0 3.8322362454603145e-15
case O 0 2.55252806907844e-15
detection O 0 4.483142101909671e-15
is O 0 1.1352766710181626e-16
the O 0 1.116968186212159e-16
measurement O 0 2.9535190482557483e-13
of O 0 1.5991227655442542e-16
serum O 0 1.749922093081252e-13
transferrin O 0 3.126150813909101e-12
saturation O 0 3.4284385226623915e-12
and O 0 5.96103705676268e-14
the O 0 9.722368682428106e-15
serum O 0 6.368462181216561e-12
ferritin O 0 1.8399712864436424e-09
level O 0 1.0820589563254046e-10
. O 0 4.489883725228294e-12

Once O 0 4.197515113268935e-10
the O 0 6.995611230055376e-13
diagnosis O 0 1.0270976069648441e-08
is O 0 1.464802027774121e-14
suspected O 0 1.6965261417922761e-09
, O 0 5.746678089987856e-13
physicians O 0 1.0516355147816014e-11
must O 0 3.719082469289328e-14
use O 0 6.133113765113829e-13
serum O 0 6.951353381801084e-11
ferritin O 0 4.888507731948266e-08
levels O 0 8.551847563431636e-10
and O 0 3.617659340496293e-12
hepatic O 0 2.9247944066668197e-09
iron O 0 1.5983584944478935e-07
stores O 0 1.1908813348782132e-06
on O 0 2.3187778086519728e-10
liver O 0 8.735667189618823e-10
biopsy O 0 3.601121845164812e-09
specimens O 0 6.626900092045196e-13
to O 0 5.032175305792752e-15
assess O 0 3.1319280936054072e-12
patients O 0 2.3760058590754918e-12
for O 0 2.378381430315186e-16
the O 0 5.846626389577087e-16
presence O 0 9.76136164086705e-13
of O 0 2.2669012663106142e-13
iron B-Disease 0 3.989362085121684e-06
overload I-Disease 0 1.5235970352023287e-07
. O 0 2.9746323459978186e-11

Liver O 0 0.4389371871948242
biopsy O 1 0.9949138164520264
is O 0 5.23044715178278e-12
also O 0 5.9115323008636974e-15
used O 0 3.890551922779931e-15
to O 0 3.226289733180914e-16
establish O 0 4.750414539273114e-14
the O 0 5.820370803431927e-15
presence O 0 2.9402949259377253e-12
or O 0 1.6085310861058133e-10
absence O 0 1.3263962150844577e-10
of O 0 3.205780503253222e-14
cirrhosis B-Disease 0 1.829669922515098e-11
, O 0 7.001236799374566e-15
which O 0 2.3760068263871175e-15
can O 0 4.792051087540439e-13
affect O 0 1.8433565784903294e-10
prognosis O 0 9.805607987800613e-07
and O 0 3.65615870911995e-12
management O 0 2.178480139336525e-11
. O 0 9.642121085937094e-13

A O 0 8.962700026593495e-11
DNA O 0 1.161838958374517e-10
- O 0 2.8598411833113957e-11
based O 0 2.1309625071463945e-13
test O 0 2.459637582583746e-13
for O 0 2.7457311492099033e-16
the O 0 1.4586036524243508e-15
HFE O 0 5.123351187741321e-10
gene O 0 4.80568232777423e-12
is O 0 4.576275492042649e-15
commercially O 0 2.0503274100226732e-13
available O 0 1.7574917215990027e-13
, O 0 8.221953154386678e-15
but O 0 6.47320874203397e-15
its O 0 2.739140174089081e-16
place O 0 9.28745809100108e-14
in O 0 5.598864471004217e-13
the O 0 1.0316381538096053e-13
diagnosis O 0 1.855555820107213e-09
of O 0 9.06504892309555e-14
hemochromatosis B-Disease 1 1.0
is O 0 3.311417459683774e-11
still O 0 2.5786739063504704e-11
being O 0 1.5801520248520662e-12
evaluated O 0 1.922810174970202e-11
. O 0 1.2950561846872266e-12

Currently O 0 2.893552064620053e-11
, O 0 9.933849092434981e-15
the O 0 5.244719152430016e-17
most O 0 1.1029785106459681e-16
useful O 0 1.633807758882693e-15
role O 0 2.5003516865605225e-15
for O 0 2.20604648914699e-16
this O 0 2.1215261005986077e-16
test O 0 1.2916702721245312e-14
is O 0 4.990286336942585e-17
in O 0 2.3774393708591614e-15
the O 0 7.277326447378276e-16
detection O 0 3.6656249324980295e-13
of O 0 9.554568914478187e-14
hemochromatosis B-Disease 1 1.0
in O 0 1.0637146545533493e-12
the O 0 1.45665187675564e-15
family O 0 1.9527143506228688e-14
members O 0 7.493537033469755e-17
of O 0 9.41604705210835e-17
patients O 0 3.0681263414345525e-15
with O 0 3.353808963475079e-18
a O 0 1.1946498477966028e-14
proven O 0 1.383115410397151e-12
case O 0 1.0240346765000297e-11
of O 0 4.684870198078334e-15
the O 0 3.7185688556151675e-12
disease O 0 7.949915392657658e-09
. O 0 3.865661610258364e-11

It O 0 2.0990067323145567e-12
is O 0 2.7225275392407308e-14
crucial O 0 1.5846679871089897e-11
to O 0 7.34295697163434e-12
diagnose O 1 0.9991023540496826
hemochromatosis B-Disease 1 1.0
before O 0 2.794099032144004e-07
hepatic B-Disease 1 0.9753004312515259
cirrhosis I-Disease 0 0.0011121834395453334
develops O 0 2.1369062963572105e-08
because O 0 1.6647455983176407e-11
phlebotomy O 0 3.205777375114849e-06
therapy O 0 2.5357819595228648e-06
can O 0 2.5423163574345153e-10
avert O 0 3.897889200743521e-06
serious O 0 0.10765354335308075
chronic O 1 0.9999984502792358
disease O 0 0.00589710334315896
and O 0 7.1951372811185355e-12
can O 0 4.592693413074667e-13
even O 0 2.8079871327441053e-13
lead O 0 6.800427733953673e-13
to O 0 7.832258875749981e-14
normal O 0 1.925909015598748e-10
life O 0 2.6955186346877547e-11
expectancy O 0 1.0436883995934565e-11
. O 0 8.141087765945257e-15
. O 0 5.202962626710272e-13

Prevalence O 0 1.9240512756368844e-06
of O 0 4.135237210165302e-14
the O 0 3.841701330426113e-14
I1307K O 0 3.505108703283355e-10
APC B-Disease 0 4.666259045826848e-11
gene O 0 5.583225548555504e-11
variant O 0 2.148343947183662e-09
in O 0 2.2040364325293105e-12
Israeli O 0 5.086443419233255e-12
Jews O 0 3.573538492028516e-14
of O 0 1.1726860134825468e-17
differing O 0 1.6671061063469172e-15
ethnic O 0 5.708614462217321e-14
origin O 0 4.168779470931083e-12
and O 0 2.2129857668584663e-10
risk O 0 7.180563699193954e-08
for O 0 1.1799905763609786e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.6208284714380738e-10

BACKGROUND O 0 1.3736997971136589e-05
& O 0 7.495411402658192e-09
AIMS O 0 6.7770984137072166e-12
Israeli O 0 2.4348346689545552e-12
Jews O 0 9.715334006038523e-13
of O 0 2.28223075000541e-15
European O 0 6.540566421797678e-10
birth O 0 7.36268268575202e-10
, O 0 6.0224381037699e-11
i O 0 1.3848440172381515e-09
. O 0 2.6856088035533522e-15
e O 0 2.7481680126006935e-12
. O 0 2.942888073260031e-15
, O 0 7.499406945324447e-15
Ashkenazim O 0 3.74266381775179e-11
, O 0 1.3784781472623566e-15
have O 0 3.383976033619735e-15
the O 0 1.2534787932009378e-13
highest O 0 0.0028251586481928825
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 3.773592638367518e-08
of O 0 1.822567780628893e-15
any O 0 1.3430432438919782e-13
Israeli O 0 7.700234894159053e-10
ethnic O 0 3.604691545255889e-11
group O 0 4.734384412286019e-11
. O 0 2.8705249982552417e-11

The O 0 3.440071578292292e-12
I1307K O 0 1.7979895350350716e-09
APC B-Disease 0 7.044503869124696e-11
gene O 0 4.054154581489833e-11
variant O 0 3.5258971298191e-09
was O 0 1.8897474696188965e-09
found O 0 4.00233374220349e-10
in O 0 3.076091326104091e-10
6 O 0 3.992595143387234e-11
. O 0 1.2595818485450216e-11

1 O 0 1.941257397886087e-11
% O 0 4.6348158872031725e-14
of O 0 6.151867119829362e-18
American O 0 7.163846267061065e-16
Jews O 0 1.1083827608439518e-14
, O 0 2.910100698421238e-15
28 O 0 2.221744211945275e-14
% O 0 2.5593727305669653e-15
of O 0 7.053914625397258e-15
their O 0 7.718424233082999e-10
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 4.7907722233730965e-09
, O 0 1.2908286093661625e-13
but O 0 3.3561020173870915e-13
not O 0 6.578700258164094e-14
in O 0 4.9268011545478e-12
non O 0 2.9015589930736496e-08
- O 0 1.3318777192239395e-09
Jews O 0 8.240961732464136e-12
. O 0 2.3416201703346795e-12

We O 0 7.24478159755404e-12
assessed O 0 4.444648208506985e-12
the O 0 2.635825077353191e-15
I1307K O 0 2.4254648289812053e-10
prevalence O 0 3.681950300205017e-10
in O 0 5.849666454352254e-14
Israeli O 0 4.237448066046756e-13
Jews O 0 3.427458893483508e-15
of O 0 3.547196139269311e-18
differing O 0 6.054233635553524e-16
ethnic O 0 5.602736699063249e-15
origin O 0 1.5884771796537134e-12
and O 0 3.0275563306370046e-11
risk O 0 1.7384625294880607e-08
for O 0 4.938778985774661e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.393294475579239e-11

METHODS O 0 1.7171202237875605e-09
DNA O 0 8.778225368821779e-10
samples O 0 5.593861311659065e-12
from O 0 6.19065278098345e-14
500 O 0 1.5553854252193904e-14
unrelated O 0 2.608251884871765e-13
Jews O 0 2.472525764858624e-13
of O 0 1.1137224353676193e-15
European O 0 9.329243974565138e-12
or O 0 1.866845436918063e-12
non O 0 9.677154216847228e-11
- O 0 1.0908820721744483e-11
European O 0 7.235401514038564e-13
origin O 0 2.8310995447934292e-14
, O 0 3.14989733515153e-14
with O 0 3.780817322155479e-16
or O 0 1.3562439474430754e-13
without O 0 3.411468563153594e-14
a O 0 8.575612279754924e-14
personal O 0 4.42175029230496e-12
and O 0 6.783826278500271e-11
/ O 0 2.79811501968652e-07
or O 0 1.0634115116259224e-10
family O 0 1.8746320468165933e-11
history O 0 2.5736656729391516e-12
of O 0 1.4538983844023532e-15
neoplasia B-Disease 0 6.3761100566051e-11
, O 0 1.5546980749233524e-13
were O 0 5.8958746088425e-13
examined O 0 1.7036127716862914e-11
for O 0 3.88029313617882e-16
the O 0 6.855846029198088e-16
I1307K O 0 2.6602607269832212e-11
variant O 0 3.647711299681333e-11
by O 0 1.4121592689154451e-14
the O 0 2.0845816256975444e-14
allele O 0 5.944390119028142e-11
- O 0 1.3932524578486039e-10
specific O 0 1.1164017843859342e-12
oligonucleotide O 0 3.679818005863922e-09
( O 0 1.9259897843237894e-10
ASO O 0 3.4495869272177515e-07
) O 0 6.994783441696684e-13
method O 0 1.603573870911923e-11
. O 0 1.0796298750836986e-11

RESULTS O 0 7.409853619577689e-09
In O 0 1.2918976327082332e-13
persons O 0 7.609750774396212e-15
at O 0 2.805239459507166e-14
average O 0 1.7449736317357023e-12
risk O 0 2.219618377985455e-10
for O 0 5.848300688171548e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.4926253321442123e-13
I1307K O 0 4.154375107812136e-11
was O 0 2.587738400297579e-12
found O 0 7.196098317924227e-12
in O 0 6.932733033482297e-12
5 O 0 1.0202150539304067e-12
. O 0 6.453924634303165e-12

0 O 0 2.951721644883776e-10
% O 0 1.2660169136993749e-12
of O 0 1.1349914326731748e-15
120 O 0 9.821966373904645e-13
European O 0 9.135368905788255e-09
and O 0 1.4047806251582529e-09
1 O 0 1.8001359083918977e-11
. O 0 2.243589342088015e-11

6 O 0 1.5185880331003432e-09
% O 0 3.989890882960534e-12
of O 0 3.08321475108223e-15
188 O 0 1.5290732222061898e-11
non O 0 3.3410280098067346e-10
- O 0 3.191784891942717e-10
European O 0 4.187635047753213e-12
Jews O 0 1.9095157041942173e-13
( O 0 1.8002713577693064e-13
P O 0 3.0061022560090578e-09
= O 0 5.765732682960767e-11
0 O 0 2.5422602391300675e-12
. O 0 2.6006627407149097e-12
08 O 0 1.58556986984415e-10
) O 0 5.510411463065246e-13
. O 0 3.36872500381058e-12

It O 0 8.411856280976515e-12
occurred O 0 2.1041837716673228e-10
in O 0 9.314046062192105e-11
15 O 0 8.795512061732236e-12
. O 0 1.4035196616024592e-12

4 O 0 8.067602835781784e-11
% O 0 6.263915709910084e-13
of O 0 1.3238047116159333e-15
52 O 0 9.770494309446764e-12
Ashkenazi O 0 3.758271702736238e-07
Israelis O 0 2.1181130183123287e-09
with O 0 3.797547129189005e-13
familial O 0 5.148054242454236e-06
cancer B-Disease 0 5.491225607556771e-08
( O 0 2.1420742957189987e-10
P O 0 0.00010689214832382277
= O 0 3.746231769241604e-09
0 O 0 1.0914878376122594e-11
. O 0 7.555450948042164e-13
02 O 0 3.053007152642451e-11
) O 0 5.950836069572307e-14
and O 0 6.157138736579207e-14
was O 0 2.1188615098588492e-12
not O 0 3.041684725678352e-15
detected O 0 1.9737570952638173e-12
in O 0 1.9890590910454087e-12
51 O 0 1.6829657459305203e-11
non O 0 3.656141500663068e-10
- O 0 5.741537800751928e-10
European O 0 7.523028207334637e-12
Jews O 0 8.700845084566936e-14
at O 0 4.0162914227009905e-13
increased O 0 2.883556457847214e-12
cancer B-Disease 0 7.968337101260659e-11
risk O 0 2.1888606205333616e-10
. O 0 5.485184789016939e-12

Colorectal B-Disease 1 0.7598958015441895
neoplasia I-Disease 0 3.088237644988112e-05
occurred O 0 2.7760940213283902e-09
personally O 0 1.7626533913017717e-11
or O 0 2.274393780948847e-13
in O 0 3.082681205028755e-14
the O 0 5.823632621432685e-16
families O 0 1.1467025102019127e-15
of O 0 1.6448004730628204e-16
13 O 0 6.055395171834094e-14
of O 0 4.865306956447458e-16
20 O 0 8.453488424672514e-14
Ashkenazi O 0 2.1987217602159603e-11
I1307K O 0 2.171041775175797e-12
carriers O 0 1.0642884278955558e-13
, O 0 4.040644466967499e-15
8 O 0 9.331916139897027e-15
of O 0 8.550382026992415e-17
whom O 0 2.1539616878313295e-12
also O 0 1.9893247205776676e-12
had O 0 1.9166002118709002e-11
a O 0 3.7385147603520574e-13
personal O 0 9.070974006653021e-12
or O 0 5.1744653700724896e-11
family O 0 2.1956332585393312e-11
history O 0 2.0367265166076898e-11
of O 0 1.726226041449952e-13
noncolonic O 0 1.9975077236722427e-07
neoplasia B-Disease 0 2.5527955926918366e-07
. O 0 3.5837433021157494e-10

CONCLUSIONS O 0 5.83770987105936e-09
The O 0 7.875370819886152e-14
I1307K O 0 4.730514313600054e-10
APC O 0 1.2845505215075548e-10
variant O 0 1.6304693151170113e-09
may O 0 1.0388107908598787e-11
represent O 0 7.385223515902779e-15
a O 0 3.149021841897248e-13
susceptibility O 0 1.3295591190509715e-11
gene O 0 1.9963826147773034e-09
for O 0 5.876604064480873e-11
colorectal B-Disease 1 1.0
, I-Disease 0 3.547597599799085e-13
or I-Disease 0 3.877458250312049e-13
other I-Disease 0 4.991448335385507e-13
, I-Disease 0 6.19199309881413e-12
cancers I-Disease 0 8.8881613180547e-09
in O 0 2.0461181360342806e-11
Ashkenazi O 0 2.2045455239094736e-08
Jews O 0 3.4205414108784415e-12
, O 0 3.350837944789131e-13
and O 0 2.115168663049255e-14
partially O 0 1.9651324838221296e-12
explains O 0 4.600647553892889e-12
the O 0 2.0223965324682805e-14
higher O 0 1.171529956378592e-10
incidence O 0 8.621581741863338e-07
of O 0 2.6762898414744996e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.3186426395250805e-09
European O 0 2.4434995693489725e-10
Israelis O 0 2.7541751101978207e-09
. O 0 5.1787181314100206e-12

Systematic O 0 3.108157065057071e-10
analysis O 0 4.5823903699337976e-11
of O 0 3.731139813886904e-14
coproporphyrinogen O 0 2.6394365804094377e-08
oxidase O 0 1.5507488626553823e-07
gene O 0 9.552260598866269e-05
defects O 1 0.8778131604194641
in O 0 4.7395070507105785e-11
hereditary B-Disease 0 0.0002720280026551336
coproporphyria I-Disease 1 0.5306565165519714
and O 0 1.081030154281848e-09
mutation O 0 1.2843679897400762e-08
update O 0 8.793849701760337e-07
. O 0 6.716773665038644e-11

Hereditary B-Disease 0 0.013216962106525898
coproporphyria I-Disease 0 6.520278111565858e-05
( O 0 1.9787064431397994e-08
HC B-Disease 0 2.418054918962298e-06
) O 0 7.0891556513963394e-12
is O 0 5.671792245934282e-13
an O 0 5.769225158366864e-13
acute O 0 6.99784231983358e-06
hepatic B-Disease 1 0.9999816417694092
porphyria I-Disease 1 0.9999992847442627
with O 0 2.7102256439093253e-08
autosomal O 1 0.9999600648880005
dominant O 0 0.0006982523482292891
inheritance O 0 0.000376541109289974
caused O 0 2.905644835848875e-09
by O 0 1.2650078467374426e-12
deficient B-Disease 0 4.069729129696498e-06
activity I-Disease 0 8.447505889241924e-11
of I-Disease 0 1.2461263269902042e-14
coproporphyrinogen I-Disease 0 3.9317495925672574e-09
III I-Disease 0 3.2170638375461635e-10
oxidase I-Disease 0 7.308953442475286e-10
( O 0 9.828943214884589e-12
CPO O 0 1.3070546422966345e-08
) O 0 3.866729419294002e-12
. O 0 9.884496866841008e-12

Clinical O 0 5.729182106506414e-08
manifestations O 0 4.804119879686652e-10
of O 0 1.7463202040576657e-14
the O 0 1.0140182422034572e-13
disease O 0 3.149855654083211e-10
are O 0 4.118862030415803e-15
characterized O 0 4.119539656773606e-14
by O 0 1.0273569443623211e-14
acute O 0 9.427707503562033e-10
attacks O 0 1.0003611827791303e-10
of O 0 1.6570078642530461e-13
neurological B-Disease 0 1.185687210636388e-07
dysfunction I-Disease 0 4.265058084484963e-09
often O 0 1.138639556990187e-13
precipitated O 0 4.392771953479202e-13
by O 0 8.226654504881294e-16
drugs O 0 6.446386480174482e-11
, O 0 3.157000892260384e-14
fasting O 0 7.536111491790454e-12
, O 0 6.657400291579154e-15
cyclical O 0 3.2524472004524796e-10
hormonal O 0 3.6504624323363544e-10
changes O 0 3.962157425069224e-12
, O 0 1.7090862145657804e-12
or O 0 7.726628781234979e-10
infectious B-Disease 0 9.636131835577544e-06
diseases I-Disease 0 0.00015003970474936068
. O 0 4.63559260421853e-11

Skin O 1 1.0
photosensitivity O 1 0.9900327920913696
may O 0 0.00021483957243617624
also O 0 4.907032245815568e-12
be O 0 1.1662014839334146e-14
present O 0 1.3306022780725912e-14
. O 0 2.154569925250094e-12

The O 0 3.5191999054468015e-12
seven O 0 1.6703043028559739e-12
exons O 0 2.0305125636443933e-11
, O 0 5.61090675535599e-15
the O 0 1.2488906825410396e-15
exon O 0 4.326917296681998e-11
/ O 0 1.640212826670151e-10
intron O 0 9.314281568251204e-10
boundaries O 0 1.058798448222431e-11
and O 0 1.1642374347572981e-13
part O 0 2.3252924650878082e-14
of O 0 1.580059177335553e-15
3 O 0 1.2753952116693976e-14
noncoding O 0 4.932125541312615e-11
sequence O 0 1.5702066383238567e-13
of O 0 1.8897707393893386e-15
the O 0 8.719996668910945e-15
CPO O 0 5.0342782026424615e-11
gene O 0 1.6024722781365908e-12
were O 0 1.560056744160862e-13
systematically O 0 3.094452591303337e-13
analyzed O 0 9.927332867971754e-15
by O 0 1.612832457016708e-17
an O 0 1.0245928243925241e-16
exon O 0 1.7561120743345149e-12
- O 0 1.606677464682793e-12
by O 0 4.449786079972068e-13
- O 0 3.659692549007332e-10
exon O 0 3.151918726018721e-09
denaturing O 0 2.768455544810422e-07
gradient O 0 1.205847421914541e-09
gel O 0 3.563686590268844e-08
electrophoresis O 0 9.193887873237827e-10
( O 0 2.4565174547297453e-11
DGGE O 0 6.391495332991326e-09
) O 0 9.465688053256899e-14
strategy O 0 4.024112857173301e-13
followed O 0 1.0967282651160905e-14
by O 0 2.635168964308759e-17
direct O 0 7.507020077454369e-15
sequencing O 0 1.0153288799996663e-12
in O 0 4.755557384515663e-13
seven O 0 2.1065458676462062e-13
unrelated O 0 3.188522015862283e-11
heterozygous O 0 1.6304298355862556e-08
HC B-Disease 0 4.758182512887288e-06
patients O 0 3.1762215080277656e-09
from O 0 2.302736994141963e-12
France O 0 5.97081793785037e-07
, O 0 6.038173433475791e-11
Holland O 0 2.0888777726213448e-05
, O 0 2.193172206343963e-11
and O 0 1.001750678936153e-11
Czech O 0 1.7359433890362652e-09
Republic O 0 2.8503277862967913e-11
. O 0 3.590626407312669e-10

Seven O 0 1.9023815509000563e-11
novel O 0 3.387455463702005e-12
mutations O 0 3.7144946840594883e-11
and O 0 4.2300592282412675e-13
two O 0 2.5069190294621166e-14
new O 0 2.715377564726368e-13
polymorphisms O 0 1.4823465788182943e-09
were O 0 9.502623687929201e-11
detected O 0 1.4190189467910841e-08
. O 0 4.1090776614627345e-11

Among O 0 2.6686918300211637e-11
these O 0 4.661083734150244e-14
mutations O 0 5.9524082711426285e-12
two O 0 4.47019164577251e-14
are O 0 5.502927842272959e-15
missense O 0 1.7514951711206095e-09
( O 0 4.8476804168084975e-12
G197W O 0 3.550927052398123e-10
, O 0 1.3145117860966643e-13
W427R O 0 5.183404747088893e-11
) O 0 4.433162753450341e-14
, O 0 1.2084230270354313e-14
two O 0 5.02770424238067e-15
are O 0 6.587625105516134e-15
nonsense O 0 5.794719704077522e-10
( O 0 2.1315192449619658e-13
Q306X O 0 5.6342860932367955e-11
, O 0 3.002066368933132e-14
Q385X O 0 1.1650893791403938e-11
) O 0 4.113745273788029e-14
, O 0 3.383661487934772e-14
two O 0 8.110396056497089e-16
are O 0 6.052752519035911e-17
small O 0 6.959856275285878e-15
deletions O 0 1.2733420984289978e-09
( O 0 3.0917996027973738e-12
662de14bp O 0 1.2650237801725694e-10
; O 0 1.4466799611555226e-13
1168del3bp O 0 3.891051369997456e-10
removing O 0 1.6321875491789872e-12
a O 0 9.501721512459455e-14
glycine O 0 1.0242828286932681e-11
at O 0 1.303297205400289e-13
position O 0 3.3093919450536205e-14
390 O 0 1.9616449577989498e-13
) O 0 1.0442404285834674e-14
, O 0 6.205169570446673e-14
and O 0 5.1852954845469854e-14
one O 0 4.642139079955249e-15
is O 0 5.062400935361693e-16
a O 0 8.049529602984287e-14
splicing O 0 1.1749072825750773e-09
mutation O 0 1.1474077243889269e-10
( O 0 6.584318593821914e-12
IVS1 O 0 3.765029887858873e-08
- O 0 3.275925364309984e-10
15c O 0 6.063709090398106e-09
- O 0 8.938440959616045e-11
- O 0 1.3808262866454868e-10
> O 0 3.7019597456944275e-12
g O 0 1.3348640769128561e-12
) O 0 5.972938801407845e-15
which O 0 9.931158068761554e-15
creates O 0 1.782459948954443e-13
a O 0 2.9340371278385735e-12
new O 0 3.596436690123106e-11
acceptor O 0 3.229012890404448e-11
splice O 0 3.346924515312821e-08
site O 0 2.4038291357442176e-09
. O 0 3.775928458793487e-10

The O 0 7.327140603237067e-14
pathological O 0 9.977615088307967e-12
significance O 0 6.032155975893225e-14
of O 0 1.1455438750091872e-15
the O 0 7.88676104133447e-15
point O 0 6.465395926968931e-12
mutations O 0 5.283602375061314e-11
G197W O 0 3.3007557798114817e-10
, O 0 4.076830222693971e-14
W427R O 0 4.325143021510769e-11
, O 0 3.452142407654388e-14
and O 0 5.974237302915986e-15
the O 0 1.505364000398406e-15
in O 0 1.073781168148269e-11
- O 0 7.008513325246213e-09
frame O 0 2.439384472197048e-09
deletion O 0 2.1272064110178235e-09
390delGly O 0 5.217141163527117e-10
were O 0 1.5768122755849961e-13
assessed O 0 8.587676061802899e-14
by O 0 4.2061234175815e-17
their O 0 6.127048293468648e-16
respective O 0 3.46134487005489e-15
expression O 0 1.0666574096424367e-14
in O 0 6.210808776996313e-13
a O 0 5.910229987707294e-13
prokaryotic O 0 9.218276505627496e-14
system O 0 4.055608151013693e-15
using O 0 7.890932509193108e-14
site O 0 1.3658979503006208e-10
- O 0 7.959530257117819e-10
directed O 0 1.5468338415702831e-12
mutagenesis O 0 2.4974711188008314e-09
. O 0 3.222535849278785e-10

These O 0 1.097562253755957e-12
mutations O 0 1.3054854940131033e-11
resulted O 0 1.5314240489876924e-13
in O 0 2.5838801042364634e-13
the O 0 1.1184360254883237e-14
absence O 0 1.7893996831150338e-12
or O 0 2.841184319063439e-13
a O 0 5.855775391493123e-13
dramatic O 0 6.407164243604768e-10
decrease O 0 5.251865609068318e-10
of O 0 3.824558942114309e-13
CPO O 0 6.014411724208912e-08
activity O 0 4.2533901400965135e-10
. O 0 4.9074342679811256e-12

The O 0 1.0726485888748472e-12
two O 0 1.1605039845763443e-13
polymorphisms O 0 1.0794141969139304e-10
were O 0 2.9463112722130647e-13
localized O 0 3.848195633676665e-12
in O 0 5.066717444907054e-13
noncoding O 0 4.90593232704839e-10
part O 0 2.1369702069094082e-13
of O 0 7.318053909064631e-16
the O 0 1.012061752796395e-15
gene O 0 1.2530991869152963e-12
1 O 0 1.685497648027355e-14
) O 0 2.6315854656939466e-15
a O 0 5.642206537051497e-13
C O 0 8.026342612765802e-08
/ O 0 6.223737614163838e-08
G O 0 3.2930542737119595e-09
polymorphism O 0 6.6211778282365685e-09
in O 0 1.302801529851072e-11
the O 0 2.0990296360854505e-13
promotor O 0 3.6504432809891796e-09
region O 0 1.548328305844837e-11
, O 0 1.140722607519129e-12
142 O 0 3.6240613374843855e-12
bp O 0 8.096444348293375e-11
upstream O 0 1.0446843043410148e-11
from O 0 1.076279568397974e-13
the O 0 3.305914112475489e-15
transcriptional O 0 1.399483285334513e-12
initiation O 0 1.0378782794133457e-14
site O 0 4.294407067635415e-15
( O 0 2.0265205664818722e-14
- O 0 4.688053070744935e-11
142C O 0 2.3236446100582953e-09
/ O 0 4.628341321311069e-10
G O 0 2.9156291964094194e-11
) O 0 3.3860697720104055e-14
, O 0 1.7021000020133077e-14
and O 0 1.2573283377176423e-14
2 O 0 4.884855100441548e-15
) O 0 3.3607940124028056e-15
a O 0 1.5759493861809692e-13
6 O 0 4.0369050875559143e-13
bp O 0 8.423564623605273e-11
deletion O 0 1.3380185848177462e-10
polymorphism O 0 1.5861323365840008e-10
in O 0 7.582158642258086e-13
the O 0 1.4018354619477202e-14
3 O 0 2.5892269150127115e-14
noncoding O 0 8.644104876331937e-11
part O 0 2.5980536081868233e-13
of O 0 8.529249084354013e-15
the O 0 2.111407836763446e-14
CPO O 0 2.849731284282342e-10
gene O 0 5.0888989203135004e-12
, O 0 4.9001994410942384e-14
574 O 0 2.3087311142727662e-12
bp O 0 2.3047275893306463e-12
downstream O 0 5.210112397936728e-13
of O 0 1.826116213403178e-16
the O 0 8.210257535209227e-16
last O 0 2.1140322836472186e-13
base O 0 1.9919339242565216e-15
of O 0 5.555992180017395e-17
the O 0 5.16047877444515e-15
normal O 0 8.886808823549419e-12
termination O 0 9.197653749737356e-11
codon O 0 3.438966611479799e-10
( O 0 4.430158063312151e-12
+ O 0 8.949533336632953e-10
574 O 0 1.6013351755717053e-09
delATTCTT O 0 1.0012078277554792e-08
) O 0 1.869640033069775e-11
. O 0 2.1164632546533113e-11

Five O 0 4.5229524986423186e-11
intragenic O 0 7.263318835271093e-09
dimorphisms O 0 2.858442593733912e-09
are O 0 2.4421994442480784e-14
now O 0 6.790311195948142e-15
well O 0 2.750763583707778e-16
characterized O 0 2.9324996376784308e-15
and O 0 2.90411217548415e-15
the O 0 1.0625186584313864e-15
high O 0 2.6502519796800517e-12
degree O 0 8.877321620859302e-12
of O 0 2.6102101657535107e-15
allelic O 0 6.334154988713037e-12
heterogeneity O 0 7.194687901002084e-11
in O 0 8.348081774467442e-12
HC B-Disease 0 2.236700780144929e-08
is O 0 1.787995580315293e-14
demonstrated O 0 3.070293856394929e-14
with O 0 1.3224519999991682e-15
seven O 0 1.278754933973364e-13
new O 0 5.3724009968373135e-14
different O 0 6.524103140186218e-15
mutations O 0 5.750263546572265e-13
making O 0 1.1964730421698544e-12
a O 0 1.77038762881436e-13
total O 0 1.2221080301444507e-14
of O 0 4.4897167716462585e-14
nineteen O 0 9.693045255332322e-10
CPO O 0 3.2275343642140797e-07
gene B-Disease 0 2.126301268390307e-07
defects I-Disease 0 4.5747103285975754e-05
reported O 0 5.289695348409396e-10
so O 0 4.643446000970886e-13
far O 0 1.915123008094932e-12
. O 0 2.2420811680769898e-13
. O 0 3.245472684001993e-12

Coincidence O 0 5.257899116095643e-10
of O 0 2.1481909201243217e-14
two O 0 9.60481236781047e-15
novel O 0 6.388910667870507e-13
arylsulfatase O 0 8.107513549404644e-10
A O 0 7.041638539623252e-12
alleles O 0 3.0245334015077674e-10
and O 0 9.723830247942988e-12
mutation O 0 4.0741099383012624e-10
459 O 0 1.5778083284345712e-09
+ O 0 1.026251084113028e-09
1G O 0 5.868287633603586e-09
> O 0 3.2481756173652343e-10
A O 0 8.994222033820165e-12
within O 0 9.329376057494801e-14
a O 0 2.8715436278803352e-11
family O 0 7.221648973265715e-11
with O 0 2.0810450584995976e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 7.495682134879555e-13
molecular O 0 1.697196745122087e-12
basis O 0 7.453027453009631e-13
of O 0 4.946038407804094e-15
phenotypic O 0 2.3491388834173677e-09
heterogeneity O 0 2.8734547186104464e-08
. O 0 4.0135636480975734e-10

In O 0 1.838583799096405e-11
a O 0 6.830704079620331e-13
family O 0 1.3970314976467085e-13
with O 0 1.9623987324187114e-15
three O 0 1.1419303816342236e-13
siblings O 0 6.329275645255983e-12
, O 0 3.141555627632028e-15
one O 0 7.709646240305359e-16
developed O 0 5.652331359039253e-13
classical O 0 2.1306729991454887e-10
late O 0 0.04245338588953018
infantile O 1 0.9999163150787354
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 2.444924689370964e-07
MLD B-Disease 1 1.0
) O 0 2.07524514066193e-12
, O 0 1.1195202276608092e-14
fatal O 0 2.3842820079389426e-12
at O 0 2.5627713926695828e-12
age O 0 4.2680949920159694e-12
5 O 0 6.438070427250073e-14
years O 0 2.0632577406570068e-13
, O 0 3.955091598195973e-15
with O 0 4.8551496549813396e-15
deficient O 0 5.491874688345888e-08
arylsulfatase O 0 2.3719015640466523e-10
A O 0 7.118286429047549e-12
( O 0 6.7558549900204046e-12
ARSA O 0 2.368947633613061e-07
) O 0 6.743350994785346e-13
activity O 0 1.6746116646149112e-11
and O 0 1.7518247323686925e-14
increased O 0 8.729419910449149e-14
galactosylsulfatide O 0 2.2343331629315344e-09
( O 0 2.953574329556119e-10
GS O 1 1.0
) O 0 1.9073227372490287e-11
excretion O 0 5.246658663082826e-10
. O 0 1.4456278188412774e-11

The O 0 1.2834855791024613e-13
two O 0 1.6397434693155195e-14
other O 0 2.1848592305208445e-15
siblings O 0 8.878744094109603e-12
, O 0 2.7442783288866845e-14
apparently O 0 2.388672315500884e-10
healthy O 0 1.4503954981481826e-10
at O 0 7.795539387622785e-13
12 O 0 5.1000778714159825e-14
( O 0 1.2538636849721702e-13
1 O 0 1.794232080618019e-12
/ O 0 1.3828782563507502e-08
2 O 0 4.806450376593219e-13
) O 0 6.928786429154232e-14
and O 0 6.2226661540557e-13
15 O 0 9.079689040555894e-14
years O 0 4.5250998789519124e-15
, O 0 6.739800794888575e-17
respectively O 0 9.37283248993062e-16
, O 0 3.0697418450232033e-15
and O 0 8.976539231711749e-15
their O 0 4.013773617265277e-16
father O 0 3.5993359985206363e-13
, O 0 1.0887587354032821e-13
apparently O 0 2.0139744039138208e-10
healthy O 0 2.353200967419866e-10
as O 0 6.077495277867495e-14
well O 0 2.9303711285852754e-14
, O 0 2.57467798064914e-15
presented O 0 1.7763304119722961e-13
ARSA O 0 1.3931612841133756e-07
and O 0 3.098891629416123e-11
GS O 1 1.0
values O 0 2.074744185048133e-14
within O 0 8.097571448280067e-15
the O 0 2.6209172974815155e-14
range O 0 2.864115368483855e-11
of O 0 9.137080848875545e-12
MLD B-Disease 1 1.0
patients O 0 3.80512465980587e-09
. O 0 4.602464243053106e-12

Mutation O 0 1.0549578988161556e-08
screening O 0 2.315985625500616e-09
and O 0 5.984516132434212e-14
sequence O 0 3.5210224492987496e-14
analysis O 0 1.0708430398919527e-13
disclosed O 0 7.103272831043839e-12
the O 0 2.068377800713275e-15
involvement O 0 2.0118214277657642e-13
of O 0 4.286221764749623e-16
three O 0 2.577744028159964e-15
different O 0 1.1206696513702333e-14
ARSA O 0 2.5849812956835194e-08
mutations O 0 7.33814051190329e-12
being O 0 3.461625788531847e-13
the O 0 1.2069988681895653e-15
molecular O 0 1.0105852515495534e-13
basis O 0 1.851945517512138e-13
of O 0 5.528133848717353e-15
intrafamilial O 0 2.3375761326605016e-09
phenotypic O 0 1.555550355192281e-08
heterogeneity O 0 6.729477775024861e-08
. O 0 6.410696973269125e-10

The O 0 7.40673321286689e-12
late O 0 2.9247567923107454e-08
infantile O 0 7.663285214221105e-05
patient O 0 1.0126218086270455e-07
inherited O 0 4.4247375541317524e-08
from O 0 1.525790604972599e-10
his O 0 9.330488638659151e-12
mother O 0 4.3605539318258835e-11
the O 0 1.0367657863404219e-15
frequent O 0 2.027616789745945e-12
0 O 0 6.562361331424738e-13
- O 0 1.5262308084018628e-09
type O 0 5.221785670528334e-08
mutation O 0 4.047753687785871e-09
459 O 0 1.412197914163471e-09
+ O 0 1.6101088518016837e-10
1G O 0 1.2906047341942894e-09
> O 0 4.626335772806023e-11
A O 0 7.807880210430884e-12
, O 0 1.425963839195299e-13
and O 0 7.47245283228351e-14
from O 0 4.2413614937883426e-13
his O 0 6.529376106630125e-13
father O 0 8.00869136632909e-13
a O 0 9.415445446957563e-15
novel O 0 7.811163011978844e-14
, O 0 5.155185665557758e-15
single O 0 7.607461074933194e-14
basepair O 0 3.222462019447647e-10
microdeletion O 0 5.5577265012374255e-11
of O 0 2.7003592999946347e-16
guanine O 0 1.6683302959605295e-12
at O 0 6.728431288689773e-14
nucleotide O 0 6.997720003280861e-13
7 O 0 4.120265055789635e-13
in O 0 5.930318627660192e-13
exon O 0 7.349381658805498e-10
1 O 0 4.3174366859410895e-11
( O 0 8.134957291128231e-11
7delG O 0 2.3517451097632147e-08
) O 0 1.7791806222744455e-11
. O 0 1.6077575035189362e-11

The O 0 7.874053514246582e-13
two O 0 2.9797854721874684e-13
clinically O 0 1.024014828487907e-08
unaffected O 0 2.8933673235087554e-09
siblings O 0 1.444333264100095e-10
carried O 0 1.7658323804917164e-12
the O 0 3.2376851850576815e-14
maternal O 0 1.4718092022913964e-10
mutation O 0 5.920537671233461e-11
459 O 0 2.366781215457081e-10
+ O 0 2.2655473330690512e-10
1G O 0 2.334417104066233e-09
> O 0 1.2677217609002867e-10
A O 0 2.957073128029286e-11
and O 0 3.008172324518027e-13
, O 0 1.567094131055876e-14
on O 0 1.11040828767138e-13
their O 0 3.0110566495803468e-15
paternal O 0 3.0079286283957174e-11
allele O 0 1.9605620946161473e-11
, O 0 3.923626357084549e-14
a O 0 1.944593506944363e-14
novel O 0 8.331708803779869e-13
cytosine O 0 4.282700496321956e-12
to O 0 8.240509952195125e-15
thymidine O 0 3.4031438778114875e-10
transition O 0 2.929228474363166e-12
at O 0 1.2478608641189326e-13
nucleotide O 0 2.479208895470042e-12
2435 O 0 2.7455876461246476e-10
in O 0 1.8645065417814688e-13
exon O 0 1.6456590257174497e-10
8 O 0 8.88806302862255e-12
, O 0 4.635311232070727e-14
resulting O 0 2.2688983667123325e-14
in O 0 4.2206760683021274e-14
substitution O 0 5.426533246193077e-13
of O 0 6.3644696168807784e-15
alanine O 0 6.360565962815201e-10
464 O 0 2.2413780900731872e-11
by O 0 2.0126733396227947e-13
valine O 0 2.0740904460581078e-07
( O 0 1.586007540577139e-11
A464V O 0 4.198694281143389e-09
) O 0 9.74588899166351e-12
. O 0 7.47986134835843e-12

The O 0 5.145782671495125e-12
fathers O 0 1.3030108936273876e-10
genotype O 0 2.6414484488590517e-10
thus O 0 2.8011200130240166e-12
was O 0 2.402095466980114e-10
7delG O 0 8.455180591226963e-07
/ O 0 1.97511462829425e-06
A464V O 0 1.917214262903144e-07
. O 0 1.4717557728083364e-10

Mutation O 0 1.9147542218433955e-08
A464V O 0 1.7047465661335082e-08
was O 0 5.5305388740878314e-11
not O 0 1.457875669957833e-14
found O 0 9.332312890129521e-14
in O 0 1.403337624057699e-12
18 O 0 6.624916002069547e-13
unrelated O 0 3.4258094139261175e-09
MLD B-Disease 1 1.0
patients O 0 2.1444235187573213e-07
and O 0 2.64771082662818e-12
50 O 0 9.132040826656529e-13
controls O 0 3.3212266714599536e-08
. O 0 1.9310585075427156e-10

A464V O 0 1.3518804564682796e-07
, O 0 6.744058436702893e-13
although O 0 3.985056913364399e-14
clearly O 0 7.626904208017649e-13
modifying O 0 1.1728289173174034e-10
ARSA O 0 7.192667226263438e-07
and O 0 3.2798955218460435e-10
GS O 1 1.0
levels O 0 1.6867096261363734e-11
, O 0 8.172082395551186e-14
apparently O 0 8.691914375746901e-12
bears O 0 1.4972719244998878e-11
little O 0 6.356508635424474e-12
significance O 0 4.240703992933366e-14
for O 0 1.015038861847757e-15
clinical O 0 1.6369380623128954e-13
manifestation O 0 1.0811976314251126e-12
of O 0 1.5780016182631584e-12
MLD B-Disease 1 1.0
, O 0 3.661260097181929e-12
mimicking O 0 9.871845563225179e-10
the O 0 5.806227894311622e-13
frequent O 0 1.5696707267309762e-09
ARSA O 0 0.001262993784621358
pseudodeficiency O 0 7.3639280344650615e-06
allele O 0 4.5504586410061165e-07
. O 0 8.648826654855668e-10

Our O 0 4.975453642835914e-12
results O 0 1.5405058684855172e-13
demonstrate O 0 3.0288048273856977e-14
that O 0 4.112705212620007e-16
in O 0 7.55396010229236e-15
certain O 0 1.7392232538058008e-14
genetic O 0 2.1155370788505934e-09
conditions O 0 3.0322706123797616e-08
MLD B-Disease 1 1.0
- O 0 7.638522703246053e-09
like O 0 2.8425423473366074e-11
ARSA O 0 3.972937975049717e-06
and O 0 4.341648915384688e-11
GS O 1 1.0
values O 0 1.308509795335715e-14
need O 0 1.3241134127735602e-14
not O 0 1.670485688397123e-16
be O 0 2.7226998932401403e-17
paralleled O 0 1.9865016478558956e-14
by O 0 6.667537370133657e-16
clinical O 0 1.0807569249260407e-11
disease O 0 1.1558219659146829e-11
, O 0 5.291145041503914e-15
a O 0 7.289127797443368e-14
finding O 0 2.1515022836232633e-12
with O 0 9.206731785369598e-14
serious O 0 3.513511037667172e-09
diagnostic O 0 3.256286618125159e-08
and O 0 6.820293028259039e-12
prognostic O 0 6.238427374682942e-08
implications O 0 2.2922015396886763e-09
. O 0 1.5380449691626552e-10

Moreover O 0 1.974057584064326e-09
, O 0 1.8607025642491948e-12
further O 0 4.380264055116323e-13
ARSA O 0 8.513738407600613e-07
alleles O 0 1.1606252070528456e-10
functionally O 0 3.0247410132133723e-10
similar O 0 1.0607742576039872e-13
to O 0 1.4666834573565622e-14
A464V O 0 1.3939109415328499e-11
might O 0 3.936731854132375e-13
exist O 0 3.677486036502385e-14
which O 0 1.1909778752669607e-14
, O 0 2.429403359865555e-15
together O 0 3.027167375055801e-16
with O 0 1.2533961566666037e-15
0 O 0 2.2070442261962198e-12
- O 0 7.838438875751308e-08
type O 0 3.516576541073846e-08
mutations O 0 1.4139288850856246e-08
, O 0 1.2838908755585798e-11
may O 0 1.0982915098212143e-11
cause O 0 7.158803714754636e-13
pathological O 0 1.7383489092637205e-09
ARSA O 0 1.5557614460703917e-05
and O 0 2.854954050945935e-10
GS O 1 1.0
levels O 0 2.8772273192451125e-12
, O 0 3.63474416106087e-15
but O 0 2.616989817463334e-15
not O 0 1.8014302851883986e-15
clinical O 0 5.210579689073069e-13
outbreak O 0 1.776970904405692e-13
of O 0 3.272586436495466e-16
the O 0 1.3458692168545616e-13
disease O 0 1.354834300304475e-10
. O 0 2.412859950902402e-13
. O 0 1.6245936887426815e-12

Human O 0 1.936548876813049e-08
MLH1 O 0 0.03479186072945595
deficiency O 1 0.5262909531593323
predisposes O 0 2.75430306828639e-06
to O 0 2.154309092228246e-10
hematological B-Disease 0 0.009593695402145386
malignancy I-Disease 0 0.418880432844162
and O 0 1.1130165677997184e-09
neurofibromatosis B-Disease 0 0.0001785065105650574
type I-Disease 0 0.04193439334630966
1 I-Disease 0 8.566022557943143e-09
. O 0 3.4628394596225576e-10

Heterozygous O 0 1.8562758441476035e-07
germ O 0 7.024607839412056e-06
- O 0 1.2845003766415175e-05
line O 0 7.86189099932777e-11
mutations O 0 8.810724719254814e-12
in O 0 5.830596015764591e-14
the O 0 3.1037478885148585e-15
DNA O 0 2.33476321609416e-10
mismatch O 0 4.707743972431899e-09
repair O 0 3.918715130168948e-09
genes O 0 5.546101911058088e-10
lead O 0 3.038421736434316e-10
to O 0 5.1307316034643335e-11
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.5422981497769115e-09

The O 0 3.753318998916261e-13
disease O 0 4.428302169401377e-11
susceptibility O 0 1.903142790929402e-12
of O 0 7.691961780553465e-16
individuals O 0 1.0070870054773931e-13
who O 0 7.805992657816674e-11
constitutionally O 0 4.412091803018825e-10
lack O 0 7.528654782928967e-12
both O 0 1.0116381473843084e-13
wild O 0 1.72595548963983e-10
- O 0 6.441639470722293e-07
type O 0 4.6872887793369955e-09
alleles O 0 3.8716682637662814e-11
is O 0 1.5525415154871158e-12
unknown O 0 3.0303193288006014e-10
. O 0 6.910279987115686e-11

We O 0 9.487858415591077e-12
have O 0 9.68125116206954e-15
identified O 0 4.430798176274786e-13
three O 0 3.2086052734290205e-15
offspring O 0 7.690443876336162e-14
in O 0 9.024353394551307e-14
a O 0 2.2756381501398693e-10
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 3.4578715446542674e-09
who O 0 8.019375636637849e-13
developed O 0 7.173322699727258e-12
hematological B-Disease 0 2.810448904710938e-07
malignancy I-Disease 0 7.432120696648781e-08
at O 0 1.0132264818829562e-11
a O 0 1.4849845528588923e-12
very O 0 2.6675113506957615e-11
early O 0 1.0107419790017502e-08
age O 0 1.0555158309888402e-11
, O 0 2.401550163702755e-14
and O 0 1.0912987839241904e-14
at O 0 1.6176911698216612e-13
least O 0 3.779970585669756e-14
two O 0 5.859132725164178e-15
of O 0 1.2842108711805803e-16
them O 0 4.3412344370914215e-15
displayed O 0 9.095419729876486e-12
signs O 0 1.338731459021858e-09
of O 0 8.34448663460238e-15
neurofibromatosis B-Disease 0 2.2755797246531984e-08
type I-Disease 0 7.98835984028301e-08
1 I-Disease 0 1.0655941407033964e-10
( O 0 3.90238591441161e-10
NF1 B-Disease 0 4.717382580565754e-06
) O 0 4.8201706515094145e-11
. O 0 8.078365754116135e-11

DNA O 0 1.7996022450006421e-09
sequence O 0 6.8209565599886e-12
analysis O 0 1.5247271761137382e-12
and O 0 1.6518982227020293e-14
allele O 0 3.240259796588596e-11
- O 0 7.655186207156106e-11
specific O 0 1.223900863468741e-12
amplification O 0 1.5997865532302313e-10
in O 0 3.464390233021142e-11
two O 0 1.0601357031819747e-12
siblings O 0 3.892801359040021e-11
revealed O 0 6.80463879687565e-11
a O 0 6.3670657288184e-12
homozygous O 0 6.066638320589846e-07
MLH1 O 0 7.846560947655234e-06
mutation O 0 1.0020460017301502e-09
( O 0 2.3391972386876958e-11
C676T O 0 1.2084407252643814e-08
- O 0 3.5244906371190154e-07
- O 0 7.72206760757399e-07
> O 0 4.2325512539242993e-10
Arg226Stop O 0 1.863910270571978e-08
) O 0 5.5545654881195006e-12
. O 0 3.5429200805764394e-12

Thus O 0 3.4196756537596684e-11
, O 0 2.2783969264202064e-13
a O 0 5.969604286804389e-14
homozygous O 0 3.267120740613194e-10
germ O 0 5.3466388635570183e-05
- O 0 7.50042863728595e-06
line O 0 1.1850310954741872e-08
MLH1 O 0 6.581708476005588e-06
mutation O 0 3.9498848636299044e-10
and O 0 6.077463293903407e-13
consequent O 0 4.787024665553474e-10
mismatch O 0 1.1593005183385685e-05
repair O 0 0.004511805716902018
deficiency O 1 0.9997782111167908
results O 0 9.82686640393915e-11
in O 0 1.0049786523802506e-12
a O 0 2.538942146801393e-11
mutator O 0 1.1722546332748607e-05
phenotype O 0 4.294324185138976e-08
characterized O 0 6.656143691774474e-11
by O 0 9.953658990785597e-13
leukemia B-Disease 1 0.9884178042411804
and O 0 1.0728900861067814e-06
/ O 1 1.0
or O 1 0.9999984502792358
lymphoma B-Disease 1 1.0
associated O 0 4.825950195019857e-10
with O 0 3.3486592405235216e-13
neurofibromatosis B-Disease 0 5.3488161029235926e-06
type I-Disease 0 1.3463854884321336e-05
1 I-Disease 0 2.1135598826660384e-10
. O 0 4.003513232736511e-12
. O 0 1.1386754386610853e-11

Missense O 0 1.7990654669119976e-05
mutations O 0 4.367844397279441e-08
in O 0 3.952234026161072e-11
the O 0 2.463785697744028e-15
most O 0 2.0077012837509828e-16
ancient O 0 1.397076068520393e-14
residues O 0 2.0167449307773033e-11
of O 0 8.203776674371548e-16
the O 0 1.3517675985454027e-14
PAX6 O 0 1.6267852620543977e-09
paired O 0 1.3869520115727951e-11
domain O 0 1.6439955299873965e-11
underlie O 0 2.5224150893010666e-11
a O 0 3.8694199754052416e-13
spectrum O 0 5.9498656002077155e-12
of O 0 6.785136417563481e-14
human O 0 1.8776388777119735e-10
congenital B-Disease 1 0.9999984502792358
eye I-Disease 1 0.9999973773956299
malformations I-Disease 1 0.9999841451644897
. O 0 2.7045181649754113e-09

Mutations O 0 4.7839900929602663e-08
of O 0 6.259839787367896e-14
the O 0 4.785040737937101e-15
human O 0 3.724832806561648e-14
PAX6 O 0 4.407285203456013e-08
gene O 0 1.2818208006137866e-07
underlie O 0 6.27036172318185e-07
aniridia B-Disease 1 1.0
( O 0 4.343343334767269e-06
congenital B-Disease 1 0.9999995231628418
absence I-Disease 0 9.142894774605281e-10
of I-Disease 0 2.0901103367992153e-15
the I-Disease 0 1.0754991630623507e-14
iris I-Disease 0 1.3025723092141561e-05
) O 0 1.751271111634367e-13
, O 0 1.3615825081184172e-14
a O 0 1.609544474697605e-13
rare O 0 7.226337306320829e-10
dominant O 0 0.006624680943787098
malformation B-Disease 1 0.9999043941497803
of I-Disease 0 1.5598553265022685e-12
the I-Disease 0 2.502657803216124e-10
eye I-Disease 1 0.9724611043930054
. O 0 1.059731502550676e-08

The O 0 8.476548998305466e-13
spectrum O 0 4.054485046312006e-12
of O 0 5.796090603998882e-14
PAX6 O 0 1.2794662040960247e-07
mutations O 0 4.498522887530498e-09
in O 0 2.3381336866634683e-09
aniridia B-Disease 1 1.0
patients O 0 1.1038080671710304e-08
is O 0 2.918082501641452e-15
highly O 0 2.685087666532554e-14
biased O 0 3.236206658555063e-12
, O 0 1.5882112341781651e-15
with O 0 3.3697143810681367e-16
92 O 0 9.589994813888336e-13
% O 0 3.191681131626406e-14
of O 0 1.1531419723042951e-15
all O 0 2.4583183118277382e-14
reported O 0 5.92970561541506e-10
mutations O 0 5.6637767392730964e-11
leading O 0 2.472160323674366e-11
to O 0 2.509585150366894e-13
premature O 0 1.746196416629875e-11
truncation O 0 1.1669820491888583e-11
of O 0 1.6439607193049566e-15
the O 0 7.1526274215538e-15
protein O 0 1.7099511043228155e-11
( O 0 2.8390349966767037e-12
nonsense O 0 2.1470452082894553e-09
, O 0 1.848697688260504e-14
splicing O 0 8.832177177120482e-12
, O 0 2.7443674367527357e-14
insertions O 0 3.34026799275744e-11
and O 0 4.963903433804519e-14
deletions O 0 5.664251706560819e-11
) O 0 4.2880416150367986e-14
and O 0 3.739254728334779e-14
just O 0 8.301126713100571e-13
2 O 0 7.075717676976057e-15
% O 0 3.485007794227623e-15
leading O 0 2.800989048177844e-14
to O 0 2.1690050766190694e-16
substitution O 0 1.1502604932726781e-14
of O 0 1.5109899138247303e-16
one O 0 7.774120058909751e-15
amino O 0 5.3250643911734175e-14
acid O 0 7.402768109339257e-15
by O 0 6.551180454169333e-17
another O 0 1.8946956091732414e-13
( O 0 6.035165422968447e-12
missense O 0 1.0786418869201952e-07
) O 0 1.5701162592307583e-10
. O 0 1.2654628733788087e-10

The O 0 9.651940433962752e-14
extraordinary O 0 9.737331519441353e-14
conservation O 0 8.053426632168015e-15
of O 0 7.377191102463966e-17
the O 0 5.480446634940764e-16
PAX6 O 0 5.0140204488346996e-11
protein O 0 4.542711692923085e-13
at O 0 4.319431639622506e-14
the O 0 4.24852059296513e-16
amino O 0 4.1967560611595733e-13
acid O 0 5.767640596891777e-13
level O 0 9.672170968874974e-15
amongst O 0 3.897546403221002e-16
vertebrates O 0 1.2203297183530082e-12
predicts O 0 1.2726809883734091e-10
that O 0 7.38260703112871e-14
pathological O 0 8.510736648759121e-08
missense O 0 1.9393974071135744e-05
mutations O 0 7.241176547267969e-08
should O 0 1.9854072552671909e-10
in O 0 2.1790765535305984e-13
fact O 0 3.498409380112491e-14
be O 0 9.260178378495219e-15
common O 0 6.663284968276909e-14
even O 0 4.701776077850606e-13
though O 0 2.4232417288050367e-13
they O 0 9.782641683482238e-14
are O 0 2.47563738274201e-15
hardly O 0 3.5362095196500576e-12
ever O 0 4.30461569167484e-12
seen O 0 1.1149197537418942e-10
in O 0 1.6626877652470284e-09
aniridia B-Disease 1 1.0
patients O 0 2.2823682943595713e-09
. O 0 1.349844389909871e-12

This O 0 2.3271307298712574e-13
indicates O 0 1.876856309257491e-12
that O 0 1.3375455977236478e-15
there O 0 1.1233105306931827e-14
is O 0 1.3547378254540683e-15
a O 0 4.4799756894649267e-13
heavy O 0 2.459010417510399e-08
ascertainment O 0 6.575984912160493e-08
bias O 0 1.831202034452417e-08
in O 0 3.968495670969574e-12
the O 0 7.843706356625534e-15
selection O 0 2.7088012009238854e-14
of O 0 7.972239159448401e-16
patients O 0 5.7596978334201014e-15
for O 0 1.9363194350056987e-16
PAX6 O 0 1.8169010740365366e-10
mutation O 0 6.838538524518711e-13
analysis O 0 1.1827621347604289e-11
and O 0 7.139902818281696e-13
that O 0 1.4824729985263296e-14
the O 0 8.237841967817863e-14
missing O 0 1.1151420231669817e-08
PAX6 O 0 3.5892035157303326e-06
missense O 0 4.664616426452994e-06
mutations O 0 1.1628027607457625e-07
frequently O 0 2.611671989782849e-09
may O 0 9.587535626520705e-11
underlie O 0 2.6424512578060444e-10
phenotypes O 0 2.7291463533529736e-10
distinct O 0 6.973676497379344e-11
from O 0 3.937962178568455e-10
textbook O 0 0.18586547672748566
aniridia B-Disease 1 1.0
. O 0 5.732641028544094e-10

Here O 0 7.521490097417427e-09
we O 0 3.210506133947272e-13
present O 0 1.0481509679427037e-15
four O 0 2.2938742766566043e-15
novel O 0 5.104761557038484e-13
PAX6 O 0 3.628883149531248e-08
missense O 0 2.6596104873988224e-08
mutations O 0 9.451978089103363e-10
, O 0 5.797768515281021e-11
two O 0 2.397231176586023e-13
in O 0 1.4422169784377575e-13
association O 0 3.348676994334096e-14
with O 0 2.5688603466091607e-15
atypical O 0 5.8540341463242385e-09
phenotypes O 0 3.054637076616018e-08
ectopia B-Disease 0 5.37023993274488e-07
pupillae I-Disease 0 8.226637646657764e-07
( O 0 5.435384781149466e-11
displaced B-Disease 0 2.378166552574612e-10
pupils I-Disease 0 8.149408259328084e-09
) O 0 2.052246740602559e-11
and O 0 2.2641130636991136e-10
congenital B-Disease 1 0.9999713897705078
nystagmus I-Disease 0 2.4103758278215537e-07
( O 0 3.766415564848691e-12
searching B-Disease 0 3.683481575311731e-10
gaze I-Disease 0 3.760155298238033e-09
) O 0 5.916433792538256e-13
, O 0 1.7205763723493472e-12
and O 0 7.608901573044613e-13
two O 0 1.5128088397872025e-13
in O 0 6.418189764378912e-12
association O 0 2.110394378782715e-13
with O 0 8.04464141819733e-16
more O 0 2.3108788442375607e-14
recognizable O 0 5.124868529549076e-09
aniridia B-Disease 1 1.0
phenotypes O 0 9.521578192561719e-08
. O 0 8.26177251611604e-11

Strikingly O 0 5.275966827866796e-07
, O 0 4.730476080294643e-11
all O 0 1.3097657757899037e-14
four O 0 2.410019434384114e-15
mutations O 0 5.124415499682851e-14
are O 0 4.061830296225546e-16
located O 0 5.490284181469294e-15
within O 0 2.2281864057289123e-14
the O 0 5.2529164964185485e-14
PAX6 O 0 1.158228513098436e-09
paired O 0 7.378293288839988e-12
domain O 0 2.2775379672490548e-12
and O 0 2.2335820056029222e-14
affect O 0 2.1591505100222556e-14
amino O 0 2.99929657119561e-14
acids O 0 7.553700063177553e-15
which O 0 4.5362085175318056e-17
are O 0 2.94181887945258e-17
highly O 0 2.823331278579218e-16
conserved O 0 1.3542812535196746e-14
in O 0 2.4186310940144118e-11
all O 0 1.1826829874936177e-15
known O 0 1.5234727813052268e-14
paired O 0 1.3976853528718802e-12
domain O 0 8.835918108296426e-12
proteins O 0 1.5001618003385175e-11
. O 0 2.1568816177541805e-11

Our O 0 2.6582863514590382e-12
results O 0 9.598370682246601e-14
support O 0 1.1025368623733138e-16
the O 0 1.226660541068367e-16
hypothesis O 0 1.368889268431317e-14
that O 0 9.805006566720995e-17
the O 0 1.129962201018632e-16
under O 0 2.971934018867507e-14
- O 0 5.510456240614969e-12
representation O 0 3.568472828428121e-13
of O 0 3.294924961127696e-14
missense O 0 6.293523142630875e-07
mutations O 0 4.861753222229481e-09
is O 0 6.877335615058933e-13
caused O 0 1.481026672828234e-13
by O 0 3.093678064376368e-14
ascertainment O 0 2.3680886584998007e-08
bias O 0 5.091906452037165e-09
and O 0 8.653808328566368e-14
suggest O 0 1.0817250415719182e-13
that O 0 1.0075853954283928e-15
a O 0 3.402111559591865e-14
substantial O 0 2.452683021958446e-11
burden O 0 9.58874757372996e-10
of O 0 3.430553909521128e-14
PAX6 B-Disease 0 4.047767288284376e-05
- I-Disease 0 8.998609700938687e-05
related I-Disease 0 3.777020367579098e-07
disease I-Disease 0 3.07340087601915e-05
remains O 0 4.946494880364583e-10
to O 0 1.3030678627594904e-14
be O 0 1.169701813706625e-13
uncovered O 0 3.0468962908258845e-09
. O 0 5.312204127104481e-13
. O 0 2.2078654009216603e-12

The O 0 1.5161546063763298e-12
chromosomal O 0 1.8871048723667627e-08
order O 0 9.234365659291366e-13
of O 0 2.2199261827789358e-15
genes O 0 2.293786861840008e-11
controlling O 0 3.477027693543633e-11
the O 0 5.842173262087663e-14
major O 0 5.729995606685093e-14
histocompatibility O 0 9.49575227476851e-12
complex O 0 1.1263646265691207e-12
, O 0 5.249671343791028e-14
properdin O 0 9.173231618753164e-11
factor O 0 9.54506656006271e-13
B O 0 2.1441601827376644e-09
, O 0 3.4536522947048454e-13
and O 0 1.0730788653490198e-11
deficiency B-Disease 0 3.4031600648631866e-08
of I-Disease 0 1.8653251038337835e-16
the I-Disease 0 1.6931858272764035e-14
second I-Disease 0 5.078463149142676e-13
component I-Disease 0 5.813031805045055e-13
of I-Disease 0 1.5618654390241226e-15
complement I-Disease 0 3.686795660429176e-12
. O 0 7.57119367200687e-12

The O 0 8.933926867607869e-14
relationship O 0 2.577935044253965e-12
of O 0 2.622964840812825e-16
the O 0 4.623844862360451e-16
genes O 0 2.4397996643832354e-12
coding O 0 2.947770499917013e-11
for O 0 7.391847313550307e-15
HLA O 0 3.7435207711489227e-11
to O 0 7.891271280020362e-16
those O 0 1.3699542429558998e-15
coding O 0 4.7615132323097775e-12
for O 0 1.3698287762005878e-15
properdin O 0 9.059083344586938e-11
Factor O 0 7.047426336080631e-13
B O 0 2.4494914430128745e-10
allotypes O 0 2.3284751904384393e-10
and O 0 6.52301224645345e-14
for O 0 1.2249084057713681e-14
deficiency B-Disease 0 7.444741489948115e-10
of I-Disease 0 3.428200748761515e-17
the I-Disease 0 1.3803092207360836e-15
second I-Disease 0 4.4829225509697423e-14
component I-Disease 0 2.4446509270040218e-14
of I-Disease 0 2.6700993126517708e-17
complement I-Disease 0 6.718941809175094e-14
( O 0 5.618044549536572e-13
C2 O 0 3.761155623061008e-11
) O 0 1.9904118907536003e-14
was O 0 7.34040432603944e-13
studied O 0 4.5169324010274625e-12
in O 0 2.9680932326714773e-14
families O 0 1.6553446303578176e-15
of O 0 2.147533188452867e-16
patients O 0 4.0535400014883594e-13
with O 0 5.0210178489983395e-14
connective O 0 0.0009767062729224563
tissue O 0 0.032636608928442
disorders O 0 0.00784034002572298
. O 0 5.847199113784285e-11

Patients O 0 7.624531917826971e-06
were O 0 9.712481470122714e-13
selected O 0 4.883495189044731e-15
because O 0 5.55947216194163e-16
they O 0 2.528831263587817e-15
were O 0 3.90253422025838e-14
heterozygous O 0 3.2509446523665275e-11
or O 0 4.519868637350988e-13
homozygous O 0 6.704559041281755e-08
for O 0 2.6093681881889097e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.0899967040067793e-10

12 O 0 7.016508485335748e-10
families O 0 2.55309526775091e-13
with O 0 1.6853939711946112e-15
15 O 0 4.896564653310981e-14
matings O 0 5.339864106446157e-10
informative O 0 3.5555050459379345e-08
for O 0 6.107127026311332e-10
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 3.089213260198953e-11
found O 0 1.0852931400795462e-11
. O 0 6.229007110461482e-13

Of O 0 1.304183215415644e-12
57 O 0 5.502865871309659e-11
informative O 0 5.567649119520013e-10
meioses O 0 1.3670669929410906e-08
, O 0 3.0524031652962025e-14
two O 0 5.887246383958259e-16
crossovers O 0 2.072858621944909e-13
were O 0 2.613677495123096e-15
noted O 0 8.213144011735233e-15
between O 0 1.7610645065705213e-14
the O 0 9.675664713881815e-10
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 2.0969030331552396e-11
and O 0 1.106772974727695e-14
the O 0 1.5692109087427119e-15
HLA O 0 2.9714694593785396e-10
- O 0 1.596554659311078e-11
B O 0 1.8582562572033723e-11
gene O 0 6.540260086979055e-12
, O 0 9.72882392051913e-15
with O 0 2.058285264180397e-17
a O 0 1.2338133902007947e-15
recombinant O 0 7.402686455363142e-14
fraction O 0 5.886166662590064e-13
of O 0 2.7764485046981313e-13
0 O 0 1.632845421373208e-11
. O 0 2.3700551937677616e-11

035 O 0 0.0006538261659443378
. O 0 1.4763006817020141e-08

A O 0 1.6179260153847963e-09
lod O 0 6.382580295394291e-07
score O 0 5.7474185133354894e-11
of O 0 1.832131629636341e-15
13 O 0 4.608503316916486e-14
was O 0 9.757293544909295e-15
calculated O 0 9.664830581354068e-15
for O 0 3.094313847306577e-15
linkage O 0 1.9149222652004028e-08
between O 0 6.378080342983594e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.3326234213351107e-11
HLA O 0 3.550610472302651e-09
- O 0 3.915170271318047e-11
B O 0 6.230056401324013e-12
at O 0 1.3339228378082412e-15
a O 0 5.2420787919147465e-17
maximum O 0 8.827725098469605e-17
likelihood O 0 7.020592878647866e-17
value O 0 4.0980602114853274e-17
of O 0 7.39984402256516e-19
the O 0 1.6281071742081123e-17
recombinant O 0 6.271895268492988e-15
fraction O 0 2.319119288968219e-13
of O 0 8.146373251536124e-14
0 O 0 1.2014910767688125e-11
. O 0 3.462289829836429e-11

04 O 0 2.206456338171847e-05
. O 0 7.649030853151828e-10

18 O 0 2.151148370543865e-09
families O 0 1.374994952965669e-13
with O 0 1.8047870767583674e-15
21 O 0 8.208481095360598e-14
informative O 0 4.643395043468779e-12
matings O 0 2.2079589892531892e-11
for O 0 4.995071874571225e-15
both O 0 1.584883178200932e-14
properdin O 0 1.6694883253620674e-09
Factor O 0 5.8737997105096085e-12
B O 0 1.0102172431913914e-09
allotype O 0 8.151674335543646e-10
and O 0 1.4810075908699982e-12
HLA O 0 5.372312372742272e-09
- O 0 1.0057433774690594e-09
B O 0 6.861727852580657e-10
were O 0 2.4605911926045554e-12
found O 0 7.884366770571916e-12
. O 0 6.332339166914558e-13

Of O 0 8.262788240079311e-13
72 O 0 4.4490015838061225e-11
informative O 0 2.4889668104322027e-10
meioses O 0 5.5151967437439e-09
, O 0 3.937788409149462e-14
three O 0 4.7598622600634934e-15
recombinants O 0 2.6966909608128198e-11
were O 0 7.555201852593035e-14
found O 0 1.088463832412366e-13
, O 0 2.0328712648253383e-16
giving O 0 1.421242405549503e-16
a O 0 6.065792458909993e-16
recombinant O 0 2.9379822278361237e-14
fraction O 0 3.42098989110709e-13
of O 0 1.637272267632564e-13
0 O 0 2.4628698386264247e-11
. O 0 3.141705992582011e-11

042 O 0 1.6956097169895656e-05
. O 0 3.2350080392262726e-09

A O 0 8.90770790462625e-10
lod O 0 1.193273959643193e-07
score O 0 1.6856505340862027e-12
of O 0 2.0605566690552431e-16
16 O 0 1.2302749524152872e-14
between O 0 5.0309661662605466e-15
HLA O 0 5.950646642105539e-09
- O 0 5.741636055489607e-10
B O 0 2.375568630696989e-10
and O 0 2.3363355724343414e-14
Factor O 0 1.234158310487246e-13
B O 0 5.880573805683298e-11
allotypes O 0 1.3326183906370304e-11
was O 0 2.6330830622963396e-14
calculated O 0 6.82065996293179e-15
at O 0 1.4705989095068926e-15
a O 0 1.275783290402094e-16
maximum O 0 1.3233799245928853e-16
likelihood O 0 1.6247452475009008e-16
value O 0 1.3078422963155872e-16
of O 0 3.466612203994395e-18
the O 0 4.392436255263964e-17
recombinant O 0 1.2491533686338069e-14
fraction O 0 4.2414265459186917e-13
of O 0 1.8060942010619113e-13
0 O 0 2.3348602565254062e-11
. O 0 2.8209379276944446e-11

04 O 0 2.9576209271908738e-05
. O 0 1.6131529445573278e-09

A O 0 8.22312912207579e-11
crossover O 0 2.7330086978250012e-12
was O 0 1.4779261798755772e-12
shown O 0 4.270604594784622e-15
to O 0 4.759006968545003e-16
have O 0 1.1786969563229574e-15
occurred O 0 3.5652667070788097e-14
between O 0 2.718944261648578e-16
genes O 0 7.244331951808056e-14
for O 0 3.0012403847546167e-15
Factor O 0 2.803073257447858e-14
B O 0 7.216798339482189e-12
and O 0 7.094721538774065e-14
HLA O 0 6.316293599262224e-10
- O 0 1.2991395459405197e-10
D O 0 2.942412979933806e-10
, O 0 9.036767509426266e-15
in O 0 5.233911872290888e-15
which O 0 2.222808254733616e-14
HLA O 0 8.592641598248463e-10
- O 0 5.3210113398760583e-11
D O 0 2.3032400986444657e-10
segregared O 0 9.985978016713304e-11
with O 0 1.5871035903688643e-14
HLA O 0 1.184888076544155e-09
- O 0 6.077226222256371e-11
A O 0 9.089336228118583e-11
and O 0 8.953195823613314e-12
B O 0 8.726091516031431e-10
. O 0 5.189760296855916e-13

These O 0 4.860211015654363e-14
studies O 0 1.9291560265487923e-13
suggest O 0 2.0235503607490303e-14
that O 0 3.94288576078181e-17
the O 0 1.4710910885888065e-17
genes O 0 6.330887555730871e-14
for O 0 3.237473426820868e-15
Factor O 0 4.68378764592603e-12
B O 0 0.053198833018541336
and O 0 0.07460945844650269
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.8691503648181306e-15
located O 0 1.67689028979977e-15
outside O 0 4.32477370701425e-14
those O 0 4.945168399088146e-16
for O 0 6.723857120192187e-16
HLA O 0 8.858242264708771e-12
, O 0 2.9443688456705093e-16
that O 0 1.0131466961227093e-16
the O 0 4.847633614002997e-16
order O 0 5.0858831238793055e-15
of O 0 2.681410114173372e-16
genese O 0 7.802330309614192e-11
is O 0 7.672067835358658e-15
HLA O 0 3.700563466768614e-11
- O 0 4.1785612513514647e-13
A O 0 4.2177811807389554e-13
, O 0 1.6528499489215642e-14
- O 0 1.108100590452299e-12
B O 0 1.6490979588834609e-12
, O 0 4.044838974122302e-15
- O 0 3.722578235249019e-12
D O 0 2.7555697307279914e-11
, O 0 3.714175522722589e-15
Factor O 0 2.0866670208136845e-13
B O 0 6.858822954036725e-10
allotype O 0 2.413243862520176e-07
, O 0 1.1424803858517407e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.80534925252546e-14
that O 0 4.0975447125275844e-17
the O 0 7.572358081423198e-17
genes O 0 2.874974217026427e-11
coding O 0 3.066066156520719e-08
for O 0 3.981342755476902e-10
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.1143786631320762e-12
Factor O 0 4.3086218729122827e-13
B O 0 4.739942882636683e-10
allotypes O 0 2.179153558989899e-11
are O 0 2.697682146485719e-16
approximately O 0 2.647513179113235e-16
3 O 0 1.3024615565758457e-14
- O 0 8.278082386237173e-11
- O 0 1.6930663815362124e-10
5 O 0 1.9968469694604807e-13
centimorgans O 0 8.56224049994303e-11
from O 0 1.226966102910133e-14
the O 0 9.780062637564438e-15
HLA O 0 4.263020492167868e-11
- O 0 1.2343325959864732e-13
A O 0 2.287672004955277e-13
and O 0 9.875215608353555e-14
HLA O 0 1.3508037743914514e-10
- O 0 8.917304394895353e-12
B O 0 1.7332410463463677e-12
loci O 0 3.410161083096212e-14
, O 0 1.0674756434694843e-14
and O 0 7.201740403538855e-16
that O 0 1.5714198250853633e-17
the O 0 9.143699489786491e-17
apparent O 0 7.485077011329389e-14
lack O 0 3.528843341669974e-13
of O 0 3.8936381402628116e-16
recombinants O 0 2.4993113047905302e-12
between O 0 1.0335474846573291e-15
the O 0 1.6598341167365022e-15
Factor O 0 4.683159784447943e-13
B O 0 1.2599795651269119e-09
gene O 0 2.922817259332078e-07
and O 0 0.0005622316966764629
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 3.59693247409254e-10
suggests O 0 6.1381260317572295e-12
that O 0 8.266259118516945e-16
these O 0 5.274275109809923e-16
two O 0 2.2539646252808234e-15
genes O 0 1.7065162217361207e-12
lie O 0 1.0922624783804569e-11
in O 0 4.1968682760844256e-13
close O 0 1.0801649288558202e-12
proximity O 0 2.6082235329849546e-12
to O 0 5.776010312402713e-12
one O 0 1.863704850169068e-11
another O 0 7.04381830640699e-11
. O 0 4.343048490285106e-11

Distribution O 0 3.3833487227130643e-12
of O 0 5.352231787110473e-14
emerin O 0 2.329761095154481e-08
and O 0 1.4111108115333337e-12
lamins O 0 4.590994695519157e-09
in O 0 5.5867730580638764e-11
the O 0 2.8448659985906566e-13
heart O 0 1.373513386360159e-10
and O 0 9.821286714667768e-14
implications O 0 3.012714318469112e-13
for O 0 4.827597536679641e-14
Emery B-Disease 1 0.9983580708503723
- I-Disease 0 0.0005796606419607997
Dreifuss I-Disease 0 3.809485860983841e-05
muscular I-Disease 0 2.5357156118843704e-05
dystrophy I-Disease 0 0.000507874705363065
. O 0 7.022984971349899e-11

Emerin O 0 1.5511647006860585e-06
is O 0 1.1826171552459241e-12
a O 0 6.600872192591423e-14
nuclear O 0 1.718128948575287e-13
membrane O 0 1.0036167860313916e-12
protein O 0 4.517699148803844e-12
which O 0 3.713652988097428e-14
is O 0 2.3774813836933452e-14
missing O 0 3.5569125422796333e-10
or O 0 7.190555009056743e-12
defective O 0 2.6493630400636903e-08
in O 0 2.3262644588406545e-10
Emery B-Disease 1 0.9999998807907104
- I-Disease 1 0.9956561326980591
Dreifuss I-Disease 0 0.0002536081010475755
muscular I-Disease 0 0.0002737587201409042
dystrophy I-Disease 0 0.0143560990691185
( O 0 1.871465826752683e-08
EDMD B-Disease 1 1.0
) O 0 2.8419908093546553e-10
. O 0 3.777612250788209e-11

It O 0 7.773149528558787e-13
is O 0 5.3006199520519e-15
one O 0 3.764557042425275e-15
member O 0 1.6418934083422404e-14
of O 0 8.109371014282014e-17
a O 0 1.858113706301734e-12
family O 0 3.1852684552469146e-12
of O 0 1.3166764634966674e-14
lamina O 0 2.788819175592039e-10
- O 0 3.826182426447389e-11
associated O 0 5.062717823092755e-13
proteins O 0 1.8735505497285282e-13
which O 0 1.3052519372139856e-14
includes O 0 1.7133404680365512e-14
LAP1 O 0 1.7498856808018104e-09
, O 0 2.726306864726108e-13
LAP2 O 0 8.458916767040137e-08
and O 0 6.7099325228026085e-12
lamin O 0 4.1432087982684607e-07
B O 0 1.4285883587206172e-09
receptor O 0 1.2850863602420493e-11
( O 0 3.2436671404401096e-11
LBR O 0 1.0779812100736308e-06
) O 0 2.98837170287225e-11
. O 0 8.038281151812043e-11

A O 0 9.294147673699626e-08
panel O 0 2.8999531664908318e-09
of O 0 5.547695651117717e-15
16 O 0 3.532363542836127e-14
monoclonal O 0 7.192376035025649e-13
antibodies O 0 3.1114223610767544e-12
( O 0 1.6110933117111093e-12
mAbs O 0 6.619583214906299e-10
) O 0 4.2220954922338183e-13
has O 0 7.331613614824928e-14
been O 0 9.718401180103167e-15
mapped O 0 5.961471550783304e-13
to O 0 7.254878697847498e-15
six O 0 1.4691409540464311e-15
specific O 0 6.129195919036631e-17
sites O 0 5.288057606411172e-15
throughout O 0 2.4987414345761447e-14
the O 0 7.94922463899679e-15
emerin O 0 1.693110755762728e-11
molecule O 0 6.148079549801733e-14
using O 0 2.581161196238413e-13
phage O 0 4.8334277552575244e-11
- O 0 2.618411780799801e-12
displayed O 0 7.58303281414097e-15
peptide O 0 3.9079546381977446e-15
libraries O 0 1.214690782853911e-13
and O 0 8.417123097961225e-15
has O 0 5.5794642570792e-16
been O 0 1.7582703301659866e-16
used O 0 2.1469771642625536e-15
to O 0 4.901505227085726e-15
localize O 0 1.277243755204438e-09
emerin O 0 2.561162375513959e-07
in O 0 1.2628324774777155e-10
human O 0 6.5497225698596395e-12
and O 0 6.335970637039168e-11
rabbit O 0 3.2176919830817496e-06
heart O 0 1.4131923080640263e-06
. O 0 2.589478909076348e-10

Several O 0 4.15235294065619e-12
mAbs O 0 1.1729099913537766e-09
against O 0 1.0579777613879682e-13
different O 0 3.105999683253487e-14
emerin O 0 1.2533012128113086e-10
epitopes O 0 4.954480575802833e-11
did O 0 1.7011775668707152e-11
not O 0 1.46959013561836e-14
recognize O 0 6.521692907934806e-14
intercalated O 0 1.8408505622624638e-11
discs O 0 2.7529370782986007e-08
in O 0 2.812469441365595e-12
the O 0 1.60714167939547e-14
heart O 0 2.6566455632592856e-11
, O 0 1.207027777424055e-13
though O 0 4.4137660377713966e-14
they O 0 4.120025006652383e-15
recognized O 0 3.359251353647619e-14
cardiomyocyte O 0 3.827804739842122e-10
nuclei O 0 3.435853489740237e-13
strongly O 0 3.829829248874761e-13
, O 0 5.0408617980734344e-14
both O 0 8.377913942832823e-15
at O 0 1.6080448604627318e-12
the O 0 3.5202435178004546e-14
rim O 0 8.089471870142972e-10
and O 0 1.2718268105338382e-10
in O 0 3.1965412955470285e-11
intranuclear O 0 6.141229391687375e-08
spots O 0 5.3587627668605364e-09
or O 0 4.201566178307914e-11
channels O 0 8.920838290293887e-09
. O 0 4.091124106153643e-10

A O 0 3.0867661759970133e-09
polyclonal O 0 5.636369593275958e-08
rabbit O 0 3.8420577652686916e-07
antiserum O 0 7.298261550658935e-08
against O 0 2.9710716525910286e-11
emerin O 0 2.8528667428417975e-08
did O 0 3.5817785369596233e-12
recognize O 0 5.914072806782397e-14
both O 0 2.701452554831744e-15
nuclear O 0 4.267206163074966e-13
membrane O 0 5.0619669046680915e-12
and O 0 5.320630546389038e-13
intercalated O 0 2.049570929640865e-11
discs O 0 1.1806446931217351e-09
but O 0 4.5760507742017426e-14
, O 0 1.711992949790544e-16
after O 0 5.880016693055647e-17
affinity O 0 3.575472607060277e-15
purification O 0 3.919435746281303e-15
against O 0 1.0584732290752998e-15
a O 0 2.0240599357700985e-14
pure O 0 4.386394459460208e-12
- O 0 4.02125408527354e-07
emerin O 0 3.770060743590875e-07
band O 0 1.539966938690629e-11
on O 0 6.108935514566316e-13
a O 0 4.8618986440984724e-14
western O 0 3.4941116840159214e-12
blot O 0 2.9495377020793967e-06
, O 0 9.870824296820402e-11
it O 0 8.875894810800311e-13
stained O 0 6.406112902368477e-07
only O 0 3.7598678510886163e-13
the O 0 2.5378248900151737e-14
nuclear O 0 3.1792229439331354e-12
membrane O 0 1.081272849035031e-10
. O 0 3.436827211711346e-11

These O 0 5.691059060640435e-13
results O 0 6.243649802901985e-13
would O 0 2.8782384953190835e-15
not O 0 1.1056962687967927e-15
be O 0 3.1574266957229685e-15
expected O 0 4.837287254783051e-13
if O 0 3.206537454246536e-15
immunostaining O 0 1.809847757772154e-11
at O 0 5.179318345732709e-13
intercalated O 0 4.997223555097685e-12
discs O 0 1.655135029032806e-09
were O 0 1.0715540732291959e-13
due O 0 2.980941875448378e-15
to O 0 1.1773259011489283e-16
a O 0 5.613197555961839e-15
product O 0 3.662876751041322e-14
of O 0 7.592663711100149e-17
the O 0 8.934927891144934e-15
emerin O 0 1.1445028258449952e-10
gene O 0 1.2506929519817689e-11
and O 0 4.359462443814799e-12
, O 0 5.4747449385354405e-15
therefore O 0 8.983899312748679e-16
, O 0 5.048999921224064e-15
cast O 0 5.720192115116207e-13
some O 0 2.111166262966889e-14
doubt O 0 2.104472500397917e-14
upon O 0 1.824416324157157e-17
the O 0 1.1509879410496478e-16
hypothesis O 0 1.5011334731675208e-13
that O 0 7.6409371722614e-14
cardiac B-Disease 0 1.4757917199403892e-07
defects I-Disease 0 0.00024082165327854455
in O 0 1.013329975485533e-09
EDMD B-Disease 1 1.0
are O 0 3.7350761372678676e-11
caused O 0 2.8500598148878398e-12
by O 0 5.3564290047707075e-14
absence O 0 6.541523572822783e-11
of O 0 4.07111105623411e-14
emerin O 0 1.3934531750692258e-08
from O 0 1.84491050908564e-11
intercalated O 0 6.18009776687245e-09
discs O 0 1.2750119822158013e-06
. O 0 3.0330009337387054e-11

Although O 0 1.471578241207805e-11
emerin O 0 4.227010741431059e-09
was O 0 6.086848147908441e-13
abundant O 0 4.130468075859081e-14
in O 0 6.187630567427646e-14
the O 0 1.849758385268703e-15
membranes O 0 3.2884736600458098e-12
of O 0 1.8266257037209514e-15
cardiomyocyte O 0 2.4469604120724853e-10
nuclei O 0 6.99499757162575e-13
, O 0 4.2533270200144357e-13
it O 0 2.8592875137879725e-13
was O 0 5.259584434647024e-10
absent O 0 1.4091311667865924e-12
from O 0 1.4452232000115167e-14
many O 0 1.0286314748380546e-14
non O 0 4.452600788074079e-11
- O 0 7.774758614687016e-11
myocyte O 0 1.741425115220352e-09
cells O 0 6.870668617375841e-11
in O 0 4.9394214413078785e-11
the O 0 5.109262080256471e-13
heart O 0 3.6120162416608537e-10
. O 0 2.5123654892600378e-11

This O 0 2.3196932384932784e-14
distribution O 0 9.415122727404659e-15
of O 0 2.9818392009768754e-16
emerin O 0 1.592376785986005e-10
was O 0 1.7397517346022517e-13
similar O 0 9.800262255774085e-16
to O 0 2.520028103106562e-16
that O 0 5.326846739076854e-16
of O 0 7.301212247095255e-16
lamin O 0 4.499071781793873e-09
A O 0 1.136531754125647e-11
, O 0 1.635308404803696e-14
a O 0 2.053990183774508e-14
candidate O 0 9.23316327908208e-14
gene O 0 7.807660074021783e-11
for O 0 1.177350046881881e-13
an O 0 7.47980744995793e-15
autosomal O 0 3.755761479595776e-09
form O 0 8.073644863770824e-09
of O 0 7.89015857094455e-08
EDMD B-Disease 1 1.0
. O 0 5.215700760174968e-09

In O 0 2.9861949718545944e-11
contrast O 0 5.0250397592987994e-11
, O 0 5.283186648580296e-12
lamin O 0 2.2418307707994245e-05
B1 O 0 2.2357917259796523e-06
was O 0 3.110853935561764e-11
absent O 0 3.3319385445151894e-11
from O 0 3.9791428615640334e-13
cardiomyocyte O 0 1.899522761306116e-09
nuclei O 0 1.0778496151164774e-12
, O 0 3.874661415282851e-14
showing O 0 1.0065676590842454e-11
that O 0 5.492601748316277e-14
lamin O 0 4.957210535394552e-07
B1 O 0 4.561379274292676e-09
is O 0 6.988372804125496e-16
not O 0 2.3743836995019415e-16
essential O 0 2.720844315367947e-15
for O 0 1.161037854619922e-16
localization O 0 2.609406289134919e-13
of O 0 2.7530833951920706e-16
emerin O 0 3.7225963978038124e-10
to O 0 1.4621091067468922e-13
the O 0 7.584399688148613e-13
nuclear O 0 1.1365394181339639e-09
lamina O 0 2.8940146279410328e-08
. O 0 6.120570023027128e-11

Lamin O 0 0.007273780647665262
B1 O 0 0.0035839483607560396
is O 0 6.471567726151761e-11
also O 0 3.858424268022437e-13
almost O 0 1.7779540047255932e-13
completely O 0 1.7214438208235094e-11
absent O 0 3.867293429937746e-10
from O 0 1.734305949720183e-12
skeletal O 0 6.542824735333852e-07
muscle O 0 2.4668400655514233e-09
nuclei O 0 2.6114116424835743e-10
. O 0 1.8231765055998217e-11

In O 0 2.9841027426869005e-09
EDMD B-Disease 1 1.0
, O 0 1.2495305354645603e-13
the O 0 4.4403685262601046e-16
additional O 0 5.6232920711107425e-15
absence O 0 1.6857813701833674e-13
of O 0 1.090478940734543e-14
lamin O 0 3.3863498174468987e-06
B1 O 0 1.0024827190591168e-07
from O 0 3.938874400255532e-12
heart O 0 7.133030166528442e-09
and O 0 9.885778827489755e-12
skeletal O 0 1.2057726905823074e-07
muscle O 0 2.618474326254727e-10
nuclei O 0 4.370168723427659e-12
which O 0 9.312398129100036e-14
already O 0 1.2492696113697299e-11
lack O 0 1.8597410937626346e-12
emerin O 0 6.190600032596194e-08
may O 0 3.1181652312278763e-12
offer O 0 1.9577938378009634e-14
an O 0 1.5500233096165766e-16
alternative O 0 7.477742383632524e-14
explanation O 0 1.1466298830559163e-12
of O 0 7.158987791954733e-15
why O 0 6.608197929830473e-12
these O 0 2.2067209391312412e-15
tissues O 0 7.860709018382359e-14
are O 0 1.0637921724675832e-15
particularly O 0 8.344204911444122e-14
affected O 0 1.9801815623419344e-13
. O 0 8.307299347119074e-14
. O 0 5.012258403463976e-12

Genetic O 0 4.644260975794623e-09
mapping O 0 3.4927158387709767e-10
of O 0 7.989322331686862e-15
the O 0 1.8778500212061552e-14
copper B-Disease 0 1.741408572897285e-09
toxicosis I-Disease 0 2.1862717858311953e-08
locus O 0 1.1166095131853737e-10
in O 0 3.778736351600642e-11
Bedlington O 0 2.338913327548653e-05
terriers O 0 1.3853671134711476e-06
to O 0 4.597092563389527e-13
dog O 0 4.586711843668212e-10
chromosome O 0 5.15039850768062e-08
10 O 0 6.417654602186573e-11
, O 0 1.4132971052141508e-13
in O 0 2.454753793897785e-13
a O 0 8.01191469938789e-13
region O 0 9.295110514617733e-11
syntenic O 0 1.0218820989393862e-06
to O 0 4.8787217348704795e-14
human O 0 3.192559335386119e-13
chromosome O 0 1.1986432291166693e-08
region O 0 4.45495018652764e-09
2p13 O 0 6.06853473072988e-06
- O 0 1.067460999593095e-07
p16 O 0 1.488907770408332e-07
. O 0 1.5162747446506586e-10

Abnormal O 1 0.9973044395446777
hepatic B-Disease 0 0.006847463082522154
copper I-Disease 0 3.941415513963875e-07
accumulation I-Disease 0 2.093957472693031e-11
is O 0 7.827530991948292e-16
recognized O 0 9.397571145946366e-16
as O 0 3.0429570538684225e-14
an O 0 1.14077931129275e-12
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 2.671739218751412e-10
man O 0 5.644435141505255e-09
, O 0 4.833349432492584e-13
mouse O 0 1.4305058471109078e-08
, O 0 9.250522570170006e-11
rat O 0 1.295789729738317e-06
and O 0 1.6367188160337776e-10
dog O 0 4.95577353376575e-07
. O 0 1.7486635750518786e-10

The O 0 1.0953449247879526e-13
major O 0 3.6166433888505656e-13
cause O 0 1.932560014794582e-12
of O 0 6.477139652535588e-14
hepatic B-Disease 0 6.854852472315542e-07
copper I-Disease 0 3.388283585081808e-05
accumulation I-Disease 0 3.786653213211366e-10
in O 0 2.3303621185521983e-11
man O 0 2.61631893927472e-09
is O 0 2.5990731648047743e-14
a O 0 5.723531457807463e-13
dysfunctional O 0 1.3049690217314946e-09
ATP7B O 0 9.427513880666538e-09
gene O 0 9.282252744213793e-10
, O 0 1.287249495364462e-12
causing O 0 7.84084602800661e-12
Wilson B-Disease 0 1.1706600133720713e-08
disease I-Disease 0 8.13253166143113e-07
( O 0 4.823778043672178e-10
WD B-Disease 1 0.9972119927406311
) O 0 1.3432152057291091e-09
. O 0 2.6246446682698377e-10

Mutations O 0 1.3942772270070236e-08
in O 0 6.061594802486692e-12
the O 0 8.254415692090199e-15
ATP7B O 0 9.205153306268699e-10
genes O 0 7.33081043785555e-12
have O 0 3.269428456263712e-13
also O 0 9.221541817639161e-15
been O 0 1.0062377871851349e-14
demonstrated O 0 5.380317366762352e-14
in O 0 2.81295234501322e-12
mouse O 0 1.8994191464116739e-07
and O 0 1.5474589387665105e-09
rat O 0 1.2235821031936212e-06
. O 0 1.455411485773439e-10

The O 0 2.570452314540339e-12
ATP7B O 0 7.53599316283271e-09
gene O 0 2.862423909011369e-10
has O 0 1.2522940583820086e-12
been O 0 4.5996860427487476e-14
excluded O 0 2.63082036624368e-13
in O 0 6.917324379311987e-14
the O 0 9.846353553598928e-16
much O 0 2.954183935238025e-13
rarer O 0 4.057291835835031e-09
human O 0 3.1619498686019654e-13
copper B-Disease 0 8.627148773143745e-09
overload I-Disease 0 3.5669285303185916e-09
disease O 0 4.922842133936456e-10
non B-Disease 0 8.970999498814081e-10
- I-Disease 0 1.2664294057884717e-09
Indian I-Disease 0 3.9980744409584545e-11
childhood I-Disease 0 5.251149204354988e-08
cirrhosis I-Disease 0 2.0557521906994225e-08
, O 0 7.528474913788552e-14
indicating O 0 6.322543183445717e-12
genetic O 0 3.869189968419562e-10
heterogeneity O 0 8.249324778830669e-09
. O 0 1.77740752671518e-10

By O 0 6.327832816109893e-14
investigating O 0 3.508275701197272e-12
the O 0 4.475045483373456e-14
common O 0 1.2906434254666976e-10
autosomal O 0 2.3915068595670164e-05
recessive O 0 2.2106856704340316e-05
copper B-Disease 0 3.033399025298422e-07
toxicosis I-Disease 0 3.1929807846609037e-06
( O 0 8.27549750948009e-10
CT B-Disease 1 0.9999979734420776
) O 0 8.474197038532694e-11
in O 0 5.998032626131078e-11
Bedlington O 0 0.0006722130929119885
terriers O 0 0.00011136726971017197
, O 0 2.1951756818544554e-12
we O 0 2.5332449828693697e-14
have O 0 4.163677537803403e-16
identified O 0 1.5053274721025557e-14
a O 0 2.1249045444482906e-15
new O 0 9.998440436860805e-15
locus O 0 1.1744260078327962e-12
involved O 0 3.846933622347892e-12
in O 0 2.3198641230237627e-08
progressive O 0 2.43803187913727e-05
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.806436277287162e-10

We O 0 2.614580253690324e-11
examined O 0 1.140536103061418e-11
whether O 0 6.874889129797378e-15
the O 0 6.335740376892281e-15
WD B-Disease 0 1.842562596721109e-06
gene O 0 2.718270764034969e-08
ATP7B O 0 9.082622455025557e-06
was O 0 7.436903870505773e-11
also O 0 4.9547470076447e-14
causative O 0 8.539549276043168e-12
for O 0 3.977787846017652e-15
CT B-Disease 0 5.047593276685802e-07
by O 0 6.6743096103051916e-15
investigating O 0 1.012480355631895e-12
the O 0 3.1720102737340826e-15
chromosomal O 0 5.923153079123722e-09
co O 0 5.2389714788603214e-09
- O 0 1.430605356400605e-10
localization O 0 9.438354264812432e-11
of O 0 4.905451977103457e-15
ATP7B O 0 1.9424557518021857e-09
and O 0 1.495793946874619e-14
C04107 O 0 5.598237585308086e-12
, O 0 6.474810904853702e-16
using O 0 1.9329634057653824e-14
fluorescence O 0 7.011186336364217e-13
in O 0 8.546062620594375e-13
situ O 0 8.258585655618322e-12
hybridization O 0 8.537102231739868e-13
( O 0 3.3164345835529074e-12
FISH O 0 1.1974086167043652e-09
) O 0 3.682712121366727e-12
. O 0 2.884931876723229e-12

C04107 O 0 2.1662581275450066e-06
is O 0 4.22235510444402e-12
an O 0 6.6197937227869576e-15
anonymous O 0 1.48068432515025e-10
microsatellite O 0 7.497913401266487e-09
marker O 0 6.3709504338760325e-09
closely O 0 2.2567836488462945e-10
linked O 0 2.961117351318876e-09
to O 0 5.570046854308508e-11
CT B-Disease 1 0.9999978542327881
. O 0 7.294664317036847e-10

However O 0 1.8887630348629614e-10
, O 0 5.42192159225241e-12
BAC O 0 9.558936397979778e-08
clones O 0 1.9578726140334624e-10
containing O 0 4.795656059763953e-12
ATP7B O 0 2.506247831490782e-08
and O 0 1.6424329344483235e-13
C04107 O 0 4.226047636834984e-11
mapped O 0 1.4911415852081333e-11
to O 0 3.464285810799404e-14
the O 0 4.189186093828644e-15
canine O 0 5.037979478039745e-10
chromosome O 0 9.06835850855714e-09
regions O 0 2.8828939235836515e-10
CFA22q11 O 0 2.740322884164925e-07
and O 0 4.315088217299312e-12
CFA10q26 O 0 2.262042331224734e-09
, O 0 2.108988880072677e-14
respectively O 0 8.470948653627446e-15
, O 0 2.256974874496247e-16
demonstrating O 0 1.099622407290269e-15
that O 0 5.174827089055164e-16
WD B-Disease 0 5.017022175479724e-08
cannot O 0 3.1022549980275205e-12
be O 0 1.9133173235867662e-14
homologous O 0 9.032538172276672e-13
to O 0 9.280862536820145e-12
CT B-Disease 1 0.9998142123222351
. O 0 7.892996256586571e-10

The O 0 5.373346624419628e-13
copper O 0 1.0332899813558782e-10
transport O 0 3.0188707436651363e-12
genes O 0 1.5962813015857336e-10
CTR1 O 0 1.5071051961967896e-07
and O 0 1.481338164112389e-12
CTR2 O 0 1.8348799812883954e-08
were O 0 1.737086819872391e-12
also O 0 2.6433130180135087e-14
excluded O 0 4.920391690117244e-14
as O 0 1.7669247040161002e-15
candidate O 0 2.428579832082587e-14
genes O 0 5.143064359808269e-12
for O 0 8.825486999194943e-13
CT B-Disease 1 0.9999954700469971
since O 0 3.257351610663761e-10
they O 0 4.356482215988125e-14
both O 0 2.9549472813300906e-15
mapped O 0 1.1447074191317519e-11
to O 0 1.2175716435514766e-13
canine O 0 5.286258542014366e-09
chromosome O 0 8.587849720242957e-08
region O 0 2.9201247642163253e-08
CFA11q22 O 0 7.12800829205662e-05
. O 0 4.986574486665063e-10

2 O 0 9.153529134664495e-08
- O 0 0.00020440299704205245
22 O 0 1.110112002322694e-09
. O 0 6.9043347428188184e-12

5 O 0 6.565056764884503e-08
. O 0 4.381006113440833e-10

A O 0 1.4915981783047982e-09
transcribed O 0 6.719124812093469e-09
sequence O 0 2.960288481360096e-12
identified O 0 9.310578349963627e-12
from O 0 4.0141372485095334e-14
the O 0 1.4955884566816152e-14
C04107 O 0 1.3849066338167404e-10
- O 0 8.227203640576164e-12
containing O 0 7.745740355537267e-13
BAC O 0 1.3215237792962853e-08
was O 0 1.7178776847218136e-12
found O 0 4.1786066523174376e-14
to O 0 1.5737422173731671e-16
be O 0 8.045036214960089e-17
homologous O 0 2.571017104251107e-15
to O 0 4.5408013286951654e-15
a O 0 1.343058693772936e-13
gene O 0 9.071635803659106e-11
expressed O 0 5.1031912257169104e-14
from O 0 1.0331932554787874e-14
human O 0 5.073384305709621e-15
chromosome O 0 5.069905606447378e-10
2p13 O 0 1.9943007245615263e-09
- O 0 2.738876903052301e-10
p16 O 0 9.864730143860356e-10
, O 0 1.910266107622849e-13
a O 0 8.264690879366751e-14
region O 0 3.0498804436812632e-12
devoid O 0 1.0367210562245432e-10
of O 0 9.340106948496976e-15
any O 0 1.8170820479789657e-13
positional O 0 7.010488300984719e-10
candidate O 0 1.8215716435232565e-10
genes O 0 8.340629520375842e-09
. O 0 1.6139245495594423e-10

Molecular O 0 4.380569518236399e-11
analysis O 0 4.0403427131741054e-12
of O 0 5.484001526341272e-16
the O 0 1.0180757502493715e-14
APC B-Disease 0 1.600243375310395e-11
gene O 0 9.829148779616492e-12
in O 0 3.458115141897339e-13
205 O 0 3.813355881066016e-13
families O 0 6.7597887872103066e-15
: O 0 2.4051517477944803e-15
extended O 0 1.9129140545887102e-12
genotype O 0 4.265105530976143e-07
- O 0 5.005207640351728e-06
phenotype O 0 7.652919720158025e-08
correlations O 0 1.6829265092610513e-08
in O 0 6.8509191375465406e-12
FAP B-Disease 0 2.876641633231536e-11
and O 0 1.3079627602825545e-15
evidence O 0 1.8589260346150733e-15
for O 0 1.915125281001967e-17
the O 0 7.15406260638636e-18
role O 0 2.6662850174111663e-15
of O 0 7.446632584015548e-17
APC B-Disease 0 1.1156376386947664e-12
amino O 0 5.630477637949549e-13
acid O 0 3.359363568572471e-12
changes O 0 8.633950325520612e-12
in O 0 0.0018854063237085938
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 1.3776144442090299e-05
. O 0 4.50186554701304e-11

BACKGROUND O 0 1.846650889092416e-06
/ O 0 8.787107930174898e-09
AIMS O 0 4.822724684883095e-12
The O 0 6.054029077096762e-15
development O 0 7.703577359352565e-12
of O 0 1.954065531606375e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.789495793641822e-13
a O 0 4.470624225498673e-15
variable O 0 9.135311322509831e-14
range O 0 1.9980050329059668e-13
of O 0 2.2730871140430944e-14
extracolonic O 0 3.381252255962863e-08
manifestations O 0 7.353142983390626e-09
in O 0 2.720491636409861e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 1.0
( O 0 1.218866003682706e-07
FAP B-Disease 0 3.678823290442779e-08
) O 0 3.2028503113568085e-12
is O 0 1.6247408217537514e-14
the O 0 4.0116001836621817e-16
result O 0 1.952930513431008e-14
of O 0 3.7189087428318463e-16
the O 0 2.6183889041339614e-14
dominant O 0 3.052661012858948e-09
inheritance O 0 2.3242591851158068e-06
of O 0 6.045924205722031e-09
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999953508377075
coli I-Disease 1 1.0
( O 0 3.5768358941368206e-08
APC B-Disease 0 9.80757164370516e-09
) O 0 1.7004639016326983e-11
gene O 0 2.360863859962592e-08
mutations O 0 5.4986141861945725e-08
. O 0 1.697897933361503e-10

In O 0 5.906063832439301e-12
this O 0 1.9045341001435075e-15
study O 0 1.810241121905738e-15
, O 0 3.498991196456048e-17
direct O 0 1.1616099724362332e-15
mutation O 0 2.9081839475648963e-13
analysis O 0 3.151377271116973e-13
of O 0 2.4760234180077213e-16
the O 0 2.186810370914845e-15
APC B-Disease 0 1.2491307901235649e-12
gene O 0 4.961163858202555e-12
was O 0 3.44716529626643e-12
performed O 0 1.772004784117258e-14
to O 0 7.149486411627145e-16
determine O 0 3.88593535604817e-13
genotype O 0 5.744621844883113e-08
- O 0 1.3985435316499206e-06
phenotype O 0 9.909958187392931e-09
correlations O 0 8.710132171074747e-09
for O 0 6.191139723284167e-13
nine O 0 1.5151949790334629e-12
extracolonic O 0 5.921285683996302e-10
manifestations O 0 6.696979776288359e-12
and O 0 9.412788304602026e-15
to O 0 5.02875625730116e-16
investigate O 0 1.993386839870947e-14
the O 0 5.556421784540331e-15
incidence O 0 6.516343714624284e-11
of O 0 1.2597528001225683e-14
APC B-Disease 0 1.0265207434079215e-10
mutations O 0 3.2175838382553223e-11
in O 0 7.201635121578676e-11
non O 1 0.9570809602737427
- O 1 0.999998927116394
FAP O 1 0.9999654293060303
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.7841405009508833e-10

METHODS O 0 5.277873693643187e-10
The O 0 8.51235043824311e-14
APC B-Disease 0 2.920048230992123e-11
gene O 0 6.320195061748635e-11
was O 0 2.2008322247968337e-11
analysed O 0 4.384590260309018e-11
in O 0 1.0886548552826308e-13
190 O 0 6.543588912909237e-13
unrelated O 0 1.8612252364325066e-11
FAP B-Disease 0 1.3103439444606124e-09
and O 0 9.611676688933701e-13
15 O 0 1.0974267501684398e-11
non O 1 0.6406269073486328
- O 1 0.9999997615814209
FAP O 1 0.9999984502792358
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.0614442658152257e-09
using O 0 4.3658341373521703e-13
denaturing O 0 8.445036314697063e-08
gradient O 0 2.6812957409916294e-10
gel O 0 1.615232037011083e-08
electrophoresis O 0 1.5994387758677675e-10
, O 0 1.8182146665547162e-14
the O 0 6.150532546629069e-17
protein O 0 3.176201096295565e-14
truncation O 0 2.7235290411820046e-11
test O 0 1.0538748346222704e-10
, O 0 9.241262438717136e-15
and O 0 1.013591706057373e-15
direct O 0 9.644138244079004e-14
sequencing O 0 1.421992523731319e-10
. O 0 4.674855641484399e-11

RESULTS O 0 4.311258849920563e-10
Chain O 0 1.1647805983616699e-11
terminating O 0 6.245311906516449e-11
signals O 0 2.4288106248437913e-11
were O 0 1.7647305329288737e-13
only O 0 6.187647677493181e-16
identified O 0 1.5425227555768833e-13
in O 0 6.778875827643735e-14
patients O 0 1.522504559119044e-15
belonging O 0 5.342906377877677e-15
to O 0 4.41013717921877e-15
the O 0 2.098512098954678e-14
FAP B-Disease 0 3.1972854919182225e-11
group O 0 5.900667324545972e-13
( O 0 2.67205745377308e-12
105 O 0 3.746437049478857e-10
patients O 0 8.991967725968664e-10
) O 0 1.6960221204884163e-12
. O 0 1.711625112477133e-11

Amino O 0 5.325352159246677e-09
acid O 0 4.0655787070242866e-10
changes O 0 4.257723934162315e-14
were O 0 8.273582353620669e-15
identified O 0 1.0193703384652961e-13
in O 0 1.589224899681968e-13
four O 0 1.1951975054189795e-13
patients O 0 1.283032789170177e-13
, O 0 2.6430443391626396e-15
three O 0 3.854433590876061e-15
of O 0 2.1015902537426916e-16
whom O 0 5.900802307716446e-13
belonged O 0 2.950999167250501e-11
to O 0 1.1608049862044806e-13
the O 0 1.4861511543964867e-13
non O 0 1.8687087433022498e-08
- O 0 3.0810782813972537e-09
FAP O 0 7.043070016088393e-10
group O 0 3.178424190508622e-11
of O 0 8.539134399576653e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 7.20461272862849e-08
. O 0 1.3927594971416268e-12

Genotype O 0 0.018319323658943176
- O 0 0.29026681184768677
phenotype O 0 1.3895919437345583e-07
correlations O 0 2.273717214507087e-09
identified O 0 4.657874086433367e-11
significant O 0 3.6852750126721567e-13
differences O 0 1.3860165792856094e-10
in O 0 2.471688652361248e-11
the O 0 3.6024434066502745e-15
nature O 0 8.949767061347882e-15
of O 0 4.972559856415574e-16
certain O 0 7.118958878339979e-14
extracolonic O 0 7.095060650108564e-10
manifestations O 0 1.9585726269977233e-12
in O 0 2.343688828079782e-12
FAP B-Disease 0 1.180114894694384e-10
patients O 0 1.3299515568693243e-12
belonging O 0 2.494495224530241e-13
to O 0 7.164140293372881e-14
three O 0 1.3116065308502178e-13
mutation O 0 2.9543107543661407e-11
subgroups O 0 1.6824699411444044e-09
. O 0 4.104456011178037e-11

CONCLUSIONS O 0 9.594148586700157e-09
Extended O 0 1.200724242256257e-10
genotype O 0 9.269731435779249e-07
- O 0 3.844510047201766e-06
phenotype O 0 1.1015365508626473e-08
correlations O 0 1.3602101667231636e-09
made O 0 2.1491276640250856e-12
in O 0 5.998572813600486e-14
this O 0 2.0350747416282816e-16
study O 0 7.781656111041473e-15
may O 0 2.6419282885513373e-13
have O 0 7.483798669205392e-16
the O 0 2.5562084537040396e-17
potential O 0 1.9897998247459144e-15
to O 0 1.9462360732356784e-15
determine O 0 2.02100841487432e-14
the O 0 2.760635593889349e-15
most O 0 5.794694270185334e-15
appropriate O 0 3.888802799743851e-14
surveillance O 0 4.4150590301772485e-12
and O 0 7.518053528625303e-15
prophylactic O 0 5.906954179263346e-12
treatment O 0 1.1245866027688803e-13
regimens O 0 8.624893876353623e-13
for O 0 3.5433439591566515e-17
those O 0 1.795762258342728e-16
patients O 0 1.2875697856268731e-14
with O 0 2.7318344487445634e-17
mutations O 0 8.246681332604866e-13
associated O 0 1.26120381499506e-12
with O 0 1.7616297147155652e-13
life O 0 9.348253421359587e-11
threatening O 0 2.52499972930309e-07
conditions O 0 1.8424270109562713e-08
. O 0 2.5243451426404384e-11

This O 0 1.2943048325816942e-13
study O 0 1.1387997139798538e-14
also O 0 1.3253502026375376e-16
provided O 0 4.208241992566371e-17
evidence O 0 7.090818262722352e-16
for O 0 2.033420876711543e-17
the O 0 5.179959513145484e-17
pathological O 0 1.4989475860625184e-13
nature O 0 3.3164990597008524e-15
of O 0 8.565044167309387e-16
amino O 0 8.35854497595323e-13
acid O 0 5.502828553070882e-13
changes O 0 1.732439366931241e-14
in O 0 1.1656462199551715e-13
APC O 0 6.372447708402618e-12
associated O 0 2.3298309353818325e-13
with O 0 1.0732983173554998e-14
both O 0 5.649992192852116e-13
FAP B-Disease 0 2.7991470252786144e-10
and O 0 3.723082606099659e-12
non O 1 0.991356372833252
- O 1 1.0
FAP O 1 0.9999963045120239
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 5.801963993690151e-07
. O 0 5.330419672279138e-14
. O 0 2.53434805693592e-13

Inherited B-Disease 1 0.9999996423721313
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.9999994039535522
and O 0 2.6314642909142094e-08
cancer B-Disease 0 5.451714173432265e-07
risk O 0 1.417725048469265e-09
of O 0 1.6210316433019011e-15
the O 0 7.167967527041755e-14
APC O 0 8.48390524499365e-10
I1307K O 0 2.2476605021637397e-09
polymorphism O 0 2.3152093575617982e-08
. O 0 5.7431118888340293e-11

Germ O 0 7.5681714406528044e-06
- O 0 3.2643129088683054e-05
line O 0 1.5006900166980586e-09
and O 0 2.5048604683497455e-13
somatic O 0 2.2860255355361403e-11
truncating O 0 6.336429991815606e-11
mutations O 0 1.8560743220152887e-11
of O 0 1.193474081362519e-15
the O 0 7.059348871149486e-16
APC B-Disease 0 5.220218788487552e-13
gene O 0 1.1641891877606225e-12
are O 0 5.428701074555644e-15
thought O 0 3.5561877336116876e-13
to O 0 2.7883186211330457e-14
initiate O 0 5.089178412021056e-09
colorectal B-Disease 1 1.0
tumor I-Disease 0 1.4115555302396388e-07
formation O 0 4.327158631411976e-10
in O 0 1.7466061308368808e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.1231869595794706e-07
sporadic O 1 0.9999185800552368
colorectal O 1 1.0
carcinogenesis O 0 3.428290074225515e-05
, O 0 7.790894318571162e-11
respectively O 0 7.214793346088655e-11
. O 0 2.7495729217758003e-12

Recently O 0 3.5034530831978827e-09
, O 0 6.538183622978311e-14
an O 0 5.679060720357966e-15
isoleucine O 0 8.444811072649827e-08
- O 0 1.7715970912490775e-09
- O 0 1.1042543768269297e-08
> O 0 1.368343910401748e-10
lysine O 0 2.2124426735103953e-09
polymorphism O 0 1.0355160062758273e-09
at O 0 5.8394608593026476e-12
codon O 0 1.0206836487114401e-09
1307 O 0 3.316039665079984e-10
( O 0 3.229680791468764e-13
I1307K O 0 1.2825740469679658e-11
) O 0 6.619061462804056e-15
of O 0 5.904945269740036e-17
the O 0 4.657480011300327e-16
APC B-Disease 0 1.196813156391363e-12
gene O 0 1.4146679704410414e-12
has O 0 2.2625620096954546e-15
been O 0 1.598073900527537e-16
identified O 0 7.63970948270765e-15
in O 0 1.211002157656526e-15
6 O 0 4.011066076449379e-15
% O 0 6.5392773119198055e-15
- O 0 8.654201660851513e-11
7 O 0 1.353910690157778e-12
% O 0 6.907700052152105e-14
of O 0 1.0589739314262455e-15
the O 0 3.0166285593623277e-14
Ashkenazi O 0 3.2444467251702136e-11
Jewish O 0 3.909822769362914e-13
population O 0 2.3347673756357948e-14
. O 0 4.039834005514775e-12

To O 0 1.1885486084911578e-12
assess O 0 9.564662430128212e-12
the O 0 6.690165220044845e-15
risk O 0 8.313168404529281e-13
of O 0 2.18425676510222e-17
this O 0 2.9730252937651023e-16
common O 0 1.0874123866980168e-12
APC B-Disease 0 1.2012373040715119e-10
allelic O 0 2.582504488035653e-10
variant O 0 1.214527571846702e-07
in O 0 6.059005954739405e-07
colorectal O 1 1.0
carcinogenesis O 0 1.3166859957891575e-07
, O 0 2.4715568133770738e-11
we O 0 9.74333257846606e-14
have O 0 9.154663272497514e-16
analyzed O 0 4.948919759780769e-14
a O 0 6.7344108330776205e-15
large O 0 6.606808199485781e-13
cohort O 0 2.7046160866461832e-09
of O 0 4.550948105776914e-14
unselected O 0 3.8119918599477387e-07
Ashkenazi O 0 2.7392664136982603e-08
Jewish O 0 4.2042116316087785e-11
subjects O 0 2.751432692793543e-10
with O 0 2.4652174290644424e-13
adenomatous B-Disease 0 8.673118401247848e-08
polyps I-Disease 0 1.6803786593300174e-06
and O 0 5.89669892775424e-12
. O 0 4.095890727279228e-12
or O 1 0.9999192953109741
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.5871769773034144e-13
for O 0 2.4279662096518605e-16
the O 0 4.615773697164301e-16
APC O 0 6.080194681068463e-11
I1307K O 0 7.620024056187447e-10
polymorphism O 0 1.2346017541631227e-08
. O 0 2.7806432503774126e-11

The O 0 7.037584057179025e-12
APC O 0 2.8518423178525154e-09
I1307K O 0 2.0218311469477612e-09
allele O 0 2.821439748501575e-10
was O 0 4.484637487756071e-12
identified O 0 9.700225648764937e-13
in O 0 2.498679601170995e-14
48 O 0 5.378091025363789e-14
( O 0 2.586615681842916e-14
10 O 0 7.205755869104432e-15
. O 0 8.555900976039369e-16
1 O 0 1.2761057029055545e-14
% O 0 2.784635383065205e-14
) O 0 2.4448559089772573e-14
of O 0 1.1396950278051016e-14
476 O 0 2.142597210763597e-10
patients O 0 2.1215407208785564e-10
. O 0 2.4770441774124574e-12

Compared O 0 1.9149201668788862e-10
with O 0 2.1033558145119044e-15
the O 0 1.265995665877893e-15
frequency O 0 4.724898315482118e-13
in O 0 4.699606047202376e-13
two O 0 1.844931144502301e-15
separate O 0 1.555598242247388e-15
population O 0 4.525544174202527e-17
control O 0 1.6691760007601225e-13
groups O 0 6.999073900743752e-15
, O 0 3.910260854803234e-14
the O 0 4.7872340450507214e-14
APC O 0 3.786515823112069e-10
I1307K O 0 1.6337527164456134e-10
allele O 0 1.480197908687586e-11
is O 0 1.2870713914407087e-14
associated O 0 3.4625995376080104e-15
with O 0 5.95679956797976e-17
an O 0 7.034157317204755e-17
estimated O 0 1.1454045380893639e-14
relative O 0 2.5122107085578937e-12
risk O 0 3.4263303305692716e-10
of O 0 1.1222916178202716e-13
1 O 0 4.579900000911685e-11
. O 0 5.095894539675072e-11

5 O 0 1.0441005571237838e-07
- O 0 5.4397974054154474e-06
1 O 0 1.890063938692066e-10
. O 0 2.0060756875106556e-11

7 O 0 1.6501491728604378e-08
for O 0 3.785690511071138e-11
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 9.608894657731071e-08
( O 0 5.610915378151393e-12
both O 0 2.0649042371811976e-12
P O 0 2.320689964108169e-05
= O 0 7.043785554827764e-09
. O 0 3.017732244647853e-11
01 O 0 3.5899365702363184e-09
) O 0 5.037445720973421e-12
. O 0 9.936403262689186e-12

Furthermore O 0 4.7938198549646316e-11
, O 0 2.1802655167380003e-13
compared O 0 8.991760921993677e-14
with O 0 1.8447693612093754e-15
noncarriers O 0 9.655347632531175e-10
, O 0 3.661968392908686e-14
APC O 0 4.863127695681202e-12
I1307K O 0 9.799498018603359e-12
carriers O 0 4.818669768757999e-12
had O 0 1.8317014571778145e-12
increased O 0 4.606103841983504e-14
numbers O 0 1.3745413498817555e-13
of O 0 1.4119599620629562e-14
adenomas B-Disease 1 0.6023273468017578
and O 0 0.18268418312072754
colorectal B-Disease 1 1.0
cancers I-Disease 0 3.7324118693504715e-06
per O 0 4.17342028991019e-11
patient O 0 3.449484031747829e-10
( O 0 4.579775361029936e-12
P O 0 5.3455678425962105e-06
= O 0 6.079826087024287e-10
. O 0 1.492979242838366e-12
03 O 0 1.0561023583433027e-10
) O 0 5.026019409145287e-14
, O 0 1.2413156033662734e-14
as O 0 1.6425441625797922e-15
well O 0 1.9637842665621826e-15
as O 0 2.6193665919133297e-15
a O 0 2.36378218431213e-13
younger O 0 1.9374916601644365e-11
age O 0 7.730006955711244e-13
at O 0 4.151133430052578e-12
diagnosis O 0 1.3023282452451213e-09
. O 0 5.359960305456601e-12

We O 0 2.5399207043141914e-11
conclude O 0 2.5541290003122663e-12
that O 0 2.720427628097457e-16
the O 0 3.861775672462861e-16
APC O 0 5.155567379261372e-12
I1307K O 0 6.816170024237511e-12
variant O 0 4.1669953598777454e-10
leads O 0 3.390325346852574e-12
to O 0 2.732934592606512e-13
increased O 0 1.4323351393841222e-08
adenoma B-Disease 1 1.0
formation O 0 1.2580372941300988e-12
and O 0 2.8681986137952782e-15
directly O 0 1.264301097057572e-16
contributes O 0 2.9920725236500098e-15
to O 0 3.0726456327850686e-16
3 O 0 5.042013169958637e-15
% O 0 2.181836762855157e-14
- O 0 3.258213837620261e-11
4 O 0 9.844335497602094e-14
% O 0 4.1997326704614965e-14
of O 0 3.0061216238714064e-15
all O 0 2.4277520098425764e-13
Ashkenazi O 0 1.0914148873553131e-07
Jewish O 0 2.0686238713096827e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.1185322940375784e-10

The O 0 1.1548467531655865e-13
estimated O 0 8.692966322904755e-14
relative O 0 5.961278562796601e-13
risk O 0 8.119541280646181e-13
for O 0 8.102232776467926e-16
carriers O 0 5.897857723036193e-12
may O 0 3.28932519243208e-13
justify O 0 4.323132157162471e-14
specific O 0 2.8231068148481956e-15
clinical O 0 4.284691904662269e-13
screening O 0 1.025204294830169e-13
for O 0 3.681796788341287e-17
the O 0 5.040565683296008e-17
360 O 0 1.3382659780694639e-14
, O 0 3.4700290224070555e-16
000 O 0 1.3499298546872161e-15
Americans O 0 7.542322822509152e-16
expected O 0 2.4342747734001566e-14
to O 0 3.3359088990965235e-17
harbor O 0 2.587816029173129e-13
this O 0 1.0245107019013098e-16
allele O 0 1.2084981453053256e-12
, O 0 5.503035838973734e-14
and O 0 1.3282668388304216e-14
genetic O 0 9.000451425822398e-12
testing O 0 8.844331517154913e-12
in O 0 5.835258085106279e-14
the O 0 9.423058367329248e-16
setting O 0 1.3762299947654016e-14
of O 0 1.5223527284632487e-16
long O 0 9.729005795433565e-12
- O 0 1.6725703044784268e-09
term O 0 1.5958803167848146e-09
- O 0 2.4749060439921422e-11
outcome O 0 5.692598085624279e-14
studies O 0 1.0905709793345916e-13
may O 0 1.5032845980403678e-14
impact O 0 5.261981781833243e-14
significantly O 0 2.381221331226868e-10
on O 0 0.093673475086689
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 6.999385515626955e-10
in O 0 1.6489862928359585e-14
this O 0 6.113506883620012e-16
population O 0 5.116317441190626e-15
. O 0 2.55202543125721e-12

Localization O 0 1.3435795587213306e-08
of O 0 5.06696337245296e-15
human O 0 5.506098286594532e-15
BRCA1 O 0 6.804252716818837e-10
and O 0 2.5159832984372743e-13
its O 0 7.725989952780867e-15
loss O 0 2.4504280982801108e-12
in O 0 5.758498278912727e-12
high O 0 3.599777542717675e-08
- O 0 1.4891820683260448e-06
grade O 0 1.033098783409514e-06
, O 0 1.4268304419917666e-11
non B-Disease 0 0.06771235913038254
- I-Disease 1 0.6697177886962891
inherited I-Disease 1 0.9998470544815063
breast I-Disease 1 0.9999914169311523
carcinomas I-Disease 1 1.0
. O 0 4.89709073292488e-09

Although O 0 5.147586458649489e-13
the O 0 5.828099132042675e-16
link O 0 8.001270544559513e-13
between O 0 2.989792522714238e-14
the O 0 1.453875648343983e-12
BRCA1 O 1 0.999363124370575
tumour B-Disease 1 1.0
- O 0 2.5693447369690148e-08
suppressor O 0 1.743170763290891e-08
gene O 0 4.8349658499091674e-08
and O 0 4.788613949813225e-10
hereditary B-Disease 1 0.9999995231628418
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.196949576129716e-13
established O 0 6.062906660010345e-14
, O 0 2.1978662684588816e-15
the O 0 9.865448323208e-17
role O 0 1.1878296740305827e-13
, O 0 4.873743298722992e-15
if O 0 2.0542780373337206e-16
any O 0 1.0602594098028223e-15
, O 0 3.61513619536488e-15
of O 0 3.84812891289141e-16
BRCA1 O 0 2.6616948645141747e-09
in O 0 1.2313274844188982e-09
non B-Disease 0 0.23808573186397552
- I-Disease 0 0.015733150765299797
familial I-Disease 0 0.0002644588821567595
cancers I-Disease 0 0.00023723910271655768
is O 0 2.146289916626909e-11
unclear O 0 4.0545358737098525e-10
. O 0 2.231652015960428e-11

BRCA1 O 0 0.00014662327885162085
mutations O 0 1.9240310678014794e-08
are O 0 2.2209543232287743e-12
rare O 0 1.574034479145947e-11
in O 0 3.090250624837587e-11
sporadic B-Disease 0 4.97765086038271e-06
cancers I-Disease 0 1.6504865925526246e-05
, O 0 4.798409933282066e-12
but O 0 4.345530012217491e-13
loss O 0 2.000576137042853e-12
of O 0 4.0622953702531476e-16
BRCA1 O 0 4.856646640405415e-09
resulting O 0 2.493591270968931e-13
from O 0 7.321831400723677e-14
reduced O 0 2.4742441168817964e-12
expression O 0 5.18079990800141e-13
or O 0 6.386948804039394e-13
incorrect O 0 7.109551836137484e-11
subcellular O 0 2.016704803153857e-09
localization O 0 2.500400997362817e-10
is O 0 3.581178644509455e-15
postulated O 0 7.078879989781336e-14
to O 0 1.8971452199863714e-15
be O 0 1.0055733745413086e-15
important O 0 4.2417372884257214e-15
in O 0 7.90000280904285e-13
non B-Disease 0 4.321366759540979e-06
- I-Disease 0 3.2027346605900675e-05
familial I-Disease 1 0.9999853372573853
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 1.7993609380262399e-10

Epigenetic O 0 2.5296563421761675e-07
loss O 0 2.646665819838745e-08
, O 0 6.258804238767901e-13
however O 0 1.7290986689872702e-14
, O 0 3.068584205094191e-14
has O 0 2.738693840665437e-14
not O 0 6.689268529791058e-16
received O 0 3.0412511295126524e-14
general O 0 2.110790646206429e-15
acceptance O 0 1.4244204774027658e-12
due O 0 2.1330322490936693e-13
to O 0 6.901059059735747e-15
controversy O 0 1.4671038906302614e-13
regarding O 0 3.249315625049841e-14
the O 0 1.999669029130848e-15
subcellular O 0 8.173965670987826e-11
localization O 0 2.3095912335402424e-11
of O 0 3.3345492788672824e-16
BRCA1 O 0 4.8644477335102465e-11
proteins O 0 1.5703563937489312e-13
, O 0 2.098500071086827e-14
reports O 0 8.11678063086449e-14
of O 0 8.878208923870451e-18
which O 0 3.8419392196293494e-16
have O 0 7.218631616935645e-15
ranged O 0 1.789750259887507e-13
from O 0 2.3174279335791415e-15
exclusively O 0 6.369521321378203e-15
nuclear O 0 4.506751742627824e-12
, O 0 5.4225677089845756e-14
to O 0 3.881138845637094e-15
conditionally O 0 2.827691856707726e-12
nuclear O 0 2.1517473404192994e-13
, O 0 5.4082384526158746e-15
to O 0 5.038376963395193e-16
the O 0 1.0460788458328471e-13
ER O 0 3.7099655969541345e-07
/ O 0 2.4610491422549785e-10
golgi O 0 6.302887656239875e-10
, O 0 1.42299149893943e-13
to O 0 1.50256512825497e-14
cytoplasmic O 0 4.955286736496589e-10
invaginations O 0 2.1619344536816243e-08
into O 0 1.0549838997189753e-12
the O 0 8.54951485583684e-14
nucleus O 0 1.9656694674741182e-11
. O 0 4.452794469950172e-12

In O 0 2.0008709966656824e-11
an O 0 3.301830566636776e-15
attempt O 0 7.027158260668187e-13
to O 0 1.4883695675666636e-13
resolve O 0 1.6204971392541623e-11
this O 0 1.0177145754006623e-14
issue O 0 1.2335406134045268e-11
, O 0 2.125725675128018e-13
we O 0 1.817507394043759e-14
have O 0 2.346624100479813e-15
comprehensively O 0 7.061975570293866e-12
characterized O 0 1.359206529879392e-13
19 O 0 8.519712713095373e-13
anti O 0 1.3357390193924346e-10
- O 0 3.636632661674355e-10
BRCA1 O 0 5.20763920874856e-09
antibodies O 0 2.2742929761676578e-10
. O 0 2.608020743810613e-11

These O 0 2.788667300551717e-12
reagents O 0 1.30048263824456e-11
detect O 0 7.1207176439991304e-12
a O 0 1.7139885160038365e-13
220 O 0 7.190897616943248e-12
- O 0 1.752837736068713e-10
kD O 0 7.722330330750538e-09
protein O 0 3.524864428117169e-11
localized O 0 1.0003802647373661e-10
in O 0 8.959186474297165e-13
discrete O 0 1.8835133105965518e-11
nuclear O 0 1.782802655503346e-10
foci O 0 5.211285625250639e-09
in O 0 1.350378836528776e-10
all O 0 7.616113685895987e-14
epithelial O 0 4.743029428412593e-13
cell O 0 2.6340829517579323e-10
lines O 0 4.811995246711831e-11
, O 0 3.1464610071878143e-15
including O 0 1.569216282107971e-16
those O 0 8.311914459071748e-17
derived O 0 7.339364982731841e-14
from O 0 6.532584195806379e-11
breast B-Disease 0 7.830474402226173e-08
malignancies I-Disease 0 7.435665452248941e-07
. O 0 8.857558575492419e-10

Immunohistochemical O 0 9.274627700506244e-06
staining O 0 1.3536276810555137e-06
of O 0 6.745859296511392e-13
human O 0 5.873012579732384e-13
breast O 0 5.865523622361479e-09
specimens O 0 7.058238993273847e-10
also O 0 6.4540603764151605e-12
revealed O 0 4.351226323695556e-10
BRCA1 O 0 5.543501629290404e-06
nuclear O 0 7.21247461754615e-09
foci O 0 8.971055649453774e-07
in O 0 3.8788567913172756e-09
benign O 1 0.9658180475234985
breast O 0 0.027480678632855415
, O 0 7.918494748793137e-10
invasive B-Disease 0 0.02509753406047821
lobular I-Disease 1 0.9999892711639404
cancers I-Disease 1 0.9999898672103882
and O 0 5.820691129088118e-08
low B-Disease 1 0.9999845027923584
- I-Disease 1 0.9999611377716064
grade I-Disease 0 0.01400341559201479
ductal I-Disease 1 0.9994433522224426
carcinomas I-Disease 1 1.0
. O 0 8.475466550805777e-09

Conversely O 0 3.3698419610317387e-09
, O 0 2.388697096025738e-12
BRCA1 O 0 8.54479242917705e-09
expression O 0 4.436365337590065e-12
was O 0 8.900888706642185e-12
reduced O 0 1.3311588973035499e-13
or O 0 2.3238958771643753e-14
undetectable O 0 1.7505039301771164e-12
in O 0 4.762641375163435e-15
the O 0 9.877536409807605e-17
majority O 0 1.3181507666930109e-15
of O 0 7.546471484005685e-15
high O 0 2.5494555302429944e-06
- O 0 0.02969978377223015
grade O 0 1.2585962849698262e-06
, O 0 8.598240175405891e-12
ductal B-Disease 0 1.644352960283868e-05
carcinomas I-Disease 1 1.0
, O 0 7.541960220409927e-13
suggesting O 0 3.5893764089439673e-12
that O 0 3.420314382331655e-15
absence O 0 5.3041623285406125e-14
of O 0 1.4424457578016462e-16
BRCA1 O 0 1.923824433092136e-09
may O 0 7.521431936476086e-13
contribute O 0 3.805836822532799e-16
to O 0 1.0655827339436298e-16
the O 0 3.4085381362055375e-16
pathogenesis O 0 3.134819064488231e-13
of O 0 2.0344295407504902e-17
a O 0 1.483912954536662e-14
significant O 0 3.2827709734589705e-12
percentage O 0 7.450331196423576e-08
of O 0 7.481701889966441e-12
sporadic B-Disease 1 0.9952898025512695
breast I-Disease 0 0.0156415868550539
cancers I-Disease 0 6.765621219528839e-05
. O 0 1.3818986233093966e-10
. O 0 2.845878567525606e-11

